PREFERRED_AB	VARIANT_AB	EXPANSION
+dP/dt	+dP/dt:18|+dp/dt:3	contractility
+dP/dt	+dP/dt:6	rate of left ventricular pressure development
1,5-AG	1,5-AG:10|1,5AG:3	anhydrodglucitol
1,5-AG	1,5-AG:14|1,5AG:11	anhydroglucitol
14C	14C:8	labeled with radioactive carbon
14C	14C:10	radiocarbon
15N'	15N':28	n excess
15N'	15N':10	atom nexcess
17-KS	17-KS:38|17KS:2	ketosteroids
17-KS	17-KS:11|17KS:1	urinary ketosteroid
17-OHP	17-OHP:83|17OHP:22|17-OH-P:3|17OH-P:2	 alphahydroxyprogesterone
17-OHP	17-OHP:11|17-OH-P:10|17OHP:2|17OH-P:1	ohprogesterone
1RM	1RM:49|1-RM:1	 repetition maximum
1RM	1RM:31|1-RM:13	one repetition maximum
2,3-DPG	2,3-DPG:291|2,3DPG:6	diphosphoglycerate
2,3-DPG	2,3-DPG:8	diphosphoglycerate concentration
2,4-D	2,4-D:39|2,4-d:2	dichlorophenoxyacetate
2,4-D	2,4-D:462|2,4D:4|2,4-d:3	dichlorophenoxyacetic acid
2-AG	2-AG:87|2AG:1	arachidonoylglycerol
2-AG	2-AG:31	arachidonylglycerol
2-APB	2-APB:47|2APB:5	aminoethoxydiphenyl borate
2-APB	2-APB:8	aminoethyl diphenylborate
2DE	2DE:14|2-DE:6	twodimensional
2DE	2DE:9|2-DE:1	twodimensional echocardiograms
2DE	2DE:16|2-DE:6	twodimensional echocardiographic
2-DG	2-DG:9|2DG:2	cdeoxydglucose
2-DG	2-DG:6|2DG:3	hdeoxyglucose
2-PAM	2-PAM:8	pyridine aldoxime methiodide
2-PAM	2-PAM:4	pyridine aldoxime methochloride
2-PAM	2-PAM:8	pralidoxime chloride
2-PAM	2-PAM:5	pyridinealdoxime methochloride
2PN	2PN:8	two pronuclear
2PN	2PN:5|2-PN:1	two pronuclei
2VO	2VO:3|2-VO:1|2-vo:1	carotid artery occlusion
2VO	2VO:1	permanent bilateral occlusion of common carotid arteries
2VO	2VO:6	permanent occlusion of bilateral common carotid arteries
2C	2C:25|2c:15	diploid
2C	2C:5	diploid cells
32P	32P:48|32-P:2|32p:1	radioactive phosphorus
32P	32P:11	radiophosphorus
3-CLT	3-CLT:8|3CLT:4	lissajous trajectory
3-CLT	3-CLT:4|3CLT:3	threechannel lissajous trajectories
3D-CRT	3D-CRT:39|3DCRT:26|3-DCRT:3	threedimensional conformal radiation therapy
3D-CRT	3D-CRT:69|3DCRT:25|3-D-CRT:1|3-DCRT:1	threedimensional conformal radiotherapy
3D-CT	3D-CT:20|3DCT:9|3-D-CT:2|3-DCT:2	threedimensional computed tomography
3D-CT	3D-CT:9|3DCT:2|3-DCT:1	threedimensional ct
3DFT	3DFT:12	fourier transformation
3DFT	3DFT:21|3-DFT:3	threedimensional fourier transform
3MS	3MS:13	modified minimental state
3MS	3MS:9|3-MS:1	modified minimental state exam
3MS	3MS:20	modified minimental state examination
3D	3D:29|3-D:10	three dimensions
3D	3D:10|3-D:4	threedimensionally
3D	3D:8|3-D:5	tridimensional
3H	3H:18|3-H:1	tritiated
3H	3H:28	tritium
4-AP	4-AP:5	 mmaminopyridine
4-AP	4-AP:11	aminophenol
4-DAMP	4-DAMP:22	diphenylacetoxynmethylpiperidine
4-DAMP	4-DAMP:50|4DAMP:2	diphenylacetoxynmethylpiperidine methiodide
4-DAMP	4-DAMP:11	diphenylacetoxynmethylpiperidine methobromide
4E-BP1	4E-BP1:8	eifebinding protein
4E-BP1	4E-BP1:6	eukaryotic initiation factor ebinding protein
4-HBA	4-HBA:10|4HBA:4	hydroxybenzoate
4-HBA	4-HBA:8|4HBA:2	hydroxybenzoic acid
4-HPR	4-HPR:12	hydroxyphenylretinamide
4-HPR	4-HPR:44|4HPR:11	fenretinide
4-OHA	4-OHA:8|4-OH-A:7	hydroxyandrostenedione
4-OHA	4-OHA:5|4OHA:4	hydroxyantipyrine
5-ALA	5-ALA:24	aminolaevulinic acid
5-ALA	5-ALA:78|5-Ala:1	aminolevulinic acid
5-ASA	5-ASA:15|5ASA:1	aminosalicylate
5-ASA	5-ASA:9	mesalamine
5-ASA	5-ASA:14	mesalazine
5-CT	5-CT:190|5CT:2	carboxamidotryptamine
5-CT	5-CT:17	carboxyamidotryptamine
5-FC	5-FC:156|5FC:58|5-Fc:4|5-fc:1	fluorocytosine
5-FC	5-FC:40|5FC:27	flucytosine
5-HIAA	5-HIAA:206|5HIAA:32|5hiaa:1	hydroxyindole acetic acid
5-HIAA	5-HIAA:11|5HIAA:1	hydroxyindoleacetic
5-HT3	5-HT3:19|5HT3:2	hydroxytryptamine type 
5-HT3	5-HT3:12|5HT3:3	serotonin receptor
5-HTP	5-HTP:41|5HTP:2	hydroxyltryptophan
5-HTP	5-HTP:11	hydroxytryptophane
5-HTT	5-HTT:4	ht transporters
5-HTT	5-HTT:1	serotonin ht transporter
5-HT	5-HT:7|5HT:2	chydroxytryptamine
5-HT	5-HT:9	hydroxytrypamine
5-HT	5-HT:25|5HT:1	central serotonergic
5-HT	5-HT:10|5HT:1	serotonine
5-HT	5-HT:65|5HT:9	serotoninergic
5-TG	5-TG:10|5TG:9|5-T-G:3	thiodglucose
5-TG	5-TG:6|5TG:4	thioglucose
6MWD	6MWD:11|6-MWD:1	min walking distance
6MWD	6MWD:29|6-MWD:2|6mwD:1|6MWd:1	walk distance
6MWD	6MWD:6	walking distance test
8-SPT	8-SPT:13|8SPT:1	psulfophenyltheophylline
8-SPT	8-SPT:10|8SPT:4	sulfophenyltheophylline
8-oxodG	8-oxodG:10	hydrooxodeoxyguanosine
8-oxodG	8-oxodG:4|8-oxo-dG:4	formation of dihydrooxodeoxyguanosine
9-AC	9-AC:9|9AC:3	aminoscamptothecin
9-AC	9-AC:48|9AC:9	aminocamptothecin
A&E	A&E:654	accident and emergency
A&E	A&E:40	accidentemergency
A23187	A23187:20	calcium ionophore a
A23187	A23187:4	ionophore calcimycin
A549	A549:6	human alveolar epithelial
A549	A549:15	human alveolar epithelial cells
A549	A549:17	human lung epithelial
A549	A549:14|A-549:2	lung adenocarcinoma
A6	A6:12	distal nephron cell line
A6	A6:5	distal nephron epithelium
A6	A6:11	kidney cells
AA-2G	AA-2G:17	oalphadglucopyranosyllascorbic acid
AA-2G	AA-2G:10	ascorbic acid oalphaglucoside
AAA	AAA:7	abdominal aortic aneurysm repair
AAA	AAA:6	aleuria aurantia agglutinin
AAA	AAA:8	anguilla anguilla agglutinin
AAA	AAA:5	antialbumin antibodies
AAA	AAA:5	autolyzed antigenextracted allogeneic
AAA	AAA:14	cellular activities
AACN	AACN:13	american association of colleges of nursing
AACN	AACN:9	atypical acinar cell nodules
AAC	AAC:48	adpatp carrier
AAC	AAC:14	antibioticassociated colitis
AAC	AAC:1	area above curve
AAC	AAC:52	augmentative and alternative communication
AAD	AAD:25	acute aortic dissection
AAD	AAD:13	american academy of dermatology
AAD	AAD:31	antibioticassociated diarrhea
AAH	AAH:15	acute alcoholic hepatitis
AAH	AAH:126	atypical adenomatous hyperplasia
AAI	AAI:52	adult attachment interview
AAI	AAI:11	agrobacterium autoinducer
AAI	AAI:18|AA-I:5	aristolochic acid i
AAMI	AAMI:5	acute anterior myocardial infarction
AAMI	AAMI:52	ageassociated memory impairment
AAMI	AAMI:66	association for the advancement of medical instrumentation
AAM	AAM:12	africanamerican men
AAM	AAM:14	aggressive angiomyxoma
AAPCC	AAPCC:23	adjusted average per capita cost
AAPCC	AAPCC:19	american association of poison control centers
AAP	AAP:16	alanineaminopeptidase
AAP	AAP:199	american academy of pediatrics
AAP	AAP:12	aminopeptidase from aeromonas proteolytica
AAP	AAP:8	amplitude of the action potential
AAP	AAP:10	antiarrhythmic peptide
AAR	AAR:13	active anterior rhinomanometry
AAR	AAR:11	rejection
AAS	AAS:7	aids attitude scale
AAS	AAS:4	alcohol abstinence syndrome
AAs	AAs:16	anaplastic astrocytomas
AAS	AAS:5	aplastic anemia serum
AAs	AAs:10	aromatic amines
AAS	AAS:157	atomic absorption spectrometry
AAS	AAS:14	transacetylaminostilbene
AAT	AAT:15	aachen aphasia test
AAT	AAT:16	acute acoustic trauma
AAT	AAT:12	animalassisted therapy
AAV	AAV:65	adenoassociated viral
AAV	AAV:26	adenoassociated virus 
AAN	AAN:9	alphaamino nitrogen
AAN	AAN:27	american academy of neurology
AAN	AAN:6	amino acid nitrogen
AAN	AAN:21|AAn:1	aminoacetonitrile
AAN	AAN:9	analgesicassociated nephropathy
AAN	AAN:8	aristolochic acid nephropathy
AAO	AAO:18	age at onset
AAO	AAO:8	anodic aluminum oxide
AA	AA:10	active avoidance
AA	AA:26	acupuncture analgesia
AA	AA:34|aA:1	acute appendicitis
AA	AA:17	adjuvant arthritic
AA	AA:206	adjuvant arthritis
AA	AA:7	adjuvantinduced arthritic
AA	AA:17	adrenal androgen
AA	AA:5	adrenal autoantibodies
AA	AA:9	afferent arteriolar
AA	AA:8	aggregative adherence
AA	AA:9	alcohol abuse
AA	AA:16	alcoholpreferring
AA	AA:2	alcoholpreferring alko alcohol
AA	AA:14|aA:1	allergic asthma
AA	AA:27	allyl alcohol
AA	AA:164|Aa:2	alopecia areata
AA	AA:8	ambient air
AA	AA:6|aa:4	aminoacid
AA	AA:13	amyloid angiopathy
AA	AA:1	amyloid protein
AA	AA:10	androgen ablation
AA	AA:141	aplastic anaemia
AA	AA:357|Aa:1	aplastic anemia
AA	AA:64	arachidonate
AA	AA:45	arachidonic
AA	AA:3321|Aa:4	arachidonic acid
AA	AA:42	aromatase activity
AA	AA:6	ascaris antigen
AA	AA:22	atomic absorption
AA	AA:8	atopic asthmatic
AA	AA:19	normal haemoglobin
AA	AA:14	rats with adjuvantinduced arthritis
AA	AA:27	secondary
AA	AA:8	secondary amyloidosis
Ab3	Ab3:8|AB3:1	antiantiid
Ab3	Ab3:14|ab3:7|Ab-3:2	antiantiidiotypic
ABA	ABA:721	abscisic acid
ABA	ABA:10	activitybased anorexia
ABA	ABA:9	atopic bronchial asthma
ABA	ABA:6	hapten azobenzenearsonate
ABCA1	ABCA1:14	atpbinding cassette transporter 
ABCA1	ABCA1:5	cassette transporter
ABC	ABC:17	active breathing control
ABC	ABC:26	activitybased costing
ABC	ABC:14	activitiesspecific balance confidence
ABC	ABC:8	activitiesspecific balance confidence scale
ABC	ABC:7	adenoid basal carcinoma
ABC	ABC:49	advanced breast cancer
ABC	ABC:4	advanced breast carcinoma
ABC	ABC:27	antibody binding capacity
ABC	ABC:14	antigenbinding cells
ABC	ABC:23	argon beam coagulator
ABC	ABC:31	aspiration biopsy cytology
ABC	ABC:36	behavior checklist
ABD	ABD:17|Abd:4	abdominal
ABD	ABD:15	actinbinding domain
ABD	ABD:27	adynamic bone disease
ABD	ABD:18	autologous blood donation
ABD	ABD:24	automated border detection
ABD	ABD:6	automatic boundary detection
ABG	ABG:25	airbone gap
ABG	ABG:99	arterial blood gas
ABG	ABG:11	atrophic body gastritis
ABI	ABI:137	anklebrachial index
ABI	ABI:9	ankle brachial indices
ABI	ABI:10	applied biosystems
ABI	ABI:16	atherothrombotic brain infarction
ABI	ABI:39	auditory brainstem implant
ABL	ABL:4	acute basophilic leukemia
ABL	ABL:8	agaricus bisporus lectin
ABL	ABL:7	alveolar bone level
ABL	ABL:28	alveolar bone loss
ABL	ABL:9	antigenbinding lymphocytes
ABL	ABL:8	patients with abetalipoproteinemia
ABMS	ABMS:15	american board of medical specialties
ABMS	ABMS:10	autologous bone marrow support
ABMT	ABMT:21|A-BMT:1	autologous bmt
ABMT	ABMT:15	autologous bone marrow
ABMT	ABMT:58|aBMT:1|-ABMT:1	autologous bone marrow transplant
ABP1	ABP1:15	auxinbinding protein
ABP1	ABP1:10|ABP-1:1	auxinbinding protein 
ABPM	ABPM:12	allergic bronchopulmonary mycosis
ABPM	ABPM:9	ambulatory blood pressure monitor
ABPM	ABPM:453	ambulatory blood pressure monitoring
ABP	ABP:24	acute biliary pancreatitis
ABP	ABP:6	albuminbinding proteins
ABP	ABP:39|aBP:1	ambulatory bp
ABP	ABP:11	human bladder carcinogen aminobiphenyl
ABRM	ABRM:12|abrm:1	anterior byssal retractor muscle
ABRM	ABRM:34	anterior byssus retractor muscle
ABR	ABR:17	american board of radiology
ABR	ABR:12	auditory brainstem
ABR	ABR:7	response testing
ABS	ABS:12	acrylonitrilebutadienestyrene
ABS	ABS:9	acute bacterial sinusitis
ABS	ABS:28	adaptive behavior scale
ABS	ABS:7	adult bovine serum
ABs	ABs:13	alveolar buds
ABS	ABS:14	american board of surgery
ABS	ABS:20	american brachytherapy society
ABS	ABS:16	amniotic band syndrome
ABS	ABS:12	antleybixler syndrome
ABs	ABs:10	apoptotic bodies
ABS	ABS:5	aqueous biphasic systems
ABs	ABs:18	asbestos bodies
ABS	ABS:31	australian bureau of statistics
ABT	ABT:7	allogeneic blood transfusions
ABT	ABT:42	aminopyrine breath test
ABT	ABT:33	blood transfusion
ABZSO	ABZSO:17|ABZ-SO:3	albendazole sulfoxide
ABZSO	ABZSO:25|ABZ-SO:6	albendazole sulphoxide
AB	AB:45|A-B:2	ablebodied
AB	AB:8	acute bronchitis
AB	AB:79	alcian blue
AB	AB:9	amobarbital
AB	AB:29	anterior burster
AB	AB:9|Ab:1	aortic banding
AB	ab:4|AB:4|A-B:3|a-b:2	apicaltobasolateral
AB	AB:53	attentional blink
AB	AB:6	autogenous bone
AB	AB:20	autologous blood
AB	AB:13	autonomic blockade
AC/A	AC/A:16	accommodative convergenceaccommodation
AC/A	AC/A:8	accommodative convergence to accommodation
ACB	ACB:46	antibodycoated bacteria
ACB	ACB:20	aortocoronary bypass
ACCESS	ACCESS:17	access to community care and effective services and supports
ACCESS	ACCESS:7	case control etiologic study of sarcoidosis
ACC	ACC:112	aminocyclopropanecarboxylate
ACC	ACC:8	accident compensation corporation
ACC	ACC:45	adrenocortical carcinoma
ACC	ACC:40	agenesis of the corpus callosum
ACC	ACC:37	american college of cardiology
ACC	ACC:273|acc:1|ACc:1	anterior cingulate cortex
ACC	ACC:14	antibodycontaining cells
ACC	ACC:27	aplasia cutis congenita
ACC	ACC:13	articular chondrocalcinosis
ACD	ACD:38	active compressiondecompression
ACD	ACD:208	allergic contact dermatitis
ACD	ACD:10	alveolar capillary dysplasia
ACD	ACD:47	anemia of chronic disease
ACD	ACD:11	anterior cervical discectomy
ACD	ACD:107	anterior chamber depth
ACD	ACD:9	available chemicals directory
ACD	ACD:21	chronic disorders
ACE	ACE:9	addenbrookes cognitive examination
ACE	ACE:61	affinity capillary electrophoresis
ACE	ACE:10|ACe:9	amygdaloid central nucleus
ACE	ACE:8	angiotensin converting enzyme gene
ACE	ACE:23	antegrade continence enema
ACE	ACE:6	arm crank ergometer
ACE	ACE:5	arm crank ergometry
ACE	ACE:3	cyclophosphamide and etoposide
ACFs	ACFs:15	aberrant crypt foci
ACFs	ACFs:9	activated carbon fibers
ACF	ACF:11	aberrant crypt focus
ACF	ACF:9	activated carbon fiber
ACF	ACF:30	aortocaval fistula
ACF	ACF:12|acf:1	apobec complementation factor
ACF	ACF:20	autocorrelation function
ACF	ACF:3	corpectomy and fusion
ACG	ACG:8|Acg:3	acycloguanosine
ACG	ACG:5	ambulatory care group
ACG	ACG:9	american college of gastroenterology
ACG	ACG:14|Acg:1|acg:1	anterior cingulate gyrus
ACG	ACG:17	apexcardiogram
ACI	ACI:13	acute cardiac ischemia
ACI	ACI:10	acute coronary insufficiency
ACI	ACI:10	andersen cascade impactor
ACI	ACI:11	aortic calcification index
ACI	ACI:27	autologous chondrocyte implantation
ACM	ACM:28	aclacinomycin
ACM	ACM:9	aclacinomycina
ACM	ACM:9	alcoholic cardiomyopathy
ACM	ACM:13	anterior chamber maintainer
ACM	ACM:25	arnoldchiari malformation
ACM	ACM:8	asbestoscontaining materials
ACM	ACM:23	astrocyteconditioned medium
AcP	AcP:11|ACP:2|acP:2|Ac-P:1	acetyl phosphate
ACP	ACP:6|AcP:3|acP:1	acid phosphatase activity
ACP	ACP:184	acyl carrier protein
ACP	ACP:17	advance care planning
ACP	ACP:9	alcoholic chronic pancreatitis
ACP	ACP:44	alternative complement pathway
ACP	ACP:27	american college of physicians
ACP	ACP:64	amorphous calcium phosphate
ACP	ACP:9	antegrade cerebral perfusion
ACP	ACP:16	anterior clinoid process
ACP	ACP:8	antrochoanal polyp
AcP	AcP:9	muscle acylphosphatase
ACQ	ACQ:5	agoraphobic cognitions questionnaire
ACQ	ACQ:11	asthma control questionnaire
ACR	ACR:16	acquired cellular resistance
ACR	ACR:14|acr:3	acrolein
ACR	ACR:77	acute cellular rejection
ACR	ACR:35	adenomatosis of the colon and rectum
ACR	ACR:7	adequate clinical response
ACR	ACR:9	albumin creatinine ratio
ACR	ACR:89	american college of radiology
ACR	ACR:303	american college of rheumatology
ACR	ACR:10	urinary albumintocreatinine ratio
ACS	ACS:84	abdominal compartment syndrome
ACS	ACS:14|Acs:10|acs:1	acetylcoa synthetase
ACS	ACS:15	acute confusional state
ACs	ACs:34|Acs:1	adenylyl cyclases
ACs	ACs:12	amacrine cells
ACS	ACS:11	ambulatory care sensitive
ACS	ACS:100	american cancer society
ACS	ACS:33	american college of surgeons
ACS	ACS:14	anterior cricoid split
ACS	ACS:5	anticoagulation service
ACS	ACS:14	ars consensus sequence
ACS	ACS:10	asymptomatic carotid stenosis
ACS	ACS:10	automated corneal shaper
ACTA1	ACTA1:6|acta1:1	skeletal muscle alphaactin
ACTA1	ACTA1:7	skeletal muscle alphaactin gene
ACTH	ACTH:10	adrenocorticotrophic
ACTH	ACTH:17	adrenocorticotropic
ACTH	ACTH:2106|Acth:2	adrenocorticotropic hormone
ACTH	ACTH:1027	adrenocorticotropin
ACTH	ACTH:99	corticotrophin
ACTH	ACTH:598	corticotropin
ACTH	ACTH:23	plasma adrenocorticotrophin
Act	Act:13|act:7|ACT:4	actinorhodin
ACT	ACT:87	activated coagulation time
ACT	ACT:7	adrenocortical tumors
ACT	ACT:57	alphaantichymotrypsin
ACT	ACT:10	american college testing
ACT	ACT:11	anticoagulant therapy
ACT	ACT:87	assertive community treatment
ACT	ACT:38	australian capital territory
ACT	ACT:23	autologous chondrocyte transplantation
ACT	ACT:9	combination therapy
Act	Act:10	cytotoxic enterotoxin
ACV	ACV:9	hydroxyethoxymethylguanine
ACV	ACV:17|Acv:1	aciclovir
ACV	ACV:406|acv:2|Acv:1	acyclovir
ACV	ACV:6	assistcontrol ventilation
ACV	ACV:27	deltalalphaaminoadipyllcysteinyldvaline
ACV	ACV:6	tripeptide deltalalphaaminoadipoyllcysteinyldvaline
AChE	AChE:28|Ach-E:1|AchE:1	acetylcholinesterase activity
AChE	AChE:6	acetylcholinesterase enzyme
AChR	AChR:6	acetylcholine receptor channel
AChR	AChR:8|AchR:2	acetylcholine receptor protein
AChR	AChR:9	channel complex
ACh	ACh:23	cacetylcholine
ACh	ACh:19|Ach:3|ACH:1	acetylcholine chloride
ACH	ACH:6	active chronic hepatitis
ACH	ACH:8|ach:3	air changes per hour
ACH	ACH:9|a-CH:1|aCH:1	alphachlorohydrin
ACH	ACH:4	arkansas childrens hospital
ACh	ACh:25|Ach:3	cholinergic
ACh	ACh:1	release hacetylcholine
AC	AC:15	aberrant crypts
AC	AC:10	acebutolol
AC	AC:9|Ac:5|ac:1	acetone
AC	AC:9	acid ceramidase
AC	AC:66|A-C:2	acromioclavicular
AC	AC:36	activated carbon
AC	AC:60	activated charcoal
AC	AC:8	activation coefficient
AC	AC:9	activity coefficient
AC	AC:39	acute cholecystitis
AC	AC:22	adherent cells
AC	AC:28	aesthetic component
AC	AC:13	affinity chromatography
AC	AC:15	air conduction
AC	AC:15	allergic conjunctivitis
AC	AC:7	allyl chloride
AC	AC:9	alternating
AC	AC:21	amniocentesis
AC	AC:13	amygdaloid complex
AC	AC:12	anchor cell
AC	AC:157	anterior chamber
AC	AC:64|ac:1	anterior commissure
AC	AC:15|ac:1|Ac:1	anticoagulant
AC	AC:19	anticoagulation
AC	AC:23	aortic constriction
AC	AC:6	apatite cement
AC	AC:8	arachnoid cysts
AC	AC:22	arm circumference
AC	AC:18	arterial compliance
AC	AC:30	articular cartilage
AC	AC:8	artificial circulation
AC	AC:6	asbestos cement
AC	AC:12	attenuationcorrected
AC	AC:38	attenuation correction
AC	AC:21	atypical carcinoid
AC	AC:8	axillary clearance
AC	AC:21	doxorubicin and cyclophosphamide
Ac	Ac:16|AC:1	maize activator
Ac	Ac:15	maize transposable element activator
AC	AC:1	patients had alcoholic cirrhosis
ADAM	ADAM:37	anthryldiazomethane
ADAM	ADAM:13	alkenyldiarylmethane
ADAM	ADAM:13	disintegrin and metalloprotease
ADAM	ADAM:19	disintegrin and metalloproteinase
ADA	ADA:29	adenosine deaminase activity
ADA	ADA:6|Ada:1	adenosine deaminase gene
ADA	ADA:6	alcohol dependence and abuse
ADA	ADA:47	american dental association
ADA	ADA:183	american diabetes association
ADA	ADA:337	americans with disabilities act
ADA	ADA:17	americans with disabilities act of 
ADA	ADA:10	azodicarbonamide
ADCC	ADCC:17	antibodydependent
ADCC	ADCC:15	antibodydependent cellmediated cytolysis
ADCC	ADCC:16	antibodydependent cellmediated cytotoxic
ADCC	ADCC:833	antibodydependent cellular cytotoxicity
ADCC	ADCC:9	cytoxicity
ADC	ADC:136	aids dementia complex
ADC	ADC:5	analogtodigital conversion
ADC	ADC:59|adc:2	arginine decarboxylase
ADC	ADC:10	converter
ADD1	ADD1:5	adipocyte determination and differentiationdependent factor 
ADD1	ADD1:7	adipocyte determination and differentiation factor 
ADE	ADE:22	alcohol deprivation effect
ADE	ADE:39	antibodydependent enhancement
ADE	ADE:24	arrhythmogenic dose of epinephrine
ADF	ADF:25	actin depolymerizing factor
ADF	ADF:5	australian defence force
ADH	ADH:14	adipic acid dihydrazide
ADH	ADH:738|adh:1	antidiuretic hormone
ADH	ADH:103	atypical ductal hyperplasia
ADH	ADH:17	autosomal dominant hypocalcemia
ADIs	ADIs:25	acceptable daily intakes
ADIs	ADIs:12	aidsdefining illnesses
ADI	ADI:11	aidsdefining illness
ADI	ADI:19	arginine deiminase
ADI	ADI:11	autism diagnostic interview
ADL	ADL:16	acid detergent lignin
ADL	ADL:39	activities of daily life
ADL	ADL:11	activities of daily living scale
ADL	ADL:6	acute adenolymphangitis
ADL	ADL:8	aerobic dive limit
ADL	ADL:5	daily activities
ADMA	ADMA:7	asymmetric dimethyl arginine
ADMA	ADMA:6	asymmetric dimethyllarginine
ADMA	ADMA:176	asymmetric dimethylarginine
ADMA	ADMA:36	asymmetrical dimethylarginine
ADPRT	ADPRT:13	adenosine diphosphate ribosyl transferase
ADPRT	ADPRT:27|ADPrT:1|ADP-RT:1	adpribosyltransferase
ADP	ADP:7	aortic diastolic pressure
ADP	ADP:11	death protein
ADP	ADP:5	presence of atp
ADs	ADs:45	advance directives
ADs	ADs:11	afterdischarges
ADS	ADS:14	alcohol dependence scale
ADS	ADS:6	alcohol dependence syndrome
ADs	ADs:22|ADS:1	antidepressants
ADs	ADs:9|ADS:2	antidepressant drugs
ADs	ADs:5	cortical epileptic afterdischarges
ADTN	ADTN:14	aminodihydroxytetrahydronaphthalene
ADTN	ADTN:6	anterodorsal thalami nuclei
ADT	ADT:15	afterdischarge threshold
ADT	ADT:8	agar diffusion test
ADT	ADT:76	androgen deprivation therapy
ADV	ADV:23	adefovir dipivoxil
ADV	ADV:48	aleutian mink disease parvovirus
ADV	ADV:116	aujeszkys disease virus
AEA	AEA:5	antiendomysium antibody
AEA	AEA:16	arachidonylethanolamide
AECG	AECG:14	ambulatory ecg
AECG	AECG:9	ambulatory electrocardiography
AEC	AEC:9	absolute eosinophil count
AEC	AEC:36	adenylate energy charge
AEC	AEC:8	anionexchange chromatography
AEC	AEC:5	apical epithelial cap
AEC	AEC:17	automatic exposure control
AEDs	AEDs:920|AEDS:5	antiepileptic drugs
AEDs	AEDs:86	automated external defibrillators
AED	AED:10	aminoethyldextran
AED	AED:12	anhidrotic ectodermal dysplasia
AED	AED:50	automated external defibrillator
AED	AED:12	emission detection
AED	AED:11	external defibrillation
AED	AED:27	external defibrillators
AEF	AEF:23	allogeneic effect factor
AEF	AEF:37	amyloid enhancing factor
AEF	AEF:18	aortoenteric fistula
AEF	AEF:19	aortoesophageal fistula
AEF	AEF:7	auditory evoked magnetic field
AEF	AEF:8	axolemmaenriched fractions
AEM	AEM:10	ambulatory ecg monitoring
AEM	AEM:17	ambulatory electrocardiographic monitoring
AEP	AEP:7	aminoethylphosphonic acid
AEP	AEP:8	acute edematous pancreatitis
AEP	AEP:33	acute eosinophilic pneumonia
AEP	AEP:21	acute experimental pancreatitis
AEP	AEP:17	alkaline extracellular protease
AEP	AEP:10	artificial endocrine pancreas
AEP	AEP:5	asparaginyl endopeptidase
AEP	AEP:11	auditory
AER	AER:15	agranular endoplasmic reticulum
AER	AER:181|aer:1	apical ectodermal ridge
AES	AES:8	advanced expert system
AEs	AEs:298	adverse events
AEs	AEs:16	adverse experiences
AES	AES:10	affinity enhancement system
AES	AES:11	anal endosonography
AES	AES:22|AEs:2	anterior ectosylvian sulcus
AES	AES:13	apathy evaluation scale
AES	AES:32	auger electron spectroscopy
AET	AET:16	aminoethylisothiouronium bromide
AET	AET:11	atrial ectopic tachycardia
AET	AET:27	bromide hydrobromide
AEV	AEV:12	anterior ectosylvian visual area
AEV	AEV:22	avian encephalomyelitis virus
AEV	AEV:84	avian erythroblastosis virus
AE	AE:5	absence epilepsy
AE	AE:10	absolute error
AE	AE:28	acoustic emission
AE	AE:8	acridinium ester
AE	AE:27	acrodermatitis enteropathica
AE	AE:9	acute exacerbation
AE	AE:6	aerobic exercise
AE	AE:15	aldrin epoxidase
AE	AE:9	allylestrenol
AE	AE:110	alveolar echinococcosis
AE	AE:11	anion exchange
AE	AE:11	aqueous extract
AE	AE:12	assimilation efficiency
AE	AE:72	atopic eczema
AE	AE:11	avian encephalomyelitis
AF-2	AF-2:21|AF2:1	furylnitrofurylacrylamide
AF-2	AF-2:17|AF2:3	furylfuramide
AF64A	AF64A:36|AF-64A:1	ethylcholine aziridinium
AF64A	AF64A:37	ethylcholine aziridinium ion
AFB	AFB:29	acetatefree biofiltration
AFB	AFB:29	acidfast bacillus
AFB	AFB:9	aortofemoral bypass
AFC	AFC:7	aminotrifluoromethyl coumarin
AFC	AFC:20	alveolar fluid clearance
AFC	AFC:13	antral follicle count
AFC	AFC:14	nacetylsfarnesyllcysteine
AFD	AFD:11|AFd:5	andersonfabry disease
AFD	AFD:9	appropriatefordate
AFD	AFD:11	averagefordates
AFE	AFE:11	age at first egg
AFE	AFE:40	amniotic fluid embolism
AFLP	AFLP:40	acute fatty liver of pregnancy
AFLP	AFLP:8	amplified fragment length polymorphic
AFM	AFM:324	atomic force microscope
AFM	AFM:9	atomic force microscopic
AFP	AFP:12	afetoprotein
AFP	AFP:166	acute flaccid paralysis
AFP	AFP:16	alfafetoprotein
AFP	AFP:6	anterior fontanel pressure
AFP	AFP:7	anterior fontanelle pressure
AFP	AFP:17	anterior forebrain pathway
AFP	AFP:14	antialphafetoprotein
AFP	AFP:12	antifreeze polypeptide
AFP	AFP:17	antifungal protein
AFP	AFP:16	atypical facial pain
AFP	AFP:38	serum alphafetoprotein
AFs	AFs:16	actin filaments
AFs	AFs:13|Afs:1	aflatoxins
AFS	AFS:55	allergic fungal sinusitis
AFS	AFS:41	american fertility society
AFS	AFS:16	atomic fluorescence spectrometry
AFT	AFT:6	accelerated failure time
AFT	AFT:10	anodic fenton treatment
AFT	AFT:12	atrial fibrillation threshold
AF	AF:14	abdominal fat
AF	AF:19	accelerated fractionation
AF	AF:7	accessory function
AF	AF:14	aggregation factor
AF	AF:8	aggressive fibromatosis
AF	AF:13	aldehyde fuchsin
AF	AF:23	amaurosis fugax
AF	AF:9	ameloblastic fibroma
AF	AF:10	anaerobic filter
AF	AF:11	anchoring fibrils
AF	AF:33	annulus fibrosus
AF	AF:15	anulus fibrosus
AF	AF:6	arterial filter
AF	AF:9	attributable fraction
AF	AF:23	autonomic failure
AF	AF:9	factors
AGA	AGA:6	alphaglycyrrhetinic acid
AGA	AGA:5	allergic granulomatosis and angiitis
AGA	AGA:11	allergic granulomatous angiitis
AGA	AGA:68	androgenetic alopecia
AGA	AGA:23	antigliadin antibodies
AGA	AGA:9	antibodies to gliadin
AGA	AGA:15	appropriate
AGA	AGA:39	aspartylglucosaminidase
AGA	AGA:11	presents the official recommendations of the american gastroenterological association
AGC	AGC:22	absolute granulocyte count
AGC	AGC:29	advanced gastric cancer
AGC	AGC:12	advanced gastric carcinoma
AGC	AGC:13	atypical glandular cells
AGC	AGC:22	automatic gain control
AGD	AGD:13	agar gel diffusion
AGD	AGD:18	amoebic gill disease
AGD	AGD:47	anogenital distance
AGD	AGD:23|AgD:10	argyrophilic grain disease
AGEPC	AGEPC:12	oalkylacetylsnglycerophosphocholine
AGEPC	AGEPC:28	acetyl glyceryl ether phosphorylcholine
AGHD	AGHD:5	adult gh deficiency
AGHD	AGHD:9	adult growth hormone deficiency
AGL	AGL:8	acute granulocytic leukemia
AGL	AGL:1	caused by the deficiency of glycogendebranching enzyme
AGP	AGP:88	alphaacid glycoprotein
AGP	AGP:16	arabinogalactanprotein
AGP	AGP:5	growth promoter
AGT	AGT:3	alanine glyoxylate aminotransferase
AGT	AGT:32|Agt:5	angiotensinogen gene
AGT	AGT:11|AgT:1|agT:1	antiglobulin test
AGT	AGT:23	average generation time
AGT	AGT:12	oalkylguaninednaalkyltransferase
AGU	AGU:68	aspartylglucosaminuria
AGU	AGU:22	aspartylglycosaminuria
AHAS	AHAS:21	acetohydroxy acid synthase
AHAS	AHAS:27	acetohydroxyacid synthase
AHA	AHA:12	aminonhydroxyadenine
AHA	AHA:33|Aha:1	acetohydroxamic acid
AHA	AHA:44	american hospital association
AHA	AHA:76	anterior hypothalamic area
AHD	AHD:17	alveolar hydatid disease
AHD	AHD:6	antihypertensive drugs
AHF	AHF:15	acute heart failure
AHF	AHF:32	acute hepatic failure
AHF	AHF:58	altered hepatic foci
AHF	AHF:41	antihemophilic factor
AHF	AHF:8	aqueous humor formation
AHF	AHF:39	argentine hemorrhagic fever
AHG	AHG:7	aggregated human igg
AHG	AHG:53	globulin
AHH	AHH:552	aryl hydrocarbon hydroxylase
AHH	AHH:8	aryl hydrocarbon hydroxylase activity
AHL	AHL:15|Ahl:3|ahl:1	agerelated hearing loss
AHL	AHL:10	lactones
AHL	AHL:19	nacyl homoserine lactone
AHL	AHL:18	nacylhomoserine lactone
AHO	AHO:13	acute hematogenous osteomyelitis
AHO	AHO:61	hereditary osteodystrophy
AhpC	AhpC:17|ahpC:4	alkyl hydroperoxide reductase
AhpC	AhpC:3|ahpC:2	alkyl hydroperoxide reductase subunit c
AHP	AHP:9	acute hemorrhagic pancreatitis
AHP	AHP:7	afterhyperpolarizing potential
AHP	AHP:32	analytic hierarchy process
AHP	AHP:9	anosognosia for hemiplegia
AHRF	AHRF:8	acute hypercapnic respiratory failure
AHRF	AHRF:11	acute hypoxemic respiratory failure
AHSV	AHSV:56	african horse sickness virus
AHSV	AHSV:39	african horsesickness virus
AHS	AHS:48	african horse sickness
AHS	AHS:15	african horsesickness
AHS	AHS:11	alien hand syndrome
AHS	AHS:5	alphahaemolytic streptococci
AHS	AHS:6	alphahemolytic streptococci
AHS	AHS:24	ammons horn sclerosis
AHS	AHS:12	anticonvulsant hypersensitivity syndrome
AHS	AHS:24	health study
AHC	AHC:18	acute haemorrhagic conjunctivitis
AHC	AHC:52	acute hemorrhagic conjunctivitis
AHC	AHC:13|AH-C:2|aHC:1	acute hepatitis c
AHC	AHC:46	adrenal hypoplasia congenita
AHC	AHC:2	alternating hemiplegia in childhood
AHC	AHC:9	congenital adrenal hypoplasia
AIA	AIA:69	adjuvantinduced arthritis
AIA	AIA:48|aia:1	allylisopropylacetamide
AIA	AIA:74|AiA:6	antigeninduced arthritis
AIA	AIA:52	aspirininduced asthma
AIA	AIA:16	aspirinintolerant asthma
AIB	AIB:10|Aib:1	aminoisobutyrate
AIB	AIB:5	airflowinduced bronchoconstriction
AIB	AIB:14	alphaaminoisobutyrate
AIB	AIB:204|Aib:53	alphaaminoisobutyric acid
AICAR	AICAR:30	aminoimidazolecarboxamidebetadribofuranoside
AICAR	AICAR:34	aminoimidazolecarboxamide ribonucleoside
AICAR	AICAR:12	aminoimidazolecarboxamide ribonucleotide
AICAR	AICAR:6	aminoimidazolecarboxamide ribotide
AICD	AICD:217	activationinduced cell death
AICD	AICD:13	app intracellular domain
AIC	AIC:12	autoimmune cholangitis
AIC	AIC:10	information criteria
AIC	AIC:93	information criterion
AIDP	AIDP:37	acute inflammatory demyelinating polyneuropathy
AIDP	AIDP:18	acute inflammatory demyelinating polyradiculoneuropathy
AIDS	AIDS:13	acquired immune deficiency
AIDS	AIDS:2376	acquired immune deficiency syndrome
AIDS	AIDS:12	acquired immunodeficiency
AIDS	AIDS:18	acquired immunodeficiency disease
AIDS	AIDS:11	acquired immunodeficiency virus
AID	AID:129	activationinduced cytidine deaminase
AID	AID:37	agency for international development
AID	AID:69	artificial insemination by donor
AID	AID:22|aid:1	artificial insemination with donor semen
AID	AID:6	artificial insemination with donor sperm
AID	AID:6	donor artificial insemination
AIF	AIF:51	arterial input function
AIF	AIF:20	cytochrome c and apoptosisinducing factor
AIH	AIH:5	amiodaroneinduced hypothyroidism
AIH	AIH:8	anastomotic intimal hyperplasia
AIH	AIH:7	artificial insemination by husband
AIH	AIH:2	artificial insemination using the husbands semen
AIH	AIH:337|AiH:2|AI-H:1	autoimmune hepatitis
AIH	AIH:11	homologous artificial insemination
AIIt	AIIt:7	annexin ii heterotetramer
AIIt	AIIt:14|A-IIt:1	annexin ii tetramer
AILD	AILD:9	angioimmunoblastic lymphadenopathy with dysproteinaemia
AILD	AILD:60	angioimmunoblastic lymphadenopathy with dysproteinemia
AIMS	AIMS:127	abnormal involuntary movement scale
AIMS	AIMS:18	anesthesia information management system
AIMS	AIMS:7	first  incidents reported to the australian incident monitoring study
AIM	AIM:6	activation inducer molecule
AIM	AIM:13	acute infectious mononucleosis
AIM	AIM:16	acute myocardial infarction
AIM	AIM:6	analytical ion microscopy
AIM	AIM:6	artificial intelligence in medicine
AIN	AIN:66	acute interstitial nephritis
AIN	AIN:36	anal intraepithelial neoplasia
AIN	AIN:10	anterior interosseous nerve
AIN	AIN:25	autoimmune neutropenia
AION	AION:22	anterior ischaemic optic neuropathy
AION	AION:88	anterior ischemic optic neuropathy
AIP1	AIP1:5|Aip1:1	actininteracting protein 
AIP1	AIP1:6|Aip1:1	interacting protein 
AIP	AIP:6	aminoindanphosphonic acid
AIP	AIP:241	acute intermittent porphyria
AIP	AIP:27	acute interstitial pneumonia
AIP	AIP:15	autoimmune pancreatitis
AIP	AIP:9	autoinducing peptide
AIP	AIP:7	inhibitory peptide
AIRE	AIRE:13	acute infarction ramipril efficacy
AIRE	AIRE:50|Aire:5|aire:1	autoimmune regulator
AIRE	Aire:4|AIRE:4	autoimmune regulator gene
AISA	AISA:11	acquired idiopathic sideroblastic anaemia
AISA	AISA:12	acquired idiopathic sideroblastic anemia
AIS	AIS:140	abbreviated injury scale
AIS	AIS:23	abbreviated injury score
AIS	AIS:6	acute ischaemic stroke
AIS	AIS:33	acute ischemic stroke
AIS	AIS:84	adolescent idiopathic scoliosis
AIs	AIs:11	american indians
AIS	AIS:7	anemiainducing substance
AIS	AIS:7	antiinsulin serum
AIs	AIs:51	aromatase inhibitors
AIs	AIs:9	asymmetry indices
AIT	AIT:42	adoptive immunotherapy
AIT	AIT:33	amiodaroneinduced thyrotoxicosis
AIV	AIV:17	anterior interventricular vein
AIV	AIV:58	avian influenza virus
AIV	AIV:9	influenza viruses
AJC	AJC:17	american joint committee
AJC	AJC:7	ankle joint complex
AJC	AJC:7	apical junctional complex
AKAP	AKAP:13	akinase anchoring protein
AKAP	AKAP:12	kinase anchoring protein
AKAPs	AKAPs:14	akinase anchor proteins
AKAPs	AKAPs:55	akinase anchoring proteins
AKAPs	AKAPs:9	kinase anchor proteins
AKAPs	AKAPs:6	protein kinase a anchoring proteins
AKA	AKA:8	aboveknee amputation
AKA	AKA:9	alcoholic ketoacidosis
ALA	ALA:22	aminolevulinate
ALA	ALA:8	antilymphocyte antibodies
ALA	ALA:13	antilysozyme activity
ALA	ALA:10	deltaaminolaevulinate
ALA	ALA:40	deltaaminolevulinate
ALA	ALA:69	liver abscess
ALC	ALC:29	absolute lymphocyte count
ALC	ALC:7	adult leydig cells
ALC	ALC:30	alcoholic liver cirrhosis
ALC	ALC:8|Alc:1	alcoholism
ALC	ALC:10	allogeneic lymphocyte cytotoxicity
ALC	ALC:12	alveolar liquid clearance
ALC	ALC:20	anaplastic large cell
ALD	ALD:9	adrenoleukodystrophy
ALD	ALD:10	adrenoleucodystrophy
ALD	ALD:239	alcoholic liver disease
ALD	ALD:54|Ald:4	aldolase
ALD	ALD:108|ald:1	anterior latissimus dorsi
ALD	ALD:9	anterior latissimus dorsi muscle
ALD	ALD:11	atomic layer deposition
ALE	ALE:9	active life expectancy
ALE	ALE:8	artichoke leaf extract
ALF	ALF:165	acute liver failure
ALF	ALF:7	alveolar lining fluid
ALH	ALH:10	allan hills
ALH	ALH:70|Alh:1	amplitude of lateral head displacement
ALH	ALH:21	atypical lobular hyperplasia
ALI	ALI:437	acute lung injury
ALI	ALI:22	airliquid interface
ALI	ALI:5	annual limit of intake
ALK	ALK:149|Alk:3|alk:1|AlK:1	anaplastic lymphoma kinase
ALK	ALK:11	automated lamellar keratoplasty
ALLN	ALLN:18	nacetylleuleunorleucinal
ALLN	ALLN:23	nacetylleucylleucylnorleucinal
ALL	ALL:36	acute lymphoblastic
ALL	ALL:5	acute lymphoblastic leukemic
ALL	ALL:12	acute lymphocytic
ALL	ALL:716	acute lymphocytic leukemia
ALL	ALL:8	acute lymphoid
ALL	ALL:10	anterior longitudinal ligament
ALM	ALM:28	acral lentiginous melanoma
ALM	ALM:7|Alm:2	almitrine bismesylate
ALM	ALM:6	autoclaved leishmania major
ALP	ALP:10|AlP:2|Alp:1	alkaline
ALP	ALP:9|AlP:6	aluminium phosphide
ALP	ALP:21	antileukoprotease
ALP	ALP:13|aLP:1	antileukoproteinase
ALP	ALP:13	atherogenic lipoprotein phenotype
ALP	ALP:6	lim protein
ALS	ALS:49	acetolactate synthase
ALS	ALS:23	acid labile subunit
ALS	ALS:228	advanced life support
ALS	ALS:10	alternating least squares
ALS	ALS:2625	amyotrophic lateral sclerosis
ALS	ALS:8	antilymphocyte sera
ALTS	ALTS:5	ascuslsil triage study
ALTS	ALTS:5	squamous intraepithelial lesion triage study
ALT	ALT:14	alanine aminotransaminase
ALT	ALT:18	alanine aminotransferase activity
ALT	ALT:36	alternative lengthening of telomeres
ALT	ALT:9	altitude
ALT	ALT:13	anterolateral thigh
ALT	ALT:112	argon laser trabeculoplasty
ALT	ALT:16	autolymphocyte therapy
ALT	ALT:8	auxiliary liver transplantation
ALT	ALT:117	serum alanine transaminase
ALT	ALT:14	serum alanine transferase
ALV-J	ALV-J:16	avian leukosis virus subgroup j
ALV-J	ALV-J:1	subgroup j of avian leukosis virus
AL	AL:39	acute leukaemia
AL	AL:15	ad lib
AL	AL:257|A-L:1	ad libitum
AL	AL:10	adductor longus
Al	Al:7|AL:4	albumin
Al	Al:193|AL:1	aluminium
AL	AL:10	amyotrophic leukospongiosis
AL	AL:34	annulate lamellae
AL	AL:46	antennal lobe
AL	AL:59	anterior lobe
AL	AL:20|al:2|A-L:1	anterolateral
AL	AL:10	argon laser
AL	AL:9	assisted living
AL	AL:9	attachment levels
AL	AL:6	atypical lymphocytes
AL	AL:48	axial length
AL	AL:2	lateral nucleus of amygdala
AL	AL:9	ligament
AL	AL:12	light chain amyloidosis
AL	AL:11	patients with primary amyloidosis
AL	AL:43	primary systemic amyloidosis
AMA	AMA:14	advanced maternal age
AMA	AMA:45|ama:1	against medical advice
AMA	AMA:14|ama:3	amantadine
AMA	AMA:19	antimitochondrial autoantibodies
AMA	AMA:30	arm muscle area
AMD	AMD:30	acid maltase deficiency
AMD	AMD:56	acid mine drainage
AMD	AMD:7	agerelated macular disease
AMD	AMD:13	automated multiple development
AMD	AMD:10	dactinomycin
AME	AME:12	absolute magnitude estimation
AME	AME:29|AmE:1	amphotericin b methyl ester
AME	AME:24	apparent metabolisable energy
AME	AME:9	apparent metabolizable energy
AME	AME:55	apparent mineralocorticoid excess
AMFR	AMFR:9	amplitudemodulation following response
AMFR	AMFR:11|AMF-R:9	autocrine motility factor receptor
AMF	AMF:14	alternating magnetic field
AMF	AMF:9	angiomyofibroblastoma
AMF	AMF:48	arbuscular mycorrhizal fungi
AMF	AMF:59	autocrine motility factor
AMG	AMG:10	acoustic myography
AMG	AMG:10	alpha macroglobulin
AMG	AMG:9	alphamethylglucoside
AMG	AMG:10	aminoglutethimide
AMG	AMG:30|amG:1|AmG:1	aminoguanidine
AMG	AMG:12	autometallographic
AMG	AMG:23	autometallography
AMH	AMH:10	accreditation manual for hospitals
AMH	AMH:163|Amh:9	antimullerian hormone
AMI	AMI:17	acute mesenteric ischemia
AMI	AMI:30|aMI:1|Ami:1	acute myocardial infarct
AMI	AMI:14	acute myocardial ischemia
AMI	AMI:9|Ami:2	amifostine
AMKL	AMKL:46|AMkL:4	acute megakaryoblastic leukemia
AMKL	AMKL:10|AMkL:1	acute megakaryocytic leukemia
AMLR	AMLR:8	auditory middle latency response
AMLR	AMLR:14	autologous mixed lymphocyte response
AML	AML:14	acute myeloblastic
AML	AML:8	acute myelogenous
AML	AML:169	acute myelogenous leukaemia
AML	AML:27	acute myeloid
AML	AML:19	acute myeloid leukemic
AML	AML:13	amlodipine
AML	AML:11	anatomic medullary locking
AML	AML:26	anterior mitral leaflet
AMPA	AMPA:10	aminohydroxymethylisoxazolepropionate
AMPA	AMPA:11	acid hydrobromide
AMPA	AMPA:13	alphaaminohydroxymethylisoxazole
AMPA	AMPA:165	alphaaminohydroxymethylisoxazole propionic acid
AMPA	AMPA:6	alphaaminohydroxymethylisoxazole proprionate
AMPA	AMPA:9	alphaaminohydroxymethylisoxazoleproprionate
AMPA	AMPA:22	alphaaminohydroxymethylisoxazolepropionate
AMPA	AMPA:9	lalphaaminohydroxymethylisoxazolepropionate
AMP-PNP	AMP-PNP:14|AMPPNP:7	adenylyl imidodiphosphate
AMP-PNP	AMP-PNP:12|AMPPNP:5|AMP--PNP:1	adenylylimidodiphosphate
AMP-PNP	AMP-PNP:3|AMPPNP:1	atp analogue adenylylimidodiphosphate
AMP	AMP:9	aminomethylpropanol
AMP	AMP:7	allosteric activator
AMP	AMP:10	antimicrobial peptide
AMP	AMP:10	antimicrobial prophylaxis
AMR	AMR:7|amr:2|Amr:2	amrinone
AMR	AMR:9	antibodymediated rejection
AMS	AMS:86	accelerator mass spectrometry
AMS	AMS:16	acute maxillary sinusitis
AMS	AMS:210	acute mountain sickness
AMS	AMS:7	altered mental status
AMS	AMS:8	antimacrophage serum
AMS	AMS:12	atypical mole syndrome
AMS	AMS:6	automatic milking systems
AMS	AMS:12	automatic mode switching
AMS	AMS:20	automicrobic system
AMT	AMT:16	aminodihydromethylhthiazine
AMT	AMT:31	aminodeoxythymidine
AMT	AMT:13	aminomethyltrimethylpsoralen
AMT	AMT:25	abbreviated mental test
AMT	AMT:9|aMT:1	active motor threshold
AMT	AMT:8	aea membrane transporter
AMT	AMT:63	amniotic membrane transplantation
AMT	AMT:9	autobiographical memory test
AMV	AMV:13	ammonium metavanadate
AMV	AMV:20	anterior medullary velum
AMV	AMV:17	apical membrane vesicles
AMV	AMV:8	assisted mechanical ventilation
AMV	AMV:190	avian myeloblastosis virus
AM	AM:22	acetoxymethyl
AM	AM:28	acetoxymethyl ester
AM	AM:13	actomyosin
AM	AM:25	adrenal medulla
AM	AM:11	alternative medicine
AM	AM:10	alveolar
AM	AM:8	ambulatory monitoring
AM	AM:64	amniotic membrane
AM	AM:29	amplitude modulated
AM	AM:83	amplitude modulation
AM	AM:17	amygdaloid
AM	AM:19|Am:1|A-m:1	anteromedial
AM	AM:7	anteromedial nucleus
AM	AM:21	apparent motion
AM	AM:12	arbuscular mycorrhiza
AM	AM:165	arbuscular mycorrhizal
AM	AM:10	arithmetic mean
AM	AM:9	artemether
AM	AM:25	aseptic meningitis
AM	AM:29	astragalus membranaceus
AM	AM:7	autobiographical memory
AM	AM:11	sinusoidally amplitudemodulated
ANA	ANA:7	aortic nerve activity
ANA	ANA:13	nuclear antigens
ANCAs	ANCAs:44	antineutrophil cytoplasmic antibodies
ANCAs	ANCAs:12	antineutrophil cytoplasmic autoantibodies
ANCA	ANCA:48	antineutrophil cytoplasmic antibody
ANCA	ANCA:27	neutrophil cytoplasmic antigens
ANC	ANC:10	active noise control
ANC	ANC:46	antenatal care
ANH	ANH:15	acute normovolaemic haemodilution
ANH	ANH:83	acute normovolemic hemodilution
ANH	ANH:12	artificial nutrition and hydration
ANH	ANH:52	atrial natriuretic hormone
A-NK	A-NK:7|ANK:1	activated nk
A-NK	A-NK:5|ANK:3	ilactivated nk
A-NK	A-NK:44|ANK:1	natural killer
ANN	ANN:10	alloimmune neonatal neutropenia
ANN	ANN:9	auditory nerve neurophonic
ANN	ANN:6	axillary nodenegative
ANP	ANP:67	acute necrotizing pancreatitis
ANP	ANP:175	atrial natriuretic polypeptide
ANP	ANP:12	atrial np
ANR	ANR:9	active noise reduction
ANR	ANR:10	neural ridge
ANS	ANS:9	anilinonaphthalenesulphonate
ANS	ANS:17	anilinonaphthalene sulfonic acid
ANS	ANS:8|Ans:1	anterior nasal spine
ANS	ANS:11	anthocyanidin synthase
ANS	ANS:19	antineutrophil serum
ANS	ANS:386	autonomic nervous system
ANS	ANS:6|Ans:1	probe anilinonaphthalenesulfonate
ANT	ANT:12|ant:2	aintegumenta
ANT	ANT:10	alcoholsensitive
ANT	ANT:13|Ant:5	anthracene
ANT	ANT:7	attention network test
ANV	ANV:17	anticipatory nausea and vomiting
ANV	ANV:14	avian nephritis virus
AN	AN:52	acanthosis nigricans
AN	AN:5	acceptor number
AN	AN:6	accessory nuclei
AN	AN:25	alae nasi
AN	AN:16	analgesic nephropathy
AN	AN:14|an:1	aneuploid
AN	AN:13	aniline
AN	AN:10	anticipatory nausea
AN	AN:10|an:2	area of necrosis
AN	AN:10	areca nut
AN	AN:11	artificial nutrition
AN	AN:7	aseptic necrosis
AN	AN:18	auditory neuropathy
AN	AN:74	autonomic neuropathy
AN	AN:5	stimulation of the aortic nerve
AOA	AOA:14	alpha omega alpha
AOA	AOA:7	american optometric association
AOA	AOA:12	american osteopathic association
AOA	AOA:9	aminooxyacetate
AOA	AOA:26	antioxidative activity
AOB	AOB:135	accessory olfactory bulb
AOB	AOB:52	ammoniaoxidizing bacteria
AOB	AOB:11	anterior open bite
AOC	AOC:12	advanced ovarian cancer
AOC	AOC:27	assimilable organic carbon
AOD	AOD:19	accumulated oxygen deficit
AOD	AOD:66	alcohol and other drug
AOD	AOD:13	antioxidant defense
AOD	AOD:5	antioxidative defense
AOD	AOD:10	atlantooccipital dislocation
AOD	AOD:55	occlusive disease
AOM	AOM:512	acute otitis media
AOM	AOM:12	angular overlap model
AOM	AOM:13	colon carcinogen azoxymethane
AOM	AOM:7	number and histology of colon tumors induced by azoxymethane
AON	AON:5	accessory optic nuclei
AON	AON:28	anterior olfactory nucleus
AON	AON:9	aseptic osteonecrosis
AOP	AOP:16	advanced oxidation process
AOP	AOP:7	anemia of prematurity
AOP	AOP:19	antioxidant potential
AOP	AOP:10|AoP:1	apnea of prematurity
AOS	AOS:56	accessory optic system
AOS	AOS:65|aos:1	active oxygen species
AOS	AOS:9	adamsoliver syndrome
AOS	AOS:28	allene oxide synthase
AOS	AOS:14	apraxia of speech
AOT	AOT:13	aerosolot
AOT	AOT:17	sodium bisethylhexylsulfosuccinate
AOX	AOX:10	adsorbable organic halogens
AOX	AOX:74|Aox:4|aox:1	alternative oxidase
AO	AO:330	acridine orange
AO	AO:10	active oxygen
AO	AO:11	adaptive optics
AO	AO:9	adultonset
AO	AO:8	adverse outcome
AO	AO:11	age of onset
AO	AO:12	airway obstruction
AO	AO:10	albino oxford
AO	AO:41|Ao:3	aldehyde oxidase
AO	AO:10	antisense oligonucleotide
AO	AO:7	aortic output
AO	AO:6	aqueous oxygen
AO	AO:10	arbeitsgemeinschaft fur osteosynthesefragen
AO	AO:8	arterial occlusion
AP-1	AP-1:3	activated by the fosjun heterodimeric complex
AP-1	AP-1:22|AP1:5	activator protein
AP3	AP3:11|AP-3:1	aminophosphonopropionate
AP3	AP3:11|AP-3:3	aminophosphonopropionic acid
APAs	APAs:11	aldosteroneproducing adenomas
APAs	APAs:30	anticipatory postural adjustments
APA	APA:9	abrus precatorius agglutinin
APA	APA:73	action potential amplitude
APA	APA:32	american psychiatric association
APA	APA:33	american psychological association
APA	APA:13	amplitude of action potential
APA	APA:13	ap amplitude
APA	APA:10	atypical polypoid adenomyoma
APB	APB:67	aminophosphonobutyrate
APB	APB:130	abductor pollicis brevis
APB	APB:21	abductor pollicis brevis muscle
APB	APB:25|aPB:1	adult peripheral blood
APC/C	APC/C:11	anaphasepromoting complex
APC/C	APC/C:19	anaphasepromoting complex or cyclosome
APC	APC:19|aPC:2	activated pc
APC	APC:725|aPC:22	activated protein c
APC	APC:7|Apc:1	adenomatous polyposis
APC	APC:765|Apc:38|apc:3	adenomatous polyposis coli
APC	APC:21|Apc:5	adenomatous polyposis coli gene
APC	APC:9	adenomatous polyposis coli gene product
APC	APC:20	adenomatous polyposis coli protein
APC	APC:20|apc:1	ageperiodcohort
APC	APC:12	air pollution control
APC	APC:35|apc:1	allophycocyanin
APC	APC:17	alternative pathway of complement
APC	APC:13	anaphasepromoting complexcyclosome
APC	APC:17	anesthetic preconditioning
APC	APC:21|aPC:4	anterior piriform cortex
APC	APC:9	aqueous protein concentration
APC	APC:111	argon plasma coagulation
APD90	APD90:7	action potential duration at  of repolarization
APD90	APD90:4	action potential duration at  repolarisation
APDs	APDs:22	action potential durations
APDs	APDs:56	antipsychotic drugs
APDs	APDs:10	atrial premature depolarizations
APD	APD:15	aminohydroxypropylidenebisphosphonate
APD	APD:9	aminohydroxypropylidene bisphosphonate
APD	APD:9	aminohydroxypropylidene diphosphonate
APD	APD:6	anteroposterior diameter
APD	APD:7	auditory processing disorders
APD	APD:22	automated pd
APD	APD:122	automated peritoneal dialysis
APD	APD:22	avoidant personality disorder
APD	APD:11	disodium pamidronate
APE	APE:8	abdominoperineal excision
APE	APE:10	acute pulmonary edema
APE	APE:29	acute pulmonary embolism
APE	APE:11	ap endonuclease
APE	APE:17	arecaidine propargyl ester
APE	APE:4	atom percent excess
APF	APF:66	acidulated phosphate fluoride
APF	APF:6	anionic polypeptide fraction
APF	APF:54	antiperinuclear factor
API	API:12	achromobacter protease i
API	API:36	active pharmaceutical ingredient
API	API:13	acute panic inventory
API	API:20	aminopeptidase i
API	API:13	ankle pressure index
API	API:13	annual parasite incidence
API	API:11	approximal plaque index
API	API:35	atmospheric pressure ionization
APLD	APLD:10	adult polycystic liver disease
APLD	APLD:17	automated percutaneous lumbar discectomy
APLs	APLs:9	acute promyelocytic leukemias
APLs	APLs:30	altered peptide ligands
APL	APL:24	abductor pollicis longus
APL	APL:8	accreditation of prior learning
APL	APL:173	acute promyelocytic leukaemia
APL	APL:4|aPL:3	antibodies to phospholipids
APL	APL:10	atrichia with papular lesions
APM	APM:17	affectedpedigreemember
APM	APM:29|AP-M:6	aminopeptidase m
APM	APM:9	antigen processing machinery
APM	APM:11|apm:1	apical plasma membrane
APM	APM:24	aspartame
APM	APM:2	mhc class i antigenprocessing machinery
APN	APN:44	acute pyelonephritis
APN	APN:67	advanced practice nurse
APP	APP:17|AP-P:3	aminopeptidase p
APP	APP:97	amyloid protein precursor
APP	APP:46|aPP:7	avian pancreatic polypeptide
APP	APP:18	precursor protein gene
APRT	APRT:32|aprt:10|Aprt:1	adenine phosphoribosyl transferase
APRT	APRT:4|aprt:1	adenine phosphoribosyltransferase gene
APS	APS:10	adenylylsulfate
APs	APs:52|Aps:2|APS:1	accessory pathways
APS	APS:5	activated sulfate
APS	APS:40	acute physiology score
APS	APS:5	addiction potential scale
APS	APS:5	adult protective services
APS	APS:13	aerodynamic particle sizer
APs	APs:25	alkylphenols
APS	APS:11	american pain society
APs	APs:12	aminopeptidases
APS	APS:9	ammonium persulfate
APs	APs:12	anterior pituitaries
APs	APs:11|Aps:1	anterior pituitary glands
APS	APS:11	antiplatelet serum
APS	APS:6	atypical parkinsonian syndromes
APS	APS:6	autoimmune polyglandular syndromes
APS	APS:7	automatic positioning system
APS	APS:8	platelet serum
APTT	APTT:7|aPTT:5	activated partial thromboplastin
APTT	APTT:4|aPTT:1	partial thromboplastin time test
APV	APV:40|apv:1	amprenavir
APV	APV:9	artificial pulmonary ventilation
APV	APV:30	average peak velocity
APV	APV:74	avian pneumovirus
APV	APV:18	avian polyomavirus
APV	APV:4	nmda antagonist daminophosphonovalerate
APV	APV:4	nmda receptor antagonist dlaminophosphonovalerate
APV	APV:9	nmda receptor antagonist dlaminophosphonovaleric acid
APV	APV:6	peak flow velocity
APW	APW:10	alkaline peptone water
APW	APW:7	artificial pond water
APH	APH:21	acetylphenylhydrazine
APH	APH:12	antepartum haemorrhage
AP	AP:68	abasic
AP	AP:20	absolute pitch
AP	AP:7	absolute power
AP	AP:61	accelerated phase
AP	AP:6	accessory processes
AP	AP:5	accumulation of caminopyrine
AP	AP:19	actinic prurigo
AP	AP:7|ap:2	activation peptide
AP	AP:19	acupuncture
AP	AP:424	acute pancreatitis
AP	AP:22	acute pneumonia
AP	AP:31	adaptor protein
AP	AP:30	adductor pollicis
AP	AP:146	adult periodontitis
AP	AP:29	aerosolized pentamidine
AP	AP:14	alpha antiplasmin
AP	AP:61	alternative pathway
AP	AP:7	alveolar permeability
AP	AP:12	ammonium perchlorate
AP	AP:11	amyloid p
AP	AP:12	anaphylactoid purpura
AP	AP:153	angina pectoris
AP	AP:5	annular pancreas
AP	AP:20|ap:1	anterior pagoda
AP	AP:8|A-P:2	anteriorposterior
AP	AP:4|A-P:1	anterior to posterior
AP	AP:10	antigen presentation
AP	AP:9	antiplasmin
AP	AP:10	antipsychotic
AP	AP:76|Ap:1|ap:1	antipyrine
AP	AP:8|ap:3	apatite
AP	AP:15|ap:3	apomorphine
AP	AP:34	apurinic
AP	AP:309|ap:9	area postrema
AP	AP:13	artificial perilymph
AP	AP:9	ascorbyl palmitate
AP	AP:8	asthmatic patients
AP	AP:6	autologous plasma
AP	AP:12|aP:8	available p
AP	AP:11|aP:4	available phosphorus
AP	AP:11	average power
AP	AP:6	pseudomonas aeruginosa alkaline protease
AQ	AQ:27	acoustic quantification
AQ	AQ:7	aggression questionnaire
AQ	AQ:52|Aq:1	amodiaquine
AQ	AQ:17	anthraquinone
AQ	AQ:5|Aq:3|aq:1	aqueous
AQ	AQ:14	areca quid
AR4-2J	AR4-2J:4|AR42J:1	pancreatic acinar cells
AR4-2J	AR4-2J:6|AR42J:3	pancreatic acinar cell line
ARAS	ARAS:9	ascending reticular activating system
ARAS	ARAS:23	atherosclerotic renal artery stenosis
ARA	ARA:5	acetylene reduction activity
ARA	ARA:9	action research arm
ARA	ARA:9	action research arm test
ARA	ARA:80	american rheumatism association
ARA	ARA:19	anorectal angle
ARA	ARA:5	antiradical activity
ARA	ARA:5	antireticulin antibodies
ARB	ARB:22	angiotensin ii type  receptor blocker
ARB	ARB:8	receptor blockade
ARC	ARC:23	accessory radula closer
ARC	ARC:15	active renin concentration
ARC	ARC:15	adult rat cardiomyocytes
ARC	ARC:14	american red cross
ARC	ARC:15	anomalous retinal correspondence
ARC	ARC:8|Arc:1	arcuate nuclei
ARC	ARC:5	arthritis and rheumatism council
ARDRA	ARDRA:16	amplified rdna restriction analysis
ARDRA	ARDRA:58	amplified ribosomal dna restriction analysis
ARDS	ARDS:10	acute respiratory failure
ARDS	ARDS:1352	adult respiratory distress syndrome
ARDS	ARDS:6	lung failure
ARF	ARF:1717|arf:1	acute renal failure
ARF	ARF:140	acute rheumatic fever
ARIC	ARIC:302	atherosclerosis risk in communities
ARIC	ARIC:12	atherosclerosis risk in communities study
ARIS	ARIS:9	acrosome reactioninducing substance
ARIs	ARIs:8	activationrecovery intervals
ARIs	ARIs:34	acute respiratory infections
ARIs	ARIs:38	aldose reductase inhibitors
ARIS	ARIS:12	apoenzyme reactivation immunoassay system
ARI	ARI:17	acute renal insufficiency
ARI	ARI:19	acute respiratory illness
ARI	ARI:17	acute respiratory insufficiency
ARI	ARI:23	acute respiratory tract infection
ARI	ARI:40	adhesive remnant index
ARI	ARI:14	autoregulatory index
ARM	ARM:1	adriamycin in a rat model
ARM	ARM:157	agerelated maculopathy
ARM	ARM:14	anorectal manometry
ARM	ARM:17	argininerich motif
ARM	ARM:13|Arm:1	armstrong
ARM	ARM:6	atpregulated module
ARN	ARN:82	acute retinal necrosis
ARN	ARN:16	acute retinal necrosis syndrome
ARN	ARN:9	afferent renal nerves
ARPKD	ARPKD:8	autosomal recessive pkd
ARPKD	ARPKD:111	autosomal recessive polycystic kidney disease
ARP	ARP:13	absolute refractory period
ARP	ARP:11	aldehyde reactive probe
ARP	ARP:13	arthromyces ramosus peroxidase
ARS	ARS:9	acute radiation sickness
ARs	ARs:13	adrenoceptors
ARS	ARS:12	agricultural research service
ARS	ARS:16|AR-S:1	alizarin red s
ARS	ARS:5	aminoacyltrna synthetase
ARs	ARs:60|ARS:1|Ars:1	androgen receptors
ARS	ARS:10	antigen recognition site
ARS	ARS:8	antireflux surgery
ARS	ARS:7|ars:1	autonomous replication sequences
ARS	ARS:10	axenfeldrieger syndrome
ARTs	ARTs:12	acoustic reflex thresholds
ARTs	ARTs:24	assisted reproductive technologies
ART	ART:18|art:1	acoustic reflex threshold
ART	ART:15	adaptive resonance theory
ART	ART:5|aRT:1	adjuvant radiotherapy
ART	ART:19	algebraic reconstruction technique
ART	ART:41	antiretroviral treatment
ART	ART:11	armretina time
ART	ART:7|Art:3	artemisinin
ART	ART:22	assisted reproduction techniques
ART	ART:18	assisted reproduction technologies
ART	ART:83	atraumatic restorative treatment
ART	ART:9	auditory reaction time
ART	ART:9	tachycardia
ARVD	ARVD:138	arrhythmogenic right ventricular dysplasia
ARVD	ARVD:11	atherosclerotic renovascular disease
ARV	ARV:13	aidsassociated retrovirus
ARV	ARV:128	antiretroviral
ARV	ARV:8	average rectified value
ARV	ARV:27	avian reovirus
AR	AR:13	access recirculation
AR	AR:8	acid resistance
AR	AR:24	acoustic reflex
AR	AR:60	acoustic rhinometry
AR	AR:13	acrosomereacted
AR	AR:9	active recovery
AR	AR:33	active renin
AR	AR:9	acute allograft rejection
AR	AR:237	acute rejection
AR	AR:25	adaptive response
AR	AR:22	adrenoceptor
AR	AR:12	airway reactivity
AR	AR:52	airway responsiveness
AR	AR:197	allergic rhinitis
AR	AR:117|Ar:5	amphiregulin
AR	AR:12	anaphylactoid reactions
AR	AR:35	androgen receptor gene
AR	AR:12	anhydroretinol
AR	AR:22	anterior resection
AR	AR:37	antigen retrieval
AR	AR:417	aortic regurgitation
AR	AR:14	apoptotic rate
AR	AR:11	applied relaxation
AR	AR:31	artificially reared
AR	AR:10	aspect ratio
AR	AR:41	atrophic rhinitis
AR	AR:35	attributable risk
AR	AR:18	augmented reality
AR	AR:165	autoregressive
AR	AR:10	autoregulation
AR	AR:104|ar:3	autosomal recessive
ASA	ASA:25	accessible surface area
ASA	ASA:12	acetylsalicylate
ASA	ASA:22	active systemic anaphylaxis
ASA	ASA:8	acute severe asthma
ASA	ASA:15	american society of anaesthesiologists
ASA	ASA:50	american society of anesthesiology
ASA	ASA:16	anterior spinal artery
ASA	ASA:9	aspirinsensitive asthma
ASA	ASA:56	atrial septal aneurysm
ASB	ASB:7	anencephaly and spina bifida
ASB	ASB:14	antisocial behavior
ASB	ASB:21|AS-B:1	arylsulfatase b
ASCA	ASCA:28	antisaccharomyces cerevisiae antibodies
ASCA	ASCA:15	cerevisiae antibody
ASCRS	ASCRS:6	american society of colon and rectal surgeons
ASCRS	ASCRS:7	members of the american society of cataract and refractive surgery
ASCs	ASCs:10	ambulatory surgery centers
ASCs	ASCs:29	antibodysecreting cells
ASC	ASC:11	acidified sodium chlorite
ASC	ASC:19	adenosquamous carcinoma
ASC	ASC:9	altered states of consciousness
ASC	ASC:18	ambulatory surgical center
ASC	ASC:8	asthma symptom checklist
ASC	AsC:3|ASC:3	asymptomatic hbv carriers
ASDs	ASDs:74	atrial septal defects
ASDs	ASDs:17	autism spectrum disorders
ASDs	ASDs:13	autistic spectrum disorders
ASD	ASD:61	acute stress disorder
ASD	ASD:21	adult stills disease
ASD	ASD:6	antisiphon device
ASD	ASD:18	arthroscopic subacromial decompression
ASES	ASES:11	aerosol solvent extraction system
ASES	ASES:19	american shoulder and elbow surgeons
ASE	ASE:47	accelerated solvent extraction
ASE	ASE:5	adaptive signal enhancer
ASE	ASE:15	american society of echocardiography
ASE	ASE:12	amplified spontaneous emission
ASE	ASE:5	left sidespecific enhancer
ASF	ASF:122	african swine fever
ASF	ASF:15	airway surface fluid
ASF	ASF:9	animal source foods
ASF	ASF:34	asialofetuin
ASF	ASF:7	intensity function
ASH	ASH:9	abnormal sperm heads
ASH	ASH:81	asymmetric septal hypertrophy
ASI	ASI:9	active specific immunization
ASI	ASI:25	active specific immunotherapy
ASI	ASI:169	addiction severity index
ASI	ASI:12	anterior segment ischemia
ASI	ASI:53	anxiety sensitivity index
ASL	ASL:62	airway surface liquid
ASL	ASL:91	american sign language
ASL	ASL:11	angiosarcoma of the liver
ASL	ASL:53	argininosuccinate lyase
ASL	ASL:46	arterial spin labeling
ASO	ASO:23	allelespecific oligonucleotides
ASO	ASO:37	amplatzer septal occluder
ASO	ASO:72	arterial switch operation
ASO	ASO:89	arteriosclerosis obliterans
ASPs	ASPs:5	acid shock proteins
ASPs	ASPs:16	affected sib pairs
ASPs	ASPs:21	affected sibling pairs
ASP	ASP:15	affected sibling pair
ASP	ASP:15	amnesic shellfish poisoning
ASP	ASP:25	antisocial personality
ASP	ASP:13|Asp:1	asparaginase
ASR	ASR:12	absolute synthesis rate
ASR	ASR:34	acoustic startle reflex
ASR	ASR:12	aldosterone secretion rate
ASR	ASR:12	androgensterilized rats
ASR	ASR:10	speech recognition
ASST	ASST:12	arylsulfate sulfotransferase
ASST	ASST:18	autologous serum skin test
ASTM	ASTM:6	american society for testing materials
ASTM	ASTM:19	astromicin
AST	AST:11	acute suppurative thyroiditis
AST	AST:4	androgen suppression therapy
AST	AST:15	antimicrobial susceptibility testing
AST	AST:6	arginine stimulation test
AST	AST:11	aryl sulfotransferase
AST	AST:32	aspartate
AST	AST:17	aspartateaminotransferase
AST	AST:15	aspartate transferase
AST	AST:44|AsT:1	serum aspartate transaminase
ASV	ASV:8	adaptive support ventilation
ASV	ASV:2	aneurysm of sinus of valsalva
ASV	ASV:32	anodic stripping voltammetry
ASV	ASV:14	autogenous saphenous vein
ASW	ASW:34	artificial sea water
ASW	ASW:41	artificial seawater
AT1	AT1:7	ang ii receptor
AT1	AT1:112	angiotensin type 
AT1	AT1:8|AT-1:1	subtype
AT1	AT1:6	type  ang ii
AT1	AT1:7	type  angiotensin
AT1	AT1:12	type  angiotensin ii receptor
ATA	ATA:14|ata:2	 atmosphere absolute
ATA	ATA:6	absolute atmospheres
ATA	ATA:11	american thyroid association
ATA	ATA:5	antithyroglobulin antibody
ATA	ATA:12	antithyroid antibodies
ATA	ATA:10	aspirintolerant asthma
ATA	ATA:86|ata:3	atmospheres absolute
ATA	ATA:5	atmospheres of absolute pressure
ATA	ATA:22	aurin tricarboxylic acid
ATA	ATA:120	aurintricarboxylic acid
ATA	ATA:9	thermolabile antigen
ATC	ATC:14	air traffic control
ATC	ATC:10	anaplastic thyroid cancer
ATC	ATC:39	anaplastic thyroid carcinoma
ATC	ATC:6|atc:5|ATc:2|aTc:2	anhydrotetracycline
ATC	ATC:8	autologous tumor cells
ATC	ATC:21	automatic tube compensation
ATD	ATD:40	acute tryptophan depletion
ATD	ATD:9	alpha  antitrypsin deficiency
ATD	ATD:22	amplatz thrombectomy device
ATD	ATD:13	aqueous tear deficiency
ATD	ATD:14	aromatase inhibitor androstatrienedione
ATD	ATD:31	autoimmune thyroid disease
ATD	ATD:9	test dummy
ATII	ATII:70|AT-II:3	alveolar type ii
ATII	ATII:9|AT-II:3	type ii cells
ATI	ATI:16	abdominal trauma index
ATI	ATI:7	treatment interaction
ATLS	ATLS:15	acute tumor lysis syndrome
ATLS	ATLS:105	advanced trauma life support
ATL	ATL:16	adult tcell leukaemialymphoma
ATL	ATL:7	adult tcell lymphoma
ATL	ATL:16	american tegumentary leishmaniasis
ATL	ATL:96	anterior temporal lobectomy
ATL	ATL:11	ascending thin limb
ATM	ATM:32	acute transverse myelitis
ATM	ATM:19	acute transverse myelopathy
ATM	ATM:24	asynchronous transfer mode
ATM	ATM:9|Atm:1	ataxiatelangiectasia gene
ATM	ATM:7	mutated protein
ATN	ATN:316	acute tubular necrosis
ATN	ATN:10	anterior thalamic nuclei
ATP	ATP:10	adenosine triphosphoric acid
ATP	ATP:41	adenosinetriphosphate
ATP	ATP:14	annual transmission potential
ATP	ATP:41	antitachycardia pacing
ATP	ATP:34	substrate
ATR-X	ATR-X:7	xlinked alphathalassemiamental retardation
ATR-X	ATR-X:8	xlinked alphathalassemiamental retardation syndrome
ATR	ATR:8	achilles tendon reflex
ATR	ATR:48	acid tolerance response
ATR	ATR:12|Atr:3	atractyloside
ATR	ATR:52	attenuated total reflectance
ATR	ATR:73	attenuated total reflection
ATR	ATR:12	radrelated protein
ATS	ATS:150	american thoracic society
ATS	ATS:9	rabbit antirat thymocyte serum
ATS	ATS:5	thymocyte antiserum
ATV	ATV:19	allterrain vehicle
ATV	ATV:7|Atv:2	atorvastatin
ATx	ATx:8|ATX:3|aTx:1	adult thymectomized
ATx	ATx:18|ATX:2|aTx:1|A-Tx:1	adult thymectomy
AUC(0-24)	AUC(0-24):6|AUC(0--24):1	area under the concentrationtime curve from  to  h
AUC(0-24)	AUC(0-24):4	concentrationtime curve from time zero to  h
AUC0-24	AUC0-24:7	concentrationtime curve from  to  hours
AUC0-24	AUC0-24:5	under the concentrationtime curve from  to  h
AUCs	AUCs:9	area under the concentrationtime curves
AUCs	AUCs:17	under the plasma concentrationtime curves
AUC	AUC:23	analytical ultracentrifugation
AUC	AUC:3	areas under concentrationtime curves
AUC	AUC:15	areaundercurve
AUC	AUC:13	area under the concentration
AUC	AUC:8	area under the curve of concentration versus time
AUC	AUC:4	area under the plasma concentration
AUC	AUC:8	concentration timecurve
AUC	AUC:7	concentrationtime profiles
AUC	AUC:4	concentration vs time curves
AUC	AUC:5	curve values
AUC	AUC:13	drug exposure
AUC	AUC:8	extent of absorption
AUC	AUC:28	plasma concentrationtime curve from time zero to time infinity
AUC	AUC:12	systemic exposure
AUC	AUC:4	under the plasma concentrationtime profile
AUL	AUL:13	acute undifferentiated leukaemia
AUL	AUL:48	acute undifferentiated leukemia
AUMC	AUMC:6	area under the first moment curve
AUMC	AUMC:6|AuMC:1	area under the moment curve
AUR	AUR:54	acute urinary retention
AUR	AUR:11	auromomycin
AV3V	AV3V:6	anteroventral third ventricle region
AV3V	AV3V:8	anteroventral third ventricular
AV3V	AV3V:7	anteroventral third ventricular region
AVA	AVA:11	anthrax vaccine adsorbed
AVA	AVA:51	aortic valve area
AVA	AVA:1	main metabolite apovincaminic acid
AVCN	AVCN:12	anteroventral
AVCN	AVCN:96	anteroventral cochlear nucleus
AVDO2	AVDO2:4|AVDo2:1	arteriovenous difference of oxygen
AVDO2	AVDO2:5	oxygen differences
AVD	AVD:12	aortic valve disease
AVD	AVD:15	apoptotic volume decrease
AVD	AVD:14|AVd:1	atrioventricular delay
AVD	AVD:12	vascular disease
AVED	AVED:6	ataxia with isolated vitamin e deficiency
AVED	AVED:8	ataxia with vitamin e deficiency
AVE	AVE:10	active voluntary euthanasia
AVE	AVE:20	anterior visceral endoderm
AVG	AVG:6	autogenous vein grafts
AVG	AVG:6	inhibitor aminoethoxyvinylglycine
AVL	AVL:33	american visceral leishmaniasis
AVL	AVL:9	artificial ventilation of the lungs
AVM	AVM:9	avermectin ba
AVM	AVM:9	avian vacuolar myelinopathy
AVN	AVN:25	atrioventricular nodal
AVN	AVN:77	atrioventricular node
AVN	AVN:11	avascular necrosis of bone
AVP	AVP:13	adenovirus proteinase
AVP	AVP:28	ambulatory venous pressure
AVP	AVP:24	argvasopressin
AVP	AVP:11	argininvasopressin
AVP	AVP:8	arginine vasopression
AVP	AVP:29	arteriovenous passage time
AVRT	AVRT:27	atrioventricular reciprocating tachycardia
AVRT	AVRT:27	atrioventricular reentrant tachycardia
AVRT	AVRT:10	av reentrant tachycardia
AVR	AVR:43	acute vascular rejection
AVR	AVR:9	arterioletovenule ratio
AVR	AVR:27	ascending vasa recta
AVS	AVS:13	aortic valve sclerosis
AVS	AVS:6	arteriovenous shunt
AVS	AVS:6	visualization system
AV	AV:12	abomasal volvulus
AV	AV:5	adriamycin and vincristine
AV	AV:5	adriamycin plus vincristine
A-V	A-V:5|AV:4|a-v:1	animalvegetal
AV	AV:6	annexin v
AV	AV:14	anterior ventral
AV	AV:5	anteroventral nucleus
AV	AV:32	aortic valve
A-V	A-V:14|a-v:2|AV:1	arterialvenous
AV	AV:9	artificial vagina
AV	AV:8	artificial ventilation
AV	AV:7	assisted ventilation
AV	AV:14	audiovisual
AV	AV:11|A-V:3	auditoryvisual
AV	AV:7	femoral anteversion
A-V	A-V:5|AV:3|A--V:1	venous
AWD	AWD:13	abdominal wall defects
AWD	AWD:8	alive with disease
AZF	AZF:48	azoospermia factor
AZF	AZF:14	bovine adrenal zona fasciculata
AZQ	AZQ:33	aziridinylbenzoquinone
AZQ	AZQ:55	diaziquone
AZT	AZT:77|az-T:1	azidodideoxythymidine
AZT	AZT:9	clinical studies on aztreonam
ABM	ABM:32	acute bacterial meningitis
ABM	ABM:10	bone matrix
AcMNPV	AcMNPV:22	autographa californica mnpv
AcMNPV	AcMNPV:37	autographa californica multicapsid nucleopolyhedrovirus
AcSDKP	AcSDKP:11|Ac-SDKP:1	nacetylserasplyspro
AcSDKP	AcSDKP:11	tetrapeptide acetylnserasplyspro
AcSDKP	AcSDKP:6	tetrapeptide acetylserasplyspro
Ad5	Ad5:49	adenovirus serotype 
Ad5	Ad5:18	type  adenovirus
ADM	ADM:86	abductor digiti minimi
ADM	ADM:14	abductor digiti minimi muscle
ADM	ADM:20	acellular dermal matrix
ADM	ADM:14|Adm:2|AdM:1	adrenodemedullated
ADM	ADM:15	amyopathic dermatomyositis
ADO	ADO:14	amplatzer duct occluder
ADO	ADO:12	autosomal dominant osteopetrosis
ADX	ADX:9|Adx:1	adrenalectomised
ADX	ADX:9|AdX:1	adrenalectomized rats
ADX	ADX:350|Adx:21|adx:7|ADx:1	adrenalectomy
AD	AD:12	acute diarrhea
Ad	Ad:7|AD:6	adherent
Ad	Ad:8|AD:2	adrenodoxin
AD	AD:9|Ad:5	adult
AD	AD:9	adultdirected
AD	AD:9	affective disorders
AD	AD:21	afterdischarge
AD	AD:40	alcohol dependence
AD	AD:6	alzheimers disease patients
AD	AD:15	alzheimertype dementia
AD	AD:31	androgen deprivation
AD	AD:30	anoxic depolarization
AD	AD:12	anterodorsal
AD	AD:5	anterodorsal thalamic nucleus
AD	AD:13	aortic diameter
AD	AD:35	aortic dissection
AD	AD:11	apparent digestibility
AD	AD:6	arrhythmogenic dose
AD	AD:12	atherogenic diet
AD	AD:1352|Ad:9|ad:1	atopic dermatitis
AD	AD:10	atypical depression
AD	AD:8	autoimmune diseases
AD	AD:8	autonomic dysfunction
AD	AD:37	autonomic dysreflexia
AD	AD:96|ad:2	autosomal dominant
AD	AD:12	axillary dissection
AD	AD:1	dementia of an alzheimers type
AD	AD:19	dementia of the alzheimer type
AFL	AFL:21|Afl:6	aflatoxicol
AFL	AFL:9	australian football league
AGE	AGE:19	advanced glycosylation endproducts
AGE	AGE:42|age:1	agarose gel electrophoresis
AGE	AGE:44	aged garlic extract
AGE	AGE:20	arterial gas embolism
AgNORs	AgNORs:4	identified by silver staining
AgNORs	AgNORs:4|Ag-NORs:2	silverstained nors
AgNORs	AgNORs:5	silverstained nucleolar organizer regions protein
AgNOR	AgNOR:71|Ag-NOR:7	argyrophilic nucleolar organizer region
AgNOR	AgNOR:5|Ag-NOR:1	argyrophilic technique
AgNOR	AgNOR:5|Ag-NOR:5	silver staining
AGS	AGS:22	adrenogenital syndrome
AGS	AGS:55	alagille syndrome
AGs	AGs:18|Ags:1	aminoglycosides
AGs	AGs:13	aminoglycoside antibiotics
AGS	AGS:10	human gastric adenocarcinoma
AHRR	AHRR:6|AhRR:2	ahr repressor
AHRR	AHRR:5|AhRR:4	aryl hydrocarbon receptor repressor
AHR	AHR:19	acute humoral rejection
AHR	AHR:10|aHR:1	adjusted hazard ratio
Al2O3	Al2O3:8	alumina ceramic
Al2O3	Al2O3:17	aluminum oxide
AlF4-	AlF4-:18	aluminum fluoride
AlF4-	AlF4-:13	fluoroaluminate
ALB	ALB:6|Alb:3	albumin concentration
ALB	ALB:12	anxietylike behavior
AMC	AMC:19	academic medical center
AMC	AMC:7	agematched controls
AMC	AMC:8	amoeboid microglial cells
AMC	AMC:10	anteromedial cortex
AMC	AMC:61	arthrogryposis multiplex congenita
AMC	AMC:11	medical centre
Ap3A	Ap3A:7|AP3A:2	diadenosine pptriphosphate
Ap3A	Ap3A:24|AP3A:3	diadenosine triphosphate
APCR	APCR:68|APC-R:27|APC-r:3|aPCR:2|APCr:2	activated protein c resistance
APCR	APCR:17|APC-R:9|APCr:2|aPCR:1|aPCr:1	resistance to activated protein c
APR	APR:5	absolute production rate
APR	APR:11	absolute proximal reabsorption
APR	APR:4	absolute proximal reabsorption rate
APR	APR:11	accessory planta retractor
APR	APR:5	adenosine phosphosulphate reductase
APR	APR:7	proximal tubular reabsorption
ARE	ARE:9	ampicillinresistant enterococci
ARE	are:3|ARE:3	androgen response elements
ARE	ARE:85|are:10	antioxidant response element
ARE	ARE:31|are:4	antioxidant responsive element
ara-U	ara-U:11|Ara-U:4|araU:2	betadarabinofuranosyluracil
ara-U	ara-U:7|Ara-U:5|araU:2|ARA-U:1|AraU:1	uracil arabinoside
Arg	Arg:4|ARG:3	ablrelated gene
Arg	Arg:180|ARG:60|arg:4	arginine
ARG	ARG:16	autoradiographic
ARG	ARG:41	autoradiography
AS	AS:11	absence seizures
AS	AS:9	acetosyringone
AS	AS:20	active
AS	AS:6	actual survival
AS	AS:7	actuarial survival
AS	AS:10	affective style
AS	AS:21	aggregation substance
AS	AS:6|As:1	alkaline secretion
AS	AS:7|as:2	alphasynuclein
AS	AS:58	alport syndrome
AS	AS:14	alternative splicing
AS	AS:22	ammonium sulfate
AS	AS:11	ammonium sulphate
AS	AS:17|As:1	anabolic steroids
AS	AS:15	anaphylactic shock
AS	AS:6	androgen suppression
AS	AS:11	angelis salt
AS	AS:31	angiosarcoma
AS	AS:8	ankylosing spondylarthritis
AS	AS:9	antisaccades
AS	AS:173|As:9|as:8	antisense
AS	AS:18|As:1	antiserum
AS	AS:62	anxiety sensitivity
AS	AS:9|As:2	argininosuccinate synthase
As	As:233|AS:1	arsenic
AS	AS:9	arteriosclerosis
AS	AS:9	artificial saliva
AS	AS:32|As:8	asparagine synthetase
AS	AS:3|As:2	assisted suicide
AS	AS:7	atherometric system
AS	AS:9	atherosclerotic
As	As:6	autism and asperger syndrome
AS	AS:19	autologous serum
AS	AS:16	plasmodium chabaudi chabaudi
AS	AS:8	sickle trait
AS	AS:14|A-S:1	stress
ATT	ATT:12	anterior tibial translation
ATT	ATT:5	antitubercular treatment
ATT	ATT:6	antituberculous therapy
att	att:24	attachment
att	att:8	attachment site
att	att:12	attenuated
ATT	ATT:13	tolerance test
att	att:1	ts and attenuation
ATP7B	ATP7B:13	coppertransporting ptype adenosine triphosphatase
ATP7B	ATP7B:5	wilson disease protein
AT	AT:47|At:3	acceleration time
AT	AT:16	acetyltransferase
AT	AT:20	achilles tendon
AT	AT:26	activation time
AT	AT:15	active tension
AT	AT:13|A-T:9	adeninethymine
AT	AT:153	adipose tissue
AT	AT:8	alopecia totalis
AT	AT:5	ambient temperature
AT	AT:13	anterior tibialis
AT	AT:314|At:2	antithrombin
AT	AT:15	area tempestas
AT	AT:30	assistive technology
AT	AT:64|At:6|A-T:1	atrial tachycardia
AT	AT:29	autogenic training
A-T	A-T:9|AT:3|At:1	autosomal recessive disorder ataxiatelangiectasia
AT	AT:5	catalase inhibitor aminotriazole
A-T	A-T:5|AT:2	cells from patients with ataxiatelangiectasia
A-T	A-T:21|AT:2	human genetic disorder ataxiatelangiectasia
AU	AU:11	alopecia universalis
AU	AU:38	anterior uveitis
Az	Az:12|AZ:1	areas
Az	Az:8|AZ:1	azone
B-PLL	B-PLL:12	bcell prolymphocytic leukemia
B-PLL	B-PLL:10	bprolymphocytic leukaemia
B-PLL	B-PLL:9	bprolymphocytic leukemia
B/W	B/W:9	f hybrid
B/W	B/W:19	nzbnzw f
B/W	B/W:11	nzb x nzw
B1	B-1:6|B1:6	b cells
B1	B1:15	thiamine
B6	B6:23	cb
B6	B6:679	cbl
B6	B6:13	cblby
B6	B6:11	cblbyj
B6	B6:387|B-6:1	cblj
B6	B6:16	cbln
BACs	BACs:127	bacterial artificial chromosomes
BACs	BACs:98|BACS:1	blood alcohol concentrations
BACs	BACs:12	bronchioloalveolar carcinomas
BAC	BAC:12|Bac:2	baclofen
BAC	BAC:7	biological activated carbon
BAC	BAC:18	blood alcohol content
BAC	BAC:7	bovine adrenal fasciculata cells
BAC	BAC:14	bovine adrenocortical
BAC	BAC:121	bronchioloalveolar carcinoma
BAC	BAC:18	bronchoalveolar cells
BAEC	BAEC:10	bovine aorta
BAEC	BAEC:10	bovine aortic ec
BAE	BAE:95	bovine aortic endothelial
BAE	BAE:28	bronchial artery embolization
BAFF	BAFF:6	b cellactivating factor belonging to the tnf family
BAFF	BAFF:1	factor from the tnf family
BAF	BAF:22	barriertoautointegration factor
BAF	BAF:8	biological aerated filter
BAF	BAF:6	bronchoalveolar fluid
BAH	BAH:11	bilateral adrenal hyperplasia
BAH	BAH:7	borderline arterial hypertension
BAI	BAI:12	blunt aortic injury
BAI	BAI:6	brain atrophy index
BAI	BAI:15	bronchial arterial infusion
BAI	BAI:9|B-AI:1	bronchial artery infusion
B-ALL	B-ALL:48|BALL:2	acute lymphoblastic leukemia
B-ALL	B-ALL:12	bcell acute lymphoblastic leukaemia
BAL	BAL:100	bioartificial liver
BAL	BAL:8	biphenotypic acute leukemia
BAL	BAL:15|Bal:1	british antilewisite
BAL	BAL:37	bronchoalveolar
BAM	BAM:28	bacteriological analytical manual
BAM	BAM:11	bidirectional associative memory
BAM	BAM:27|bAM:5	bovine alveolar macrophages
BAM	BAM:28	brewster angle microscopy
BAM	BAM:20	bronchoalveolar macrophages
BAM	BAM:4	metabolite dichlorobenzamide
BAR	BAR:28	biofragmentable anastomosis ring
BAR	BAR:17	biofragmentable anastomotic ring
BAS	BAS:24	balloon atrial septostomy
BAS	BAS:10	barnes akathisia scale
BAS	BAS:10	behavioral activation system
BAS	BAS:9	biologically active substances
BAT	BAT:16	basophil activation test
BAT	BAT:32	blunt abdominal trauma
BAT	BAT:7	brain adjacent to tumor
BAV	BAV:18	balloon aortic valvuloplasty
BAV	BAV:31	bicuspid aortic valve
BAV	BAV:9	bovine adenovirus
BAW	BAW:8	bronchoalveolar washings
BAW	BAW:20	bulk acoustic wave
BA	BA:36	bacillary angiomatosis
BA	BA:7	background activity
BA	BA:11	basilar
BA	BA:9	benzaldehyde
BA	BA:12	benzamide
BA	BA:62	benzoic acid
BA	BA:18	benzyl alcohol
BA	BA:201	biliary atresia
BA	BA:43	bioavailability
BA	BA:12	biogenic amines
BA	BA:19	blood agar
BA	BA:118	bone age
BA	BA:31|ba:1|Ba:1	brachial artery
BA	BA:289	bronchial asthma
BA	BA:7	butyl acrylate
BA	BA:45	butyric acid
BA	BA:6	lymphoma cell bioassay
BA	BA:9	mgl benzylaminopurine
BA	BA:5	nbutyl acrylate
BA	BA:14	nbenzyladenine
BBA	BBA:34	balanced budget act
BBA	BBA:22	balanced budget act of 
BBA	BBA:9	born before arrival
BBB	BBB:1	basso beattie bresnahan
BBB	BBB:68	bundle branch block
BBdp	BBdp:15|BB-DP:7|BBDP:4	diabetesprone
BBdp	BBdp:7|BBDP:3|BB-DP:1	diabetesprone bb
BBdp	BBdp:7|BB-DP:1	diabetesprone biobreeding
BBE	BBE:9	berberine bridge enzyme
BBE	BBE:15	bickerstaffs brainstem encephalitis
BBIC	BBIC:9	bbi concentrate
BBIC	BBIC:5	bowmanbirk inhibitor concentrate
BBI	BBI:48	bowmanbirk inhibitor
BBI	BBI:29	bowmanbirk protease inhibitor
BBN	BBN:17	bayesian belief network
BBN	BBN:13	broadband noise
BBP	BBP:7	bilinbinding protein
BBP	BBP:39	butyl benzyl phthalate
BBP	BBP:17	butylbenzyl phthalate
BBS	BBS:75	bardetbiedl syndrome
BBS	BBS:29	berg balance scale
BBS	BBS:7	bulletin board system
BB	BB:12	bachmanns bundle
BB	BB:11|bb:1	benzyl benzoate
BB	BB:64|Bb:1	biceps brachii
BB	BB:24	biobreeding
Bb	Bb:7|BB:7	bisbenzimide
Bb	Bb:5|BB:4	bordetella bronchiseptica
Bb	Bb:60|BB:10	borrelia burgdorferi
BB	BB:13	brain
BB	BB:38	bromobenzene
BB	BB:9	broth
BB	BB:6	diabetes in the biobreeding
BB	BB:9	spontaneously diabetic
BCA	BCA:5	balloon coronary angioplasty
BCA	BCA:33	bicinchoninic acid
BCA	BCA:6	bifunctional chelating agent
BCA	BCA:11	bronchial crosssectional area
BCB	BCB:10|bcb:1	bloodcsf barrier
BCB	BCB:16	brilliant cresyl blue
BCCA	BCCA:8	bilateral clamping of carotid arteries
BCCA	BCCA:13	british columbia cancer agency
BCCA	BCCA:4	min to bilateral clamping of the common carotid arteries
BCCs	BCCs:229|BCCS:1	basal cell carcinomas
BCCs	BCCs:9	breast cancer cells
BCC	BCC:8	basal cell
BCC	BCC:9	basal cell cancer
BCC	BCC:9	breast cancer cell
BCC	BCC:6	chromaffin cells
BCEs	BCEs:9	basal cell epitheliomas
BCEs	BCEs:6	bovine capillary endothelial cells
BCE	BCE:28|bce:2	basal cell epithelioma
BCE	BCE:39	bovine capillary endothelial
BCE	BCE:20	bovine corneal endothelial
BCF	BCF:24	beat cross frequency
BCF	BCF:37|bcf:1	breast cyst fluid
BCG-CWS	BCG-CWS:7	bcg cellwall skeleton
BCG-CWS	BCG-CWS:7	cell wall skeleton
BCG	BCG:63	bacille calmette guerin
BCG	BCG:9	bacilluscalmetteguerin
BCG	BCG:14	bacillus of calmette and guerin
BCG	BCG:11	ballistocardiogram
BCG	BCG:16	bromcresol green
BCG	BCG:24	bromocresol green
BCG	BCG:25	calmetteguerin bacillus
BCG	BCG:8	calmetteguerin vaccine
BCG	BCG:131	mycobacterium bovis
BCKA	BCKA:11	branchedchain alphaketo acid
BCKA	BCKA:10	branchedchain keto acids
BCL1	BCL1:23	b cell leukemia
BCL1	BCL1:11	murine bcell leukemia
Bcl-2	Bcl-2:7|bcl-2:4	antiapoptotic
Bcl-2	Bcl-2:9|bcl-2:3	bcl protein
B-CLL	B-CLL:8|BCLL:1	chronic lymphocytic leukemias
B-CLL	B-CLL:3	chronic lymphocytic leukemia of bcell type
B-CLL	B-CLL:4	leukemia of bcell origin
B-CLL	B-CLL:7	lymphocytic leukemia cells
BCM	BCM:6	blue cone monochromatism
BCM	BCM:120|bcm:2	body cell mass
BCM	BCM:9	bovine cervical mucus
BCM	BCM:7	bulbocavernosus muscle
BCNS	BCNS:9	basal cell naevus syndrome
BCNS	BCNS:21	basal cell nevus syndrome
BCNU	BCNU:9	bischlorethylnitrosourea
BCNU	BCNU:285	carmustine
BCNU	BCNU:18	nnbischloroethylnnitrosourea
BCP	BCP:24	blood cardioplegia
BCP	BCP:9	bromcresol purple
BCP	BCP:19	bromocresol purple
BCR	BCR:8	antigen receptors
BCR	BCR:34	bulbocavernosus reflex
BCR	BCR:25	community bureau of reference
BCR	BCR:11|BcR:1	receptor complex
BCs	BCs:8	basket cells
BCS	BCS:8	bathocuproinedisulfonic acid
BCS	BCS:29	biopharmaceutics classification system
BCs	BCs:12	bipolar cells
BCS	BCS:12	bovine calf serum
BCS	BCS:11	breast cancer survivors
BCS	BCS:116|B-CS:1	buddchiari syndrome
BCs	BCs:11	buffy coats
BCT	BCT:11	basic combat training
BCT	BCT:15	blood cell transplantation
BCT	BCT:40	breast conservation therapy
BCT	BCT:105	breastconserving therapy
BCT	BCT:9	buffy coat technique
BC	BC:8|Bc:1	bacitracin
BC	BC:17	bacterial cellulose
BC	BC:9	basaloid carcinoma
BC	BC:9	basic copy
BC	BC:11	bile canaliculi
BC	BC:7|bc:1	biliary complications
BC	BC:5	biochemical control
BC	BC:15	biotin carboxylase
BC	BC:9	biventer cervicis
BC	BC:36	black carbon
BC	BC:11	bladder capacity
BC	BC:85	blast crisis
BC	BC:31	blastic crisis
BC	BC:27	body composition
BC	BC:9	body condition
BC	BC:20	brachium conjunctivum
BC	BC:23	bronchoconstriction
BC	BC:9	bronchogenic cyst
BC	BC:43	bulbocavernosus
BDA	BDA:23	anterograde tracer biotinylated dextran amine
BDA	BDA:11	beclomethasone dipropionate aerosol
BDA	BDA:10	british diabetic association
BDD	BDD:9	butenediol
BDD	BDD:98	body dysmorphic disorder
BDD	BDD:13	borondoped diamond
BDE	BDE:17	bond dissociation energy
BDE	BDE:12	bond dissociation enthalpy
BDEs	BDEs:16	bond dissociation energies
BDEs	BDEs:13	bond dissociation enthalpies
BDI	BDI:23	baseline dyspnea index
BDI	BDI:889	beck depression inventory
BDI	BDI:14	bile duct injury
BDI	BDI:6	bleomycindetectable iron
BDL	BDL:192|bdl:1	bile duct ligation
BDL	BDL:8	ligation of the common bile duct
BDR	BDR:12	background diabetic retinopathy
BDR	BDR:15	bile duct resection
BDR	BDR:9	bronchodilator response
BD	BD:39	basal diet
BD	BD:45	base deficit
BD	BD:492|Bd:1	behcets disease
BD	BD:11	bicarbonate dialysis
BD	BD:10	biotinylated dextran
BD	BD:16	bladder drainage
BD	BD:11	body dissatisfaction
BD	BD:48	bone density
BD	BD:12	bony defect
BD	BD:66	brain death
BD	BD:33	brownian dynamics
BEA	BEA:9	bromoethanamine
BEA	BEA:17	bromoethylamine hydrobromide
BEA	BEA:10	beauvericin
BEC	BEC:15	boseeinstein condensate
BEC	BEC:9	boseeinstein condensation
BEF	BEF:5	best excitatory frequency
BEF	BEF:28	bovine ephemeral fever
BEF	BEF:7	enhancing factor
BEI	BEI:27	backscattered electron imaging
BEI	BEI:13	binary ethylenimine
BEI	BEI:26	biological exposure index
BEL	BEL:11	bovine epithelial lens
BEL	BEL:49	bromoenol lactone
BER	BER:350	base excision repair
BER	BER:14	basic electric rhythm
BER	BER:29	basic electrical rhythm
Ber	Ber:8|BER:3	berbamine
Ber	Ber:11|BER:1	berberine
BES	BES:10	balanced electrolyte solution
BES	BES:17	binge eating scale
BEV	BEV:21	beams eye view
BEV	BEV:9	berne virus
BEV	BEV:15	bovine enterovirus
BE	BE:34	butoxyethanol
BE	BE:39	bacterial endocarditis
BE	BE:35	barium enema
BE	BE:139|-BE:1	base excess
BE	BE:20	bioequivalence
BE	BE:14	brain edema
BE	BE:15	bronchiectasis
BE	BE:9	cocaine and benzoylecgonine
BE	BE:11	cocaine metabolite benzoylecgonine
BFA	BFA:9	bifunctional antibody
BFA	BFA:10	brefeldina
BFDV	BFDV:13	beak and feather disease virus
BFDV	BFDV:13	budgerigar fledgling disease virus
BFI	BFI:9	blood flow index
BFI	BFI:10	brief fatigue inventory
BFM	BFM:44	berlinfrankfurtmunster
BFM	BFM:23	body fat mass
BFP	BFP:27	basic fetoprotein
BFP	BFP:9	biological false positive
BFP	BFP:19	blue fluorescent protein
BFP	BFP:11	buccal fat pad
BFP	BFP:16|bfp:2	bundleforming pili
BFP	BFP:24|bfp:5|Bfp:1	bundleforming pilus
BFU-E	BFU-E:19|BFU-e:1	erythroid burstforming cells
BFU-E	BFU-E:48|BFUe:3|bfu-E:1	erythroid burstforming unit
BFU-E	BFU-E:11|BFUe:1|BFU-e:1	erythroid precursors
BFU-E	BFU-E:35|BFU-e:4|BFUe:3|BFUE:1	erythroid progenitor cells
BFV	BFV:5|BFv:1	barmah forest virus
BFV	BFV:9	blood flow volume
BF	BF:17	backfat
BF	BF:103|Bf:1	basal forebrain
BF	BF:86|bf:1	biceps femoris
BF	BF:20|bF:4	biochemical failure
BF	BF:21	biofiltration
BF	BF:9	blister fluid
BF	BF:7	blocking factors
BF	BF:11	boutonneuse fever
BF	BF:22	breastfed
BF	BF:19	breastfeeding
BF	BF:36	bursa of fabricius
BGA	BGA:6	blood gas analysis
BGA	BGA:13|bga:1	blood group antigens
BGA	BGA:9	brilliant green agar
BGM	BGM:9	blood glucose monitoring
BGM	BGM:21	buffalo green monkey
BG	BG:13	background
BG	BG:113	basal ganglia
BG	BG:28|B-G:1	basenjigreyhound
BG	BG:10	bioglass
BG	BG:13	brilliant green
BHA	BHA:12	tbutylmethoxyphenol
BHA	BHA:10	benzhydroxamic acid
BHA	BHA:16|Bha:1	benzohydroxamic acid
BHA	BHA:12	butylated hydroxy anisole
BHA	BHA:12	butylated hydroxyanisol
BHA	BHA:468	butylated hydroxyanisole
BHA	BHA:12	butylhydroxyanisole
BHC	BHC:26	benzene hexachloride
BHC	BHC:10	hexachlorocyclohexane
BHI	BHI:41	biosynthetic human insulin
BHI	BHI:12	breathholding index
BHL	BHL:21	bilateral hilar lymphadenopathy
BHL	BHL:5	nbutanoyllhomoserine lactone
BHMT	BHMT:16	betainehomocysteine methyltransferase
BHMT	BHMT:6	betainehomocysteine smethyltransferase
BHS	BHS:18	beck hopelessness scale
BHS	BHS:10	betahemolytic streptococci
BHS	BHS:53	british hypertension society
BHS	BHS:8	congenitally bronchialhypersensitive
BHT	BHT:18	ditertbutylmethylphenol
BHT	BHT:13	ditertbutylhydroxytoluene
BHT	BHT:5	antioxidant ionol
BHT	BHT:12	breathholding time
BHT	BHT:10	breath hydrogen test
BHT	BHT:31	butylhydroxytoluene
BHV	BHV:8	bioprosthetic heart valves
BHV	BHV:12	bovine herpesvirus
BH	BH:25	bcl homology
BH	BH:13	bleomycin hydrolase
BH	BH:10	blood hypertension
BH	BH:19	body height
BH	BH:15	breathhold
BIC	BIC:16	bayesian information criterion
BIC	BIC:75|Bic:16	bicuculline
BIC	BIC:17	binaural interaction component
BIC	BIC:11	boneimplant contact
BIC	BIC:17	bonetoimplant contact
BII	BII:11|B-II:4	billroth ii
BII	BII:10	bph impact index
BIR	BIR:23	baculovirus iap repeat
BIR	BIR:9	breakinduced replication
BIS	BIS:7	barratt impulsivity scale
BIS	BIS:17	behavioral inhibition system
BIS	BIS:20	bioelectrical impedance spectroscopy
BIS	BIS:19	bioimpedance spectroscopy
BIS	BIS:15	bispectral
BIS	BIS:6	bispectral analysis
BIS	BIS:400|Bis:1	bispectral index
BIS	BIS:7	bispectral index scale
BIS	BIS:5	bispectral index score
BIS	BIS:1	pkc inhibitor bisindolylmaleimide
BJP	BJP:22	bence jones protein
BJP	BJP:8	bence jones proteinuria
BKA	BKA:12	belowknee amputation
BKA	BKA:9	bongkrekic acid
BLA	BLA:11	bacillus licheniformis alphaamylase
BLA	BLA:52|Bla:4	basolateral nucleus of the amygdala
BLA	BLA:6	biologics license application
BLA	BLA:15	bovine alphalactalbumin
BLA	BLA:4	submitted a biologics licence application
bLF	bLF:31|bLf:13|BLF:11|BLf:9|b-LF:1	bovine lactoferrin
bLF	bLF:12|bLf:5|BLf:2|BLF:1|b-LF:1	bovine lf
BLI	BLI:28	bombesinlike immunoreactivity
BLI	BLI:12	vivo bioluminescence imaging
BLM	BLM:47|blm:1	basolateral membranes
BLM	BLM:35	biotic ligand model
BLM	BLM:6	syndrome protein
BLNAR	BLNAR:10	betalactamasenegative ampicillinresistant
BLNAR	BLNAR:1	negative but ampicillin resistant
BLSS	BLSS:6	bioartificial liver support system
BLSS	BLSS:6	bioregenerative life support system
BLS	BLS:32	bare lymphocyte syndrome
BLS	BLS:139	basic life support
BLS	BLS:23	bureau of labor statistics
BLT	BLT:13	bilateral lung transplantation
BLT	BLT:8	bright light therapy
BLT	BLT:13	thiobenzyl ester
BLV	BLV:130	bovine leukaemia virus
BLV	BLV:530	bovine leukemia virus
BL	BL:8	bacterial levan
BL	BL:74	basal lamina
BL	BL:28	bilateral
BL	BL:5	blood loss
BL	BL:8	blood lymphocytes
BL	BL:21	blue light
BL	BL:20	body length
BL	BL:6	bone loss
BL	BL:11	borderline
BL	BL:65	borderline lepromatous
BL	BL:8	borderline lepromatous leprosy
BL	BL:26	brassinolide
BL	BL:17	bright light
BL	BL:31	bronchial lavage
BMAA	BMAA:7	aminomethylaminopropanoic acid
BMAA	BMAA:26	betanmethylaminolalanine
BMA	BMA:9	bone marrow aspirate
BMA	BMA:11	bone marrow aspiration
BMA	BMA:7	bovine mesenteric arteries
BMA	BMA:18	british medical association
BMA	BMA:13	butyl methacrylate
BMC	BMC:14	balloon mitral commissurotomy
BMC	BMC:5	benchmark concentration
BMC	BMC:5	bicuculline methochloride
BMC	BMC:16	biopartitioning micellar chromatography
BMC	BMC:10	bone mass
BMD	BMD:43	benchmark dose
BMD	BMD:12	bone mineral densitometry
BMD	BMD:15	broth microdilution
BME	BME:9	basal medium eagle
BME	BME:9	bovine microvascular endothelial
BMF	BMF:8	best modulation frequency
BMF	BMF:9	biomagnification factor
BMF	BMF:14	bone marrow fibroblasts
BMG	BMG:27	benign monoclonal gammopathy
BMG	BMG:40	beta microglobulin
BMG	BMG:13	bilirubin monoglucuronide
BMG	BMG:22	bone matrix gelatin
BMI	BMI:9	bone marrow involvement
BMI	BMI:9	brainmachine interface
BMK1	BMK1:10	big map kinase 
BMK1	BMK1:9	big mitogenactivated protein kinase 
BmK	BmK:12	scorpion buthus martensi karsch
BmK	BmK:13|BMK:3	scorpion buthus martensii karsch
BMPs	BMPs:14	bacterial magnetic particles
BMPs	BMPs:22	best management practices
BMPs	BMPs:721|Bmps:18	bone morphogenetic proteins
BMs	BMs:80	basement membranes
BMS	BMS:11	black mexican sweet
BMs	BMs:4|BMS:1	body movements
BMS	BMS:9	bone marrow stromal
BMs	BMs:5|bms:1	bowel movements
BMS	BMS:16	bristolmyers squibb
BMS	BMS:11	bulk magnetic susceptibility
BMS	BMS:88	burning mouth syndrome
BMT	BMT:11	basement membrane thickness
BMT	BMT:15	basic military training
BMT	BMT:18	behavioral marital therapy
BMT	BMT:8	bone marrow transplanted
BMV	BMV:20	balloon mitral valvotomy
BMV	BMV:31	balloon mitral valvuloplasty
BMV	BMV:14	brome mosaic bromovirus
BMV	BMV:196	brome mosaic virus
BM	BM:46	bacterial meningitis
BM	BM:18	barretts metaplasia
BM	BM:9	basal medium
BM	BM:11	biological monitoring
BM	BM:24	blood meal
BM	BM:16	bone metastases
BM	BM:10	bone metastasis
BM	BM:30	brain metastases
BM	BM:9	breast milk
BM	BM:6	bronchial mucosa
BM	BM:8	buccal mucosa
BNC	BNC:17	binucleate cells
BNC	BNC:13	boron neutron capture
BNF	BNF:9	betanapthoflavone
BNF	BNF:10	british national formulary
BNML	BNML:9	leukemia model
BNML	BNML:9	rat model for human acute myelocytic leukemia
BNP	BNP:332	btype natriuretic peptide
BNP	BNP:16	brain natriuretic peptides
BNs	BNs:6	ballooned neurons
BNs	BNs:8	burst neurons
BN	BN:11	balkan nephropathy
BN	BN:18	binucleated
BN	BN:13	bladder neck
BN	BN:11	boron nitride
Boc	Boc:11|BOC:1	tertbutoxycarbonyl
Boc	Boc:7|BOC:2	tertbutyloxycarbonyl
BOP	BOP:164|BoP:5	bleeding on probing
BOP	BOP:174	nnitrosobisoxopropylamine
BOR	BOR:65	branchiootorenal
BOR	BOR:9	branchiootorenal syndrome
BOT	BOT:8	borderline ovarian tumor
BOT	BOT:19	botzinger complex
BO	BO:18	barretts oesophagus
BO	BO:9	benzene oxide
BO	BO:12	borage oil
BO	BO:9	bronchial obstruction
BO	BO:73	bronchiolitis obliterans
BPb	BPb:6|B-Pb:1	blood lead concentration
BPb	BPb:6	blood lead levels
BPDE	BPDE:12	benzoapyrene diolepoxide
BPDE	BPDE:5	beta alphadihydroxy alpha alphaepoxytetrahydrobenzoapyrene
BPD	BPD:32	benzoporphyrin derivative
BPD	BPD:101	biliopancreatic diversion
BPD	BPD:272	biparietal diameter
BPD	BPD:687	bronchopulmonary dysplasia
BPF	BPF:21	brain parenchymal fraction
BPF	BPF:8|BPf:1	brazilian pemphigus foliaceus
BPF	BPF:35	brazilian purpuric fever
BPF	BPF:44	bronchopleural fistula
BPH	BPH:18	benign hyperplasia of the prostate
BPH	BPH:12	benign hyperplastic
BPH	BPH:386|bph:3	benign prostatic hypertrophy
BPH	BPH:10	benzoapyrene hydroxylase
BPH	BPH:10	brown planthopper
BPH	BPH:6	hyperplastic prostate tissue
BPI	BPI:10	basic personality inventory
BPI	BPI:17|BP-I:6	bipolar i
BPI	BPI:8|BP-I:6	bipolar i disorder
BPI	BPI:10	brachial plexus injury
BPI	BPI:13	brain perfusion index
BPI	BPI:48	brief pain inventory
bpm	bpm:36|BPM:2	beatsmin
bpm	bpm:12|BPM:2	beats per min
bpm	bpm:138|BPM:11	beats per minute
BPM	BPM:13	behavioral pattern monitor
BPM	BPM:9	bovine peripheral nerve myelin
BPM	BPM:11	plasma membrane
BPN	BPN:4	backpropagation neural network
BPN	BPN:22	basilar pontine nuclei
BPO	BPO:9	antibenzylpenicilloyl
BPO	BPO:13	benzylpenicilloyl
BPP	BPP:19	biophysical profile
BPP	BPP:35|bPP:8	bovine pancreatic polypeptide
BPS	BPS:35	beraprost sodium
BPs	BPs:66|Bps:2|BPS:1	bisphosphonates
BPs	BPs:61	blood pressures
BPS	BPS:7	branch point sequence
BPS	BPS:16	branchpoint sequence
BPV	BPV:16	balloon pulmonary valvuloplasty
BPV	BPV:11	benign paroxysmal vertigo
BPV	BPV:19	benign positional vertigo
BPV	BPV:9	bordetella pertussis vaccine
BPV	BPV:50	bovine papilloma virus
BPV	BPV:25	bovine parvovirus
BPV	BPV:6	pulmonary vein
Bpa	Bpa:5	amino acid pbenzoylphenylalanine
Bpa	Bpa:14	bare patches
BPA	BPA:26	bauhinia purpurea
BPA	BPA:13|BpA:1	bauhinia purpurea agglutinin
BPA	BPA:11	bauhinia purpurea lectin
BPA	BPA:52|BP-A:4	bisphenola
BPA	BPA:37	boronophenylalanine
BPA	BPA:15	bovine plasma albumin
BPA	BPA:11	bovine pulmonary artery
Bpa	Bpa:16|BPA:1	pbenzoyllphenylalanine
BPA	BPA:36	pboronophenylalanine
BP	BP:15	hbenzoapyrene
BP	BP:16	backpropagation
BP	BP:9	bacterial pneumonia
BP	BP:16|bp:1	basilar papilla
BP	BP:11	beet pulp
BP	BP:10	bells palsy
BP	BP:17	bench press
BP	BP:36	benzapyrene
BP	BP:274	benzoapyrene
BP	BP:19	benzophenone
BP	BP:73|Bp:2	bereitschaftspotential
BP	BP:122	binding potential
BP	BP:18	biphenyl
BP	BP:56|bp:1	bipolar
BP	BP:28|bp:1	blastic phase
BP	BP:16	blood plasma
BP	BP:20	bodily pain
BP	BP:20	bovine pericardium
BP	BP:21	bowenoid papulosis
BP	BP:11	brachial plexus
BP	BP:7|bp:3	brevipedicellus
BP	BP:15	british pharmacopoeia
BP	BP:444	bullous pemphigoid
BP	BP:38	metabolism of benzoapyrene
BP	BP:149	myelin basic protein
BP	BP:18	systolic and diastolic blood pressures
BP	BP:5	total biopterin
BQR	BQR:10	brequinar
BQR	BQR:13	brequinar sodium
BQ	BQ:6	barriers questionnaire
BQ	BQ:35	betel quid
BRAC	BRAC:24	bangladesh rural advancement committee
BRAC	BRAC:9	basic restactivity cycle
BRCA1	BRCA1:14	breast cancer susceptibility gene 
BRCA1	BRCA1:14	cancer susceptibility gene
BRMS	BRMS:5	bechrafaelsen mania scale
BRMS	BRMS:7	bechrafaelsen melancholia scale
BRP	BRP:10	bacteriocin release protein
BRP	BRP:13	biological reference preparation
BRP	BRP:7	bovine retinal pericytes
BRP	BRP:13	bovine retractor penis
BSCC	BSCC:35	basaloid squamous cell carcinoma
BSCC	BSCC:14|BScc:8|BS-CC:1	bjorkshiley convexoconcave
BSC	BSC:13	balanced scorecard
BSC	BSC:17	basaloid squamous carcinoma
BSC	BSC:39	best supportive care
BSC	BSC:9	bundle sheath cells
BSE	BSE:627	bovine spongiform encephalopathy
BSE	BSE:13	breast selfexam
BSF	BSF:7	b cell stimulatory factors
BSF	BSF:7	benzene soluble fraction
BSH	BSH:19|bsh:2|Bsh:1	bile salt hydrolase
BSH	BSH:19	borocaptate sodium
BSH	BSH:10	mercaptoundecahydrododecaborate
BSH	BSH:16	nabhsh
BSH	BSH:14	sodium borocaptate
BSI	BSI:10	blood stream infections
BSI	BSI:6	blunt splenic injury
BSI	BSI:10	bone strength index
BSI	BSI:144	brief symptom inventory
BSL	BSL:8|bsL:1	benign symmetric lipomatosis
BSL	BSL:9	british sign language
BSM	BSM:9	body surface maps
BSM	BSM:12	body surface mapping
BSM	BSM:33	bovine submaxillary mucin
BSM	BSM:13	bronchial smooth muscle
BSN	BSN:16	bachelor of science in nursing
BSN	BSN:12	bismuth subnitrate
BSO	BSO:9	buthionine sulfoximide
BSO	BSO:507	buthionine sulfoximine
BSO	BSO:65	buthionine sulphoximine
BSO	BSO:16	dlbuthioninesrsulfoximine
BSO	BSO:13	lbuthioninesrsulfoximine
BSO	BSO:14	rsulfoximine
BSP	BSP:11	blepharospasm
BSP	BSP:336|bSP:2|Bsp:1|bsp:1	bone sialoprotein
BSP	BSP:13|bSP:1	bovine seminal plasma
BSP	BSP:59	bromosulfophthalein
BSP	BSP:17	bromosulphophthalein
BSP	BSP:21	bromosulphthalein
BSP	BSP:18	bromsulphthalein
BSP	BSP:174	sulfobromophthalein
BSP	BSP:27	sulfobromophthalein sodium
BSP	BSP:21	sulphobromophthalein
BSR	BSR:10	blood sedimentation rate
BSR	BSR:36	brain stimulation reward
BSS	BSS:82|B-SS:1|BSs:1|B-Ss:1	bernardsoulier syndrome
BSS	BSS:39	bismuth subsalicylate
BSS	BSS:22	blind source separation
BSS	BSS:9	satiety sequence
bST	bST:9|BST:6	bovine somatotrophin
bST	bST:132|BST:28|bSt:4|BSt:1	bovine somatotropin
BSV	BSV:8	banana streak virus
BSV	BSV:11	binocular single vision
BSV	BSV:7	bovine syncytial virus
Bs	Bs:12	b chromosomes
Bs	Bs:32|BS:5|bs:1	bacillus subtilis
BS	BS:22|B-S:18	bjorkshiley
BS	BS:25	black smoke
BS	BS:10	blasticidin s
BS	BS:7	blood serum
BS	BS:37	blood sugar
BS	BS:6|bs:1	body surface
BS	BS:15	bone scan
BS	BS:34|Bs:1	bone scintigraphy
BS	BS:8	borg scale
BS	BS:40|Bs:3	brain stem
BS	BS:20	brainstem
BS	BS:9	bronchial secretions
BS	BS:11	bulbospongiosus
BS	BS:12	bundle sheath
BS	BS:8	bursting strength
BS	BS:15	patients with behcets syndrome
BTB	BTB:32	bloodtestis barrier
BTB	BTB:11|bTB:1|bTb:1	bovine tuberculosis
BTB	BTB:18	breakthrough bleeding
BTB	BTB:12	bromothymol blue
BTE	BTE:12	basic transcription element
BTE	BTE:12	basic treatment equivalent
BTE	BTE:31	behindtheear
BTE	BTE:13	biphasic truncated exponential
BTS	BTS:9	blalocktaussig shunt
BTS	BTS:9	blood transfusion service
BTS	BTS:43	british thoracic society
BTs	BTs:11	butyltins
BTs	BTs:9	butyltin compounds
BTG	BTG:6|B-TG:2|b-TG:1	bthromboglobulin
BTG	BTG:5|bTG:3|BTg:2|bTg:2	bovine thyroglobulin
BT	BT:19	benzenetriol
Bt	Bt:13	bacillus thuringiensis berliner
BT	BT:202|Bt:1	bacterial translocation
BT	BT:36|Bt:1	beef tallow
BT	BT:9	behavior therapy
BT	BT:14|bT:3	bioavailable testosterone
BT	BT:7	blast transformation
BT	BT:15	blastic transformation
BT	BT:152	bleeding time
Bt	Bt:23|BT:2	blomia tropicalis
BT	BT:65	borderline tuberculoid
BT	BT:9	borderline tuberculoid leprosy
BT	BT:8	bovine trypsin
BT	BT:10	bovine turbinate
BT	BT:5	brain tumors
BT	BT:16	bretylium tosylate
BT	BT:8|B-T:3	modified blalocktaussig
BUN	BUN:939	blood urea nitrogen
BUN	BUN:6	blood urea nitrogen concentration
BUP	BUP:13|bup:3	bupivacaine
BUP	BUP:13|bup:1	bupropion
BU	BU:11	bromouracil
BU	BU:33	bethesda units
BU	BU:12	buruli ulcer
BU	BU:103|Bu:41	busulfan
BU	BU:17|Bu:9	busulphan
BV/TV	BV/TV:123	bone volume
BV/TV	BV/TV:29	bone volume fraction
BVB	BVB:13	baroreflex vagal bradycardia
BVB	BVB:12	biventricular bypass
BVD-MD	BVD-MD:9	bovine viral diarrheamucosal disease
BVD-MD	BVD-MD:7	bovine virus diarrhoeamucosal disease
BVD	BVD:86	bovine viral diarrhea
BVD	BVD:40	bovine viral diarrhoea
BVD	BVD:35	bovine virus diarrhoea
BVI	BVI:19	blood vessel invasion
BVI	BVI:8	volume index
BVP	BVP:22|BV-P:1	biventricular pacing
BVP	BVP:11	blood volume pulse
BV	BV:305	bacterial vaginosis
BV	BV:11|bv:1	baculovirus
BV	BV:5	bed volumes
BV	BV:42|bv:1	bee venom
BV	BV:5	betachain variable
BV	BV:17|Bv:1	biliverdin
BV	BV:5	biological values
BV	BV:18	blood viscosity
BV	BV:5	breeding values
BV	BV:10|B-V:1	bronchovaxom
BV	BV:30	budded virus
BV	BV:7	monkey b virus
BWS	BWS:170	beckwithwiedemann syndrome
BWS	BWS:24	body weight support
BW	BW:14|Bw:2	bandwidth
BW	BW:14	biological warfare
BW	BW:9	birth weights
BW	BW:43|bw:1	birthweight
BW	BW:9	bronchial wash
BW	BW:8	bronchial washings
BYV	BYV:16	beet yellows closterovirus
BYV	BYV:12	beet yellows virus
BZ	BZ:13	belousovzhabotinsky
BZ	BZ:22|Bz:3|bz:2	benzene
BZ	BZ:9|Bz:8	benzylamine
BZ	BZ:13	border zone
BaMV	BaMV:14	bamboo mosaic potexvirus
BaMV	BaMV:10	bamboo mosaic virus
BAP	BAP:19	benzylaminopurine
BAP	BAP:6	bioartificial pancreas
BAP	BAP:6	biotin acceptor peptide
BAP	BAP:6|BA-P:1	brachial artery pressure
BAK	BAK:9	bagby and kuslich
BAK	BAK:8	bcgactivated killer
BeWo	BeWo:11	cultured human choriocarcinoma
BeWo	BeWo:8	human placental choriocarcinoma
BI	BI:9	balloon injury
BI	BI:175	barthel index
BI	BI:9	basein
BI	BI:7	behavioral inhibition
Bi	Bi:12|B-I:4	billroth i
Bi	Bi:12|BI:8	binaural interaction
Bi	Bi:22	bismuth
BI	BI:14	bovine insulin
BI	BI:25	brain infarction
BI	BI:10	brief intervention
Bi	BI:3|Bi:3	partial gastrectomy
BK	BK:44|B-K:2	belowknee
BK	BK:2	below the knee
BK	BK:1559|Bk:75|bk:3	bradykinin
BK	BK:7	potassium channel
BmNPV	BmNPV:9	bombyx mori npv
BmNPV	BmNPV:33	bombyx mori nuclear polyhedrosis virus
BmNPV	BmNPV:48	bombyx mori nucleopolyhedrovirus
Bmax	Bmax:49	binding capacities
Bmax	Bmax:7	binding maximum
Bmax	Bmax:64	maximal binding
Bmax	Bmax:115	maximal number of binding sites
Bmax	Bmax:84	maximum binding
Bmax	Bmax:4	maximum binding value
Bmax	Bmax:161	maximum number of binding sites
Bmax	Bmax:9	maximum specific binding
Bmax	Bmax:6	number of betaadrenoceptors
Bmax	Bmax:10	receptor concentration
Bmax	Bmax:8	receptor numbers
BOS	BOS:9|BoS:3	base of support
BOS	BOS:16	birds own song
BOS	BOS:164	bronchiolitis obliterans syndrome
BR	BR:49	balbiani ring
BR	BR:7	base rate
BR	BR:7	basic region
BR	BR:66	bed rest
BR	BR:15	benzamide riboside
BR	BR:8	biochemical response
BR	BR:7	blink rate
BR	BR:64|Br:4	blink reflex
BR	BR:11	bone resorption
BR	BR:29|Br:5	brassinosteroid
BR	BR:6|Br:1	breathing rate
BR	BR:10|Br:1	bronchial reactivity
Btk	Btk:1	bacillus thuringiensis var kurstaki
Btk	Btk:182|BTK:53|btk:10|BtK:1	brutons tyrosine kinase
C/N	C/N:12	carbon to nitrogen
C/N	C/N:33	contrasttonoise
C10	C10:6	capric acid
C10	C10:7|C-10:5	decamethonium
C10	C10:8	decanoic acid
C10	C10:16	sodium caprate
C12	C12:15	lauric acid
C12	C12:7	sodium laurate
C1	C1:21|C-1:2	atlas
C1	C1:13	first complement component
C1	C1:7	first component
C1	C1:15	first component of human complement
C1	C1:10	large
C1	C1:10	onecarbon
C2	C2:8	 hours postdose
C2	C2:4	after administration
C2	C2:19|C-2:1	cervical
C2	C2:10	levels
C2	C2:8|C-2:1	second cervical vertebra
C2	C2:13	second complement component
C2	C2:10	second component
C2	C2:38	second component of complement
C2	C2:10	second component of human complement
C3	C3:21	chhej
C3	C3:5	clostridium botulinum c exoenzyme
C3	C3:7	complement c
C3	C3:26	complement factor 
C3	C3:7	flaveria pringlei
C3	C3:12	third carpal bone
C3	C3:41	third complement component
C3	C3:23	third component
C4	C4:1	f trinervia
C4	C4:11	flaveria trinervia
C4	C4:18	fourth complement component
C4	C4:100|C-4:1	fourth component of complement
C5a	C5a:11	complement factor a
C5a	C5a:6	complement fragment ca
C5	C5:6	fifth complement component
C5	C5:8	fifth component
C5	C5:54	fifth component of complement
C5	C5:6	five or more coughs
C6	C6:24|C-6:5	rat glioma
C6	C6:10	sixth
C6	C6:4|C-6:1	sixth cervical
C6	C6:5	sixth complement component
C6	C6:5	sixth component
C6	C6:24	sixth component of complement
C7	C7:5	seventh cervical
C7	C7:12	seventh component of complement
C8	C8:12	eighth component of complement
C8	C8:15	eighth component of human complement
C9	C9:5	ninth component
C9	C9:18	ninth component of complement
CAA	CAA:8	amino acid
CAA	CAA:226|CAa:1	cerebral amyloid angiopathy
CAA	CAA:11	chicken anaemia agent
CAA	CAA:27	chicken anemia agent
CAA	CAA:20	chronic aplastic anemia
CAA	CAA:70	circulating anodic antigen
CAA	CAA:19	coloanal anastomosis
CAA	CAA:8	coronary artery atherosclerosis
CABG	CABG:7	bypass graft operation
CABG	CABG:2554	coronary artery bypass grafting
CABG	CABG:14	coronary bypass
CAB	CAB:26|Cab:1	cabergoline
CAB	CAB:13|CA-B:1	carbonic anhydrase b
CAB	CAB:21	cellulose acetate butyrate
CAB	CAB:42	combined androgen blockade
CAC	CAC:6	calcium aluminate cement
CAC	CAC:10	chronic acalculous cholecystitis
CAC	CAC:11	citric acid cycle
CAC	CAC:18	conjunctival allergen challenge
CAC	CAC:101	coronary artery calcification
CAC	CAC:62	coronary artery calcium
CAC	CAC:11|cac:8	critical aggregation concentration
CAC	CAC:13|cac:2	critical association concentration
CAD	CAD:19	cadaveric
CAD	CAD:10	caspaseactivated deoxyribonuclease
CAD	CAD:40	caspaseactivated dnase
CAD	CAD:21	cervical artery dissection
CAD	CAD:31	chronic actinic dermatitis
CAD	CAD:9	chronic allograft dysfunction
CAD	CAD:19	cinnamyl alcohol dehydrogenase
CAD	CAD:18	collisionactivated dissociation
CAD	CAD:14	collisionally activated decomposition
CAD	CAD:62	collisionally activated dissociation
CAD	CAD:98	computeraided detection
CAD	CAD:119	computeraided diagnosis
CAD	CAD:15	computeraided diagnostic
CAD	CAD:6	constitutive activation domain
CAEBV	CAEBV:19	chronic active ebv infection
CAEBV	CAEBV:10	chronic active epsteinbarr virus
CAEBV	CAEBV:23	chronic active epsteinbarr virus infection
CAE	CAE:24	capillary array electrophoresis
CAE	CAE:13	caprine arthritisencephalitis
CAE	CAE:10	cefuroxime axetil
CAE	CAE:16	cellulose acetate electrophoresis
CAE	CAE:50	childhood absence epilepsy
CAE	CAE:19	chloroacetate esterase
CAE	CAE:17	coronary artery ectasia
CAF	CAF:19	antiviral factor
CAF	CAF:4	carotid artery flow
CAF	CAF:8	chronic af
CAF	CAF:9	chronic allograft failure
CAF	CAF:28	chronic atrial fibrillation
CAF	CAF:16	coronary artery fistula
CagA	CagA:6|cagA:1	cytotoxinassociated antigen
CagA	CagA:9|cagA:4	cytotoxinassociated protein
CAG	CAG:84	chronic atrophic gastritis
CAG	CAG:11	coronary angiogram
CAG	CAG:53	trinucleotide
CAHPS	CAHPS:15	consumer assessment of health plans
CAHPS	CAHPS:29	consumer assessment of health plans study
CAHPS	CAHPS:7	consumer assessment of health plans survey
CAI	CAI:22	clinical activity index
CAI	CAI:26	codon adaptation index
CAI	CAI:8	computerassisted instructional
CALB	CALB:10|Calb:1	calbindindk
CALB	CALB:12|CAL-B:4	candida antarctica lipase b
CALUX	CALUX:11	luciferase expression
CALUX	CALUX:7	luciferase gene expression
CAL	CAL:50	chronic airflow limitation
CAL	CAL:35	clinical attachment levels
CAL	CAL:9	coracoacromial ligament
CAL	CAL:25	coronary artery lesions
CAL	CAL:32	coronary artery ligation
CAMDEX	CAMDEX:18|CAM-DEX:1	cambridge examination for mental disorders of the elderly
CAMDEX	CAMDEX:14	cambridge mental disorders of the elderly examination
CA-MRSA	CA-MRSA:19|CAMRSA:2	communityacquired methicillinresistant staphylococcus aureus
CA-MRSA	CA-MRSA:11|CAMRSA:2	communityacquired mrsa
CAMs	CAMs:319|CAMS:3	cell adhesion molecules
CAMs	CAMs:5|CAMS:1	complementary and alternative medicines
CaM	CaM:20	cacalmodulin
CaM	CaM:15	calciumcalmodulin
CAM	CAM:139	chick chorioallantoic membrane
CAM	CAM:86	chick embryo chorioallantoic membrane
CAM	CAM:20	chorioamnionitis
CAM	CAM:26	complementary and alternative medical
CAM	CAM:4	complementary and alternative medical therapies
CAM	CAM:4	complementary and alternative therapies
CAM	CAM:39	confusion assessment method
CAM	CAM:8	congenital adenomatoid malformation
CAM	CAM:14	constitutively active mutant
CAM	CAM:59	crassulacean acid metabolism
CAM	CAM:17	cystic adenomatoid malformation
CAM	CAM:8	topoisomerase i inhibitor camptothecin
CAN	CAN:6	amygdaloid nucleus
CAN	CAN:17	camberwell assessment of need
CAN	CAN:44	cardiac autonomic neuropathy
CAN	CAN:30	cardiovascular autonomic neuropathy
CAN	CAN:3	child abuse or neglect
CAN	CAN:10	chloroacetonitrile
CAN	CAN:164	chronic allograft nephropathy
CAOD	CAOD:6	carotid artery occlusive disease
CAOD	CAOD:5	chronic arterial obstructive disease
CAO	CAO:6|Cao:1	chlorophyll a oxygenase
CAO	CAO:6	chlorophyllide a oxygenase
CAO	CAO:17	chronic airway obstruction
CAO	CAO:61	coronary artery occlusion
CAPD	CAPD:18	continuous ambulatory pd
CAPD	CAPD:2816|capd:1	continuous ambulatory peritoneal dialysis
CAPD	CAPD:7	continuous ambulatory peritoneal dialysis patients
cap	cap:1|CAP:1	ace inhibitor captopril
CaP	CaP:13|CAP:1	adenocarcinoma of the prostate
cap	cap:2|CAP:1	angiotensinconverting enzyme inhibitor captopril
CAP	CAP:7	artery pressure
CaP	CaP:14	calponin
CaP	CaP:25|CAP:6	cancer of the prostate
CAP	CAP:85|cap:12|Cap:7	capsaicin
CaP	CaP:28|CAP:11|cap:2	carcinoma of the prostate
CAP	CAP:10	carotid arterial pressure
CAP	CAP:41	catabolite activator protein
CAP	CAP:34	cellulose acetate phthalate
CAP	CAP:11	cellulose acetate polymer
CAP	CAP:9	central auditory processing
CAP	CAP:10	chronic alcoholic pancreatitis
CAP	CAP:88	college of american pathologists
CAP	CAP:584	communityacquired pneumonia
CAP	CAP:5	compound action potential of the auditory nerve
CAP	CAP:58	cyclic alternating pattern
CAP	CAP:13	cyclic amp receptor protein
CAP	CAP:26	cystine aminopeptidase
CAP	CAP:4	pharmacia cap system
cap	cap:8|CAP:3	transcription initiation
CARD	CARD:53	caspase recruitment domain
CARD	CARD:30	catalyzed reporter deposition
CARE	CARE:12	comprehensive assessment and referral evaluation
CARE	CARE:25	ryan white comprehensive aids resources emergency
CARS	CARS:33	childhood autism rating scale
CARS	CARS:22	coherent antistokes raman scattering
CAR	CAR:52	cancerassociated retinopathy
CAR	CAR:8	central activation ratio
CAR	CAR:49	central african republic
CAR	CAR:39	ciliaassociated respiratory
CAR	CAR:14	conditioned avoidance responding
CAR	CAR:9	coronary artery reperfusion
CAR	CAR:45	coxsackie and adenovirus receptor
CAR	CAR:88	coxsackievirus and adenovirus receptor
CASA	CASA:13	cancerassociated serum antigen
CASA	CASA:35	computeraided sperm analysis
CASA	CASA:47	computerassisted semen analysis
CASA	CASA:5	computerassisted semen analyzer
CASA	CASA:60	computerassisted sperm analysis
CASH	CASH:8	cancer and steroid hormone
CASH	CASH:14	cardiac arrest study hamburg
CAST	CAST:106	cardiac arrhythmia suppression trial
CAST	CAST:7	cellular allergen stimulation test
CAST	CAST:8	cellular antigen stimulation test
CAST	CAST:20	children of alcoholics screening test
CATT	CATT:9	card agglutination test
CATT	CATT:17	card agglutination test for trypanosomiasis
CAVB	CAVB:33	complete atrioventricular block
CAVB	CAVB:11	complete av block
CAVH	CAVH:23	continuous arteriovenous haemofiltration
CAVH	CAVH:111	continuous arteriovenous hemofiltration
CAVHD	CAVHD:17|CAVH-D:1	continuous arteriovenous hemodiafiltration
CAVHD	CAVHD:21	continuous arteriovenous hemodialysis
CAS	CAS:8	analogue scale
CAS	CAS:13	analysis system
CAs	CAs:28	carbonic anhydrases
CAS	CAS:5	carotid angioplasty and stent placement
CAS	CAS:41	carotid angioplasty and stenting
CAs	CAs:7	carotid arteries
CAS	CAS:14	carotid artery stenosis
CAS	CAS:61	carotid artery stenting
CAS	CAS:11	caspofungin
CAs	CAs:93|CAS:1	catecholamines
CAS	CAS:10	central anticholinergic syndrome
CAS	CAS:12	child assessment schedule
CAS	CAS:19	chrome azurol s
CAS	CAS:22	clinical activity score
CAs	CAs:8	cold agglutinins
CAS	CAS:8	contralateral acoustic stimulation
CAs	CAs:11	contrast agents
CAs	CAs:9	coronary arteries
CAS	CAS:15	coronary artery spasm
CAS	CAS:9	coronary artery stenosis
CAS	CAS:7	harvard school of public health college alcohol study
CA	CA:11	abnormalities
CA	CA:12	assay
CA	CA:48	caffeic acid
CA	CA:26|Ca:7|ca:1	cancer
CA	CA:32	cancer antigen
CA	CA:57|Ca:5	candida albicans
CA	CA:97	capsid
CA	CA:5	carbonate apatite
CA	CA:116	cardiac arrest
CA	CA:83	catecholaminergic
CA	CA:10	catheter ablation
CA	CA:6	caucasian american
CA	CA:20	cellular automata
CA	CA:9	cellular automaton
CA	CA:97	cellulose acetate
CA	CA:13	cerebellar atrophy
CA	CA:14	cerebral atrophy
CA	CA:30	cerebral autoregulation
CA	CA:9	choanal atresia
CA	CA:14	cholate
CA	CA:18	cholic
CA	CA:150	chronological age
CA	CA:21	cluster analysis
CA	CA:5	cobblestone areas
CA	CA:15	cochlear aqueduct
CA	CA:38|C-A:1	coldacclimated
CA	CA:10	coldacclimated rats
ca	ca:6|CA:1	cold adapted
CA	CA:14|C-A:1	communityacquired
CA	CA:9	condyloma acuminata
CA	CA:20	condyloma acuminatum
CA	CA:10	condylomata acuminata
CA	CA:6	congruence angle
CA	CA:14	conjoint analysis
ca	CA:3|ca:3	constitutively activated
CA	CA:17|ca:11|Ca:2|c-a:1	constitutively active
CA	CA:7	contact angle
CA	CA:15	contrast arteriography
CA	CA:8	controlled atmosphere
CA	CA:17	conventional angiography
CA	CA:8	conventional arteriography
CA	CA:14	conversation analysis
CA	CA:38	cornu ammonis
CA	CA:95	corpora allata
CA	CA:25	corpora amylacea
CA	CA:32	corpus allatum
CA	CA:17	correspondence analysis
CA	CA:19	cortical area
CA	CA:33	cortisone acetate
CA	CA:22	cytosine arabinoside
CA	CA:5	highly polymorphic
CA	CA:7	isolated a polymorphic dinucleotide
ca	ca:4	live attenuated coldadapted
CA	CA:4	measurement of compressed air
CA	CA:32|Ca:1	plasma catecholamines
CA	CA:4	weeks of conceptional age
CB-154	CB-154:18|CB154:2	bralphaergocryptine
CB-154	CB-154:30|CB154:5	bromoalphaergocryptine
CB-154	CB-154:11|CB154:2	bromocryptine
CB1	CB1:20	cannabinoid receptor 
CB1	CB1:14	cannabinoid receptor type 
CB1	CB1:13	cannabinoid type 
CBA	CBA:5	binding activity
CBA	CBA:9	congenital biliary atresia
CBA	CBA:47	costbenefit analysis
CBA	CBA:20	cutting balloon angioplasty
CBA	CBA:13	cytochemical bioassay
CBB	CBB:11	calvinbensonbassham
CBB	CBB:40	coomassie brilliant blue
CBC	CBC:12	cannabichromene
CBC	CBC:6	cerebralbuccal connective
CBC	CBC:126	complete blood count
CBC	CBC:16	contralateral breast cancer
CBC	CBC:11	nuclear capbinding complex
CBD	CBD:11	carotid bodydenervated
CBD	CBD:23|cbd:1	carotid body denervation
CBD	CBD:87	chronic beryllium disease
CBD	CBD:659|cbd:1	common bile duct
CBD	CBD:27	communitybased distribution
CBD	CBD:18	congenital biliary dilatation
CBE	CBE:14	clinical breast exam
CBE	CBE:96	clinical breast examination
CBE	CBE:6	communitybased education
CBE	CBE:13	conduritol b epoxide
CBE	CBE:11	cotton bracts
CBF	CBF:18	ccaatbinding factor
CBF	CBF:9	cerebral
CBF	CBF:25	cholinergic basal forebrain
CBF	CBF:265	ciliary beat frequency
CBG	CBG:17|cBG:1	capillary blood glucose
CBG	CBG:40	cortisol binding globulin
CBG	CBG:21	transcortin
CBH	CBH:9|Cbh:1	cellobiohydrolase
CBH	CBH:42	cutaneous basophil hypersensitivity
CBM	CBM:7	capillary basement membrane
CBM	CBM:27	carbohydratebinding module
CBP	CBP:6	calmodulinbinding peptide
CBP	CBP:12	chronic back pain
CBP	CBP:19	chronic bacterial prostatitis
CBP	CBP:127	creb binding protein
CBR	CBR:13	carotid baroreflex
CBR	CBR:22	casebased reasoning
CBR	CBR:12	clinical benefit response
CBR	CBR:9	critical body residue
CBR	CBR:24	crude birth rate
CBs	CBs:30	cajal bodies
CBs	CBs:9	cannabinoids
CBs	CBs:12	carotid bodies
CBS	CBS:9	central bureau of statistics
CBS	CBS:15	cerebroside sulfate
CBS	CBS:27	charles bonnet syndrome
CBs	CBs:9	chlorinated biphenyls
CBs	CBs:12	chlorobiphenyls
CBs	CBs:15	coiled bodies
CBS	CBS:83	colloidal bismuth subcitrate
CBS	CBS:6	combined behavioral score
CBV	CBV:30	capillary blood cell velocity
CBV	CBV:7	capillary blood velocity
CBV	CBV:11	cerebral blood velocity
CBZ-E	CBZ-E:3|CBZ-e:1	active metabolite carbamazepineepoxide
CBZ-E	CBZ-E:5|CBZE:2	carbamazepine epoxide
CBZ	CBZ:1117|Cbz:1	carbamazepine
CBZ	CBZ:9	carbimazole
CB	CB:9	branch
CB	CB:10	calciumbinding proteins calbindin
CB	CB:40	carbon black
CB	CB:9|cb:2|Cb:1	centroblastic
CB	CB:22	chlorobenzene
CB	CB:139	chronic bronchitis
CB	CB:14|Cb:5	clenbuterol
CB	CB:11	cocoa butter
CB	CB:17|C-B:3	cognitivebehavioral
CB	CB:28	conduction block
CB	CB:545|cb:1	cord blood
CB	CB:11	core biopsy
CB	CB:12	covalent binding
CB	CB:19	cuprolinic blue
CB	CB:14	cutting balloon
CC16	CC16:50|CC-16:3	clara cell protein
CC16	CC16:3|CC-16:2	clara cell protein 
CCAM	CCAM:84	congenital cystic adenomatoid malformation
CCAM	CCAM:26	congenital cystic adenomatoid malformation of the lung
CCA	CCA:11	canonical correlation analysis
CCA	CCA:19	canonical correspondence analysis
CCA	CCA:8	cerebellar cortical atrophy
CCA	CCA:12	chick cellagglutinating
CCA	CCA:33	chromated copper arsenate
CCA	CCA:8	clear cell acanthoma
CCA	CCA:17	clear cell adenocarcinoma
CCA	CCA:6	closedcircuit anesthesia
CCA	CCA:9	common carotid arterial
CCA	CCA:30	congenital contractural arachnodactyly
CCA	CCA:6	conjugated cholic acid
CCA	CCA:5	conventional cerebral angiography
CCA	CCA:6	conventional coronary angiography
CCA	CCA:11	conventional cytogenetic analysis
CCA	CCA:13	cortical cerebellar atrophy
CCA	CCA:6	cyclohexane carboxylic acid
CCA	CCA:18	lobenzarit disodium
CCCP	CCCP:178|cccp:1	carbonyl cyanide mchlorophenylhydrazone
CCCP	CCCP:18	carbonylcyanidemchlorophenylhydrazone
CCCs	CCCs:4	child care centers
CCCs	CCCs:8	cholangiocellular carcinomas
CCD	CCD:66|Ccd:2	cleidocranial dysplasia
CCD	CCD:9	contactless conductivity detection
CCD	CCD:41	crossed cerebellar diaschisis
CCE	CCE:42	capacitative calcium entry
CCE	CCE:14	cholesterol crystal embolization
CCE	CCE:7	citrate cleavage enzyme
CCE	CCE:49	counterflow centrifugal elutriation
CCF	CCF:33	chronic cardiac failure
CCF	CCF:26	congestive cardiac failure
CCF	CCF:5	controlled continuous flow
CCF	CCF:12|ccf:1	crosscorrelation function
CCF	CCF:11	fistulae
CCHB	CCHB:14	complete congenital heart block
CCHB	CCHB:27	congenital complete heart block
CCHS	CCHS:14	canadian community health survey
CCHS	CCHS:74	congenital central hypoventilation syndrome
CCI	CCI:24	charlson comorbidity index
CCI	CCI:203	chronic constriction injury
CCI	CCI:9	color confusion index
CCI	CCI:6	complete cerebral ischemia
CCI	CCI:66	controlled cortical impact
CCI	CCI:7	craniocerebral injuries
CCI	CCI:6	patients with chronic cardiac insufficiency
CCK-8S	CCK-8S:13|CCK-8s:6|CCK8s:2|CCK-8-S:1|CCK8-S:1	sulfated cholecystokinin octapeptide
CCK-8S	CCK8S:1|CCK-8S:1	sulfated octapeptide cholecystokinin
CCK-8	CCK-8:26|CCK8:1	cterminal octapeptide of cholecystokinin
CCK-8	CCK-8:13|CCK8:9	cckoctapeptide
CCL	CCL:9	canine ceroidlipofuscinosis
CCL	CCL:93|CCl:2	cefaclor
CCL	CCL:11	centrocytelike
CCM	CCM:11	chemical cleavage of mismatch
CCM	CCM:7	chronic care model
CCM	CCM:7	coconcentrating mechanism
CCM	CCM:9	critical care medicine
CCN	CCN:24	central cervical nucleus
CCN	CCN:13	cerebrocortical necrosis
CCPA	CCPA:6	adenosine a receptor agonist chloroncyclopentyladenosine
CCPA	CCPA:7	agonist chloroncyclopentyladenosine
CCP	CCP:9	chronic calcific pancreatitis
CCP	CCP:24	chronic calcifying pancreatitis
CCP	CCP:17	chronic cor pulmonale
CCP	CCP:6	classical complement pathway
CCP	CCP:46	complement control protein
CCP	CCP:6	conditioned cue preference
CCP	CCP:18	cooperative cardiovascular project
CCP	CCP:10|ccp:5	corpus cavernosum penis
CCP	CCP:13	critical closing pressure
CCP	CCP:59|CcP:51|ccp:1|Ccp:1	cytochrome c peroxidase
CCS	CCS:52	canadian cardiovascular society
CCS	CCS:20	cardiac conduction system
CCS	CCS:8	central cord syndrome
CCS	CCS:13	chronic cerebellar stimulation
CCS	CCS:14	chronic compartment syndrome
CCS	CCS:27	clear cell sarcoma
CCS	CCS:8	copper chaperone for sod
CCS	CCS:2	copper chaperone for the superoxide dismutase
CCS	CCS:4	coronary calcium score
CCS	CCS:8|C-C-S:1	cronkhitecanada syndrome
CCT	CCT:10	california consonant test
CCT	CCT:119	central conduction time
CCT	CCT:131	central corneal thickness
CCT	CCT:7	chaperonin containing tcomplex polypeptide 
CCT	CCT:11	computed cranial tomography
CCT	CCT:6	computerized cranial tomography
CCT	CCT:10|C-CT:1	conventional ct
CCT	CCT:42|cCT:1	cranial computed tomography
CCT	CCT:17|cCT:3	cranial computerized tomography
CCT	CCT:30	craniocerebral trauma
CCT	CCT:9	crude coal tar
CC	CC:12	cage control
CC	CC:7	calf circumference
CC	CC:14	cell culture
CC	CC:5	central complex
CC	CC:6|cc:3|Cc:3	centrocytic
CC	CC:43	cervical cancer
CC	CC:15	cervical carcinoma
CC	CC:11|cc:1	chest circumference
CC	CC:14	cholangiocarcinomas
CC	CC:22	choledochal cyst
CC	CC:12	chondrocalcinosis
CC	CC:12	choriocapillaris
CC	CC:13	choriocarcinoma
CC	CC:9	clear cell
CC	CC:10|cc:1	clomiphene
CC	CC:39	closing capacity
CC	CC:16|C-C:1	coiledcoil
CC	CC:26	collagenous colitis
CC	CC:9|cc:1	colloidal carbon
CC	CC:14	colon cancer
CC	CC:13	colorectal cancer
CC	CC:7	community care
CC	CC:12	complete chimerism
CC	CC:6	complete donor chimerism
CC	CC:12	compliance coefficient
CC	CC:6	contractile component
CC	CC:6	conventional chemotherapy
CC	CC:6	conventional cholecystectomy
CC	CC:13	conventional colonoscopy
CC	CC:27	conventional cytogenetics
CC	CC:7	coronary calcification
CC	CC:8	coronary calcium
CC	CC:34|cc:1	corpora cardiaca
CC	CC:13	corpora cavernosa
CC	CC:219|cc:3	corpus callosum
CC	CC:19	corpus cardiacum
CC	CC:50|cc:1	corpus cavernosum
CC	CC:9	crosscorrelation
CC	CC:6	crosssectional compliance
CC	CC:11	cryptogenic cirrhosis
CC	CC:8|cC:1|Cc:1	cyclocytidine
CC	CC:9	nisoldipine coat core
CD16	CD16:9	fc gamma receptor iii
CD16	CD16:8	fc gammariii
CD16	CD16:30	fcgammariii
CD16	CD16:7	receptor type iii
CD18	CD18:5	beta integrins
CD18	CD18:8|CD-18:1	common betachain
CD25	CD25:10	ilr alpha chain
CD25	CD25:7	receptor alpha
CD4+	CD4+:17	cdpositive
CD4+	CD4+:9	helper t cells
CD43	CD43:36	leukosialin
CD43	CD43:23	sialophorin
CD4	CD4:23	antilt
CD4	CD4:5	t helperinducer
CD8	CD8:15	antilyt
CD8	CD8:9	cytotoxicsuppressor
CD8	CD8:16	suppressorcytotoxic
CDAD	CDAD:36	clostridium difficileassociated diarrhea
CDAD	CDAD:21|CdAD:1	clostridium difficileassociated diarrhoea
CDAD	CDAD:14	clostridium difficileassociated disease
CDA	CDA:10	calciumdependent antibiotic
CDA	CDA:11	california dental association
CDA	CDA:4	canonical discriminant analysis
CDA	CDA:7	cellulose diacetate
CDA	CDA:7	chloridedepletion alkalosis
CDA	CDA:4	chloridedepletion metabolic alkalosis
CDA	CDA:17	clinical document architecture
CDA	CDA:1	cold dry air
CDA	CDA:35	congenital dyserythropoietic anaemia
CDA	CDA:39	congenital dyserythropoietic anemia
CDC	CDC:1	center disease control
CDC	CDC:485	centers for disease control
CDC	CDC:26	collecting duct carcinoma
CDC	CDC:13	disease controls
CDDP	CDDP:9|cDDP:1	cisdiaminedichloroplatinum
CDDP	CDDP:11	cisdichlorodiammine platinum
CDD	CDD:9	cardiodilatin
CDD	CDD:9	childhood disintegrative disorder
CDD	CDD:10	choledochoduodenostomy
CDD	CDD:10	control of diarrhoeal diseases
CDF	CDF:13	cartilagederived factor
CDF	CDF:23	cation diffusion facilitator
CDF	CDF:9|Cdf:2	chlordimeform
CDH	CDH:44	cellobiose dehydrogenase
CDH	CDH:9	ceramide dihexoside
CDH	CDH:95	chronic daily headache
CDH	CDH:88	congenital dislocation of the hip
CDH	CDH:15	congenital dysplasia of the hip
CDH	CDH:9	cutaneous delayed hypersensitivity
CDI	CDI:16	carbonyldiimidazole
CDI	CDI:6	cadependent inactivation
CDI	CDI:45	central diabetes insipidus
CDI	CDI:103	childrens depression inventory
CDI	CDI:113	color doppler imaging
CDI	CDI:30	cotreldubousset instrumentation
CDI	CDI:4	cyclindependent kinase inhibitor
CDMS	CDMS:28|CD-MS:1	clinically definite ms
CDMS	CDMS:22	clinically definite multiple sclerosis
CDO	CDO:29	cysteine dioxygenase
CDO	CDO:10	duodenal obstruction
CDP	CDP:9	chloroquine diphosphate
CDP	CDP:9	collagenasedigestible
CDP	CDP:21	computerized dynamic posturography
CDP	CDP:6	constitutional delay of puberty
CDP	CDP:5	constitutional delayed puberty
CDP	CDP:10	continuous distending pressure
CDP	CDP:11	cord dorsum potential
CDP	CDP:11	decongestive physiotherapy
CDP	CDP:13	incorporation of hproline into collagenasedigestible protein
CDR2	CDR2:12|CDR-2:1	complementaritydetermining region 
CDR2	CDR2:7	second complementarity determining region
CDR	CDR:120	clinical dementia rating
CDR	CDR:25	clinical dementia rating scale
CDR	CDR:15	cognitive drug research
CDR	CDR:5	confluence dependent resistance
CDR	CDR:6	crude death rate
CDR	CDR:7	regulator protein
CDSS	CDSS:15	calgary depression scale for schizophrenia
CDSS	CDSS:16	clinical decision support system
CDSS	CDSS:15	decision support systems
CDS	CDS:10	allogeneic cultured dermal substitute
CDS	CDS:10	calgary depression scale
CDS	CDS:8	cdpdiacylglycerol synthase
CDS	CDS:10	cervical dentine sensitivity
CDS	CDS:15	chronic disease score
CDS	CDS:7	clinical decision support
CDS	CDS:36	color doppler sonography
CDS	CDS:7	color duplex sonography
CDS	CDS:20	community dental service
CDT	CDT:272	carbohydratedeficient transferrin
CDT	CDT:36	clock drawing test
CDT	CDT:5	contralateral descended testis
CDT	CDT:7	cystic dysplasia of the testis
CDV	CDV:398	canine distemper virus
CDV	CDV:37	cidofovir
CD	CD:9	alphacyclodextrin
CD	CD:12	cadaver donor
Cd	Cd:1213|CD:11|cd:1	cadmium
CD	CD:21|Cd:1	campomelic dysplasia
CD	CD:41	capillary density
CD	CD:10	carbidopa
CD	CD:13	cardiac death
CD	CD:10	cardiacdenervated
CD	CD:5	cardiac denervation
CD	CD:16|cd:3	catalytic domain
Cd	Cd:10|CD:3	caudate
CD	CD:8	cerebellar degeneration
CD	CD:58	cervical dystonia
CD	CD:10	cesarean delivery
CD	CD:6	characteristic delay
CD	CD:54|Cd:4	chlordecone
CD	CD:9	choline deficiency
CD	CD:16	cholinedevoid
CD	CD:11	choroidal detachment
CD	CD:118|cd:1	circular dichroic
CD	CD:26	circular dichroism spectroscopy
CD	CD:15|Cd:3	clostridium difficile
CD	CD:16	cluster designation
CD	CD:5	cocaine dependent
CD	CD:5	coefficient of dispersion
CD	CD:6	colloidal dispersion
CD	CD:27	color doppler
CD	CD:14	colostrumdeprived
CD	CD:19	communication deviance
CD	CD:10	compact disc
CD	CD:8	compact disk
CD	CD:6	conduction delay
CD	CD:20	contact dermatitis
CD	CD:13|C-D:4	contrastdetail
CD	CD:4	cool dry
CD	CD:8	coronary diameter
CD	CD:44	cortical dysplasia
CD	CD:38|C-D:3	cotreldubousset
CD	CD:1592|Cd:1	crohns disease
CD	CD:6|cd:1	cumulative dose
CD	CD:131|cd:4	cytosine deaminase
CD	CD:4	rats fed a cholinedeficient
CE-LIF	CE-LIF:15	capillary electrophoresis with laserinduced fluorescence
CE-LIF	CE-LIF:22	capillary electrophoresis with laserinduced fluorescence detection
CE-LIF	CE-LIF:4	capillary electrophoresis with laserinduced fluorescence detector
CEA	CEA:10	carcinoembryonic
CEA	CEA:7	carcinoembryonic ag
CEA	CEA:8	continuous epidural analgesia
CEA	CEA:100	costeffectiveness analysis
CEA	CEA:8	cultured epidermal autograft
CEA	CEA:6	enzyme activity
CECT	CECT:22|CE-CT:13	contrastenhanced computed tomography
CECT	CECT:9|CE-CT:3|ceCT:1	contrastenhanced ct
CEC	CEC:18	capillary electrochromatographic
CEC	CEC:327	capillary electrochromatography
CEC	CEC:47	cation exchange capacity
CEC	CEC:14	chicken embryo cells
CEC	CEC:31	chlorethylclonidine
CEC	CEC:82	chloroethylclonidine
CEC	CEC:33|cEC:1	circulating endothelial cells
CEC	CEC:13	commission of the european communities
CEC	CEC:20	critical electrolyte concentration
CED	CED:26	chronic energy deficiency
CED	CED:28	convectionenhanced delivery
CEF	CEF:7	cauda epididymal fluid
CEF	CEF:1	cyclophosphamide epirubicin and fluorouracil
CEH	CEH:20|CeH:1	cervicogenic headache
CEH	CEH:45	cholesteryl ester hydrolase
CEH	CEH:13	cystic endometrial hyperplasia
CEL	CEL:27	carboxyl ester lipase
CEL	CEL:8|cel:4	celecoxib
CEL	CEL:9	chronic eosinophilic leukemia
CEM	CEM:21	cellulose ester membranes
CEM	CEM:35	contagious equine metritis
CEM	CEM:8	leukemia cells
CEN	CEN:16	centromere
CEN	CEN:6	centromere dna
CEN	CEN:7	continuous enteral nutrition
CEOs	CEOs:34	chief executive officers
CEOs	CEOs:8	cumulusenclosed oocytes
CEO	CEO:11	cyanoethylene oxide
CEO	CEO:28	chief executive officer
CEO	CEO:15	chloroethylene oxide
CEO	CEO:13	cumulus cellenclosed oocytes
CEP	CEP:5	care evaluation program
CEP	CEP:59	chronic eosinophilic pneumonia
CEP	CEP:44	congenital erythropoietic porphyria
CEP	CEP:8	cortical evoked potentials
CEP	CEP:20	counterelectrophoresis
CEP	CEP:7	evoked potential
CER	CER:8	cholesterol esterification rate
CER	CER:70	conditioned emotional response
CER	CER:17	costeffectiveness ratio
CES-D	CES-D:29|CESD:1	center for epidemiological studiesdepression
CES-D	CES-D:28|CESD:1	center for epidemiological studiesdepression scale
CESD	CESD:1	center of epidemiological studies depression
CESD	CESD:45	cholesteryl ester storage disease
CES	CES:8	carbohydrateelectrolyte solution
CES	CES:21	cat eye syndrome
CES	CES:18	cauda equina syndrome
CES	CES:9	central excitatory state
CEs	CEs:11|CES:1	cholesterol esters
CEs	CEs:40	cholesteryl esters
CES	CES:13	congenital esophageal stenosis
CEs	CEs:7	cornified envelopes
CES	CES:9	cranial electrotherapy stimulation
CET	CET:44	cephalothin
CET	CET:33	cholesteryl ester transfer
CET	CET:18	chronic ethanol treatment
CET	CET:8	competition exercise test
CET	CET:7	computed eeg topography
CET	CET:5	computerized electroencephalographic topography
CEZ	CEZ:140	cefazolin
CEZ	CEZ:10	cefazolin sodium
CE	CE:24	california encephalitis
CE	CE:72	capillary electrophoretic
CE	CE:22	capsule endoscopy
CE	CE:10	carbohydrateelectrolyte
CE	CE:7	carboplatin and etoposide
CE	CE:5	cardiac events
CE	CE:82	carotid endarterectomy
CE	CE:18|C-E:15	carpentieredwards
CE	CE:6	cataract extraction
CE	CE:10	catechol estrogens
CE	CE:6	cell extracts
CE	CE:15|Ce:6	central
CE	CE:14	centrifugal elutriation
CE	CE:9	chemoembolization
CE	CE:8	chest expansion
CE	CE:8	chicken embryo
CE	CE:67	cholesterol ester
CE	CE:19	ciliary epithelium
CE	CE:9	clinical engineering
CE	CE:12	clinical examination
CE	CE:25	cloning efficiency
CE	CE:11	coefficient of error
CE	CE:9	cold exposure
CE	CE:13	collection efficiency
CE	CE:14	combinatorial extension
CE	CE:40	competitive exclusion
CE	CE:10	constant estrous
CE	CE:6	constant estrus
CE	CE:124	continuing education
CE	CE:15	contractile element
CE	CE:18	contrast echocardiography
CE	CE:7	contrast enema
CE	CE:28	contrast enhancement
CE	CE:43	converting enzyme
CE	CE:9	corneal endothelial
CE	CE:14	cornified envelope
CE	CE:23	crude extract
CE	CE:11	cycle ergometer
CE	CE:15	cycle ergometry
CE	CE:121	cystic echinococcosis
CE	CE:8	cytochalasin e
CE	CE:6	included examination of the constant error
CE	CE:6	liver carboxylesterase
CF1	CF1:5	chloroplast atpase
CF1	CF1:25	chloroplast coupling factor
CF1	CF1:58	chloroplast coupling factor 
CF1	CF1:15	chloroplast fatpase
CFA	CFA:6	caudal forelimb area
CFA	CFA:18	cellular fatty acid
CFA	CFA:17	chicken fetal antigen
CFA	CFA:21	circulating filarial antigen
CFA	CFA:11	coal fly ash
CFA	CFA:50	common femoral artery
CFA	CFA:657|cFA:3	complete freunds adjuvant
CFA	CFA:19	confirmatory factor analyses
CFA	CFA:93	confirmatory factor analysis
CFA	CFA:11	coronafacic acid
CFA	CFA:11	craniofacial anomalies
CFA	CFA:84	cryptogenic fibrosing alveolitis
CFA	CFA:8|cfa:1	cyclopropane fatty acid
CFC	CFC:18	cytokine flow cytometry
CFC	CFC:10	fear conditioning
CFF	CFF:45|cff:1	critical flicker frequency
CFF	CFF:59|cff:1	critical flicker fusion
CFF	CFF:26	critical flicker fusion frequency
CFF	CFF:13	critical fusion frequency
CFI	CFI:34	camberwell family interview
CFI	CFI:20	chemotactic factor inactivator
CFI	CFI:19	collateral flow index
CFI	CFI:10	color flow imaging
CFM	CFM:45	cerebral function monitor
CFM	CFM:6	confocal fluorescence microscopy
CFM	CFM:13	flow mapping
cFN	cFN:4|CFN:3	caudal fastigial nucleus
cFN	cFN:7	caudal part of the fastigial nucleus
cFN	cFN:8|cFn:4|c-FN:1	cellular fn
CFP	CFP:15	center of foot pressure
CFP	CFP:8	centre of foot pressure
CFP	CFP:13	common foundation programme
CFP	CFP:9	culture filtrate proteins
CFP	CFP:50	cyan fluorescent protein
CFRs	CFRs:6	casefatality rates
CFRs	CFRs:9	climbing fiber responses
CFRs	CFRs:29	cyclic flow reductions
CFR	CFR:7	case fatality ratio
CFR	CFR:25	code of federal regulations
CFR	CFR:12	complement fixation reaction
CFR	CFR:24	coronary flow rate
CFR	CFR:225	coronary flow reserve
CFR	CFR:8	cyclic flow reduction
CFS	CFS:4	canada fitness survey
CFs	CFs:15	cardiac fibroblasts
CFS	CFS:50	cefsulodin
CFs	CFs:61|CFS:1	characteristic frequencies
CFS	CFS:924|cfs:1	chronic fatigue syndrome
CFs	CFs:26	climbing fibers
CFs	CFs:20	colonization factors
CFS	CFS:4	colorflow duplex scanning
CFS	CFS:12	conditioned fear stress
CFS	CFS:9	congenital fibrosarcoma
CFS	CFS:6	continuous flow system
CFS	CFS:7	fatigue scale
CFTR	CFTR:16|cftr:1	cystic fibrosis gene
CFTR	CFTR:9	cystic fibrosis gene product
CFTR	CFTR:1596|Cftr:8|cftr:4	cystic fibrosis transmembrane conductance regulator
CFTR	CFTR:45|Cftr:1	cystic fibrosis transmembrane conductance regulator gene
CFTR	CFTR:16	cystic fibrosis transmembrane conductance regulator protein
CFU-F	CFU-F:8	bone marrow fibroblast colonyforming cells
CFU-F	CFU-F:8|CFU-f:4	colonyforming unit
CFU-F	CFU-F:17|CFUF:1	fibroblast colonyforming units
CFU-GM	CFU-GM:2	colonyforming units for granulocytemacrophage
CFU-GM	CFU-GM:3	colonyforming units of granulocytes and macrophages
CFU-GM	CFU-GM:11	granulocytemacrophage cfu
CFU-GM	CFU-GM:4|CFU-gm:1	granulocytemacrophage colony
CFU-GM	CFU-GM:79|CFU-gm:3	granulocytemacrophage progenitor cells
CFU-GM	CFU-GM:9	granulocytemonocyte
CFU-GM	CFU-GM:38|CFUGM:1|CFU-gm:1	myeloid progenitor cells
CFU-GM	CFU-GM:20	progenitor cell
CFU-S	CFU-S:7|CFUs:3	colonyforming units in the spleen
CFU-S	CFU-S:14|CFUS:2|CFU-s:1	pluripotent
CFU-S	CFU-S:16|CFUs:3|CFU-s:1	spleen colonies
CFV	CFV:21	common femoral vein
CFV	CFV:19	constantflow ventilation
CF	CF:15	canadian forces
CF	CF:21	cardiac failure
CF	CF:11	cascade filtration
CF	CF:10	case fatality
CF	CF:29	cationic ferritin
CF	CF:130	cationized ferritin
CF	CF:8|c-f:1	cellfree
CF	CF:13	charcoalfiltered air
CF	CF:7	chicken fat
CF	CF:33	chloroform
CF	CF:20	chronic fatigue
CF	CF:8	clastogenic factors
CF	CF:12	climbing fibre
CF	CF:11	coelomic fluid
CF	CF:10	colostrumfed
CF	CF:26	complement fixation test
CF	CF:8	concentration factors
CF	CF:13	constantfrequency
CF	CF:17	continuousflow
CF	CF:40	contractile force
CF	CF:22	conventional fractionation
CF	CF:208	coronary flow
CF	CF:10	cortical fibroblasts
CF	CF:4|cf:1	counting fingers
CF	CF:20	crevicular fluid
CF	CF:12	crude fiber
CF	CF:15	crude fibre
CF	CF:47	culture filtrate
CF	CF:6	cytosolic fraction
CF	CF:42	cytotoxic factor
CF	CF:9	folinic acid
CF	CF:14	function
CGA	CGA:25	chlorogenic acid
CGA	CGA:78	comprehensive geriatric assessment
CGD	CGD:573	chronic granulomatous disease
CGD	CGD:10	chronic granulomatous disease of childhood
CGD	CGD:19	constitutional growth delay
CGE	CGE:64	capillary gel electrophoresis
CGE	CGE:18	cobalt gray equivalent
CGI-I	CGI-I:11	clinical global impressionsimprovement scale
CGI-I	CGI-I:6	clinical global impression of improvement
CGI-S	CGI-S:14	clinical global impression of severity
CGI-S	CGI-S:11	clinical global impressionsseverity of illness
CGI-S	CGI-S:14	clinical global impressionsseverity of illness scale
CGL	CGL:126|cgl:1	chronic granulocytic leukaemia
CGL	CGL:146	chronic granulocytic leukemia
CGL	CGL:19	congenital generalized lipodystrophy
cGMP	cGMP:489|C-GMP:2|Cgmp:1|CGMP:1|c-GMP:1	guanosine cyclic monophosphate
cGMP	cGMP:6	guanosine cyclic phosphate
CGM	CGM:34|-CGM:1	corn gluten meal
CGM	CGM:4|cGM:3	cortical gray matter
CGRP-LI	CGRP-LI:9	calcitonin generelated peptide
CGRP-LI	CGRP-LI:7	calcitonin generelated peptidelike immunoreactive
CGRP-LI	CGRP-LI:26|CGRP-li:2|CGRPLI:1	cgrplike immunoreactivity
CGRP-IR	CGRP-IR:10|CGRP-ir:1	calcitonin generelated peptide immunoreactivity
CGRP-IR	CGRP-IR:12	cgrpimmunoreactive
CGRP	CGRP:6	calcitonin generelated polypeptide
CGRP	CGRP:12	calcitonin generelated protein
CGTase	CGTase:24	cyclodextrin glucanotransferase
CGTase	CGTase:41	cyclodextrin glycosyltransferase
CGs	CGs:10	caregivers
CGs	CGs:17	cortical granules
CG	CG:9	capsular glaucoma
CG	CG:8	cardiac glycosides
CG	CG:6|Cg:2	catechin gallate
CG	CG:48	central gray
CG	CG:9	centre of gravity
CG	CG:6|-CG:1	cerebral ganglia
CG	CG:17	cholylglycine
CG	CG:11	choriogonadotropin
CG	CG:10|Cg:9	chromogranin
CG	CG:9	ciliary ganglia
CG	CG:72	ciliary ganglion
CG	CG:14	coagulating gland
CG	CG:11|C-G:4	cockcroftgault
CG	CG:14	collapsing glomerulopathy
CG	CG:10	colloidal gold
CG	CG:9	computer graphics
CG	CG:11	conjugate gradient
CG	CG:11|Cg:1	cryoglobulins
CG	CG:9	cycloguanil
CG	CG:10|cg:1	groups
CG	CG:10	mesencephalic central gray area
CG	CG:4	porous collagenglycosaminoglycan
CH50	CH50:15	complement hemolytic activity
CH50	CH50:8	total hemolytic activity
CH50	CH50:39	total hemolytic complement
CH50	CH50:19	total hemolytic complement activity
CHB	CHB:9	cyanohydroxybutene
CHB	CHB:163|CH-B:17|chB:1|cHB:1	chronic hepatitis b
CHB	CHB:150	heart block
CHCs	CHCs:47	community health centers
CHCs	CHCs:14	community health centres
CHCs	CHCs:9	cuticular hydrocarbons
CHD	CHD:9	cyclohexanedione
CHD	CHD:17	canine hip dysplasia
CHD	CHD:9	chronic haemodialysis
CHD	CHD:56|cHD:1	chronic hemodialysis
CHD	CHD:19	common hepatic duct
CHD	CHD:35	congenital heart diseases
CHD	CHD:20	conventional hemodialysis
CHEF	CHEF:52	contourclamped homogeneous electric field
CHEF	CHEF:8	homogeneous electric fields
CHEF	CHEF:5	homogeneous electric field electrophoresis
ChE	ChE:4|CHE:1	choline esterase
ChE	ChE:18|CHE:3|Ch-E:1	cholinesterase activity
CHF	CHF:26	congenital hepatic fibrosis
CHF	CHF:3285	congestive heart failure
CHF	CHF:22	continuous hemofiltration
CHF	CHF:6	crimean haemorrhagic fever
CHF	CHF:7	crimean hemorrhagic fever
CHF	CHF:340|cHF:1	patients with chronic heart failure
CHIP	CHIP:8	carboxyl terminus of hscinteracting protein
CHIP	CHIP:23	childrens health insurance program
CHIP	CHIP:11	platinum iv
CHLs	CHLs:12	chlordanes
CHLs	CHLs:23	chlordane compounds
CHL	CHL:13	combined hyperlipidemia
CHL	CHL:15	conductive hearing loss
CHL	CHL:13|C-HL:1	crownheel length
CHM	CHM:19	chinese herbal medicine
CHM	CHM:28	choroideremia
CHN	CHN:22	chinese herbs nephropathy
CHN	CHN:13	community health nursing
CHN	CHN:8	congenital hypomyelinating neuropathy
CHO-K1	CHO-K1:68|CHO-k1:2	chinese hamster ovary cells
CHO-K1	CHO-K1:10	chinese hamster ovary k
CHOP	CHOP:18	cebp homologous protein
CHOP	CHOP:11	cyclophosphamidedoxorubicinvincristineprednisone
CHO	CHO:42	chinese hamster ovarian
CHO	CHO:11|cho:1	cyclohexene oxide
CHO	CHO:20	highcarbohydrate
CHP	CHP:10	chandipura
CHP	CHP:17|chp:1	cricohyoidopexy
CHP	CHP:12	cytophagic histiocytic panniculitis
CHP	CHP:12	pullulan
CHRNA4	CHRNA4:8	neuronal nicotinic acetylcholine receptor alpha  subunit
CHRNA4	CHRNA4:4	neuronal nicotinic acetylcholine receptor alpha subunit
CHRNA4	CHRNA4:6	nicotinic acetylcholine receptor alpha  subunit gene
CHT	CHT:9	choline transporter
CHT	CHT:20	closed head trauma
CHX	CHX:18	chlorhexidine digluconate
CHX	CHX:64|Chx:1	protein synthesis inhibitor cycloheximide
CH	CH:26	calponin homology
CH	CH:10	cardiac hypertrophy
CH	CH:9	central hemodynamics
CH	CH:17	cerebral hemispheres
CH	CH:28	cerebral hemorrhage
CH	CH:14|C-H:3	chediakhigashi
CH	CH:94	chloral hydrate
CH	CH:181	chronic hepatitis
CH	CH:45	chronic hypoxia
CH	CH:23	chronically hypoxic
CH	CH:116	cluster headache
CH	CH:6	community hospital
CH	CH:8	concentric hypertrophy
CH	CH:5|ch:4	congenital hydrocephalus
CH	CH:9	congenital hypothyroid
CH	CH:5	crypt height
CH	CH:11|ch:1	cyclic hematopoiesis
CH	CH:10	heavy chain constant
CH	CH:15	heavy chain constant region
CIA	CIA:11	carbon immunoassay
CIA	CIA:539	collageninduced arthritis
CIA	CIA:25	common iliac artery
CIC	CIC:12|Cic:1	cicletanine
CIC	CIC:20	clean intermittent catheterisation
CIC	CIC:96	clean intermittent catheterization
CIC	CIC:36	conjunctival impression cytology
CIDP	CIDP:15	chronic inflammatory demyelinating neuropathy
CIDP	CIDP:289	chronic inflammatory demyelinating polyneuropathy
CIDP	CIDP:134	chronic inflammatory demyelinating polyradiculoneuropathy
CIDR	CIDR:18	controlled internal drug release
CIDR	CIDR:7	controlled internal drug releasing
CID	CID:10	central institute for the deaf
CID	CID:342	collisioninduced dissociation
CID	CID:20	combined immunodeficiency
CID	CID:6	combined immunodeficiency disease
CID	CID:8	cytomegalic inclusion disease
CIEF	CIEF:81|cIEF:38	capillary isoelectric focusing
CIEF	CIEF:9	crossed immunoelectrofocusing
CIE	CIE:5	capillary ion electrophoresis
CIE	CIE:9	chronic intermittent ethanol
cIg	cIg:5|CIg:3|c-Ig:1	cytoplasmic ig
cIg	cIg:21|CIg:13|C-Ig:2|cig:1	cytoplasmic immunoglobulin
CIH	CIH:14	chronic intermittent hypoxia
CIH	CIH:9	colloidal iron hydroxide
CII	CII:28	collagen type ii
CII	CII:291|cII:3|C-II:2	type ii collagen
CIMT	CIMT:29|c-IMT:1|cIMT:1	carotid intimamedia thickness
CIMT	CIMT:20	constraintinduced movement therapy
CIM	CIM:6	cardia intestinal metaplasia
CIM	CIM:12	cimaterol
CIM	CIM:23	composite interval mapping
CIM	CIM:6	critical illness myopathy
CIN3	CIN3:8|CIN-3:1	cervical intraepithelial neoplasia
CIN3	CIN3:10	cervical intraepithelial neoplasia grade 
CINCA	CINCA:2	chronic infantile neurologic cutaneous and articular
CINCA	CINCA:6	chronic infantile neurological cutaneous and articular
CIP	CIP:13	caeruleininduced pancreatitis
CIP	CIP:7|Cip:2	ciprofibrate
CIP	CIP:10|CiP:3	coprinus cinereus peroxidase
CIP	CIP:7	corticotropininhibiting peptide
CIP	CIP:33	critical illness polyneuropathy
CISH	CISH:8	chromogenic in situ hybridisation
CISH	CISH:41	chromogenic in situ hybridization
CISH	CISH:5	intrafascial supracervical hysterectomy
CISS	CISS:23	chromosomal in situ suppression
CISS	CISS:4	constructive interference in the steady state
CISS	CISS:2	constructive interference steadystate
CISS	CISS:14	coping inventory for stressful situations
CIS	CIS:45	cancer information service
CIS	CIS:4|Cis:1	carcinoma in situ testis
CIS	CIS:5	cellular injury score
CIS	CIS:5	chronic immobilization stress
CIS	CIS:32	clinical interview schedule
CIS	CIS:12	commonwealth of independent states
CIS	CIS:11	continuous interleaved sampler
CIS	CIS:41	continuous interleaved sampling
CIS	CIS:5	critical incident stress
CIS	CIS:10	cytokineinducible shcontaining protein
CIS	CIS:5|Cis:1	cytokineinducible sh protein
CIV	CIV:25	chilo iridescent virus
CIV	CIV:12|C-IV:5	collagen iv
CIV	CIV:16|C-IV:8	collagen type iv
CIV	CIV:10	continuous intravenous
CIN	CIN:12	cefsulodinirgasannovobiocin
CIN	CIN:5	cervical intraepithelial lesions
CIN	CIN:70	chromosomal instability
CIN	CIN:14	chromosome instability
CIN	CIN:12	chronic idiopathic neutropenia
CIN	CIN:23	contrastinduced nephropathy
CI	CI:11	 confidence internal
CI	CI:12	 confidence limits
CI	CI:8	carbonyl iron
CI	CI:9	cationindependent
CI	CI:7	cerebral infarct
CI	CI:6	cervical incompetence
CI	CI:8	chemical intolerance
CI	CI:10	chilling injury
CI	CI:9	chronotropic incompetence
CI	CI:24	cochlear implantation
CI	CI:12	cold ischemia
CI	CI:11	colloidal iron
CI	CI:9	conditioned inhibition
CI	CI:7	configuration interaction
CI	CI:10	constraintinduced
CI	CI:5	continuous improvement
CI	CI:12	conventional imaging
CI	CI:14	convergence insufficiency
CI	CI:14	cumulative incidence
CI	CI:12	cylindrical inclusion
CI	CI:7	cytoplasmic inclusion
CI	CI:70	cytoplasmic incompatibility
Ci	Ci:6	intercellular co concentration
Ci	Ci:15|CI:1	transcription factor cubitus interruptus
CK-BB	CK-BB:23|CKBB:7	creatine kinase bb
CK-BB	CK-BB:14|CKBB:1	creatine kinase bb isoenzyme
CK-BB	CK-BB:20	creatine kinase isoenzyme bb
CK-MB	CK-MB:37|CKMB:11	creatine kinase isoenzyme mb
CK-MB	CKMB:3|CK-MB:3	creatine kinase mb fraction
CK-MB	CK-MB:35|CKMB:4	creatine kinase mb isoenzyme
CK-MB	CK-MB:5|CKMB:1	isoenzyme of ck
CKs	CKs:131|Cks:10	cytokeratins
CKs	CKs:8|Cks:3	cytokinins
CK	CK:11	anticytokeratin
CK	CK:6	casein kinases
CK	CK:11	chick kidney
CK	CK:11	chicken kidney
CK	CK:14	color kinesis
CK	CK:3|C-K:2	compound k
CK	CK:18	conductive keratoplasty
CK	CK:35	creatine kinase activity
CK	CK:12	creatinkinase
CK	CK:13|ck:1	expression of cytokeratins
CK	CK:10	serum creatinekinase
CLA	CLA:14	caseous lymphadenitis
CLA	CLA:6|cla:1	cationic leukocyte antigen
CLA	CLA:13	common leukocyte antigen
CLA	CLA:6	cutaneous lymphocyte ag
CLA	CLA:39	cutaneous lymphocyte antigen
CLA	CLA:7	cutaneous lymphocyteassociated ag
CLA	CLA:78	cutaneous lymphocyteassociated antigen
CLC	CLC:12|cLC:2	capillary liquid chromatography
CLC	CLC:11	cardiotrophinlike cytokine
CLD	CLD:11	central lung distance
CLD	CLD:367	chronic lung disease
CLD	CLD:22	chronic lung disease of prematurity
CLD	CLD:14	congenital chloride diarrhea
CLH	CLH:13	chronic lobular hepatitis
CLH	CLH:11	cutaneous lymphoid hyperplasia
CLIA	CLIA:6	chemiluminescent assay
CLIA	CLIA:22	chemiluminescent immunoassay
CLIA	CLIA:11	clinical laboratory improvement amendments
CLIA	CLIA:28	clinical laboratory improvement amendments of 
CLIP	CLIP:21	cancer of the liver italian program
CLIP	CLIP:26	corticotropinlike intermediate lobe peptide
CLL	CLL:9	chronic lymphocytic
CLL	CLL:5	chronic lymphocytic leukemia cells
CLL	CLL:14	chronic lymphocytic leukemic
CLM	CLM:8	colorectal liver metastases
CLM	CLM:17	cutaneous larva migrans
CLO	CLO:25	cod liver oil
CLO	CLO:10	oesophagus
CLO	CLO:7	rapid urease
CLPs	CLPs:6	ctype lectinlike proteins
CLPs	CLPs:12	common lymphoid progenitors
CLPs	CLPs:20	corelike particles
CLSM	CLSM:91|cLSM:1	confocal laser scanning microscope
CLSM	CLSM:491|cLSM:3	confocal laser scanning microscopy
CLS	CLS:12	capillary leak syndrome
CLS	CLS:9	classical leastsquares
CLS	CLS:29	clinical laboratory science
CLS	CLS:36	coffinlowry syndrome
CLs	CLs:16	contact lenses
CLs	CLs:25	cycle lengths
CLZ	CLZ:13	chlorozotocin
CLZ	CLZ:40	clozapine
CLP	CLP:48	cecal ligation and perforation
CLP	CLP:11	cecal ligationpuncture
CLP	CLP:120|clp:1	cleft lip and palate
CLP	CLP:2	cleft lip or cleft palate
CLP	CLP:8	coactosinlike protein
CLP	CLP:12	cytotoxic lymphocyte precursors
CLP	CLP:5	human calmodulinlike protein
Cl	Cl:111|CL:1	 confidence interval
CL	CL:268	cardiolipin
CL	CL:17	cathodoluminescence
CL	CL:18|cl:3	central lateral
CL	CL:26	central lateral nucleus
CL	CL:18|Cl:1	centralis lateralis
CL	CL:1262|Cl:6|cl:1	chemiluminescence
CL	CL:7	chemiluminescence response
CL	CL:64	chemiluminescent
CL	CL:12	chemoluminescence
CL	CL:5	chromosome loss
Cl	Cl:13|CL:12	clearances
CL	CL:13|Cl:8	clearance rate
CL	CL:50	cleft lip
CL	CL:6	confidence level
CL	CL:11	contralateral
CL	CL:7	control line
CL	CL:16	coriaria lactone
CL	CL:594|Cl:1	corpus luteum
CL	CL:10	crithidia luciliae
CL	CL:193	cutaneous leishmaniasis
CL	CL:18	epsiloncaprolactone
CL	CL:9	liver
CL	CL:46|Cl:5	lung compliance
CL	CL:13	lymph
CL	CL:5|Cl:1	lymph protein concentration
CL	CL:6	patients with cholelithiasis
CL	CL:27|Cl:21|-Cl:1	total plasma clearance
CMA	CMA:6	canadian medical association
CMA	CMA:28	chronic metabolic acidosis
CMA	CMA:18	cingulate motor area
CMA	CMA:7	coronamic acid
CMA	CMA:15	cortical masticatory area
CMA	CMA:9	corticomedial amygdala
CMA	CMA:75	cows milk allergy
CMA	CMA:9	mesenteric artery
CMB	CMB:20	chemical mass balance
CMB	CMB:19	cosmic microwave background
CMCase	CMCase:17	carboxymethyl cellulase
CMCase	CMCase:27|CMC-ase:1	carboxymethylcellulase
CMC	CMC:52	carpometacarpal
CMC	CMC:8	cellmediated cytolysis
CMC	CMC:19	closed mitral commissurotomy
CMC	CMC:9	computermediated communication
CMD	CMD:13	cassava mosaic disease
CMD	CMD:24	cefamandole
CMD	CMD:17	common mental disorders
CMD	CMD:13	corticomedullary differentiation
CMD	CMD:16	craniomandibular disorder
CMD	CMD:27	craniomandibular dysfunction
CMD	CMD:17	craniometaphyseal dysplasia
CMD	CMD:11	signs and symptoms of craniomandibular disorders
CME	CME:10	chemically modified electrode
CME	CME:409	continuing medical education
CME	CME:183	cystoid macular edema
CMF	CMF:24	chondromyxoid fibroma
CMF	CMF:9	conditioned medium factor
CMF	CMF:20	constant magnetic field
CMF	CMF:8	cows milk formula
CMG	CMG:9	carboxymethylglucan
CMG	CMG:22	cystometrogram
CMG	CMG:9	cystometrography
CMG	CMG:18	cystometry
CMH	CMH:13	ceramide monohexoside
CMH	CMH:8	community mental health
CMI	CMI:149	cellmediated immune
CMI	CMI:9	chronic mental illness
CMI	CMI:10	chronic mesenteric ischemia
CMI	CMI:48	cornell medical index
CMI	CMI:7	cows milk intolerance
CMI	CMI:16	craniomandibular index
CML-BC	CML-BC:5|CMLbc:1	chronic myelogenous leukemia
CML-BC	CML-BC:11	chronic myelogenous leukemia in blast crisis
CML-BC	CML-BC:9|CMLBC:1	chronic myeloid leukemia in blast crisis
CML	CML:38	carboxymethyllysine
CML	CML:17	cellmediated lymphocytotoxicity
CML	CML:12	cellmediated lysis
CML	CML:215	chronic myelogenous leukaemia
CML	CML:527	chronic myeloid leukaemia
CML	CML:11	chronic myeloid leukemic
CML	CML:8	mediated lysis
CML	CML:11	n epsiloncarboxymethyllysine
CML	CML:27	nepsiloncarboxymethyllysine
CMM	CMM:5	color mmode
CMM	CMM:14	crossmodality matching
CMM	CMM:162	cutaneous malignant melanoma
CMN	CMN:6	caudal mediastinal lymph node
CMN	CMN:5	caudal mediastinal node
CMN	CMN:19	congenital melanocytic nevi
CMN	CMN:54	congenital mesoblastic nephroma
CMO	CMO:7|Cmo:1	choline monooxygenase
CMO	CMO:21	cystoid macular oedema
CMP	CMP:23	cartilage matrix protein
CMP	CMP:12	caseinomacropeptide
CMP	CMP:7	chemical mechanical polishing
CMP	CMP:7	dynamic cardiomyoplasty
CMRglc	CMRglc:8	cerebral glucose metabolic rate
CMRglc	CMRglc:10|CMRGlc:5	cerebral glucose metabolism
CMRO2	CMRO2:15|CMRo2:1	cerebral metabolic rate
CMRO2	CMRO2:7	cerebral oxygen metabolic rate
CMRO2	CMRO2:5|CMRo2:1	cerebral oxygen uptake
CMR	CMR:6	caffeine metabolic ratio
CMR	CMR:5	calculated maximal response
CMR	CMR:22	cardiac magnetic resonance
CMR	CMR:86	cardiovascular magnetic resonance
CMR	CMR:5	cellophane macular reflex
CMR	CMR:63	comodulation masking release
CMR	CMR:17	contact microradiography
CMR	CMR:6	crude mortality rate
CMs	CMs:20	cavernous malformations
CMS	CMS:46	centers for medicare and medicaid services
CMS	CMS:21	centers for medicaremedicaid services
CMS	CMS:19	cervical magnetic stimulation
CMS	CMS:53	chronic mild stress
CMS	CMS:29	chronic mountain sickness
CMs	CMs:12	chylomicrons
CMs	CMs:15	cochlear microphonics
CMS	CMS:7	cystadenoma with mesenchymal stroma
CMS	CMS:72|cms:6	cytoplasmic male sterility
CMS	CMS:9	solubilization
CMT1A	CMT1A:75|CMT1a:4|CMT-1A:2	charcotmarietooth disease type a
CMT1A	CMT1A:23|CMT-1A:1	charcotmarietooth type a
CMTC	CMTC:31	cutis marmorata telangiectatica congenita
CMTC	CMTC:13	cytoplasmic microtubule complex
CMT	CMT:37	california mastitis test
CMT	CMT:156	charcotmarietooth
CMT	CMT:14	choline magnesium trisalicylate
CMT	CMT:11	combined modality treatment
CMT	CMT:14	congenital muscular torticollis
CMT	CMT:6	crossmodal transfer
CMV	CMV:46	anticytomegalovirus
CMV	CMV:151	conventional mechanical ventilation
CMV	CMV:21	cucumber mosaic cucumovirus
CMV	CMV:226	cucumber mosaic virus
CMV	CMV:22	cytomegaloviral
CMV	CMV:21	cytomegalovirus infection
CMZ	CMZ:136	cefmetazole
CMZ	CMZ:10	ciliary marginal zone
CMZ	CMZ:11	clomethiazole
CM	CM:14	canola meal
CM	CM:16	carbomedics
CM	CM:28	carboxymethyl
CM	CM:6	cardiac mucosa
CM	CM:9	cardiac myosin
CM	CM:10	cardiomyocyte
CM	CM:46	cardiomyopathic
CM	CM:9|Cm:2	cell membrane
CM	CM:48	center of mass
CM	CM:12	centromedian
CM	CM:7	centromedian nucleus
CM	CM:23	centrum medianum
CM	CM:108	cerebral malaria
CM	CM:54	cervical mucus
CM	CM:12	chiari malformation
CM	CM:12|C-M:4	chloroformmethanol
CM	CM:16	chorismate mutase
CM	CM:15	chronic migraine
CM	CM:27	ciliary muscle
CM	CM:13	clinical mastitis
CM	CM:6	common migraine
CM	CM:27	complementary medicine
CM	CM:10	complete hydatidiform mole
CM	CM:7	complete mole
CM	CM:20	congenital malformations
CM	CM:9	consistent mapping
CM	CM:21	contingency management
CM	CM:9|cm:2	contrast material
CM	CM:31	corticomotoneuronal
CM	CM:51	cows milk
CM	CM:18	cryptococcal meningitis
CM	CM:7	culture material
CM	CM:45	cutaneous melanoma
CM	CM:6	cytokine mixture
CM	CM:23	cytoplasmic membrane
CM	CM:6	media conditioned
CM	CM:10|-CM:1	medium conditioned
CM	CM:23|Cm:1|cm:1	membranes
CM	CM:6	neonatal rat cardiac myocytes
CM	CM:5	neonatal rat cardiomyocytes
CM	CM:13	vivo confocal microscopy
CNAP	CNAP:23	compound nerve action potential
CNAP	CNAP:9	continuous negative airway pressure
CNAs	CNAs:29|CNAS:1	certified nursing assistants
CNAs	CNAs:9	copy number aberrations
CNAs	CNAs:9	copy number alterations
CNA	CNA:7	canadian nurses association
CNA	CNA:3|cna:3	collagen adhesin
CNL	CNL:9	chronic neutrophilic leukaemia
CNL	CNL:50	chronic neutrophilic leukemia
CNM	CNM:11	cat nictitating membrane
CNM	CNM:14	centronuclear myopathy
CNM	CNM:9	congenital nemaline myopathy
CNP	CNP:16	chlornitrofen
CNP	CNP:12|cnp:1	continuous negative pressure
CNP	CNP:15	nucleotide phosphodiesterase
CNQX	CNQX:6	cyanonitroquinoxaline dione
CNQX	CNQX:5	antagonist cyanonitroquinoxalinedione
CNSHA	CNSHA:9	chronic nonspherocytic hemolytic anemia
CNSHA	CNSHA:10	haemolytic anaemia
CNSs	CNSs:81	clinical nurse specialists
CNSs	CNSs:8	conserved noncoding sequences
CNS	CNS:19	canadian neurological scale
CNS	CNS:13	central nervous
CNS	CNS:27	congenital nephrotic syndrome
CNV	CNV:72	choroidal neovascularisation
CNV	CNV:547	choroidal neovascularization
CNV	CNV:22	cucumber necrosis virus
CN	CN:12	chloroacetophenone
CN	CN:13	caudate nuclei
CN	CN:11	cavernous nerve
CN	CN:15	cerebellar nuclei
CN	CN:9	cochlear nerve
CN	CN:8	cochlear nuclear complex
CN	CN:22	cochlear nuclei
CN	CN:138	cochlear nucleus
CN	CN:8	cognitively normal
CN	CN:13	congenital neutropenia
CN	CN:68	congenital nystagmus
CN	CN:9	contrast nephropathy
CN	CN:10	coordination number
CN	CN:9	criglernajjar
CN	CN:13	cyanopropyl
CN	CN:24	cyclic neutropenia
CN	CN:12	cyclic nucleotides
CN	CN:13	necrosis
cob	cob:16|COB:7	apocytochrome b
cob	cob:9	cobalamin biosynthetic
COC	COC:38	calcifying odontogenic cyst
COC	COC:9	continuity of care
COD	COD:31	calcium oxalate dihydrate
COD	COD:413	chemical oxygen demand
COD	COD:12	cystic ovarian disease
COH	COH:9|CoH:1	coefficient of haze
COH	COH:23	compensatory ovarian hypertrophy
COH	COH:212	controlled ovarian hyperstimulation
COH	COH:22|CoH:1|Coh:1	coumarin hydroxylase
COL7A1	COL7A1:5	gene encoding type vii collagen
COL7A1	COL7A1:81|Col7a1:3	type vii collagen gene
COMT	COMT:5	catecholomethyltransferase gene
COMT	COMT:9	catecholamineomethyltransferase
COM	COM:151	calcium oxalate monohydrate
COM	COM:15|CoM:10	centre of mass
COM	COM:57	chronic otitis media
COPp	COPp:6|COPP:1	colloid osmotic pressure in plasma
COPp	COPp:7|COPP:1	plasma colloid osmotic pressure
COP	COP:19|CoP:1	centerofpressure
COP	COP:18	circumoval precipitin
COP	COP:23|Cop:15	copenhagen
COP	COP:18	cryptogenic organizing pneumonia
COR	COR:10	center of rotation
COR	COR:28	cervicoocular reflex
COR	COR:6|cor:3	coldregulated
COR	COR:15	phytotoxin coronatine
COSY	COSY:6	twodimensional correlated
COSY	COSY:15	twodimensional correlated spectroscopy
COS	COS:21	carbonyl sulfide
COS	COS:27	childhoodonset schizophrenia
cos	cos:10	cohesive ends
cos	cos:8	cohesive end site
COS	COS:18	controlled ovarian stimulation
COX-2	COX-2:4|Cox-2:1	cox isoform
COX-2	COX-2:8	cyclooxygenase ii
COX-2	COX-2:16|Cox-2:2	cycloxygenase
COX-2	COX-2:13	inducible cox
COI	COI:6	cardiac output index
COI	COI:5	cytochrome c oxidase subunit 
COI	COI:5	cytochrome c oxidase subunit i gene
COI	COI:62	cytochrome oxidase i
COI	COI:10	cytochrome oxidase i gene
CO	CO:12	centric occlusion
CO	CO:9|co:1	childhoodonset
CO	CO:23	cholesteryl oleate
CO	CO:27|Co:1	coconut oil
CO	CO:32|co:1	constans
CO	CO:203|Co:3	corn oil
CO	CO:20	coronary occlusion
CPAP	CPAP:1239|C-PAP:2	continuous positive airway pressure
CPAP	CPAP:5	continuous positive airway pressure breathing
CPA	CPA:28	cardiopulmonary arrest
CPA	CPA:12	care programme approach
CPA	CPA:9	carotid phonoangiography
CPA	CPA:13	caudal pressor area
CPA	CPA:200|cpa:2	cerebellopontine angle
CPA	CPA:17	circulating platelet aggregates
CPA	CPA:35	conditioned place aversion
CPA	CPA:8	corneal polarization axis
CPA	CPA:13	cryoprotective agent
CPA	CPA:327	cyclopiazonic acid
CPA	CPA:7	ncyclopentyl adenosine
CPA	CPA:13	physical abuse
CPA	CPA:5	receptor agonist cyclopentyladenosine
CPB	CPB:22|CpB:8	carboxypeptidase b
CPB	CPB:9	cardiopulmonary bypass surgery
CPB	CPB:6	cetylpyridinium bromide
CPB	CPB:13	colorado potato beetle
CPB	CPB:19	competitive protein binding
CPB	CPB:10	plexus block
cPCR	cPCR:14|C-PCR:4|CPCR:1	competitive pcr
cPCR	cPCR:15|C-PCR:2|c-PCR:2|CPCR:1	competitive polymerase chain reaction
CPCs	CPCs:14	calcium phosphate cements
CPCs	CPCs:6	choroid plexus carcinomas
CPC	CPC:11	calcium phosphate ceramic
CPC	CPC:8	capsular polysaccharide complex
CPC	CPC:15	cephalosporin c
CPC	CPC:134	cetylpyridinium chloride
CPC	CPC:8	chest pain center
CPC	CPC:9	chronic persistent cough
CPC	CPC:11	circulating progenitor cells
CPC	CPC:9	coil planet centrifuge
CPC	CPC:10	cyclophotocoagulation
CPD	CPD:16	carboxypeptidase d
CPD	CPD:33	cephalopelvic disproportion
CPD	CPD:88	chronic peritoneal dialysis
CPD	CPD:11	chronic pulmonary disease
CPD	CPD:53	citratephosphatedextrose
CPD	CPD:11	color pixel density
CPD	CPD:53	continuing professional development
CPD	CPD:19	critical point drying
CPD	CPD:14|cPD:1	cumulative population doublings
CPE	CPE:31	carbon paste electrode
CPE	CPE:93|Cpe:4|CpE:2	carboxypeptidase e
CPE	CPE:15	cardiogenic pulmonary edema
CPE	CPE:23	chronic pulmonary emphysema
CPE	CPE:18	clinical pastoral education
CPE	CPE:46	clostridium perfringens enterotoxin
CPE	CPE:7	cloudpoint extraction
CPE	CPE:28	continuing professional education
CPE	CPE:30	cytoplasmic polyadenylation element
CPF	CPF:6	cleavage and polyadenylation factor
CPF	CPF:5	coronary perfusion flow
CPGs	CPGs:39	central pattern generators
CPGs	CPGs:102	clinical practice guidelines
CPG	CPG:174	central pattern generator
CPG	CPG:18	choline phosphoglycerides
CpG	CpG:9	cpg motifs
CpG	CpG:14	cytosinephosphateguanosine
CpG	CpG:18	dinucleotide
CPH	CPH:14|CP-H:1	carboxypeptidase h
CPH	CPH:9	centrophenoxine
CPH	CPH:45	chronic paroxysmal hemicrania
CPH	CPH:151|CpH:1	chronic persistent hepatitis
CPH	CPH:7	chronic pulmonary hypertension
CPIB	CPIB:15	clofibric acid
CPIB	CPIB:5	effect of pchlorophenoxyisobutyrate
CPI	CPI:61	california psychological inventory
CPI	CPI:8	carboxypeptidase inhibitor
CPI	CPI:6	chronic placental insufficiency
CPI	CPI:13	clinical practice improvement
CPI	CPI:17	community periodontal index
CPI	CPI:11	cyclopropylpyrroloindole
CPK	CPK:9	cell proliferation kinetics
CPK	CPK:9	creatine phosphate kinase
CPK	CPK:10	creatinephosphokinase
CPK	CPK:14	phosphokinase activity
CPMS	CPMS:9|CP-MS:2	chronic progressive ms
CPMS	CPMS:8|CP-MS:1	chronic progressive multiple sclerosis
CPM	CPM:17	carboxypeptidase m
CPM	CPM:47	cefpiramide
CPM	CPM:115	central pontine myelinolysis
CPM	CPM:30	chlorpheniramine maleate
CPM	CPM:47	confined placental mosaicism
CPM	CPM:102	continuous passive motion
cpm	cpm:66|CPM:20	counts per minute
CPM	CPM:8	critical path method
cpm	cpm:4	percentage of normal  cyclesmin
CPN	CPN:22|CpN:1	carboxypeptidase n
CPN	CPN:15	caudateputamen nucleus
CPN	CPN:30	common peroneal nerve
CPN	CPN:18	community psychiatric nurse
CPOE	CPOE:49	computerized physician order entry
CPOE	CPOE:15	computerized provider order entry
CPON	CPON:5|C-PON:1|c-PON:1	cterminal flanking peptide of neuropeptide y
CPON	CPON:6|C-PON:1	cterminal flanking peptide of npy
CPO	CPO:39|Cpo:1	chloroperoxidase
CPO	CPO:11	chlorpyrifos oxon
CPO	CPO:16|cpo:1	coproporphyrinogen oxidase
CPPD	CPPD:254	calcium pyrophosphate dihydrate
CPPD	CPPD:8	calcium pyrophosphate dihydrate deposition disease
CPPV	CPPV:40	continuous positive pressure ventilation
CPPV	CPPV:9	contralateral patent processus vaginalis
CPPs	CPPs:23	cellpenetrating peptides
CPPs	CPPs:15	choroid plexus papillomas
CPPs	CPPs:15	chronic pain patients
CPP	CPP:10	calcium polyphosphate
CPP	CPP:24	casein phosphopeptides
CPP	CPP:103	central precocious puberty
CPP	CPP:27	choroid plexus papilloma
CPP	CPP:58	chronic pelvic pain
CPP	CPP:16	collaborative perinatal project
CPP	CPP:357	conditioned place preference
CPP	CPP:14	cyclopentacdpyrene
CPP	CPP:10	perfusion pressures
CPRS	CPRS:76	comprehensive psychopathological rating scale
CPRS	CPRS:8	computerized patient record system
CPR	CPR:54	cpeptide immunoreactivity
CPR	CPR:10	cpeptide reactivity
CPR	CPR:8	carboxypeptidase r
CPR	CPR:1539	cardiopulmonary resuscitation
CPR	CPR:40	cefpirome
CPR	CPR:10	cefpirome sulfate
CPR	CPR:7	clinical pregnancy rate
CPR	CPR:51	computerbased patient record
CPR	CPR:19	computerized patient record
CPR	CPR:26	contraceptive prevalence rate
CPR	CPR:8	cortisol production rate
CPR	CPR:9	cumulative pregnancy rate
CPR	CPR:6	cytochrome p oxidoreductase
cPSA	cPSA:12|CPSA:1	complexed prostatespecific antigen
cPSA	cPSA:29|C-PSA:1	complexed psa
CPSI	CPSI:6|CpsI:1	carbamyl phosphate synthetase i
CPSI	CPSI:11	chronic prostatitis symptom index
CPT-11	CPT-11:21|CPT11:1	ethylpiperidinopiperidinocarbonyloxycamptothecin
CPT-11	CPT-11:86	irinotecan hydrochloride
CPT	CPT:5	a receptor antagonist cyclopentyltheophylline
CPT	CPT:355|Cpt:5|cpt:1	camptothecin
CPT	CPT:27	carnitine palmitoyl transferase
CPT	CPT:10	carnitine palmityl transferase
CPT	CPT:11	carnitine palmityltransferase
CPT	CPT:7	chest physical therapy
CPT	CPT:22	chest physiotherapy
CPT	CPT:13	choline phosphotransferase
CPT	CPT:24|cpt:1	cholinephosphotransferase
CPT	CPT:159	cold pressor test
CPT	CPT:12	cold pressor testing
CPT	CPT:7	congenital pseudarthrosis of the tibia
CPT	CPT:12	conjunctival provocation tests
CPT	CPT:50	continuous performance task
CPT	CPT:179	continuous performance test
CPT	CPT:48	current perception threshold
CPT	CPT:60	current procedural terminology
CPT	CPT:13	cycling probe technology
CPT	CPT:9	receptor antagonist cyclopentyldimethylxanthine
CPU	CPU:17	central processing unit
CPU	CPU:8	chest pain unit
CPV	CPV:217	canine parvovirus
CPV	CPV:32	cytoplasmic polyhedrosis virus
CPV	CPV:20	plasma volume
CPX	CPX:9	dipropylcyclopentylxanthine
CPX	CPX:7	antagonist cyclopentyldipropylxanthine
CPZ	CPZ:5	antagonist capsazepine
CPZ	CPZ:8	carboxypeptidase z
CPZ	CPZ:150	cefoperazone
CPZ	CPZ:19|cpz:1	chlorpromazine hydrochloride
CP	CP:4|C-p:2|Cp:2|C-P:1	c peptide
Cp	Cp:11	c promoter
Cp	CP:8|Cp:8	caeruloplasmin
CP	CP:46|Cp:6	campylobacter pylori
CP	CP:9|Cp:2	campylobacter pyloridis
CP	CP:9	canal paresis
CP	CP:42	cancer procoagulant
CP	CP:53	capsular polysaccharide
CP	CP:18	carbamide peroxide
C-P	C-P:12	carbonphosphorus
CP	CP:7	carbopol p
CP	CP:11	carboxypeptidase
CP	CP:22|Cp:1	cardioplegia
CP	CP:19|C-P:2	cardiopulmonary
CP	CP:9	categorical perception
CP	CP:10	cationic proteins
CP	CP:5	cellulose powder
CP	CP:21	center of pressure
cp	cp:13|cP:10|Cp:1|CP:1	centipoise
CP	CP:18	centre of pressure
CP	CP:16	centrifugal pump
CP	CP:35|C-P:2|c-p:1	cerebellopontine
CP	CP:762|cp:2	cerebral palsy
CP	CP:21	cerebral peduncle
CP	CP:26	chest pain
C-P	CP:4|C-P:4	childpugh
CP	CP:10	chloropicrin
cp	cp:45|Cp:4	chloroplast
CP	CP:27	chlorphentermine
CP	CP:12|Cp:1	chlorpropamide
CP	CP:6	cholestasis of pregnancy
CP	CP:13	chronic pain
CP	CP:317|cP:6	chronic pancreatitis
CP	CP:49	chronic periodontitis
CP	CP:130	chronic phase
CP	CP:17	chronic progressive
CP	CP:21	chronic prostatitis
CP	CP:78	cicatricial pemphigoid
CP	CP:5	ciliary processes
CP	CP:13	classical
CP	CP:40	classical pathway
CP	CP:168	cleft palate
CP	CP:9|Cp:1	clobetasol propionate
Cp	Cp:10	clostridium pasteurianum
CP	CP:12|Cp:4	clostridium perfringens
CP	CP:485|cp:9|Cp:1	coat protein
CP	CP:6	coat protein gene
cp	cp:13|CP:1	coldpassaged
CP	CP:13	cold pressor
CP	CP:19	common peroneal
CP	CP:35	constrictive pericarditis
CP	CP:8	control patients
CP	CP:15	cor pulmonale
CP	CP:11	core particle
CP	CP:38|cp:4	cortical plate
CP	CP:17	cricopharyngeal
CP	CP:14	cricopharyngeus
CP	CP:29	critical power
CP	CP:260	crude protein
CP	CP:10	cryopreserved
Cp	Cp:12|cp:1	cyclopentadienyl
CP	CP:9	cyclophosphane
CP	CP:15	cysteine proteinase
cp	cp:27|CP:23	cytopathic
cp	cp:40|CP:12	cytopathogenic
CP	CP:9|Cp:1	polymer
CQ	CQ:20	camphorquinone
CQ	CQ:62	carboquone
CQ	CQ:7	closed quotient
CR/XL	CR/XL:7	metoprolol controlled releaseextended release
CR/XL	CR/XL:7	metoprolol succinate controlled releaseextended release
CR1	CR1:33	complement receptor
CR1	CR1:11	complement receptor type one
CR1	CR1:62|CR-1:1	first complete remission
CR1	CR1:17|CR-1:1	first remission
CR2	CR2:17	cd receptor
CR2	CR2:23	second complete remission
CR2	CR2:9	second remission
CR3	CR3:13	cbi receptor
CR3	CR3:11	complement receptor type three
CR3	CR3:6	complement type  receptors
CR3	CR3:13	icb receptor
CR3	CR3:9	type  complement receptor
CRAds	CRAds:7|CRADs:4	conditionally replicating adenoviruses
CRAds	CRAds:15	conditionally replicative adenoviruses
CRA	CRA:11	cardiorespiratory arrest
CRA	CRA:6	caregiver reaction assessment
CRA	CRA:10	community reinforcement approach
CRA	CRA:6	comparative risk assessment
CRBPII	CRBPII:7|CRBP-II:1	cellular retinol binding protein ii
CRBPII	CRBPII:4	cellular retinolbinding protein type ii
CRCs	CRCs:63	colorectal cancers
CRCs	CRCs:28	colorectal carcinomas
CRCs	CRCs:23	concentrationresponse curves
CRC	CRC:21	calcium release channel
CRC	CRC:12	cerebrovascular reserve capacity
CRC	CRC:12	colorectal adenocarcinoma
CRC	CRC:6	red cells
CRC	CRC:12	research center
CRD	CRD:18|CrD:1	colorectal distention
CRD	CRD:22	conerod dystrophy
CRD	CRD:16	crossreacting determinant
CRD	CRD:41	cysteinerich domain
CREAE	CREAE:5|CR-EAE:4|cr-EAE:1	chronic relapsing eae
CREAE	CREAE:29|CR-EAE:19|Cr-EAE:2|crEAE:2|cr-EAE:1	chronic relapsing experimental allergic encephalomyelitis
CREB	CREB:202	camp response element binding protein
CREB	CREB:44	element binding
CREB	CREB:11	response elementbinding
CREB	CREB:5	response element binding factor
CREM	CREM:24|crem:1	camp response element modulator
CREM	CREM:18	campresponsive element modulator
CREM	CREM:6	modulator protein
CRE	CRE:10	campresponsive elements
CRE	CRE:28	cumulative radiation effect
CRE	CRE:9	cyclic amp response elements
CRF-R	CRF-R:5|CRFR:2	corticotropinreleasing factor receptor
CRF-R	CRF-R:6|CRFR:5	crf receptor
CRFs	CRFs:9	case report forms
CRFs	CRFs:20	circulating recombinant forms
CRF	CRF:19	cancerrelated fatigue
CRF	CRF:17	cardiorespiratory fitness
CRF	CRF:27|crf:1|cRF:1	classical receptive field
CRF	CRF:33	continuous reinforcement
CRF	CRF:14	continuously reinforced
CRF	CRF:16	corticoliberin
CRI	CRI:5	cardiac risk index
CRI	CRI:9	chronic renal impairment
CRI	CRI:232	chronic renal insufficiency
CRI	CRI:7	crossreactive idiotope
CRM	CRM:14	circumferential resection margin
CRM	CRM:25	continual reassessment method
CRM	CRM:46	crossreacting material
CRM	CRM:22	resource management
CRs	CRs:10	cancer registries
CRS	CRS:31	catheterrelated sepsis
CRS	CRS:80	chronic rhinosinusitis
CRS	CRS:1	cold and restraint stress
CRS	CRS:10	coldrestraint stress
CRs	CRs:55|CRS:1	complete remissions
Crs	Crs:33|CRS:13	compliance of the respiratory system
CRs	CRs:115|CRS:2|Crs:1	conditioned responses
CRS	CRS:111	congenital rubella syndrome
CRs	CRs:9	conserved regions
CRS	CRS:5	cytoplasmic retention signal
CRS	CRS:16	risk score
Crs	Crs:11	total respiratory compliance
CRT	CRT:154	cardiac resynchronization therapy
CRT	CRT:25	conformal radiotherapy
CRT	CRT:9	cortisoneresistant thymocytes
CRT	CRT:11	cranial radiation
CRT	CRT:8	preoperative chemoradiation
CRT	CRT:5	prophylactic cranial radiotherapy
CRVO	CRVO:12	central retinal vein obstruction
CRVO	CRVO:211	central retinal vein occlusion
CR	CR:41|C-R:5	cajalretzius
CR	CR:16	calciumbinding protein calretinin
CR	CR:205	caloric restriction
CR	CR:12	calorierestricted
CR	CR:76	calorie restriction
CR	CR:10	capturerecapture
CR	CR:91	cardiac rehabilitation
CR	CR:7	cardiac rupture
CR	CR:8|C-R:1|cr:1	cardiorespiratory
CR	CR:12	cariesresistant
CR	CR:28	centric relation
CR	CR:9	charge recombination
CR	CR:11	charles river
CR	CR:96	chronic rejection
CR	CR:29	circadian rhythm
CR	CR:13	cockroach
CR	CR:7	cognitive reserve
CR	CR:20	colonization resistance
CR	CR:129	complete
CR	CR:26	complete regression
CR	CR:14	complete remission rate
CR	CR:19	complete response rate
CR	CR:9	completely
CR	CR:8	composite resin
CR	CR:12|Cr:1	compression ratio
CR	CR:10	computed radiographic
CR	CR:221	computed radiography
CR	CR:6|C-R:4|cr:3|c-r:1	concentrationresponse
CR	CR:7	conditioned reinforcement
CR	CR:10	conditioned reward
CR	CR:42	congo red
CR	CR:8	constant routine
CR	CR:11	contractile reserve
CR	CR:8	conventional radiology
CR	CR:8	coronary risk
CR	CR:6	cortical reaction
CR	CR:9	corticosteroidresistant
Cr	Cr:22	creatine and phosphocreatine
CR	CR:9	crossreactive
CR	CR:18|C-R:6|c-r:1	crownrump
C-R	C-R:6|CR:4	crownrump length
CR	CR:10	cysteinerich
CR	CR:21	czech republic
Cr	Cr:8|CR:2	energy cost of running
C-R	C-R:8	followed by  min of running
CR	CR:15	reactivity
CR	CR:9	remodeling
CS-	CS-:7	ignore a different tone
CS-	CS-:28	stimulus
CS/DS	CS/DS:11	chondroitindermatan sulfate
CS/DS	CS/DS:8	chondroitin sulfatedermatan sulfate
CSA	CSA:9	canadian standards association
CSA	CSA:17	catalyzed signal amplification
CSA	CSA:4	cell surface antigens
CSA	CSA:29	central sleep apnea
CSA	CSA:11	central sleep apnoea
CSA	CSA:51|csa:1	chemical shift anisotropy
CSA	CSA:15	chicken serum albumin
CSA	CSA:126	childhood sexual abuse
CSA	CSA:8|CS-A:3	chondroitinsulfate
CSA	CSA:12	chronic stable angina
CSA	CSA:13	clinical skills assessment
CSA	CSA:7	colonspecific antigen
CSA	CSA:22	compressed spectral array
CSA	CSA:6	computer science and applications
CSA	CSA:11	conformational space annealing
CSA	CSA:11	continuous spinal anaesthesia
CSA	CSA:17	continuous spinal anesthesia
CSA	CSA:13	controlled substances act
CSA	CSA:20	coronary spastic angina
CSA	CSA:15	cysteine sulfinic acid
CSC	CSC:9	antagonist chlorostyrylcaffeine
CSC	CSC:97	cigarette smoke condensate
CSC	CSC:6	circulating stem cells
CSC	CSC:7	correctional service of canada
CSC	CSC:35	cryogen spray cooling
CSD	CSD:26	cambridge structural database
CSD	CSD:13	cardiac support device
CSD	CSD:8	carotid sinus denervation
CSD	CSD:7	cervical spine disorders
CSD	CSD:18	conditioned suppression of drinking
CSD	CSD:156	cortical spreading depression
CSD	CSD:5	current source density analysis
CSD	CSD:22	cysteine sulfinate decarboxylase
CSD	CSD:10	distribution
CSE	CSE:8	combined spinalepidural anesthesia
CSE	CSE:9	conventional se
CSE	CSE:11	convulsive status epilepticus
CSE	CSE:9	crosssectional echocardiography
CSE	CSE:9	cystathionine gammalyase
CSF	CSF:38	cerebrospinal
CSF	CSF:10	cerebrospinal fluid samples
CSF	CSF:152	classical swine fever
CSF	CSF:7	colonystimulating factors
CSF	CSF:18	coronary sinus flow
CSF	CSF:63	cytostatic factor
CSH	CSH:20	carotid sinus hypersensitivity
CSH	CSH:32	cell surface hydrophobicity
CSH	CSH:9	chronic severe hepatitis
CSI	CSI:14	cervical spine injury
CSI	CSI:85	chemical shift imaging
CSI	CSI:53	cholesterol saturation index
CSI	CSI:6	chromosaponin i
CSI	CSI:4|CS-I:2	clinical stage i
CSI	CSI:15	continuous subcutaneous infusion
CSI	CSI:32	craniospinal irradiation
CSI	CSI:6	salvia injection
CSK	CSK:10|Csk:1	cytoskeletal
CSK	CSK:32	cytoskeleton
CSLM	CSLM:11	confocal scanning laser microscope
CSLM	CSLM:74	confocal scanning laser microscopy
CSL	CSL:13	cerebellar soluble lectin
CSL	CSL:17	corn steep liquor
CSM	CSM:27	carotid sinus massage
CSM	CSM:68	cervical spondylotic myelopathy
CSM	CSM:19	committee on safety of medicines
CSM	CSM:17	contraceptive social marketing
CSM	CSM:36	cottonseed meal
CSN	CSN:15	carotid sinus
CSN	CSN:49	cop signalosome
CSN	CSN:8	corticospinal neurons
CSO	CSO:6	clarified slurry oil
CSO	CSO:5	statistical office
CSPs	CSPs:106	chiral stationary phases
CSPs	CSPs:11|Csps:7|csps:2	cold shock proteins
CSPs	CSPs:11|csps:6|Csps:5	cysteine string proteins
CSP	CSP:47	carotid sinus pressure
CSP	CSP:33	cavum septi pellucidi
CSP	CSP:13	cavum septum pellucidum
CSP	CSP:7	community support program
CSP	CSP:19	competencestimulating peptide
CSP	CSP:7	cooperative studies program
CSP	CSP:5|csp:4	corpus spongiosum penis
CSP	CSP:23|csp:8|Csp:3	cysteine string protein
CSP	CSP:8	cystosarcoma phyllodes
CSR	CSR:25|csr:1	central serous retinopathy
CSR	CSR:51	cheynestokes respiration
CSR	CSR:109	class switch recombination
CSR	CSR:11	combat stress reaction
CSR	CSR:19	cumulative survival rate
CSS	CSS:6	canadian stroke scale
CSS	CSS:14	cancerspecific survival
CSS	CSS:14	chronic serum sickness
CSS	CSS:9	chronic sinusitis survey
CSS	CSS:159|CSs:1	churgstrauss syndrome
CSs	CSs:5	composite scores
CSs	CSs:18	conditional stimuli
CSS	CSS:16	constitutional short stature
CSs	CSs:15	corticosteroids
CSS	CSS:17	cultured skin substitutes
Css	Css:13	steady state
Css	Css:6	steadystate plasma levels
CST	CST:12	cavernous sinus thrombosis
CST	CST:15|Cst:1	cerebroside sulfotransferase
CST	CST:31	cervical sympathetic trunk
CST	CST:16	connected speech test
CST	CST:28	contraction stress test
CST	CST:115	corticospinal tract
CST	CST:18	cortistatin
CST	CST:14	skills training
CST	CST:11	stand trial
Cst	Cst:21|CST:2	static compliance
Cst	Cst:14	static lung compliance
CSV	CSV:7	canine saphenous vein
CSV	CSV:4	chick syncytial virus
CSWS	CSWS:17	cerebral salt wasting syndrome
CSWS	CSWS:10	continuous spikes and waves during slow sleep
CS	CS:14	chlorobenzylidene malonitrile
CS	CS:10	chlorobenzylidene malononitrile
CS	CS:47	calf serum
CS	CS:8	campaniform sensilla
CS	CS:10	carcinosarcoma
CS	CS:11	cardiac surgery
CS	CS:54	cardiogenic shock
CS	CS:6	carotid stenting
CS	CS:5|Cs:4	casein
CS	CS:52	cavernous sinus
CS	CS:11	celiac sprue
CS	CS:9	cell saver
CS	CS:15	central sulcus
CS	CS:12	cervical spondylosis
CS	CS:10	cervical stimulation
CS	CS:6	charge separation
CS	CS:19	chemical shift
CS	CS:20	chinese spring
CS	CS:34	cholesterol sulfate
CS	CS:85	chondroitin sulphate
CS	CS:13	chondrosarcoma
CS	CS:9	chorionic somatomammotropin
CS	CS:7	chromogenic substrate
CS	CS:23	chronic sinusitis
CS	CS:95	cigarette smoke
CS	CS:13	cigarette smoking
CS	CS:11	citrate synthetase
CS	CS:9	clinical score
CS	CS:9	clinical supervision
CS	CS:31	cold storage
CS	CS:14	cold stress
CS	CS:7	completed stroke
CS	CS:28	complex spike
CS	CS:16	compressive strength
CS	CS:13	conditioned
CS	CS:10	conditioning stimulation
CS	CS:10	conduction system
CS	CS:22	congenital syphilis
CS	CS:14	conscious sedation
CS	CS:28	conservative surgery
CS	CS:133	contact sensitivity
CS	CS:25|Cs:5	cordyceps sinensis
CS	CS:8	corn silage
CS	CS:5	cornsoybean meal diet
CS	CS:5	corn starch
CS	CS:7	coronal scaling
CS	CS:333|cs:7	coronary sinus
CS	CS:11	coronary stenosis
CS	CS:7	coronary stenting
CS	CS:42	corpus striatum
CS	CS:34	corpuscles of stannius
CS	CS:30	corticospinal
CS	CS:10	corticosteroidsensitive
CS	CS:15	cromolyn sodium
CS	CS:11|cs:1	current smokers
CS	CS:11	hb constant spring
CS	CS:12	light
CS	CS:27	ochlorobenzylidene malononitrile
CS	CS:4	patients with cerebral stroke
CS	CS:24	patients with cushings syndrome
CS	CS:57	plasma corticosterone
CS	CS:26	plasmodium falciparum circumsporozoite
CS	CS:10	saccharin
CS	CS:7|cs:4	sensitive
CS	CS:9	sequence
CS	CS:9	sites
CS	CS:10	steroids
CS	CS:16|cs:1	strain
CTAP	CTAP:32|CT-AP:4	computed tomography during arterial portography
CTAP	CTAP:69|CT-AP:1	ct during arterial portography
CTAP	CTAP:16	dphecystyrdtrpargthrpenthrnh
CTAs	CTAs:6	cancertestis antigens
CTAs	CTAs:15	conditioned taste aversions
CTA	CTA:10	cell transit analyzer
CTA	CTA:9	composite tissue allograft
CTA	CTA:6	computed tomographic angiographic
CTA	CTA:112	computed tomographic angiography
CTA	CTA:12|CT-A:1	computed tomographic arteriography
CTA	CTA:5	computed tomographic arthrography
CTA	CTA:60	computed tomography angiography
CTA	CTA:8	conditioned taste avoidance
CTA	CTA:11	cortical taste area
CTA	CTA:1	ct during arteriography
CTA	CTA:6	ct hepatic arteriography
CTA	CTA:5	task analysis
CTB	CTB:24|CTb:6|CT-B:3	cholera toxin b
CTB	CTB:14	cytotrophoblastic cells
CTC	CTC:23	cyanoditolyl tetrazolium chloride
CTC	CTC:43	chlorotetracycline
CTC	CTC:188|cTc:4	chlortetracycline
CTC	CTC:46	common toxicity criteria
CTC	CTC:14	computed tomographic colonography
CTC	CTC:9	computed tomography colonography
CTC	CTC:11	ct cisternography
CTC	CTC:17	ct colonography
CTC	CTC:17	cultured t cells
CTDs	CTDs:29	connective tissue diseases
CTDs	CTDs:26	cumulative trauma disorders
CTD	CTD:203|C-td:2	cterminal domain
CTD	CTD:8	connective tissue disorders
CTE	CTE:11	cterminal extension
CTE	CTE:14	chronic toxic encephalopathy
CTE	CTE:8	coefficient of thermal expansion
CTE	CTE:51	constitutive transport element
CTF	CTF:17|Ctf:1	cterminal fragment
CTF	CTF:9	central tegmental field
CTF	CTF:17	colorado tick fever
CTF	CTF:8	computed tomography fluoroscopy
CTF	CTF:7	contrast transfer function
CTF	CTF:7	ct fluoroscopy
CTG	CTG:28	cardiotocogram
CTG	CTG:22	cardiotocograph
CTG	CTG:17	cardiotocographic
CTG	CTG:69	cardiotocography
CTG	CTG:10	connective tissue graft
CTG	CTG:16	cytosinethymineguanine
CTH	CTH:16|CTh:1	ceramide trihexoside
CTH	CTH:6	chronic tension headache
CTI	CTI:9|CTi:1	cardiothoracic index
CTI	CTI:24	cavotricuspid isthmus
CTLA-4	CTLA-4:43|CTLA4:5	cytotoxic t lymphocyteassociated antigen 
CTLA-4	CTLA-4:7	cytotoxic t lymphocyteassociated molecule
CTL	CTL:6	comet tail length
CTL	CTL:13	cytolytic tcell
CTL	CTL:290	cytolytic t lymphocytes
CTM	CTM:185	cefotiam
CTM	CTM:14	computed tomographic myelography
CTM	CTM:11|CT-M:2	ct myelography
CTM	CTM:10	trunci muscle
CTPA	CTPA:9|CT-PA:2	computed tomographic pulmonary angiography
CTPA	CTPA:14|CT-PA:1	ct pulmonary angiography
CTPV	CTPV:8	cavernous transformation of the portal vein
CTPV	CTPV:7	coal tar pitch volatiles
CTP	CTP:24	childturcottepugh
CTP	CTP:8	citrate transport protein
CTP	CTP:8	ct perfusion
CTR	CTR:20	capsular tension ring
CTR	CTR:58	cardiothoracic ratio
CTR	CTR:13	carpal tunnel release
CTR	CTR:20	connecticut tumor registry
CTR	CTR:11	cricotracheal resection
CTR	CTR:16|CT-R:1	ct receptor
CTT	CTT:48	cefotetan
CTT	CTT:30	colonic transit time
CTT	CTT:12	computerized transaxial tomography
CTT	CTT:8	computerized transmission tomography
CTX	CTX:20	cardiotoxin
CTX	CTX:224|Ctx:6|ctx:1	cefotaxime
CTX	CTX:160	cerebrotendinous xanthomatosis
CTX	CTX:17|CTx:1	chemotaxis
CTX	CTX:24	ciguatoxin
CTX	CTX:12	omegaconotoxin
CTZ	CTZ:15	chemoreceptor trigger zone
CTZ	CTZ:16	chlorothiazide
CTZ	CTZ:30	cyclothiazide
cTnC	cTnC:13|CTnC:2	cardiac tnc
cTnC	cTnC:58|CTnC:3|cTNC:1|C-TnC:1	cardiac troponin c
CTS	CTS:723|CTs:1|cts:1	carpal tunnel syndrome
CTS	CTS:12	cataract shionogi
CTS	CTS:9	central termination sequence
CTs	CTs:10	chromosome territories
CTS	CTS:12	circadian timing system
CTs	CTs:9	complementary therapies
CTS	CTS:11	conflict tactics scale
CTS	CTS:12	congenital tracheal stenosis
CTs	CTs:10	cytotrophoblasts
CT	CT:7|Ct:2	alone
CT	CT:10|Ct:1	cterminal
CT	CT:42|ct:6	calf thymus
CT	CT:7	carboxyl terminus
CT	CT:11	cardiac tamponade
CT	CT:10	cardiac transplantation
CT	CT:7	celiac trunk
CT	CT:5	central tendon
CT	CT:9	cerebral toxoplasmosis
CT	CT:7	charge transport
CT	CT:7	chest tube
CT	CT:9	chlamydia
CT	CT:36	cholera enterotoxin
CT	CT:97	chorda tympani
CT	CT:12	chronic tonsillitis
CT	CT:10	clinical trial
CT	CT:27	closure time
CT	CT:75	cognitive therapy
CT	CT:14	collecting tubule
CT	CT:21	computed tomograph
CT	CT:10	computed tomographic scanning
CT	CT:7	computed tomography scanning
CT	CT:9	computed tomograpy
CT	CT:8	computerized tomograph
CT	CT:354	computerized tomographic
CT	CT:20	condensed tannins
CT	CT:8	congenital toxoplasmosis
CT	CT:11	connecticut
CT	CT:16	conservative treatment
CT	CT:9	conventional treatment
CT	CT:19	corneal thickness
CT	CT:7	cortical thickness
CT	CT:17	corticothalamic
CT	CT:10	counseling and testing
CT	CT:15	countertransport
CT	CT:56	cricothyroid
CT	CT:13	cricothyroid muscle
CT	CT:39	crista terminalis
CT	CT:10	critical thinking
CT	CT:39	cytoplasmic tail
CT	CT:7|ct:2|Ct:1	twitch contraction time
CUNS	CUNS:6	capacity of urean synthesis
CUNS	CUNS:5	capacity of urea nitrogen synthesis
CVA	CVA:8	canonical variate analysis
CVA	CVA:14|cva:1	cerebral vascular accidents
CVA	CVA:13	clavulanic acid
CVA	CVA:22	cough variant asthma
CVB	CVB:8	coxsackieviruses of group b
CVB	CVB:19	group b coxsackieviruses
CVC	CVC:15	central venous catheterization
CVC	CVC:17	citrus variegated chlorosis
CVC	CVC:40|c-v-c:1	consonantvowelconsonant
CVC	CVC:56	cutaneous vascular conductance
CVD	CVD:8|CvD:1	cerebrovascular dementia
CVD	CVD:56	cerebrovascular diseases
CVD	CVD:13	cerebrovascular disorders
CVD	CVD:4	continuous ventricular drainage
CVH	CVH:33|cvh:1	chronic viral hepatitis
CVH	CVH:7	common variable hypogammaglobulinaemia
CVH	CVH:12	common variable hypogammaglobulinemia
CVID	CVID:12	common variable immune deficiency
CVID	CVID:9	common variable immunodeficiency syndrome
CVI	CVI:25	childrens vaccine initiative
CVI	CVI:263|cvi:2	chronic venous insufficiency
CVI	CVI:15	content validity index
CVI	CVI:5	continuous venous infusion
CVI	CVI:10	cyclic variation index
CVI	CVI:22	visual impairment
CVL	CVL:13	canine visceral leishmaniasis
CVL	CVL:15	central venous line
CVL	CVL:33	cervicovaginal lavage
CVM	CVM:9	cardiovascular malformations
CVM	CVM:9	center for veterinary medicine
CVM	CVM:10	congenital vascular malformations
CVM	CVM:8	contingent valuation method
CVP	CVP:716|cvp:2	central venous pressure
CVP	CVP:13	chlorphenvinphos
CVR-R	CVR-R:2|CVRR:2	coefficient of variation of rr intervals
CVR-R	CVR-R:1|CVRR:1	coefficient of variation of the rr interval
CVR	CVR:25	cardiovascular reactivity
CVR	CVR:10	cerebral vasoreactivity
CVR	CVR:30	cerebrovascular reactivity
CVR	CVR:20	cerebrovascular reserve
CVR	CVR:78	cerebrovascular resistance
CVR	CVR:10	chronic vascular rejection
CVR	CVR:16	contraceptive vaginal ring
CVR	CVR:120	coronary vascular resistance
CVR	CVR:9	coronary vasodilator reserve
CVS	CVS:32	cardiovascular system
CVS	CVS:9	centrifugal visual system
CVS	CVS:12	cerebral vasospasm
CVS	CVS:12	cervicovaginal secretions
CVS	CVS:23	challenge virus standard
CVS	CVS:12	chronic variable stress
CVS	CVS:30	cyclic vomiting syndrome
CVG	CVG:16	cochleovestibular ganglion
CVG	CVG:12	cutis verticis gyrata
CV	CV:24|cv:1	chorionic villi
CV	CV:23	chorionic villus
CV	CV:9	circularvection
CV	CV:71	closing volume
CV	CV:11|cv:1	coefficient of variability
CV	CV:59	coefficient of variance
CV	CV:30	contingent valuation
CV	CV:11	contrast venography
CV	CV:11	contrast ventriculography
CV	CV:61	conventional ventilation
CV	CV:13	crossvalidation
CV	CV:27	crystal violet
CV	CV:11	curriculum vitae
CV	CV:165	cyclic voltammetry
CV	CV:16	dichotic consonantvowel
CWA	CWA:11	chemical warfare agents
CWA	CWA:10	correlation waveform analysis
CWD	CWD:10	canal wall down
CWD	CWD:61	chronic wasting disease
CWD	CWD:17	continuous wave doppler
CWP	CWP:9	chronic widespread pain
CWP	CWP:58	coal workers pneumoconiosis
CWS	CWS:8	chest wall stimulation
CWS	CWS:14	children who stutter
CWT	CWT:14	circuit weight training
CWT	CWT:5	colour word test
CWT	CWT:40	continuous wavelet transform
CWT	CWT:6	cortical wall thickness
CW	CW:23	chemical warfare
CW	CW:20|cw:3|Cw:1	chest wall
CW	CW:58|cw:3	clockwise
CW	CW:5	coconut water
CW	CW:18	constructed wetland
CW	CW:9	contractional work
CW	CW:8	control women
CXD	CXD:28	cefroxadine
CXD	CXD:13	computed xray densitometry
CXRs	CXRs:27	chest radiographs
CXRs	CXRs:11	chest xrays
CXR	CXR:47	chest radiography
CXR	CXR:14	chest roentgenogram
CYP19	CYP19:10|Cyp19:5	aromatase gene
CYP19	CYP19:14|cyp19:1	aromatase p
CYP2D6	CYP2D6:110|Cyp2D6:1	cytochrome p d
CYP2D6	CYP2D6:49	cytochrome pd
CYP2D6	CYP2D6:10	cytochrome piid
CYP2E1	CYP2E1:161|CYP2e1:1|Cyp2E1:1	cytochrome p e
CYP2E1	CYP2E1:8	cytochrome piie
CYP51	CYP51:7|cyp51:2|cYP51:1	 alphademethylase
CYP51	CYP51:18	lanosterol alphademethylase
CYP51	CYP51:13	sterol demethylase p
CYP51	CYP51:12	sterol alphademethylase
CZE	CZE:740	capillary zone electrophoresis
CZE	CZE:26	capillary zone electrophoretic
CZX	CZX:89	ceftizoxime
CZX	CZX:16	chlorzoxazone
Ca/Cr	Ca/Cr:22|Ca/cr:2	calciumcreatinine
Ca/Cr	Ca/Cr:7	calciumcreatinine ratio
Ca2+i	Ca2+i:14	cytoplasmic ca concentration
Ca2+i	Ca2+i:7	cytoplasmic calcium concentration
CASI	CASI:6	childhood anxiety sensitivity index
CASI	CASI:40	cognitive abilities screening instrument
Caco-2	Caco-2:19|CaCo-2:5|Caco2:2	colon carcinoma
Caco-2	Caco-2:12|CACO-2:1	human colon adenocarcinoma
Caco-2	Caco-2:12|CaCo-2:1	human intestinal
Caco-2	Caco-2:40|Caco2:1|CACO-2:1	human intestinal epithelial
CBI	CBI:6	caregiver burden inventory
CBI	CBI:7	computerbased instruction
CBI	CBI:18	covalent binding index
CBL	CBL:5	computerbased learning
CBL	CBL:40	cord blood lymphocytes
CBL	CBL:9|CbL:1	cystathionine betalyase
CCR	CCR:7	california cancer registry
CCR	CCR:36	carbon catabolite repression
CCR	CCR:41	cc chemokine receptor
CCR	CCR:10	central conserved region
CCR	CCR:11	chemokine receptors
CCR	CCR:5	cinnamoyl coa reductase
CCr	CCr:7|Ccr:6	clearance of creatinine
CCR	CCR:10|cCR:2	complete clinical remission
CCR	CCR:25	complete cytogenetic response
CCR	CCR:17	complex chromosomal rearrangement
CCR	CCR:66|cCR:2	continuous complete remission
CCR	CCR:12|cCR:1	continuous cr
CCr	CCr:5|cCr:4	cyclocreatine
CEE	CEE:19	central and eastern europe
CEE	CEE:10	central and eastern european
CEE	CEE:17	chick embryo extract
ChAT-IR	ChAT-IR:8|ChAT-ir:5	chatimmunoreactive
ChAT-IR	ChAT-IR:7|ChAT-Ir:1	choline acetyltransferase immunoreactivity
CHA	CHA:4	adenosine a receptor agonist ncyclohexyladenosine
CHA	CHA:4|c-HA:2|C-HA:1	carbonated hydroxyapatite
CHA	CHA:11	catholic health association
CHA	CHA:16	chlorhexidine diacetate
CHA	CHA:10	common hepatic artery
CHA	CHA:9	congenital hypoplastic anemia
CHA	CHA:6|cHA:1	coralline hydroxyapatite
CHA	CHA:9	cyclohexylamine
CHA	CHA:12	ncyclohexyl adenosine
CHA	CHA:7	receptor agonist cyclohexyladenosine
CHA	CHA:2	receptor agonist ncyclohexyladenosine
CHH	CHH:37	cartilagehair hypoplasia
CHH	CHH:61|cHH:4	crustacean hyperglycemic hormone
CHS	CHS:71	cardiovascular health study
CHS	CHS:146|chs:8|Chs:5	chalcone synthase
CHS	CHS:159|C-HS:5	chediakhigashi syndrome
CHS	CHS:9	cholesterol hemisuccinate
CHS	CHS:12	cholesteryl hemisuccinate
CHS	CHS:10	compression hip screw
CHS	CHS:11	health services
ChAT	ChAT:11|Chat:1	cholinacetyltransferase
ChAT	ChAT:22|CHAT:1	choline acetyltransferase activity
ChAT	ChAT:13	cholineoacetyltransferase
ChAT	ChAT:23|CHAT:2	cholineacetyltransferase
CHC	CHC:8	chlorinated hydrocarbon
CHC	CHC:225|CH-C:37|cHC:5|C-HC:1	chronic hepatitis c
CHC	CHC:11|Chc:3	clathrin heavy chain
CHC	CHC:21	community health center
CHC	CHC:12	health centre
CIT	CIT:36|Cit:7	citalopram
CIT	CIT:42	cold ischemia time
CIT	CIT:22	conventional insulin therapy
CIT	CIT:17	conventional insulin treatment
CIT	CIT:10	cortical imaging technique
CIT	CIT:8	critical incident technique
CLE	CLE:10	centrilobular emphysema
CLE	CLE:17	columnarlined esophagus
CLE	CLE:24	congenital lobar emphysema
CLE	CLE:7	crosslinked envelope
CLE	CLE:21	cutaneous lupus erythematosus
CLT	CLT:7	chemiluminescence test
CLT	CLT:5	clot lysis time
Clara	Clara:11	nonciliated bronchiolar
Clara	Clara:67	nonciliated bronchiolar epithelial
CLI	CLI:7	central lymphatic irradiation
CLi	CLi:8	clearance of lithium
CLI	CLI:11|Cli:1	clindamycin
CLI	CLI:52	critical limb ischaemia
CLI	CLI:53	critical limb ischemia
CLi	CLi:48|Cli:1|C-Li:1	lithium clearance
Cmax	Cmax:8	concentrations in plasma
Cmax	Cmax:250|cmax:2|CMax:1|CMAX:1	maximum concentration
Cmax	Cmax:7	maximum concentration in serum
Cmax	Cmax:7|cmax:1	maximum plasma levels
Cmax	Cmax:18	maximum serum concentrations
Cmax	Cmax:44	peak concentrations
Cmax	Cmax:15	peak levels
Cmax	Cmax:18	peak serum concentrations
Cmax	Cmax:4	reached the maximum
CoNS	CoNS:108|CONS:24|ConS:1	coagulasenegative staphylococci
CoNS	CoNS:10|CONS:2	coagulasenegative staphylococcus
COL1A1	COL1A1:5	alpha i procollagen gene
COL1A1	COL1A1:9	collagen type i alpha 
COL1A1	COL1A1:15	type i procollagen
COMET	COMET:1	carvedilol and metoprolol european trial
COMET	COMET:11	correction of myopia evaluation trial
ConA	ConA:16|Con-A:2	canavalia ensiformis
ConA	ConA:11|Con-A:5|conA:1	ensiformis agglutinin
CPSs	CPSs:14	capsular polysaccharides
CPSs	CPSs:21	complex partial seizures
CS+	CS+:16	conditional stimulus
CS+	CS+:10	one tone
CTV	CTV:9	cell tracking velocimetry
CTV	CTV:67|Ctv:3	citrus tristeza virus
CTV	CTV:161	clinical target volume
CTV	CTV:10	ct venography
CUS	CUS:22|C-US:2	compression ultrasonography
CUS	CUS:6	cranial ultrasound
CU	CU:45	chronic urticaria
CU	CU:22	clemson university
CU	CU:5	clinical units
CU	CU:25|Cu:22	cuprophan
CYP17	CYP17:20|Cyp17:1	alphahydroxylase
CYP17	CYP17:8|Cyp17:1	cytochrome pcalpha
D&E	D&E:26	dilatation and evacuation
D&E	D&E:18	dilation and evacuation
D/P	D/P:18	dialysateplasma
D/P	D/P:15	dialysatetoplasma ratio
D1	D1:6	first day
D1	D1:6	first diagonal branch
D2	D2:27	extended
D2	D2:6	extended lymphadenectomy
D3T	D3T:15	dithiolethione
D3T	D3T:12	hdithiolethione
D3	D3:25	cholecalciferol
D3	D3:7|d3:3	diagnosed at the caries into dentine
D3	D3:9	type iii deiodinase
D3	D3:6	type iii iodothyronine deiodinase
D5W	D5W:8	 dextrose
D5W	D5W:26	 dextrose in water
D5W	D5W:9	 dextrose injection
DAA	DAA:17|daa:2	after anthesis
DAA	DAA:4	dispensable amino acids
DAA	DAA:6	double aortic arch
DAA	DAA:9	ductus arteriosus aneurysm
DAB	DAB:9	dideoxyiminodarabinitol
DAB	DAB:41|dab:3	days after birth
DAB	DAB:26	nndimethylaminoazobenzene
DAB	DAB:24	pdimethylaminoazobenzene
DAC	DAC:7	demethylating agent azadeoxycytidine
DAC	DAC:8	dry air challenge
DAD	DAD:10	dianhydrodulcitol
DAD	DAD:78	diffuse alveolar damage
DAD	DAD:13	disability assessment for dementia
DAEC	DAEC:1	diffusely adherent e coli
DAEC	DAEC:14	diffusely adhering escherichia coli
DAF	DAF:22|daf:1	days after flowering
DAF	DAF:313|Daf:1	decayaccelerating factor
DAF	DAF:48	delayed auditory feedback
DAF	DAF:23	dissolved air flotation
DAF	DAF:27	dna amplification fingerprinting
DAF	DAF:16	drugadmixed food
DAGO	DAGO:11	dalamepheglyolenkephalin
DAGO	DAGO:23	enkephalin
DAG	DAG:16	diacylsnglycerol
DAG	DAG:14	acyl glucuronide
DAG	DAG:9	diacyglycerol
DAG	DAG:22	dianhydrogalactitol
DAG	DAG:10	directed acyclic graph
DAG	DAG:52	sndiacylglycerol
DAM	DAM:10	delayed amelanotic
Dam	Dam:12|dam:2	deoxyadenosine methylase
DAM	DAM:12	diacetyl monoxime
DAM	DAM:11	diacetylmonoxime
Dam	Dam:17|dam:9	dna adenine methylase
Dam	Dam:6|DAM:1	dna adenine methyltransferase
DAN	DAN:18	diaminonaphthalene
DAN	DAN:42	diabetic autonomic neuropathy
DAN	DAN:13	diazoacetyldlnorleucine methyl ester
DAPs	DAPs:14	depolarizing afterpotentials
DAPs	DAPs:25	dystrophinassociated proteins
DAP	DAP:22|Dap:2	diaminopropane
DAP	DAP:32	diaminopurine
DAP	DAP:23|dap:1	after pollination
DAP	DAP:12	days after planting
DAP	DAP:25	depolarizing afterpotential
DAP	DAP:15	diaminopimelate
DAP	DAP:10	drawaperson
DAP	DAP:9	drawaperson test
DAP	DAP:11	dystrophinassociated protein
DARP	DARP:8	dopaminereleasing protein
DARP	DARP:14	drug abuse reporting program
DAR	DAR:12	differential absorption ratio
DAR	DAR:6	dual asthmatic response
DASH	DASH:1	arm shoulder and hand questionnaire
DASH	DASH:62	dietary approaches to stop hypertension
DASH	DASH:1	disability of the arm shoulder and hand
D-Asp	D-Asp:26|D-ASP:2|d-Asp:1|D-asp:1|d-ASP:1	daspartate
D-Asp	D-Asp:24|D-ASP:2|DAsp:1	daspartic acid
DAS	DAS:9	decayassociated spectra
DAS	DAS:18	developmental apraxia of speech
DAS	DAS:102	diallyl sulfide
DAS	DAS:11	disability assessment schedule
DAS	DAS:8	disc angiogenesis system
DAS	DAS:8	double antibody sandwich
DAS	DAS:26	dyadic adjustment scale
DAS	DAS:4	t toxin and diacetoxyscirpenol
DAT1	DAT1:21|DAT-1:1	dopamine transporter
DAT1	DAT1:43|DAT-1:1	dopamine transporter gene
DATOS	DATOS:21	drawn from electronic files of data from the drug abuse treatment outcome study
DATOS	DATOS:12	drug abuse treatment outcome studies
DAT	DAT:3	cytosine arabinoside and thioguanine
DAT	DAT:12	days after treatment
DAT	DAT:8	digital audio tape
DAT	DAT:114	direct agglutination test
DAI	DAI:41|dai:1	days after inoculation
DAI	DAI:38	dental aesthetic index
DAI	DAI:115	diffuse axonal injury
DAI	DAI:32	disease activity index
DAI	DAI:13	drug attitude inventory
DA	DA:17	degree of acetylation
DA	DA:21	delayed alternation
DA	DA:10	diagnostic accuracy
DA	DA:9	dielsalder
DA	DA:16	diffuse adherence
DA	DA:6	digital angiography
DA	DA:10	direct agglutination
DA	DA:12	directional asymmetry
DA	DA:9	directional atherectomy
DA	DA:36	discriminant analysis
DA	DA:8	displaced abomasum
DA	DA:8	dissecting aneurysm
DA	DA:11	divided attention
DA	DA:523	dopaminergic
DA	DA:8	dorsal aorta
DA	DA:131	ductus arteriosus
DA	DA:12	duodenal atresia
DA	DA:24	release of hdopamine
DBA	DBA:8	bonding agents
DBA	DBA:25	diamondblackfan anaemia
DBA	DBA:60	diamondblackfan anemia
DBA	DBA:13	dibutylamine
DBA	DBA:80	dolichos biflorus
DBA	DBA:182	dolichos biflorus agglutinin
DBA	DBA:9	dolichos biflorus lectin
DBC	DBC:34	hdibenzocgcarbazole
DBC	DBC:8	developmental behaviour checklist
DBH	DBH:25	dibromodimethylhydantoin
DBH	DBH:28|DbH:1	dopamine beta hydroxylase
DBH	DBH:11	dopaminebetahydroxylase activity
DBH	DBH:7	dopamine betahydroxylase gene
DBH	DBH:12	dot blot hybridization
DBMC	DBMC:11	bone marrow cell
DBMC	DBMC:10	donor bone marrow cells
DBMIB	DBMIB:21	dibromomethylisopropylpbenzoquinone
DBMIB	DBMIB:12	dibromothymoquinone
DBM	DBM:139	demineralized bone matrix
DBM	DBM:12	dibenzoylmethane
DBM	DBM:9	dibromomethane
DBM	DBM:9	dopamine betamonooxygenase
DBNBS	DBNBS:9	dibromonitrosobenzene sulfonate
DBNBS	DBNBS:8|DB-NBS:1	dibromonitrosobenzenesulfonic acid
DBN	DBN:10	dibutylnitrosamine
DBN	DBN:13	downbeat nystagmus
DBN	DBN:11	nndibutylnitrosamine
DBP	DBP:10	adenovirus dnabinding protein
DBP	DBP:34	demineralized bone powder
DBP	DBP:90	dinbutyl phthalate
DBP	DBP:73	dibutyl phthalate
DBP	DBP:25	dibutylphthalate
DBP	DBP:10	disinfection byproduct
DBQ	DBQ:9	debrisoquine
DBQ	DBQ:5	driver behaviour questionnaire
DBS	DBS:7	dental beliefs survey
DBS	DBS:9	dentin bonding systems
DBS	DBS:16	dibutyl sebacate
DBS	DBS:6	duodenal bicarbonate secretion
dbcGMP	dbcGMP:8|db-cGMP:6|DbcGMP:2|db-c-GMP:1|DB-cGMP:1|Db-cGMP:1	dibutyryl cyclic gmp
dbcGMP	dbcGMP:4|dbc-GMP:1|DBcGMP:1	dibutyryl cyclic guanosine monophosphate
DB	DB:13	database
DB	DB:10	decidua basalis
DB	DB:16	deep breathing
DB	DB:13	dense bodies
DB	DB:8	diaphragmatic breathing
DB	DB:13	didemnin b
DB	DB:10|dB:1	direct bilirubin
DB	DB:6	dorsal bodies
DB	DB:11|db:2	downstream box
DCA	DCA:5	desoxycholate citrate agar
DCA	DCA:254|-DCA:1	dichloroacetate
DCA	DCA:100	dichloroacetic acid
DCA	DCA:148	directional coronary atherectomy
DCBE	DCBE:29	double contrast barium enema
DCBE	DCBE:5	doublecontrast barium enema examination
DCCD	DCCD:8	dicyclohexyl carbodiimide
DCCD	DCCD:6	nndicyclohexyl carbodiimide
DCC	DCC:8	data coordinating center
DCC	DCC:17|Dcc:1	deleted in colon cancer
DCC	DCC:58|Dcc:2|dcc:1	deleted in colorectal cancer
DCC	DCC:25	deleted in colorectal carcinoma
DCC	DCC:8	dextrancoated charcoal assay
DCC	DCC:14	dextrancoated charcoal method
DCC	DCC:10	direct current cardioversion
DCD	DCD:5	after cardiac death
DCD	DCD:72	developmental coordination disorder
DCE-MRI	DCE-MRI:42|DCEMRI:3	dynamic contrastenhanced magnetic resonance imaging
DCE-MRI	DCE-MRI:18|DCEMRI:2	dynamic contrastenhanced mri
DCE	DCE:5	doublecontrast barium enema
DCE	DCE:6	doublecontrast enema
DCE	DCE:15	dynamic contrastenhanced
DCG-IV	DCG-IV:12	srrrdicarboxycyclopropylglycine
DCG-IV	DCG-IV:14	srrdicarboxycyclopropylglycine
DCIS	DCIS:15	ductal carcinoma in situ of the breast
DCIS	DCIS:1	ductal carcinoma of breast
DCIS	DCIS:14	intraductal carcinoma
DCI	DCI:26	dichloroisocoumarin
DCI	DCI:41	decompression illness
DCI	DCI:12	delayed cerebral ischemia
DCL	DCL:41	diffuse cutaneous leishmaniasis
DCL	DCL:4	metabolite descarboethoxyloratadine
DCMU	DCMU:11	dichlorophenyldimethyl urea
DCMU	DCMU:57	dichlorophenyldimethylurea
DCN	DCN:44|dcn:1	deep cerebellar nuclei
DCN	DCN:196	dorsal cochlear nucleus
DCN	DCN:73|DCn:1	dorsal column nuclei
DCP	DCP:10	dichloropropane
DCP	DCP:46	desgammacarboxy prothrombin
DCP	DCP:13	desgammacarboxyprothrombin
DCP	DCP:21	dicalcium phosphate
DCP	DCP:12	dicetyl phosphate
DCP	DCP:23	dicetylphosphate
DCP	DCP:15	digestible crude protein
DCP	DCP:39	dynamic compression plate
DCR	DCR:145	dacryocystorhinostomy
DCR	DCR:15	decidual cell reaction
DCR	DCR:9	decidual cell response
DCR	DCR:20	direct cortical response
DCR	DCR:11	dominant control region
DCR	DCR:7	icd diagnostic criteria for research
DCS	DCS:259	decompression sickness
DCS	DCS:8|dCS:1	distal coronary sinus
DCS	DCS:26	dorsal column stimulation
DCS	DCS:26	dynamic condylar screw
DCS	DCS:2|D-CS:1	partial agonist dcycloserine
DCT	DCT:6	direct contact test
DCT	DCT:39	discrete cosine transform
DCT	DCT:19|Dct:12|dct:1	dopachrome tautomerase
DCT	DCT:7|dCT:1|D-CT:1	dynamic ct
DCVs	DCVs:16|dcvs:2	dense core vesicles
DCVs	DCVs:13	densecored vesicles
DCV	DCV:11	distribution of conduction velocities
DCV	DCV:13	distribution of nerve conduction velocities
DCV	DCV:13	drosophila c virus
DC	DC:40	degree of conversion
DC	DC:17|Dc:1	dichorionic
DC	DC:8	direct compression
DC	DC:9	distensibility
DC	DC:30	distensibility coefficient
DC	DC:14	dorsal cortex
DC	DC:17	dupuytrens contracture
DC	DC:6	dynamic compression
DDAVP	DDAVP:72|dDAVP:3	desmopressin acetate
DDAVP	DDAVP:8|dDAVP:3	vasopressin analogue
DDA	DDA:5|ddA:1	cyclase inhibitor dideoxyadenosine
DDA	DDA:29	dimethyl dioctadecyl ammonium bromide
DDA	DDA:31	dimethyldioctadecylammonium bromide
DDA	DDA:8	disposition decomposition analysis
DDB	DDB:9	biphenyl dimethyl dicarboxylate
DDB	DDB:8	damaged dnabinding protein
DDB	DDB:8	dimethyl diphenyl bicarboxylate
DDC	DDC:11	diethoxycarbonyldihydrocollidine
DDC	DDC:11	analogues of diethoxycarbonyldihydrotrimethylpyridine
DDC	DDC:8	diethyl dithiocarbamate
DDC	DDC:17	diethyldithiocarbamic acid
DDC	DDC:97|Ddc:27	dopa decarboxylase
DDD	DDD:14	av universal
DDD	DDD:12	degenerative disc disease
DDD	DDD:8	dense deposit disease
DDD	DDD:10	dichlorodiphenyldichloroethane
DDD	DDD:9	digital differential display
DDD	DDD:14	dual chamber pacing
DDE	DDE:36	dichlorobispchlorophenylethylene
DDE	DDE:11	developmental defects of enamel
DDE	DDE:11	ethylene
DDE	DDE:12	ppdichlorodiphenyldichloroethylene
DDQ	DDQ:19	dichlorodicyanobenzoquinone
DDQ	DDQ:10|ddq:1	direct dialysis quantification
DDR	DDR:6	diastolic descent rate
DDR	DDR:9	discoidin domain receptor
DDS	DDS:30	denysdrash syndrome
DDS	DDS:4	diamino diphenyl sulphone
DDS	DDS:5	dietary diversity score
DDT	DDT:17	trichlorobischlorophenylethane
DDT	DDT:19	dichlorodiphenyl trichloroethane
DDT	DDT:1	pchlorophenyl ethane
DDT	DDT:17	ppdichlorodiphenyltrichloroethane
DEA	DEA:73	data envelopment analysis
DEA	DEA:16	deethylatrazine
DEA	DEA:26|dea:1	diethanolamine
DEA	DEA:38	diethylamine
DEA	DEA:31	drug enforcement administration
DEA	DEA:8	metabolite desethylamiodarone
DED	DED:13	deepidermized dermis
DED	DED:23	death effector domain
DEET	DEET:6|deet:2|Deet:1	diethyltoluamide
DEET	DEET:20	insect repellent nndiethylmtoluamide
DEF	DEF:13|def:3	deficiens
DEF	DEF:6	dose enhancement factor
DEF	DEF:14	ssstributyl phosphorotrithioate
DEH	DEH:13	delayed endolymphatic hydrops
DEH	DEH:9	dysplasia epiphysealis hemimelica
DELFIA	DELFIA:18	dissociationenhanced lanthanide fluoroimmunoassay
DELFIA	DELFIA:9	lanthanide fluorescence immunoassay
DEM	DEM:10	developmental eye movement
DEM	DEM:161	diethyl maleate
DEM	DEM:139|dEM:1	diethylmaleate
DEM	DEM:8	direct electron microscopy
DEN	DEN:17	ndiethylnitrosamine
DEN	DEN:9	nndiethylnitrosamine
DEPMPO	DEPMPO:9	diethoxyphosphorylmethylpyrrolinenoxide
DEPMPO	DEPMPO:3	spin trap diethoxyphosphorylmethylpyrrolinenoxide
DEP	DEP:14	dielectrophoresis
DEP	DEP:14	dielectrophoretic
DEP	DEP:9	diethyl phosphate
DEP	DEP:46	diethyl phthalate
DEP	DEP:10	diethylphosphate
DEP	DEP:11	diethylphthalate
DER	DER:11	dietary energy restriction
DER	DER:10	disulfiramethanol reaction
DER	DER:21	drosophila egf receptor
DER	DER:8	drosophila egf receptor homolog
DES	DES:17	desflurane
DES	DES:25|Des:5	desmosine
DES	DES:15	diethyl sulfate
DES	DES:17	diethylstibestrol
DES	DES:29	diethylstilbesterol
DES	DES:1453|des:1|-DES:1	diethylstilbestrol
DES	DES:125	diethylstilboestrol
DES	DES:34	diffuse esophageal spasm
DES	DES:4	dry eye syndrome
DETA/NO	DETA/NO:5	diethylenetriamine nitric oxide adduct
DETA/NO	DETA/NO:9	diethylenetriamineno
DET	DET:13	dipyridamole echocardiography test
DET	DET:6	double embryo transfer
DEXA	DEXA:6	dual energy xray absorptiometer
DEXA	DEXA:397|DeXA:1|dexa:1	dualenergy xray absorptiometry
DE	DE:13	degree of esterification
DE	DE:11	delayedearly
DE	DE:12	delta efficiency
DE	DE:7	dermal equivalent
DE	DE:11	diatomaceous earth
DE	DE:62	diesel exhaust
DE	DE:83	digestible energy
DE	DE:13	dissolution efficiency
DE	DE:9	dualenergy
DE	DE:5	dynamic exercise
DE	DE:13	dyscirculatory encephalopathy
DE	DE:3	pectins with different degrees of esterification
DFA	DFA:13	deep femoral artery
DFA	DFA:31	detrended fluctuation analysis
DFA	DFA:8	direct fluorescent antibody test
DFA	DFA:26	direct immunofluorescence assay
DFA	DFA:5	direct immunofluorescent staining
DFA	DFA:9	discriminant function analyses
DFA	DFA:32	discriminant function analysis
DFI	DFI:4	daily feed intake
DFI	DFI:4	daily food intake
DFI	DFI:139	diseasefree interval
DFI	DFI:15	dna fragmentation index
DFP	DFP:8|dfp:1	diastolic filling period
DFP	DFP:160	diisopropyl fluorophosphate
DFP	DFP:86	diisopropyl phosphorofluoridate
DFP	DFP:18	diisopropylphosphofluoridate
DFP	DFP:45	diisopropylphosphorofluoridate
DFT	DFT:6	dementia of frontal lobe type
DFT	DFT:2	dementia of the frontal type
DFT	DFT:5	density functional calculations
DFT	DFT:5	density functional theoretical
DFT	DFT:477	density functional theory
DFT	DFT:9	desferrithiocin
DFT	DFT:45	discrete fourier transform
DFS	DFS:2	decayed or filled surfaces
DFS	DFS:17	dental fear survey
DFS	DFS:12	diabetic foot syndrome
DF	DF:5	ankle dorsiflexors
DF	DF:14|Df:1	defibrotide
DF	DF:9	delayed fluorescence
DF	DF:108	dengue fever
DF	DF:5	deposition fraction
DF	DF:13	dermal fibroblasts
DF	DF:26	dermatofibroma
DF	DF:21|dF:1	developed force
DF	DF:6	dialysis fluid
DF	DF:18	dibenzofuran
DF	DF:55	dietary fiber
DF	DF:29	dietary fibre
DF	DF:22	diflunisal
DF	DF:21	discriminant function
DF	DF:31	dominant follicle
DF	DF:20|dF:1	dominant frequency
DF	DF:26	dorsiflexion
dGA	dGA:9	days gestation
dGA	dGA:8|DGA:5|dga:1	days gestational age
DGA	DGA:11	dental general anaesthesia
DGA	DGA:11	digeorge anomaly
DGA	DGA:4|D-GA:3	urinary excretion of dglucaric acid
DGC	DGC:9	dorsal gray commissure
DGC	DGC:48	dystrophinglycoprotein complex
DGE	DGE:36	delayed gastric emptying
DGE	DGE:9	differential gene expression
DGG	DGG:9	digestive glandgonad complex
DGG	DGG:28	gammadglutamylglycine
DGI	DGI:27	disseminated gonococcal infection
DGI	DGI:9	dynamic gait index
DGS	DGS:12	diabetic glomerulosclerosis
DGS	DGS:8	digeorge sequence
DGS	DGS:85	digeorge syndrome
DG	DG:11	dentate granule
DG	DG:453|Dg:1|dg:1	dentate gyrus
DG	DG:9	diradylglycerol
DG	DG:23	distance geometry
DG	DG:9	dorsal gastric
DG	DG:26|Dg:1	dystroglycan
DHA	DHA:17	dihydroxyadenine
DHA	DHA:8	active metabolite dihydroartemisinin
DHA	DHA:46	dehydroascorbate
DHA	DHA:12	dehydroisoandrosterone
DHA	DHA:49|Dha:5|dha:1	dihydroxyacetone
DHA	DHA:9	district health authority
DHA	DHA:14	docosahexaenoate
DHBA	DHBA:7	 and dihydroxybenzoic acids
DHBA	DHBA:11	dihydroxybenzylamine
DHBA	DHBA:7	reflected by the nonenzymatic formation of dihydroxybenzoic acid
DHC	DHC:17	dental health component
DHC	DHC:12	dihydrocodeine
DHC	DHC:8|Dhc:5	dynein heavy chain
DHE	DHE:16	dehydroergosterol
DHE	DHE:36	dihematoporphyrin ether
DHE	DHE:161|dhe:1	dihydroergotamine
DHE	DHE:18	dihydroethidium
DHE	DHE:17	dihydroetorphine
DHF/DSS	DHF/DSS:11	dengue haemorrhagic feverdengue shock syndrome
DHF/DSS	DHF/DSS:6	dengue hemorrhagic fever and dengue shock syndrome
DHF/DSS	DHF/DSS:23	dengue hemorrhagic feverdengue shock syndrome
DHF	DHF:89	dengue haemorrhagic fever
DHF	DHF:172	dengue hemorrhagic fever
DHF	DHF:29	diastolic heart failure
DHF	DHF:15	dihydrofolate
DHF	DHF:9	dihydroxyfumarate
DHI	DHI:37	dihydroxyindole
DHI	DHI:15	dairy herd improvement
DHI	DHI:32	dizziness handicap inventory
DHI	DHI:7	dose homogeneity index
DHPC	DHPC:10	dihexadecylphosphatidylcholine
DHPC	DHPC:15	dihexanoylphosphatidylcholine
DHPG	DHPG:12	dihydroxyphenylethylene glycol
DHPG	DHPG:39|dhpG:1	dihydroxypropoxymethylguanine
DHPG	DHPG:26	agonist rsdihydroxyphenylglycine
DHPG	DHPG:24	agonist sdihydroxyphenylglycine
DHPG	DHPG:4	group i mglur agonist rsdihydroxyphenylglycine
DHPG	DHPG:4	intraneuronal ne metabolite dihydroxyphenylglycol
DHPG	DHPG:6	metabolites dihydroxyphenylglycol
DHP	DHP:6	 alpha betadihydroxypregnenone
DHP	DHP:9	alphabetadihydroxypregnenone
DHP	DHP:10	dihexadecyl phosphate
DHP	DHP:17	dihydroprogesterone
DHP	DHP:9	dihydropyrimidinase
DHP	DHP:36	direct hemoperfusion
DHP	DHP:9	phthalate
DHR	DHR:13	delayed hypersensitivity reaction
DHR	DHR:20	delayed hypersensitivity response
DHR	DHR:17	dihydrorhodamine
DHR	DHR:41	dihydrorhodamine 
DHS	DHS:14	deoxyhypusine synthase
DHS	DHS:6	department of health services
DHS	DHS:6	hypersensitivity syndrome
DHT	DHT:5	 alphaandrostan betaolone
DHT	DHT:6	 alphaandrostane betaolone
DHT	DHT:16	androgen alphadihydrotestosterone
DHT	DHT:40	dihydrotachysterol
DH	DH:10	day hospital
DH	DH:13	department of health
DH	DH:218	dermatitis herpetiformis
DH	DH:15	detrusor hyperreflexia
DH	DH:17	diapause hormone
DH	DH:23	diaphragmatic hernia
DH	DH:10	diet history
DH	DH:8	diuretic hormone
DH	DH:52	dorsal horn
DH	DH:8	double haploid
DH	DH:10	ductal hyperplasia
DH	DH:13	dynamic hyperinflation
DH	DH:10	dystrophic hamsters
DIB	DIB:28	diagnostic interview for borderlines
DIB	DIB:9	diagnostic interview for borderline patients
DIC	DIC:11	days in culture
DIC	DIC:11	deviance information criterion
DIC	DIC:108	differential interference contrast
DIC	DIC:10	diisopropylcarbodiimide
DIC	DIC:11	disseminated intravascular clotting
DIC	DIC:19	disseminated intravascular coagulation syndrome
DIC	DIC:87	disseminated intravascular coagulopathy
DIC	DIC:20	dissolved inorganic carbon
DIC	DIC:7	drip infusion cholangiography
DIC	DIC:12	drug information center
DIDS	DIDS:10	diisothiocyanatostilbenedisulfonate
DIDS	DIDS:11	diisothiocyanatostilbenedisulphonate
DIDS	DIDS:17	diisothiocyanodisulfonic acid stilbene
DIDS	DIDS:11	diisothiocyanodisulfonic stilbene
DIDS	DIDS:7	diisothiocyanostilbene disulfonate
DIDS	DIDS:44	diisothiocyanostilbenedisulfonate
DIDS	DIDS:13	diisothiocyanostilbenedisulphonate
DID	DID:6	delayed ischemic deficit
DID	DID:44	dissociative identity disorder
DID	DID:34	double immunodiffusion
DID	DID:6	inhabitants per day
DIG	DIG:13	desmoplastic infantile ganglioglioma
DIG	DIG:7|Dig:4	digastric
DIG	DIG:19	digitalis investigation group
DIG	DIG:58|Dig:4|dig:2	digoxigenin
DILD	DILD:8	diffuse infiltrative lung disease
DILD	DILD:16	diffuse interstitial lung disease
DIOS	DIOS:4	desorptionionization on porous silicon
DIOS	DIOS:10	distal intestinal obstruction syndrome
DIO	DIO:24|DiO:1	dietinduced obese
DIO	DIO:51	dietinduced obesity
DIP	DIP:15	degradable intake protein
DIP	DIP:39	desquamative interstitial pneumonia
DIP	DIP:9	desquamative interstitial pneumonitis
DIP	DIP:10	digital image processing
DIP	DIP:119	distal interphalangeal
DIP	DIP:18	distal interphalangeal joint
DIP	DIP:31	drip infusion pyelography
DIP	DIP:22	druginduced parkinsonism
DISC	DISC:106	deathinducing signaling complex
DISC	DISC:33	diagnostic interview schedule for children
DISC	DISC:20	dietary intervention study in children
DISH	DISH:190	diffuse idiopathic skeletal hyperostosis
DISH	DISH:6	dna in situ hybridization
DIS	DIS:203	diagnostic interview schedule
DIS	DIS:8	difficulty initiating sleep
DIS	DIS:27	dimerization initiation site
DIS	DIS:5|Dis:4	disinhibition
DIS	DIS:10	drug information system
DIT	DIT:18	defining issues test
DIT	DIT:65	dietinduced thermogenesis
DIT	DIT:16	diffuse intimal thickening
DIT	DIT:25|Dit:1	diiodotyrosine
DI	DI:10	brattleboro homozygous
DI	DI:8	brattleboro rats
DI	DI:8	days of incubation
DI	DI:22	deep inhalation
DI	DI:34	deep inspiration
DI	DI:51	detrusor instability
DI	DI:10	dialyzed iron
DI	DI:11	diastolic interval
DI	DI:5	diestrus i
DI	DI:221	dna index
DLA	DLA:14	daltons lymphoma ascites
DLA	DLA:12	dog leukocyte antigen
DLA	DLA:6|DL-A:3	histocompatibility complex
DLB	DLB:8	dementia with lb
DLB	DLB:410	dementia with lewy bodies
DLCO	DLCO:17|DLco:3	carbon monoxide diffusion capacity
DLCO	DLCO:17	diffusing capacity for co
DLCO	DLCO:8|DLco:2	diffusing capacity of the lung
DLCO	DLCO:44|Dlco:4|DLco:2	diffusing capacity of the lung for carbon monoxide
DLCO	DLCO:21|DLco:7	diffusion capacity for carbon monoxide
DLCO	DLCO:11|Dlco:4	diffusion capacity of the lung for carbon monoxide
DLC	DLC:29	diamondlike carbon
DLC	DLC:11	differential leukocyte count
DLC	DLC:8	digitalislike compounds
DLC	DLC:5	doublelumen catheter
DLE	DLE:5	dialysable leucocyte extract
DLE	DLE:18	discoid le
DLE	DLE:136	discoid lupus erythematosus
DLF	DLF:16	digitalislike factor
DLF	DLF:12	dorsolateral funiculi
DLF	DLF:89	dorsolateral funiculus
DLH	DLH:40	dlhomocysteic acid
DLH	DLH:6	excitatory amino acid dlhomocysteic acid
DLM	DLM:16	dominant lethal mutations
DLM	DLM:8	dorsal longitudinal flight muscle
DLM	DLM:13	dorsal longitudinal muscle
DLM	DLM:4	dorsolateral nucleus of the thalamus
DLM	DLM:6	dorsolateral thalamus
DLPC	DLPC:8	dilauroyl phosphatidylcholine
DLPC	DLPC:22	dilinoleoylphosphatidylcholine
DLP	DLP:19	dorsolateral prostate
DLP	DLP:8	dorsolateralis posterior
DLP	DLP:9	doselength product
DLP	DLP:12	dyslipoproteinemia
DLST	DLST:5	dihydrolipoamide succinyltransferase
DLST	DLST:12	drug lymphocyte stimulation test
DLT	DLT:18	direct linear transformation
DLT	DLT:8	donor leukocyte transfusion
DLT	DLT:53	dose limiting toxicity
DLT	DLT:8	doublelumen endobronchial tube
DLT	DLT:5	double lung transplantation
DLV	DLV:17	delavirdine
DLV	DLV:12	differential lung ventilation
DLW	DLW:31	doubly labelled water
DLW	DLW:7	water method
DLS	DLS:7	dictyosomelike structures
DLs	DLs:32	difference limens
DLS	DLS:10|dls:1	differential light sensitivity
DLS	DLS:13	digitalislike substance
DLS	DLS:8	digoxinlike substance
DLS	DLS:18	dimer linkage structure
DLs	DLs:11	dose levels
DMAP	DMAP:17	dimethylaminophenol
DMAP	DMAP:15	dimethylaminopurine
DMA	DMA:12	dimethyl adipimidate
DMA	DMA:11	dimethyl amiloride
DMA	DMA:31	dimethylamiloride
DMA	DMA:80|dma:1	dimethylamine
DMA	DMA:51	dynamic mechanical analysis
DMA	DMA:30	nndimethylaniline
DMCM	DMCM:5	inverse agonist methyldimethoxyethylbetacarbolinecarboxylate
DMCM	DMCM:27	methyl dimethoxyethylbetacarbolinecarboxylate
DMC	DMC:10	data monitoring committee
DMC	DMC:8	dimethyl carbonate
DMD	DMD:12	differentially methylated domain
DMD	DMD:13	dm digestibility
DMD	DMD:15	dry matter digestibility
DMD	DMD:58	duchenne
DMD	DMD:1412|Dmd:3	duchenne muscular dystrophy
DMD	DMD:10	dystonia musculorum deformans
DMD	DMD:4	progressive muscular dystrophy of the duchenne type
DME	DME:37	diabetic macular edema
DME	DME:15	dimethyl ether
DME	DME:5	drugmetabolizing enzymes
DME	DME:20	durable medical equipment
DMFT	DMFT:10|DMF-T:3|dmft:2	caries experience
DMFT	DMFT:4|dmft:3|DMF-T:2	caries prevalence
DMF	DMF:2	decayed missing and filled
DMF	DMF:21	dimethyl formamide
DMF	DMF:11	dimethyl fumarate
DMF	DMF:189|dmf:2	dimethylformamide
DMF	DMF:18	dimethylfumarate
DMF	DMF:30	dose modifying factor
DMF	DMF:179	nndimethylformamide
DMG	DMG:15	dimethylglycine
DMG	DMG:12	dimethylglyoxime
DMH	DMH:6	dimethyl hydrazine
DMH	DMH:24	dimethylhydrazine dihydrochloride
DMH	DMH:9	dorsomedial hypothalamic
DMH	DMH:55	dorsomedial hypothalamus
DMH	DMH:14	dorsomedial nucleus of the hypothalamus
DMI	DMI:9	desimipramine
DMI	DMI:220	desmethylimipramine
DMI	DMI:14	diabetic muscle infarction
DMI	DMI:25	doppler myocardial imaging
DMI	DMI:117	dry matter intake
DMLC	DMLC:12|dMLC:1	dynamic multileaf collimation
DMLC	DMLC:13|dMLC:3|D-MLC:1	dynamic multileaf collimator
DMM	DMM:19	desmoplastic malignant melanoma
DMM	DMM:8	diffuse malignant mesothelioma
DMN	DMN:28	dorsal motor nucleus
DMN	DMN:5	dorsomedial hypothalamic nuclei
DMN	DMN:15	dysplastic melanocytic nevi
DMN	DMN:9	nndimethylnitrosamine
DMO	DMO:35	dimethyloxazolidinedione
DMO	DMO:30	dimethadione
DMO	DMO:3	weak acid dimethyloxazolidinedione
DMPA	DMPA:13	depoprovera
DMPA	DMPA:126	depot medroxyprogesterone acetate
DMPA	DMPA:18	dimyristoylphosphatidic acid
DMPC	DMPC:48	dimyristoylsnglycerophosphocholine
DMPC	DMPC:9|dm-PC:1	dimyristoyl
DMPC	DMPC:10	dimyristoyllalphaphosphatidylcholine
DMPC	DMPC:18	dimyristoyl phosphatidyl choline
DMPC	DMPC:549	dimyristoylphosphatidylcholine
DMPC	DMPC:15	lalphadimyristoylphosphatidylcholine
DMPG	DMPG:18	dimyristoyl phosphatidylglycerol
DMPG	DMPG:6	dimyristoylphosphatidyl glycerol
DMPG	DMPG:62	dimyristoylphosphatidylglycerol
DMPK	DMPK:5	 untranslated region of the myotonic dystrophy protein kinase gene
DMPK	DMPK:45|DM-PK:3|Dmpk:1	myotonic dystrophy protein kinase
DMPO	DMPO:17	dimethylpyrroline oxide
DMPO	DMPO:9	spin trap dimethylpyrrolineoxide
DMPO	DMPO:9	spin trap dimethylpyrrolinenoxide
DMPP	DMPP:37	dimethylphenylpiperazinium iodide
DMPP	DMPP:11	nicotinic agonist dimethylphenylpiperazinium
DMPP	DMPP:11	piperazinium
DMPS	DMPS:8	dimercaptopropane sulfonate
DMPS	DMPS:9	dimercaptopropanesulfonate
DMPS	DMPS:21	dimercaptopropanesulfonic acid
DMPS	DMPS:6	dimyristoyl phosphatidylserine
DMPS	DMPS:16	dimyristoylphosphatidylserine
DMPS	DMPS:6	sodium dimercaptopropanesulfonate
DMP	DMP:9	dimethoxypropane
DMP	DMP:16	deep muscular plexus
DMP	DMP:25	dimethyl phthalate
DMP	DMP:11	dimethylphosphate
DMP	DMP:9	dimethylphthalate
DMSP	DMSP:23	dimethylsulfoniopropionate
DMSP	DMSP:9	dimethylsulphoniopropionate
DMS	DMS:16	delayed matchtosample
DMS	DMS:19	delayed matchingtosample
DMS	DMS:9	delusional misidentification syndromes
DMS	DMS:18	demarcation membrane system
DMS	DMS:3	difficulty in maintaining sleep
DMS	DMS:24	diffuse mesangial sclerosis
DMS	DMS:6	dimercaptosuccinic acid
DMS	DMS:16	dimethyl suberimidate
DMS	DMS:68	dimethyl sulfate
DMS	DMS:60	dimethyl sulfide
DMS	DMS:26	dimethyl sulphate
DMS	DMS:9	dimethyl sulphide
DMS	DMS:16	dimethylsuberimidate
DMS	DMS:46	dimethylsulfate
DMS	DMS:16	dimethylsulfide
DMS	DMS:16	dimethylsulphate
DMS	DMS:33	nndimethylsphingosine
DMTP	DMTP:6	delayed matching to position
DMTP	DMTP:11	dimethylthiophosphate
DMTU	DMTU:16|dmtu:1	dimethylthiourea
DMTU	DMTU:12	dimethyl thiourea
DMT	DMT:14	defense mechanism test
DMT	DMT:10	dimethyltryptamine
DMT	DMT:68	nndimethyltryptamine
DMV	DMV:15	department of motor vehicles
DMV	DMV:12	dolphin morbillivirus
DMZ	DMZ:8	demilitarized zone
DMZ	DMZ:14	dimetridazole
DMZ	DMZ:10	dorsal marginal zone
DNP-KLH	DNP-KLH:7	limpet haemocyanin
DNP-KLH	DNP-KLH:27|DNPKLH:1	limpet hemocyanin
DNP-SG	DNP-SG:12	dinitrophenylsglutathione
DNP-SG	DNP-SG:4|Dnp-SG:2	dinitrophenyl sglutathione
DNP	DNP:66|Dnp:5	dinitrophenyl
DNP	DNP:18	antidinitrophenyl
DNP	DNP:26	antidinitrophenol
DNP	DNP:21	dendroaspis natriuretic peptide
DNP	DNP:29	deoxyribonucleoprotein
DNP	DNP:15	dinitrophenylated
DNP	DNP:13	dorsal nerve of the penis
DNP	DNP:22	dynamic nuclear polarization
DNP	DNP:2	mutagen dinitropyrene
DNX	DNX:8|DNx:1	denervated
DNX	DNX:23|DNx:2|Dnx:1	renal denervation
DOCA	DOCA:241|doca:1|Doca:1	deoxycorticosterone acetate
DOCA	DOCA:52	desoxycorticosterone acetate
DOC	DOC:9	department of corrections
DOC	DOC:291	dissolved organic carbon
DOD	DOD:8	dead of disease
DOD	DOD:8	died of disease
DOE	DOE:81|DoE:1	department of energy
DOE	DOE:9|DoE:5	design of experiments
DOI	DOI:4	agonist dimethoxyiodophenylaminopropane hcl
DOI	DOI:4	agonist dimethoxyiodoamphetamine
DOI	DOI:5	receptor agonist dimethoxyiodophenylaminopropane
DOM	DOM:39	dimethoxymethylamphetamine
DOM	DOM:1	da receptor antagonist domperidone
DOM	DOM:10	hallucinogen dimethoxymethylphenylaminopropane
DON	DON:62	diazooxolnorleucine
DON	DON:342	deoxynivalenol
DON	DON:19	diazooxonorleucine
DON	DON:9	dissolved organic nitrogen
DON	DON:11	dysthyroid optic neuropathy
DOPA	DOPA:8|dopa:1	dihydroxyphenyllalanine
DOPA	DOPA:7	accumulation of ldihydroxyphenylalanine
DOPA	DOPA:15|doPA:1	dioleoylphosphatidic acid
DOPC	DOPC:28	dioleoylsnglycerophosphocholine
DOPC	DOPC:163	dioleoylphosphatidylcholine
DOPE	DOPE:22	dioleoylsnglycerophosphoethanolamine
DOPE	DOPE:6	dioleoyl phosphatidyl ethanolamine
DOPE	DOPE:143	dioleoylphosphatidylethanolamine
DOPS	DOPS:9	dihydroxyphenylserine
DOPS	DOPS:22	dioleoylphosphatidylserine
DOT	DOT:10	dictionary of occupational titles
DOT	DOT:19	diffuse optical tomography
DOT	DOT:108	directly observed therapy
DOT	DOT:51	directly observed treatment
DOT	DOT:11	disodium octaborate tetrahydrate
DOT	DOT:13	dissolved oxygen tension
DOX	DOX:8|Dox:4	doxazosin
DOX	DOX:7|dox:1	doxorubicin hydrochloride
DOS	DOS:30	density of states
DOS	DOS:10	diabetesobesity syndrome
DPAG	DPAG:24|dPAG:11|D-PAG:1	dorsal periaqueductal gray
DPAG	DPAG:18|dPAG:11	dorsal periaqueductal gray matter
DPAG	DPAG:8|dPAG:3	dorsal periaqueductal grey
DPA	DPA:15	dinpropylacetate
DPA	DPA:34	diphenylamine
DPA	DPA:55|Dpa:1	dipicolinic acid
DPA	DPA:5	dorsalis pedis artery
DPA	DPA:8|dpa:2	post anthesis
DPB	DPB:16|dPB:1	deoxyphorbol isobutyrate
DPB	DPB:196	diffuse panbronchiolitis
DPCPX	DPCPX:28	a receptor antagonist cyclopentyldipropylxanthine
DPCPX	DPCPX:6	adenosine a receptor antagonist dipropylcyclopentylxanthine
DPC	DPC:3	chloride channel blocker diphenylaminecarboxylate
dpc	dpc:13	days postcoitus
dpc	dpc:8	days postconception
DPC	DPC:7	deep prepiriform cortex
DPC	DPC:5	deep prepyriform cortex
DPC	DPC:9	diagnosis procedure combination
DPC	DPC:12	diagnostic products corporation
DPC	DPC:26	diphenylaminecarboxylic acid
DPC	DPC:65	dodecylphosphocholine
DPDPE	DPDPE:19	agonist dpendpenenkephalin
DPDPE	DPDPE:10	dpendpenenkephalin
DPD	DPD:5|Dpd:3	deoxypyridinoline crosslinks
DPD	DPD:8	depressive personality disorder
DPD	DPD:40|Dpd:15|dpd:1|dPD:1	urinary deoxypyridinoline
DPE	DPE:9	dipivalyl epinephrine
DPE	DPE:14	downstream promoter element
DPH	DPH:9	diphenyl hexatriene
DPH	DPH:12	diphenylhexatriene
DPI	DPI:8	days postimplantation
DPI	DPI:23	dietary protein intake
DPI	DPI:24	diphenyleneiodonium chloride
DPI	DPI:17	diphenyliodonium
DPI	DPI:15	diphosphoinositide
DPI	DPI:12	doppler perfusion index
DPI	DPI:9	dpi 
DPI	DPI:9	dry powder inhalation
DPI	DPI:3	nadph oxidase inhibitor diphenyleneiodonium
DPL	DPL:130	diagnostic peritoneal lavage
DPL	DPL:20	dipalmitoyl lecithin
DPN	DPN:9	deep peroneal nerve
DPN	DPN:31	diabetic peripheral neuropathy
DPN	DPN:9	dippen nanolithography
DPN	DPN:10	dorsal penile nerve
dpo	dpo:7	days postoperation
dpo	dpo:5|DPO:4	days postoperative
DPPC	DPPC:16	dipalmitoylsnglycerophosphatidylcholine
DPPC	DPPC:61	dipalmitoylsnglycerophosphocholine
DPPC	DPPC:13	dipalmitoyl
DPPC	DPPC:16	dipalmitoyl phosphatidyl choline
DPPC	DPPC:12	dipalmitoylphosphatidyl choline
DPPC	DPPC:23	lalphadipalmitoylphosphatidylcholine
DPPE	DPPE:6	dipalmitoyl phosphatidylethanolamine
DPPE	DPPE:39	dipalmitoylphosphatidylethanolamine
DPPE	DPPE:7	nndiethylphenylmethylphenoxyethanamine hcl
DPPH	DPPH:9	diphenylpicrylhydrazyl radical
DPPH	DPPH:16	alphaalphadiphenylbetapicrylhydrazyl
DPPH	DPPH:5	stable free radical diphenylpicrylhydrazyl
dpp	dpp:11|DPP:3	days postpartum
dpp	dpp:189|Dpp:101|DPP:21	decapentaplegic
DPP	DPP:5	dentin phosphophoryn
DPP	DPP:6	diphloretin phosphate
DPP	DPP:31	diabetes prevention program
DPP	DPP:12|dpp:1	differential pulse polarographic
DPP	DPP:44|dpp:1	differential pulse polarography
DPP	DPP:37	dipeptidyl peptidase
DPS	DPS:7	degree of phosphorus saturation
DPS	DPS:8	dipropyl sulfide
DP	DP:11|dp:1	degree of polymerisation
DP	DP:6	delayed puberty
DP	DP:7	delusional parasitosis
DP	DP:27	dermal papilla
DP	DP:21|Dp:5|dp:1	desmoplakin
DP	DP:16	directed percolation
DP	DP:24	directional preponderance
DP	DP:42	disopyramide
DP	DP:5	disopyramide phosphate
DP	DP:12	distal pancreatectomy
DP	DP:14|dp:1	distortion product
DP	DP:14	dorsal prostate
DP	DP:115	double positive
DP	DP:6	double potential
DP	DP:37	double product
DP	DP:9	dynamic programming
DP	DP:15	pattern
DR1	DR1:8|DR-1:1	direct repeat 
DR1	DR1:8|DR-1:4	one nucleotide
DRB	DRB:10	dichlorobetadribofuranosyl benzimidazole
DRB	DRB:92	dichlorobetadribofuranosylbenzimidazole
DRB	DRB:9	dichlorobenzimidazole riboside
DRCs	DRCs:17	dendritic reticulum cells
DRCs	DRCs:24	doseresponse curves
DRC	DRC:4	democratic republic of the congo
DRC	DRC:24	dna repair capacity
DRC	DRC:13	dryrolled corn
DRC	DRC:6	dynamic reaction cell
DRE	DRE:26	digital rectal exam
DRE	DRE:7	dioxin response element
DRE	DRE:12	dioxin responsive element
DRE	DRE:8	distal regulatory element
DRE	DRE:11	downstream regulatory element
DRG	DRG:31	diagnostic related group
DRG	DRG:39	dorsal respiratory group
DRG	DRG:1451|drg:3	dorsal root ganglion
DRO	DRO:24	differential reinforcement of other behavior
DRO	DRO:10|Dro:1	droloxifene
DRPs	DRPs:23	dorsal root potentials
DRPs	DRPs:29	drugrelated problems
DRP	DRP:32	dissolved reactive phosphorus
DRP	DRP:16	dystrophinrelated protein
DRRs	DRRs:36|DRRS:1	digitally reconstructed radiographs
DRRs	DRRs:9	dorsal root reflexes
DRSP	DRSP:13	drospirenone
DRSP	DRSP:12	drugresistant streptococcus pneumoniae
DRS	DRS:14	diabetic retinopathy study
DRs	DRs:5	diet records
DRS	DRS:11	diffuse reflectance spectroscopy
DRs	DRs:25	direct repeats
DRS	DRS:24	doseresponse slope
DRS	DRS:9	renal scintigraphy
DR	DR:16	dahl saltresistant rats
DR	DR:18	darkreared
DR	DR:19	death receptor
DR	DR:24	delayed response
DR	DR:9	delivery room
DR	DR:17	detection rate
DR	DR:10|dr:1	diabetes resistant
DR	DR:235|dR:1	diabetic retinopathy
DR	DR:7	diameter reduction
DR	DR:9	dietrestricted
DR	DR:9	dietary records
DR	DR:10	dietary restricted
DR	DR:161	dietary restriction
DR	DR:34	digital radiography
DR	DR:10	distal radius
DR	DR:6|dr:1	dose ratios
DR	DR:14|D-R:6	doseresponse
DR	DR:14	drug resistance
DR	DR:9	drugresistant
DR	DR:8	dynamic range
DR	DR:12	hladr
DSA	DSA:22	datura stramonium agglutinin
DSA	DSA:11	delayed spatial alternation
DSA	DSA:16	destructive spondyloarthropathy
DSA	DSA:6	digital subtraction angiograms
DSA	DSA:23	digital subtraction angiographic
DSA	DSA:26	digital subtraction arteriography
DSA	DSA:7	dog serum albumin
DSA	DSA:5	donorspecific antibodies
DSBR	DSBR:7	distal small bowel resection
DSBR	DSBR:11	dna doublestrand break repair
DSBR	DSBR:10	doublestrandbreak repair
DSC-MRI	DSC-MRI:6	dynamic susceptibility contrastenhanced magnetic resonance imaging
DSC-MRI	DSC-MRI:6	dynamic susceptibility contrast magnetic resonance imaging
DSC	DSC:7	decidual stromal cells
DSC	DSC:10	delayed sternal closure
DSC	DSC:12	dermal sheep collagen
DSC	DSC:9	dextran sulfate cellulose
DSC	DSC:50	differential scanning calorimeter
DSC	DSC:36	differential scanning calorimetric
DSC	DSC:20	differential scanning microcalorimetry
DSC	DSC:31	dynamic susceptibility contrast
DSE	DSE:16	distal sequence element
DSE	DSE:273	dobutamine stress echocardiography
DSE	DSE:16	dyad symmetry element
DSH	DSH:7	dexamethasonesuppressible hyperaldosteronism
DSH	DSH:12	disproportionate share hospital
DSH	DSH:18	dyschromatosis symmetrica hereditaria
DSI	DSI:34	depolarizationinduced suppression of inhibition
DSI	DSI:8	dysphonia severity index
DSM-IV	DSM-IV:1	diagnostic and statistical manual of mental disorders th edition
DSM-IV	DSM-IV:5	diagnostic and statistical manual of mental disorders fourth edition
DSM-IV	DSM-IV:10	diagnostic and statistical manual of mental disordersiv
DSM	DSM:18	diagnostic and statistical manual
DSM	DSM:9	dried skim milk
DSO	DSO:13	daily sperm output
DSO	DSO:12	diffuse sclerosing osteomyelitis
DSP-4	DSP4:4|DSP-4:4	nchloroethylnethylbromobenzylamine hydrochloride
DSP-4	DSP-4:7|DSP4:3	noradrenergic neurotoxin nchloroethylnethylbromobenzylamine
DSPC	DSPC:8	disaturated pc
DSPC	DSPC:104	disaturated phosphatidylcholine
DSPC	DSPC:7	phosphatidyl choline
DSP	DSP:39	daily sperm production
DSP	DSP:9	deliberate selfpoisoning
DSP	DSP:67|Dsp:2	dentin sialoprotein
DSP	DSP:51	diarrhetic shellfish poisoning
DSP	DSP:30	digital signal processing
DSP	DSP:15	digital signal processor
DSP	DSP:14	disseminated superficial porokeratosis
DSP	DSP:12	distal sensory polyneuropathy
DSP	DSP:9	distal symmetric polyneuropathy
DSP	DSP:12	distal symmetrical polyneuropathy
DSP	DSP:10	dithiobissuccinimidylpropionate
DSRS	DSRS:10	depression selfrating scale
DSRS	DSRS:57|D-SRS:1	distal splenorenal shunt
DSR	DSR:10	dahl saltresistant
DSR	DSR:10	daily spontaneous running
DSR	DSR:10	daily symptom report
DSR	DSR:26	digital subtraction radiography
DSR	DSR:28	dynamic spatial reconstructor
DSS	DSS:25	dejerinesottas syndrome
DSS	DSS:14	demographic surveillance system
DSS	DSS:49	dextran sodium sulfate
DSS	DSS:19	dextran sodium sulphate
DSS	DSS:102	dextran sulfate sodium
DSS	DSS:30	dextran sulphate sodium
DSS	DSS:12	digit symbol substitution
DSS	DSS:14	dioctyl sodium sulfosuccinate
DSS	DSS:21	disability status scale
DSS	DSS:20	discrete subaortic stenosis
DSS	DSS:85	diseasespecific survival
DST	DST:4	double stapling technique
DST	DST:15	drug susceptibility testing
DST	DST:10	dural sinus thrombosis
DST	DST:5	vitro drug sensitivity testing
DT104	DT104:8	definitive phage type 
DT104	DT104:14	typhimurium definitive type 
DTCs	DTCs:9	distal tip cells
DTCs	DTCs:13	dithiocarbamates
DTG	DTG:38	ditolylguanidine
DTG	DTG:22	diffuse toxic goiter
DTG	DTG:11	guanidine
DTH	DTH:16	hypersensitivity response
DTH	DTH:5	hypersensitivity skin test
DTH	DTH:6	hypersensitivity test
DTIC	DTIC:234	dacarbazine
DTIC	DTIC:7	dimethyl triazeno imidazole carboxamide
DTIC	DTIC:9	dimethyltriazenoimidazole carboxamide
DTIC	DTIC:10	imidazolecarboxamide
DT-MRI	DT-MRI:19|DTMRI:3	diffusion tensor magnetic resonance imaging
DT-MRI	DT-MRI:12|DTMRI:2	diffusion tensor mri
DTPA	DTPA:25	diethylenetriaminepentaacetate
DTPA	DTPA:273|dtpa:2|DT-PA:1	diethylenetriaminepentaacetic acid
DTP	DTP:10	developmental therapeutics program
DTP	DTP:8	diphtheria and tetanus toxoids and pertussis vaccine
DTP	DTP:1	diphtheria and tetanus toxoids with pertussis
DTP	DTP:17	diphtheriatetanuspertussis vaccine
DTT	DTT:22	dithiotreitol
DTT	DTT:20	dldithiothreitol
DTaP	DTaP:11	diphtheria and tetanus toxoids and acellular pertussis vaccine
DTaP	DTaP:5	pertussis vaccine combined with diphtheria and tetanus toxoids
DTI	DTI:211	diffusion tensor imaging
DTI	DTI:11	direct thrombin inhibitor
DTI	DTI:7	drug targeting index
DTX	DTX:7|DTx:2|Dtx:1	alphadendrotoxin
DTX	DTX:26|DTx:2|Dtx:1|DtX:1	dendrotoxin
DT	DT:8|dt:2	decayed teeth
DT	DT:6	decidual tissue
DT	DT:14	definitive phage type
DT	DT:25	delirium tremens
DT	DT:7	desmoid tumor
DT	DT:68|dt:2	developed tension
DT	DT:9	diffraction tomography
DT	DT:16	diphtheria and tetanus toxoids
DT	DT:19|D-T:2|dT:1	diphtheriatetanus
DT	DT:9	dipole tracing
DT	DT:11	drive for thinness
dt	dt:25	dystonia musculorum
dt	dt:13	genetically dystonic
DT	DT:5	impedance detection times
DT	DT:16	sabinfeldman dye test
DT	DT:4	salmonella typhimurium definitive type
DUE	DUE:12	dna unwinding element
DUE	DUE:52	evaluation
DUI	DUI:11	doubly uniparental inheritance
DUI	DUI:23	driving under the influence of alcohol
DUs	DUs:10	drug users
DUs	DUs:13|Dus:1	duodenal ulcers
DU	DU:7	densitometric units
DU	DU:71	depleted uranium
DU	DU:21	duodenal
DU	DU:11	duodenal ulcer disease
DU	DU:11	duodenal ulcer patients
DVA	DVA:9	developmental venous anomaly
DVA	DVA:22	dynamic visual acuity
DVC	DVC:17	direct viable count
DVC	DVC:83	dorsal vagal complex
DVD	DVD:47	dissociated vertical deviation
DVD	DVD:6	double vessel disease
DVR	DVR:14	aortic and mitral valve replacement
DVR	DVR:33	descending vasa recta
DVR	DVR:13	distribution volume ratio
DVR	DVR:23	dorsal ventricular ridge
DVR	DVR:20	double valve replacement
DVR	DVR:9	valve replacements
DVT	DVT:7	deep vein thrombophlebitis
DVT	DVT:11	deep vein thromboses
DVT	DVT:6	deep venous thrombophlebitis
DVT	DVT:13	deep venous thromboses
DV	DV:77	domestic violence
DV	DV:45	ductus venosus
DWI	DWI:13	diffusion
DWI	DWI:34	diffusionweighted images
DWI	DWI:318|D-WI:1	diffusionweighted imaging
DWI	DWI:19	driving while impaired
DW	DW:7	daily wear
DW	DW:15	deionized water
DW	DW:53	distilled water
dw	dw:53|DW:1	dwarf
dw	dw:8	dwarf gene
dw	dw:5	sexlinked dwarfing gene
DXA	DXA:437	dual energy xray absorptiometry
DXA	DXA:10	xray absorptiometer
DXA	DXA:15	xray absorptiometric
DXA	DXA:7	xray densitometry
DXR	DXR:11|Dxr:1	deoxydxylulose phosphate reductoisomerase
DXR	DXR:32	delayed xenograft rejection
DXR	DXR:15	digital xray radiogrammetry
DZ	DZ:5	definitive zone
DZ	DZ:15|Dz:2	diazoxide
DZ	DZ:10	dizygotic twins
DAO	DAO:211|dao:1	diamine oxidase
DAO	DAO:24	dorsal accessory olive
DD	DD:8	 disc diameter
DD	DD:61	constant dark
DD	DD:206|D-D:1	constant darkness
DD	DD:6	constant dim red light
DD	DD:56	continuous darkness
DD	DD:33	death domain
DD	DD:10	degree of deacetylation
DD	DD:6	delayed depolarization
DD	DD:10	deletion allele
DD	DD:12	delusional disorder
DD	DD:8	density dependence
DD	DD:14	developmental disabilities
DD	DD:12	developmental dyslexia
DD	DD:13	diastolic depolarization
DD	DD:6|Dd:5	diastolic diameter
DD	DD:12	diastolic dysfunction
DD	DD:16	dibenzopdioxin
DD	DD:111|dd:1|Dd:1	differential display
DD	DD:7	digital dermatitis
DD	DD:11	disc diameters
DD	DD:7	disc displacement
DD	DD:10	disk diffusion
DD	DD:11	diverticular disease
DD	DD:10	dopaminedeficient
DD	DD:11|dd:1	doubling doses
DD	DD:19	drug discrimination
DD	DD:9	duchenne dystrophy
DD	DD:30	dysthymic disorder
DEX	DEX:14|Dex:4	hdexamethasone
Dex	Dex:3|DEX:2	agonist dexmedetomidine
DEX	DEX:6	dexamethasone phosphate
DEX	DEX:8|Dex:3	dexrazoxane
Dex	Dex:9|dex:1	dextranase
DIA	DIA:7|Dia:1	diaphragmatic
DIA	DIA:23	digital image analysis
DIA	DIA:21	dot immunobinding assay
DL	DL:10	decidual lymphocytes
DL	DL:5	developmental level
DL	DL:29	diagnostic laparoscopy
DL	DL:34	dichotic listening
DL	DL:17	difference limen
DL	DL:6	diffuse leiomyomatosis
DL	DL:6	dim light
DL	DL:11	direct laryngoscopy
DL	DL:16	distal latency
DL	DL:14	dominant lethal
DL	DL:34|dl:3	dorsolateral
DL	DL:5	dorsolateral area
DL	DL:7	dorsolateral visual area
dl	dl:8|DL:1|Dl:1|dL:1	downless
DL	DL:9	ductal lavage
dl	dl:6	maternal morphogen dorsal
Dmax	Dmax:5|dmax:2	displacement limit
Dmax	Dmax:7|dmax:1	maximum diameter
Dmax	Dmax:6|dmax:3	maximum dose
DM	DM:19	defined medium
DM	DM:9	deltamethrin
DM	DM:9|Dm:1	dermorphin
DM	DM:22	descemets membrane
DM	DM:13	desmoplastic melanoma
DM	DM:10	deutschmarks
DM	DM:6	diabetic group
DM	DM:8	differentiation medium
DM	DM:38	disease management
DM	DM:9	dorsal medulla
DM	DM:14	dorsomedial medulla
DM	DM:5	dorsomedial nucleus of the intercollicular complex
DM	DM:12	dorsomedial visual area
DM	DM:11	doublemuscled
Dm	Dm:36|dm:1	drosophila melanogaster
DM	DM:6|dm:5	dry mass
DM	DM:515|dm:5	dry matter
DM	DM:9	dura mater
DM	DM:11|Dm:2	dystrophia myotonica
DM	DM:18	hladm
Dm	Dm:18|DM:9	membrane diffusing capacity
DM	DM:30	patients with dermatomyositis
DM	DM:249|Dm:1	patients with diabetes mellitus
DN	DN:25	dentate nucleus
DN	DN:12	dibucaine number
DN	DN:8	donor number
DN	DN:112|dn:1	double negative
DN	DN:31	dysplastic nevi
Dol-P	Dol-P:9	dolichyl monophosphate
Dol-P	Dol-P:29|dol-P:1|dol-p:1|DolP:1	dolichyl phosphate
DQ	DQ:11	diquat
DQ	DQ:11	duroquinone
DRMs	DRMs:43	detergentresistant membranes
DRMs	DRMs:7	detergentresistant membrane domains
DTS	DTS:11	davidson trauma scale
DTS	DTS:11	dense tubular system
DTS	DTS:35	diametral tensile strength
DTS	DTS:7	dipyridamole thallium scintigraphy
DXS	DXS:8|Dxs:1	deoxydxylulose phosphate synthase
DXS	DXS:8	diagnostic xray spectrometry
E(2)	E(2):18	estradiol beta
E(2)	E(2):89	estradiolbeta
E(a)	E(a):16|E(A):1	activation energies
E(a)	E(a):4	effective arterial elastance
E/A	E/A:12	filling velocity
E/A	E/A:10	velocities
E1S	E1S:17|E1-S:1	estrone sulphate
E1S	E1S:24	oestrone sulphate
E1	E1:6	fecal elastase
E1	E1:12	pyruvate dehydrogenase component
E1	E1:71	ubiquitinactivating enzyme
E2	E2:5	dihydrolipoamide acetyltransferase component
E2	E2:6	dihydrolipoamide acyltransferase
E2	E2:28	dihydrolipoyl acetyltransferase
E2	E2:21	dihydrolipoyl transacetylase
E2	E2:15	dihydrolipoyl transacylase
E2	E2:13	lipoate acetyltransferase
E2	E2:4	second envelope glycoprotein
E2	E2:15	second envelope protein
E2	E2:7|e2:2	second extracellular loop
E2	E2:32	serum oestradiol
E2	E2:8	ubiquitin carrier protein
E3	E3:34	dihydrolipoyl dehydrogenase
E3	E3:6	lipoamide dehydrogenase component
E3	E3:13	ubiquitinprotein isopeptide ligase
EAA	EAA:19	electroacupuncture analgesia
EAA	EAA:12	essential aa
EAA	EAA:73	extrinsic allergic alveolitis
EAC	EAC:9	air condensate
EAC	EAC:10	antibody and complement
EAC	EAC:5	ascites carcinoma cells
EAC	EAC:9	early arthritis clinic
EAC	EAC:140	ehrlich ascites carcinoma
EAC	EAC:13	erythema annulare centrifugum
EAC	EAC:70	external auditory canal
EADs	EADs:9	early after depolarizations
EADs	EADs:115	early afterdepolarizations
EAD	EAD:11	early after depolarization
EAD	EAD:5	extracranial arterial disease
EAE	EAE:31	experimental allergic encephalitis
EAE	EAE:18	experimental autoimmune encephalitis
EAE	EAE:1477	experimental autoimmune encephalomyelitis
EAF	EAF:18	enzymealtered foci
EAF	EAF:36	epec adherence factor
EAG	EAG:20	electroantennogram
EAG	EAG:22	experimental autoimmune glomerulonephritis
EAH	EAH:15	essential arterial hypertension
EAH	EAH:8	experimental autoimmune hepatitis
EAM	EAM:62	experimental autoimmune myocarditis
EAM	EAM:10	experimental autoimmune myositis
EAM	EAM:10	external acoustic meatus
EAM	EAM:18	external auditory meatus
EAN	EAN:186	experimental allergic neuritis
EAN	EAN:124	experimental autoimmune neuritis
EAO	EAO:28	experimental allergic orchitis
EAO	EAO:54	experimental autoimmune orchitis
EAP	EAP:19	electroacupuncture
EAP	EAP:5	embryonic alkaline phosphatase
EAP	EAP:24	employee assistance program
EAP	EAP:13	erythrocyte acid phosphatase
EAP	EAP:14	experimental autoimmune prostatitis
EARS	EARS:4	electronic appetite rating system
EARS	EARS:9	european atherosclerosis research study
EAS	EAS:7	ectopic acth syndrome
EAS	EAS:15	electronic article surveillance
EAs	EAs:11|eas:1	european americans
EAS	EAS:2	euthanasia and assisted suicide
EAS	EAS:5	euthanasia and physicianassisted suicide
EAs	EAs:13|eas:1	evolutionary algorithms
EAS	EAS:85	external anal sphincter
EAT	EAT:19	ectopic atrial tachycardia
EAT	EAT:160	experimental autoimmune thyroiditis
EAU	EAU:153	experimental autoimmune uveitis
EAU	EAU:279	experimental autoimmune uveoretinitis
EAV	EAV:9	entityattributevalue
EAV	EAV:161	equine arteritis virus
EAST	EAST:13	emory angioplasty versus surgery trial
EAST	EAST:23	enzyme allergosorbent test
EBA	EBA:17	early bactericidal activity
EBA	EBA:6	electron beam angiography
EBA	EBA:29	endothelial barrier antigen
EBA	EBA:138	epidermolysis bullosa acquisita
EBA	EBA:9	epizootic bovine abortion
EBA	EBA:25	expanded bed adsorption
EBC	EBC:12	early breast cancer
EBC	EBC:68	exhaled breath condensate
EBER	EBER:11	ebv encoded rna
EBER	EBER:9	ebvencoded small nuclear rnas
EBER	EBER:5	ebvencoded small rnas
EBER	EBER:7	epsteinbarr virus encoded rna
EBL	EBL:12	endoscopic band ligation
EBL	EBL:42	enzootic bovine leukosis
EBL	EBL:48	estimated blood loss
EBM	EBM:320|EbM:14|E-BM:1	evidencebased medicine
EBM	EBM:18	expressed breast milk
EBP	EBP:14	elastin binding protein
EBP	EBP:34	epidural blood patch
EBP	EBP:74	evidencebased practice
EBRT	EBRT:4	empty bed retention time
EBRT	EBRT:130	external beam radiation therapy
EBRT	EBRT:8	external beam rt
EBS	EBS:11	electrical brain stimulation
EBs	EBs:98	elementary bodies
EBs	EBs:123	embryoid bodies
EBS	EBS:75	epidermolysis bullosa simplex
EBS	EBS:9	ets binding site
EBUS	EBUS:20	endobronchial ultrasonography
EBUS	EBUS:11	endobronchial ultrasound
EBV	EBV:37	epsteinbarr viral
EBV	EBV:19	estimated blood volume
EB	EB:9	electron beam
EB	EB:17	empirical bayes
EB	EB:8	endometrial biopsy
EB	EB:30	energy balance
EB	EB:194	epidermolysis bullosa
EB	EB:8	erythromycin base
EB	EB:14	ethylbenzene
EB	EB:152|Eb:2	evans blue
EB	EB:17	eyeblink
EB	EB:1	metabolites epoxybutene
EC50	EC50:24	 effective concentrations
EC50	EC50:1	 maximal contraction
EC50	EC50:4	 of maximal response
EC50	EC50:4	 of the maximal effect
EC50	EC50:7	 of the maximum effect
EC50	EC50:9	apparent affinity
EC50	EC50:5	half maximal contraction
EC50	EC50:1	half of the maximal effect
EC50	EC50:9	relaxation
ECA	ECA:10	economic commission for africa
ECA	ECA:33	electrical control activity
ECA	ECA:67	enterobacterial common antigen
ECA	ECA:25	eosinophil chemotactic activity
ECA	ECA:81	epidemiologic catchment area
ECA	ECA:8	epidemiologic catchment area program
ECA	ECA:9	erythrina cristagalli
ECA	ECA:11	erythrina cristagalli agglutinin
ECA	ECA:10	external carotid
ECA	ECA:111	external carotid artery
ECC	ECC:78	early childhood caries
ECC	ECC:61	endocervical curettage
ECC	ECC:24	excitationcontraction coupling
ECC	ECC:5	external cardiac compression
ECC	ECC:15	extracorporeal circuit
ECDs	ECDs:61	equivalent current dipoles
ECDs	ECDs:18	extracellular domains
ECD	ECD:74	cysteinate dimer
ECD	ECD:36	electron capture detector
ECD	ECD:57	electron capture dissociation
ECD	ECD:16	endocardial cushion defect
ECD	ECD:50	endothelial cell density
ECD	ECD:7	endothelial cell dysfunction
ECD	ECD:35|E-Cd:1	erdheimchester disease
ECD	ECD:11	expanded criteria donor
ECE	ECE:11	embryonated chicken eggs
ECE	ECE:9	embryonating chicken eggs
ECE	ECE:45	extracapsular extension
ECF	ECF:53	east coast fever
ECF	ECF:64	eosinophil chemotactic factor
ECF	ECF:10	executive cognitive functioning
ECF	ECF:393|ecf:2	extracellular fluid
ECF	ECF:36	extracytoplasmic function
ECG	ECG:90	electrocardiograph
ECG	ECG:18	electrocardiographically
ECG	ECG:23|ECg:12	epicatechin gallate
eCG	eCG:13|ECG:1	equine cg
eCG	eCG:57|ECG:1	equine chorionic gonadotrophin
eCG	eCG:76	equine chorionic gonadotropin
ECG	ECG:43	exercise electrocardiography
ECH	ECH:8	enoylcoa hydratase
ECH	ECH:51	epichlorohydrin
ECLAM	ECLAM:10	european consensus lupus activity measure
ECLAM	ECLAM:13	european consensus lupus activity measurement
ECL	ECL:80	electrochemiluminescence
ECL	ECL:19	electrochemiluminescent
ECL	ECL:28	electrogenerated chemiluminescence
ECL	ECL:55	enhanced chemiluminescence
ECL	ECL:9	enhanced chemiluminescent
ECL	ECL:7	enterochromaffinlike cells
ECl	ECl:51	equilibrium potential
ECl	ECl:3	equilibrium potential for cl
ECL	ECL:15	extracorporeal lithotripsy
ECMO	ECMO:1130	extracorporeal membrane oxygenation
ECMO	ECMO:17	extracorporeal membrane oxygenator
ECM	ECM:10	caries monitor
ECM	ECM:11	endothelial cell monolayers
ECM	ECM:8	energycorrected milk
ECM	ECM:43	erythema chronicum migrans
ECM	ECM:15	experimental cerebral malaria
ECM	ECM:9	extracellular mass
ECM	ECM:8	extracellular material
ECM	ECM:28	extracellular matrix components
ECM	ECM:25|ecm:1	extracellular matrix proteins
ecNOS	ecNOS:27|ec-NOS:1|ECNOS:1	endothelial cell nitric oxide synthase
ecNOS	ecNOS:39|ECNOS:1	endothelial constitutive nitric oxide synthase
ecNOS	ecNOS:13	endothelial constitutive nos
ECP	ECP:28	energy charge potential
ECP	ECP:25	estradiol cypionate
ECP	ECP:12	external counterpulsation
ECP	ECP:54	extracorporeal photochemotherapy
ECP	ECP:43	extracorporeal photopheresis
EcR	EcR:63|ECR:1	ecdysone receptor
EcR	EcR:20	ecdysteroid receptor
EC-SOD	EC-SOD:18|ECSOD:6|ecSOD:2|Ec-SOD:1	extracellular sod
EC-SOD	EC-SOD:116|ecSOD:12|ECSOD:6|Ec-SOD:2	extracellular superoxide dismutase
ECS	ECS:9	cow serum
ECS	ECS:6	elective caesarean section
ECS	ECS:5	elective cesarean section
ECS	ECS:10	electrocerebral silence
ECS	ECS:17	electrochemical stimulation
ECS	ECS:10	electroconvulsive stimulation
ECS	ECS:13	electroconvulsive stimuli
ECS	ECS:6	environmental control system
ECS	ECS:21	extracapsular spread
ECT	ECT:40	ecarin clotting time
ECT	ECT:26	electrochemotherapy
ECT	ECT:1245	electroconvulsive therapy
ECT	ECT:48	electroconvulsive treatment
ECT	ECT:12	endocurietherapy
ECU	ECU:6	care unit
ECU	ECU:5	environmental control unit
ECU	ECU:43	extensor carpi ulnaris
ECV	ECV:13	ethchlorvynol
ECV	ECV:78	external cephalic version
ECV	ECV:9	extracellular virus
ECV	ECV:88	extracellular volume
EC	EC:9	committee
EC	EC:12	complex environment
EC	EC:8|Ec:1	ecadherin
EC	EC:55	electrochemical
EC	EC:14	electron capture
EC	EC:10	elimination capacity
EC	EC:9	elongation complex
EC	EC:121	emergency contraception
EC	EC:21	emulsifiable concentrate
EC	EC:10	endochondral
EC	EC:53	endometrial cancer
EC	EC:33	endothelial
EC	EC:12	endothelium
EC	EC:83	energy charge
EC	EC:7	energy cost
EC	EC:9	enkephalincontaining
EC	EC:8	enriched
EC	EC:11	enriched condition
EC	EC:8|ec:1	entericcoated
EC	EC:96|Ec:1	enterochromaffin
EC	EC:14	enzyme commission
EC	EC:10	eosinophilic cystitis
EC	EC:33	epicatechin
EC	EC:68	esophageal cancer
EC	EC:6	esophageal candidiasis
EC	EC:25	ethyl carbamate
EC	EC:32	ethyl cellulose
EC	EC:56|Ec:1	ethylcellulose
EC	EC:30	eurocollins
EC	EC:45	european commission
EC	EC:108	european community
EC	EC:14	experimental immunemediated blepharoconjunctivitis
ED50	ED50:1	 of its maximal response
ED50	ED50:2	half the maximal response
EDA	EDA:80	electrodermal activity
EDA	EDA:9	electron donoracceptor
EDA	EDA:6	electronic dental anesthesia
EDA	EDA:15|EDa:2	enddiastolic area
EDA	EDA:15	exploratory data analysis
EDB	EDB:72	ethylene dibromide
EDB	EDB:46|Edb:1	extensor digitorum brevis
EDB	EDB:4|ED-B:3	extra domain b
EDCF	EDCF:12	contracting factors
EDCF	EDCF:28	endotheliumderived contracting factor
EDC	EDC:25	ethyldimethylaminopropylcarbodiimide
EDC	EDC:8	ethyldimethylaminopropylcarbodiimide hydrochloride
EDC	EDC:5	ethyldimethylaminopropyl carbodiimide hydrochloride
EDC	EDC:9	compounds
EDC	EDC:13	date of confinement
EDC	EDC:14	endocrine disrupting chemicals
EDC	EDC:13	epidermal differentiation complex
EDC	EDC:34	ethanolderived calories
EDC	EDC:13	ethylene dichloride
EDC	EDC:68|edc:1	extensor digitorum communis
EDC	EDC:9	ndimethylaminopropylnethylcarbodiimide
EDD	EDD:12	date of delivery
EDD	EDD:29	enddiastolic diameter
EDD	EDD:13	endotheliumdependent dilation
EDD	EDD:11	esophageal detector device
EDH	EDH:18	epidural hematoma
EDH	EDH:7	extradural haematoma
EDH	EDH:15	extradural hematoma
EDL	EDL:12	efferent duct ligation
EDL	EDL:7	electric double layer
EDL	EDL:9|edL:3	enddiastolic length
EDL	EDL:9	enddiastolic segment length
EDL	EDL:8|edl:1	fasttwitch
EDPVR	EDPVR:8	enddiastolic pressurevolume relation
EDPVR	EDPVR:8	enddiastolic pressurevolume relationship
EDP	EDP:9	elastinderived peptides
EDP	EDP:20	electronic data processing
EDP	EDP:10	erythema dyschromicum perstans
EDP	EDP:13	estradiol dipropionate
EDR	EDR:70	endotheliumdependent relaxation
EDR	EDR:8	excess death rate
EDR	EDR:10	extreme drug resistance
EDSS	EDSS:5	expanded disability scale score
EDSS	EDSS:368	expanded disability status scale
EDSS	EDSS:13	expanded disability status score
EDs	EDs:61|Eds:1	eating disorders
EDS	EDS:6	edinburgh depression scale
EDs	EDs:283|EDS:1	emergency departments
EDs	EDs:9|EDS:1	endocrine disrupters
EDs	EDs:22	endocrine disruptors
EDS	EDS:17	energy dispersive spectrometry
EDS	EDS:20	energydispersive spectroscopy
EDs	EDs:15|EDS:1	epileptiform discharges
EDS	EDS:21	ethane dimethane sulfonate
EDS	EDS:42	ethane dimethane sulphonate
EDS	EDS:19	ethane dimethanesulfonate
EDS	EDS:29	ethane dimethanesulphonate
EDS	EDS:14	ethylene dimethane sulfonate
EDS	EDS:9	ethylene dimethanesulphonate
EDS	EDS:155	excessive daytime sleepiness
EDS	EDS:22	excessive daytime somnolence
EDTA	EDTA:16	acid disodium salt
EDTA	EDTA:6	calcium disodium ethylenediaminetetraacetate
EDTA	EDTA:23	disodium edetate
EDTA	EDTA:7	ethylene diamine tetraacetate
EDTA	EDTA:48	ethylene diamine tetraacetic acid
EDTA	EDTA:128	ethylenediamine tetraacetic acid
EDTA	EDTA:573|edta:2	ethylenediaminetetraacetic acid
EDU	EDU:16|EdU:1	ethyldeoxyuridine
EDU	EDU:15	ethylenediurea
EDV	EDV:39	enddiastolic
EDV	EDV:6	end diastolic velocities
EDV	EDV:18	enddiastolic volumes
EDV	EDV:14	endotheliumdependent vasodilatation
EDV	EDV:23	endotheliumdependent vasodilation
EDX	EDX:11	edatrexate
EDX	EDX:16	electrodiagnostic
EDX	EDX:33	energydispersive xray
EDX	EDX:8	xray spectrometry
ED	ED:8|E-D:1	deprivation
ED	ED:10	early distal
ED	ED:5	effector domain
ED	ED:13	electrodialysis
ED	ED:38	elemental diet
ED	ED:9	endogenous depression
ED	ED:10	endolymphatic duct
ED	ED:30	energy density
ED	ED:15	enteric drainage
ED	ED:17|E-D:1	entnerdoudoroff
ED	ED:10	enumeration district
ED	ED:16	epithelial dysplasia
ED	ED:18	equilibrium dialysis
ED	ED:978	erectile dysfunction
ED	ED:7	erythrocyte deformability
ED	ED:9	essential dynamics
ED	ED:11	external diameter
EE2	EE2:19	alphaethynylestradiol
EE2	EE2:61|eE2:1	ethinyl estradiol
EEA1	EEA1:6	early endosomal autoantigen 
EEA1	EEA1:14|EEA-1:1	early endosome antigen 
EEA	EEA:21	endtoend anastomosis
EEA	EEA:8	european economic area
EEC	EEC:18	ectrodactylyectodermal dysplasiaclefting
EEC	EEC:8	endogenous erythroid colony
EEC	EEC:16	endometrial epithelial cells
EEC	EEC:40	european economic community
EEE	EEE:87	eastern equine encephalitis
EEE	EEE:61	eastern equine encephalomyelitis
EEG	EEG:18	brain electrical activity
EEG	EEG:6	electrical activity of the brain
EEG	EEG:128	electroencephalograph
EEG	EEG:19	electroencephalographic activity
EEG	EEG:11	electroencephalographically
EEG	EEG:874	electroencephalography
EEG	EEG:14	videoelectroencephalographic
EEG	EEG:13	videoelectroencephalography
EEM	EEM:12	excitationemission matrix
EEM	EEM:45	external elastic membrane
EEP	EEP:27	ethanol extract of propolis
EEP	EEP:15	ethanolic extract of propolis
EER	EER:16	electrically evoked response
EER	EER:10	ethanol elimination rate
EE	EE:12	alphaethinylestradiol
EE	EE:9	emotional exhaustion
EE	EE:14	encapsulation efficiency
EE	EE:12|E-E:3	endtoend
EE	EE:9	endocardial endothelial
EE	EE:20	endocardial endothelium
EE	EE:15	enriched environment
EE	EE:13	environmental enrichment
EE	EE:10	eosinophilic esophagitis
EE	EE:8	erosive esophagitis
EE	EE:11	erythromycin estolate
EE	EE:23	ether extract
EE	EE:10	exercise echocardiography
EE	EE:26	exoerythrocytic
EE	EE:239	expressed emotion
EFAD	EFAD:13|EFA-D:1	efadeficient
EFAD	EFAD:66	essential fatty acid deficiency
EFA	EFA:6	enamelfree area
EFA	EFA:9	ethoxyformic anhydride
EFA	EFA:12	euglobulin fibrinolytic activity
EFA	EFA:18	exploratory factor analysis
EFE	EFE:23	endocardial fibroelastosis
EFE	EFE:8	ethyleneforming enzyme
EFM	EFM:51	electronic fetal monitoring
EFM	EFM:7	epifluorescence microscopy
EFP	EFP:17	early follicular phase
EFP	EFP:18	endoneurial fluid pressure
EFs	EFs:12	electric fields
EFS	EFS:668	electrical field stimulation
EFs	EFs:9	embryonic fibroblasts
EFS	EFS:11	empty follicle syndrome
EFs	EFs:12	enantiomer fractions
EFs	EFs:10	enantiomeric fractions
EFS	EFS:27	eventfree
EFS	EFS:742	eventfree survival
EFs	EFs:10	executive functions
EFT	EFT:16	embedded figures test
EFT	EFT:6	emotionally focused therapy
EF	EF:17	early follicular
EF	EF:6	enteral feeding
EF	EF:51	eosinophilic fasciitis
EF	EF:9	eosinophilic folliculitis
EF	EF:24	erectile function
EF	EF:17	executive functioning
EF	EF:7	exoplasmic face
EF	EF:11	external fixation
EGb	EGb:13|EGB:5	extract of ginkgo biloba
EGb	EGb:6|EGB:1	extract of ginkgo biloba leaves
EGFR	EGFR:12|egfr:1|Egfr:1	epidermal growth factor receptor gene
EGFR	EGFR:5|EGF-r:1	receptor for egf
EGFP	EGFP:35|eGFP:3|egfp:1	enhanced gfp
EGFP	EGFP:721|eGFP:98|egfp:2|E-GFP:1|EGFp:1	enhanced green fluorescent protein
EGP	EGP:128	endogenous glucose production
EGP	EGP:14	ethanolamine glycerophospholipids
Egr-1	Egr-1:26|EGR-1:4|egr-1:2|EGR1:1	early growth response factor
Egr-1	Egr-1:9|Egr1:1	early growth response protein
EGRAC	EGRAC:7|EGR-AC:2	erythrocyte glutathione reductase activation coefficient
EGRAC	EGRAC:9|EGR-AC:2	erythrocyte glutathione reductase activity coefficient
EGS	EGS:12	equine grass sickness
EGS	EGS:17	external guide sequence
EGTA	EGTA:8	calcium chelator
EGTA	EGTA:7	chelating agent
EGR	EGR:11	enterogastric reflux
EGR	EGR:16|E-GR:1|eGR:1	erythrocyte glutathione reductase
EG	EG:42	embryonic germ
EG	EG:12	enteroglucagon
EG	EG:31	eosinophilic granuloma
EG	EG:248	ethylene glycol
EG	EG:8	excitable gap
EG	EG:26	experimental group
EG	EG:7	local treatment with essaven gel
EHC	EHC:36	enterohepatic circulation
EHC	EHC:5	first drafts of environmental health criteria
EHD	EHD:13	epizootic haemorrhagic disease
EHD	EHD:25	epizootic hemorrhagic disease
EHDP	EHDP:25	diphosphonate
EHDP	EHDP:27	disodium ethanehydroxydiphosphonate
EHDP	EHDP:23	disodium etidronate
EHDP	EHDP:18	etidronate disodium
EHDV	EHDV:21	epizootic haemorrhagic disease virus
EHDV	EHDV:51	epizootic hemorrhagic disease virus
EHEC	EHEC:15	coli oh
EHEC	EHEC:1	enterohaemorrhagic e coli
EHEC	EHEC:17	enterohemorrhagic
EHEC	EHEC:189	enterohemorrhagic escherichia coli
EHL	EHL:47	electrohydraulic lithotripsy
EHL	EHL:9	evaporative heat loss
EHL	EHL:25	extensor hallucis longus
EHPVO	EHPVO:22	extrahepatic portal vein obstruction
EHPVO	EHPVO:22	extrahepatic portal venous obstruction
EHS	EHS:89	engelbrethholmswarm
EHS	EHS:9	exertional heat stroke
EHT	EHT:8	engineered heart tissue
EHT	EHT:15	essential hypertensives
EHV-4	EHV-4:9|EHV4:3	equine herpesvirus 
EHV-4	EHV-4:11|EHV4:1	equine herpesvirus type 
EIA	EIA:17	electroimmunoassay
EIA	EIA:20	environmental impact assessment
EIA	EIA:6	enzyme immunoassay method
EIA	EIA:42	enzyme immunosorbent assay
EIA	EIA:45	enzymeimmunoassay
EIA	EIA:12	enzymoimmunoassay
EIA	EIA:40	equine infectious anemia
EIA	EIA:9	exerciseinduced anaphylaxis
EIA	EIA:246|E-IA:1	exerciseinduced asthma
EIA	EIA:20	external iliac artery
EIB	EIB:88	exerciseinduced bronchoconstriction
EIB	EIB:87	exerciseinduced bronchospasm
EIC	EIC:27	elastase inhibitory capacity
EIC	EIC:18	endometrial intraepithelial carcinoma
EIC	EIC:41	extensive intraductal component
EIEC	EIEC:1	enteroinvasive e coli
EIEC	EIEC:63	enteroinvasive escherichia coli
eIF-5A	eIF-5A:40|eIF5A:10	eukaryotic initiation factor a
eIF-5A	eIF-5A:15|eIF5A:10	eukaryotic translation initiation factor a
EIH	EIH:10	exerciseinduced hypoxaemia
EIH	EIH:19	exerciseinduced hypoxemia
EIPA	EIPA:20	ethylisopropyl amiloride
EIPA	EIPA:70	ethylisopropylamiloride
EIPH	EIPH:37	exerciseinduced pulmonary haemorrhage
EIPH	EIPH:31	exerciseinduced pulmonary hemorrhage
EIP	EIP:10	early intervention program
EIP	EIP:9	endinspiratory pause
EIP	EIP:11	extensor indicis proprius
EIS	EIS:18	electrical impedance scanning
EIS	EIS:66	electrochemical impedance spectroscopy
EIS	EIS:94	endoscopic injection sclerotherapy
EIS	EIS:14	epidemic intelligence service
EITB	EITB:9	blot technique
EITB	EITB:65	enzymelinked immunoelectrotransfer blot
EITB	EITB:10	enzymelinked immunoelectrotransfer blot assay
EIT	EIT:194	electrical impedance tomography
EIT	EIT:10	electromagnetically induced transparency
EJCs	EJCs:10	excitatory junction currents
EJCs	EJCs:8|ejcs:2	excitatory junctional currents
EKC	EKC:36	electrokinetic chromatography
EKC	EKC:40	epidemic keratoconjunctivitis
EKC	EKC:9	ethylketazocine
EKC	EKC:96|Ekc:2	ethylketocyclazocine
EK	EK:10	electrophoretic karyotype
EK	EK:15	electrophoretic karyotyping
EK	EK:16	enterokinase
EK	EK:4	equilibrium potential of k
EK	EK:38|Ek:4	k equilibrium potential
EK	EK:8	potential for potassium
ELC	ELC:4	diagonal earlobe crease
ELC	ELC:5	ear lobe crease
ELC	ELC:11	ebiligand chemokine
ELC	ELC:11	epidermal langerhans cells
ELC	ELC:14|E-LC:2	essential light chain
ELC	ELC:9	expressionlinked copy
ELC	ELC:9	ligand chemokine
ELISAs	ELISAs:13	enzymelinked immunoassays
ELISAs	ELISAs:567|ELISAS:2|ELI-SAs:1	enzymelinked immunosorbent assays
ELISA	ELISA:39	enzymelinked immunosorbent
ELISA	ELISA:4	enzymelinked immunosorbent analysis
ELISA	ELISA:15	immunoenzymatic
ELISA	ELISA:12	immunoenzymatic test
ELISA	ELISA:10|Elisa:1	immunoenzyme test
ELI	ELI:13	enkephalinlike immunoreactivity
ELI	ELI:11	expression library immunization
ELP	ELP:9	elastaselike protease
ELP	ELP:11	elastinlike polypeptide
ELP	ELP:13	endozepinelike peptide
ELP	ELP:5	lipid pneumonia
ELP	ELP:6	lipoid pneumonia
ELS	ELS:6	eatonlambert syndrome
ELS	ELS:9	extended least squares
ELS	ELS:6	extralobar pulmonary sequestration
ELT	ELT:12	endoscopic laser therapy
ELT	ELT:76	euglobulin lysis time
EL	EL:6	ejaculation latency
EL	EL:34	endothelial lipase
EL	EL:17	erythroleukemia
EL	EL:22	lung elastance
EMAP	EMAP:9	echinoderm microtubuleassociated protein
EMAP	EMAP:7	endothelial monocyteactivating polypeptide
EMAP	EMAP:10	environmental monitoring and assessment program
EMA	EMA:10|EmA:2	antiendomysial antibody
EMA	EMA:13|EmA:2	antiendomysium
EMA	EMA:12	ecological momentary assessment
EMA	EMA:9|EmA:3	endomysium
EMA	EMA:9|EmA:6	endomysium antibodies
EMA	EMA:16	eosinmaleimide
EMA	EMA:656	epithelial membrane antigen
EMA	EMA:9	eyelid myoclonia with absences
EMA	EMA:4|EmA:3	iga antiendomysial antibodies
EMC-D	EMC-D:8	d variant of encephalomyocarditis
EMC-D	EMC-D:20	d variant of encephalomyocarditis virus
EMC	EMC:12	electromagnetic compatibility
EMC	EMC:233	encephalomyocarditis
EMC	EMC:18	epithelialmyoepithelial carcinoma
EMC	EMC:17	essential mixed cryoglobulinaemia
EMC	EMC:50	essential mixed cryoglobulinemia
EMC	EMC:28	extraskeletal myxoid chondrosarcoma
EMD	EMD:28	electromechanical delay
EMD	EMD:63	electromechanical dissociation
EMD	EMD:9	emdogain
EMD	EMD:10	enzymatic mutation detection
EMD	EMD:9	extramedullary disease
EMD	EMD:17	eye movement desensitization
EME	EME:9	early myoclonic encephalopathy
EME	EME:39	ecgonine methyl ester
EMF	EMF:12	electromagnetic flowmeter
EMF	EMF:11|emf:6	electromotive force
EMF	EMF:61	endomyocardial fibrosis
EMGdi	EMGdi:22|EMGdI:1	diaphragmatic electromyogram
EMGdi	EMGdi:6|EMGDi:1|EMG-DI:1	diaphragmatic emg
EMG	EMG:75	electromyograph
EMG	EMG:162	electromyographic activity
EMG	EMG:30	electromyographical
EMG	EMG:13	electromyographically
EMG	EMG:11	experimental myasthenia gravis
EMLA	EMLA:6|Emla:1	eutectic mixture of lidocaine and prilocaine
EMLA	EMLA:17	eutectic mixture of local anaesthetics
EMND	EMND:19	equine motor neuron disease
EMND	EMND:9	ethylmorphinendemethylase
EMR	EMR:21	eastern mediterranean region
EMR	EMR:12	educable mentally retarded
EMR	EMR:17	electromagnetic radiation
EMR	EMR:176	endoscopic mucosal resection
EMSA	EMSA:9	electrophoretic mobility shift analyses
EMSA	EMSA:262	electrophoretic mobility shift assays
EMS	EMS:10	electrical muscle stimulation
EMS	EMS:24	electromyostimulation
EMS	EMS:14	electrophoretic mobility shift
EMS	EMS:36	ethyl methane sulfonate
EMS	EMS:11	ethyl methane sulphonate
EMS	EMS:306	ethyl methanesulfonate
EMS	EMS:80	ethyl methanesulphonate
EMS	EMS:8	ethylmethane sulphonate
EMS	EMS:42	ethylmethanesulfonate
EMS	EMS:17	ethylmethanesulphonate
EMTALA	EMTALA:17	emergency medical treatment and active labor act
EMTALA	EMTALA:19	emergency medical treatment and labor act
EMTs	EMTs:104	emergency medical technicians
EMTs	EMTs:5	epithelialmesenchymal transitions
EMT	EMT:6	epithelialmesenchymal transdifferentiation
EMT	EMT:30	epithelialmesenchymal transformation
EMT	EMT:71	epithelialmesenchymal transition
EMT	EMT:27	epithelial to mesenchymal transition
EMT	EMT:18	extraneuronal monoamine transporter
EMT	EMT:9	transitions
EMU	EMU:12	early morning urine
EMU	EMU:5	extravehicular mobility unit
Em	Em:5|EM:1|em:1	early diastolic velocity
EM	EM:12	egg mass
EM	EM:9|Em:3	elastic modulus
EM	EM:139|em:5	electromagnetic
EM	EM:9	electron micrographs
EM	EM:118	electron microscope
EM	EM:12	electron microscopical
EM	EM:11	electronmicroscopy
EM	EM:218	emergency medicine
EM	EM:14|Em:3	endometriosis
EM	EM:14	epidural morphine
EM	EM:5	episodic memory
EM	EM:9	ergonovine maleate
EM	EM:83|Em:1	erythema migrans
EM	EM:87	erythema multiforme
EM	EM:7	erythrocyte membrane
EM	EM:6	esophageal manometry
EM	EM:21	estramustine
EM	EM:23	ethylmorphine
EM	EM:19	extracellular matrix
EM	EM:10	extramedullary
EM	EM:14	eye movement
EM	EM:13	eye muscle
Em	Em:10|E-m:1	midpoint potentials
ENA-78	ENA-78:10	neutrophilactivating peptide
ENA-78	ENA-78:5	neutrophil activating peptide
ENA	ENA:1|Ena:1	ace inhibitor enalapril
ENA	ENA:13	erythrocytic nuclear abnormalities
ENG	ENG:16	electroneurogram
ENG	ENG:19	electronystagmogram
ENG	ENG:40	electronystagmographic
ENG	ENG:135	electronystagmography
ENG	ENG:11	endoglin
ENL	ENL:16|Enl:5	enterolactone
ENL	ENL:149	erythema nodosum leprosum
eNOS	eNOS:6	endothelial isoform
eNOS	eNOS:12|e-NOS:1	endothelial nitric oxide
eNOS	eNOS:5	endothelial nitric oxide synthetase
eNOS	eNOS:10|e-NOS:1	endothelial nosynthase
ENR	ENR:8	enoyl acyl carrier protein reductase
ENR	ENR:14|Enr:2	enrofloxacin
ENS	ENS:9	electrical nerve stimulation
ENS	ENS:192	enteric nervous system
ENS	ENS:10	epidermal nevus syndrome
ENS	ENS:5	extranodal spread
ENT	ENT:3	ear nose and throat
ENT	ENT:18	earnosethroat
ENT	ENT:6	embryonic nervous tissue
ENT	ENT:12|Ent:1	equilibrative nucleoside transporter
ENU	ENU:13	nethylnitrosourea
ENU	ENU:10	nnitrosonethylurea
EN	EN:5	egg number
EN	EN:9	electronic nose
EN	EN:16|En:1	enalapril
EN	EN:13	endemic nephropathy
EN	EN:9	enteral
EN	EN:137	enteral nutrition
EN	EN:11	epinephrine
EN	EN:66	erythema nodosum
EN	EN:8	ethyl nicotinate
EOAD	EOAD:11	earlyonset ad
EOAD	EOAD:16	earlyonset alzheimers disease
EOCA	EOCA:7	early onset cerebellar ataxia
EOCA	EOCA:14	early onset cerebellar ataxia with retained tendon reflexes
EOC	EOC:113	epithelial ovarian cancer
EOC	EOC:28	epithelial ovarian carcinoma
EOC	EOC:10	obstetric care
EOD	EOD:88	electric organ discharge
EOD	EOD:21	extent of disease
EOF	EOF:294	electroosmotic flow
EOF	EOF:10	erythrocyte osmotic fragility
EORTC	EORTC:60	european organisation for research and treatment of cancer
EORTC	EORTC:14	european organization for research on treatment of cancer
EOS	EOS:10	endogenous opioid system
EOS	EOS:9	equation of state
EOS	EOS:10	ethanolamineosulphate
EOS	EOS:2	gabatransaminase inhibitor ethanolamineosulfate
EPA	EPA:10	eicosapentaenoate
EPA	EPA:106	eicosapentaenoic
EPA	EPA:1006	eicosapentaenoic acid
EPA	EPA:5	extrapulmonary artery
EPC	EPC:5	early prostate cancer
EPC	EPC:26	ectoplacental cone
EPC	EPC:9	enhanced primary care
EPC	EPC:44|epc:1|Epc:1	epilepsia partialis continua
EPC	EPC:13	epithelioma papulosum cyprini
EPC	EPC:15	erosive prepyloric changes
EPC	EPC:5	exocrine pancreatic cancer
EPC	EPC:13	external pneumatic compression
EPD	EPD:12	eukaryotic promoter database
EPD	EPD:8	expected progeny differences
EPEC	EPEC:8	education for physicians on endoflife care
EPEC	EPEC:57	enteropathogenic
EPEC	EPEC:2	enteropathogenic e coli
EPE	EPE:8	eosinophilic pleural effusion
EPE	EPE:21	extraprostatic extension
EPF	EPF:113	early pregnancy factor
EPF	EPF:11	endemic pemphigus foliaceus
EPF	EPF:26	eosinophilic pustular folliculitis
EPIC	EPIC:96	european prospective investigation into cancer and nutrition
EPIC	EPIC:4	european prospective investigation of cancer
EPIC	EPIC:7	evaluation of e for the prevention of ischemic complications
EPI	EPI:10	echoplanar
Epi	Epi:15|EPI:13|epi:4	epicardial
Epi	Epi:7|epi:4|EPI:3	epicardium
EPI	EPI:10|Epi:6	epididymal
EPI	EPI:15	epidoxorubicin
EPI	EPI:9	epidural
EPI	EPI:6|Epi:5|epi:1	epimastigotes
EPI	EPI:34|epi:1	exocrine pancreatic insufficiency
EPI	EPI:20	expanded program of immunization
EPI	EPI:3	expanded programme of immunisation
EPI	EPI:165	expanded programme on immunization
EPI	EPI:35	extrinsic pathway inhibitor
EPI	EPI:57	eysenck personality inventory
EPI	EPI:13|Epi:10|epi:1	subepicardium
EPL	EPL:11	early pregnancy loss
EPL	EPL:17	essential phospholipids
EPL	EPL:10	expressed protein ligation
EPL	EPL:28	extensor pollicis longus
EPL	EPL:46|epl:1	external plexiform layer
EPL	EPL:20	extracorporeal piezoelectric lithotripsy
EPMA	EPMA:55	electron probe microanalysis
EPMA	EPMA:7	electron probe microanalyzer
EPM	EPM:6	electronic performance monitoring
EPM	EPM:67	equine protozoal myeloencephalitis
EPM	EPM:13	extrapontine myelinolysis
EPM	EPM:6	ph monitoring
EPN	EPN:21	emphysematous pyelonephritis
EPN	EPN:8	oethyl opnitrophenyl phenylphosphonothioate
EPP	EPP:118	erythropoietic protoporphyria
EPP	EPP:8	ethyl phenylpropiolate
EPP	EPP:11	extrapair paternity
EPP	EPP:14	extrapleural pneumonectomy
EPR	EPR:8	earlyphase reaction
EPR	EPR:53	electron paramagnetic resonance spectroscopy
EPs	EPs:17	ectopic pregnancies
EPS	EPS:17	elastosis perforans serpiginosa
EPS	EPS:5	electrical promontory stimulation
EPs	EPs:85	emergency physicians
EPS	EPS:7	emotionalpain stress
EPS	EPS:29	encapsulating peritoneal sclerosis
EPS	EPS:10	expanded polystyrene
EPS	EPS:19	extrapyramidal signs
EPS	EPS:203	extrapyramidal symptoms
EP	EP:5	bovine encephalitogenic protein
EP	EP:25	eprostanoid
EP	EP:6	early phase
EP	EP:27	egg production
EP	EP:58	electrophysiologic
EP	EP:28	electrophysiological
EP	EP:32	electrophysiology
EP	EP:36	emergency physician
EP	EP:6	encephalitogenic peptide
EP	EP:206|-EP:1	endocochlear potential
EP	EP:10	endocrineparacrine
EP	EP:62	endogenous pyrogen
EP	EP:9	enzootic pneumonia
EP	EP:13	eosinophilic pneumonia
EP	EP:5	equilibrium point
EP	EP:9	escape protein
EP	EP:8|E-P:3	estrogenprogesterone
EP	EP:24	etoposide and cisplatin
EP	EP:11	etoposide phosphate
EP	EP:10	etoposide plus cisplatin
EP	EP:6	pge receptors
EP	EP:40|E-P:13	phosphoenzyme
EP	EP:8|E-P:2	phosphoenzyme intermediate
EP	EP:18|E-P:3	phosphorylated intermediate
EP	EP:9	vivo electroporation
EQA	EQA:95	external quality assessment
EQA	EQA:24	external quality assurance
EQ	EQ:6	efficiency quotient
EQ	EQ:39	ethoxyquin
ERA	ERA:6	early rheumatoid arthritis
ERA	ERA:23	ecological risk assessment
ERA	ERA:11	electrical response activity
ERA	ERA:9	estrogen replacement and atherosclerosis
ERCP	ERCP:51	endoscopic retrograde cholangiopancreaticography
ERCP	ERCP:14	endoscopic retrograde cholangiopancreatogram
ERCP	ERCP:10	endoscopic retrograde cholangiopancreatographic
ERCP	ERCP:1372|ER-CP:1	endoscopic retrograde cholangiopancreatography
ERD	ERD:132	eventrelated desynchronization
ERD	ERD:12	extrapolated response dose
ERF	ERF:5	excitatory receptive field
ERF	ERF:13	external respiration function
ERF	ERF:10	external respiratory function
ERGIC	ERGIC:14	endoplasmic reticulumgolgi intermediate compartment
ERGIC	ERGIC:17	ergolgi intermediate compartment
ERG	ERG:146	electroretinographic
ERG	ERG:248	electroretinography
ERG	ERG:6|erg:5	etheragogorelated gene
ERISA	ERISA:24	employee retirement income security act
ERISA	ERISA:22	employee retirement income security act of 
ERK	ERK:7|Erk:2	extracellular regulated kinases
ERK	ERK:11	extracellular regulated protein kinase
ERK	ERK:10|Erk:1	extracellular signalregulated
ERNA	ERNA:13	equilibrium radionuclide angiocardiography
ERNA	ERNA:24	equilibrium radionuclide angiography
EROD	EROD:5	ethoxyresorufin odealkylation
EROD	EROD:9	deethylation
EROD	EROD:8	ethoxyresorufin deethylase
EROD	EROD:8	odeethylase activity
ERPs	ERPs:46	effective refractory periods
ERPs	ERPs:1412|ERPS:4	eventrelated potentials
ERP	ERP:13	effective
ERP	ERP:6	eledoisinrelated peptide
ERP	ERP:7	endoscopic retrograde pancreaticography
ERP	ERP:5	enzymereleasing peptide
ERP	ERP:4	exposure and response prevention
ERs	ERs:8|ers:1	enantiomeric ratios
ERs	ERs:368|Ers:1	estrogen receptors
ERT	ERT:11	emergency room thoracotomy
ERT	ERT:437	estrogen replacement therapy
ERT	ERT:5	external irradiation
ERT	ERT:17|eRT:2	external radiotherapy
ER	ER:7	electrical resistance
ER	ER:14	electrorheological
ER	ER:316	emergency room
ER	ER:11	endoplasmic reticular
ER	ER:10	endoscopic resection
ER	ER:10	energyrestricted
ER	ER:34	energy restriction
ER	ER:9	energy retention
ER	ER:12	enhanced reactivation
ER	ER:8	estrogen receptor status
ER	ER:15	external rotation
ER	ER:27	extraction ratio
ER	ER:94	oestrogen receptors
ER	ER:6	oestrogen receptor status
ER	ER:1	receptors of estrogens
ESAS	ESAS:10	edmonton symptom assessment scale
ESAS	ESAS:14	edmonton symptom assessment system
ESA	ESA:4	endocardial surface area
ESA	ESA:5	epidermal surface antigen
ESA	ESA:7	ethanesulfonic acid
ESA	ESA:27	european space agency
ESA	ESA:5	excited state absorption
ESBL-KP	ESBL-KP:2|ESBL-Kp:2	betalactamase producing klebsiella pneumoniae
ESBL-KP	ESBL-KP:5|ESBLKp:1|ESBL-Kp:1	extendedspectrum betalactamaseproducing klebsiella pneumoniae
ESC	ESC:7	enteric septicemia of catfish
ESC	ESC:11	environmental stress cracking
ESC	ESC:15	esophageal squamous cell carcinoma
ESC	ESC:27	european society of cardiology
ESEM	ESEM:29	environmental scanning electron microscope
ESEM	ESEM:54	environmental scanning electron microscopy
ESES	ESES:7	electrical status epilepticus during sleep
ESES	ESES:7	epidural spinal electrical stimulation
ESF	ESF:7	erythropoiesis stimulating factors
ESF	ESF:11	external skeletal fixator
ESI-MS	ESI-MS:5|ESIMS:1	electrospray ionization mass spectrometric
ESI-MS	ESI-MS:11	electrospray ionization mass spectroscopy
ESI	ESI:77	electron spectroscopic imaging
ESI	ESI:75	electrospray ionisation
ESI	ESI:579	electrospray ionization
ESI	ESI:7	emergency severity index
ESM	ESM:55	ethosuximide
ESM	ESM:17	experience sampling method
ESP	ESP:12	electrostatic potential
ESP	ESP:17	electrostatic precipitator
ESP	ESP:14	endsystolic pressure
ESP	ESP:11	eosinophil stimulation promoter
ESP	ESP:9	european spine phantom
ESP	ESP:9	extrasensory perception
ESRD	ESRD:22	endstage renal failure
ESRD	ESRD:9	renal disease patients
ESs	ESs:12	effect sizes
ESS	ESS:24	empty sella syndrome
ESS	ESS:16	endsystolic stress
ESS	ESS:118	endoscopic sinus surgery
ESS	ESS:176	epworth sleepiness scale
ESS	ESS:12	epworth sleepiness score
ESS	ESS:10	euthyroid sick syndrome
ESs	ESs:13	expression sites
ESS	ESS:11	splicing silencer
EST	EST:7	electroshock seizure threshold
EST	EST:6	electroshock treatment
EST	EST:12	embryonic stem cell test
EST	EST:45	estrogen sulfotransferase
EST	EST:16	exercise stress test
EST	EST:15	exercise stress testing
EST	EST:566	expressed sequence tag
ESWT	ESWT:55	extracorporeal shock wave therapy
ESWT	ESWT:7	extracorporeal shock wave treatment
ESWT	ESWT:24	extracorporeal shockwave therapy
ES	ES:13	ectoplasmic specialization
Es	Es:9|ES:1	ego strength
ES	ES:8	electrically stimulated
ES	ES:24	electrostimulation
ES	ES:12	embolic signals
ES	ES:15	emotional stress
ES	ES:10	endometrial stromal
ES	ES:17	endostatin
ES	ES:9	endotoxic shock
ES	ES:7	endotoxin shock
ES	ES:9	engraftment syndrome
ES	ES:20	enzyme estrone sulfatase
ES	ES:13|E-S:3	enzymesubstrate
ES	ES:10	enzymesubstrate complex
ES	ES:6	epilepsy surgery
ES	ES:25	epileptic seizures
ES	ES:23	epithelioid sarcoma
ES	ES:37|Es:1	erector spinae
ES	ES:11	erythromycin stearate
Es	Es:8|ES:1	estrogens
ES	ES:17	exanthem subitum
ES	ES:9|E-S:2	excretory and secretory
ES	ES:14	expression site
ES	ES:15	extent score
es	es:7|ES:2	external sensory
es	es:7	nitrobenzylthioinosine nbmprsensitive
ES	ES:6	sweetened ethanol solution
ETAAS	ETAAS:5|ET-AAS:4	atomic absorption spectrophotometry
ETAAS	ETAAS:53|ET-AAS:7	electrothermal atomic absorption spectrometry
ETA	ETA:8	eicosatetraynoic acid
ETA	ETA:32|ET-A:10|ETa:1	endothelina
ETA	ETA:6	endothelin receptor
ETA	ETA:13|Eta:1	etanidazole
ETA	ETA:13	european thyroid association
ETA	ETA:6	extrathoracic airway
ETBF	ETBF:1	enterotoxigenic b fragilis
ETBF	ETBF:18	enterotoxigenic bacteroides fragilis
ETB	ETB:22|ET-B:7	endothelinb
ETB	ETB:10|ET-B:1|ETb:1	endothelin type b
ETCO2	ETCO2:5|EtCO2:1	carbon dioxide concentration
ETCO2	ETCO2:12	endtidal co concentration
ETC	ETC:76	electron transport chain
ETC	ETC:13	esophageal tracheal combitube
ETEC	ETEC:12	enterotoxigenic e coli
ETEC	ETEC:500	enterotoxigenic escherichia coli
ETF	ETF:39	electron transfer flavoprotein
ETF	ETF:26	electrontransferring flavoprotein
ETF	ETF:8	enteral tube feeding
ETI	ETI:10	eicosatriynoic acid
ETI	ETI:9	early transient incapacitation
ETL	ETL:14	echo train length
ETL	ETL:7	enteropathytype tcell lymphoma
ETP	ETP:11	electron transport particles
ETP	ETP:36	endogenous thrombin potential
ETR	ETR:15	effective thyroxine ratio
ETR	ETR:6	electron transport rate
ETR	ETR:12	endoftreatment response
ETT	ETT:12	epithelioid trophoblastic tumor
ETT	ETT:6	esophageal transit time
ETT	ETT:23	exercise tolerance test
ETT	ETT:6	exercise tolerance time
ETT	ETT:24	exercise treadmill test
ETT	ETT:20	exercise treadmill testing
ETU	ETU:11	erythron transferrin uptake
ETU	ETU:24	ethylene thiourea
ETU	ETU:110	ethylenethiourea
ETV	ETV:69	endoscopic third ventriculostomy
ETV	ETV:9	extravascular thermal volume
ET	ET:86	ejection time
ET	ET:21|et:1|Et:1	endtidal
ET	ET:11	endometrial thickness
ET	ET:9	endotoxins
ET	ET:67	endotracheal
ET	ET:27|E-T:1	endotracheal tube
ET	ET:11	endurance training
ET	ET:15	escherichia coli endotoxin
ET	ET:14	esotropia
ET	ET:141	essential thrombocythaemia
ET	ET:363	essential thrombocythemia
ET	ET:32	essential thrombocytosis
ET	ET:251	essential tremor
ET	ET:20	estrogen therapy
ET	ET:147	eustachian tube
ET	ET:9	evapotranspiration
ET	ET:10	evolutionary trace
ET	ET:33	exchange transfusion
ET	ET:30	exercise testing
ET	ET:11	exercise tolerance
ET	ET:26	exfoliative toxin
EUA	EUA:11	examination under anaesthesia
EUA	EUA:14	examination under anesthesia
EUS	EUS:7	endoscopic sonography
EUS	EUS:11	endoscopic ultrasonographic
EUS	EUS:545	endoscopic ultrasonography
EUS	EUS:320	endoscopic ultrasound
EUS	EUS:18	epizootic ulcerative syndrome
EUS	EUS:58	external urethral sphincter
EU	EU:15	elisa units
EU	EU:18	endotoxin units
EU	EU:11|Eu:1	european
EU	EU:440	european union
EVAR	EVAR:30	endovascular abdominal aortic aneurysm repair
EVAR	EVAR:73	endovascular aneurysm repair
EVAR	EVAR:19	endovascular aortic aneurysm repair
EVA	EVA:12	enlarged vestibular aqueduct
EVA	EVA:15	equine viral arteritis
EVA	EVA:6	ethylene vinyl acetate copolymer
EVD	EVD:11	external ventricular drain
EVD	EVD:24	external ventricular drainage
EVLW	EVLW:246	extravascular lung water
EVLW	EVLW:9	extravascular lung water volume
EVL	EVL:70	endoscopic variceal ligation
EVL	EVL:12	enveloping layer
EVR	EVR:6	early virological response
EVR	EVR:17|evr:1	endocardial viability ratio
EVS	EVS:11	endophthalmitis vitrectomy study
EVS	EVS:28	endoscopic variceal sclerotherapy
EV	EV:24	ectromelia virus
ev	ev:16	endogenous viral
ev	ev:6|EV:5	endogenous virus
EV	EV:9	enteroviral
EV	EV:105|Ev:2|ev:1	epidermodysplasia verruciformis
EV	EV:5	erythrocyte volume
EV	EV:24	esophageal varices
EV	EV:76	estradiol valerate
EW	EW:24|E-W:1	edingerwestphal nucleus
EW	EW:34	egg weight
EW	EW:9	egg white
EW	EW:7	emergency ward
EW	EW:21	extended wear
EW	EW:23	external work
EW	EW:7	nucleus of edingerwestphal
EXAFS	EXAFS:186|EX-AFS:2	extended xray absorption fine structure
EXAFS	EXAFS:14	extended xray absorption fine structure spectroscopy
EZ	EZ:20|E-Z:5	edmonstonzagreb
EZ	EZ:10	epileptogenic zone
EA	EA:9|Ea:3	early amniocentesis
EA	EA:62|Ea:2	early antigens
EA	EA:16	effect of electroacupuncture
EA	EA:20	effort angina
EA	EA:45|Ea:5	egg albumin
EA	EA:12	ehrlich ascites
EA	EA:18|Ea:1	electrical activity
EA	EA:9	electron affinity
EA	EA:60	ellagic acid
EA	EA:8	endometrial ablation
EA	EA:9	entorhinal area
EA	EA:14	epidural anaesthesia
EA	EA:32	epidural anesthesia
EA	EA:14	epileptiform activity
EA	EA:9|Ea:1	erythrocyte
EA	EA:13	erythrocyte aggregation
EA	EA:17	erythrocyteantibody
EA	EA:11	erythromycin acistrate
EA	EA:114	esophageal atresia
EA	EA:26	ethyl acetate
EA	EA:21	ethyl acrylate
EA	EA:7	evolutionary algorithm
EA	EA:6	igg antibodies
EA	EA:17	sensitized sheep erythrocytes
Emax	Emax:12	contractility index
Emax	Emax:4	lv contractility
Emax	Emax:6	maximal contractile response
Emax	Emax:8	maximal contraction
Emax	Emax:39	maximal effect
Emax	Emax:8	maximal elastance
Emax	Emax:6	maximum contraction
Emax	Emax:5	slope of the endsystolic pressurevolume relationship
Emax	Emax:9	systolic elastance
emm	emm:13	m protein
emm	emm:7	m protein gene
EMP	EMP:11	electromagnetic pulse
EMP	EMP:20	embdenmeyerhofparnas
EMP	EMP:6	embdenmeyerhof pathway
EMP	EMP:61	estramustine phosphate
Endo	Endo:12|ENDO:8|endo:5	endocardial
Endo	Endo:6|endo:3|ENDO:1	endocardium
Endo	Endo:8|endo:5	endoglycosidase
EOA	EOA:58	effective orifice area
EOA	EOA:12	erosive osteoarthritis
EOA	EOA:32	esophageal obturator airway
EO	EO:11	 ethanolamine oleate
EO	EO:9	early onset
EO	EO:6	electric organ
EO	EO:17	electrolyzed oxidizing
EO	EO:10	endocrine ophthalmopathy
EO	EO:16	endogenous ouabain
EO	EO:40	eyes open
EpRE	EpRE:8|EPRE:4	electrophile response element
EpRE	EpRE:8|EPRE:1	electrophile responsive element
ERAD	ERAD:59	erassociated degradation
ERAD	ERAD:19	erassociated protein degradation
ESD	ESD:8	electrostatic spray deposition
ESD	ESD:13	endsystolic diameter
ESD	ESD:22|EsD:1	endsystolic dimension
ESD	ESD:30	entrance surface dose
ESD	ESD:11	environmental sex determination
ESD	ESD:62|EsD:43	esterase d
ETS	ETS:33	electron transport system
ETs	ETs:103	electrophoretic types
ETs	ETs:6	endocrine tumors
ETS	ETS:13	endoscopic thoracic sympathectomy
ETS	ETS:10	endoscopic transthoracic sympathicotomy
ETs	ETs:254|Et-s:1|Ets:1|ETS:1	endothelins
ETS	ETS:17	endotracheal suctioning
ETS	ETS:726	environmental tobacco smoke
ETs	ETs:8	exfoliative toxins
ETS	ETS:46	external transcribed spacer
F0	F0:9	fusion
F0	F0:11	membrane sector
F0	F0:9	precursor
F1	F1:13	beef heart mitochondrial atpase
F1	F1:9	crossbred
F1	F1:17|f1:1	first formant
F1	F1:21|F-1:2	fraction 
F1	F1:10	fragment 
F1	F1:6	granulosa cells from the first
F1	F1:1	granulosa cells obtained from the largest
F1	F1:15	largest follicle
F1	F1:7	largest preovulatory follicle
F1	F1:52|F-1:2	offspring
F2	F2:9	follicle
F2	F2:26|f2:1	second formant
F2	F2:12	second generation
F344	F344:7	fischer  rats
F344	F344:8|F-344:2	male fischer
F9	F9:16	factor ix gene
F9	F9:11	mouse embryonal carcinoma
FAAH	FAAH:131	fatty acid amide hydrolase
FAAH	FAAH:11	fatty acid amidohydrolase
FAA	FAA:25	federal aviation administration
FAA	FAA:100	flavone acetic acid
FACE	FACE:9	fatality assessment and control evaluation
FACE	FACE:35	fluorophoreassisted carbohydrate electrophoresis
FACE	FACE:22	freeair co enrichment
FACE	FACE:10	freedom of access to clinic entrances act
FACS	FACS:9	cell scanning
FACS	FACS:11	facial action coding system
FACS	FACS:13	fluorescenceactivated cellsorting
FACT-G	FACT-G:10	functional assessment of cancer therapy
FACT-G	FACT-G:36|Fact-G:1	functional assessment of cancer therapygeneral
FAC	FAC:33	ferric ammonium citrate
FAC	FAC:44	fractional area change
FAC	FAC:6|fac:1|Fac:1	group c gene
FADS	FADS:22	factor analysis of dynamic structures
FADS	FADS:14	fetal akinesia deformation sequence
FAD	FAD:66	familial ad
FAD	FAD:227	familial alzheimers disease
FAD	FAD:47	family assessment device
FAD	FAD:283	flavin adenine dinucleotide
FAD	FAD:8	focal acantholytic dyskeratosis
FAE	FAE:15	fetal alcoholexposed
FAE	FAE:21	fetal alcohol exposure
FAE	FAE:6	follicleassociated epithelial
FAE	FAE:83	follicleassociated epithelium
FAE	FAE:15	fumaric acid esters
FAF	FAF:5	auditory feedback
FAF	FAF:7	familial amyloidosis of the finnish type
FAF	FAF:10	fibroblastactivating factor
FAH	FAH:5	caused by a deficiency of fumarylacetoacetate hydrolase
FAH	FAH:18	foci of altered hepatocytes
FAH	FAH:12	fumarylacetoacetase
FAI	FAI:30	frenchay activities index
FAI	FAI:13	functional aerobic impairment
FALS	FALS:4	cases are familial
FALS	FALS:49|fALS:4	familial als
FALS	FALS:178|fALS:11|F-ALS:1	familial amyotrophic lateral sclerosis
FALS	FALS:7	forward angle light scatter
FAMA	FAMA:9	fluorescenceassisted mismatch analysis
FAMA	FAMA:13	fluorescent antibody to membrane antigen
FAMIS	FAMIS:9	factor analysis of biomedical image sequences
FAMIS	FAMIS:17	factor analysis of medical image sequences
FAM	FAM:2	doxorubicin and mitomycin
FAM	FAM:7	family assessment measure
FAM	FAM:10|Fam:3|fam:1	famotidine
FAM	FAM:9	faschingbauer abbreviated mmpi
FAO	FAO:14	fatty acid betaoxidation
FAO	FAO:40	fatty acid oxidation
FAO	FAO:12	food and agriculture organization of the united nations
FAP	FAP:886	familial adenomatous polyposis
FAP	FAP:30	familial adenomatous polyposis coli
FAP	FAP:131	familial amyloid polyneuropathy
FAP	FAP:246	familial amyloidotic polyneuropathy
FAP	FAP:9	femoral artery pressure
FAP	FAP:24	fibroblast activation protein
FAP	FAP:8|FAp:3|F-AP:1	fluorapatite
FAS	FAS:11|fas:2|FA-S:1|Fas:1	acid synthesis
FAS	FAS:6	facial affective scale
FAS	FAS:7	fatigue assessment scale
FAS	FAS:391|fas:2|Fas:1	fatty acid synthase
FAS	FAS:92|Fas:3	fatty acid synthetase
FAS	FAS:420	fetal alcohol syndrome
FAS	FAS:10	fibrin adhesive system
FAS	FAS:9	fluorescence actin staining
FAS	FAS:11	fluorescent actin staining
FAs	FAs:24	focal adhesions
FAS	FAS:2	fractional area of shortening
FAS	FAS:16	free alphasubunit
FAs	FAs:10	frequent attenders
FAT	FAT:18	fluorescent antibody technique
FAT	FAT:56	fluorescent antibody test
FAT	FAT:17	focal adhesion targeting
FA	FA:8	data were acquired by frontal analysis
FA	FA:35	factor analysis
FA	FA:7	fast adapting
FA	FA:14	femoral
FA	FA:54	femoral artery
FA	FA:33	fibrinolytic activity
FA	FA:22	fibrosing alveolitis
FA	FA:55	filtered air
FA	FA:12	flip angle
FA	FA:98	fluctuating asymmetry
FA	FA:8	fluid accumulation
FA	FA:24	fluocinolone acetonide
FA	FA:18	fly ash
FA	FA:32	food allergy
Fa	Fa:4|FA:1	fraction absorbed
FA	FA:158	fractional anisotropy
FA	FA:24	freunds adjuvant
Fa	Fa:6	local absorption ratio
FA	FA:6	protein phosphatase activating factor
FBA	FBA:11	flux balance analysis
FBA	FBA:13	foreign body aspiration
FBC	FBC:7	brain cells
FBC	FBC:21	full blood count
FBD	FBD:17	familial british dementia
FBD	FBD:6	fibrocystic breast disease
FBD	FBD:15	functional bowel disorders
FBM	FBM:74	felbamate
FBM	FBM:18	fetal bone marrow
FBP	FBP:7	fetal biophysical profile
FBP	FBP:81	filtered backprojection
FBP	FBP:10	fructosebisphosphatase
FBR	FBR:11	fluidizedbed reactor
FBR	FBR:8	foreign body reaction
FBS	FBS:8	fake bad scale
FBS	FBS:7	fanconibickel syndrome
FBS	FBS:57	fasting blood sugar
FBS	FBS:28	fetal blood sampling
FBS	FBS:12	forepaw barrel subfield
FB	FB:9	bronchoscope
FB	FB:205|Fb:1	fast blue
FB	FB:16|Fb:1	feedback
FB	FB:10	ferruginous bodies
FB	FB:6	fetal blood
FB	FB:9	fetal breathing
FB	FB:9|Fb:1	fibroblast
FB	FB:30	flexible bronchoscopy
FB	FB:10	free breathing
FCA	FCA:8	flow cytometric assay
FCA	FCA:316	freunds complete adjuvant
FCCL	FCCL:9	cell lymphoma
FCCL	FCCL:6	follicular center cell lymphomas
FCCP	FCCP:9	carbonyl cyanide ptrifluoromethoxyphenyl hydrazone
FCCP	FCCP:88	carbonyl cyanide ptrifluoromethoxyphenylhydrazone
FCC	FCC:8	familycentered care
FCC	FCC:33	follicular center cell
FCD	FCD:18	fibrocystic disease
FCD	FCD:61	focal cortical dysplasia
FCD	FCD:62	functional capillary density
FCE	FCE:16	feed conversion efficiency
FCE	FCE:8	food conversion efficiency
FCE	FCE:23	functional capacity evaluation
FCI	FCI:7	after transient focal cerebral ischemia
FCI	FCI:18	flow cytometric immunophenotyping
FCM	FCM:11	family and community medicine
FCM	FCM:20	fatcorrected milk
FCM	FCM:26	flow cytometer
FCM	FCM:8	flow cytometric method
FCM	FCM:9	fluorescence correlation microscopy
FCM	FCM:31	fuzzy cmeans
FCs	FCs:12	febrile convulsions
FCs	FCs:23	fibrillar centers
FCS	FCS:184	fluorescence correlation spectroscopy
FCs	FCs:8	fusion cells
FCS	FCS:11	medium supplemented with  fetal calf serum
FCT	FCT:9	fecal chymotrypsin
FCT	FCT:14	fever clearance time
FCT	FCT:20	functional communication training
FCU	FCU:12	firstcatch urine
FCU	FCU:42|fcu:3	flexor carpi ulnaris
FCV	FCV:17	famciclovir
FCV	FCV:163	feline calicivirus
fc	fc:10|fC:7|Fc:2|FC:1	cardiac frequency
fc	fc:9|Fc:7	centroid frequency
Fc	Fc:7|FC:1	constant region
fc	fc:11	corner frequency
Fc	Fc:7	crystallizable fragment
FC	FC:15	facilitated communication
FC	FC:15	fecal coliform
FC	FC:25	feed consumption
FC	FC:18	feed conversion
Fc	Fc:10	ferrocene
FC	FC:8	fibrillar centres
FC	FC:9	flow convergence
FC	FC:197|fc:2	flow cytometry
FC	FC:14	fluorocarbon
FC	FC:13	fluorocitrate
FC	FC:29	free carnitine
FC	FC:151|fC:1	free cholesterol
FC	FC:8	frequency of contractions
FC	FC:9	frontal
FC	FC:45	functional class
FC	FC:5|F-C:1	fusarin c
FC	FC:29	fusicoccin
FDA	FDA:147	fluorescein diacetate
FDA	FDA:8|F-DA:6	fluosolda 
FDB	FDB:17	familial defective apo b
FDB	FDB:61	familial defective apolipoprotein b
FDB	FDB:42|fdb:1	flexor digitorum brevis
FDG	FDG:14	deoxyffluorodglucose
FDG	FDG:15	deoxyfluorodglucose
FDG	FDG:10	fluorine fluorodeoxydglucose
FDG	FDG:10	f deoxyglucose
FDG	FDG:12	fluorine deoxyglucose
FDG	FDG:22	fluorinefluorodeoxyglucose
FDH	FDH:44	familial dysalbuminemic hyperthyroxinemia
FDH	FDH:13	focal dermal hypoplasia
FDH	FDH:48|fdh:1|Fdh:1	formate dehydrogenase
FDI	FDI:8	disability index
FDI	FDI:42	first dorsal interosseous muscle
FDI	FDI:56	first dorsal interosseus
FDI	FDI:14	first dorsal interosseus muscle
FDLE	FDLE:11	fetal distal lung epithelial
FDLE	FDLE:11	fetal distal lung epithelium
FDM	FDM:10	filter diagonalization method
FDM	FDM:7	freedom from distant metastasis
FD	FD:79	familial dysautonomia
FD	FD:12	familial dysbetalipoproteinemia
FD	FD:17	fascia dentata
FD	FD:9	fetal distress
FD	FD:20	fiber density
FD	FD:7	fibre density
FD	FD:45	fibrous dysplasia
FD	FD:14	field desorption
FD	FD:9	finite difference
FD	FD:13	fixation disparity
FD	FD:22	flavor dilution
FD	FD:18	food deprivation
FD	FD:11	freezedried
FD	FD:12|Fd:1	freezedrying
FD	FD:9	friedreichs disease
FD	FD:109	functional dyspepsia
FEC	FEC:28	egg count
FEC	FEC:12	epirubicin and cyclophosphamide
FELi	FELi:18|FeLi:1	fractional excretion of lithium
FELi	FELi:17|FeLi:1|FE-Li:1	fractional lithium excretion
FEM	FEM:9	finite element
FEM	FEM:185	finite element method
FEM	FEM:20	finite element modeling
FEN	FEN:10	dlfenfluramine
FEN	FEN:9|Fen:3	fenoterol
FEO	FEO:11	familial expansile osteolysis
FEO	FEO:22	oscillator
FEP	FEP:7	flash evoked potential
FEP	FEP:7	fluorinated ethylene propylene
FEP	FEP:24	free energy perturbation
FEP	FEP:9	free erythrocyte porphyrin
FEP	FEP:76	free erythrocyte protoporphyrin
FER	FER:23|Fer:16	ferritin
FER	FER:10	food efficiency ratio
FER	FER:4	fractional esterification rate
FES	FES:13	falls efficacy scale
FES	FES:49	family environment scale
FES	FES:62	fat embolism syndrome
FES	FES:364	functional electrical stimulation
FET	FET:7	fieldeffect transistor
FET	FET:16	fluorescence energy transfer
FET	FET:11	forced expiration technique
FET	FET:12	forced expiratory time
FET	FET:7	frozen embryo transfer
FEV(1)	FEV(1):71	forced expiratory volume in  s
FEV(1)	FEV(1):22	forced expired volume in  sec
FEV1	FEV1:15	forced expiratory volume at one second
FEV1	FEV1:1	forced expiratory volume during first second of expiration
FEV1	FEV1:4	volume of air expelled in the first second of forced expiration
FFA	FFA:33	fundus fluorescein angiography
FFA	FFA:22	fusiform face area
FFI	FFI:12	furoylfuranylhimidazole
FFI	FFI:7	foot function index
FFM	FFM:31	fivefactor model
FFM	FFM:12	fivefactor model of personality
FFM	FFM:9	fundus flavimaculatus
FFP	FFP:17	federal financial participation
FFP	FFP:54	freedom from progression
FFR	FFR:16	fluid filtration rate
FFR	FFR:10	forcefrequency relation
FFR	FFR:13	forcefrequency relationship
FFR	FFR:88	fractional flow reserve
FFR	FFR:32	freedom from relapse
FFR	FFR:14	fructosefed rats
FF	FF:19	fast fatigable
FF	FF:15	feeding
FF	FF:9	fenofibrate
FF	FF:10	fibrotic focus
FF	FF:224	filtration fraction
FF	FF:42|F-F:1	fimbriafornix
FF	FF:9	fluorescein flowmetry
FF	FF:22	form factor
FF	FF:20|ff:1	french francs
FF	FF:2	rats fed a fiberfree
FGD	FGD:17	familial glucocorticoid deficiency
FGD	FGD:18	flue gas desulfurization
FGM	FGM:90	female genital mutilation
FGM	FGM:5	fibrous glass membrane
FGR	FGR:88	fetal growth restriction
FGR	FGR:28	fetal growth retardation
FGS	FGS:13	female genital schistosomiasis
FGS	FGS:56	focal glomerular sclerosis
FGS	FGS:91	focal glomerulosclerosis
FG	FG:13	fasting glucose
FG	FG:61	fibrin glue
FG	FG:6	fluorescein glucuronide
FG	FG:9	fourniers gangrene
FG	FG:18	fusiform gyrus
FHA	FHA:8	family history of alcoholism
FHA	FHA:51	forkheadassociated
FHA	FHA:11	functional hypothalamic amenorrhea
FHD	FHD:7|FHd:2	focal hand dystonia
FHD	FHD:10	frontal hypothalamic deafferentation
FHH	FHH:23	familial hypocalciuric hypercalcaemia
FHH	FHH:56	familial hypocalciuric hypercalcemia
FHI	FHI:59	family health international
FHI	FHI:9	fibrous hamartoma of infancy
FHM	FHM:88	familial hemiplegic migraine
FHM	FHM:11	fathead minnow
FHP	FHP:12	family health program
FHP	FHP:18	fasting heat production
FHR	FHR:7	familial hypophosphatemic rickets
FHR	FHR:13	fawnhooded rat
FHS	FHS:10	fetal hydantoin syndrome
FHS	FHS:8|F-HS:1	floatingharbor syndrome
FHS	FHS:13	framingham heart study
FHS	FHS:7	nhlbi family heart study
FHV	FHV:21	feline herpesvirus
FHV	FHV:43	flock house virus
FIA	FIA:13	fluorescence immunoassay
FIA	FIA:7	fluorescent immunoassay
FIA	FIA:22	fluoroimmunoassay
FIA	FIA:90	freunds incomplete adjuvant
FIC	FIC:6	feline interstitial cystitis
FIC	FIC:77	fractional inhibitory concentration
FID	FID:44	flame ionization detection
FID	FID:49	free induction decay
FIGO	FIGO:277	international federation of gynecology and obstetrics
FIGO	FIGO:13	international federation of obstetrics and gynecology
FIM	FIM:13	factor increasing monocytopoiesis
FIM	FIM:409	functional independence measure
FIM	FIM:13	functional independence measurement
FIO2	FIO2:10	fractional inspired o concentration
FIO2	FIO2:30|FiO2:4|FIo2:1|Fio2:1	inspired o
FIO2	FIO2:27|FiO2:17|Fio2:1	inspired oxygen fraction
FIR	FIR:10	farinfrared
FIR	FIR:40	finite impulse response
FIS	FIS:3	factor of inversion stimulation
FIS	FIS:18	fatigue impact scale
FI	FI:10	fasting insulin
FI	FI:19	fatigue index
FI	FI:24	fecal incontinence
FI	FI:34	feed intake
FI	FI:43	fixed interval
FI	FI:58	fluorescence intensity
FI	FI:11	fluorescent intensity
FI	FI:91	food intake
f-I	f-I:11|F-I:7	frequencycurrent
FI	FI:17	fundamental imaging
FI	FI:10	furcation involvement
f-I	f-I:4|F-I:1	injected current
FI	FI:6	purified fraction
FI	FI:24	under a fixedinterval
FI	FI:1	under multiple fixedinterval
FJHN	FJHN:10	familial juvenile hyperuricaemic nephropathy
FJHN	FJHN:13	familial juvenile hyperuricemic nephropathy
FLC	FLC:18	fibrolamellar carcinoma
FLC	FLC:33	flowering locus c
FLC	FLC:39	friend leukemia cells
FLC	FLC:10	friend leukemia complex
FLD	FLD:20	farmers lung disease
FLD	FLD:9	frontal lobe degeneration
FLD	FLD:9	frontal lobe degeneration of nonalzheimer type
FLD	FLD:27	frontal lobe dementia
FLE	FLE:9	family life education
FLE	FLE:48	frontal lobe epilepsy
FLF	FLF:9	fermented liquid feed
FLF	FLF:9	fulminant liver failure
FLIM	FLIM:26	fluorescence lifetime imaging
FLIM	FLIM:38	fluorescence lifetime imaging microscopy
FLM	FLM:20	fetal lung maturity
FLM	FLM:4	fraction of labeled mitoses
FLM	FLM:9	fraction of labelled mitoses
FLS	FLS:8	fibroblastlike synovial cells
FLS	FLS:11	forward light scatter
FLU	FLU:6|Flu:1	antiandrogen flutamide
FLU	FLU:13	flumequine
FLU	FLU:8|flu:1	flunisolide
FLU	FLU:22|flu:2	fluphenazine
FLV	FLV:14	fluvoxamine
FLV	FLV:60	friend leukemia virus
FL	FL:5	facial lobe
FL	FL:36	farmers lung
FL	FL:109	fetal liver
FL	FL:19	filtration leukapheresis
FL	FL:7|fl:3	firefly luciferase
FL	FL:11|Fl:5	fluorescent
FL	FL:7	fluorescent light
FL	FL:9	flutamide
FL	FL:9	foreign language
FL	FL:11	friend leukemia
FL	FL:8	frontal lobe
FL	FL:9	fructoselysine
FL	FL:25|fl:5|Fl:2|-FL:1	fulllength
FMA	FMA:15	fluorescein mercuric acetate
FMA	FMA:10	foundational model of anatomy
FMA	FMA:10	fuglmeyer assessment
FMD	FMD:150	fibromuscular dysplasia
FMD	FMD:8	flowmediated dilation of the brachial artery
FMD	FMD:22	flowmediated vasodilatation
FMD	FMD:11	foramen magnum decompression
FMF	FMF:476|fMf:1	familial mediterranean fever
FMF	FMF:32	flow microfluorometry
FMH	FMH:8	fetomaternal haemorrhage
FMH	FMH:27	fetomaternal hemorrhage
FMH	FMH:8	fibromuscular hyperplasia
FMLP	FMLP:12|fMLP:6	chemotactic peptide
FMLP	FMLP:5|fMLP:5	chemotactic peptide nformylmetleuphe
fMLP	fMLP:4|FMLP:4|fmlp:1	fmethionylleucylphenylalanine
fMLP	fMLP:9|FMLP:8|f-MLP:1	formylmethionineleucinephenylalanine
fMLP	fMLP:6|FMLP:3|f-MLP:1	formyl peptide
FMLP	FMLP:5|fMLP:4	nformylmethionineleucinephenylalanine
FMLP	FMLP:5|fMLP:3	nformyl methionylleucylphenylalanine
FMN	FMN:10	facial motor nucleus
FMN	FMN:217	flavin mononucleotide
FMN	FMN:11	riboflavin phosphate
FMR1	FMR1:9|FMR-1:6|Fmr1:1	fragile x gene
FMR1	FMR1:17	fragile x mental retardation
FMRP	FMRP:26	fmr protein
FMRP	FMRP:75	fragile x mental retardation protein
FNR	FNR:10	ferredoxinnadp oxidoreductase
FNR	FNR:32	ferredoxinnadp reductase
FNR	FNR:23|FnR:11|FNr:1|FN-R:1	fibronectin receptor
FNS	FNS:9	fineneedle sampling
FNS	FNS:97	functional neuromuscular stimulation
FN	FN:22	facial nerve
FN	FN:14	facial nucleus
FN	FN:41	febrile neutropenia
FN	FN:9|Fn:1	femoral nerve
Fn	Fn:7|FN:2	fibrin
Fn	Fn:12|FN:4	fusobacterium nucleatum
FOBT	FOBT:31	faecal occult blood test
FOBT	FOBT:79	fecal occult blood test
FOBT	FOBT:74	fecal occult blood testing
FOBT	FOBT:17	occult blood tests
FOB	FOB:24	faecal occult blood
FOB	FOB:22	fecal occult blood
FOB	FOB:9	fiberoptic bronchoscope
FOB	FOB:68	functional observational battery
FOH	FOH:12|F-OH:6	farnesol
FOH	FOH:13	functional ovarian hyperandrogenism
FOM	FOM:12|FoM:1	figure of merit
FOM	FOM:13	final oocyte maturation
FOM	FOM:113	fosfomycin
FOR	FOR:13	fastigial oculomotor region
FOR	FOR:8	fractional outflow rate
FOR	FOR:12	free oxygen radicals
FOS	FOS:12	framingham offspring study
FOS	FOS:28	fructooligosaccharides
FO	FO:8	fasttwitch oxidative
FO	FO:5	fecal output
FO	FO:222	fish oil
FO	FO:26|Fo:1	foramen ovale
FO	FO:8	forced oscillation
FPA	FPA:35|fpa:1	family planning association
FPA	FPA:6|FpA:3|Fp-A:1	fibrinopeptidea
FPA	FPA:7	flavor profile analysis
FPA	FPA:17	fluorescence polarization anisotropy
FPA	FPA:15	fluorescence polarization assay
FPA	FPA:16	fundus pulsation amplitude
FPC	FPC:70	familial polyposis coli
FPC	FPC:17	family planning clinic
FPC	FPC:10	fish protein concentrate
FPD	FPD:5	filtered p wave duration
FPD	FPD:6	fine particle dose
FPD	FPD:12	flame photometric detector
FPD	FPD:10	flatpanel detector
FPD	FPD:4|fPD:2	parkinsons disease
FPF	FPF:4	fibroblast pneumonocyte factor
FPF	FPF:35	fine particle fraction
FPG	FPG:6	endonuclease formamidopyrimidinedna nglycosylase
FPG	FPG:464|fpg:2|F-PG:1	fasting plasma glucose
FPG	FPG:18	fluorescence plus giemsa
FPG	Fpg:3|FPG:3	formamidopyrimidine dna nglycosylase
FPI	FPI:23	fasting plasma insulin
FPI	FPI:39	fluid percussion brain injury
FPI	FPI:53	fluid percussion injury
FPI	FPI:9	fluorescence polarization immunoassay
FPI	FPI:15	personality inventory
FPIR	FPIR:7	first phase insulin release
FPIR	FPIR:26	firstphase insulin response
FPLC	FPLC:7	fast protein liquid chromatographic
FPLC	FPLC:307	fast protein liquid chromatography
FPL	FPL:35	flexor pollicis longus
FPL	FPL:16	forcedchoice preferential looking
FPP	FPP:92	farnesyl diphosphate
FPP	FPP:63|F-P-P:3|Fpp:2|F-PP:2	farnesyl pyrophosphate
FPP	FPP:15|Fpp:1	farnesylpyrophosphate
FPP	FPP:11	fetal pig pancreas
FPP	FPP:12	free portal pressure
FPR	FPR:53	fluorescence photobleaching recovery
FPR	FPR:9	footpad reaction
FPR	FPR:48|fPR:1	formyl peptide receptor
FPR	FPR:33	nformyl peptide receptor
FPS	FPS:13	faces pain scale
FPs	FPs:62	family physicians
FPs	FPs:8	family practitioners
FPS	FPS:17	fearpotentiated startle
FPs	FPs:13	fluorescent proteins
FPT	FPT:15	failure of passive transfer
FPT	FPT:28	farnesyl protein transferase
FPU	FPU:11	fermipastaulam
FPU	FPU:6	fetoplacental unit
FPV	FPV:19	feline parvovirus
FPV	FPV:8	finger pulse volume
FPV	FPV:72	fowl plague virus
FPV	FPV:9	fowl poxvirus
FP	FP:8	facial paralysis
FP	FP:13	family physician
FP	FP:578	family planning
FP	FP:30	family practice
FP	FP:16	fast pathway
FP	FP:14	femoropopliteal
FP	FP:33	ferriprotoporphyrin ix
FP	FP:12	fibropapillomatosis
FP	FP:10|fp:1	firstpass
FP	FP:17|Fp:1	fixation point
FP	FP:14	flavopiridol
FP	FP:14	floor plate
FP	FP:111	fluorescence polarization
FP	FP:302	fluticasone propionate
FP	FP:18	follicular phase
FP	FP:8	following lateral fluidpercussion
FP	FP:8|fp:1	footpad
FP	FP:11	fungal peritonitis
FP	FP:13	fusion peptide
FP	FP:22|fp:1	fusion protein
FP	FP:8	hamster female protein
FP	F-P:6|FP:6	parasagittal fluidpercussion
FP	FP:8	pgf alpha
FP	FP:5	prostaglandin f
FQ	FQ:9	furoylquinolinecarboxaldehyde
FQ	FQ:14	fear questionnaire
FR3	Fr3:5|FR3:5	framework 
FR3	FR3:9	framework region 
FRAP	FRAP:21	ferric reducing ability of plasma
FRAP	FRAP:9	fkbprapamycinassociated protein
FRAP	FRAP:254	fluorescence recovery after photobleaching
FRAP	FRAP:30	fluorideresistant acid phosphatase
fRa	fRa:7|FRa:2	fractional resistance
fRa	fRa:8|FRa:2|fRA:1|FRA:1	fractional resistance of the apical membrane
FRC	FRC:900|frc:1	functional residual capacity
FRC	FRC:6	primary cultures of fetal rat calvaria
FRDA	FRDA:5	ataxia gene
FRDA	FRDA:11	ataxia locus
FRDA	FRDA:59	friedreichs ataxia
FRL	FRL:46	flinders resistant line
FRL	FRL:7	future remnant liver
FRP	FRP:11	follicle regulatory protein
FRP	FRP:49	functional refractory period
FRTL-5	FRTL-5:27|FRTL5:11|FRT-L5:2	rat thyroid cells
FRTL-5	FRTL-5:27|FRTL5:11	rat thyroid cell line
FRT	FRT:9	female reproductive tract
FRT	FRT:18	fischer rat thyroid
FRT	FRT:18	flp recognition target
FRT	FRT:7	flp recombination target
FRT	FRT:7	functional reach test
FRs	FRs:12	folate receptors
FRs	FRs:21	free radicals
FR	FR:11	family of repeats
FR	FR:19	farred light
FR	FR:21	fasciculus retroflexus
FR	FR:6	fast fatigueresistant
FR	FR:7	fast resistant
FR	FR:15	fatigue resistant
FR	FR:13	fertilization rate
FR	FR:12	firing rate
FR	FR:7	flexor reflex
FR	FR:58	food restriction
FR	FR:8	fractional reabsorption
FR	FR:11	framework
FR	FR:15	functional reach
FR	FR:35	under a fixedratio
FSBA	FSBA:12	pfluorosulfonylbenzoyl adenosine
FSBA	FSBA:35	pfluorosulfonylbenzoyladenosine
FSC	FSC:14	fetal spinal cord
FSC	FSC:25	forward scatter
FSC	FSC:26|fSC:2	free secretory component
FSH	FSH:8	folliclestimulating hormones
FSH	FSH:4	patients with facioscapulohumeral
FSM	FSM:11	federated states of micronesia
FSM	FSM:15	fluorescent speckle microscopy
FSP	FSP:16	fallopian tube sperm perfusion
FSP	FSP:16	familial spastic paraplegia
FSP	FSP:11	finger systolic pressure
FSP	FSP:16	split products
FSR	FSR:7	fractional rate of protein synthesis
FSR	FSR:35	fragmented sarcoplasmic reticulum
FSS	FSS:11	daily intake of fluid and salt supplementation
FSS	FSS:15	familial short stature
FSS	FSS:56	fatigue severity scale
FSS	FSS:15	fluid shear stress
FST	FST:21	finger skin temperature
FST	FST:69	forced swim test
FST	FST:97	forced swimming test
FSU	FSU:35	former soviet union
FSU	FSU:10	functional spinal unit
FSA	FSA:8	fractal signature analysis
FSA	FSA:5	free sialic acid
FS	FS:20|-FS:3	familial sinistrality
FS	FS:12|fs:1	fat saturation
FS	FS:11	fat suppression
FS	FS:8	fecal streptococci
FS	FS:7	femoral shaft
fs	fs:14	femtosecond
FS	FS:8	fermi surface
FS	FS:34	fibrin sealant
FS	FS:21	fibrous sheath
FS	FS:48	field stimulation
FS	FS:18	fisher syndrome
FS	FS:12	flaxseed
FS	FS:57	flexible sigmoidoscopy
FS	FS:16	flexural strength
FS	FS:20	fogo selvagem
FS	FS:69	follistatin
FS	FS:12	foot shock
FS	FS:18	footshock
FS	FS:5	former smokers
FS	FS:243|fs:1|Fs:1	fractional shortening
FS	FS:8	freeze substitution
FS	FS:11	functional status
FS	FS:6	functional systems
FS	FS:11	furosemidesensitive
FS	FS:16	patients with feltys syndrome
fs	fs:8	signal frequency
FT	FT:44	fast twitch
FT	FT:8	fat thickness
FT	FT:11	femurtibia
FT	FT:24	fetal thymus
FT	FT:8	filled teeth
FT	FT:20	fixedtime
FT	FT:23	flowering locus t
FT	FT:10	free t
FT	FT:9	freezethaw
FT	FT:8	frozenthawed
FT	FT:28	ftorafur
FT	FT:9	fullterm
FT	FT:11	futraful
FT	FT:84	tegafur
FTA-ABS	FTA-ABS:6|FTA-Abs:3	fluorescent treponemal antibodyabsorbed
FTA-ABS	FTA-ABS:10|FTA-abs:1	fluorescent treponemal antibody absorption test
FTCs	FTCs:10	follicular thyroid carcinomas
FTCs	FTCs:16	frequency tuning curves
FTC	FTC:14	emtricitabine
FTC	FTC:42	federal trade commission
FTC	FTC:6	follicular carcinomas
FTC	FTC:15	follicular thyroid cancer
FTC	FTC:9	fumitremorgin c
FTD	FTD:12	formal thought disorder
FTD	FTD:12	frontotemporal degeneration
FTE	FTE:66	fulltime equivalent
FTE	FTE:5	number of fulltimeequivalent
FTIR	FTIR:10|FT-IR:2	fourier transform infrared spectrometry
FTIR	FTIR:6	fourier transform infrared spectrophotometry
FTIR	FTIR:5|FT-IR:2	fourier transform infrared spectroscopic
FTIR	FTIR:14|FT-IR:1	fourier transform ir
FTIs	FTIs:28	farnesyl transferase inhibitors
FTIs	FTIs:69	farnesyltransferase inhibitors
FTI	FTI:14	farnesyl transferase inhibitor
FTI	FTI:14	forcetime integral
FTMS	FTMS:7	fourier transform mass spectrometer
FTMS	FTMS:26|FT-MS:2	fourier transform mass spectrometry
FTP	FTP:9	federal test procedure
FTP	FTP:11	formycin triphosphate
FTR	FTR:10	fasttwitch red
FTR	FTR:10	ferredoxinthioredoxin reductase
FTR	FTR:8	fractional turnover rate
FTS	FTS:26	facteur thymique serique
FTS	FTS:13	farnesylthiosalicylic acid
fu	fu:6|fU:1	fraction unbound
fu	fu:28|Fu:3|fU:1	unbound fraction
FVa	FVa:10	activated factor v
FVa	FVa:26|fVa:3	factor va
FVL	FVL:103|fVL:3|FvL:2	factor v leiden
FVL	FVL:12|FvL:1	factor v leiden mutation
FVR	FVR:10	feline viral rhinotracheitis
FVR	FVR:147	forearm vascular resistance
FX	FX:98|fX:13|F-X:1	factor x
FX	FX:10|F-X:6	fusarenonx
FZ	FZ:18	fetal zone
FZ	FZ:38|Fz:8	furazolidone
Fab	Fab:41|FAB:1	antibody fragments
Fab	Fab:12	antigenbinding
F-ara-A	F-ara-A:15|F-araA:1|Fara-A:1|F-Ara-A:1	betadarabinofuranosylfluoroadenine
F-ara-A	F-ara-A:9|F-Ara-A:1	arabinosylfluoroadenine
FasL	Fas-L:5|FasL:5	fas and fasligand
FasL	FasL:7|Fas-L:5	fasfasligand
FCR	FCR:52	feed conversion ratio
FCR	FCR:123	flexor carpi radialis
FCR	FCR:13|Fcr:1	flexor carpi radialis muscle
FCR	FCR:25	fuji computed radiography
Fe2+	Fe2+:10	ferrous ion
Fe2+	Fe2+:22	ferrous iron
Fe3+	Fe3+:5	ferric ion
Fe3+	Fe3+:14	ferric iron
FeLV	FeLV:78|FeLv:1	feline leukaemia virus
FeLV	FeLV:325|FELV:1|FeLv:1	feline leukemia virus
FEL	FEL:22	familial erythrophagocytic lymphohistiocytosis
FEL	FEL:6|Fel:3	felodipine
FE	FE:5|Fe:4	fentanyl
FE	FE:22	fertilization envelope
FE	FE:64	fractional excretion
FM	FM:9	face mask
FM	FM:9	family medicine
FM	FM:9|F-M:2	farnsworthmunsell
FM	FM:10	feather meal
FM	FM:20	ferromagnetic
FM	FM:34	fish meal
FM	FM:20	flunixin meglumine
FM	FM:21	fluorescence microscopy
FM	FM:25	fragrance mix
FM	FM:76	frequency modulation
FM	FM:10|fM:3	full mutation
FM	FM:96	patients with fibromyalgia
Fur	Fur:46|fur:8	ferric uptake regulator
Fur	Fur:9	ferric uptake repressor
FUS	FUS:22	focused ultrasound
FUS	FUS:11	focused ultrasound surgery
FV	FV:173|F-V:1|fV:1	factor v
FV	FV:7	fasting volume
FV	FV:18|fv:2	femoral vein
FV	FV:34|Fv:5	friend virus
FV	FV:13	friend virus complex
FW	FW:13	feed withdrawal
FW	FW:51	fresh water
FW	FW:33|fw:14	fresh weight
FW	FW:85	freshwater
G/F	G/F:13	gainfeed
G/F	G/F:11	gainfeed ratio
G0	G0:18	quiescence
G0	G0:17	quiescent state
G0	G0:9	resting state
G1	G1:9	activated
G1	G1:7	first gap phase
G1	G1:7|G-1:1	first group
G3P	G3P:9|G-3-P:2	glyceraldehydephosphate
G3P	G3P:7|G-3-P:3	snglycerolphosphate
GAA	GAA:21	gossypol acetic acid
GAA	GAA:11	guanidinoacetate
GAA	GAA:36	guanidinoacetic acid
GABA-T	GABA-T:9	gabaaminotransferase
GABA-T	GABA-T:23|GABAT:2	gammaaminobutyric acid transaminase
GABA-IR	GABA-IR:20|GABAir:6|GABA-ir:6|GABA-Ir:1	gabaimmunoreactive
GABA-IR	GABA-IR:8|GABA-ir:2	gaba immunoreactivity
GABA	GABA:12	aminobutyrate
GABA	GABA:16	gammaaminobutyric
GABA	GABA:14	inhibitory
GABHS	GABHS:17	group a betahaemolytic streptococci
GABHS	GABHS:54	group a betahemolytic streptococcal
GABHS	GABHS:55	group a betahemolytic streptococci
GABHS	GABHS:37	group a betahemolytic streptococcus
GAD	GAD:9	decarboxylase activity
GAD	GAD:5	general acylcoa dehydrogenase
GAD	GAD:412	generalized anxiety disorder
GAD	GAD:21|gad:20	gracile axonal dystrophy
GAD	GAD:12	graft arterial disease
GAF	GAF:13	activation factor
GAF	GAF:15	global assessment of function
GAF	GAF:141	global assessment of functioning
GAF	GAF:33	global assessment of functioning scale
GA-I	GA-I:5|GAI:2	glutaric acidemia type i
GA-I	GA-I:11|GAI:2	glutaric aciduria type i
GALT	GALT:45|galT:2|Galt:1	galactosephosphate uridyl transferase
GALT	GALT:70|galT:2	galactosephosphate uridyltransferase
GALT	GALT:16|GalT:2	galactosephosphate uridylyltransferase
GAN	GAN:13	gastrointestinal autonomic nerve
GAN	GAN:41	giant axonal neuropathy
GAO	GAO:29	general accounting office
GAO	GAO:7	glycolic acid oxidase
GAP	GAP:7	glyceraldehyde phosphate
GAP	GAP:32	gnrhassociated peptide
GAP	GAP:6	gonadotropinreleasing hormone associated peptide
GAP	GAP:6	good agricultural practice
GAP	GAP:5	guidelines applied in practice
GAS	GAS:9	activation sequence
GAS	GAS:9	gammaactivated sequence
GAS	GAS:22	gastric acid secretion
GAS	GAS:4|G-A-S:1	general adaptation syndrome
GAs	GAs:49	genetic algorithms
GAs	GAs:11	gestational ages
GAs	GAs:75|gas:3	gibberellins
GAS	GAS:73	global assessment scale
GAS	GAS:31	goal attainment scaling
GAS	GAS:143	group a streptococcal
GAS	GAS:168	group a streptococci
GAS	GAS:197	group a streptococcus
GAS	GAS:15	ifngamma activation site
GAT	GAT:8	galactosyltransferase associated with tumor
GAT	GAT:15	gelatin agglutination test
GAT	GAT:26	goldmann applanation tonometer
GAT	GAT:20	goldmann applanation tonometry
GAT	GAT:52	lglutamic acidlalanineltyrosine
GA	GA:41	gallic acid
GA	GA:10	gardnerarnstein
GA	GA:14	general
GA	GA:83	general anaesthesia
GA	GA:10	general anaesthetic
GA	GA:156	general anesthesia
GA	GA:26	geographic atrophy
GA	GA:9|Ga:1	georgia
GA	GA:191	gibberellin
GA	GA:55	glatiramer acetate
GA	GA:24	glutaminase
GA	GA:20	glycated albumin
GA	GA:31	glycolic acid
GA	GA:33	glycyrrhetic acid
GA	GA:88	golgi apparatus
GA	GA:11	gouty arthritis
GA	GA:5	granulocyte agglutination
GA	GA:60	granuloma annulare
GA	GA:7	graphical analysis
GA	GA:16	gum arabic
GA	GA:21	gyrate atrophy
GA	GA:10	hsp inhibitor geldanamycin
GA	GA:7	metabolite glycidamide
GBA	GBA:7	gammaband activity
GBA	GBA:18|Gba:1	glucocerebrosidase
GBA	GBA:10	glucocerebrosidase gene
GBC	GBC:25	gallbladder cancer
GBC	GBC:27	gallbladder carcinoma
GBF	GBF:6	gbox binding factor
GBF	GBF:25	germinated barley foodstuff
GBI	GBI:13	general behavior inventory
GBI	GBI:13	glasgow benefit inventory
GBMs	GBMs:20	glioblastomas
GBMs	GBMs:22	glioblastomas multiforme
GBMs	GBMs:12	glomerular basement membranes
GBP	GBP:15	blood pool
GBP	GBP:155	gabapentin
GBP	GBP:18	growthblocking peptide
GBRs	GBRs:7	induced gamma band responses
GBRs	GBRs:11	receptor complexes
GBR	GBR:8	gamma band response
GBR	GBR:15	great barrier reef
GBR	GBR:10	group b rotavirus
GBR	GBR:96|gbr:1	guided bone regeneration
GBS	GBS:232	group b streptococcal
GBS	GBS:403	group b streptococci
GBS	GBS:417	group b streptococcus
GBS	GBS:946	guillainbarre syndrome
GBS	GBS:15	streptococcus agalactiae
GB	GB:3	cell surface protease guanidinobenzoatase
GB	GB:141	gallbladder
GB	GB:10	gastric banding
GB	GB:24	generalized born
GB	GB:22	glycine betaine
GB	GB:24	great britain
GB	GB:21	sarin
GB	GB:6	surface protease referred to as guanidinobenzoatase
GC-ECD	GC-ECD:13	gas chromatographyelectron capture detection
GC-ECD	GC-ECD:14	gas chromatography with electroncapture detection
GCAP	GCAP:6	cyclaseactivating protein
GCAP	GCAP:15	germ cell alkaline phosphatase
GCA	GCA:10	gastric cardia adenocarcinoma
GCA	GCA:7|gca:2	general combining ability
GCA	GCA:383	giant cell arteritis
GC-A	GC-A:7	guanylate cyclasea
GC-A	GC-A:16	guanylyl cyclasea
GCC	GCC:6	gastric cardia cancer
GCC	GCC:5	germ cell cancer
GCC	GCC:9	glassy cell carcinoma
GCD	GCD:13	granular corneal dystrophy
GCD	GCD:8	gross cystic disease
GCF	GCF:6	gc factor
GCF	GCF:20	giant cell fibroblastoma
GCF	GCF:545	gingival crevicular fluid
GCI	GCI:13	general cognitive index
GCI	GCI:12	global cerebral ischemia
GC-MS	GC-MS:12|GCMS:1	gas chromatographmass spectrometer
GC-MS	GC-MS:12	gas chromatography coupled with mass spectrometry
GCs	GCs:20|GCS:1	ganglion cells
GCs	GCs:11	gastric carcinomas
GCs	GCs:100	germinal centers
GCs	GCs:13	germinal centres
GCS	GCS:13	gianotticrosti syndrome
GCS	GCS:681	glasgow coma scale
GCS	GCS:25	glasgow coma scale score
GCs	GCs:296|GCS:13|gcs:1|Gcs:1	glucocorticoids
GCS	GCS:23|GcS:1	glucosylceramide synthase
GCS	GCS:10	glycine cleavage system
GCs	GCs:9|Gcs:1	glycoconjugates
GCS	GCS:9	graduated compression stockings
GCs	GCs:80|Gcs:1	granulosa cells
GCs	GCs:6	guanylate cyclases
GCs	GCs:14	guanylyl cyclases
GCVF	GCVF:13	great cardiac vein flow
GCVF	GCVF:8	great cardiac venous flow
GCV	GCV:9	gancyclovir
GCV	GCV:39	great cardiac vein
GCV	GCV:7	herpes simplex virus thymidine kinase hsvtkganciclovir
GCL	GCL:33	cells in the ganglion cell layer
GCl	GCl:15|gCl:11|Gcl:3|gcl:1	chloride conductance
GCl	GCl:26|gCl:9|Gcl:2	cl conductance
GCL	GCL:8	ganglion cell
GC	GC:55	gas chromatograph
GC	GC:262|gc:1	gas chromatographic
GC	GC:174|Gc:1	gastric cancer
GC	GC:6|G-C:1	gemcitabine and cisplatin
GC	GC:9	genomic control
GC	GC:54	glassy carbon
GC	GC:28	gliomatosis cerebri
GC	GC:16	glucocorticosteroids
GC	GC:22|Gc:1	glycocalicin
GC	GC:34	golgi complex
GC	GC:10|Gc:1	gonococcal
GC	GC:9|Gc:5	gonococci
GC	GC:10	gonorrhea
GC	GC:14	granule cell
GC	GC:9	growth cartilage
GC	GC:20|G-C:10	guaninecytosine
GC	GC:6	guanine plus cytosine
GC	GC:10	gustatory cortex
GC	GC:17	human glucocerebrosidase
GDC	GDC:7	glycine decarboxylase
GDC	GDC:13	glycine decarboxylase complex
GDC	GDC:6	sodium glycodeoxycholate
GDEE	GDEE:22	glutamic acid diethyl ester
GDEE	GDEE:22	glutamic acid diethylester
GDI	GDI:52	gdp dissociation inhibitor
GDI	GDI:27	guanine nucleotide dissociation inhibitor
GDL	GDL:11	gluconodeltalactone
GDL	GDL:24	graduated driver licensing
GDN	GDN:13|GdN:1	gliaderived nexin
GDN	GDN:5	glyceryl dinitrate
GDP	GDP:10	general dental practitioner
GDP	GDP:150	gross domestic product
GDP	GDP:74	guanosine diphosphate
GDP	GDP:7	purine nucleotide
GDPs	GDPs:108|gdps:2	general dental practitioners
GDPs	GDPs:23	giant depolarizing potentials
GDS	GDS:14	gdp dissociation stimulator
GDS	GDS:19	general dental service
GDS	GDS:58	global deterioration scale
GDS	GDS:6	gordon diagnostic system
Gd	Gd:14|GD:1	gadoliniumdtpa
GD	GD:13	gastroduodenal
GD	GD:8	germinal disc
GD	GD:11	glucose deprivation
GD	GD:11	gonadal dysgenesis
GD	GD:468|Gd:1	graves disease
GD	GD:7	growth delay
Gd	Gd:5|GD:1	patients with graves disease without ophthalmopathy
GEA	GEA:21	gastric electrical activity
GEA	GEA:88	gastroepiploic artery
GEC	GEC:42	galactose elimination capacity
GEC	GEC:9	gastric emptying coefficient
GED	GED:9	gastric epithelial dysplasia
GED	GED:8	gtpase effector domain
GEMs	GEMs:15|GEMS:1	genetically engineered microorganisms
GEMs	GEMs:6	glycolipidenriched microdomains
GEMs	GEMs:7	membrane microdomains
GEM	GEM:9|gem:3	gemfibrozil
GEM	GEM:9	genetically engineered mice
GEM	GEM:29	geriatric evaluation and management
GEM	GEM:17	glycolipidenriched membrane
GEM	GEM:8	guideline elements model
GEPs	GEPs:7	gdpgtp exchange proteins
GEPs	GEPs:7	guanine nucleotideexchange proteins
GEP	GEP:5	gdpgtp exchange protein
GEP	GEP:6	guanine nucleotideexchange protein
GER	GER:13	gastric emptying rate
GER	GER:27|gER:3|ger:1	granular endoplasmic reticulum
GES	GES:24	gastric electrical stimulation
GES	GES:12	guanidinoethane sulfonate
GES	GES:7	guanidinoethanesulfonic acid
GES	GES:11	guanidinoethyl sulfonate
GET	GET:17	gas exchange threshold
GET	GET:30	gastric emptying time
GE	GE:17	ganglionic eminence
GE	GE:141	gastric emptying
GE	GE:50	gastroesophageal
GE	GE:5|ge:1	genome equivalents
Ge	Ge:16	gerbich
Ge	Ge:20	germanium
GE	GE:15	glandular epithelial
GE	GE:28	glandular epithelium
GE	GE:11	glycyrrhetinic acid
GE	GE:62	gradient echo
GE	GE:9	gross efficiency
GE	GE:22	gross energy
GFA	GFA:15	genetic function approximation
GFA	GFA:97	glial fibrillary acidic
GFC	GFC:19	gel filtration chromatography
GFC	GFC:13	global fibrinolytic capacity
GFD	GFD:100	glutenfree diet
GFD	GFD:7	growth factor domain
GFP	GFP:33	gelfiltered platelets
GFP	GFP:31	global field power
GFS	GFS:11	geer fear scale
GFS	GFS:5	glaucoma filtration surgery
GF	GF:15	gastric fistula
GF	GF:11	gel filtration
GF	GF:3|gf:2	gene frequency
GF	GF:77|Gf:6	germfree
GF	GF:11	giant fiber
GF	GF:54	gingival fibroblasts
GF	GF:5	gingival fluid
GF	GF:17	glomerular filtrate
GF	GF:10	graft failure
GF	GF:14	granulocyte factor
GF	GF:8	granuloma faciale
GF	GF:55|Gf:2	griseofulvin
GGR	GGR:25	global genome repair
GGR	GGR:19	global genomic repair
GGT	GGT:51	gamma glutamyltransferase
GGT	GGT:64	serum gammaglutamyltransferase
GG	GG:7	geniculate ganglion
GG	GG:12|gg:1	genioglossal
GG	GG:68|Gg:5	genioglossus
GG	GG:9	glucosylglycerol
GG	GG:33	guar gum
GH3	GH3:16	pituitary tumor cells
GH3	GH3:7	rat pituitary cells
GH3	GH3:12	rat pituitary tumor
GHBP	GHBP:4|GH-BP:3	ghbinding proteins
GHBP	GHBP:38|GH-BP:15	growth hormonebinding protein
GHC	GHC:25	group health cooperative
GHC	GHC:26	group health cooperative of puget sound
GHD	GHD:9	genetic hypertension development
GHD	GHD:371|GH-D:1	gh deficiency
GHD	GHD:287|GHd:1	growth hormone deficiency
GHIS	GHIS:8	gh insensitivity syndrome
GHIS	GHIS:14	growth hormone insensitivity syndrome
GHRH-R	GHRH-R:7|GHRHR:4|GHRHr:1	ghreleasing hormone receptor
GHRH-R	GHRH-R:10|GHRHR:4	growth hormonereleasing hormone receptor
GHRP-6	GHRP-6:12	ghreleasing hexapeptide
GHRP-6	GHRP-6:5|GHRP6:1	growth hormone releasing peptide
GHRP-6	GHRP-6:9|GH-RP-6:1	hisdtrpalatrpdphelysnh
GHRPs	GHRPs:21	ghreleasing peptides
GHRPs	GHRPs:15	growth hormonereleasing peptides
GHR	GHR:7	growth hormone receptor gene
GHR	GHR:5	growth hormone replacement
GHSs	GHSs:17	gh secretagogues
GHSs	GHSs:26	growth hormone secretagogues
GHS	GHS:22	general household survey
GHS	GHS:11	genetic hypercalciuric stoneforming
GH	GH:17	genetic haemochromatosis
GH	GH:31	genetic hemochromatosis
GH	GH:11|Gh:1	geniohyoid
GH	GH:14	genital herpes
GH	GH:31	gestational hypertension
GH	GH:13	gingival hyperplasia
GH	GH:7	gland of harder
GH	GH:12	glenohumeral
GH	GH:11	glycoside hydrolase
GH	GH:26	new zealand genetically hypertensive
GIA	GIA:9	gravitoinertial acceleration
GIA	GIA:8	growth inhibition assay
GIF	GIF:22	glycosylationinhibiting factor
GIF	GIF:6	gravitoinertial force
GIF	GIF:48	growth inhibitory factor
GIH	GIH:10	gastrointestinal hemorrhage
GIH	GIH:8	gonadinhibiting hormone
GIP	GIP:85	gastric inhibitory peptide
GIP	GIP:538	gastric inhibitory polypeptide
GIP	GIP:10	general import pore
GIP	GIP:56	glucosedependent insulinotropic peptide
GIP	GIP:176	glucosedependent insulinotropic polypeptide
GISH	GISH:11	genomic in situ hybridisation
GISH	GISH:76	genomic in situ hybridization
GIT	GIT:17	gastrointestinal transit
GIT	GIT:20	glucoseinduced thermogenesis
GIT	GIT:11	glucose infusion test
GIT	GIT:11	glutathioneinsulin transhydrogenase
GITR	GITR:8	glucocorticoidinduced tumor necrosis factor receptor
GITR	GITR:5	receptor familyrelated gene
GI	GI:12	gastroenterology
GI	GI:12	gigantea
GI	GI:5	gingival indices
GI	GI:7	gingival inflammation
GI	GI:14	glass ionomer
GI	GI:7	glass ionomer cement
GI	GI:7|gI:2	global ischemia
GI	GI:11	glucagon immunoreactivity
GI	GI:5	glycaemic indices
GI	GI:96	glycemic index
GI	GI:34|G-I:7	group i
Gi	Gi:27	inhibitory gtpbinding protein
Gi	Gi:12	inhibitory guanine nucleotide regulatory protein
GK	GK:46|G-K:2	diabetic gotokakizaki
GK	GK:38	gamma knife
GK	GK:13	glandular kallikrein
gK	gK:25	glycoprotein k
GK	GK:19	guanylate kinase
gK	gK:17|GK:7|gk:4	k conductance
gK	gK:21|GK:20|gk:4	potassium conductance
GLC	GLC:110	gasliquid chromatographic
GLC	GLC:287|glc:2	gasliquid chromatography
gld	gld:9	fas ligand
gld	gld:12	generalized lymphoproliferative disease
GLI	GLI:7	glucagonlike immunoreactive
GLI	GLI:79	glucagonlike immunoreactivity
GLI	GLI:5	grey level index
GLM	GLM:16	general linear models
GLM	GLM:22|glm:1	generalized linear model
GLO	GLO:15|Glo:1	glyoxalase
GLO	GLO:7	lgulonogammalactone oxidase
GLPs	GLPs:13	germinlike proteins
GLPs	GLPs:9	glucagonlike peptides
GM-CSA	GM-CSA:13|gm-CSA:1	colony stimulating activity
GM-CSA	GM-CSA:28|gm-CSA:1	granulocytemacrophage colonystimulating activity
GM1	GM1:11	ganglioside gm
GM1	GM1:11	gm ganglioside
GM1	GM1:57|Gm1:1|GM-1:1	monosialoganglioside
GMA	GMA:8	gastric myoelectrical activity
GMA	GMA:10	geomagnetic activity
GMA	GMA:38	glycidyl methacrylate
GMA	GMA:51	glycol methacrylate
GM-CSF	GM-CSF:9|GMCSF:1	colony stimulating factors
GM-CSF	GM-CSF:9	granulocytemacrophage
GMCs	GMCs:18	geometric mean concentrations
GMCs	GMCs:17	giant migrating contractions
GMC	GMC:7	ganglion mother cell
GMC	GMC:32	general medical council
GMC	GMC:6	general medicine clinic
GME	GME:9	glucocorticoid modulatory element
GME	GME:117	graduate medical education
GMF	GMF:20	geomagnetic field
GMF	GMF:45	glia maturation factor
GMO	GMO:9	glycerol monooleate
GMO	GMO:11	glyceryl monooleate
GMP	GMP:8	generalized motor program
GMP	GMP:14	glycomacropeptide
GMP	GMP:34	good manufacturing practices
GMS	GMS:29	general medical services
GMs	GMs:28	general movements
GMs	GMs:9	geometric means
GMS	GMS:15	geriatric mental state
GMS	GMS:13	geriatric mental state schedule
GMS	GMS:14	glyceryl monostearate
GMS	GMS:10	gomori methenamine silver
GMTs	GMTs:72	geometric mean titers
GMTs	GMTs:46	geometric mean titres
GNB	GNB:54	gramnegative bacilli
GNB	GNB:9	gramnegative bacteremia
GNB	GNB:31|GnB:1	gramnegative bacteria
GN	GN:15	gallium nitrate
GN	GN:10	ganglioneuroma
GN	GN:7|gn:4|Gn:1	gnotobiotic
GN	GN:21	gramnegative
GN	GN:10	guanine nucleotides
GN	GN:16	gustatory neocortex
GON	GON:13	glaucomatous optic neuropathy
GON	GON:14	greater occipital nerve
GOS	GOS:13	galactooligosaccharides
GOS	GOS:10|GO-S:1	galactose oxidaseschiff
GOS	GOS:265	glasgow outcome scale
GOS	GOS:54	glasgow outcome score
GOT	GOT:11	transferase
GOT	GOT:9	transminase
GO	GO:10	garlic oil
GO	GO:18	gemtuzumab ozogamicin
GO	GO:118	gene ontology
GO	GO:41	gingival overgrowth
GO	GO:14	glycolate oxidase
GO	GO:15	glyoxal
GO	GO:157|Go:1	graves ophthalmopathy
GO	GO:11	graves orbitopathy
GPC	GPC:209	gel permeation chromatography
GPC	GPC:52	giant papillary conjunctivitis
GPC	GPC:67	glycerophosphocholine
GPC	GPC:72	glycerophosphorylcholine
GPC	GPC:27	glycerylphosphorylcholine
GPC	GPC:22	glycophorin c
GPC	GPC:16|GP-C:3	glycoprotein precursor
GPC	GPC:20	grampositive cocci
GPC	GPC:19	guinea pig complement
GPe	GPe:12|Gpe:1	external globus pallidus
GPe	GPe:11	external segment
GPE	GPE:16	glycerophosphorylethanolamine
GPE	GPE:12	guinea pig embryo
GPi	GPi:15	globus pallidus interna
GPi	GPi:76|GPI:8|Gpi:3	globus pallidus internus
GPi	GPi:6|GPI:1	globus pallidus pars interna
GPI	GPI:11	glycoinositol phospholipid
GPI	GPI:21	glycophosphatidylinositol
GPI	GPI:15	glycosyl phosphatidyl inositol
GPI	GPI:71	glycosyl phosphatidylinositol
GPI	GPI:537|G-PI:1	glycosylphosphatidylinositol
GPi	GPi:7	internal pallidal segment
GPi	GPi:15	internal pallidum
GPi	GPi:8	internal segment
GPI	GPI:4	plasma membrane by a glycosylphosphatidylinositol
GPN	GPN:10	glossopharyngeal neuralgia
GPN	GPN:6|gpn:1	greater petrosal nerve
GPP	GPP:18	generalized pustular psoriasis
GPP	GPP:16	geranyl diphosphate
GPP	GPP:9	geranyl pyrophosphate
GPR	GPR:10	gastropyloric receptor
GPR	GPR:9	general practice residency
GPR	GPR:7	germination protease
GPR	GPR:8	glucose production rate
GPR	GPR:6	ground penetrating radar
GPS	GPS:9|G-P-S:1	gastrocnemiusplantarissoleus
GPS	GPS:51	global positioning system
GPS	GPS:16	gray platelet syndrome
GPS	GPS:20|GpS:2|gps:1	guinea pig serum
GPT	GPT:6	glucose pump test
GPT	GPT:9	goniopora toxin
gpt	gpt:7|GPT:1	guanine phosphoribosyl transferase
gpt	gpt:11	guanine phosphoribosyltransferase
gpt	gpt:6|GPT:3	xanthineguanine phosphoribosyl transferase
gpt	gpt:9|GPT:3	xanthineguanine phosphoribosyltransferase
gpt	gpt:5	xanthineguanine phosphoribosyltransferase gene
GPV	GPV:17|gpV:2	glycoprotein v
GPV	GPV:11	goose parvovirus
GP	GP:7|Gp:1	against platelet glycoproteins
GP	GP:25|gp:1|Gp:1	antiglycoprotein
GP	GP:16	general population
GP	GP:78	general practice
GP	GP:24	generalized polarization
GP	GP:19	genetic programming
GP	GP:312	globus pallidus
GP	GP:11	glucose polymer
GP	GP:8	glycolytic potential
GP	GP:11	glycophorin
GP	GP:13	goodpasture
GP	GP:10	gossypol
GP	GP:8|Gp:1	grampositive
GP	GP:13	growth plate
GP	GP:17	guttapercha
GP	GP:391|Gp:9	platelet glycoprotein
GRE	GRE:122	glucocorticoid response element
GRE	GRE:26	glycopeptideresistant enterococci
GRF	GRF:12	growth hormonereleasing hormone
GRF	GRF:9	somatocrinin
GRU	GRU:10	geriatric rehabilitation unit
GRU	GRU:19	glucocorticoid response unit
GR	GR:7	effect of glycyrrhizin
GR	GR:7	glycyrrhizae radix
GR	GR:8	good recovery
GR	GR:9	good response
GSD	GSD:62	geometric standard deviation
GSD	GSD:11	sex determination
GSE	GSE:10	general solubility equation
GSE	GSE:6	genetic suppressor element
GSE	GSE:41	glutensensitive enteropathy
GSE	GSE:7	gonadotropespecific element
GSE	GSE:27	grape seed extract
GSH-Px	GSH-Px:26|GSH-px:3|GSH-PX:3|GSHPx:1|GSHpx:1	glutathioneperoxidase
GSH-Px	GSH-Px:7|GSH-px:2|GSHpx:1|GSH-PX:1	gshperoxidase
GSH	GSH:11	glucocorticoidsuppressible hyperaldosteronism
GSH	GSH:26	glutathione content
GSH	GSH:1	glutathione in reduced
GSH	GSH:16	glutathione levels
GSH	GSH:9	gluthathione
GSH	GSH:17	reduced form
GSH	GSH:7	reduced glutathion
GSH	GSH:9	reducedglutathione
GSI	GSI:10	gametophytic selfincompatibility
GSI	GSI:93|gsi:1	genuine stress incontinence
GSI	GSI:25	global severity index
GSI	GSI:10|gsI:1	glutamine synthetase i
GSI	GSI:81	gonadosomatic index
GSK	GSK:11	glaxosmithkline
GSK	GSK:17	glycogen synthase kinase
GSM	GSM:13	goat synovial membrane
GSM	GSM:9	gray scale median
GSM	GSM:9	grey scale median
GSP	GSP:19|Gsp:1|gsp:1	general secretory pathway
GSP	GSP:14	generalized social phobia
GSP	GSP:9	german shepherd dog pyoderma
GSP	GSP:13	greater superficial petrosal
GSR	GSR:12	galvanic skin resistance
GSR	GSR:40	galvanic skin response
GSR	GSR:15	generalized shwartzman reaction
GSSG	GSSG:33	glutathione disulphide
GSSG	GSSG:24	oxidized form
GSSG	GSSG:25	oxidized gsh
GSS	GSS:16	general social survey
GSS	GSS:29	gerstmannstrausslerscheinker
GSS	GSS:33	gerstmannstraussler syndrome
GSS	GSS:11	global seasonality score
GSS	GSS:9	granulomatous slack skin
GSTM1	GSTM1:115	glutathione stransferase m
GSTM1	GSTM1:4	glutathione stransferase m gene
GSTM1	GSTM1:9	glutathione stransferase mu
GSTM1	GSTM1:7	glutathione stransferase mu 
GST-P	GST-P:9	glutathione stransferase pform
GST-P	GST-P:88|GSTP:3	glutathione stransferase placental form
GST-P	GST-P:14	glutathione transferase p
GST-P	GST-P:10	placental type
GST-P	GST-P:4	placental type of glutathionestransferase
GSTs	GSTs:467|GSTS:1	glutathione stransferases
GSTs	GSTs:72	glutathione transferases
GST	GST:5	general systems theory
GST	GST:6	generalized seizure triggering threshold
GST	GST:9	glucagon stimulation test
GST	GST:8	glutathione stransferase activity
GST	GST:14	gshstransferase
GS	GS:9	galactosialidosis
GS	GS:22|G-S:6	gastrocnemiussoleus
GS	GS:22|Gs:1	gastroschisis
GS	GS:12	general surgery
GS	GS:14	gentamicin sulfate
GS	GS:12	gestational sac
GS	GS:17	ginsenosides
GS	GS:19	gitelmans syndrome
GS	GS:8	glomerular sclerosis
GS	GS:50|gs:1	glomerulosclerosis
GS	GS:9	glucosamine sulfate
GS	GS:13	glucosesensitive
GS	GS:167	glycogen synthase
GS	GS:24|gs:1	graft survival
GS	GS:6	gram stain
GS	GS:39	gramicidin s
GS	GS:16	grip strength
GS	GS:12	patients with gilberts syndrome
Gs	Gs:5|GS:1	protein of adenylate cyclase
Gs	Gs:8	protein of adenylyl cyclase
Gs	Gs:20|GS:2	stimulatory gtpbinding protein
Gs	Gs:8	stimulatory guanine nucleotide regulatory protein
GTG	GTG:46	gold thioglucose
GTG	GTG:19	goldthioglucose
GTH	GTH:15|GtH:3	gonadotrophin
GTH	GTH:10	gonadotropic
GTH	GTH:17|GtH:9	gonadotropic hormone
GTN	GTN:39	gestational trophoblastic neoplasia
GTN	GTN:441	glyceryl trinitrate
GTN	GTN:23	glyceryltrinitrate
GTTs	GTTs:10	gestational trophoblastic tumors
GTTs	GTTs:19	glucose tolerance tests
GTC	GTC:20	generalized tonicclonic
GTC	GTC:16	gillthomascosman
GTC	GTC:19	green tea catechins
GTR	GTR:5	glutamyltrna reductase
GTR	GTR:21	gross total resection
GTR	GTR:335	guided tissue regeneration
GT	GT:11	gambling task
GT	GT:12|gt:1	gene therapy
GT	GT:9	genital tubercle
GT	GT:8	germ tube
GT	GT:5	gingival tissue
GT	GT:9	gliotoxin
GT	GT:6	glucose transport
GT	GT:10	glucuronosyltransferase
GT	GT:18	glutathione transferase
GT	GT:7	granulation tissue
GT	GT:13	green tea
GT	GT:23	lglutamic acidltyrosine
GT	GT:9	udpglcglycoprotein glucosyltransferase
GT	GT:10	udpglucuronosyltransferase
GU	GU:117	genitourinary
GU	GU:13	gonococcal urethritis
GVD	GVD:22	graft vascular disease
GVD	GVD:11	granulovacuolar degeneration
GVHD	GVHD:20|GvHD:1	acute graftversushostdisease
GVHD	GVHD:15|GvHD:1	chronic graftversushostdisease
GVHD	GVHD:28|GvHD:5	graft vs host disease
GVL	GVL:30|GvL:6	graftversusleukaemia
GVL	GVL:4|GvL:2	graftversusleukemia effect
GVL	GVL:12	graftversuslymphoma
GV	GV:18	gas ventilation
GV	GV:9	gastric varices
GV	GV:19|Gv:4	gentian violet
GV	GV:9	germinal vesicle stage
GV	GV:8	gilvocarcin v
GV	GV:42	growth velocity
GXT	GXT:10	exercise tests
GXT	GXT:31	graded exercise test
GXT	GXT:7	graded exercise testing
GalNAc	GalNAc:48|GalNAC:1	nacetyldgalactosamine
GalNAc	GalNAc:113|GalNac:9|galNac:1|GalNAC:1	nacetylgalactosamine
Gal	Gal:130|gal:18	galactose
Gal	Gal:13	galactosyl
Gb4	Gb4:12	globoside
Gb4	Gb4:9	globotetraosylceramide
Gla	Gla:26|GLA:1	gammacarboxyglutamate
Gla	Gla:181|gla:11|GLA:9	gammacarboxyglutamic acid
Gla	Gla:16	gammacarboxyglutamyl
GlcA	GlcA:10	dglucuronic acid
GlcA	GlcA:20	glucuronic acid
GMR	GMR:11	geometric mean ratio
GMR	GMR:10	gmcsf receptor
GM	GM:26	galactomannan
GM	GM:10	gastric metaplasia
GM	GM:19	gastric mucosa
GM	GM:7	gastrocnemius medialis muscle
GM	GM:8	gastrocnemius muscle
GM	GM:160	genetically modified
GM	GM:9	germinal matrix
GM	GM:11	gluteus maximus
GM	GM:15|Gm:1	gluteus medius
GM	GM:10	glyceryl methacrylate
GM	GM:141|gm:1|Gm:1	gray matter
GM	GM:21	grey matter
GM	GM:10	growth medium
GM	GM:9	growth monitoring
Gm	Gm:6	heavy chain allotypes
Gm	Gm:18|gm:6|GM:2|gM:1	membrane conductance
GM	GM:5	rat medial gastrocnemius
GnRHa	GnRHa:3	gnrh agonist daladesglygnrh nethylamide
GnRHa	GnRHa:1	gnrh and its analogues
GnRHa	GnRHa:11|GnRH-a:10|GnRHA:1|Gn-RHa:1|GNRHa:1|GN-RH-a:1	gonadotropinreleasing hormone analogue
GnRH	GnRH:2	frequency lh
GnRH	GnRH:19	gonadoliberin
GPA	GPA:11	betaguanidinopropionic acid
GPA	GPA:7	generalized procrustes analysis
GPA	GPA:11	global program on aids
GPA	GPA:12	glomerular polyanion
GPA	GPA:8|GpA:1	glycophorina
GQ	GQ:9	general quotient
GQ	GQ:8	medical school graduation questionnaire
GSV	GSV:22	great saphenous vein
GSV	GSV:61	greater saphenous vein
GTS	GTS:16	ginseng total saponin
GTs	GTs:5	glutamate transporters
GTs	GTs:11	glycosyltransferases
GTS	GTS:15	green tobacco sickness
GUS	GUS:9|Gus:2|gus:1	betaglucuronidase reporter gene
GUS	GUS:11	glucuronidase
GUS	GUS:28	promoterbetaglucuronidase
GVBD	GVBD:8	breakdown of the germinal vesicle
GVBD	GVBD:10	germinal vesicle break down
H&E	H&E:6	hematoxylin and eosin staining
H&E	H&E:21	stained with haematoxylin and eosin
H-12	H-12:9	heterokaryon 
H-12	H-12:8	twocomponent heterokaryon
H2	H2:64	breath hydrogen
H2	H2:22	histamine type 
H-2	H-2:12	histocompatibility
H2	H2:12	hydrogen gas
H-2	H-2:22	major histocompatibility
H-7	H-7:5|H7:3	isoquinoline sulfonylmethylpiperazine
H-7	H-7:8|H7:2	isoquinolinesulphonylmethylpiperazine
H7	H7:9|H-7:9	protein kinase c inhibitor
H-7	H-7:4|H7:2	protein kinase c inhibitor isoquinolinesulfonylmethylpiperazine
H7	H7:2|H-7:1	protein kinase c inhibitor isoquinolinesulfonylmethylpiperazine dihydrochloride
H7	H7:3|H-7:1	protein kinase inhibitor isoquinolinylsulphonylmethylpiperazine
HAA	HAA:8	haloacetic acid
HAA	HAA:11	hospital activity analysis
HABR	HABR:7	hepatic arterial buffer response
HABR	HABR:6	hyaluronic acidbinding region
HACE	HACE:8	hepatic arterial chemoembolization
HACE	HACE:7	hepatic artery chemoembolization
HAC	HAC:5	hepatic arterial chemotherapy
HAC	HAC:6	hepatic artery chemotherapy
HAC	HAC:10	human articular chondrocytes
HAC	HAC:24	hydroxyapatite cement
HAC	HAC:9	hyperadrenocorticism
HAD	HAD:15	hydroxyacylcoa dehydrogenase
HAD	HAD:15	haloacid dehalogenase
HAD	HAd:6|HAD:6|Had:1	hemadsorption
HAD	HAD:126	hospital anxiety and depression
HAEC	HAEC:13	human airway epithelial cells
HAEC	HAEC:14|hAEC:1	human amniotic epithelial cells
HAE	HAE:10	hepatic arterial embolization
HAE	HAE:20	hepatic artery embolization
HAE	HAE:10	hereditary angiooedema
HAE	HAE:111	hereditary angioedema
HAE	HAE:12	human amniotic epithelial
HAF	HAF:9	hepatic arterial flow
HAF	HAF:13|hAF:1	human amniotic fluid
HAI	HAI:5|hai:4	h after inoculation
HAI	HAI:132	hepatic arterial infusion
HAI	HAI:55	hepatic artery infusion
HAI	HAI:75	histological activity index
HAI	HAI:9	inhibition assay
HAI	HAI:8	titers of hemagglutinationinhibiting
HAM/TSP	HAM/TSP:11	htlv associated myelopathytropical spastic paraparesis
HAM/TSP	HAM/TSP:13	htlviassociated myelopathy
HAM/TSP	HAM/TSP:9	human tcell lymphotropic virus type i htlviassociated myelopathytropical spastic paraparesis
HAM/TSP	HAM/TSP:16	human t lymphotropic virus type i htlviassociated myelopathytropical spastic paraparesis
HAP1	HAP1:6|HAP-1:2	huntingtinassociated protein
HAP1	HAP1:10|Hap1:2|HAP-1:1	huntingtinassociated protein 
HAP	HAP:5	base analog nhydroxylaminopurine
HAP	HAP:12	hepatic arterial phase
HAP	HAP:33	hospitalacquired pneumonia
HAP	HAP:11	human activity profile
HAP	HAP:12	hyperthermic antiblastic perfusion
HARP	HARP:12	harmonic phase
HARP	HARP:22	heparin affin regulatory peptide
HAS	HAS:16	ha synthase
HAs	HAs:15	haemagglutinins
HAs	HAs:13	health authorities
HAs	HAs:11	hearing aids
HAS	HAS:13	high alcohol sensitivity
HAS	HAS:8	human albumin solution
HAS	HAS:37|has:3	hyaluronan synthase
HAs	HAs:11	hydrophobic agents
HAT	HAT:7	handgripapexcardiographic test
HAT	HAT:26	heparinassociated thrombocytopenia
HAT	HAT:80	hepatic artery thrombosis
HAT	HAT:12	histone acetyl transferase
HAT	HAT:81	human african trypanosomiasis
HAT	HAT:9	humanized antitac
HAT	HAT:10	hydrogen atom transfer
HA	HA:9	habitual abortion
HA	HA:20	haemagglutinating
HA	HA:92	haemagglutination
HA	HA:15	head activator
HA	HA:17	headache
HA	HA:9	health authority
HA	HA:23	hearing aid
HA	HA:6	heart area
HA	HA:8	heat acclimation
HA	HA:5	height age
HA	HA:60	hemagglutinating
HA	HA:205	hemagglutination
HA	HA:9	hemagglutination activity
HA	HA:10	hemagglutination assay
HA	HA:10	hemagglutinin glycoprotein
HA	HA:8	hemagglutinin protein
HA	HA:11	hemolytic anemia
HA	HA:22	hepatic arterial
HA	HA:78	hepatic artery
HA	HA:7	hepatocellular adenoma
HA	HA:31	hippocampal atrophy
HA	HA:22	human albumin
HA	HA:6	hydropic abortion
HA	HA:16	hydroxyapatitecoated
HA	HA:13	hyperandrogenism
HA	HA:26	hyperstriatum accessorium
HA	HA:24	hypothalamic amenorrhea
HA	HA:2	influenza a hemagglutinin
HA	HA:6	influenza a virus haemagglutinin
HA	HA:182	influenza virus hemagglutinin
HA	HA:5	lines of chickens selected for high
HA	HA:1	lines selected for either a high
HA	HA:9	mice selectively bred for high
HA	HA:4	minor histocompatibility antigen
HA	HA:8	sperm hyperactivation
HBD	HBD:7	heartbeating donor
HBD	HBD:18	heparinbinding domain
HBD	HBD:13	hydroxybutyrate dehydrogenase
HB-EGF	HB-EGF:22	heparinbinding egf
HB-EGF	HB-EGF:167	heparinbinding epidermal growth factorlike growth factor
HBIG	HBIG:86|HBIg:22	hepatitis b immune globulin
HBIG	HBIG:49|HBIg:35	hepatitis b immunoglobulin
HBI	HBI:18	halfbody irradiation
HBI	HBI:22	hemibody irradiation
HBI	HBI:12	human blood index
HBL	HBL:13	hemolysin bl
HBL	HBL:9	hepatoblastoma
HBL	HBL:10	hexagonal bilayer
HBL	HBL:10	hypobetalipoproteinemia
HBP	HBP:8	dimethylbenzaanthracene dmbainduced hamster buccal pouch
HBP	HBP:19	hepatic binding protein
HBP	HBP:17	hexosamine biosynthesis pathway
HBP	HBP:7	hexosamine biosynthetic pathway
HBP	HBP:82	high blood pressure
HBP	HBP:16	hydrocortisone butyrate propionate
HBV-DNA	HBV-DNA:9|HBVDNA:1	hepatitis b virus deoxyribonucleic acid
HBV-DNA	HBV-DNA:27	hepatitis b virus dna
HBV	HBV:9	hepatitis b infection
HBV	HBV:52	hepatitis b viral
HBV	HBV:25	hepatitis b virus infection
HBV	HBV:10	honey bee venom
HBV	HBV:8	honeybee venom
HBcAb	HBcAb:18|HBcAB:2|HbcAb:1|HBc-Ab:1	hepatitis b core antibody
HBcAb	HBcAb:10	hepatitis b core antigen
HbC	HbC:6	haemoglobin c
HbC	HbC:9|Hb-C:1	hemoglobin c
HBC	HBC:13	hereditary breast cancer
HBC	HBC:21	human breast carcinoma
HBsAg	HBsAg:22|HbsAg:1	hepatitis b surface ag
HBsAg	HBsAg:20|HBSAg:1|HBs-Ag:1	surface antigen of hepatitis b virus
HBs	HBs:10	hemangioblastomas
HbS	HbS:36	hemoglobin s
HBs	HBs:11	hepatoblastomas
HbS	HbS:17|Hbs:1	sickle cell hemoglobin
HbS	HbS:9|Hb-S:1	sickle haemoglobin
HbS	HbS:34	sickle hemoglobin
HB	HB:13	bodies
hb	hb:11	gap gene hunchback
HB	HB:9	heartbeating
HB	HB:18	hexobarbital
HB	HB:21|Hb:3	his bundle
HB	HB:5	homologous blood
HB	HB:9|H-B:8	housebrackmann
HB	HB:30	hypocrellin b
hb	hb:9	segmentation gene hunchback
HCA	HCA:28	homocysteic acid
HCA	HCA:4	hurthle cell adenomas
HCA	HCA:7	hybrid capture assay
HCA	HCA:36	hydrophobic cluster analysis
HCA	HCA:6	hydroxycarbonate apatite
HCA	HCA:9	hydroxycitric acid
HCA	HCA:88	hypothermic circulatory arrest
HCC	HCC:22	hepatocarcinoma
HCC	HCC:14	hepatocellular
HCC	HCC:44	hepatocellular cancer
HCC	HCC:19	human corpus cavernosum
HCD	HCD:25	high cholesterol diet
HCD	HCD:5|h-CD:2	high molecular weight caldesmon
HCD	HCD:8	hydrocolloid dressing
HCF	HCF:11	host cell factor
HCF	HCF:5	human corneal fibroblasts
HCF	HCF:16	hydatid cyst fluid
hCG	hCG:152|HCG:12	human choriogonadotropin
hCG	hCG:7|HCG:2	human chorionic gonadotropin hormone
HCHs	HCHs:50	hexachlorocyclohexanes
HCHs	HCHs:19	hexachlorocyclohexane isomers
HCHWA-D	HCHWA-D:14	hereditary cerebral hemorrhage with amyloidosisdutch type
HCHWA-D	HCHWA-D:7	hereditary cerebral hemorrhage with amyloidosis of the dutch type
HCI	HCI:20	humancomputer interaction
HCI	HCI:10	translational inhibitor
HCM	HCM:8|h-CM:1	human ciliary muscle
HCM	HCM:11	hypertrophic
HCN	HCN:60	hydrogen cyanide
HCN	HCN:19	hyperpolarizationactivated cyclic nucleotidegated
HCN	HCN:3	hyperpolarizationactivated cyclic nucleotidegated cation
HCPs	HCPs:14	health care professionals
HCPs	HCPs:20	health care providers
HCP	HCP:6	health care provider
HCP	HCP:12	hearing conservation program
HCP	HCP:11	hematopoietic cell phosphatase
HCP	HCP:20	hereditary coproporphyria
HCP	HCP:38	hexachlorophene
HCR	HCR:4	hemincontrolled translational repressor
HCR	HCR:10	hyperthermochemoradiotherapy
HCS	HCS:7	cord serum
HCS	HCS:5	haemoglobin colour scale
HCs	HCs:52	hairy cells
HCs	HCs:26	healthy controls
HCs	HCs:18|hcs:1	heavy chains
HCs	HCs:14	hepatocytes
HCS	HCS:29	holocarboxylase synthetase
HCS	HCS:6	hybrid capture system
HCs	HCs:21	hydrocarbons
HCT	HCT:9	haematocrit centrifugation technique
HCT	HCT:11	halstead category test
HCT	HCT:19|hCT:7	helical computed tomography
HCT	HCT:16|hCT:1	helical ct
HCT	HCT:13	hematopoietic cell transplant
HCU	HCU:5	handcarried cardiac ultrasound
HCU	HCU:6	handcarried ultrasound
HCV	HCV:15	hepatitis c infection
HCV	HCV:52	hepatitis c viral
HCV	HCV:35	hepatitis c virus infection
HCWs	HCWs:181	health care workers
HCWs	HCWs:116	healthcare workers
HCW	HCW:14	healthcare worker
HCW	HCW:12	hot carcass weight
HCL	HCL:108	hairy cell leukaemia
HCL	HCL:581	hairy cell leukemia
HCl	HCl:141|HCL:2	hydrochloric acid
HCl	HCl:23|HCL:1	hydrogen chloride
HCL	HCL:9	patients with hairycell leukaemia
HC	HC:5	fed a highcholesterol
HC	HC:16	haemorrhagic colitis
HC	HC:13	haemorrhagic cystitis
HC	HC:12	hair cell
HC	HC:11|Hc:3	haptocorrin
HC	HC:8	hassalls corpuscles
HC	HC:11	healthy children
HC	HC:9	healthy comparison
HC	HC:16	helper component
HC	HC:31	hemicrania continua
Hc	Hc:24|HC:4	hemocyanin
HC	HC:15	hemorrhagic colitis
HC	HC:53	hemorrhagic cystitis
HC	HC:23	hepatic cirrhosis
HC	HC:21	hepatitis c
HC	HC:20	high cholesterol
HC	HC:7	hippocampal commissure
Hc	Hc:23|HC:8	histoplasma capsulatum
HC	HC:23	hog cholera
HC	HC:18	home care
HC	HC:5	horizontal canal
HC	HC:6	horizontal semicircular canal
HC	HC:31	huntingtons chorea
HC	HC:16	hybrid capture
HC	HC:10	hydrocephalus
HC	HC:7	hydrogen clearance
HC	HC:10	hypercholesterolaemia
HC	HC:9	plasma homocysteine
HDA	HDA:5	hexamethylene diamine
HDA	HDA:5	electrical stimulation of the hypothalamic defense area
HDA	HDA:12	hypothalamic defence area
HDB	HDB:13|hDB:2	horizontal limb of the diagonal band
HDB	HDB:10|hDB:1	horizontal limb of the diagonal band of broca
HDCV	HDCV:23	human diploid cell rabies vaccine
HDCV	HDCV:26	human diploid cell vaccine
HDFs	HDFs:17|hDFs:8	human dermal fibroblasts
HDFs	HDFs:38	human diploid fibroblasts
HDF	HDF:24	haemodiafiltration
HDF	HDF:125	hemodiafiltration
HDR	HDR:11	headdown rotation
HDR	HDR:9	hemodynamic response
HDR	HDR:8	homologydirected repair
HDS-R	HDS-R:7	hasegawa dementia scale
HDS-R	HDS-R:3|HDSR:2	revised version of hasegawas dementia scale
HDS	HDS:13	hasegawas dementia scale
HDS	HDS:9	headdown suspension
HDS	HDS:15	highdose sequential
HDS	HDS:10	hydrodesulfurization
HDT	HDT:113	highdose therapy
HDT	HDT:7	highdose treatment
HD	HD:7	enoylcoa hydratasehydroxyacylcoa dehydrogenase
HD	HD:9	haemodialysed
HD	HD:13	haemodialysis patients
HD	HD:10	hand dermatitis
HD	HD:21|H-D:19	hanganutziudeicher
HD	HD:39	healthy donors
HD	HD:10	heavy distillate
HD	HD:5	heavy drinkers
HD	HD:15|hd:1	helperdependent
HD	HD:9	hemodialyses
HD	HD:9	hemodialysed
HD	HD:23	hemodialysis patients
HD	HD:7	hemodialysis treatment
HD	HD:29	hemodialyzed
HD	HD:21	hemodilution
HD	HD:28	high density
HD	HD:7	hip dysplasia
HD	HD:10	hodgkins
HD	HD:11	hodgkins lymphoma
HD	HD:78	homeodomain
HD	HD:9	homozygous deletion
HD	HD:10	hormonedependent
HD	HD:31	house dust
HD	HD:10	huntingtons
HD	HD:1535	huntingtons disease
HD	HD:8	hypoxic depolarization
HD	HD:9	patients on chronic haemodialysis
HECs	HECs:11	ethics committees
HECs	HECs:6|hECs:3	human endothelial cells
HEC	HEC:29	hydroxyethyl cellulose
HEC	HEC:48	hydroxyethylcellulose
HEF	HEF:8	hamster embryo fibroblasts
HEF	HEF:7	hepatic erythropoietic factor
HEF	HEF:8	hepatic extraction fraction
HELLP	HELLP:2	elevated liver enzymes and low platelet
HELLP	HELLP:1	hemolysis elevated liver enzymes and low platelets
HEL	HEL:152	hen egg lysozyme
HEL	HEL:60	hen egg white lysozyme
HEL	HEL:27	human embryo lung
HEL	HEL:71	human embryonic lung
HEL	HEL:17	human erythroleukaemia
HEL	HEL:15	human erythroleukemia cell line
HEL	HEL:12	human erythroleukemic
HEPM	HEPM:8	human embryonic palatal mesenchymal
HEPM	HEPM:6	human embryonic palatal mesenchyme
HEPT	HEPT:27	hydroxyethoxymethylphenylthiothymine
HEPT	HEPT:9	hamster egg penetration test
HERS	HERS:68	heart and estrogenprogestin replacement study
HERS	HERS:20	hertwigs epithelial root sheath
HES	HES:10	hetastarch
HES	HES:15	hospital episode statistics
HES	HES:10	hydroxyethyl starch solution
HES	HES:57	hydroxyethylstarch
HES	HES:193	hypereosinophilic syndrome
Hex	Hex:9|hex:1|HEX:1	betanacetylhexosaminidase
Hex	Hex:17|HEX:16|hex:6	hexosaminidase
HEp-2	HEp-2:5|Hep-2:2|HEP-2:2|HEp2:1	carcinoma cell line
HEp-2	HEp-2:8	human epithelial cell line
HEp-2	HEp-2:9|Hep2:7|HEp2:5	laryngeal carcinoma
HE	HE:13	haemagglutininesterase
HE	HE:15	haematoxylin and eosin
HE	HE:6	hamster embryo
HE	H-E:8|HE:8	hasemanelston
HE	HE:14	health education
HE	HE:18	hemorrhagic enteritis
HE	HE:328	hepatic encephalopathy
HE	HE:88	hereditary elliptocytosis
HE	HE:13	hydroalcoholic extract
HE	HE:18	hypothalamic extract
HE	HE:4|H-E:1	sections were stained with hematoxylineosin
HFA	HFA:5	fatty acid
HFA	HFA:10	hexafluoroacetone
HFA	HFA:9	high functioning autism
HFA	HFA:15	human fetal adrenal
HFA	HFA:9	humanfloraassociated
HFA	HFA:11	humphrey field analyser
HFA	HFA:19	humphrey field analyzer
HFA	HFA:63	hydrofluoroalkane
HFA	HFA:18	hydrofluoroalkanea
HFA	HFA:7	hypoglossalfacial nerve anastomosis
HFBA	HFBA:11	heptafluorobutyric acid
HFBA	HFBA:24	heptafluorobutyric anhydride
HFCs	HFCs:6	high sce frequency cells
HFCs	HFCs:9	hydrofluorocarbons
HFE	HFE:17	haemochromatosis
HFE	HFE:55|Hfe:1	hemochromatosis
HFE	HFE:60|Hfe:3	hemochromatosis gene
HFE	HFE:5	hemochromatosis protein
HFE	HFE:16	human factors engineering
HFI	HFI:51	hereditary fructose intolerance
HFI	HFI:13|Hfi:1	hyperostosis frontalis interna
HFO	HFO:18	highfrequency oscillatory ventilation
HFO	HFO:18	hydrous ferric oxide
HFP	HFP:11	heterochromatic flicker photometry
HFP	HFP:5	highfrequency power
HFP	HFP:9	human fetal pancreas
HFRS	HFRS:66	haemorrhagic fever with renal syndrome
HFRS	HFRS:23	hemorrhagic fever with the renal syndrome
HFS	HFS:17	handfoot syndrome
HFS	HFS:111	hemifacial spasm
HFS	HFS:5	highfat sucrose
HF	HF:31	haemofiltration
HF	HF:21	hageman factor
HF	HF:18|Hf:16	halofantrine
HF	HF:43	hartreefock
HF	HF:1123	heart failure
HF	HF:6	hemorrhagic fever
HF	HF:93	high fat
HF	HF:5	high fiber
HF	HF:5	high flow
HF	HF:10	highflux
HF	HF:10	high frequencies
HF	HF:7	high frequency band
HF	HF:13	highfrequency component
HF	HF:9	hip fracture
HF	HF:6	hollow fiber
HF	HF:11	hydrofluoric
HF	HF:75	hydrofluoric acid
HF	HF:43	hydrogen fluoride
HF	HF:8	hypoxic fraction
HF	HF:2	rats fed highfat
HGEC	HGEC:13	human gingival epithelial cells
HGEC	HGEC:7|hGEC:2	human glomerular epithelial cells
HGFA	HGFA:21|HGF-A:1	hepatocyte growth factor activator
HGFA	HGFA:22	hgf activator
HGF	HGF:35|hGF:1	hematopoietic growth factors
HGF	HGF:2058|Hgf:1	hepatocyte growth factor
HGF	HGF:20	hereditary gingival fibromatosis
hGH	hGH:1076|HGH:187|h-GH:3|hgh:2|hGh:2|hgH:1	human growth hormone
hGH	hGH:10	human growth hormone gene
HGP	HGP:183	hepatic glucose production
HGP	HGP:43	human genome project
HGV	HGV:10	hepatitis g
HGV	HGV:363	hepatitis g virus
HG	HG:32	handgrip
HG	HG:48|hg:3	harderian gland
HG	HG:39	herpes gestationis
HG	HG:25	heschls gyrus
HG	HG:55	high glucose
HG	HG:15	histological grade
HG	HG:23	hyperemesis gravidarum
HG	HG:15	hyperglycemia
HG	HG:17|hg:4	hypergravity
HG	HG:10	hypoglossal
HHD	HHD:21	haileyhailey disease
HHD	HHD:10	handheld dynamometer
HHD	HHD:10	home hemodialysis
HHD	HHD:41	hypertensive heart disease
HHL	HHL:9	hippuryllhistidyllleucine
HHL	HHL:7	nhexanoyllhomoserine lactone
HHP	HHP:33	high hydrostatic pressure
HHP	HHP:10	honolulu heart program
HHS	HHS:27	harris hip score
HHS	HHS:11	hypothenar hammer syndrome
HHT	HHT:30	hydroxyheptadecatrienoic acid
HHT	HHT:55	hereditary haemorrhagic telangiectasia
HHT	HHT:148	hereditary hemorrhagic telangiectasia
HHT	HHT:6	hereditary hemorrhagic teleangiectasia
HHT	HHT:7	heterotopic heart transplantation
HHT	HHT:50	homoharringtonine
HHV-6B	HHV-6B:7	human herpesvirus  variant b
HHV-6B	HHV-6B:8	human herpesvirus b
HHV-8	HHV-8:11|HHV8:4	herpesvirus
HHV-8	HHV-8:10|HHV8:8	human herpes virus type 
HHV-8	HHV-8:45|HHV8:11	human herpesvirus type 
HH	HH:15|H-H:3	hamburger and hamilton
HH	HH:11|H-H:2	hamburgerhamilton
HH	HH:12|H-H:5|hh:2|h-h:1	headtohead
HH	HH:12	heated humidifier
Hh	Hh:267|hh:82|HH:15	hedgehog
Hh	Hh:11	hemopoietic histocompatibility
HH	HH:12	hemorrhagic hypotension
HH	HH:62	hereditary haemochromatosis
HH	HH:16	hereford
HH	HH:20	hiatal hernia
HH	HH:11	hiatus hernia
HH	HH:29|H-H:1	hodgkinhuxley
HH	HH:9	hyperhidrosis
HH	HH:7	hypobaric hypoxia
HH	HH:17	hypogonadotrophic hypogonadism
HH	HH:6	hyporeninemic hypoaldosteronism
HH	HH:20	hypothalamic hamartoma
HH	HH:13	hypoxic hypoxia
HIC	HIC:14	handlinginduced convulsions
HIC	HIC:11	head injury criterion
HIC	HIC:20	health insurance commission
HIC	HIC:26	hepatic iron concentration
HIE	HIE:6	hyperimmunoglobulin e
HIE	HIE:1	hypoxic and ischemic encephalopathy
HIE	HIE:27	hypoxicischaemic encephalopathy
HIE	HIE:81	hypoxicischemic encephalopathy
HIE	HIE:10	rand health insurance experiment
HIG	HIG:9	haemolysisingel
HIG	HIG:27|HIg:3|hIg:3	human immunoglobulin
HII	HII:6	hepatic iron index
HII	HII:11	hexagonal phase
HIPAA	HIPAA:103	health insurance portability and accountability act
HIPAA	HIPAA:47	health insurance portability and accountability act of 
HIP	HIP:11	health insurance plan
HIP	HIP:9	hypnotic induction profile
HIP	HIP:15|Hip:4|hip:1	interacting protein
HIT	HIT:7	haemagglutination inhibition test
HIT	HIT:11	headache impact test
HIT	HIT:5	hemagglutination inhibition test
HIT	HIT:436	heparininduced thrombocytopenia
HIT	HIT:6	highintensity interval training
HIT	HIT:19	histidine triad
HIT	HIT:18	holtzman inkblot technique
HIT	HIT:10	home infusion therapy
HIT	HIT:8	hydrothermal isometric tension
HIV+	HIV+:31	hivinfected
HIV+	HIV+:20	human immunodeficiency viruspositive
HIV-	HIV-:22	hivnegative
HIV-	HIV-:22	hivseronegative
HIV-1	HIV-1:24	human immunodeficiency virus type
HIV-1	HIV-1:9	human immunodeficiency virus type one
HIVE	HIVE:10	encephalopathy
HIVE	HIVE:36|HIV-E:1	hiv encephalitis
HIV	HIV:59	human immunodeficiency
HIV	HIV:13	human immunodeficiency syndrome
HIV	HIV:10	human immunodeficiency viral
HIV	HIV:61	human immunodeficiency virus infection
Hib	Hib:756|HIB:48|HIb:5|HiB:2	haemophilus influenzae type b
Hib	Hib:9|HIB:1	haemophilus influenzae type b vaccine
HIB	HIB:13	hyperpneainduced bronchoconstriction
HIB	HIB:10	hyperventilationinduced bronchoconstriction
HI	HI:20|H-I:2	after hypoxiaischemia
HI	HI:15|H-I:2	cerebral hypoxiaischemia
HI	HI:7	familial hyperinsulinism
HI	HI:12	harlequin ichthyosis
HI	HI:15	harmonic imaging
HI	HI:41	head injury
HI	HI:15	healthy individuals
HI	HI:16	hearingimpaired
HI	HI:17	hospital insurance
HI	HI:11	humoral immunity
HI	HI:5	hyperinsulinism of infancy
HI	HI:29	hypomelanosis of ito
HI	HI:14	hypoxiaischaemia
HI	HI:5|H-I:1	hypoxic ischemia
HI	HI:60|H-I:14	hypoxicischemic
HI	HI:17	neonatal hypoxiaischemia
HJ	HJ:13	highlands j
HJ	HJ:13	holliday junction
HJ	HJ:6	rouxeny hepaticojejunostomy
hK2	hK2:43	human glandular kallikrein
hK2	hK2:45|HK2:1	human glandular kallikrein 
HK	HK:9	head kidney
HK	HK:17|H-K:1	heatkilled
HK	HK:1	high in potassium
HK	HK:9	high k
HK	HK:8	histidine kinase
HK	HK:12	hong kong
HK	HK:6	horseshoe kidney
HK	HK:79|Hk:2	hypokinesia
HL-60	HL-60:51|HL60:5	human leukemia
HL-60	HL-60:25|HL60:1	human leukemic
HL-60	HL-60:6	human promyelocytes
HL-60	HL-60:13|HL60:5	human promyelocytic
HL-60	HL-60:11|HL60:2	human promyelocytic leukaemia
HL-60	HL-60:130|HL60:11	human promyelocytic leukemia
HL-60	HL-60:23|HL60:2	human promyelocytic leukemia cell line
HL-60	HL-60:11	human promyelocytic leukemic
HL7	HL7:21|HL-7:1	health level 
HL7	HL7:24	health level seven
HLA-DR	HLA-DR:15	human leucocyte antigendr
HLA-DR	HLA-DR:16	human leukocyte antigen
HLA	HLA:5|HL-A:1	histocompatibility system
HLA	HLA:8|HL-A:1	human leukocyte
HLA	HLA:6	human major histocompatibility
HLA	HLA:23	human major histocompatibility complex
HLA	HLA:7	human mhc
HLA	HLA:11	symposium on major histocompatibility antigens
HLD	HLD:19	hepatolenticular degeneration
HLD	HLD:5	highlevel disinfection
HLE	HLE:29	human lens epithelial
HLE	HLE:151|hLE:3	human leukocyte elastase
HLP	HLP:50	hyperlipoproteinaemia
HLP	HLP:10|hlp:1	hyperlipoproteinemias
HLP	HLP:43	type iii hyperlipoproteinemia
HLR	HLR:12	hearttolung ratio
HLR	HLR:13	highlevel resistance
HLR	HLR:12	hydraulic loading rate
HL	HL:9	hydroxymethylglutaryl coenzyme a lyase
HL	HL:17	db hearing level
HL	HL:11	heatlabile
HL	HL:15	high light
HL	HL:10	human lymphocytes
HL	HL:8|hL:2	human lysozyme
HL	HL:9	hyaline layer
HL	HL:9	hybrid layer
HL	HL:14	hyperlipidemic
HMA	HMA:20	hydroxymethylantipyrine
HMA	HMA:15	heteroduplex mobility analysis
HMA	HMA:99	heteroduplex mobility assay
HMA	HMA:7	hexamethylene amiloride
HMBA	HMBA:50	hexamethylenebisacetamide
HMBA	HMBA:11	nnhexamethylenebisacetamide
HMB	HMB:37|hmb:1	betahydroxybetamethylbutyrate
HMB	HMB:13	heavy menstrual bleeding
HMB	HMB:10	hypersensitivity to mosquito bites
HMC-1	HMC-1:8	human leukemic mast cells
HMC-1	HMC-1:25	human mast cell line
HMEC-1	HMEC-1:9	human dermal microvascular endothelial cell line
HMEC-1	HMEC-1:13	human microvascular endothelial cell line
HME	HME:12	hemimegalencephaly
HME	HME:9	hereditary multiple exostosis
HME	HME:36	human monocytic ehrlichiosis
HMG1	HMG1:9|HMG-1:4	high mobility group  protein
HMG1	HMG1:7|HMG-1:4|hmg-1:1	high mobility group protein 
HMGB1	HMGB1:20	high mobility group box 
HMGB1	HMGB1:5	high mobility group box  protein
HMG	HMG:15	hydroxymethylglutaric acid
HMG	HMG:21	hydroxymethylglutaryl
HMG	HMG:10	high mobility group proteins
HMMA	HMMA:14	hydroxymethoxymandelic acid
HMMA	HMMA:11	hydroxymethoxymethamphetamine
HMM	HMM:233|HmM:1	heavy meromyosin
HMM	HMM:56	hexamethylmelamine
HMPAO	HMPAO:7|HM-PAO:2	mtchexamethylpropyleneamineoxime
HMPAO	HMPAO:8|HM-PAO:1	hexamethylpropyleneamineoxime
HMPAO	HMPAO:10	tcm hexamethylpropylene amineoxime
HMP	HMP:43	hexose monophosphate
HMP	HMP:17	hexose monophosphate pathway
HMR	HMR:5	hearttomediastinum ratio
HMR	HMR:13	histiocytic medullary reticulosis
HMS	HMS:12	hairless mouse skin
HMS	HMS:6	hypermobility syndrome
HMS	HMS:6	hyperreactive malarial splenomegaly
HMS	HMS:8	hyperreactive malarious splenomegaly
HMT	HMT:7	heparin management test
HMT	HMT:17	hexamethylenetetramine
HMT	HMT:12	histamine methyltransferase
HMT	HMT:6	histone methyltransferase
HM	HM:5	heuristic method
HM	HM:26|H-M:1	holter monitoring
HM	HM:45	human milk
HM	HM:12	hydromorphone
HM	HM:9	malignancies
HM	HM:4	patients with hypercalcaemia of malignancy
HN2	HN2:21|HN-2:1	mechlorethamine
HN2	HN2:6	mechlorethamine hydrochloride
HNA	HNA:11	heparin neutralizing activity
HNA	HNA:24	hereditary neuralgic amyotrophy
HNA	HNA:8	higher nervous activity
HNCM	HNCM:17	hypertrophic nonobstructive cardiomyopathy
HNCM	HNCM:11	patients with hypertrophic nonobstructive cardiomyopathy
HNC	HNC:5	guinea pig hypothalamoneurohypophyseal complex
HNC	HNC:72	head and neck cancer
HNC	HNC:10|hNC:1	human neutrophil collagenase
HNE	HNE:11	hydroxyenonenal
HNE	HNE:10	ehydroxynonenal
HNE	HNE:11	human nasal epithelial
HNE	HNE:192|hNE:2	human neutrophil elastase
HNE	HNE:17	transhydroxynonenal
HNF	HNF:9	heterotrophic nanoflagellates
HNF	HNF:10	nuclear factors
HNL	HNL:27	histiocytic necrotizing lymphadenitis
HNL	HNL:36	human neutrophil lipocalin
HN	HN:81	haemagglutininneuraminidase
HN	HN:10	hemagglutininneuraminidase protein
HN	HN:15	hereditary nephritis
hn	hn:14	heterogeneous nuclear
hn	hn:27	heteronuclear
HN	HN:59	heymann nephritis
HN	HN:26	humanin
HN	HN:19	hyaluronectin
HN	HN:9|Hn:1	hydronephrosis
HOA	HOA:6	hemoglobinoxygen affinity
HOA	HOA:51	hypertrophic osteoarthropathy
HOCs	HOCs:24	hydrophobic organic compounds
HOCs	HOCs:20	hydrophobic organic contaminants
HOME	HOME:40	home observation for measurement of the environment
HOME	HOME:14	human omental microvascular endothelial
HOPS	HOPS:11	hiv outpatient study
HOPS	HOPS:9	hypophosphatasia
HOP	HOP:5	oocyte penetration
HOP	HOP:10	urinary hydroxyproline
HOS	HOS:7	health opinion survey
HOS	HOS:28	holtoram syndrome
HOS	HOS:14	human osteogenic sarcoma
HOS	HOS:7	human osteosarcoma cell line
HOS	HOS:9	medicare health outcomes survey
HOS	HOS:16	swelling test
HOT	HOT:46	home oxygen therapy
HOT	HOT:64	hypertension optimal treatment
Ho	Ho:7|ho:5|HO:3	cook and medley hostility
Ho	Ho:6|HO:6|ho:4	cookmedley hostility
Ho	Ho:5|ho:3|HO:2	hostility scale
HPA	HPA:8	activity of the hypothalamuspituitaryadrenocortical
HPA	HPA:17	adrenocortical
HPA	HPA:9	habitual physical activity
HPA	HPA:88|HpA:3	helix pomatia agglutinin
HPA	HPA:4|Hpa:3|hpa:2	heparanase
HPA	HPA:11	human pancreatic alphaamylase
HPA	HPA:26	hybridization protection assay
HPA	HPA:23	hyperphenylalaninaemia
HPA	HPA:58	hyperphenylalaninemia
HPA	HPA:68	hypothalamicpituitaryadrenal axis
HPA	HPA:5	hypothalamicpituitaryadrenal cortical
HPA	HPA:228|H-P-A:3	hypothalamicpituitaryadrenocortical
HPA	HPA:17	hypothalamopituitaryadrenal axis
HPA	HPA:7	hypothalamopituitaryadrenal cortical
HPA	HPA:130	hypothalamopituitaryadrenocortical
HPA	HPA:160	hypothalamuspituitaryadrenal
HPB	HPB:22	hydroxypyridylbutanone
HPB	HPB:13	portal blood
HPCs	HPCs:11	hemangiopericytomas
HPCs	HPCs:119	hematopoietic progenitor cells
HPC	HPC:12	haemangiopericytoma
HPC	HPC:38	hereditary prostate cancer
HPC	HPC:17	hippocampal
HPC	HPC:13|hPC:6	human protein c
HPC	HPC:50	hydroxypropyl cellulose
HPC	HPC:52	hydroxypropylcellulose
HPC	HPC:6	hypopharyngeal carcinoma
HPD	HPD:10	hepatopancreatoduodenectomy
HPD	HPD:8	hereditary progressive dystonia
HPD	HPD:13	hereditary progressive dystonia with marked diurnal fluctuation
HPD	HPD:11	high protein diet
HPD	HPD:11	hypothalamicpituitary disconnection
HPD	HPD:17	hypothalamopituitary disconnected
HPD	HPD:17	hypothalamopituitary disconnection
HPE	HPE:1	h pylori water extract
HPE	HPE:98	holoprosencephaly
HPFH	HPFH:25	hereditary persistence of fetal haemoglobin
HPFH	HPFH:122	hereditary persistence of fetal hemoglobin
hpf	hpf:24	h postfertilization
HPF	HPF:12	heparin precipitable fraction
HPF	HPF:11	highpressure freezing
hpf	hpf:15|hPF:1	hours postfertilization
HPF	HPF:20|hpf:11	per highpower field
HPH	HPH:12	helix pomatia haemocyanin
HPH	HPH:24	hypoxic pulmonary hypertension
hpi	hpi:9	h post insemination
hpi	hpi:6|HPI:1	h postinsemination
HPI	HPI:12	health practice index
HPI	HPI:33	hepatic perfusion index
HPI	HPI:33	highpathogenicity island
HPI	HPI:11|hPI:4	human proinsulin
HPI	HPI:9	hydroperoxidase i
HPI	HPI:9	hypothalamicpituitaryinterrenal
hpi	hpi:7|HPI:2	postinoculation
HPLC-UV	HPLC-UV:8	liquid chromatography with ultraviolet detection
HPLC-UV	HPLC-UV:6	liquid chromatography with uv detection
HPLC	HPLC:6	highperformance liquid chromatographic assay
HPLC	HPLC:9	high performance liquid chromotography
HPLC	HPLC:12	liquid chromatography method
HPLC	HPLC:5	liquid chromatography system
HPMC	HPMC:14	hydroxypropyl methyl cellulose
HPMC	HPMC:160	hydroxypropyl methylcellulose
HPMC	HPMC:38	hydroxypropylmethyl cellulose
HPMC	HPMC:160	hydroxypropylmethylcellulose
HPMC	HPMC:8	propyl methyl cellulose
HPNS	HPNS:33	high pressure nervous syndrome
HPNS	HPNS:29	high pressure neurological syndrome
HPRT	HPRT:83|hprt:22|Hprt:8	hypoxanthine phosphoribosyl transferase
HPRT	HPRT:183|hprt:35|Hprt:21	hypoxanthine phosphoribosyltransferase
HPRT	HPRT:7|Hprt:2|hprt:1	hypoxanthine phosphoribosyltransferase gene
HPr	HPr:32	histidinecontaining phosphocarrier protein
HPr	HPr:30	histidinecontaining protein
HPR	HPR:12|Hpr:1	hydroxypyruvate reductase
HPR	HPR:9	hypoxic pressor response
HPR	HPR:22	nhydroxyphenylretinamide
HPR	HPR:5	synthetic retinoid fenretinide
HPS	HPS:6	hexulosephosphate synthase
HPS	HPS:166	hantavirus pulmonary syndrome
HPS	HPS:9	highpressure sodium
HPS	HPS:40	hispurkinje system
HPS	HPS:72	hypertrophic pyloric stenosis
HPT	HPT:16|Hpt:10|hpt:1	haptoglobin
HPT	HPT:12	hepaplastin test
HPT	HPT:29	human proximal tubule
HPT	HPT:10	hypertension prevention trial
HPT	HPT:8|H-P-T:2	hypothalamicpituitarytesticular
HPT	HPT:55|H-P-T:1	hypothalamicpituitarythyroid
HPT	HPT:13	hypothalamopituitarythyroid
HPT	HPT:14	hypothalamuspituitarythyroid
HPT	HPT:56	patients with primary hyperparathyroidism
HPV	HPV:22	heart period variability
HPV	HPV:10|hpv:1	hepatic portal vein
HPV	HPV:19	hepatopancreatic parvovirus
HPV	HPV:20	human papillomavirus infection
HPV	HPV:289	hypoxic pulmonary vasoconstriction
HPP	HPP:32	hereditary pyropoikilocytosis
HPP	HPP:9	highpressure processing
HPP	HPP:7	pressure processing
HP	HP:7	atp to hydroxymethyldihydropterin
HP	HP:17|Hp:6	haematoporphyrin
HP	HP:9	haemoperfusion
HP	HP:10	health promotion
HP	HP:8	healthy persons
HP	HP:63|Hp:5	heat production
HP	HP:8	helix pomatia a hemagglutinin
HP	HP:12	hemangiopericytoma
HP	HP:56|Hp:29	hematoporphyrin
HP	HP:24	hemoperfusion
HP	HP:42|hp:1	hereditary pancreatitis
HP	HP:12	hewlettpackard
HP	HP:8|Hp:1	highpass
HP	HP:23	highly pathogenic
HP	HP:8|hp:2	highly purified
HP	HP:16	hotplate
HP	HP:8	human plasma
HP	HP:24|hp:1	hydrostatic pressure
HP	HP:9	hydroxylysyl pyridinoline
HP	HP:57	hydroxylysylpyridinoline
HP	HP:15	hyperparathyroidism
HP	HP:20	hyperpolarized
HP	HP:214	hypersensitivity pneumonitis
HP	HP:1	hypertension during pregnancy
HP	HP:14	hypoparathyroidism
HP	HP:9|H-P:5|h-p:2	hypothalamicpituitary
HP	HP:5	protein diet
HRA	HRA:39	health risk appraisal
HRA	HRA:13	health risk assessment
HRA	HRA:40	high right atrium
HRA	HRA:17	histaminereleasing activity
HRA	HRA:6	human reliability assessment
HRF	HRF:27	heidelberg retina flowmeter
HRF	HRF:12|hrf:1	hemodynamic response function
HRG	HRG:71|hrg:3|Hrg:1	heregulin
HRG	HRG:9	heregulinbeta
HRG	HRG:92|Hrg:1	histidinerich glycoprotein
HRI	HRI:8	hemeregulated eif alpha kinase
HRI	HRI:11	hemeregulated inhibitor
HRM	HRM:8	heme regulatory motif
HRM	HRM:6	human resource management
HRP-WGA	HRP-WGA:2	horseradish peroxidase conjugated wheat germ agglutinin
HRP-WGA	HRP-WGA:18	horseradish peroxidasewheat germ agglutinin
HRPC	HRPC:8|HRP-C:3	horseradish peroxidase c
HRPC	HRPC:6|HRP-C:3|HRPc:2	horseradish peroxidase isoenzyme c
HRP	HRP:20	highpass resolution perimetry
HRP	HRP:18	horseradishperoxidase
HRP	HRP:86	retrograde axonal transport of horseradish peroxidase
HRP	HRP:259	retrograde transport of horseradish peroxidase
HRP	HRP:44	transganglionic transport of horseradish peroxidase
HRR	HRR:36	haplotype relative risk
HRR	HRR:19	hazard rate ratio
HRR	HRR:16	heart rate recovery
HRR	HRR:28	heart rate reserve
HRR	HRR:22	homologous recombination repair
HRR	HRR:11	homologous recombinational repair
HRS	HRS:9	florida department of health and rehabilitative services
HRS	HRS:17	hamilton rating scale
HRS	HRS:89	hepatorenal syndrome
HRS	HRS:7	hyperrayleigh scattering
HRS	HRS:7	lowdose hyperradiosensitivity
HRTEM	HRTEM:10	highresolution transmission electron microscope
HRTEM	HRTEM:48|HR-TEM:4|HrTEM:1	highresolution transmission electron microscopy
HRT	HRT:35	heart rate turbulence
HRT	HRT:98	heidelberg retina tomograph
HRT	HRT:8	heidelberg retinal tomography
HRT	HRT:20	histamine release test
HRT	HRT:9	hormone replacement
HRT	HRT:2376	hormone replacement therapy
HRT	HRT:14	hormone replacement treatment
HRV2	HRV2:22|HRV-2:2	human rhinovirus serotype 
HRV2	HRV2:12|HRV-2:6	human rhinovirus type 
HRV	HRV:1592|HRv:1	heart rate variability
HRV	HRV:26	heart rate variation
HRV	HRV:91	human rotavirus
hr	hr:32|HR:5|Hr:3	hairless
HR	HR:6|hr:3	hairless gene
HR	HR:10	heart
hr	hr:11	hemerythrin
HR	HR:10|Hr:1	heparinreleasable
HR	HR:9	hepatic resection
HR	HR:24	heptad repeat
HR	HR:5	high responders to novelty
HR	HR:94	histamine release
HR	HR:194	homologous recombination
hr	hr:10	homologous region
HR	HR:6	hormone receptor
hr	hr:14|HR:3	host range
HR	HR:12|Hr:2	hybrid resistance
HR	HR:39	hypersensitive reaction
HR	HR:224	hypersensitive response
HR	HR:3	lightdriven chloride pump halorhodopsin
HR	HR:8|H-R:1	rutosides
HSA	HSA:7	heatstable ag
HSA	HSA:10	hemangiosarcoma
HSA	HSA:19|Hsa:1	human chromosome
HSA	HSA:13	human salivary alphaamylase
HSA	HSA:9	humoral stimulatory activity
HSCT	HSCT:64	hematopoietic stem cell transplant
HSCT	HSCT:476|hSCT:1	hematopoietic stem cell transplantation
HSCT	HSCT:20	stem cell transplants
HSC	HSC:9	hepatosplenic candidiasis
HSC	HSC:28	hospital for sick children
HSD	HSD:24	hallervordenspatz disease
HSD	HSD:12	hypertonic salinedextran
HSD	HSD:2	hypertonic saline in dextran
HSES	HSES:4	haemorrhagic shock encephalopathy syndrome
HSES	HSES:5	hemorrhagic shock and encephalopathy syndrome
HSE	HSE:30	health and safety executive
HSE	HSE:10	hepatic sinusoidal endothelial
HSE	HSE:10	hepatic sinusoidal endothelium
HSE	HSE:170	herpes simplex encephalitis
HSE	HSE:11	human skin equivalent
HSF	HSF:6	heated soya flour
HSF	HSF:11	human synovial fibroblasts
HSG	HSG:17	human salivary gland
HSG	HSG:27	hysterosalpingogram
HSG	HSG:217	hysterosalpingography
HSG	HSG:8	salivary gland tumor
HSI	HSI:22	hepatosomatic index
HSI	HSI:11	hippocampal sympathetic ingrowth
HSK	HSK:50	herpes simplex keratitis
HSK	HSK:53	herpetic stromal keratitis
HSL	HSL:6	homoserine lactone
HSL	HSL:238|hsl:1	hormonesensitive lipase
HSN	HSN:16	headshaking nystagmus
HSN	HSN:11	henochschonlein nephritis
HSP	HSP:219	henochschonlein purpura
HSP	HSP:27	hereditary spastic paraparesis
HSP	HSP:73	hereditary spastic paraplegia
HSP	HSP:18|hsp:1	human seminal plasma
HSRs	HSRs:72|hsrs:8	homogeneously staining regions
HSRs	HSRs:27	hypersensitivity reactions
HSR	HSR:25	health services research
HSR	HSR:21	heat shock response
HSR	HSR:4	heavy fraction of sr
HSR	HSR:8	hypersensitivity reaction
HSR	HSR:18	hypotonic shock response
HSS	HSS:11	hallervordenspatz syndrome
HSS	HSS:33	hepatic stimulator substance
HSS	HSS:9	hepatosplenic schistosomiasis
HSS	HSS:7	high speed supernatant
HSS	HSS:9	homospermidine synthase
HSS	HSS:57	hospital for special surgery
HST	HST:5	head shaking test
HST	HST:11	hydroxysteroid sulfotransferase
HSV1-tk	HSV1-tk:11|HSV1-TK:9|HSV-1-tk:2|HSV-1-TK:1	herpes simplex virus type  thymidine kinase
HSV1-tk	HSV1-tk:3|HSV1-TK:2|HSV-1-tk:1	type  thymidine kinase gene
HSV-2	HSV-2:11|HSV2:2	type  herpes simplex virus
HSV-2	HSV-2:10	type  virus
HSV-tk	HSV-tk:108|HSV-TK:102|HSVtk:64|HSVTK:5|hsvTK:1|hsv-TK:1	herpes simplex virus thymidine kinase
HSV-tk	HSV-tk:17|HSVtk:10|HSV-TK:10|hsv-tk:1	herpes simplex virus thymidine kinase gene
HSV	HSV:21	herpes simplex viral
HSV	HSV:82	highly selective vagotomy
HSV	HSV:26	human saphenous vein
HS	HS:9|hs:4	bedtime
HS	HS:16|hs:1	haemorrhagic septicaemia
HS	HS:15	harmonic scalpel
HS	HS:26	headspace
HS	HS:7	healthy smokers
HS	HS:112	healthy subjects
HS	HS:19	heatstable
HS	HS:70|Hs:2|hs:1	heat stress
HS	HS:9	heat stroke
HS	HS:118|hs:1	hemorrhagic shock
HS	HS:13	hemorrhagic stroke
HS	HS:26	hemosorption
HS	HS:116	heparan sulphate
HS	HS:11	hepatosplenic
HS	HS:212	hereditary spherocytosis
HS	HS:23	heterogeneous stock
HS	HS:37	hidradenitis suppurativa
HS	HS:6	highsalt diet
HS	HS:11|hs:1	highspin
HS	HS:61	hindlimb suspension
HS	HS:14	hopelessness scale
HS	HS:5	horizontal system
HS	HS:45|hS:1	horse serum
HS	HS:11	hs
HS	HS:13	hunger sensation
HS	HS:7	hypertrophic scar
HS	HS:11	hyposensitization
HS	HS:7	hypothalamic stimulation
HT-1080	HT-1080:10|HT1080:9	human fibrosarcoma
HT-1080	HT-1080:11|HT1080:7	human fibrosarcoma cells
HT1	HT1:11	hereditary tyrosinemia type 
HT1	HT1:8	hereditary tyrosinemia type i
HTA	HTA:110	health technology assessment
HTA	HTA:18	heteroduplex tracking assay
HTB	HTB:9	hydroxytrifluoromethylbenzoic acid
HTB	HTB:7	heterotopically transplanted rat urinary bladder
HTC	HTC:62	hepatoma tissue culture
HTC	HTC:50	rat hepatoma
HTF	HTF:4|hTf:2	human tenons capsule fibroblasts
HTF	HTF:46	human tubal fluid
HTF	HTF:7|hTF:1	human tubal fluid medium
HTF	HTF:9	tiny fragment
HTG	HTG:15	hightension glaucoma
HTG	HTG:15	hypertriglyceridaemia
HTG	HTG:11	hypertriglyceridaemic
HTG	HTG:78	hypertriglyceridemia
HTG	HTG:57|HTg:1	hypertriglyceridemic
HTH	HTH:101|HtH:2|H-T-H:1	helixturnhelix
HTH	HTH:5	homeostatic thymus hormone
HTH	HTH:8	hypertrehalosemic hormone
HTK	HTK:39	histidinetryptophanketoglutarate
HTK	HTK:9	histidinetryptophanketoglutarate solution
HTLV	HTLV:10	human tcell leukemia viruses
HTLV	HTLV:33	human t lymphotropic virus
HTLV	HTLV:10	retrovirus
HTLV-I	HTLV-I:6	human tcell leukemia virusi
HTLV-I	HTLV-I:14	human tcell leukemia virus type 
HTLV-I	HTLV-I:5	human tcell lymphotrophic virusi
HTLV-I	HTLV-I:12	human tlymphotropic virusi
HTLV-I	HTLV-I:18	human tlymphotropic virus type 
HTLV-I	HTLV-I:9	lymphotropic virusi
HTLV-I	HTLV-I:12	type i human tcell leukemia virus
HTM	HTM:33	haemophilus test medium
HTM	HTM:40|hTM:1|h-TM:1	human trabecular meshwork
HTP	HTP:7	heart transplant patients
HTP	HTP:6	heart transplanted patients
HTR	HTR:9	hard tissue replacement
HTR	HTR:32	headtwitch response
hTR	hTR:78|HTR:1	human telomerase rna
hTR	hTR:18	rna component of human telomerase
hTR	hTR:10	rna component of telomerase
HUAEC	HUAEC:11	human umbilical arterial endothelial cells
HUAEC	HUAEC:7	human umbilical artery endothelial cells
HUMARA	HUMARA:5	human androgen receptor assay
HUMARA	HUMARA:46|Humara:2|HU-MARA:1	human androgen receptor gene
HUS	HUS:135|hus:1	haemolytic uraemic syndrome
HUS	HUS:6	head ultrasound
HUS	HUS:523	hemolytic uremic syndrome
HUVEC	HUVEC:4	endothelial cells from human umbilical cord veins
HUVEC	HUVEC:47	human umbilical vein ec
HUVEC	HUVEC:10	umbilical vein endothelium
HUVE	HUVE:89|Huve:1	human umbilical vein endothelial
HUVE	HUVE:17	human umbilical vein endothelium
HU	HU:47	hindlimb unloading
HU	HU:16	hindlimb unweighting
HU	HU:7	htlv uveitis
HU	HU:791|Hu:9|hu:1	hydroxyurea
HVEM	HVEM:11	highvoltage electron microscope
HVEM	HVEM:16	high voltage electron microscopy
HVS	HVS:156	herpesvirus saimiri
HVS	HVS:10	high vaginal swab
HVS	HVS:9	human visual system
HVS	HVS:36	hyperventilation syndrome
HVc	HVc:16	caudal nucleus of the ventral hyperstriatum
HVC	HVC:63|HVc:9	high vocal center
HVC	HVC:29|HVc:4	higher vocal center
HVc	HVc:7	hyperstriatum ventrale pars caudale
HVc	HVc:6	hyperstriatum ventralis pars caudalis
HV	HV:15	hallux valgus
HV	HV:9	heart volume
HV	HV:71	height velocity
HV	HV:6	hemorrhagic vasculitis
HV	HV:46	hepatic vein
HV	HV:13	high voltage
HV	HV:8	hippocampal volume
HV	HV:11|H-V:2	hisventricular
HV	HV:13	hydroa vacciniforme
HV	HV:11	hydroxyvalerate
HV	HV:12	hypersensitivity vasculitis
HV	HV:15	hyperstriatum ventrale
HV	HV:18	hypervariable
HV	HV:89|hv:1	hyperventilation
HWE	HWE:56|HWe:1	hardyweinberg equilibrium
HWE	HWE:15	hardyweinberg expectations
HWE	HWE:14	healthy worker effect
HWE	HWE:10	hornerwadsworthemmons
HW	HW:3	dogs with heartworm
HW	HW:10|H-W:7	hardyweinberg
HW	HW:28	heart weight
HW	HW:45	hydrostatic weighing
Hz	Hz:19	hertz
Hz	Hz:7|HZ:6	hydrazine
HaPV	HaPV:12|HapV:1	hamster papovavirus
HaPV	HaPV:16	hamster polyomavirus
HAL	HAL:10	acute leukemia
HAL	HAL:29|Hal:11	halothane
HAL	HAL:13	handassisted laparoscopic
HAL	HAL:48	hepatic artery ligation
HAL	HAL:27	hip axis length
HAM	HAM:5	highdose cytarabine and mitoxantrone
HAM	HAM:25	htlv associated myelopathy
HAM	HAM:74	htlvi associated myelopathy
HAM	HAM:15|h-AM:1	human alveolar macrophages
HAM	HAM:10|hAM:2	human amniotic membrane
HAM	HAM:33	patients with htlviassociated myelopathy
HbA1c	HbA1c:52|HbA1C:3|HBA1c:1	haemoglobin ac
HbA1c	HbA1c:5	hemoglobin levels
HbA	HbA:10	adult haemoglobin
HbA	HbA:19|Hb-A:1	human adult hemoglobin
HbA	HbA:17	human hemoglobin
HbF	HbF:38	fetal haemoglobin
HbF	HbF:224|Hb-F:2	fetal hemoglobin
HbF	HbF:23	foetal haemoglobin
HbF	HbF:14	haemoglobin f
HbF	HbF:33	hemoglobin f
HbH	HbH:13	haemoglobin h
HbH	HbH:14	hemoglobin h
HbNO	HbNO:12	nitrosyl hemoglobin
HbNO	HbNO:9|HB-NO:1|Hb-NO:1	nitrosylhemoglobin
HBOC	HBOC:11	hereditary breast and ovarian cancer
HBOC	HBOC:11	hereditary breastovarian cancer
HBOC	HBOC:16	oxygen carrier
HeLa	HeLa:13	cervical carcinoma cells
HeLa	HeLa:29	human cervical carcinoma
He-Ne	He-Ne:5	effect of lowenergy laser
He-Ne	He-Ne:42|HeNe:15	heliumneon
He-O2	He-O2:16|HeO2:5	heliumoxygen
He-O2	He-O2:3|HeO2:2	mixture of  helium and  oxygen
HepG2	HepG2:8|Hep-G2:2|hepg2:1	human hepatocellular carcinoma
HepG2	HepG2:103|Hep-G2:4|HEPG2:2	human hepatoma
HFR	HFR:8	hemodiafiltration reinfusion
HFR	HFR:7	high fluorescence reticulocytes
Hg0	Hg0:25	elemental mercury
Hg0	Hg0:16	mercury vapor
HIS	HIS:7	hachinski ischemic score
HIS	HIS:13	health interview survey
HIS	HIS:7	hyperimmune serum
HlyA	HlyA:7	escherichia coli alphahemolysin
HlyA	HlyA:7|Hlya:1	escherichia coli haemolysin
HlyA	HlyA:30|hlyA:1	escherichia coli hemolysin
Hly	Hly:7|hly:5|HLY:1	alphahemolysin
Hly	Hly:12|hly:5|HLY:3	haemolysin
Hly	Hly:21|hly:16|HLY:4|HLy:1	hemolysin
hnRNA	hnRNA:65|HnRNA:13|HNRNA:2	heterogeneous nuclear rna
hnRNA	hnRNA:20|hn-RNA:2	heteronuclear rna
HPAI	HPAI:11	highpathogenicity avian influenza
HPAI	HPAI:20	highly pathogenic avian influenza
HRE	HRE:35	hormone response element
HRE	HRE:27	hypoxia response element
HRE	HRE:8	regeneration efficiency
HRE	HRE:11	responsive elements
HT	HT:11|Ht:1	harringtonine
HT	HT:11|H-T:4|h-t:2|ht:1	headtotail
HT	HT:38	hemorrhagic transformation
HT	HT:12	high threshold
HT	HT:8	highly trained
HT	HT:21	hormonal therapy
HT	HT:122	hormone therapy
HT	HT:26	hypertensive patients
HT	HT:11	hypertensive subjects
HT	HT:13|Ht:1	hyperthyroidism
HT	HT:20	hypothermia
HT	HT:10	hypothyroidism
HT	HT:25	local hyperthermia
HT	HT:19	patients with essential hypertension
HT	HT:40	patients with hashimotos thyroiditis
HUD	HUD:18	department of housing and urban development
HUD	HUD:11	headup display
HX	HX:34|H-X:4|Hx:1	histiocytosis x
HX	HX:29	hydrogen exchange
I-1	I-1:4|I1:2	inhibitor 
I-1	I-1:7	protein phosphatase inhibitor
i3	i3:16|I3:2	third intracellular
i3	i3:17|I3:2	third intracellular loop
IAA	IAA:17	ileoanal anastomosis
IAA	IAA:9	indispensable amino acids
IAA	IAA:323	indoleacetic acid
IAA	IAA:22	insulin autoantibody
IAA	IAA:8	internal auditory artery
IAA	IAA:41	interrupted aortic arch
IAA	IAA:21	interruption of the aortic arch
IAA	IAA:11	intraabdominal abscess
IAA	IAA:38	iodoacetate
IAA	IAA:80	iodoacetic acid
IABP	IABP:264	balloon pump
IABP	IABP:113|I-ABP:1	intraaortic balloon pumping
IAC	IAC:36	immunoaffinity chromatography
IAC	IAC:14	immunoaffinity column
IAC	IAC:152	internal auditory canal
IAC	IAC:10	interposed abdominal compression
IAD	IAD:10	implantable atrial defibrillator
IAD	IAD:9	inflammatory airway disease
IAD	IAD:10	intermittent androgen deprivation
IAHA	IAHA:32	immune adherence hemagglutination
IAHA	IAHA:9	immune adherence hemagglutination assay
IAHS	IAHS:8	idiopathic adult hydrocephalus syndrome
IAHS	IAHS:8	infectionassociated hemophagocytic syndrome
IAM	IAM:53	immobilized artificial membrane
IAM	IAM:11	indoleacetamide
IAM	IAM:30	internal auditory meatus
IAN	IAN:9	indoleacetonitrile
IAN	IAN:121	inferior alveolar nerve
IAPs	IAPs:32|iaps:1	inhibitors of apoptosis
IAPs	IAPs:70	inhibitor of apoptosis proteins
IAP	IAP:14	ciodoantipyrine
IAP	IAP:163	immunosuppressive acidic protein
IAP	IAP:21	increased intraabdominal pressure
IAP	IAP:69|I-AP:4	intestinal alkaline phosphatase
IAP	IAP:154	intraabdominal pressure
IAP	IAP:53	intracarotid amobarbital procedure
IAP	IAP:18	intracellular action potential
IAP	IAP:12	intrapartum antibiotic prophylaxis
IAP	IAP:129	isletactivating protein
IAR	IAR:11	immediate asthmatic reaction
IAR	IAR:27	immediate asthmatic response
IAT	IAT:36	implicit association test
IAT	IAT:48	indirect antiglobulin test
IAT	IAT:36	individual anaerobic threshold
IAT	IAT:11	intraarterial thrombolysis
IAT	IAT:24	intraoperative autotransfusion
IBA	IBA:8	immunoblot assay
IBA	IBA:35	indolebutyric acid
IBC	IBC:74	inflammatory breast cancer
IBC	IBC:24	inflammatory breast carcinoma
IBMX	IBMX:10	isobutyl methylxanthine
IBMX	IBMX:29	isobutyllmethylxanthine
IBMX	IBMX:9	isobutyl methyl xanthine
IBMX	IBMX:11	phosphodiesterase inhibitor isobutylmethylxanthine
IBO	IBO:10	ibogaine
IBO	IBO:12|Ibo:2|ibo:1	ibotenate
IBO	IBO:6|ibo:3	ibotenic
IBO	IBO:9	intestinal bacterial overgrowth
IBR	IBR:27	immediate breast reconstruction
IBR	IBR:146	infectious bovine rhinotracheitis
IBS	IBS:14	ichthyosis bullosa of siemens
IBS	IBS:5	identical by state
IBS	IBS:10	imidazoline binding sites
IBS	IBS:10	injectable bone substitute
IBS	IBS:1125	irritable bowel syndrome
IBS	IBS:13	isolated bowel segment
IC50	IC50:10	 inhibition of cell growth
IC50	IC50:9	 inhibition of growth
IC50	IC50:6	 inhibitory dose
IC50	IC50:10	cell growth by 
IC50	IC50:5	inhibition of protein synthesis
IC50	IC50:8	inhibitory concentration 
ICAD	ICAD:11	inhibitor of caspaseactivated dnase
ICAD	ICAD:13	internal carotid artery dissection
ICAM-1	ICAM-1:7	adhesion molecule i
ICAM-1	ICAM-1:8	intercellular adhesion molecular
ICAM-1	ICAM-1:106|ICAM1:1	intercellular adhesion molecule
ICAs	ICAs:40	internal carotid arteries
ICAs	ICAs:65	islet cell antibodies
ICA	ICA:12	arthritis
ICa	ICa:7	ca channels
ICA	ICA:25	immunocytochemical assay
ICA	ICA:198	independent component analysis
ICA	ICA:29	internal carotid
ICa	ICa:37|ica:2|Ica:1|iCa:1	inward calcium current
ICB	ICB:7	intracavitary brachytherapy
ICB	ICB:28|I-CB:4	irisciliary body
ICCs	ICCs:11	intraclass correlations
ICCs	ICCs:208	intraclass correlation coefficients
ICCs	ICCs:48	isletlike cell clusters
ICC	ICC:11	fetal porcine isletlike cell clusters
ICC	ICC:70	immunocytochemical
ICC	ICC:8	immunoglobulincontaining cells
ICC	ICC:51	indian childhood cirrhosis
ICC	ICC:5	intensive consolidation chemotherapy
ICC	ICC:9	intercompany collaboration for aids drug development
ICC	ICC:13	intraclass correlation
ICC	ICC:82	intrahepatic cholangiocarcinoma
ICC	ICC:36	invasive cervical cancer
ICC	ICC:15	invasive cervical carcinoma
ICD-10	ICD-10:1	international classification of diseases th edition
ICD-10	ICD-10:1	international classification of diseases tenth edition
ICDS	ICDS:40|ICDs:1	integrated child development services
ICDS	ICDS:6	integrated child development services scheme
ICD	ICD:18	icell disease
ICD	ICD:11	idiopathic cervical dystonia
ICD	ICD:13	immune complex dissociation
ICD	ICD:24	induced circular dichroism
ICD	ICD:22	initial claudication distance
ICD	ICD:10	intercapillary distance
ICD	ICD:32	intracellular domain
ICD	ICD:52	irritant contact dermatitis
ICE	ICE:16	caspase
ICE	ICE:14	ifosfamidecarboplatinetoposide
ICE	ICE:4	insulin control element
ICE	ICE:5	integrative and conjugative element
ICE	ICE:53	interleukinbeta converting enzyme
ICE	ICE:7	international collaborative effort
ICE	ICE:78	intracardiac echocardiography
ICE	ICE:36	iridocorneal endothelial
ICF	ICF:3	instability and facial anomalies
ICF	ICF:10	intermediate care facility
ICF	ICF:9	intermittent compressive force
ICF	ICF:4	international classification of functioning disability and health
ICF	ICF:26	intracellular fluid
ICH	ICH:11	infectious canine hepatitis
ICH	ICH:22	international conference on harmonisation
ICH	ICH:58	intracerebral haemorrhage
ICH	ICH:45	intracranial haemorrhage
ICI	ICI:11	interclick interval
ICI	ICI:9	intracavernosal injection
ICI	ICI:20	intracavernous injection
ICI	ICI:12	intracervical insemination
ICL	ICL:6	idiopathic cd lymphocytopenia
ICL	ICL:15	implantable contact lens
ICL	ICL:7	innermost chorionic layer
ICL	ICL:50|Icl:2|icl:1	isocitrate lyase
ICM	ICM:10	intensive case management
ICM	ICM:11	intracytoplasmic membrane
ICM	ICM:8	introduction to clinical medicine
ICM	ICM:10	iodinated contrast media
ICM	ICM:10	ischemic
ICM	ICM:49	ischemic cardiomyopathy
ICN	ICN:9	infection control nurse
ICN	ICN:9	inferior cardiac nerve
ICN	ICN:21	intensive care nursery
ICN	ICN:32	international council of nurses
ICN	ICN:7	intrinsic cardiac nerves
ICP-AES	ICP-AES:99|ICPAES:4	inductively coupled plasma atomic emission spectrometry
ICP-AES	ICP-AES:23	inductively coupled plasmaatomic emission spectroscopy
ICP-MS	ICP-MS:13|ICPMS:6	inductively coupled plasma mass spectrometer
ICP-MS	ICP-MS:7|ICPMS:2	inductively coupled plasma mass spectrometric
ICPs	ICPs:19|ICPS:1	infection control practitioners
ICPs	ICPs:9	infection control professionals
ICPs	ICPs:12	insecticidal crystal proteins
ICPs	ICPs:11	integrated care pathways
ICP	ICP:9	idiopathic chronic pancreatitis
ICP	ICP:7	immunocompromised patients
ICP	ICP:62	inductively coupled plasma
ICP	ICP:5	inductively coupled plasma emission spectroscopy
ICP	ICP:12	infancychildhoodpuberty
ICP	ICP:22	infantile cerebral paralysis
ICP	ICP:9	infected cell protein
ICP	ICP:12	infection control practitioner
ICP	ICP:12	insecticidal crystal protein
ICP	ICP:13	integrated care pathway
ICP	ICP:78	intrahepatic cholestasis of pregnancy
ICP	ICP:11|iCP:1	isolated cleft palate
ICRS	ICRS:9	international cartilage repair society
ICRS	ICRS:10|ICR-S:1	intracorneal ring segments
ICRS	ICRS:13|ICRs:1	intrastromal corneal ring segments
ICSH	ICSH:15	international council for standardization in haematology
ICSH	ICSH:6	interstitial cellstimulating hormone
ICS	ICS:7	control scale
ICS	ICS:16	ileocecal sphincter
ICS	ICS:11	image correlation spectroscopy
ICS	ICS:22	immotile cilia syndrome
ICS	ICS:9	intercellular spaces
ICS	ICS:9	intercellular substance
ICS	ICS:6|ics:1	intercostal space
ICS	ICS:11	interferon consensus sequence
ICS	ICS:9	intracellular cytokine staining
ICS	ICS:6	intracellular space
ICS	ICS:9	intracranial stimulation
ICS	ICS:9	irritable colon syndrome
ICTP	ICTP:10	ctelopeptide
ICTP	ICTP:11	carboxyterminal telopeptide
ICTP	ICTP:9	telopeptide of collagen i
ICTP	ICTP:5	telopeptide of collagen type i
ICTP	ICTP:13	type i collagen carboxyterminal telopeptide
ICAT	ICAT:31	isotopecoded affinity tag
ICAT	ICAT:9	isotopecoded affinity tags
IDA	IDA:16|Ida:1	idazoxan
IDA	IDA:14	iminodiacetate
IDA	IDA:70	iminodiacetic acid
IDA	IDA:8	interdigitated array
IDC	IDC:11	interdigitating dendritic cells
IDC	IDC:14	interdigitating reticulum cells
IDDM	IDDM:11	diabetes mellitus type i
IDDM	IDDM:5	diabetic mothers
IDDM	IDDM:16	insulin dependent
IDDM	IDDM:23	insulindependent diabetic patients
IDDM	IDDM:11	patients with insulindependent
IDDs	IDDs:11	insulindependent diabetics
IDDs	IDDs:7	iodine deficiency disorders
IDD	IDD:15	insulindependent
IDD	IDD:84|Idd:10|idd:1	insulindependent diabetes
IDD	IDD:14	insulindependent diabetes mellitus
IDD	IDD:19	inventory to diagnose depression
IDF	IDF:9	defense force
IDF	IDF:12	insoluble dietary fiber
IDF	IDF:7	international dairy federation
IDF	IDF:13	international diabetes federation
IDF	IDF:23	israel defense forces
IDH	IDH:10	infectious diseases hospital
IDH	IDH:18	intradialytic hypotension
IDH	IDH:9	isolated diastolic hypertension
IDPN	IDPN:33	iminodipropionitrile
IDPN	IDPN:6	chronic administration of iminodipropionitrile
IDPN	IDPN:31	intradialytic parenteral nutrition
IDPs	IDPs:11	internally displaced persons
IDPs	IDPs:10	interplanetary dust particles
IDR	IDR:9	immunodominant region
IDR	IDR:15	incidence density ratio
IDR	IDR:5	intradermal reaction
IDS	IDS:7	deficiency of the lysosomal enzyme iduronatesulfatase
IDS	IDS:14	iduronatesulphatase
IDS	IDS:9	sulphatase
IDT	IDT:6	interdivision time
IDT	IDT:10	intradermal testing
IDT	IDT:29	isometric developed tension
IDUS	IDUS:42	intraductal ultrasonography
IDUS	IDUS:12	intraductal ultrasound
IDU	IDU:43	drug user
IDU	IDU:39|IdU:1	idoxuridine
IE1	IE1:6|IE-1:2|ie-1:1	immediate early
IE1	IE1:7|IE-1:2	immediate early 
IEA	IEA:14	immediate early antigen
IEA	IEA:32	inferior epigastric artery
IEC	IEC:1	information education and communication
IEC	IEC:17	international electrotechnical commission
IEC	IEC:29	ionexchange chromatography
IEF	IEF:27	isoelectric focussing
IEF	IEF:57	isoelectrofocusing
IEL	IEL:113	internal elastic lamina
IEL	IEL:13	intraepithelial
IEL	IEL:10	intraepithelial leukocytes
iEMG	iEMG:18|IEMG:10|I-EMG:2	integrated electromyogram
IEMG	IEMG:30|iEMG:5	integrated electromyographic
iEMG	iEMG:5|IEMG:4	integrated electromyographic activity
IEMG	IEMG:8|iEMG:6|I-EMG:3|Iemg:1	integrated electromyography
IEMG	IEMG:47|iEMG:36|I-EMG:1	integrated emg
IEMG	IEMG:4|iEMG:3	neural activation
IEM	IEM:7	isocyanatoethyl methacrylate
IEM	IEM:80	immune electron microscopy
IEM	IEM:10	immunoelectron microscopic
IEM	IEM:40	inborn errors of metabolism
IEM	IEM:8	ineffective esophageal motility
IEM	IEM:11	internal elastic membrane
IET	IET:6	incremental exercise test
IET	IET:8	intramolecular electron transfer
IFA	IFA:12	idiopathic fibrosing alveolitis
IFA	IFA:9	immunofluorescence analysis
IFA	IFA:36	immunofluorescence assays
IFA	IFA:17	imported fire ant
IFA	IFA:170	incomplete freunds adjuvant
IFA	IFA:8	indirect fluorescent antibody technique
IFA	IFA:26	indirect fluorescent antibody test
IFA	IFA:6	isoferulic acid
IFM	IFM:18	indirect flight muscle
IFM	IFM:10	interfibrillar mitochondria
IFN	IFN:8	alpha and gammainterferon
IFN	IFN:116	alphainterferon
IFN	IFN:25	betainterferon
IFN	IFN:14	interferon alfa
IFN	IFN:15	interferon alfaa
IFN	IFN:23	interferon alfab
IFN	IFN:6	interferonalpha 
IFN	IFN:10	interferonalphab
IFN	IFN:23	interferon gamma
IFT	IFT:12	interfacial tension
IFT	IFT:54	intraflagellar transport
If	If:12|if:7	hyperpolarizationactivated current
IF	IF:5	immediate function
IF	IF:10	immunofixation
IF	IF:8	immunofluorescence method
IF	IF:7	immunofluorescence technique
IF	IF:16	integrateandfire
IF	IF:7	intermediate frequency
IF	IF:21	interstitial fibrosis
IF	IF:11	intestinal failure
IF	IF:125	intrinsic factor
IF	IF:21	involved field
If	If:13|if:8	pacemaker current
IF	IF:9	staining
IGC	IGC:26	interdisciplinary generalist curriculum
IGC	IGC:46	inverse gas chromatography
IGF-1R	IGF-1R:7|Igf1r:1	insulinlike growth factor type  receptor
IGF-1R	IGF-1R:12|IGF1R:11|Igf1r:3|IGF1-R:1	type  igf receptor
IGFBPs	IGFBPs:289|IGF-BPs:5|IG-FBPs:1	igf binding proteins
IGFBPs	IGFBPs:218|IGF-BPs:7	insulinlike growth factor binding proteins
IGHD	IGHD:5|iGHD:1	idiopathic ghd
IGHD	IGHD:8|iGHD:1	isolated ghd
IGHD	IGHD:51|I-GHD:1	isolated growth hormone deficiency
IGL	IGL:5	human immunoglobulin lambda
IGL	IGL:18	internal granular layer
IGT	IGT:1090|iGT:1	impaired glucose tolerance
IGT	IGT:10	iowa gambling task
IHA	IHA:5	idiopathic adrenal hyperplasia
IHA	IHA:9	immune hemolytic anemia
IHA	IHA:17	indirect haemagglutination assay
IHA	IHA:148	indirect hemagglutination
IHA	IHA:6	indirect hemagglutination antibody
IHA	IHA:27	indirect hemagglutination assay
IHA	IHA:12	intermittent high altitude
IHC	IHC:9	immunohistochemical analysis
IHC	IHC:24	immunohistochemically
IHC	IHC:15	induced hypertension chemotherapy
IHC	IHC:14	intermountain health care
IHD	IHD:43	intermittent hemodialysis
IHD	IHD:614	ischaemic heart disease
IHH	IHH:62	idiopathic hypogonadotropic hypogonadism
IHH	IHH:16	isolated hypogonadotropic hypogonadism
IHN	IHN:9	infectious haematopoietic necrosis
IHN	IHN:10	infectious hematopoietic necrosis
IHNV	IHNV:27	infectious haematopoietic necrosis virus
IHNV	IHNV:79	infectious hematopoietic necrosis virus
IHP	IHP:21	idiopathic hypoparathyroidism
IHP	IHP:43	isolated hepatic perfusion
IHR	IHR:19	instantaneous heart rate
IHR	IHR:22	intrinsic heart rate
IHS	IHS:115	indian health service
IHS	IHS:219	international headache society
IHT	IHT:13	intermittent hypoxic training
IHT	IHT:6	interstitial hyperthermia
IHTT	IHTT:12	interhemispheric transfer time
IHTT	IHTT:7	interhemispheric transmission time
Ih	Ih:4|ih:4|IH:2	current activated by hyperpolarization
Ih	Ih:29|IH:3	hyperpolarizationactivated cation current
IH	IH:8	idiopathic haemochromatosis
IH	IH:37	idiopathic hirsutism
IH	IH:12	immunohistology
IH	IH:8	infantile hydrocephalus
IH	IH:13	inguinal hernia
IH	IH:50	intermittent hypoxia
IH	IH:131	intimal hyperplasia
IIDs	IIDs:35	interaural intensity differences
IIDs	IIDs:9	interaural intensity disparities
IIF	IIF:15	indirect immunofluorescence technique
IIF	IIF:7	indirect immunofluorescent test
IIF	IIF:29|iif:1	intracellular ice formation
IIP	IIP:120	idiopathic interstitial pneumonia
IIP	IIP:16	inventory of interpersonal problems
IKK	IKK:55	i kappa b kinase
IKK	IKK:14	kinase complex
IL-1R1	IL-1R1:3|IL-1-R1:1|Il1r1:1	il receptor type 
IL-1R1	IL-1R1:8	type  il receptor
IL-1RII	IL-1RII:7	il receptor type ii
IL-1RII	IL-1RII:9	type ii il receptor
IL-1RI	IL-1RI:27	il receptor type i
IL-1RI	IL-1RI:11|IL1RI:1|IL-1-RI:1	interleukin receptor type i
IL-1RI	IL-1RI:27	type i il receptor
IL-1RI	IL-1RI:20	type i receptor
IL-1ra	IL-1ra:5|IL-1Ra:2|IL-1RA:1	receptor agonist
IL-1ra	IL-1ra:3|IL-1RA:2|IL1-Ra:1	receptor antagonists
IL-1ra	IL-1ra:3|IL-1Ra:1	receptor antagonist of il
IL-2R	IL-2R:74|IL-2r:1	il receptors
IL-2R	IL-2R:8|IL-2r:1	interleukinr
IL-2R	IL-2R:1	receptors of il
ILC	ILC:10	immobilized liposome chromatography
ILC	ILC:35	infiltrating lobular carcinoma
ILC	ILC:38	interstitial laser coagulation
ILC	ILC:54	invasive lobular carcinoma
ILC	ILC:11	lobular carcinomas
ILDs	ILDs:17	interaural level differences
ILDs	ILDs:22	interstitial lung diseases
ILI	ILI:73	influenzalike illness
ILI	ILI:9	isolated limb infusion
ILL	ILL:15	interlibrary loan
ILL	ILL:18	intermediate lymphocytic lymphoma
ILM	ILM:30	inner limiting membrane
ILM	ILM:158	internal limiting membrane
ILM	ILM:12	intubating laryngeal mask
ILN	ILN:8	inferior laryngeal nerve
ILN	ILN:15	intralaminar nuclei
ILO	ILO:15|Ilo:4	iloprost
ILO	ILO:48	international labour office
ILO	ILO:27	international labour organisation
ILR	ILR:13	irreversible loss rate
ILR	ILR:23	loop recorder
ILS	ILS:14	inbred longsleep
ILS	ILS:1	increase of lifespan
ILS	ILS:28	intermittent light stimulation
ILS	ILS:24	isolated lissencephaly sequence
ILT	ILT:7	immunoglobulinlike transcript
ILT	ILT:44	infectious laryngotracheitis
ILT	ILT:13	interstitial laser therapy
ILT	ILT:9	interstitial laser thermotherapy
ILV	ILV:6	indolactam v
ILV	ILV:14	instantaneous lung volume
ILP	ILP:14	inductive logic programming
ILP	ILP:6	insulinlike peptide
ILP	ILP:33	interstitial laser photocoagulation
ILP	ILP:138	isolated limb perfusion
IL	IL:10	independent living
IL	IL:16|il:2	infralimbic
IL	IL:8	insertion loss
IL	IL:94	intermediate lobe
IL	IL:24	intralipid
IL	IL:14	intraluminal
IL	IL:9	ionic liquid
IMAC	IMAC:111	immobilized metal affinity chromatography
IMAC	IMAC:45	immobilized metal ion affinity chromatography
IMAC	IMAC:10	inner membrane anion channel
IMB	IMB:11	immunomagnetic beads
IMB	IMB:12	informationmotivationbehavioral skills
IMC	IMC:7	instrument meteorological conditions
IMC	IMC:8	interdigestive migrating complex
IMC	IMC:16	interdigestive migrating contractions
IMC	IMC:16	internal mammary chain
IMC	IMC:10	intimamedia complex
IMC	IMC:6	invasive micropapillary carcinoma
IMC	IMC:8	isothermal microcalorimetry
IMD	IMD:5	intramammary device
IMD	IMD:18	invasive meningococcal disease
IMF	IMF:5	initial median frequency
IMF	IMF:38|IMf:1	intermaxillary fixation
IMF	IMF:18	intramuscular fat
IMG	IMG:8	inferior mesenteric ganglia
IMG	IMG:65	inferior mesenteric ganglion
IMG	IMG:9	international medical graduate
IMHV	IMHV:25	intermediate and medial part of the hyperstriatum ventrale
IMHV	IMHV:32	intermediate medial hyperstriatum ventrale
IMI	IMI:9	imidacloprid
IMI	IMI:32	inferior myocardial infarction
IMI	IMI:17	intermeal interval
IML	IML:28|iml:2	inner molecular layer
IML	IML:26	intermediolateral
IML	IML:81	intermediolateral cell column
IML	IML:36	intermediolateral nucleus
IML	IML:11	internal medullary lamina
IML	IML:21	intravascular malignant lymphomatosis
IMO	IMO:10	inflammationmediated osteopenia
IMO	IMO:9	intravenous membrane oxygenator
IMPs	IMPs:13	inner membrane proteins
IMPs	IMPs:11|Imps:2	integral membrane proteins
IMPs	IMPs:66|IMPS:1|Imps:1|imps:1	intramembrane particles
IMPs	IMPs:69|imps:1	intramembranous particles
IMP	IMP:11	iiodoamphetamine
IMP	IMP:7	electrical impedance
IMP	IMP:9	index of myocardial performance
IMP	IMP:117	inosine monophosphate
IMP	IMP:15	intramammary pressure
IMP	IMP:30	intramuscular pressure
IMP	IMP:26	intramyocardial pressure
IMP	IMP:41	iodoamphetamine
IMP	IMP:9	nisopropyl i piodoamphetamine
IMP	IMP:35	nisopropylpiiodoamphetamine
IMP	IMP:23	nisopropylpiodoamphetamine
IMSS	IMSS:36	mexican institute of social security
IMSS	IMSS:18	mexican social security institute
IMS	IMS:138	immunomagnetic separation
IMS	IMS:6	intermediate myasthenia syndrome
IMS	IMS:21	intermembrane space
IMS	IMS:33	ion mobility spectrometry
IMS	IMS:11	mouse serum
IMTG	IMTG:7	intramuscular triacylglycerol
IMTG	IMTG:8|imTG:1	intramuscular triglyceride
IMT	IMT:105	carotid artery intimamedia thickness
IMT	IMT:8	immunemediated thrombocytopenia
IMT	IMT:7	immune modulation therapy
IMT	IMT:52	inflammatory myofibroblastic tumor
IMT	IMT:47	inspiratory muscle training
IMT	IMT:12	intimamedia thickening
IMT	IMT:15	tyrosine
IMV	IMV:17	inferior mesenteric vein
IMV	IMV:14	inouemelnick virus
IMV	IMV:121	intermittent mandatory ventilation
IMV	IMV:9	intracellular mature virions
IMV	IMV:45	intracellular mature virus
IMZ	IMZ:10	iiomazenil
IMZ	IMZ:7	involuting marginal zone
IMZ	IMZ:12	iomazenil
INA	INA:14|iNA:1	dichloroisonicotinic acid
INA	INA:5|ina:1	ice nucleation active
INA	INA:5	intradental nerve activity
INA	INA:11	isonicotinic acid
INF	INF:9	infected
INF	INF:7|inf:1|Inf:1	infundibulum
INH	INH:9	immunoreactive inhibin
INH	INH:641	isoniazid
INH	INH:9	isoniazide
iNOS	iNOS:37	inducible nitric oxide
iNOS	iNOS:3|i-NOS:1	inducible nitric oxide synthase enzyme
iNOS	iNOS:7	inducible nitric oxide synthase gene
iNOS	iNOS:38	inducible nitric oxide synthetase
iNOS	iNOS:23|iNOs:1	inducible nosynthase
Inr	Inr:87|INR:7	initiator
Inr	Inr:29|inr:2|INR:2|InR:1	initiator element
INS	INS:96|iNS:2	idiopathic nephrotic syndrome
INS	INS:18	immigration and naturalization service
INS	INS:21	inelastic neutron scattering
Ins	Ins:14	inositol
INS	INS:45|ins:1	insulin gene
Ins	Ins:35	myoinositol
Int	Int:9|INT:1	integrin
INT	INT:6	iodonitrotetrazolium violet
Int	Int:20	lambda integrase
INT	INT:9	piodonitrotetrazolium violet
INV	INV:5	intracellular naked vaccinia virus
INV	INV:8|Inv:2	invertase
INV	INV:8|Inv:1|inv:1	involucrin
IN	IN:8	cerebellar interpositus nucleus
IN	IN:10	indiana
in	in:10	indium
IN	IN:10	infundibular nucleus
IN	IN:11	intact
IN	IN:14	integration protein
IN	IN:12	interstitial nephritis
in	in:6|IN:3	inulin
IOC	IOC:11	inferior olivary complex
IOC	IOC:48	international olympic committee
IOC	IOC:11	intraoperative cholangiogram
IOC	IOC:95	intraoperative cholangiography
IOERT	IOERT:7	intraoperative electron beam radiation therapy
IOERT	IOERT:6	intraoperative electron beam radiotherapy
IOERT	IOERT:8	intraoperative electron irradiation
IOL	IOL:9	interosseous ligament
IOL	IOL:73	intraocular lenses
IOL	IOL:11	intraocular lens implantation
IOM	IOM:8	international organization for migration
IOM	IOM:19	interosseous membrane
ION	ION:35|ion:5	infraorbital nerve
ION	ION:20	ischemic optic neuropathy
ION	ION:31	isthmooptic nucleus
IORT	IORT:14	intraoperative irradiation
IORT	IORT:169	intraoperative radiation therapy
IOS	IOS:17	impulse oscillometry
IOS	IOS:7	impulse oscillometry system
IOS	IOS:15	intrinsic optical signal
IOUS	IOUS:42	intraoperative ultrasonography
IOUS	IOUS:52	intraoperative ultrasound
IOV	IOV:10	insideout vesicles
IOV	IOV:6	interoccasion variability
IO	IO:32	inferior oblique
IO	IO:10	inferior olivary
IO	IO:84	inferior olive
IO	IO:9|I-O:4|i-o:1	insideout
IO	IO:36	intraosseous
IO	IO:6	transection of the infraorbital
IP-10	IP-10:36	interferoninducible protein
IP-10	IP-10:3|IP10:1	protein  kda
IP3	IP3:6	inositol phosphate
IP3	IP3:11	inositoltrisphosphate
IPA	IPA:29	immunoperoxidase assay
IPA	IPA:12	immunoprecipitation assay
IPA	IPA:36	independent practice association
IPA	IPA:9	indolepropionic acid
IPA	IPA:11	international pharmaceutical abstracts
IPA	IPA:122	invasive pulmonary aspergillosis
IPA	IPA:19	isopropanol
IPA	IPA:46	isopropyl alcohol
IPC	IPC:6	ifnalpha producing cells
IPC	IPC:54	intermittent pneumatic compression
IPC	IPC:7	intraperitoneal chemotherapy
IPC	IPC:29	intrapulmonary chemoreceptors
IPC	IPC:7	ionpair chromatography
IPD	IPD:150|iPD:8	idiopathic parkinsons disease
IPD	IPD:8|iPD:1	idiopathic pd
IPD	IPD:17	immediate pigment darkening
IPD	IPD:25	individual patient data
IPD	IPD:20	interpupillary distance
IPD	IPD:47	invasive pneumococcal disease
IPD	IPD:10	iterated prisoners dilemma
IPE	IPE:16	interprofessional education
IPE	IPE:24	iris pigment epithelial
IPE	IPE:20	iris pigment epithelium
IPF	IPF:619	idiopathic pulmonary fibrosis
IPF	IPF:7	immune protection factor
IPG	IPG:58	impedance plethysmography
IPG	IPG:9	inositol phosphoglycan
IPG	IPG:10	pulse generator
IPH	IPH:75	idiopathic portal hypertension
IPH	IPH:16	idiopathic pulmonary haemosiderosis
IPH	IPH:32	idiopathic pulmonary hemosiderosis
IPH	IPH:10	intraparenchymal hemorrhage
IPH	IPH:6	isolated postchallenge hyperglycemia
IPK	IPK:1	isolated and perfused rat kidney
IPK	IPK:23	isolated perfused kidney
IPL	IPL:10	inferior parietal lobe
IPL	IPL:35	inferior parietal lobule
IPL	IPL:410|ipl:1	inner plexiform layer
IPL	IPL:47	intense pulsed light
IPL	IPL:1	isolated and perfused rat lung
IPL	IPL:9	isolated perfused liver
IPM	IPM:71	integrated pest management
IPM	IPM:104	interphotoreceptor matrix
IPM	IPM:15	isophosphoramide mustard
IPM	IPM:51	isopropyl myristate
IPNS	IPNS:56	isopenicillin n synthase
IPNS	IPNS:17	isopenicillin n synthetase
IPN	IPN:28	infectious pancreatic necrosis
IPN	IPN:13	interpenetrating network
IPN	IPN:13	interpenetrating polymer network
IPN	IPN:6	polymer networks
IPP	IPP:11	ileal peyers patch
IPP	IPP:8	induratio penis plastica
IPP	IPP:16	inflatable penile prosthesis
IPP	IPP:17	intraperitoneal pressure
IPP	IPP:76	isopentenyl diphosphate
IPP	IPP:31	isopentenyl pyrophosphate
IPSS	IPSS:20	inferior petrosal sinus sampling
IPSS	IPSS:62	international prognostic scoring system
IPS	IPS:34	idiopathic pneumonia syndrome
IPS	IPS:14	individual placement and support
IPS	IPS:27	inferior petrosal sinus
IPS	IPS:28	inspiratory pressure support
IPS	IPS:6	interim payment system
IPS	IPS:58	intermittent photic stimulation
IPS	IPS:10	international prognostic score
IPS	IPS:7	intracellular polysaccharide
IPS	IPS:66|IPs:2|iPs:1	intraparietal sulcus
IPS	IPS:5	iodophilic polysaccharide
IPS	IPS:14|Ips:1	ipsapirone
IPT	IPT:7	intermittent preventive treatment
IPT	IPT:75	interpersonal psychotherapy
IPT	IPT:15	interpersonal therapy
IPV	IPV:9	infectious pustular vulvovaginitis
IPV	IPV:186	intimate partner violence
IPV	IPV:12	intraperitoneal volume
IP	IP:12	idiopathic parkinsonism
IP	IP:19	imaging plate
IP	IP:14	immunophenotype
IP	IP:60	immunoprecipitation
IP	IP:10	inphase
IP	IP:87|Ip:1	incontinentia pigmenti
IP	IP:30	inflammatory polyarthritis
IP	IP:35	integrated project
IP	IP:18	interference pattern
IP	IP:53	interphalangeal
IP	IP:9	interpositus nucleus
IP	IP:80	interstitial pneumonitis
IP	IP:29	intestinal permeability
IP	IP:33	inverted papilloma
IP	IP:14|Ip:1	ionization potential
IP	IP:22	ipriflavone
IP	IP:26	ischaemic preconditioning
IP	IP:6	nucleus interpositus
IP	IP:6|ip:5	peripheral
IP	IP:3	planning nutrition and parasite control project
IP	IP:21	prostacyclin receptor
IRA	IRA:17	colectomy with ileorectal anastomosis
IRA	IRA:6	immunoradiometric assay
IRES	IRES:124	internal ribosomal entry site
IRES	IRES:35	internal ribosome entry segment
IRE	IRE:17	insulin response element
IRE	IRE:8	iron response element
IRF	IRF:25	idiopathic retroperitoneal fibrosis
IRF	IRF:9	immature reticulocyte fraction
IRF	IRF:11	impaired renal function
IRF	IRF:16	impulse response function
IR-GIP	IR-GIP:21|IRGIP:3	immunoreactive gastric inhibitory polypeptide
IR-GIP	IR-GIP:10	immunoreactive gip
IRG	IRG:22|IR-G:1	immunoreactive gastrin
IRG	IRG:157	immunoreactive glucagon
IRI	IRI:639|IR-I:2	immunoreactive insulin
IRI	IRI:6	insulin immunoreactivity
IRI	IRI:11	insulin level
IRI	IRI:7	insulinlike immunoreactivity
IRI	IRI:8	interpersonal reactivity index
IRL	IRL:8	inspiratory resistive load
IRL	IRL:20	inspiratory resistive loading
IRM	IRM:34	interference reflection microscopy
IRM	IRM:17	intermediate restorative material
IRMS	IRMS:9	isotope ratio mass spectrometer
IRMS	IRMS:41|IR-MS:2	isotope ratio mass spectrometry
IRR	IRR:29	insulin receptorrelated receptor
IRR	IRR:9	interrater reliability
IRR	IRR:8	intrarenal reflux
IRS	IRS:18	activation of the inflammatory response system
IRS	IRS:6	immune rabbit serum
IRS	IRS:4	immune rat serum
IRS	IRS:14	immunoreactive score
IRS	IRS:18	immunoreactive secretin
IRS	IRS:35	inner root sheath
IRS	IRS:93	insulin resistance syndrome
IRS	IRS:8	insulin response sequence
IRS	IRS:9	interferon response sequence
IRS	IRS:30	internal revenue service
IRT	IRT:66	immunoreactive trypsin
IRT	IRT:33	immunoreactive trypsinogen
IRT	IRT:11	infrared thermography
IRT	IRT:19	inhibitorresistant tem
IRT	IRT:17	intracoronary radiation therapy
IRT	IRT:90	item response theory
IR	IR:9|ir:3	calcitonin generelated peptide cgrpimmunoreactive
IR	IR:17	implantation rate
IR	IR:19	inactive renin
IR	IR:9	incomplete repair
IR	IR:21	inferior rectus
IR	IR:24	information retrieval
IR	IR:15	intermediate risk
IR	IR:16	internal rotation
IR	IR:8	ionizing irradiation
IR	IR:403|ir:1|I-R:1	ionizing radiation
IR	IR:34|I-R:18	ischaemiareperfusion
IR	IR:2|I-R:2	min of reperfusion
IR	IR:23	nearinfrared
ISAAC	ISAAC:155	international study of asthma and allergies in childhood
ISAAC	ISAAC:6	international study of asthma and allergy in children
ISAV	ISAV:47	infectious salmon anaemia virus
ISAV	ISAV:19	infectious salmon anemia virus
ISA	ISA:11	index of spouse abuse
ISA	ISA:22	infectious salmon anaemia
ISA	ISA:12	infectious salmon anemia
ISA	ISA:8	internal surface area
ISA	ISA:186	intrinsic sympathomimetic activity
ISA	ISA:6	isotopomer spectral analysis
ISD	ISD:7	infantile seborrheic dermatitis
ISD	ISD:37	intrinsic sphincter deficiency
ISF	ISF:126|isf:1	interstitial fluid
ISF	ISF:12	isosafrole
ISG	ISG:59	immune serum globulin
ISG	ISG:12	international study group
ISH	ISH:7	isocapnic hyperventilation
ISH	ISH:162	isolated systolic hypertension
ISH	ISH:109	situ hybridisation
ISI	ISI:116	international sensitivity index
ISI	ISI:19	interspike intervals
ISI	ISI:9	sensitivity indices
ISO	ISO:67	international organization for standardization
ISO	ISO:10	international standards organisation
ISO	ISO:68|Iso:13|iso:2	isoflurane
ISO	ISO:6|Iso:3	isometric
ISO	ISO:14	isoprinosine
ISP	ISP:9	intrasinus pressure
ISP	ISP:19	isepamicin
ISP	ISP:6	isovolumic systolic pressure
ISP	ISP:18	rieske ironsulfur protein
ISRs	ISRs:9	injection site reactions
ISRs	ISRs:9	insulin secretion rates
ISRs	ISRs:9	intergenic spacer regions
ISR	ISR:149	instent restenosis
ISR	ISR:21	induced systemic resistance
ISR	ISR:10|Isr:1	isradipine
ISSD	ISSD:7	infantile free sialic acid storage disease
ISSD	ISSD:9	infantile sialic acid storage disease
ISS	ISS:81	idiopathic short stature
ISS	ISS:17	immunostimulatory dna sequences
ISS	ISS:16	immunostimulatory sequences
ISS	ISS:9	internal state scale
ISS	ISS:159	international space station
ISS	ISS:7	international staging system
ISS	ISS:19	istituto superiore di sanita
IST	IST:12	inappropriate sinus tachycardia
IST	IST:9	insulin stress test
IST	IST:8	insulin suppression test
IST	IST:16	international stroke trial
ISV	ISV:13	internal spermatic vein
ISV	ISV:7	interstitial volume
ISVPs	ISVPs:10	infectious subvirion particles
ISVPs	ISVPs:6	intermediate subviral particles
ITAM	ITAM:96	immunoreceptor tyrosinebased activation motif
ITAM	ITAM:13	tyrosinebased activation motifs
ITB	ITB:16	iliotibial band
ITB	ITB:34	intrathecal baclofen
ITC	ITC:215	isothermal titration calorimetry
ITC	ITC:16	isothermal titration microcalorimetry
ITD	ITD:44	idiopathic torsion dystonia
ITD	ITD:9	impedance threshold device
ITD	ITD:1	interaural differences of time
ITD	ITD:7	interaural time
ITD	ITD:20	interaural time delay
ITD	ITD:5	ion trap detector
ITDs	ITDs:20	interaural temporal disparities
ITDs	ITDs:8	interaural time delays
ITDs	ITDs:69	interaural time differences
ITDs	ITDs:22	internal tandem duplications
ITE	ITE:28	intheear
ITE	ITE:10	intraining examination
ITF	ITF:11	infratemporal fossa
ITF	ITF:48	intestinal trefoil factor
ITF	ITF:5	tissue fluid
ITMS	ITMS:11	ion trap mass spectrometer
ITMS	ITMS:10	ion trap mass spectrometry
ITP	ITP:29	idiopathic thrombocytopenia
ITP	ITP:1091	idiopathic thrombocytopenic purpura
ITP	ITP:63	immune thrombocytopenia
ITP	ITP:32	intrathoracic pressure
ITP	ITP:10	ion transport peptide
ITP	ITP:12	isotachophoretic
ITS	ITS:12	internal transcribed spacer region
ITS	ITS:8	interrupted time series
ITS	ITS:5|ITs:1	interstitial telomeric sequences
ITT	ITT:6	immune tolerance therapy
ITT	ITT:91	intenttotreat
ITT	ITT:105|itt:1	intentiontotreat
ITT	ITT:6	intentiontotreat analysis
ITT	ITT:7	intestinal transit time
ITT	ITT:10	intratesticular testosterone
IT	IT:12	ca current
IT	IT:9	immune tolerance
IT	IT:63	inferior temporal
IT	IT:26	inferior temporal cortex
IT	IT:26	inferotemporal
IT	IT:17	inferotemporal cortex
IT	IT:212	information technology
IT	IT:5	information transfer
IT	IT:17	inspection time
IT	IT:8	intensive therapy
IT	IT:16	intermediate trophoblast
IT	IT:19	intratracheal instillation
IUFD	IUFD:37	intrauterine fetal death
IUFD	IUFD:9	intrauterine fetal demise
IUGR	IUGR:6	growth retarded fetuses
IUGR	IUGR:316	intrauterine growth restriction
IUGR	IUGR:850	intrauterine growth retardation
IUP	IUP:15	intraurethral pressure
IUP	IUP:52	intrauterine pregnancy
IUP	IUP:33	intrauterine pressure
IUT	IUT:19	intrauterine transfusion
IUT	IUT:8	utero transplantation
IU	IU:6	idiopathic uveitis
IU	IU:11	indiana university
IU	IU:7	intermediate uveitis
IVAP	IVAP:9	access port
IVAP	IVAP:11	vitro antibody production
IVBT	IVBT:9	vitro bleeding test
IVBT	IVBT:9	vitro bleeding time
IVCT	IVCT:11	isovolumic contraction time
IVCT	IVCT:46	vitro contracture test
IVDA	IVDA:28	intravenous drug abuse
IVDA	IVDA:24|ivDA:1	intravenous drug addicts
IVD	IVD:14	interactive videodisc
IVD	IVD:40	intervertebral disc
IVD	IVD:22	ischemic vascular dementia
IVD	IVD:22	isovalerylcoa dehydrogenase
IVD	IVD:12	vitro diagnostic
IVF	IVF:6	fertilization in vitro
IVF	IVF:16	idiopathic ventricular fibrillation
IVF	IVF:48	invitro fertilisation
IVF	IVF:10	intravenous fluid
IVF	IVF:145	vitro fertilisation
IVF	IVF:1931|ivf:1	vitro fertilization
IVH	IVH:76	intravenous hyperalimentation
IVH	IVH:118	intraventricular haemorrhage
IVIG	IVIG:10|IVIg:1	intravenous igg
IVIG	IVIG:22|IVIg:9|ivIG:2	intravenous immunoglobulin g
IVIG	IVIG:8|IVIg:1|ivIg:1	intravenous immunoglobulin preparations
IVIG	IVIG:8|IVIg:5	intravenous immunoglobulin therapy
IVIVC	IVIVC:13|IV-IVC:2	vitroin vivo correlation
IVIVC	IVIVC:7	vivo correlations
IVL	IVL:25	intravascular lymphoma
IVL	IVL:17	intravenous leiomyomatosis
IVL	IVL:10	vitro lipogenesis
IVM	IVM:23	intravital microscopy
IVM	IVM:9	maturation in vitro
IVM	IVM:186	vitro maturation
IVN	IVN:4|ivn:2	inferior ventricular nerve
IVN	IVN:25|ivn:1	intravenous nutrition
IVP	IVP:16	excretory urogram
IVP	IVP:107|ivp:1	intravenous pyelography
IVP	IVP:34	intraventricular pressure
IVP	IVP:11	intravesical pressure
IVP	IVP:8	vitro embryo production
IVP	IVP:18	vitro production
IVRA	IVRA:24	intravenous regional anaesthesia
IVRA	IVRA:44	intravenous regional anesthesia
IVR	IVR:38	interactive voice response
IVR	IVR:7	intramolecular vibrational energy redistribution
IVR	IVR:9	isovolumetric regulation
IVS	IVS:20	interventricular septal
IVS	IVS:7	interventricular septum thickness
IVS	IVS:6	intravaginal electrical stimulation
IVS	IVS:9	intravaginal slingplasty
IVS	IVS:13	vitro sensitization
IVS	IVS:7	vitro stimulation
IVUS	IVUS:30	intravascular ultrasonography
IVUS	IVUS:818	intravascular ultrasound
IVUS	IVUS:19	intravascular ultrasound imaging
IAS	IAS:10	illness attitude scales
IAS	IAS:9	image analysis system
IAS	IAS:13	insulin autoimmune syndrome
IAS	IAS:25	interatrial septum
IAS	IAS:9	intermittent androgen suppression
IAS	IAS:140	internal anal sphincter
IA	IA:21|iA:1	acurrent
IA	IA:15	atype k current
Ia	Ia:28	class ii mhc
IA	IA:16	idiopathic anaphylaxis
IA	IA:21	immune adherence
Ia	Ia:10	immuneassociated
IA	IA:56	immunoadsorption
IA	IA:8	induced abortion
IA	IA:10	infantile autism
IA	IA:11	infarct area
IA	IA:16	inflammatory arthritis
IA	IA:25	inhibitory avoidance
IA	IA:7	innominate artery
IA	IA:20	insulin antibodies
IA	IA:13	interarytenoid
IA	IA:10	intestinal atresia
IA	IA:15	intimal area
IA	IA:12	intraabdominal
IA	IA:16	intracranial aneurysm
IA	IA:116	invasive aspergillosis
IA	IA:18	transient k current
IA	IA:14|Ia:1	transient potassium current
IB	IB:12	binding
IB	IB:44	infectious bronchitis
IB	IB:10	intrinsic bursting
IB	IB:16	intrinsically bursting
IB	IB:63	ipratropium bromide
IC	IC:10	iliac crest
IC	IC:20|Ic:1	immunocytoma
IC	IC:9	impoverished
IC	IC:8	impoverished condition
IC	IC:15	impression cytology
IC	IC:10	imprint cytology
IC	IC:23	imprinting center
IC	IC:27	indeterminate colitis
IC	IC:36|Ic:1	indirect calorimetry
IC	IC:20	infection control
IC	IC:8	infectious centers
IC	IC:15	inferior cardiac
IC	IC:22	inferior collicular
IC	IC:494	inferior colliculus
IC	IC:18	informed consent
ic	IC:6|ic:6	inoculated intracerebrally
IC	IC:110	inspiratory capacity
IC	IC:15	integrated circuit
IC	IC:7	integrated concentration
IC	IC:11	intercalated
IC	IC:23	intercellular communication
IC	IC:10	intercostal
IC	IC:20	intermediate compartment
IC	IC:11	intermittent catheterization
IC	IC:123|Ic:1	intermittent claudication
IC	IC:29|ic:3	internal capsule
IC	IC:10	internal carotid artery
IC	IC:24	internal control
IC	IC:271	interstitial cystitis
IC	IC:7|ic:2	intracameral
IC	IC:33|ic:23	intracerebral
ic	ic:9|IC:8	intracisternally
IC	IC:8	invasive cancer
IC	IC:21	ion chromatographic
IC	IC:131	ion chromatography
IC	IC:6	ischaemic cardiopathy
IC	IC:5	ischemic cardiopathy
IC	IC:18	ischiocavernosus
IC	IC:8	systemic immunecomplex
Id	Id:33|id:1	antiidiotype
ID	ID:30|Id:1	identification
ID	ID:22|Id:1|id:1	identifier
Id	Id:31|ID:2|id:2	idiotypic
ID	ID:116	immunodiffusion
ID	ID:19	incidence density
ID	ID:8	index of difficulty
ID	ID:12	infantdirected
ID	ID:8	infective dermatitis
ID	ID:4|Id:4|id:1	inhibitor of differentiation
Id	Id:6|ID:1	inhibitor of dna binding
ID	ID:36|id:2	injected dose
ID	ID:41	internal derangement
ID	ID:25	iodine deficiency
ID	ID:66	iron deficiency
ID	ID:14	isotope dilution
ID	ID:8	microm inner diameter
ID	ID:9|I-D:1	onedimensional
ID	ID:5	primary immunodeficiency
IE	IE:6	idiopathic epilepsy
IE	IE:10	idiopathic erythrocytosis
IE	IE:422	infective endocarditis
IE	IE:8	isometric exercise
IE	IE:15	patients with infectious endocarditis
IFG	IFG:142	impaired fasting glucose
IFG	IFG:13	impaired fasting glycaemia
IFG	IFG:10	impaired fasting glycemia
IFG	IFG:47|ifg:1	inferior frontal gyrus
IGD	IGD:9	interglobular domain
IGD	IGD:5	isolated gonadotropin deficiency
IgH	IgH:12|Igh:1	ig heavychain
IgH	IgH:9|Igh:1	immunoglobulin h
IgH	IgH:36|IGH:5	immunoglobulin heavy
IGP	IGP:7	imidazole glycerol phosphate
IGP	IGP:19|IgP:1	intragastric pressure
IGR	IGR:10	impaired glucose regulation
IGR	IGR:21	insect growth regulator
IGR	IGR:5	integrated gastrin response
IGS	IGS:6	immuno gold staining
IGS	IGS:10	immunogold staining
IGS	IGS:155	intergenic spacer
IGS	IGS:13	internal guide sequence
IG	IG:7|ig:2	administered intragastrically
IG	IG:1	flavors that were paired with intragastric
Ig	Ig:9	gating current
Ig	Ig:26	immunoglobin
IG	IG:11|ig:2	intergenic
IG	IG:23|ig:5	intervention group
IG	IG:5	intraductal growth
IM	IM:18|im:4	administered intramuscularly
IM	IM:10|Im:5	imatinib mesylate
IM	IM:9	induced motion
IM	IM:13	infant mortality
IM	IM:20	infantile myofibromatosis
IM	IM:429|Im:3	infectious mononucleosis
IM	IM:9	inflammatory myopathy
IM	IM:31	inner medulla
IM	IM:12	inner medullary
IM	IM:26|Im:1	inner membrane
IM	IM:14	intermetatarsal
IM	IM:18	internal mammary
IM	IM:48	internal medicine
IM	IM:14	interstitial macrophages
IM	IM:5	interval mapping
IM	IM:268	intestinal metaplasia
IM	IM:5	intracellular membranes
IM	IM:15|im:6	intrahepatic metastasis
IM	IM:63|Im:2	intramedullary
IM	IM:10	intramembranous
IM	IM:377|im:118|Im:1	intramuscular
IM	IM:34|Im:2	mcurrent
ISC	ISC:16	igsecreting cells
ISC	ISC:19|Is-c:1	indian subcontinent
ISC	ISC:9	intermittent selfcatheterization
ISC	ISC:11	interstrand crosslinks
ISC	ISC:14|isc:1	intersystem crossing
ISC	ISC:6	ironsulfur cluster
IS	IS:34|is:1	idiopathic scoliosis
IS	IS:7	immune serum
IS	IS:18	immune system
IS	IS:25	immunological synapse
IS	IS:52	immunoscintigraphy
IS	IS:9	immunostaining
IS	IS:13	immunosuppressed
IS	IS:30	immunosuppression
IS	IS:34	immunosuppressive
IS	IS:11	immunosuppressive substance
IS	IS:15	incentive spirometry
IS	IS:11	indoxyl sulfate
IS	IS:55	induced sputum
IS	IS:32	inescapable shock
IS	IS:72|Is:2	infantile spasms
IS	IS:144|Is:4	infarct size
IS	IS:20	initial segment
IS	IS:10	inner segments
IS	IS:7|Is:3	insertion
IS	IS:12|Is:1	ischaemic stroke
IS	IS:59|Is:4	ischemic stroke
IS	IS:8	isotonic saline
JAS	JAS:7|Jas:5	jasplakinolide
JAS	JAS:70	jenkins activity survey
JA	JA:15	jasmonate
JA	JA:195	jasmonic acid
JA	JA:39	juvenile arthritis
JCML	JCML:52	juvenile chronic myelogenous leukemia
JCML	JCML:8|jCML:1	juvenile chronic myeloid leukaemia
JCML	JCML:14|jCML:1	juvenile chronic myeloid leukemia
JCV	JCV:28	human polyomavirus jc
JCV	JCV:14	jc polyomavirus
JE	JE:433	japanese encephalitis
JE	JE:59	junctional epithelium
JGCT	JGCT:12	juvenile granulosa cell tumor
JGCT	JGCT:7	juxtaglomerular cell tumor
JH	JH:9	h secretion
JH	JH:12	juvenile hemochromatosis
JMML	JMML:11	juvenile myelomonocytic leukaemia
JMML	JMML:78	juvenile myelomonocytic leukemia
JM	JM:38	juxtamedullary
JM	JM:41	juxtamembrane
JNCL	JNCL:9	juvenile ncl
JNCL	JNCL:25	juvenile neuronal ceroid lipofuscinosis
JPS	JPS:10	japan pancreas society
JPS	JPS:12	joint position sense
JPS	JPS:11	juvenile polyposis syndrome
JP	JP:12	joining peptide
JP	JP:10	juvenile papillomatosis
JP	JP:18	juvenile parkinsonism
JP	JP:80	juvenile periodontitis
JP	JP:17	juvenile polyposis
JP	JP:10	psychotropic drugs in japanese pharmacopoeia
Jv	Jv:32|JV:6	fluid absorption
Jv	Jv:3|JV:2	fluid absorption rate
Jv	Jv:10|JV:6	fluid reabsorption
Jv	Jv:5	net water flux
Jv	Jv:11	volume flux
Jv	Jv:6|JV:1	water flow
K(m)	K(m):94|K(M):4|k(M):1	michaelis constant
K(m)	K(m):56|k(m):1	michaelismenten constant
K8/18	K8/18:8	keratins  and 
K8/18	K8/18:11	keratin polypeptides  and 
KAP	KAP:20|Kap:2	kidney androgenregulated protein
KAP	KAP:1	knowledge attitude and practice
KBD	KBD:8	diffusive mass transport coefficients
KBD	KBD:23	kashinbeck disease
KB	KB:31|Kb:11	dissociation constant
KB	KB:11	human oral epidermoid carcinoma
KB	KB:7|K-B:2	kleihauerbetke
KB	KB:13	knowledge base
KCO	KCO:15	carbon monoxide transfer coefficient
KCO	KCO:13	channel opener
KCO	KCO:4	per unit lung volume
KCs	KCs:45	keratinocytes
KCs	KCs:75	kupffer cells
KCl	KCl:6	high potassium
KCl	KCl:263|KCL:4	potassium chloride
KC	KC:20	kangaroo care
KC	KC:26	keratinocyte
KC	KC:8	keratinocyte chemoattractant
KC	KC:15	keratinocytederived chemokine
KC	KC:18	keratoconus
KDO	KDO:26|Kdo:1	ketodeoxyoctonate
KDO	KDO:12|Kdo:2	deoxydmannooctulosonate
KDR	KDR:10	kinase domain receptor
KDR	KDR:34|kdr:2	kinase insert domaincontaining receptor
KDR	KDR:7	kinase insert domaincontaining region
KDR	KDR:7	kinase insert domain receptor
KDR	KDR:6	receptor 
Ke	Ke:3|ke:2	elimination rate
KE	KE:9	kinetic energy
KE	KE:21	knee extension
Ke	Ke:6	total exchangeable potassium
KFD	KFD:15	kikuchifujimoto disease
KFD	KFD:18	kyasanur forest disease
KGFR	KGFR:21	keratinocyte growth factor receptor
KGFR	KGFR:33|KGF-R:3|KgfR:1	kgf receptor
KGM	KGM:22	keratinocyte growth medium
KGM	KGM:9	konjac glucomannan
KHB	KHB:12	krebshenseleit bicarbonate
KHB	KHB:13	krebshenseleit bicarbonate buffer
KHC	KHC:17|Khc:3	kinesin heavy chain
KHC	KHC:16	kurosawa and kusanagihypercholesterolemic
KHN	KHN:7	knoop hardness
KHN	KHN:16	knoop hardness number
KH	KH:13	ketamine hydrochloride
KH	KH:59|K-H:44	krebshenseleit
KIC	KIC:29|KIc:8	fracture toughness
KIC	KIC:14	ketoisocaproate
KID	KID:16	keratitisichthyosisdeafness
KID	KID:9	kinaseinducible domain
KLC	KLC:9	keratosis lichenoides chronica
KLC	KLC:10|Klc:2	kinesin light chain
KLH	KLH:175	keyhole limpet haemocyanin
KLH	KLH:627	keyhole limpet hemocyanin
KLH	KLH:11	keyhole limpet hemocyanine
KO	KO:747|ko:20|Ko:2|-KO:1	knockout
KO	KO:9	knockout mice
KPI	KPI:19	karyopyknotic index
KPI	KPI:47	protease inhibitor
KRB	KRB:13	krebsringer bicarbonate buffer
KRB	KRB:10	krebsringer bicarbonate solution
KR	KR:12	ketoreductase
KR	KR:9	knotted reactor
KR	KR:66	knowledge of results
KSHV	KSHV:20|kshv:1	kaposis sarcomaassociated herpes virus
KSHV	KSHV:349	kaposis sarcomaassociated herpesvirus
KSP	KSP:77	karolinska scales of personality
KSP	KSP:15	lysserpro
KSS	KSS:97	kearnssayre syndrome
KSS	KSS:9	knee society score
KSS	KSS:9	sleepiness scale
KS	KS:9	betaketoacyl synthase
KS	KS:21	kallmanns syndrome
KS	KS:7	karnofsky scale
KS	KS:58	kawasaki syndrome
KS	KS:150	keratan sulfate
KS	KS:48	keratan sulphate
KS	KS:10	ketosynthase
KS	KS:24	klinefelter syndrome
KS	KS:13|K-S:9	kolmogorovsmirnov
KS	KS:8	patients with klinefelters syndrome
Kt/V	Kt/V:10	dialysis adequacy
Kt/V	Kt/V:16	dialysis dose
Kt/V	Kt/V:11|KT/V:1	urea clearance
KTA	KTA:7	kidney transplant alone
KTA	KTA:10	kidney transplantation alone
KT	KT:12	keratinized tissue
KT	KT:17	ketorolac tromethamine
Kw	Kw:11|kw:3	weighted kappa
Kw	Kw:8|kw:2	weighted kappa statistic
KYN	KYN:30|Kyn:10|kyn:2	kynurenine
KYN	KYN:5|Kyn:2	receptor antagonist kynurenate
Ka	Ka:5|ka:2	absorption rate
KA	KA:10	acid ampakainate
KA	KA:810|Ka:87	kainic acid
KA	KA:18|Ka:4	kalaazar
Ka	Ka:5	weak acids
Kd	Kd:9|kd:7|KD:3|kD:1	degradation
Kd	Kd:5|kd:2	disappearance rate
KD	KD:3|Kd:2	dissociation constant values
KD	KD:44	ketogenic diet
KD	KD:6|kd:4	kinasedead
KD	KD:8	kinase domain
KD	KD:16|Kd:1	potassium depletion
KF	KF:8|Kf:5	dna polymerase i
Kf	Kf:9	filtration capacity
Kf	Kf:20	glomerular capillary ultrafiltration coefficient
KF	KF:21|Kf:2	klenow fragment
KF	KF:10	kollikerfuse
KF	KF:15	kollikerfuse nucleus
KF	KF:9	potassium fluoride
Ki-67	Ki-67:8|Ki67:2	proliferation marker
Ki-67	Ki-67:4|Ki67:2|ki-67:2	proliferative index
Kir6.2	Kir6.2:3|KIR6.2:1	inwardly rectifying potassium channel
Kir6.2	Kir6.2:8	poreforming subunit
Kir	Kir:7|KIR:3	inward rectifier k
Kir	Kir:4|KIR:1	inward rectifier potassium channels
KI	KI:12|Ki:1	karnofsky index
KI	KI:78	potassium iodide
Km	Km:5	apparent michaelis
Km	Km:6|KM:3	apparent michaelismenten
KM	KM:21|K-M:6	kaplanmeier
KM	KM:12	knowledge management
Km	Km:93|KM:7|kM:1|km:1	michaelis constants
Km	Km:25|KM:3	michaelismenten constants
KPS	KPS:63	karnofsky performance scale
KPS	KPS:49	karnofsky performance score
KPS	KPS:215	karnofsky performance status
KP	KP:11	kaiser permanente
KP	KP:10	kidneypancreas
KP	KP:5	knob protein
KP	KP:7	korsakoffs psychosis
KP	KP:13	kynurenine pathway
L-NIL	L-NIL:7|l-NIL:2|L-Nil:1	lniminoethyllysine
L-NIL	L-NIL:9	niminoethylllysine
L-NOARG	L-NOARG:11	lngnitro arginine
L-NOARG	L-NOARG:5|L-NOArg:3|L-Noarg:1	lngnitroarginine
L/D	L/D:11	leveldose
L/D	L/D:17|l/d:1	lightdark
L/P	L/P:45	lactatepyruvate
L/P	L/P:16	lymphplasma
L/P	L/P:21	lymphtoplasma protein concentration ratio
L1210	L1210:7	mouse leukemia cells
L1210	L1210:12|L-1210:1	murine leukemia
L1CAM	L1CAM:11|L1-CAM:3	cell adhesion molecule l
L1CAM	L1CAM:9|L1-CAM:1	l cell adhesion molecule
L1	L1:22	first language
L1	L1:8	first larval stage
L1	L1:23	firststage larvae
L1	L1:17	iron chelator deferiprone
L1	L1:53	line
L1	L1:9	major
L1	L1:10	native language
L1	L1:14	oral iron chelator dimethylhydroxypyridone
L2	L2:36	second language
L2	L2:5	second lumbar
L3	L3:22|L-3:1	infective
L3	L3:174	infective larvae
L3	L3:7	infective larval
L3	L3:13	infective stage larvae
L3	L3:4	infective thirdstage
L3	L3:38	infective thirdstage larvae
L3	L3:16	larva
L3	L3:8	third larval stage
L3	L3:11	third stage
L3	L3:69	third stage larvae
L4	L4:7	fourth larval stage
L4	L4:10	fourth lumbar
L4	L4:6	layer 
L6	L6:5	rat skeletal muscle cell line
L6	L6:11|L-6:1	sixth lumbar
LAAM	LAAM:25	alphaacetylmethadol
LAAM	LAAM:64	lalphaacetylmethadol
LAAM	LAAM:39	levoalphaacetylmethadol
LAA	LAA:28	laboratory animal allergy
LAA	LAA:129	left atrial appendage
LAA	LAA:7	leucocyte ascorbic acid
LAA	LAA:11	leukocyte adhesivenessaggregation
LAA	LAA:7	low attenuation areas
LABC	LABC:82	locally advanced breast cancer
LABC	LABC:12	locally advanced breast carcinoma
LABC	LABC:8|Labc:1	lymphadenosis benigna cutis
LAB	LAB:296	lactic acid bacteria
LAB	LAB:9	lactic acid bacterium
LAC	LAC:10|L-AC:3|L-Ac:3	lacetylcarnitine
LAC	LAC:72|LaC:1	la crosse
LAC	LAC:7	laparoscopicassisted colectomy
LAC	LAC:10	latin america and the caribbean
LAC	LAC:18	los angeles county
LADA	LADA:57	latent autoimmune diabetes in adults
LADA	LADA:8	latent autoimmune diabetes of the adult
LADA	LADA:5|LADa:2	left anterior descending artery
LAD	LAD:916|lad:1	left anterior descending
LAD	LAD:23	left anterior descending branch
LAD	LAD:25	left anterior descending coronary
LAD	LAD:35	left atrial diameter
LAD	LAD:37|LAd:1	left atrial dimension
LAD	LAD:23	left axis deviation
LAD	LAD:76	leukocyte adhesion deficiency
LAD	LAD:28	ligament augmentation device
LAD	LAD:10	linear iga dermatosis
LAD	LAD:37	linear iga disease
LAF	LAF:15	laminar air flow
LAF	LAF:9	lone atrial fibrillation
LAGB	LAGB:9	laparoscopic adjustable gastric band
LAGB	LAGB:94	laparoscopic adjustable gastric banding
LAI	LAI:10	adherence inhibition assay
LAI	LAI:34	leaf area index
LAI	LAI:5	leukemia associated inhibitor
LAI	LAI:155	leukocyte adherence inhibition
LAI	LAI:13	leukocyte adherence inhibition test
LAI	LAI:10	lupus activity index
LAL	LAL:197	limulus amebocyte lysate
LAL	LAL:7	limulus amebocyte lysate test
LAL	LAL:115	limulus amoebocyte lysate
LAL	LAL:11	long attack latency
LAL	LAL:9	lysate assay
LAL	LAL:18	lysinoalanine
LAL	LAL:41	lysosomal acid lipase
LAM-1	LAM-1:6	leucocyte adhesion molecule
LAM-1	LAM-1:7	leukocyte adhesion molecule
LAMP-1	LAMP-1:10|Lamp-1:3|LAMP1:1	lysosomeassociated membrane protein
LAMP-1	LAMP-1:9|LAMP1:3|Lamp1:2|lamp-1:2	membrane protein 
LAN	LAN:17|Lan:1	lanreotide
LAN	LAN:54	local area network
L-AP4	L-AP4:3	group iii mglur agonist laminophosphonobutyrate
L-AP4	L-AP4:11|l-AP4:2|LAP4:1|l-AP-4:1	laminophosphonobutanoate
LAP	LAP:10	laminaassociated polypeptide
LAP	LAP:19|lap:3	laparotomy
LAP	LAP:12	leucine amino peptidase
LAP	LAP:220|lap:2|Lap:1	leucine aminopeptidase
LAP	LAP:55|l-AP:1	leukocyte alkaline phosphatase
LAP	LAP:8	lipid aassociated protein
LAP	LAP:6	liver activator protein
LAP	LAP:6	liverenriched activating protein
LAP	LAP:23	lysosomal acid phosphatase
LAR	LAR:5	antigenrelated phosphatase
LAR	LAR:7	late allergic reaction
LAR	LAR:11	leaf area ratio
LAR	LAR:23	leukocyte common antigenrelated
LAR	LAR:6	locus activation region
LAR	LAR:12	longacting release
LAR	LAR:46	low anterior resection
LAR	LAR:7	lymphatic absorption rate
LASEK	LASEK:26|LasEk:2	laserassisted subepithelial keratectomy
LASEK	LASEK:27	laser epithelial keratomileusis
LASEK	LASEK:14	laser subepithelial keratomileusis
LAS	LAS:7	 microv
LAS	LAS:11	lateral amyotrophic sclerosis
LAS	LAS:8	linear alkyl benzene sulfonate
LAs	LAs:9	local anaesthetics
LAs	LAs:40	local anesthetics
LAS	LAS:8	low amplitude signal
LAs	LAs:22	lupus anticoagulants
LAS	LAS:78	lymphadenopathy syndrome
LAT	LAT:5	llysine epsilonaminotransferase
LAT	LAT:18	lactic acidosis threshold
LAT	LAT:74	linker for activation of t cells
LAT	LAT:4|lat:2	lysine epsilonaminotransferase
LAT	LAT:12	lysolecithin acyltransferase
LAVH	LAVH:52	laparoscopically assisted vaginal hysterectomy
LAVH	LAVH:11	vaginal hysterectomies
LAV	LAV:8	left atrial volume
LAV	LAV:43	lymphadenopathyassociated virus
LAMP	LAMP:38	limbic systemassociated membrane protein
LAMP	LAMP:43	loopmediated isothermal amplification
LAM	LAM:40	lactational amenorrhea method
LAM	LAM:9	levator ani muscle
LAM	LAM:50	pulmonary lymphangioleiomyomatosis
LAM	LAM:12	pulmonary lymphangiomyomatosis
LA	LA:110|La:3	lactic acid
LA	LA:10	lactic acidosis
LA	LA:30	laparoscopic adrenalectomy
LA	LA:60	laparoscopic appendectomy
LA	LA:7	large aggregates
LA	LA:9	large aspiny
LA	LA:7	large surfactant aggregates
LA	LA:12	laser ablation
LA	LA:32	lateral amygdala
LA	LA:29	lateral nucleus of the amygdala
LA	LA:155	latex agglutination
LA	LA:13	left atria
LA	LA:224	left atrium
LA	LA:9|La:6	leucoagglutinin
LA	LA:9|L-A:1|La:1	leukoagglutinin
LA	LA:24	leukoaraiosis
LA	LA:34	linoleic
LA	LA:396	linoleic acid
LA	LA:44	local anaesthesia
LA	LA:34	localized adherence
LA	LA:10	longacting
LA	LA:21	los angeles
LA	LA:8	low affinity
LA	LA:9	low altitude
LA	LA:7|L-A:2	lowaverage
LA	LA:27	lumen area
LA	LA:14	lyme arthritis
LA	LA:10	lymphadenectomy
LA	LA:6	lymphoid aggregates
LBD	LBD:20	left braindamaged
LBD	LBD:20	lewy body dementia
LBD	LBD:39	lewy body disease
LBD	LBD:12	patients with left brain damage
LBP	LBP:5	ligand binding pocket
LBP	LBP:71	lipopolysaccharide binding protein
LBP	LBP:535|lbp:1	low back pain
LBP	LBP:10	lycium barbarum polysaccharide
LBT	LBT:21	lupus band test
LBT	LBT:15	lymphocyte blast transformation
LBV	LBV:14	lewy body variant
LBV	LBV:9	lewy body variant of ad
LCA	LCA:31	latent class analysis
LCA	LCA:98	left coronary artery
LCA	LCA:31	lens culinaris
LCA	LCA:13	lentil lectin
LCA	LCA:13	littoral cell angioma
LCA	LCA:10	longitudinal chromatic aberration
LCA	LCA:7	lymphocytotoxic activity
LCA	LCA:20	lymphocytotoxic antibodies
LCD	LCD:17	lattice corneal dystrophy
LCD	LCD:36	liquid crystal display
LCD	LCD:26	liver cell dysplasia
LCD	LCD:10	lowcalorie diet
LCF	LCF:10	lymphocyte chemoattractant factor
LCF	LCF:8	lymphocyte chemotactic factor
LCG	LCG:16	cell granulomatosis
LCG	LCG:7	liquid cooling garment
LCIS	LCIS:8	light chain isotype suppression
LCIS	LCIS:114|LCIs:1	lobular carcinoma in situ
LCI	LCI:13	lung clearance index
LCI	LCI:8|LC-I:1	myosin light chain i
LCLs	LCLs:7	large cell lymphomas
LCLs	LCLs:237|LCL-s:1	lymphoblastoid cell lines
LCL	LCL:32	lateral collateral ligament
LCL	LCL:34	localized cutaneous leishmaniasis
LCL	LCL:10	luminol chemiluminescence
LCL	LCL:8	lymphoblastoid cells
LCM	LCM:168	laser capture microdissection
LCM	LCM:12	lincomycin
LCM	LCM:12|L-CM:1	lymphocyteconditioned medium
LCM	LCM:140	lymphocytic choriomeningitis
LCN	LCN:44|LCn:1	lateral cervical nucleus
LCN	LCN:13|lcn:1	low copy number
LCP	LCP:5	lectin complement pathway
LCP	LCP:12	leggcalveperthes
LCP	LCP:13	locking compression plate
LCR	LCR:7	laparoscopic colon resection
LCR	LCR:21	laryngeal chemoreflex
LCR	LCR:176	ligase chain reaction
LCS	LCS:12	laparosonic coagulating shears
LCS	LCS:8	low contact stress
LCT	LCT:11	liquid crystal thermography
LCT	LCT:8	lower critical temperature
LCT	LCT:15	lymphocytotoxicity test
LC	LC:35|L-C:12	lcarnitine
LC	LC:11	lab chow
LC	LC:8|lc:3	lactobacillus casei
LC	LC:10	lake casitas
LC	LC:14	lamina cribrosa
LC	LC:9	lateral column
LC	LC:6	leukemia cutis
LC	LC:24	lightcycler
LC	LC:367	liquid chromatographic
LC	LC:14	liquid crystalline
LC	LC:390	liver cirrhosis
LC	LC:70	local control
LC	LC:120	locus ceruleus
LC	LC:1365|Lc:1	locus coeruleus
LC	LC:11	lowcarbohydrate
LC	LC:25	lumped constant
LC	LC:72	lung cancer
LC	LC:12	lysine clonixinate
LD50	LD50:35	acute toxicity
LD50	LD50:1	lethal dose at 
LDA	LDA:10	larval development assay
LDA	LDA:16	laser doppler anemometer
LDA	LDA:32	laser doppler anemometry
LDA	LDA:18	left displaced abomasum
LDA	LDA:10|lda:1	left displacement of the abomasum
LDA	LDA:90	limiting dilution analysis
LDA	LDA:136	linear discriminant analysis
LDA	LDA:10	local density approximation
LDA	LDA:11	low density area
LDA	LDA:7	lowdose aspirin
LDF	LDF:37	laser doppler flowmeter
LDF	LDF:415	laser doppler flowmetry
LDF	LDF:39|LDf:1	laser doppler fluxmetry
LDF	LDF:9	linear discriminant function
LDH	LDH:9	dehydrogenase level
LDH	LDH:26	lactate dehydrogenase activity
LDH	LDH:14	lactate dehydrogenase release
LDH	LDH:18	lactatedehydrogenase
LDH	LDH:10	layered double hydroxide
LDH	LDH:9	lowdose heparin
LDH	LDH:14	lumbar disc herniation
LDH	LDH:101	serum lactic dehydrogenase
LDI	LDI:10	laser desorptionionization
LDI	LDI:13	laser doppler imager
LDI	LDI:35	laser doppler imaging
LDI	LDI:9	laser doppler interferometry
LDI	LDI:6	learning disability index
LDLR	LDLR:8|Ldlr:1	ldl receptor gene
LDLR	LDLR:10	low density lipoprotein receptor gene
LDLs	LDLs:9	loudness discomfort levels
LDLs	LDLs:124	lowdensity lipoproteins
LDR	LDR:19	detection reaction
LDR	LDR:11	longdistance runners
LDS	LDS:11	lipodermatosclerosis
LDS	LDS:13	lithium dodecyl sulfate
LDT	LDT:14	lexical decision task
LDT	LDT:15	lymphocyte doubling time
LDV	LDV:114	lactate dehydrogenaseelevating virus
LDV	LDV:42	lactic dehydrogenase virus
LDV	LDV:9	laser doppler velocimeter
LDV	LDV:75	laser doppler velocimetry
LDV	LDV:11	vesicles
LD	LD:8|L-D:1	ldopa
LD	LD:17	lamina densa
LD	LD:11	lateral dorsal
LD	LD:10	laterodorsal
LD	LD:93	latissimus dorsi
LD	LD:68	legionnaires disease
LD	LD:6|Ld:3	leishmania donovani
ld	ld:11|LD:3|Ld:1	lesion depth
LD	LD:66	levodopa
ld	ld:20|Ld:2	limb deformity
LD	LD:43	limiting dilution
LD	LD:63	linear dichroism
LD	LD:34	lipodystrophy
LD	LD:20	loading dose
LD	LD:29|Ld:1|ld:1	longissimus dorsi
LD	LD:30	low density
LD	LD:12	lumen diameter
LD	LD:9	luminancedefined
LD	LD:84	lyme disease
LD	LD:10	lymphocytic depletion
LD	LD:39	patients with limited disease
LD	LD:9	photoperiod
LD	LD:29	under lightdark
LECs	LECs:127	lens epithelial cells
LECs	LECs:14	lymphatic endothelial cells
LEC	LEC:9	cinnamonlike coat color
LEC	LEC:26	lateral entorhinal cortex
LEC	LEC:10	leprosy elimination campaign
LEC	LEC:160	longevans cinnamon
LEC	LEC:7	lymphoepithelial carcinoma
LEC	LEC:10	lymphoepithelial cyst
LEH	LEH:14	linear enamel hypoplasia
LEH	LEH:36	liposomeencapsulated hemoglobin
LEM	LEM:24	endogenous mediator
LEM	LEM:9	lentinus edodes mycelia
LEP	LEP:7	leptin gene
LEP	LEP:11	limited english proficiency
LEP	LEP:8	lupus erythematosus profundus
LES	LES:6	lamberteaton syndrome
LES	LES:763|les:1	lower esophageal sphincter
LETO	LETO:7	longevans tokushima
LETO	LETO:83	longevans tokushima otsuka
LET	LET:6	esterase test
LET	LET:335	linear energy transfer
LET	LET:9	lupus erythematosus tumidus
Le	Le:8|LE:1	huifnalpha
LE	LE:7	labelling efficiency
LE	LE:9	lateral epicondylitis
LE	LE:6	left ear
LE	LE:7	leg exercise
LE	LE:7	leg extension
LE	LE:6	lens epithelial
LE	LE:17	leucine enkephalin
LE	LE:18	leukocyte elastase
LE	LE:28	leukocyte esterase
Le	Le:51|LE:7	lewis
LE	LE:10	life events
LE	LE:10	liquidexpanded
LE	LE:10	liver extract
LE	LE:18	local excision
LE	LE:18	longevans rats
LE	LE:15	loteprednol etabonate
LE	LE:34	lower extremity
LE	LE:6	luminal epithelial
LE	LE:31	luminal epithelium
LE	LE:307	lupus erythematosus
LE	LE:11|-LE:1	lymphedema
LF/HF	LF/HF:16	low frequencyhigh frequency
LF/HF	LF/HF:5	sympathovagal balance
LFA-1	LFA-1:10	functionassociated ag
LFA-1	LFA-1:13	function associated antigen
LFA-1	LFA-1:11	functionassociated molecule
LFA	LFA:22	limax flavus
LFA	LFA:30	limax flavus agglutinin
LFS	LFS:72	leukemiafree survival
LFS	LFS:77	lifraumeni syndrome
LF	LF:1	fed either a lowfat
LF	LF:370|Lf:185	lactoferrin
LF	LF:12	laparoscopic fundoplication
LF	LF:12	laser fluorescence
LF	LF:10	lassa fever
LF	LF:12	lateral funiculus
LF	LF:13	lipofuscin
LF	LF:6	liver function
LF	LF:18	local failure
LF	LF:39	low fat
LF	LF:9	low flow
LF	LF:8	low frequency band
LF	LF:35	lymphatic filariasis
LF	LF:7	lymphoid follicles
LGA	LGA:11	left gastric artery
LGA	LGA:35	local government area
LGE	LGE:32	lateral ganglionic eminence
LGE	LGE:9	linear gingival erythema
LGL	LGL:17	large granular lymphocytic
LGL	LGL:3	patients with lowgrade lymphoma
LGMD	LGMD:8	giant movement detector
LGMD	LGMD:19	muscular dystrophies
LGM	LGM:16	last glacial maximum
LGM	LGM:11	lymphogranulomatosis
LGS	LGS:8|LG-S:3	lateral gastrocnemiussoleus
LGS	LGS:69	lennoxgastaut syndrome
LGV	LGV:10	large granular vesicles
LGV	LGV:12	left gastric vein
LGV	LGV:72	lymphogranuloma venereum
LG	LG:9	granules
LG	LG:22	lacrimal gland
LG	LG:10	lateral gastric
LG	LG:87	lateral gastrocnemius
LG	LG:17	lateral giant
LG	LG:41	linkage group
LG	LG:6	loop gain
LH/CG	LH/CG:13	luteinizing hormonechorionic gonadotropin
LH/CG	LH/CG:10	lutropinchoriogonadotropin
LHCII	LHCII:31|LHC-II:5	lightharvesting complex ii
LHCII	LHCII:13|LHC-II:4	lightharvesting complex of photosystem ii
LHCII	LHCII:6|LHC-II:2	major lightharvesting complex
LHCP	LHCP:14	lightharvesting chlorophyll abbinding protein
LHCP	LHCP:14	lightharvesting chlorophyll ab protein
LHD	LHD:14	left hemisphere damage
LHD	LHD:15	local health department
LHON	LHON:237	lebers hereditary optic neuropathy
LHON	LHON:10	leber hereditary optic neuroretinopathy
LHRHa	LHRHa:9	dtrppronetlhrh
LHRHa	LHRHa:3|LH-RH-a:3|LH-RH-A:2|LHRH-A:2|LH-RHa:1	luteinizing hormonereleasing hormone agonist
LHRHa	LHRHa:4|LH-RHa:2|LHRH-a:1|LHRHA:1	luteinizing hormonereleasing hormone analog
LHR	LHR:8	leukocyte histamine release
LHR	LHR:7	lungheart ratio
LHS	LHS:10	london handicap scale
LHS	LHS:11	lung health study
LH	LH:34	genetically hypertensive
LH	LH:7	genetically hypertensive rats
LH	LH:5	hypertensive rats of the lyon strain
LH	LH:20	laparoscopic hysterectomy
LH	LH:9	lateral hypothalamic nucleus
LH	LH:39	learned helplessness
LH	LH:11	lefthanded
LH	LH:17	lightharvesting
LH	LH:13	loop of henle
LH	LH:9	lung hypoplasia
LH	LH:32	lyon hypertensive
LH	LH:25	lysyl hydroxylase
LIA	LIA:11	inhibitory activity
LIA	LIA:25	line immunoassay
LIFE	LIFE:13	fluorescence endoscopy
LIFE	LIFE:13	longitudinal interval followup evaluation
LIFE	LIFE:12	losartan intervention for endpoint
LIFE	LIFE:12	losartan intervention for endpoint reduction
LIFE	LIFE:48	losartan intervention for endpoint reduction in hypertension
LIFR	LIFR:32|LIF-R:8	leukemia inhibitory factor receptor
LIFR	LIFR:29|LIF-R:3	lif receptor
LIF	LIF:271	laserinduced fluorescence
LIF	LIF:1040|lif:1	leukemia inhibitory factor
LIF	LIF:16	local intraarterial fibrinolysis
LIMA	LIMA:5	large intestinal mucin antigen
LIMA	LIMA:185	left internal mammary artery
LINEs	LINEs:19|LINES:2	long interspersed elements
LINEs	LINEs:15	long interspersed nuclear elements
LIPC	LIPC:9|Lipc:4	hepatic lipase
LIPC	LIPC:18	hepatic lipase gene
LIPC	LIPC:13	left inferior prefrontal cortex
LIP	LIP:29	labile iron pool
LIP	LIP:45	lateral intraparietal area
LIP	LIP:21	lower inflection point
LIP	LIP:30	lymphocytic interstitial pneumonitis
LISS	LISS:18	less invasive stabilization system
LISS	LISS:12	low ionic strength solution
LITT	LITT:70	laserinduced thermotherapy
LITT	LITT:5	laser interstitial thermal therapy
LLC-PK1	LLC-PK1:9	cultured renal epithelial cells
LLC-PK1	LLC-PK1:8	renal epithelial
LLD	LLD:5	languagelearning disabilities
LLD	LLD:7	latelife depression
LLD	LLD:13	leg length discrepancy
LLD	LLD:5	longlasting depression
LLD	LLD:14	lower limit of detection
LLE	LLE:22	largest lyapunov exponent
LLE	LLE:94	liquidliquid extraction
LLO	LLO:9	lipidlinked oligosaccharide
LLO	LLO:129	listeriolysin o
L-LTP	L-LTP:9	late phase of longterm potentiation
L-LTP	L-LTP:4	late phase of ltp
LL	LL:14	constant illumination
LL	LL:22	continuous illumination
LL	LL:8	continuous lighting
LL	LL:12	genetically lean
LL	LL:12	late luteal
LL	LL:17	lateral lemniscus
LL	LL:12	lateral longissimus
LL	LL:7	left lateral
LL	LL:10	leg length
LL	LL:83	lepromatous
LL	LL:99	lepromatous leprosy
LL	LL:11	lesion load
LL	LL:5|ll:1	lining layer
LL	LL:16	long latency
LL	LL:19	longissimus lumborum
LL	LL:24	lymphoid leukosis
LL	LL:11	lysolecithin
LMAT	LMAT:10	agarose test
LMAT	LMAT:5	leucocyte migration agarose technique
LMA	LMA:450	laryngeal mask airway
LMA	LMA:6	liver membrane antibodies
LMA	LMA:7	locomotor and motor activity
LMA	LMA:30	longissimus muscle area
LMC	LMC:37	lateral motor column
LMC	LMC:22	lymphocytemediated cytotoxicity
LMG	LMG:18	lethal midline granuloma
LMG	LMG:10	leucomalachite green
LMI	LMI:12	lateral medullary infarction
LMI	LMI:80	leukocyte migration inhibition
LMI	LMI:9	linear matrix inequality
LMM	LMM:46	lentigo maligna melanoma
LMM	LMM:58	light meromyosin
LMPCR	LMPCR:19|LM-PCR:8	ligationmediated pcr
LMPCR	LMPCR:23|LM-PCR:11	ligationmediated polymerase chain reaction
LMP	LMP:98	last menstrual period
LMP	LMP:117|lmp:1	low malignant potential
LMP	LMP:7	low molecular mass polypeptide
LMS	LMS:11	effect of levamisole
LMS	LMS:15	least mean square
LMS	LMS:9	leucomyosuppressin
LMS	LMS:10	linearized multistage
LMT	LMT:26	left main trunk
LMT	LMT:16	leucocyte migration test
LM	LM:11	lactose malabsorption
LM	LM:33	laryngeal mask
LM	LM:24	lean mass
LM	LM:57	left main
LM	LM:49	lentigo maligna
LM	LM:20	leptomeningeal metastases
LM	LM:16	leptomeningeal metastasis
LM	LM:10|L-M:1	levenbergmarquardt
LM	LM:72	light microscope
LM	LM:100	light microscopic
LM	LM:403	light microscopy
LM	LM:13	lipid microspheres
LM	LM:12	lipomannan
LM	LM:89|Lm:18	listeria monocytogenes
LM	LM:27	liver metastases
LM	LM:12	logical memory
LM	LM:40	longitudinal muscle
LM	LM:11	lymphatic mapping
LM	LM:7	pretectal nucleus lentiformis mesencephali
LM	LM:1	studied at the light
L-NAME	L-NAME:11	lnitroargininemethylester
L-NAME	L-NAME:46|l-NAME:2|L-Name:1	methyl ester hydrochloride
L-NAME	L-NAME:30	ngnitrolarginine methylester
L-NAME	L-NAME:10	nitric oxide synthase inhibitor
L-NAME	L-NAME:15|l-NAME:2	nitric oxide synthase inhibitor ngnitrolarginine methyl ester
L-NAME	L-NAME:11|l-NAME:1	nitric oxide synthase inhibitor n omeganitrolarginine methyl ester
L-NAME	L-NAME:5	synthase inhibitor ngnitrolarginine methylester
LNA	LNA:21|LnA:2	alphalinolenic acid
L-NA	L-NA:4|LNA:3|l-NA:1	inhibitor nomeganitrolarginine
LNA	LNA:7	latent nuclear antigen
L-NA	L-NA:12|LNA:2	nomeganitrolarginine
LNCaP	LNCaP:14|LnCaP:2|LNCap:1	androgendependent
LNCaP	LNCaP:9	androgensensitive
LNCaP	LNCaP:10	lymph node carcinoma of the prostate
LND	LND:13	leschnyhan disease
LND	LND:69	lonidamine
L-NMMA	L-NMMA:10	lnmonomethyl arginine
L-NMMA	L-NMMA:12|LNMMA:2	lngmonomethylarginine
L-NMMA	L-NMMA:11|LNMMA:1	ngmonomethyl larginine
L-NMMA	L-NMMA:7|l-NMMA:6	ngmonomethyllarginine acetate
L-NMMA	L-NMMA:6	ngmonomethyllarginine monoacetate
L-NMMA	L-NMMA:4|LNMMA:1	synthase inhibitor nmonomethyllarginine
L-NNA	L-NNA:4	nos inhibitor ngnitrolarginine
L-NNA	L-NNA:3|l-NNA:1	synthase inhibitor ngnitrolarginine
LNS	LNS:31	leschnyhan syndrome
LNS	LNS:10	lipid nanosphere
LNT	LNT:15	lentinan
LNT	LNT:13	linear nothreshold
LN	LN:9	laparoscopic nephrectomy
LN	LN:7	lead nitrate
LN	LN:11|L-N:2	leschnyhan
LN	LN:21	lingual nerve
LN	LN:14	lipoid nephrosis
LN	LN:148	lupus nephritis
LN	LN:10	lyon normotensive
ln	ln:8|Ln:2	natural log
ln	ln:11|Ln:2|LN:1	natural logarithm
LOC	LOC:18	lateral occipital complex
LOC	LOC:11	lateral olivocochlear
LOD	LOD:11	detection limits
LOD	LOD:10	laparoscopic ovarian drilling
LOD	LOD:86|lod:22|Lod:1	logarithm of odds
LOOH	LOOH:24	linoleic acid hydroperoxide
LOOH	LOOH:9|L-OOH:1	lipid peroxides
LOP	LOP:4|L-o-p:1|LoP:1	levels of processing
LOP	LOP:5	lipid ozonation products
LOS	LOS:10	lateonset schizophrenia
LOS	LOS:26	lipooligosaccharide
LOS	LOS:18|Los:15	losartan
LOS	LOS:20	low output syndrome
LOS	LOS:174	lower oesophageal sphincter
LOT	LOT:104	lateral olfactory tract
LOT	LOT:13	life orientation test
LpA	LpA:10	glomerular permeability coefficient
LpA	LpA:21	glomerular ultrafiltration coefficient
LPA	LPA:16	latex particle agglutination
LPA	LPA:45|lPA:1	left pulmonary artery
LPA	LPA:18	limulus polyphemus
LPA	LPA:16	limulus polyphemus agglutinin
LPA	LPA:20	linear polyacrylamide
LPA	LPA:14	lysophosphatidate
LPC	LPC:9|L-PC:1	lpropionylcarnitine
LPC	LPC:13	late positive complex
LPC	LPC:8	leukemic progenitor cell
LPC	LPC:38|L-PC:1	lysophosphatidyl choline
LPD	LPD:5	lag phase duration
LPD	LPD:9	lateral patellar displacement
LPD	LPD:40	leiomyomatosis peritonealis disseminata
LPD	LPD:13	luteal phase deficiency
LPG	LPG:158	lipophosphoglycan
LPG	LPG:17	lipoprotein glomerulopathy
LPG	LPG:27	liquefied petroleum gas
LPHD	LPHD:10	lymphocyte predominance hodgkins disease
LPHD	LPHD:10|LP-HD:1	lymphocyte predominant hodgkins disease
LPH	LPH:66|L-Ph:1	lactasephlorizin hydrolase
LPH	LPH:10	lipotropin
L-PIA	L-PIA:25|l-PIA:1	lnphenylisopropyladenosine
L-PIA	L-PIA:21|LPIA:2	lphenylisopropyladenosine
LPI	LPI:16	laser peripheral iridotomy
LPI	LPI:7	learning preference inventory
LPI	LPI:55	lysinuric protein intolerance
LPL	LPL:13	lipoprotein lipase gene
LPL	LPL:23	lymphoplasmacytic lymphoma
LPL	LPL:8	lymphoplasmacytoid lymphoma
LPL	LPL:14	lysophospholipase
LPO	LPO:12	lipid peroxidase
LPO	LPO:12	lipoperoxidation
LPO	LPO:48	lobus parolfactorius
LPO	LPO:6	peroxide oxidation
LPP	LPP:19	lateral perforant path
LPP	LPP:25	leak point pressure
LPP	LPP:11	lichen planus pemphigoides
LPS	LPS:190	bacterial lipopolysaccharides
LPS	LPS:6	bacterial products
LPS	LPS:10	endotoxinlipopolysaccharide
LPS	LPS:10|LP-s:2	lactoperoxidase system
LPs	LPs:40|LPS:2	late potentials
LPS	LPS:16	levator palpebrae superioris
LPS	LPS:24	lipolysaccharide
LPS	LPS:10	lipopolisaccharide
LPS	LPS:41	lipopolysaccaride
LPS	LPS:7	lipopolysaccharide from escherichia coli
LPS	LPS:27	lipopolysacharide
LPs	LPs:16	lumbar punctures
LPS	LPS:20	lypopolysaccharide
LPV	LPV:28|Lpv:1	lopinavir
LPV	LPV:12	lymphotropic papovavirus
LPV	LPV:6	monkey blymphotropic papovavirus
LPN	LPN:31	laparoscopic partial nephrectomy
LPN	LPN:11	lateral plantar nerve
LPN	LPN:8	licensed practical nurse
LRC	LRC:15	leukocyte receptor complex
LRC	LRC:39	lipid research clinics
LRC	LRC:5	locomotorrespiratory coupling
LRC	LRC:21	locoregional control
LRE	LRE:26|lre:1	lamina rara externa
LRE	LRE:9	leukemic reticuloendotheliosis
LRE	LRE:5	lightresponsive element
LRE	LRE:13	localizationrelated epilepsy
LRI	LRI:13|lri:1	lamina rara interna
LRI	LRI:22	lower respiratory illness
LRP5	LRP5:12	ldl receptorrelated protein 
LRP5	LRP5:15	lowdensity lipoprotein receptorrelated protein 
LRP	LRP:6	laminin receptor precursor
LRP	LRP:37	laparoscopic radical prostatectomy
LRP	LRP:11	late receptor potential
LRP	LRP:53	lateralized readiness potential
LRP	LRP:12	low density lipoprotein receptorrelated proteinalpha macroglobulin receptor
LRR	LRR:14	light reflection rheography
LRR	LRR:10	localregional recurrence
LRR	LRR:32	locoregional recurrence
LRR	LRR:22	loss of righting reflex
LRT	LRT:17	likelihood ratio test
LRT	LRT:29	lower respiratory tract
LR	LR:21	latencyrelated
LR	LR:27	lateral rectus
LR	LR:9	leukoregulin
LR	LR:10	light rough
LR	LR:11	linear regression
LR	LR:8	livedo reticularis
LR	LR:10	liver regeneration
LR	LR:13	liver resection
LR	LR:5	local relapse
LR	LR:65	logistic regression
LR	LR:12	low level of response
LR	LR:4	pcna labeling rate
LSA	LSA:8	latent semantic analysis
LSA	LSA:12	lateral septal area
LSA	LSA:11	left subclavian artery
LSA	LSA:6	lenticulostriate artery
LSA	LSA:66	lichen sclerosus et atrophicus
LSA	LSA:9	liverspecific antigen
LSCM	LSCM:25	laser scanning confocal microscope
LSCM	LSCM:78	laser scanning confocal microscopy
LSD	LSD:7	lumpy skin disease
LSD	LSD:264	lysergic acid diethylamide
LSD	LSD:16	lysergide
LSE	LSE:15	living skin equivalent
LSE	LSE:9	low selfesteem
LSF	LSF:33	line spread function
LSF	LSF:21	lisofylline
LSI	LSI:11	learning style inventory
LSI	LSI:10	light scattering intensity
LSI	LSI:16	liver somatic index
LSM	LSM:5	laser scanning microscope
LSM	LSM:13	laser scanning microscopy
LSM	LSM:15	limited sampling model
LSN	LSN:7|LSn:2|lsn:1	lateral spinal nucleus
LSN	LSN:12	low score normal
LSN	LSN:8	lumbar splanchnic nerve
LSO	LSO:34	lateral superior olivary nucleus
LSO	LSO:137	lateral superior olive
LSO	LSO:14	lutetium oxyorthosilicate
lSSc	lSSc:6|LSSc:1	limited cutaneous systemic sclerosis
lSSc	lSSc:6	limited ssc
LSS	LSS:10	laminar shear stress
LSS	LSS:5	life satisfaction scale
LSS	LSS:17	life span study
LSS	LSS:9	limbsparing surgery
LSS	LSS:24	lumbar spinal stenosis
LST	LST:13	lateral sinus thrombosis
LST	LST:30	leishmanin skin test
LST	LST:9	lifesustaining treatments
LST	LST:7	lumbar sympathetic trunk
LSC	LSC:32	laser scanning cytometer
LSC	LSC:88	laser scanning cytometry
LSC	LSC:13	least significant change
LSC	LSC:41	liquid scintillation counting
LS	LS:91	laparoscopic splenectomy
LS	LS:14	laparoscopic surgery
LS	LS:12	laparoscopy
LS	LS:24	laron syndrome
LS	LS:83	lateral septum
LS	LS:29	lateral suprasylvian
LS	LS:7	lateral suprasylvian area
LS	LS:14	lateral suprasylvian visual area
LS	LS:32	leigh syndrome
LS	LS:7	leukocyte scintigraphy
LS	LS:77|Ls:1	lichen sclerosus
LS	LS:11	lichen striatus
LS	LS:13	liquid scintillation
LS	LS:10	litter size
LS	LS:13	low salt
LS	LS:12|ls:1	lowspin
LS	LS:172	lumbar spine
LS	LS:13	lung surfactant
LS	LS:7	lymphocyte stimulation
LS	LS:28	lymphoscintigraphy
LTA	LTA:7	laser thermal ablation
LTA	LTA:6	laser trabecular ablation
LTA	LTA:8	latent transition analysis
LTA	LTA:22	lotus tetragonolobus
LTA	LTA:10	lotus tetragonolobus agglutinin
LTB	LTB:8|LT-B:2	escherichia coli heatlabile enterotoxin
LTB	LTB:5|LT-B:2	escherichia coli heatlabile enterotoxin b subunit
LTF	LTF:9|ltf:1	lactotransferrin
LTF	LTF:58	longterm facilitation
LTM	LTM:42	lean tissue mass
LTM	LTM:125	longterm memory
LTM	LTM:7	longterm monitoring
LTM	LTM:35	lowthreshold mechanoreceptive
LTP	LTP:19	laser trabeculoplasty
LTP	LTP:23	lipid transfer particle
LTRA	LTRA:10	leukotriene receptor antagonist
LTRA	LTRA:7	longterm repopulating ability
LTR	LTR:32	laryngotracheal reconstruction
LTR	LTR:9	longterm retention
LTR	LTR:14	lung transplant recipients
LTS	LTS:11	laryngotracheal stenosis
LTS	LTS:8	longterm survival
LTS	LTS:33	longterm survivors
LTS	LTS:23	lowthreshold spike
LTV	LTV:6	longterm variability
LTV	LTV:6	lung thermal volume
LT	LT:9	after lung transplantation
LT	LT:12	anthrax lethal toxin
LT	LT:16	cysteinylleukotrienes
LT	LT:23|lt:1	escherichia coli heatlabile toxin
LT	LT:10	heatlabile enterotoxin of escherichia coli
LT	LT:12	heat labile toxin
LT	LT:169	lactate threshold
LT	LT:10	lamina terminalis
LT	LT:21|lT:1	large t
LT	LT:9	large tumor antigen
LT	LT:11	laryngeal tube
LT	LT:8	latency time
LT	LT:12	light transmittance
LT	LT:10	lissauers tract
LT	LT:12|lt:1	longterm
LT	LT:11	longissimus thoracis
LT	LT:10	low temperature
LT	LT:36	lowthreshold
LT	LT:12	lunotriquetral
LT	LT:36	lymphocytic thyroiditis
LT	LT:13	lymphoid tissue
luc	luc:7|LUC:2	firefly luciferase gene
luc	luc:7|LUC:3	luciferase reporter gene
LUS	LUS:25	laparoscopic ultrasonography
LUS	LUS:23	laparoscopic ultrasound
LUS	LUS:10	lower uterine segment
LVA	LVA:37|LV-A:1	left ventricular aneurysm
LVA	LVA:4|LVa:1	left ventricular apex
LVDd	LVDd:5|LVDD:4	left ventricular diastolic diameter
LVDd	LVDd:7|LVDD:1	left ventricular enddiastolic diameter
LVD	LVD:8	left ventricular diameter
LVD	LVD:73	left ventricular dysfunction
LVD	LVD:8	lymphatic vessel density
LVF	LVF:42	left ventricular failure
LVF	LVF:74	left visual field
LVF	LVF:1	presented in either the left
LVG	LVG:10	left ventriculogram
LVG	LVG:81	left ventriculography
LVI	LVI:16	lymphatic vessel invasion
LVI	LVI:33	lymphovascular invasion
LVMM	LVMM:7	left ventricular muscle mass
LVMM	LVMM:8	left ventricular myocardial mass
LVP	LVP:10	large volume paracentesis
LVP	LVP:17	late ventricular potentials
LVP	LVP:20	levator veli palatini
LVP	LVP:26	lysinevasopressin
LVSF	LVSF:9	left ventricular shortening fraction
LVSF	LVSF:8	left ventricular systolic function
LVSI	LVSI:29	space invasion
LVSI	LVSI:21	space involvement
LVSP	LVSP:10	left ventricular systolic
LVSP	LVSP:112	left ventricular systolic pressure
LVs	LVs:11	left ventricles
LVs	LVs:8	lentiviral vectors
LV	LV:13	fluorouracil fuleucovorin
LV	LV:9	lassa virus
LV	LV:1181|lv:3	left ventricle
LV	LV:10	left ventricule
LV	LV:23	lelystad virus
LV	LV:7|Lv:6	lipovitellin
LV	LV:13	liquid ventilation
LV	LV:9	lupus vulgaris
LW	LW:29	large white
LW	LW:10	lateral wall
LW	LW:34|lw:2	live weight
LY	LY:187	lucifer yellow
LY	LY:23	lucifer yellow ch
LB	LB:105|L-B:7	langmuirblodgett
LB	LB:10	large bowel
LB	LB:13	live births
LB	LB:9	liver biopsy
LB	LB:6|Lb:2	low back
LB	LB:57	luriabertani
LB	LB:13	luria broth
LB	LB:71|Lb:1	lyme borreliosis
LB	LB:11	lymphoblastoid
LCH	LCH:10	leydig cell hypoplasia
LCH	LCH:9	lobular capillary hemangioma
LDD	LDD:28	lhermitteduclos disease
LDD	LDD:7	lowdose dobutamine
LDD	LDD:10	lowdose dopamine
LEA	LEA:11	lateral entorhinal area
LEA	LEA:5	loin eye area
LEA	LEA:20	longevans agouti
LEA	LEA:8	lumbar epidural anesthesia
LIS	LIS:38	laboratory information system
LIS	LIS:11|lis:2	lisinopril
LIS	LIS:14|LiS:1	lithium diiodosalicylate
LIS	LIS:16|LiS:4	lockedin syndrome
LIS	LIS:11|lis:1	low ionic strength
LIS	LIS:39	lung injury score
LIS	LIS:10	lymphocytic infiltration of the skin
LI	LI:774|Li:3	labeling index
LI	LI:11	lacunar infarcts
LI	LI:11	lacunar infarction
LI	LI:33	lamellar ichthyosis
LI	LI:163	latent inhibition
LI	LI:11	lowintensity
LI	LI:10	lymphocytic infiltration
LO	LO:8	leucine oxidation
LO	LO:24	linseed oil
LpA-I	LpA-I:4|LpAI:1	containing apo ai but not apo aii
LpA-I	LpA-I:2	containing apoai but no apoaii
LpA-I	LpA-I:4|LPA-I:1	containing only apo ai
LpA-I	LpA-I:6	containing only apoai
LpA-I	LpA-I:5|Lp-A-I:1|LP-A-I:1	lipoprotein ai
LPM	LPM:24	lateral plate mesoderm
LPM	LPM:10|-LPM:1	lateral pterygoid muscle
Lp	Lp:22|LP:1	hydraulic conductance
Lp	Lp:29	hydraulic permeability
LP	LP:10	insulin lispro
LP	LP:10	late proximal
LP	LP:6|Lp:1	latency period
LP	LP:14	latent period
LP	LP:21	lateral posterior
LP	LP:31	lateral posterior nucleus
LP	LP:15	lateral prostate
LP	LP:46	lateral pyloric
LP	LP:4|Lp:1	lateroposterior thalamic nucleus
LP	LP:11	leg press
LP	LP:5	legionella pneumonia
Lp	Lp:17|LP:7	legionella pneumophila
LP	LP:9	leukapheresis
LP	LP:38	leukocytic pyrogen
LP	LP:194|Lp:2	lichen planus
LP	LP:9	light peak
LP	LP:11	linear prediction
LP	LP:17	linear programming
LP	LP:28	link protein
Lp	Lp:11	lipophorin
Lp	Lp:3|LP:2	lipoprotein particles
LP	LP:16	long photoperiod
Lp	Lp:30	looptail
LP	LP:5	low passage
LP	LP:9	lowpressure
LP	LP:7	low protein diet
LP	LP:21	lumboperitoneal
LP	LP:21	luteal phase
LP	LP:19	lymphocyte predominance
LP	LP:14	lymphocyte predominant
LP	LP:33	lymphocyte proliferation
LP	LP:6	lymphocyte proliferative
LP	LP:11	lymphocytic predominance
LP	LP:12|Lp:1	nucleus lateralis posterior
LP	LP:7|Lp:6	serum lipoprotein
Lp	Lp:21	water permeability
M(r)	M(r):16	molecular masses
M(r)	M(r):69	relative molecular mass
M1	M1:8	antagonists pirenzepine
M1	M1:9	deacetyldiltiazem
M1	M1:5	first transmembrane domain
M1	M1:13	metastatic
M1	M1:7	metastatic disease
M1	M1:9|M-1:1	middle cerebral artery
M1	M1:7	mouse myeloid leukemia
M1	M1:21	mouse myeloid leukemia cells
M2	M2:5	guineapig atria
M2	M2:7	muscarinic receptors
M2	M2:8	second molar
M2	M2:7	transmembrane segment
M6G	M6G:9	morphinebetadglucuronide
M6G	M6G:3	morphine and morphinebetaglucuronide
MAAs	MAAs:19	melanomaassociated antigens
MAAs	MAAs:19	mycosporinelike amino acids
MAA	MAA:12	methylaminoantipyrine
MAA	MAA:19	maackia amurensis
MAA	MAA:65|maa:1	macroaggregated albumin
MAA	MAA:6	marketing authorization application
MAA	MAA:59	methacrylic acid
MAA	MAA:13	minimum audible angle
MAA	MAA:6	mitral annular area
MAB	MAB:29	maximal androgen blockade
MAB	MAB:12	maximum androgen blockade
MAB	MAB:22	mesenteric arterial bed
MAB	MAB:15	nmethylaminoazobenzene
MACS	MACS:23	cell sorter
MACS	MACS:18	magnetic cell separation
MACs	MACs:7	malignancyassociated changes
MACs	MACs:10	mammalian artificial chromosomes
MACs	MACs:9	microfloraassociated characteristics
mACh	mACh:32|m-ACh:2|mAch:2|M-ACh:1	muscarinic acetylcholine
mACh	mACh:8|M-Ach:2	muscarinic cholinergic
MAC	MAC:7	aerobic capacity
MAC	MAC:11	anesthetic requirement
MAC	MAC:20	macandrew alcoholism scale
MAC	MAC:8	malignancy associated changes
MAC	MAC:12	maximum allowable concentrations
MAC	MAC:9	maximum allowable cost
MAC	MAC:30	mental adjustment to cancer
MAC	MAC:43	microcystic adnexal carcinoma
MAC	MAC:16	midarm circumference
MAC	MAC:9	minimal auditory capabilities
MAC	MAC:135	minimum alveolar anesthetic concentration
MAC	MAC:37	mitral annular calcification
MAC	MAC:7	mitral annular calcium
MAC	MAC:19	mitral annulus calcification
MAC	MAC:9	mitral anular calcium
MAC	MAC:23	monitored anesthesia care
MAC	MAC:10	mycobacterium avium
MAC	MAC:698	mycobacterium avium complex
MAC	MAC:8	mycobacterium aviumintracellulare
MADRS	MADRS:45	montgomery and asberg depression rating scale
MADRS	MADRS:178	montgomeryasberg depression rating scale
MAD	MAD:7	absolute deviation
MAD	MAD:6	major affective disorder
MAD	MAD:7	mandibular advancement device
MAD	MAD:9	mandibuloacral dysplasia
MAD	MAD:4	maximum acceptable dose
MAD	MAD:61	multiwavelength anomalous diffraction
MAD	MAD:9	myoadenylate deaminase
MAE	MAE:52	microwaveassisted extraction
MAE	MAE:70	motion aftereffect
MAE	MAE:7	myoclonicastatic epilepsy
MAF	MAF:90	macrophageactivating factor
MAF	MAF:6|Maf:2|maf:1	mafosfamide
MAGE	MAGE:8	mean amplitude of glycemic excursions
MAGE	MAGE:13	melanoma antigen
MAGE	MAGE:6	melanoma antigen gene
MAI	MAI:56	mitotic activity index
MAI	MAI:12	movement assessment of infants
MAI	MAI:8	multidimensional anger inventory
MAI	MAI:7	mycobacterium aviumintracellulare complex
MAIDS	MAIDS:5	immunodeficiency disease
MAIDS	MAIDS:58	murine acquired immunodeficiency syndrome
MAIDS	MAIDS:5	retrovirusinduced immunodeficiency
MAL	MAL:13	medullary thick ascending limb
MAL	MAL:14	motor activity log
MAL	MAL:6	myelin and lymphocyte protein
MAM	MAM:150	methylazoxymethanol
MAM	MAM:12	mitral annulus motion
MAM	MAM:10	mycoplasma arthritidis mitogen
MAO-A	MAO-A:21|maoA:2	monoamine oxidase
MAO-A	MAO-A:58|MAOA:4|Mao-a:1	monoamine oxidasea
MAO	MAO:38	medial accessory olive
MAO	MAO:24	monoamine oxidase activity
MAO	MAO:15	monoamineoxidase
MAO	MAO:13	monoaminoxidase
MAPs	MAPs:13	mean arterial pressures
MAPs	MAPs:94	monophasic action potentials
MAPs	MAPs:14	multiple antigen peptides
MAPs	MAPs:13	multiple antigenic peptides
MAP	MAP:20	magnesium ammonium phosphate
MAP	MAP:9|map:2	maprotiline
MAP	MAP:65	maximum a posteriori
MAP	MAP:12	maximum a posteriori probability
MAP	MAP:31	mean arterial
MAP	MAP:21	mean arterial bp
MAP	MAP:2766|Map:4	mitogenactivated protein
MAP	MAP:33	modified atmosphere packaging
MAP	MAP:9|Map:1	mycobacterium avium subsp paratuberculosis
MAP	MAP:11|Map:4	mycobacterium avium subspecies paratuberculosis
MAP	MAP:8	repeated administration of methamphetamine
MAR	MAR:14	matrix association region
MAR	MAR:8	mean adequacy ratio
MAR	MAR:20	melanomaassociated retinopathy
MAR	MAR:12	microautoradiography
MAR	MAR:72	mineral apposition rate
MAR	MAR:25	missing at random
MAR	MAR:47	mixed antiglobulin reaction
mar	mar:9	monoclonal antibodyresistant
mar	mar:28|MAR:14|Mar:12	multiple antibiotic resistance
MAR	MAR:7	multivariate autoregressive
MAST	MAST:7	medical antishock trousers
MAST	MAST:113	michigan alcoholism screening test
MAST	MAST:8	military antishock trousers
MAST	MAST:11	motion artifact suppression technique
MAS	MAS:10	exogenous metabolic activation system
MAS	MAS:4	german multicentre allergy study
MAS	MAS:15	mandibular advancement splint
MAS	MAS:26	manifest anxiety scale
MAS	MAS:10	maximal aerobic speed
MAS	MAS:62	mccunealbright syndrome
MAS	MAS:138	meconium aspiration syndrome
MAS	MAS:26	minimal access surgery
MAS	MAS:34	modified ashworth scale
MAS	MAS:21	motor assessment scale
MAS	MAS:13	mycoplasma arthritidis
MAS	MAS:6	mycoplasma arthritidisderived superantigen
MAT	MAT:42	mean absorption time
MAT	MAT:72	methionine adenosyltransferase
MAT	MAT:134	microscopic agglutination test
MAT	MAT:19	multifocal atrial tachycardia
MAV	MAV:6	maximal aerobic velocity
MAV	MAV:10	myeloblastosisassociated virus
MA	MA:11	dmethamphetamine
MA	MA:10	macular amyloidosis
MA	MA:18	maleic anhydride
MA	MA:45	mandelic acid
MA	MA:7|ma:5	maximal amplitude
MA	MA:38|ma:5|mA:1	maximum amplitude
MA	MA:8	mean acceleration
MA	MA:106	megestrol acetate
MA	MA:12	meglumine antimoniate
MA	MA:11	meningioangiomatosis
MA	MA:32	mental age
MA	MA:31	mental arithmetic
MA	MA:9	mesaconitine
MA	MA:19	metabolic acidosis
MA	MA:6	metastatic adenocarcinoma
MA	MA:15	methyl acrylate
MA	MA:28	methylamine
MA	MA:46	microagglutination
MA	MA:5	microbiological assay
MA	MA:20	microscopic agglutination
MA	MA:11	middleaged
MA	MA:64	migraine with aura
MA	MA:13	mitotic activity
MA	MA:23	mitotic apparatus
MA	MA:19	mitral annulus
MA	MA:12	monoamine
MA	MA:11	monoaminergic
MA	MA:51	motor activity
MA	MA:2	weeks menstrual age
MBC	MBC:24	carbendazim
MBC	MBC:37	maximal binding capacity
MBC	MBC:26	maximum binding capacity
MBC	MBC:218|mbc:3	metastatic breast cancer
MBC	MBC:8	methyl benzimidazolyl carbamate
MBD	MBD:20	marchiafavabignami disease
MBD	MBD:8	metabolic bone disease
MBD	MBD:27	methylcpg binding domain
MBD	MBD:50	minimal brain dysfunction
MBF	MBF:8	bite force
MBF	MBF:377	myocardial blood flow
MBG	MBG:21	marinobufagenin
MBG	MBG:24	mean blood glucose
MBG	MBG:17	myocardial blush grade
MBH	MBH:11	medial basal hypothalami
MBH	MBH:41	medial basal hypothalamic
MBH	MBH:300|mbh:1	medial basal hypothalamus
MBH	MBH:14	mediobasal hypothalami
MBH	MBH:23	mediobasal hypothalamic
MBH	MBH:182	mediobasal hypothalamus
MBI	MBI:59	maslach burnout inventory
MBI	MBI:26	modified barthel index
MBL	MBL:65	menstrual blood loss
MBL	MBL:9	metallobetalactamase
MBP	MBP:11|mBP:2	mononbutyl phthalate
MBP	MBP:8|mBP:1	monobutyl phthalate
MBP	MBP:6|Mbp:1	myelin basic protein gene
MBP	MBP:5	myosinbound phosphatase
MBRs	MBRs:12	membrane bioreactors
MBRs	MBRs:6	mitochondrial benzodiazepine receptors
MBR	MBR:34|mbr:29|Mbr:4	major breakpoint region
MBR	MBR:17	medical birth registry
MBR	MBR:64	membrane bioreactor
MBR	MBR:9	mitochondrial benzodiazepine receptor
mBSA	mBSA:54|MBSA:29|M-BSA:2|m-BSA:2	methylated bovine serum albumin
mBSA	mBSA:4|MBSA:2	methylated bsa
MBT-2	MBT-2:5|MBT2:3	bladder cancer cell line
MBT-2	MBT-2:6|MBT2:2	transitional cell carcinoma
MBV	MBV:14	mean blood velocity
MBV	MBV:9	mitral balloon valvotomy
MBV	MBV:10	monodon baculovirus
MBS	MBS:6	mmaleimidobenzoic acid nhydroxysuccinimide ester
MBS	MBS:9	mmaleimidobenzoylnhydroxysuccinimide ester
MBs	MBs:53	mallory bodies
MBS	MBS:14	martinbell syndrome
MBs	MBs:21	medulloblastomas
MBS	MBS:13	modified barium swallow
MBs	MBs:29|mbs:1	mushroom bodies
MBS	MBS:21	myosinbinding subunit
MBS	MBS:14	sodium metabisulfite
MBS	MBS:8	sodium metabisulphite
MCAO	MCAO:650|MCAo:112|MCA-O:7	middle cerebral artery occlusion
MCAO	MCAO:4|MCAo:1	occlusion of middle cerebral artery
MCAT	MCAT:62	medical college admission test
MCAT	MCAT:11	transacylase
MCA	MCA:13	carcinoma associated antigen
MCA	MCA:28	metabolic control analysis
MCA	MCA:7	microcytotoxicity assay
MCA	MCA:43	middle cerebral
MCA	MCA:12	middle cerebral arterial
MCA	MCA:19	minimal crosssectional area
MCA	MCA:12	monochloroacetate
MCA	MCA:21	monochloroacetic acid
MCA	MCA:13	monocyte chemotactic activity
MCA	MCA:33	mucinlike carcinomaassociated antigen
MCA	MCA:37	multiple congenital anomalies
MCA	MCA:15	multiple correspondence analysis
MCB	MCB:8	cell cycle box
MCB	MCB:9	microcirculatory bed
MCB	MCB:15	monochlorobenzene
MCB	MCB:21	monochlorobimane
MCC	MCC:10	methylcrotonylcoa carboxylase
MCC	MCC:17	mandibular condylar cartilage
MCC	MCC:11	maternal cell contamination
MCC	MCC:7	meningococcal c conjugate
MCC	MCC:9	meningococcal serogroup c conjugate
MCC	MCC:14	metacerebral cell
MCC	MCC:133	microcrystalline cellulose
MCC	MCC:4	minimum cidal concentration
MCC	MCC:6	moth cytochrome c
MCC	MCC:5	multiple conductance channel
MCD	MCD:30	macular corneal dystrophy
MCD	MCD:180	magnetic circular dichroism
MCD	MCD:23	malonylcoa decarboxylase
MCD	MCD:22	mast cell degranulating
MCD	MCD:6|mCd:1	mast cell density
MCD	MCD:6	mean consecutive difference
MCD	MCD:26	medullary collecting duct
MCD	MCD:87	minimal change disease
MCD	MCD:75	multicentric castlemans disease
MCD	MCD:10	multiple carboxylase deficiency
MCE	MCE:8	malathion carboxylesterase
MCE	MCE:6	microchip electrophoresis
MCE	MCE:228	myocardial contrast echocardiography
MCF-7	MCF-7:16|MCF7:4	breast adenocarcinoma
MCF-7	MCF-7:16	estrogendependent
MCF-7	MCF-7:42|MCF7:6	human breast cancer cell line
MCF-7	MCF-7:14|MCF7:2	human breast carcinoma cells
MCF-7	MCF-7:12	human breast carcinoma cell line
MCF-7	MCF-7:5|MCF7:1	human mammary carcinoma cells
MCF-7	MCF-7:5|MCF7:1	human mammary carcinoma cell line
MCF	MCF:16	macrophage chemotactic factor
MCF	MCF:81	malignant catarrhal fever
MCF	MCF:18	mean channel fluorescence
MCF	MCF:11	middle cranial fossa
MCF	MCF:43	mink cell focusforming
MCF	MCF:49	mink cell focusinducing
MCF	MCF:10	mitochondrial carrier family
MCF	MCF:5	monocyte cytotoxic factors
MCF	MCF:20	mononuclear cell factor
MCF	MCF:11	myocardial contractile force
MCGN	MCGN:34	mesangiocapillary glomerulonephritis
MCGN	MCGN:9	mesangiocapillary gn
MCI	MCI:5	mandibular cortical index
MCI	MCI:5	mass casualty incident
MCI	MCI:4|mCI:1	metacarpal cortical index
MCI	MCI:25	metacarpal index
MCI	MCI:380	mild cognitive impairment
MCLs	MCLs:15	magnetite cationic liposomes
MCLs	MCLs:26	mantle cell lymphomas
MCLs	MCLs:17	medial collateral ligaments
MCL	MCL:19	comfortable loudness
MCL	MCL:11	mast cell leukemia
MCL	MCL:25	maximum contaminant level
MCL	MCL:9|mcl:4	mediumchainlength
MCL	MCL:8|mcl:1	mitral cell layer
MCL	MCL:23	mucocutaneous leishmaniasis
MCL	MCL:6	myocardial chord length
MCM	MCM:76|Mcm:23|mcm:1	minichromosome maintenance
MCM	MCM:14	monocyteconditioned medium
MCM	MCM:12	mucous cell metaplasia
MCNs	MCNs:10	magnocellular neurons
MCNS	MCNS:184	minimal change nephrotic syndrome
MCNs	MCNs:11	mucinous cystic neoplasms
MCNS	MCNS:10	patients with minimalchange nephrotic syndrome
MCNU	MCNU:10	methyl chloroethylnitrosoureidodeoxyalphadglucopyranoside
MCNU	MCNU:21	ranimustine
MCN	MCN:6	main cuneate nucleus
MCN	MCN:35	minimal change nephropathy
MCN	MCN:6	musculocutaneous nerve
MCO	MCO:72	managed care organization
MCO	MCO:27	metalcatalyzed oxidation
MCP-1	MCP-1:29	monocyte chemotactic peptide
MCP-1	MCP-1:20	monocyte chemotactic protein
MCP-1	MCP-1:81|MCP1:1	monocyte chemotactic protein 
MCPG	MCPG:5	antagonist rsalphamethylcarboxyphenylglycine
MCPG	MCPG:5	mglur antagonist alphamethylcarboxyphenylglycine
MCPG	MCPG:5	mglur antagonist rsalphamethylcarboxyphenylglycine
MCPG	MCPG:4	receptor antagonist alphamethylcarboxyphenylglycine
MCPG	MCPG:12	salphamethylcarboxyphenylglycine
mCPP	mCPP:7|m-CPP:5|MCPP:2	metachlorophenylpiperazine
mCPP	mCPP:3|m-CPP:1	receptor agonist chlorophenylpiperazine
mCPP	mCPP:8|m-CPP:7|MCPP:3	receptor agonist mchlorophenylpiperazine
MCP	MCP:11	mean circulatory pressure
MCP	MCP:6	medial coronoid process
MCP	MCP:20	methylclofenapate
MCP	MCP:6	microchannel plate
MCP	MCP:13	monocrotophos
MCP	MCP:9	multicatalytic protease
MCP	MCP:35	multicatalytic proteinase
MCP	MCP:7	multifocal choroiditis and panuveitis
MCRs	MCRs:11|MC-Rs:4	melanocortin receptors
MCRs	MCRs:10	metabolic clearance rates
MCR	MCR:13	macromomycin
MCR	MCR:5	major cytogenetic remission
MCR	MCR:10|Mcr:1	major cytogenetic response
MCR	MCR:19	methylcoenzyme m reductase
MCR	MCR:29	micronomicin
MCR	MCR:19	mineralocorticoid receptor
MCR	MCR:5	multicomponent reaction
MCR	MCR:9	multivariate curve resolution
MCT1	MCT1:10|MCT-1:1	monocarboxylate transporter
MCT1	MCT1:24|MCT-1:1	monocarboxylate transporter 
MCTs	MCTs:13	mediumchain triacylglycerols
MCTs	MCTs:38	mediumchain triglycerides
MCTs	MCTs:30	monocarboxylate transporters
MCT	MCT:11	cell tumor
MCT	MCT:13	injection of monocrotaline
MCT	MCT:9	mast cell tryptase
MCT	MCT:13	mean circulation time
MCT	MCT:13	medullary carcinoma of the thyroid gland
MCT	MCT:15	medullary thyroid carcinoma
MCT	MCT:7	metacontrast technique
MCT	MCT:6|mCT:2	microcomputed tomography
MCT	MCT:57	microwave coagulation therapy
MCT	MCT:16	monocarboxylic acid transporter
MCT	MCT:6	motor conduction time
MCT	MCT:24	mucociliary transport
MCU	MCU:14	micturating cystourethrogram
MCU	MCU:22	micturating cystourethrography
MCV	MCV:147	mean cell volume
MCV	MCV:10	measlescontaining vaccine
MCV	MCV:10	melanoma cell vaccine
MCV	MCV:13	middle cardiac vein
MCV	MCV:60	molluscum contagiosum virus
MCh	MCh:10|Mch:1	acetylbetamethylcholine
MCh	MCh:3|Mch:2	intrafemoral artery infusions of the endotheliumdependent vasodilator methacholine chloride
MCH	MCH:169	maternal and child health
MCH	MCH:9	mean corpuscular hb
MCH	MCH:327	melaninconcentrating hormone
MCH	MCH:9	muscle contraction headache
MC	MC:30	magnetic coil
MC	MC:32|Mc:1|mc:1	magnocellular
MC	MC:14	managed care
MC	MC:7	marlowecrowne social desirability scale
MC	MC:6	matched control
MC	MC:8|Mc:2	melanocytes
MC	MC:17	meningeal carcinomatosis
MC	MC:9	menstrual cycle
MC	MC:112	mesangial cell
MC	MC:21|mc:1	methyl cellulose
MC	MC:61|Mc:1|mc:1	methylcellulose
MC	MC:9	microcirculation
MC	MC:8	microscopic colitis
MC	MC:9	minnesota code
MC	MC:9	mitotic count
MC	MC:74	mixed cellularity
MC	MC:11	mixed chimaerism
MC	MC:45	mixed chimerism
MC	MC:25	mixed cryoglobulinaemia
MC	MC:85	mixed cryoglobulinemia
MC	MC:17|mc:1	moisture content
MC	MC:34	molluscum contagiosum
MC	MC:38|Mc:1	monochorionic
MC	MC:17	monocomponent
MC	MC:188	monte carlo
MC	MC:14|m-c:1	musculocutaneous
MC	MC:12	myocardial contractility
MC	MC:9	myocarditis
MC	MC:12	myotonia congenita
MDA-LDL	MDA-LDL:11	lowdensity lipoprotein
MDA-LDL	MDA-LDL:15	malondialdehydemodified ldl
MDAS	MDAS:11	memorial delirium assessment scale
MDAS	MDAS:8	modified dental anxiety scale
MDA	MDA:32	methylenedianiline
MDA	MDA:17	malondiadehyde
MDA	MDA:3388|mda:1	malondialdehyde
MDA	MDA:17	malonedialdehyde
MDA	MDA:111	malonic dialdehyde
MDA	MDA:10	malonildialdehyde
MDA	MDA:55	malonyl dialdehyde
MDA	MDA:215	malonyldialdehyde
MDA	MDA:26	mass drug administration
MDA	MDA:17	medical devices agency
MDA	MDA:21	minimal deviation adenocarcinoma
MDA	MDA:10	minimum detectable activity
MDA	MDA:19	multiple displacement amplification
MDA	MDA:8	multivariate discriminant analysis
MDBK	MDBK:9	bovine kidney cell line
MDBK	MDBK:69	madindarby bovine kidney
MDCK	MDCK:9	canine kidney epithelial cells
MDCK	MDCK:5	cultured renal epithelial
MDCK	MDCK:1054|MDCk:1	madindarby canine kidney
MDCK	MDCK:32	madindarby canine kidney cells
MDCT	MDCT:16|mDCT:1	immortalized mouse distal convoluted tubule
MDCT	MDCT:16	multidetector row ct
MDCT	MDCT:64|MD-CT:2	multidetector ct
MDC	MDC:12	minimum detectable concentration
MDC	MDC:26	monodansylcadaverine
MDC	MDC:12|mDC:7	myeloid dc
MDF	MDF:10	membrane differential filtration
MDF	MDF:9	multiple daily fractionation
MDF	MDF:63	myocardial depressant factor
MDI	MDI:16	diphenylmethanediisocyanate
MDI	MDI:41	diphenylmethane diisocyanate
MDI	MDI:10	isocyanate
MDI	MDI:11	major depression inventory
MDI	MDI:52	mental development index
MDI	MDI:44	mental developmental index
MDI	MDI:11	modulation detection interference
MDL	MDL:26	method detection limit
MDL	MDL:25	minimum description length
MDM2	MDM2:12|mdm-2:3|Mdm2:3|MDM-2:2|mdm2:2	double minute
MDM2	MDM2:8|mdm2:3|Mdm2:2|MDM-2:1	mouse double minute 
MDM2	MDM2:23|Mdm2:8|mdm2:4|MDM-2:1|mdm-2:1	murine double minute 
MDP	MDP:10	dihydrogen phosphate
MDP	MDP:13	major duodenal papilla
MDP	MDP:7	manicdepressive psychosis
MDP	MDP:50	maximum diastolic potential
MDP	MDP:8|mdp:1	minimal distending pressure
MDP	MDP:54	muramyldipeptide
MDR-TB	MDR-TB:17|MDRTB:3	multidrugresistant tb
MDR-TB	MDR-TB:125|MDRTB:17|MDR-Tb:1|MDRTb:1	multidrugresistant tuberculosis
MDR	MDR:5	dbi receptor
MDR	MDR:8|mdr:1	macrophage disappearance reaction
MDR	MDR:7	medium dose rate
MDR	MDR:8	multidrug resistance phenotype
MDR	MDR:6	multifactor dimensionality reduction
MDS-HC	MDS-HC:11	minimum data set for home care
MDS-HC	MDS-HC:7	minimum data sethome care
MDT	MDT:32	mean dissolution time
MDT	MDT:7	mirror drawing test
MDT	MDT:16	multidisciplinary team
MDT	MDT:6	multidrug treatment
MDS	MDS:29	microdialysis system
MDS	MDS:159	minimum data set
MDS	MDS:130	multidimensional scaling
MDS	MDS:21	myelodysplastic
MDS	MDS:21	patients with myelodysplasia
MD	MD:70	macula densa
MD	MD:11	maintenance dose
MD	MD:5	major depressive disorder
MD	MD:250|md:1	mareks disease
MD	MD:13	maternal deprivation
MD	MD:42	mean defect
MD	MD:124	mean deviation
MD	MD:31|Md:1	meckels diverticulum
MD	MD:10	medial dorsal
MD	MD:10	medialis dorsalis
MD	MD:52	mediodorsal
MD	MD:33	mediodorsal nucleus of the thalamus
MD	MD:39	mediodorsal thalamic nucleus
MD	MD:10	mediodorsal thalamus
MD	MD:9	methyldopa
MD	MD:19	microdensitometry
MD	MD:46|mD:1	microdialysis
MD	MD:9|md:1	mixed dementia
MD	MD:6	moderate disability
MD	MD:8|md:1	moderately differentiated
MD	MD:13	molecular dynamics simulations
MD	MD:54	monocular deprivation
MD	MD:20	monocularly deprived
MD	MD:11	motiondefined
MD	MD:8	movement disorders
md	md:5|MD:4	multiple dendritic
md	md:6	myelin deficiency
MD	MD:18	patients with menieres disease
MD	MD:19	thalamic mediodorsal nucleus
MEA	MEA:7	lhrh release from explants of the median eminence area
MEA	MEA:7	malt extract agar
MEA	MEA:10	mean electrical axis
MEA	MEA:15	medial entorhinal area
MEA	MEA:10	mercaptoethylamine
MEA	MEA:10	microelectrode array
MEA	MEA:12	microwave endometrial ablation
MEA	MEA:18	monoethanolamine
MEA	MEA:18	multiple endocrine adenomatosis
MED	MED:9	male erectile dysfunction
MED	MED:12|Med:2	medetomidine
MED	MED:16	medical entities dictionary
MED	MED:25	minimal effective dose
MED	MED:61	multiple epiphyseal dysplasia
MEE	MEE:9	medial edge epithelia
MEE	MEE:17	medial edge epithelial
MEE	MEE:20	medial edge epithelium
MEF50	MEF50:4	expiratory flow at  of fvc
MEF50	MEF50:4	expiratory flow at  of vital capacity
MEFV	MEFV:36	flow volume
MEFV	MEFV:37	maximal expiratory flowvolume
MEFs	MEFs:165|mEFs:4	mouse embryonic fibroblasts
MEFs	MEFs:35	murine embryonic fibroblasts
MEF	MEF:74	middle ear fluid
MEF	MEF:8	migration enhancement factor
MEGX	MEGX:11	monoethylglycine xylidide
MEGX	MEGX:9	monoethylglycinexylide
MEGX	MEGX:138|MEG-X:2	monoethylglycinexylidide
MEG	MEG:155	magnetoencephalographic
MEG	MEG:570	magnetoencephalography
MEG	MEG:27	mercaptoethylguanidine
MEI	MEI:5	medicare economic index
MEI	MEI:19	metabolizable energy intake
MEKC	MEKC:21	micellar electrokinetic chromatographic
MEKC	MEKC:307	micellar electrokinetic chromatography
MEKK1	MEKK1:11|MEKK-1:2	kinase kinase
MEKK1	MEKK1:7|MEKK-1:2	mitogenactivated protein kinase kinase kinase 
MEMS	MEMS:36	medication event monitoring system
MEMS	MEMS:26|MEMs:1	microelectromechanical systems
MEM	MEM:45	macrophage electrophoretic mobility
MEM	MEM:37	maximum entropy method
MEM	MEM:110	minimal essential medium
MEM	MEM:10	mitochondrial encephalomyopathy
MENT	MENT:13	 alphamethylnortestosterone
MENT	MENT:10	alphamethylnortestosterone
MEN	MEN:29	mitotic exit network
MEN	MEN:365|Men:1	multiple endocrine neoplasia
MEN	MEN:9	multiple endocrine neoplasia syndrome
MEPM	MEPM:7	mouse embryo palate mesenchyme
MEPM	MEPM:18	murine embryonic palate mesenchymal
MEP	MEP:21	cmethylderythritol phosphate
MEP	MEP:22	major excreted protein
MEP	MEP:10|Mep:1	mepyramine
MEP	MEP:14	methylerythritol phosphate
MEP	MEP:11|ME-P:1	middle ear pressure
MEP	MEP:48	molecular electrostatic potential
MEP	MEP:6|mEP:2	monoethyl phthalate
MEP	MEP:20	multiple exposure photography
MERRF	MERRF:4	epilepsy and raggedred fiber
MERRF	MERRF:14	epilepsy with ragged red fibers
MERRF	MERRF:18	myoclonic epilepsy with raggedred fibers
MERRF	MERRF:10	myoclonus epilepsy and raggedred fibers
MERRF	MERRF:4	myoclonus epilepsy and raggedred fibres
MERRF	MERRF:19	myoclonus epilepsy associated with raggedred fibers
MESA	MESA:10	erythrocyte surface antigen
MESA	MESA:9	marshfield epidemiologic study area
MESA	MESA:49|mesa:1	microsurgical epididymal sperm aspiration
MESA	MESA:9	multiethnic study of atherosclerosis
MESA	MESA:14	myoepithelial sialadenitis
MEST	MEST:9	maximal electroshock seizure threshold
MEST	MEST:21	mouse ear swelling test
MES	MES:8|Mes:5	nmorpholinoethanesulfonic acid
MES	MES:6	maximal electrical stimulation
MES	MES:6	maximal electroconvulsive shock
MES	MES:170	maximal electroshock
MES	MES:13	maximal electroshockinduced seizures
MES	MES:9	melancholia scale
MES	MES:8|mes:2	mesencephalon
MES	MES:7|mes:5|Mes:1	mesenteric
MES	MES:90	microembolic signals
MES	MES:12	myoelectric signal
MET	MET:12|Met:4	cmethionine
MET	MET:4	cochlear mechanoelectric transduction
MET	MET:7|Met:4	dlmethionine
MET	MET:13	mechanoelectrical transduction
MET	MET:21	medical emergency team
MET	MET:6	melbourne edge test
MET	MET:16|Met:6	metformin
Met	Met:188|MET:43|met:9	methionine
Met	Met:14|MET:1	methoprenetolerant
MET	MET:10|Met:6	metoprolol
MET	MET:13	metyrapone
MET	MET:23	motivational enhancement therapy
ME	ME:29	methoxyethanol
ME	ME:12	macular edema
ME	ME:17	magnitude estimation
ME	ME:189|me:5	malic enzyme
ME	ME:8	maximum entropy
ME	ME:13	mccollough effect
ME	ME:25	mechanical efficiency
ME	ME:581	median eminence
ME	ME:20	medical examiner
ME	ME:57	metabolisable energy
ME	ME:10	methanolic extract
ME	ME:106	middle ear
ME	ME:11	minimum evolution
ME	ME:5	moderate exercise
ME	ME:18	mouse embryo
ME	ME:20	myalgic encephalomyelitis
ME	ME:10	myoelectric
ME	ME:12	myoepithelial
MFA	MFA:18	metabolic flux analysis
MFA	MFA:11	musculoskeletal function assessment
MFCV	MFCV:42	muscle fiber conduction velocity
MFCV	MFCV:13	muscle fibre conduction velocity
MFC	MFC:10	fungicidal concentrations
MFC	MFC:31|mfc:1	medial frontal cortex
MFC	MFC:9	microbial fuel cell
MFD	MFD:17	mandibulofacial dysostosis
MFD	MFD:21	multiple fractions per day
MFD	MFD:19	mutation frequency decline
mfERG	mfERG:25|MF-ERG:2|mfERg:1|mf-ERG:1|MFERG:1	multifocal electroretinography
mfERG	mfERG:12|mf-ERG:2|MF-ERG:2|MFERG:1	multifocal erg
M-FISH	M-FISH:9|mFISH:6|MFISH:1	multicolor fish
M-FISH	M-FISH:10	multiplexfish
MFI	MFI:14	mean fluorescence index
MFI	MFI:156|mfi:2	mean fluorescence intensity
MFI	MFI:6	myofibrillar fragmentation index
MFM	MFM:9	maternalfetal medicine
MFM	MFM:10	myofibrillar myopathy
MFO	MFO:5	mixedfunction monooxygenase
MFO	MFO:11	mixed function oxidase system
MFP	MFP:15	membrane fusion protein
MFP	MFP:10	myofascial pain
MFR	MFR:12	maximum flow rate
MFR	MFR:11	myocardial flow reserve
MFs	MFs:10	actin microfilaments
MFs	MFs:71	magnetic fields
MFS	MFS:51	major facilitator superfamily
MFS	MFS:111|MfS:3	marfan syndrome
MFS	MFS:23	medicare fee schedule
MFS	MFS:31	metastasisfree survival
MFS	MFS:5|mFS:4	midwall fractional shortening
MFS	MFS:76	miller fisher syndrome
MFs	MFs:14	mossy fibers
MFS	MFS:12	mossy fiber sprouting
MFs	MFs:26|Mfs:13|MFS:1	mutant frequencies
MFT	MFT:19	family therapy
MFT	MFT:13	magnetic field tomography
MGA	MGA:8	medial giant axon
MGA	MGA:84	melengestrol acetate
MGC	MGC:22	macroglomerular complex
MGC	MGC:5	mucinous gastric carcinoma
MGDG	MGDG:11	monogalactosyl diacylglycerol
MGDG	MGDG:55	monogalactosyldiacylglycerol
MGD	MGD:17	mean glandular dose
MGD	MGD:24	meibomian gland dysfunction
MGD	MGD:24	mixed gonadal dysgenesis
MGD	MGD:10	molybdopterin guanine dinucleotide
MGD	MGD:28	mouse genome database
MGD	MGD:13	multiglandular disease
MGD	MGD:15	nmethyldglucamine dithiocarbamate
MGL	MGL:8	mean gray level
MGL	MGL:7	monoglyceride lipase
MGN	MGN:151|mGn:1|mGN:1	membranous glomerulonephritis
MGN	MGN:14	membranous glomerulonephropathy
MGN	MGN:12	membranous glomerulopathy
MGN	MGN:17	membranous gn
MGP	MGP:18	manufactured gas plant
MGP	MGP:115|Mgp:1	matrix gla protein
MGP	MGP:8	mucous glycoprotein
MGS	MGS:5	grading system
MGS	MGS:6|mgs:1	methylglyoxal synthase
MGS	MGS:5	morning glory syndrome
MG	MG:47	malachite green
MG	MG:21	mammary gland
MG	MG:9	matrigel
MG	MG:6	mean gradient
MG	MG:281	medial gastrocnemius
MG	MG:15	medial gastrocnemius muscle
MG	MG:10	medial geniculate
MG	MG:13	meningeal gliomatosis
MG	MG:108	methylglyoxal
MG	MG:55	methylguanidine
MG	MG:9	microgravity
MG	MG:20	molten globule
MG	MG:1353	myasthenia gravis
MG	MG:198|Mg:5	mycoplasma gallisepticum
MG	MG:8	serum myoglobin
MHA	MHA:15	mayhegglin anomaly
MHA	MHA:9	methylhippuric acid
MHA	MHA:17	muellerhinton agar
MHC-I	MHC-I:15|MHCI:1	class i major histocompatibility complex
MHC-I	MHC-I:75|MHCI:6	major histocompatibility complex class i
MHC-I	MHC-I:6	major histocompatibility complex class i molecules
MHC	MHC:10	class i and class ii major histocompatibility
MHC	MHC:9	major histocompatability
MHC	MHC:17	major histocompatibility class
MHC	MHC:9	major histocompatibility complex antigens
MHC	MHC:8	major histocompatibility complex molecules
MHC	MHC:10	myosin heavy
MHD	MHD:20	magnetohydrodynamic
MHD	MHD:10	maintenance haemodialysis
MHD	MHD:60	maintenance hemodialysis
MHE	MHE:9	mh equivocal
MHE	MHE:11|mHE:3	minimal hepatic encephalopathy
MHI	MHI:10	malignant histiocytosis of the intestine
MHI	MHI:7	mental health index
MHI	MHI:22	mental health inventory
MHN	MHN:5	mh negative
MHN	MHN:15	nonsusceptible
MHPG	MHPG:16	methoxyhydroxyphenethyleneglycol
MHPG	MHPG:27	methoxyhydroxyphenyl glycol
MHS	MHS:6	major histocompatibility system
MHS	MHS:23	malignant hyperthermia susceptibility
MHS	MHS:6	mh susceptibility
MHS	MHS:20	milan hypertensive
MHS	MHS:10	milan hypertensive rats
MHS	MHS:32	milan hypertensive strain
MHS	MHS:6	milan hypertensive strain of rats
MHS	MHS:6	military health system
MHS	MHS:3	patients were susceptible to mh
MHV-A59	MHV-A59:12	mouse hepatitis virus
MHV-A59	MHV-A59:28	mouse hepatitis virus strain a
MHV	MHV:8|mHV:1	medial hyperstriatum ventrale
MHV	MHV:46	middle hepatic vein
MHV	MHV:10	mouse hepatitis coronavirus
MHV	MHV:6	murine coronavirus
MHB	MHB:37|mhb:2	midbrainhindbrain boundary
MHB	MHB:20	muellerhinton broth
MH	MH:24	macular hole
MH	MH:51	maleic hydrazide
MH	MH:100	malignant histiocytosis
MH	MH:33	malignant hyperpyrexia
MH	MH:10|M-H:2	mantelhaenszel
MH	MH:10	medial hypothalamic
MH	MH:37	medial hypothalamus
MH	MH:57	mental health
MH	MH:10	metal halide
MH	MH:18|M-H:1	muellerhinton
MH	MH:7	myocardial hypertrophy
MH	MH:5	selection for high
MIBG	MIBG:17	iodinemetaiodobenzylguanidine
MIBG	MIBG:22|mIBG:1	miodobenzylguanidine
MIBG	MIBG:5|mIBG:2	metaiodobenzyl guanidine
MIBI	MIBI:22	mtcmethoxyisobutylisonitrile
MIBI	MIBI:26|mibi:3	isobutyl isonitrile
MIBI	MIBI:9	methoxyisobutylisonitrile
MIBI	MIBI:20	tcm sestamibi
MIBI	MIBI:34	technetiumm sestamibi
MIB	MIB:18	methylisoborneol
MIB	MIB:18	medical information bus
MIC90s	MIC90s:7	 of strains tested
MIC90s	MIC90s:8|MIC90S:1	mics at which  of the isolates are inhibited
MIC90	MIC90:3	 of the isolates are inhibited
MIC90	MIC90:5	mic for  of strains tested
MICU	MICU:37	medical icu
MICU	MICU:112	medical intensive care unit
MICU	MICU:27	mobile intensive care unit
MICs	MICs:9	activities
MICS	MICS:6	interaction coding system
MICS	MICS:9	malnutritioninflammation complex syndrome
MICS	MICS:15	membrane invasion culture system
MICs	MICs:13	minimal inhibitory concentration
MICS	MICS:23	minimally invasive cardiac surgery
MICs	MICs:702|MICS:3	minimum inhibitory concentrations
MIC	MIC:7	ifosfamide and cisplatin
MIC	MIC:16	methacholine inhalation challenge
MIC	MIC:92	methyl isocyanate
MIC	MIC:9	methylisocyanate
MIC	MIC:5	mhc class i chainrelated
MIC	MIC:12	microinvasive carcinoma
MIC	MIC:6	minimal inhibitory
MIC	MIC:7	minimum inhibitory
MIDAS	MIDAS:30	metal iondependent adhesion site
MIDAS	MIDAS:34	migraine disability assessment
MIDAS	MIDAS:8	migraine disability assessment scale
MIDCAB	MIDCAB:110	minimally invasive direct coronary artery bypass
MIDCAB	MIDCAB:10|MID-CAB:1	minimally invasive direct coronary artery bypass surgery
MID	MID:17	important difference
MID	MID:10	inclusion disease
MID	MID:224	multiinfarct dementia
MID	MID:22	multiple indicator dilution
MIF	MIF:637|Mif:2|mif:1	macrophage migration inhibitory factor
MIF	MIF:13	maximal isometric force
MIF	MIF:13	microimmunofluorescence test
MIF	MIF:6|Mif:6	mifepristone
MIF	MIF:16	migration inhibition
MIG	MIG:10	metal inert gas
MIG	MIG:12|Mig:9|MiG:1	monokine induced by interferongamma
MIH	MIH:40	moltinhibiting hormone
MIH	MIH:13	myointimal hyperplasia
MIL	MIL:11	mean intercept length
MIL	MIL:9|mil:3	milrinone
MIMS	MIMS:9	membrane inlet mass spectrometry
MIMS	MIMS:20	membrane introduction mass spectrometry
MIPs	MIPs:10	major intrinsic proteins
MIPs	MIPs:16	maximum intensity projections
MIPs	MIPs:76	molecularly imprinted polymers
MIPs	MIPs:4	molluscan insulinrelated peptides
MIP	MIP:9	imprinted polymers
MIP	MIP:8	inspiratory pressures
MIP	MIP:11	main intrinsic polypeptide
MIP	MIP:8	maximum inspiratory
MIP	MIP:7	methylation induced premeiotically
MIP	MIP:23	minimally invasive parathyroidectomy
MIP	MIP:15|mip:1	mitochondrial intermediate peptidase
MIP	MIP:67	molecularly imprinted polymer
MIR	MIR:65	main immunogenic region
MIR	MIR:23	midinfrared
MIR	MIR:8	minimum infection rate
MIR	MIR:13	myocardial infarction registry
MIT	MIT:8	injection therapy
MIT	MIT:14	macrophage migration inhibition test
MIT	MIT:16	magnetic induction tomography
MIT	MIT:17	massachusetts institute of technology
MIT	MIT:7	melodic intonation therapy
MIT	MIT:8	metalinsulator transition
MIT	MIT:9	minimally invasive therapy
MIT	MIT:16	monoiodotyrosine
MIS	MIS:12	information systems
MIS	MIS:22	management information system
MIS	MIS:20	maturationinducing steroid
MIS	MIS:13	medical information system
MIS	MIS:13	melanoma in situ
MIS	MIS:18	microbial identification system
MIS	MIS:75	minimally invasive surgery
MI	MI:118	after acute myocardial infarction
MI	MI:10	cardiac remodeling after myocardial infarction
MI	MI:7	first meiotic division
MI	MI:5	first meiotic metaphase
MI	MI:12	intervention
MI	MI:11	magical ideation
MI	MI:22	meconium ileus
MI	MI:23|M-I:2	meiosis i
MI	MI:37	metabolic inhibition
MI	MI:13	metabolic intermediate
MI	MI:77|M-I:7|mi:1	metaphase i
MI	MI:18	mitotic
MI	MI:26	mitotic indices
MI	MI:33|Mi:1	mitral insufficiency
MI	MI:42	motivational interviewing
MI	MI:14	motor imagery
MI	MI:13	multiple imputation
MI	MI:37	mutual information
MI	MI:49	myocardial infarct
MI	MI:9	myocardial infarcted
MI	MI:45	myocardial ischemia
MI	MI:9	myometrial invasion
MI	MI:53|mi:1	patients after myocardial infarction
MI	MI:201	patients with acute myocardial infarction
MI	MI:9	ventricular remodeling after myocardial infarction
MK-801	MK-801:15	methyldihydrohdibenzoadcycloheptenimine
MK-801	MK-801:8|MK801:2	cycloheptenimine
MK-801	MK-801:59|MK801:3	hydrogen maleate
MK-801	MK-801:8	nmda receptor antagonist dizocilpine maleate
MK-801	MK-801:16|MK801:1	noncompetitive
MKPs	MKPs:15	map kinase phosphatases
MKPs	MKPs:11	mapk phosphatases
MK	MK:17|Mk:7	megakaryocytic
MK	MK:20|Mk:1	mevalonate kinase
MK	MK:8	microbial keratitis
MK	MK:202	midkine
MLCP	MLCP:29	myosin light chain phosphatase
MLCP	MLCP:5|MLC-P:2|MLC-p:1	myosin light chain phosphorylation
MLCs	MLCs:11	lethal concentrations
MLCs	MLCs:26	mixed lymphocyte cultures
MLCs	MLCs:32	multileaf collimators
MLCs	MLCs:11	myosin light chains
MLC	MLC:26	lethal concentration
MLC	MLC:7	light chain of myosin
MLC	MLC:7	macrophagelike cells
MLC	MLC:17	megalencephalic leukoencephalopathy with subcortical cysts
MLC	MLC:10	metastatic liver cancer
MLC	MLC:29	micellar liquid chromatography
MLC	MLC:23	multileaf collimator
MLC	MLC:13	multileaf collimation
MLD	MLD:11	lethal doses
MLD	MLD:5	liver disease
MLD	MLD:5	manual lymph drainage
MLD	MLD:5	manual lymphatic drainage
MLD	MLD:5	marine natural product manoalide
MLD	MLD:19	mean lung density
MLD	MLD:15	mean lung dose
MLD	MLD:15	median lethal dose
MLD	MLD:18	metachromatic leucodystrophy
MLD	MLD:212	metachromatic leukodystrophy
MLD	MLD:79	minimal lumen diameter
MLD	MLD:55	minimal luminal diameter
MLD	MLD:10	minimum lethal dose
MLD	MLD:34	minimum lumen diameter
MLEs	MLEs:14	marinerlike elements
MLEs	MLEs:12	maximum likelihood estimates
MLE	MLE:13	maximum likelihood estimate
MLE	MLE:30	maximum likelihood estimation
MLE	MLE:25|mle:1	maximum likelihood estimator
MLF	MLF:10	logistic function
MLF	MLF:13	malolactic fermentation
MLF	MLF:11|mlf:3	medial longitudinal fascicle
MLF	MLF:104|mlf:3	medial longitudinal fasciculus
MLI	MLI:8	metenkephalinlike immunoreactivity
MLI	MLI:10|ML-I:8	mistletoe lectin i
MLO	MLO:13	mediolateral oblique
MLO	MLO:10	mycoplasmalike organisms
MLP	MLP:10	molecular lipophilicity potential
MLP	MLP:15	multiple lymphomatous polyposis
MLP	MLP:27	muscle lim protein
MLRs	MLRs:34	middle latency responses
MLRs	MLRs:34	mixed lymphocyte reactions
MLR	MLR:98	mesencephalic locomotor region
MLR	MLR:16	mixed lymphocyte reactivity
MLR	MLR:123	multiple linear regression
MLR	MLR:20	multiple logistic regression
MLSS	MLSS:22	maximal lactate steady state
MLSS	MLSS:12	mixed liquor suspended solids
MLV	MLV:26	multilamellar
MLV	MLV:17	multilamellar liposomes
ML	ML:12	machine learning
ML	ML:8	macrocyclic lactone
ML	ML:23|M-L:5|m-l:1|M--L:1	mediallateral
ML	ML:19|ml:1	medial lemniscus
ML	ML:9	midluteal
ML	ML:8	mink lung
ML	ML:8|M-L:1	mitochondriallysosomal
ML	ML:14	monolayer
ML	ML:7	mouse lysozyme
ML	ML:14	mucosal leishmaniasis
ML	ML:8|M-L:5	mullerlyer
ML	ML:17	muscle larvae
ML	ML:8	muscle length
ML	ML:10|Ml:1	mycobacterium leprae
ML	ML:10|Ml:2	myeloid leukemia
MMA	MMA:24	manual metal arc
MMA	MMA:8	maxillomandibular advancement
MMA	MMA:1	medicare prescription drug improvement and modernization act
MMA	MMA:189	methyl methacrylate
MMA	MMA:7	methyl methacrylate monomer
MMA	MMA:14	methylmalonic
MMA	MMA:163	methylmalonic acid
MMA	MMA:8	methylmalonic acidaemia
MMA	MMA:22	methylmalonic acidemia
MMA	MMA:20	methylmalonic aciduria
MMA	MMA:58	methylmethacrylate
MMA	MMA:10	methylmethacrylate monomer
MMA	MMA:25|mmA:1	middle meningeal artery
MMA	MMA:19	monocyte monolayer assay
MMA	MMA:11	monomethylamine
MMA	MMA:16	monomethylarsonate
MMA	MMA:5	monterrey metropolitan area
MMCs	MMCs:27	migrating motor complexes
MMCs	MMCs:30	migrating myoelectric complexes
MMCs	MMCs:13	mucosal mast cells
MMC	MMC:6	children with meningomyelocele
MMC	MMC:17	children with myelomeningocele
MMC	MMC:26	medicaid managed care
MMC	MMC:11	metropolis monte carlo
MMC	MMC:63	mitomycin
MMC	MMC:12	patients with myelomeningocele
MMD	MMD:18	mass median diameter
MMD	MMD:6	minimal melanogenic dose
MMD	MMD:27	moyamoya disease
MMD	MMD:18	myotonic muscular dystrophy
MMF	MMF:11	macrophagic myofasciitis
MMF	MMF:33	maxillomandibular fixation
MMF	MMF:17	mismatch field
MMG	MMG:32	mechanomyogram
MMG	MMG:40	mechanomyographic
MMG	MMG:22	mechanomyography
MMH	MMH:6	methylmercury hydroxide
MMH	MMH:14	monomethylhydrazine
MMMF	MMMF:16	manmade mineral fibers
MMMF	MMMF:11	mineral fibres
MMM	MMM:5	mass molecules
MMM	MMM:12	metastatic malignant melanoma
MMM	MMM:109	myelofibrosis with myeloid metaplasia
MMM	MMM:9	myeloid metaplasia with myelofibrosis
MMN	MMN:5	medial mamillary nucleus
MMN	MMN:96	multifocal motor neuropathy
MMO	MMO:7	maximal mouth opening
MMO	MMO:6	maximum mouth opening
MMO	MMO:46	methane monooxygenase
MMP-8	MMP-8:18|Mmp8:1	collagenase
MMP-8	MMP-8:38|MMP8:5	neutrophil collagenase
MMPIs	MMPIs:13	matrix metalloproteinase inhibitors
MMPIs	MMPIs:18	mmp inhibitors
MMPI	MMPI:16|MMP-i:1|MMPi:1	matrix metalloproteinase inhibitor
MMPI	MMPI:7|MMPi:2	mmp inhibitor
MMPs	MMPs:9	matrix metalloproteinases
MMPs	MMPs:87|MMPS:1	matrix metalloproteases
MMP	MMP:6	methadone maintenance program
MMP	MMP:17	microsatellite mutator phenotype
MMP	MMP:30	mitochondrial membrane permeabilization
MMP	MMP:31	mucous membrane pemphigoid
MMP	MMP:10	peptides
MMR	MMR:29	maternal mortality rate
MMR	MMR:38	maternal mortality ratio
MMR	MMR:15	measlesmumpsrubella vaccine
MMR	MMR:12	midline malignant reticulosis
MMR	MMR:12	mild mental retardation
MMR	MMR:13	mismatch repair system
MMR	MMR:9	mouthtomouth resuscitation
MMR	MMR:9	mumpsmeaslesrubella
MMSE	MMSE:94	minimental state exam
MMSE	MMSE:5	minimum mean square error
MMSE	MMSE:9	state evaluation
MMs	MMs:27	malignant melanomas
MMs	MMs:14	malignant mesotheliomas
MMS	MMS:9	methyl methane sulphonate
MMS	MMS:473	methyl methanesulfonate
MMS	MMS:102|mms:1	methyl methanesulphonate
MMS	MMS:52	methylmethane sulfonate
MMS	MMS:9	methylmethane sulphonate
MMS	MMS:37	methylmethanesulfonate
MMS	MMS:12	methylmethanesulphonate
MMS	MMS:17	minimental state examination
MMS	MMS:62	mohs micrographic surgery
MMS	MMS:7	multiple metabolic syndrome
MMT	MMT:24	manual muscle test
MMT	MMT:37	manual muscle testing
MMT	MMT:13	methadone maintenance therapy
MMT	MMT:76	methadone maintenance treatment
MMT	MMT:68	methylcyclopentadienyl manganese tricarbonyl
MMT	MMT:7	mixed mesodermal tumor
MMT	MMT:8	mixed mullerian tumors
MMT	MMT:8|mmt:1	montmorillonite
MMVF	MMVF:28	manmade vitreous fibers
MMVF	MMVF:10	vitreous fibres
MM	MM:4|Mm:4	masseter muscle
MM	MM:16	maternal mortality
MM	MM:6	meningococcal meningitis
MM	MM:9	menstrual migraine
MM	MM:15	mesangial matrix
MM	MM:11	metanephric mesenchyme
MM	MM:31	methadone maintenance
MM	MM:9|M-M:7	michaelismenten
MM	MM:11	minimal medium
MM	MM:8	mirror movements
MM	MM:15	mitochondrial myopathy
MM	MM:12	mixed micelles
MM	MM:23	miyoshi myopathy
MM	MM:12	model
MM	MM:17|Mm:1	muscle mass
MM	MM:11	muscularis mucosae
MM	MM:13	mycoplasma meleagridis
MM	MM:8	myeloid metaplasia
MM	MM:12	myelomeningocele
MNA	MNA:45	mean nuclear area
MNA	MNA:61	mini nutritional assessment
MNA	MNA:9	mycn amplification
MNC	MNC:14	mononuclear
MNC	MNC:183	mononuclear cell
MND	MND:24	minor neurological dysfunction
MND	MND:9	modified neck dissection
MND	MND:96	motor neurone disease
MNNG	MNNG:27	methylnitronitrosoguanidine
MNNG	MNNG:11	nmethylnnitronitrosoguanidine
mNTS	mNTS:5|m-NTS:1	medial nucleus of the solitary tract
mNTS	mNTS:14|mnTS:1	medial nucleus tractus solitarius
MNT	MNT:25	medical nutrition therapy
MNT	MNT:15	mouse neutralization test
MNU	MNU:24	methyl nitrosourea
MNU	MNU:41	nmethylnitrosourea
MNs	MNs:76|Mns:9|mns:1|MNS:1	motoneurons
MNs	MNs:24|Mns:3	motoneurones
MOC	MOC:31	medial olivocochlear
MOC	MOC:9	myositis ossificans circumscripta
MODY	MODY:7	diabetes of young people
MODY	MODY:2	maturityonset diabetes of young
MODS	MODS:18|MODs:1	multiple organ dysfunction score
MODS	MODS:279	multiple organ dysfunction syndrome
MOD	MOD:10	magnetooptical disk
MOD	MOD:5	maturity onset diabetes
MOD	MOD:23|mOD:1	mean optical density
MOE	MOE:12	main olfactory epithelium
MOE	MOE:7	margin of exposure
MOE	MOE:9	massive ovarian edema
MOF	MOF:11	methoxyflurane
MOF	MOF:374	multiple organ failure
MOH	MOH:9	medication overuse headache
MOH	MOH:108|MoH:18|MOh:1	ministry of health
MOI	MOI:11|moi:3	different multiplicities of infection
MOI	MOI:8	mechanism of injury
MOS	MOS:6	main olfactory system
MOS	MOS:91	medical outcomes study
MOX	MOX:9|Mox:1	methanol oxidase
MOX	MOX:12	moxidectin
MOX	MOX:6|Mox:3	moxonidine
MPAG	MPAG:8	glucuronide metabolite
MPAG	MPAG:23	mycophenolic acid glucuronide
MPA	MPA:34	maclura pomifera
MPA	MPA:25	maclura pomifera agglutinin
MPA	MPA:54|mPA:2	main pulmonary artery
MPA	MPA:34	medroxyprogesterone
MPA	MPA:17|mPA:3	microscopic polyarteritis
MPA	MPA:7	multiprobe assembly
MPA	MPA:384|mPA:1	mycophenolic acid
MPA	MPA:5	peak amplitude
MPB	MPB:10	male pattern baldness
MPB	MPB:32|mPB:9	mobilized peripheral blood
MPC	MPC:64	methacryloyloxyethyl phosphorylcholine
MPC	MPC:21	maximum permissible concentration
MPC	MPC:8	mean platelet component
MPC	MPC:7	model predictive control
MPC	MPC:7	mouse plasmacytoma
MPC	MPC:23	multicatalytic proteinase complex
MPC	MPC:12	multiple primary cancer
MPC	MPC:26	mutant prevention concentration
MPC	MPC:10	partially thiolated polycytidylic acid
MPD	MPD:26	methylpentanediol
MPD	MPD:83	main pancreatic duct
MPD	MPD:5	maximum population density
MPD	MPD:15	mevalonate pyrophosphate decarboxylase
MPD	MPD:34	minimal phototoxic dose
MPD	MPD:73	multiple personality disorder
MPE	MPE:19	massive pulmonary embolism
MPE	MPE:11	maximum permissible exposure
MPE	MPE:6	maximum possible effect
MPF	MPF:57	mphase promoting factor
MPF	MPF:161|mpf:2	mean power frequency
MPGN	MPGN:291	membranoproliferative glomerulonephritis
MPGN	MPGN:19	membranoproliferative gn
MPG	MPG:20	major pelvic ganglia
MPG	MPG:36	major pelvic ganglion
MPG	MPG:31	nmethylpurinedna glycosylase
MPI	MPI:22	mannheim peritonitis index
MPI	MPI:14|Mpi:3	mannose phosphate isomerase
MPI	MPI:32	maudsley personality inventory
MPI	MPI:18	mucus proteinase inhibitor
MPI	MPI:36	multidimensional pain inventory
MPI	MPI:61	myocardial performance index
MPI	MPI:96	myocardial perfusion imaging
MPL	MPL:9	massperlength
MPL	Mpl:2|MPL:2	tpo receptor
MPM	MPM:130	malignant pleural mesothelioma
MPM	MPM:11	minor psychiatric morbidity
MPM	MPM:8	mortality prediction model
MPM	MPM:7	mortality probability model
MPN	MPN:9	omethylpyridoxine
MPN	MPN:11|mPN:2	male pronucleus
MPN	MPN:7	modulatory proctolin neuron
MPN	MPN:47	mostprobablenumber
MPN	MPN:158	probable number
MPO	MPO:10	medial preoptic
MPO	MPO:62	myeloperoxidase activity
MPO	MPO:5	release of mast cell peroxidase
MPP+	MPP+:6	methylphenylpyridinium cation
MPP+	MPP+:7	metabolite methylphenylpyridine
MPP+	MPP+:21	nmethylphenylpyridinium
MPP	MPP:15	massive periretinal proliferation
MPP	MPP:18|mPP:1	medial perforant path
MPP	MPP:64	mitochondrial processing peptidase
MP-RAGE	MP-RAGE:7	magnetizationprepared rapid gradientecho
MP-RAGE	MP-RAGE:6|MPRAGE:2	rapid acquisition gradientecho
MPRs	MPRs:31	mannose phosphate receptors
MPRs	MPRs:8|MPRS:1	multiplanar reconstructions
MPR	MPR:5	cationindependent mannosephosphate receptor
MPR	MPR:18|MP-R:1|Mpr:1	mannose phosphate receptor
MPR	MPR:14	medication possession ratio
MPR	MPR:13	mouse prostate reconstitution
MPR	MPR:14	multiplanar
MPR	MPR:11	multiplanar reformatted
MPR	MPR:15	myocardial perfusion reserve
MPS	MPS:4	cells of the mononuclear phagocyte series
MPS	MPS:15	macular photocoagulation study
MPs	MPs:5	membrane potentials
MPs	MPs:13	metalloproteinases
MPs	MPs:24|mps:1	microparticles
MPS	MPS:133	mononuclear phagocyte system
MPS	MPS:56	mononuclear phagocytic system
MPs	MPs:5	motor potentials
MPs	MPs:24	movement proteins
MPS	MPS:64	mucopolysaccharidoses
MPS	MPS:9	multidimensional perfectionism scale
MPs	MPs:11	muramyl peptides
MPS	MPS:7	myeloproliferative syndromes
MPS	MPS:5	myocardial perfusion singlephoton emission computed tomography
MPS	MPS:10	myocardial perfusion spect
MPS	MPS:32	myofascial pain syndrome
MPS	MPS:13	patients with mucopolysaccharidosis
MPTP	MPTP:11	tetrahydropyridine
MPTP	MPTP:37	methylphenyltetrahydropyridine
MPTP	MPTP:21	neurotoxin nmethylphenyltetrahydropyridine
MPT	MPT:25	maximum phonation time
MPT	MPT:6	methylprednisolone pulse therapy
MPT	MPT:244|mPT:21	mitochondrial permeability transition
MPT	MPT:29	molybdopterin
MPT	MPT:19|MP-T:1	munich personality test
MPT	MPT:6	primary cultures of mouse proximal tubular
MPV	MPV:12	main portal vein
MPV	MPV:6	masonpfizer virus
MPV	MPV:5	maximum peak velocity
MPV	MPV:169	mean platelet volume
MPV	MPV:8	monkeypox virus
MP	MP:17	machine perfusion
MP	MP:32	macular pigment
MP	MP:8|mp:1	main process
MP	MP:16	mannoprotein
MP	MP:23	mastoparan
MP	MP:12	matching pursuit
MP	MP:11	meconium peritonitis
MP	MP:30	melphalan and prednisone
MP	MP:10|M-P:1	melphalanprednisone
mp	mp:3|MP:2	melting points
MP	MP:16|M-P:1	metatarsophalangeal
MP	MP:21	methapyrilene
MP	MP:20	methyl palmoxirate
MP	MP:10	methyl prednisolone
MP	MP:11	methylphosphonate
MP	MP:24	micronized progesterone
MP	MP:8	micturition pressure
MP	MP:16	migration percentage
MP	MP:10	mitral prolapse
MP	MP:10	monopolar
MP	MP:22	motor potential
MP	MP:151	movement protein
mp	mp:8|MP:3	muscularis propria
MP	MP:5	mycoplasma pneumoniae pneumonia
MP	MP:35|Mp:11|mp:1	mycoplasma pneumoniae
MP	MP:11	myenteric plexus
MP	MP:12	myocardial perfusion
MP	MP:12	myosin phosphatase
MQMAS	MQMAS:8	magic angle spinning
MQMAS	MQMAS:8	multiplequantum magicangle spinning
MQSA	MQSA:16	mammography quality standards act
MQSA	MQSA:9	mammography quality standards act of 
MQ	MQ:7	maastricht questionnaire
MQ	MQ:45	mefloquine
MRA	MRA:12	magnetic resonance angiogram
MRA	MRA:10	magnetic resonance angiographic
MRA	MRA:9	magnetic resonance arteriography
MRA	MRA:11|MRa:3	magnetic resonance arthrography
MRA	MRA:14	malignant rheumatoid arthritis
MRA	MRA:16|MrA:2	mesenteric resistance arteries
MRA	MRA:6|MRa:1	mr arthrography
MRA	MRA:22	multiple regression analysis
MRCP	MRCP:214	magnetic resonance cholangiopancreatography
MRCP	MRCP:99	mr cholangiopancreatography
MRC	MRC:10	magnetic resonance colonography
MRC	MRC:205	medical research council
MRC	MRC:33	mitochondrial respiratory chain
MRC	MRC:20	mr cholangiography
MRD	MRD:11	magnetic relaxation dispersion
MRD	MRD:653	minimal residual disease
MRD	MRD:7	modified robbins device
MRD	MRD:13	rate of depolarization
MRE	MRE:25	magnetic resonance elastography
MRE	MRE:13	metal response element
MRF	MRF:14	markov random field
MRF	MRF:8	muscle regulatory factor
MRHA	MRHA:24	mannoseresistant haemagglutination
MRHA	MRHA:22|MR-HA:1	mannoseresistant hemagglutination
MRI	MRI:11	magnetic resonance imagery
MRI	MRI:8	magnetic resonance imaging scan
MRI	MRI:9	research institute
MRLs	MRLs:15	maximum residue levels
MRLs	MRLs:11	minimal risk levels
MRM	MRM:15|MR-M:1	magnetic resonance mammography
MRM	MRM:44	magnetic resonance microscopy
MRM	MRM:9	mechanically recovered meat
MRM	MRM:63	modified radical mastectomy
MRM	MRM:17	mr mammography
MRM	MRM:9	murine respiratory mycoplasmosis
MRPs	MRPs:25	maillard reaction products
MRPs	MRPs:24	movementrelated potentials
MRPs	MRPs:14|Mrps:2	multidrug resistance proteins
MRP	MRP:11	maximum resting pressure
MRP	MRP:9	median root prior
MRP	MRP:10	mitochondrial rna processing
MRP	MRP:5|mrp:2	protein gene
MRP	MRP:11	reaction products
MRP	MRP:9	requirements planning
MRR	MRR:9	maximal relaxation rate
MRR	MRR:9	maximum relaxation rate
MRR	MRR:8	mortality rate ratio
MRSA	MRSA:17	methicillinresistant s aureus
MRSA	MRSA:2240|MR-SA:2|mrsa:1	methicillinresistant staphylococcus aureus
MRSA	MRSA:7	methicillinresistant staphylococcus aureus strains
MRSA	MRSA:12	methicillinresistant strains
MRSA	MRSA:15	resistant to methicillin
MRS	MRS:11	magnetic resonance spectroscopic
MRS	MRS:14	mania rating scale
MRS	MRS:43	melkerssonrosenthal syndrome
MRS	MRS:17	menopause rating scale
MRs	MRs:11|MRS:1	metabolic ratios
MRS	MRS:10	methicillinresistant staphylococci
MRs	MRs:8|MRS:1	mineralocorticoid
MRs	MRs:41	mineralocorticoid receptors
mRS	mRS:68|MRS:29|m-RS:3|mRs:2	modified rankin scale
mRS	mRS:7|MRS:1	modified rankin score
MRS	MRS:5	rogosa and sharpe
MRT	MRT:65	malignant rhabdoid tumor
MRT	MRT:406	mean residence time
MRT	MRT:9	mental rotations test
MRT	MRT:6	microbeam radiation therapy
MRT	MRT:7	microwave resonance therapy
MRT	MRT:18	milk ring test
MRT	MRT:11	modified rhyme test
MRU	MRU:22	magnetic resonance urography
MRU	MRU:15	mr urography
MRV	MRV:31	magnetic resonance venography
MRV	MRV:5	mouse rotavirus
MRV	MRV:5	murine rotavirus
MR	MR:10	magnetoresistance
MR	MR:9	maillard reaction
MR	MR:12	mandelate racemase
MR	MR:29	medial rectus
MR	MR:28	median raphe
MR	MR:19	menstrual regulation
MR	MR:11	mental rotation
MR	MR:42	mentally retarded
MR	MR:25|M-R:1	methicillinresistant
MR	MR:12	milk replacer
MR	MR:50|mr:1	mitochondriarich
MR	MR:23	mitotic rate
MR	MR:764	mitral regurgitation
MR	MR:11	molecular remission
MR	MR:9	molecular replacement
MR	MR:5	morbid risk
MR	MR:7	morphinone reductase
MR	MR:29	mortality rate
MR	MR:13	motherreared
MR	MR:10	multiresistant
MS/MS	MS/MS:12	tandem mass
MS/MS	MS/MS:38|ms/ms:1	tandem mass spectrometric
MS/MS	MS/MS:433|ms/ms:4	tandem mass spectrometry
MSAs	MSAs:18	medical savings accounts
MSAs	MSAs:32	metropolitan statistical areas
MSA	MSA:18	mammary serum antigen
MSA	MSA:7	mannitol salt agar
MSA	MSA:28	master settlement agreement
MSA	MSA:65	medial septal area
MSA	MSA:17	methanesulfonic acid
MSA	MSA:16	metropolitan statistical area
MSA	MSA:13	middle stone age
MSA	MSA:12	mouse serum albumin
MSA	MSA:15	multiple sequence alignment
MSA	MSA:8	multivariate statistical analysis
MSA	MSA:21	muscle nerve sympathetic activity
MSA	MSA:18	muscle sympathetic activity
MSBP	MSBP:4|mSBP:4	mean systemic blood pressure
MSBP	MSBP:31|MSbP:4	munchausen syndrome by proxy
MSCT	MSCT:28	multislice computed tomography
MSCT	MSCT:38|MS-CT:4	multislice ct
MSCT	MSCT:29|msCT:1	multislice spiral ct
MSC	MSC:13	magnitudesquared coherence
MSC	MSC:9	mercurascan
MSD	MSD:12|msd:1	displacement
MSD	MSD:8	marble spleen disease
MSD	MSD:5	mean sac diameter
MSD	MSD:6	mean segment diameter
MSD	MSD:12	membranespanning domain
MSD	MSD:6	merck sharp and dohme
MSD	MSD:20	multiple sulfatase deficiency
MSD	MSD:10	multiple sulphatase deficiency
MSD	MSD:5	multisomatoform disorder
MSD	MSD:7	sibling donor
MSE	MSE:11	mean spherical equivalent
MSE	MSE:35|mse:1	mean square error
MSE	MSE:32|mse:1	mean squared error
MSE	MSE:13	monocytespecific esterase
MSFC	MSFC:15	ms functional composite
MSFC	MSFC:27	multiple sclerosis functional composite
MSF	MSF:16	medecins sans frontieres
MSF	MSF:42	mediterranean spotted fever
MSF	MSF:10	methanesulfonyl fluoride
MSF	MSF:33	modified sham feeding
MSF	MSF:12|msf:1	stimulating factor
MSG	MSG:8	administration of monosodiumlglutamate
MSG	MSG:13	minor salivary gland
MSG	MSG:411	monosodium glutamate
MSG	MSG:74	monosodium lglutamate
MSHA	MSHA:7	mannosesensitive hemagglutination
MSHA	MSHA:19	mannosesensitive hemagglutinin
MSHA	MSHA:20	mine safety and health administration
MSH	MSH:34	alphamelanocyte stimulating hormone
MSH	MSH:17	melanotropin
MSH	MSH:9	mycothiol
MSH	MSH:8	stimulating hormones
MSI	MSI:42	magnetic source imaging
MSI	MSI:6	marital satisfaction inventory
MSI	MSI:5	massive splenic injury
MSI	MSI:5	muscle strength index
MSK	MSK:18	medullary sponge kidney
MSK	MSK:22	musculoskeletal
MSLR	MSLR:6	cell lymphocyte culture reaction
MSLR	MSLR:6	mixed skin celllymphocyte culture reaction
MSL	MSL:13|msl:6	malespecific lethal
MSL	MSL:8	mean sleep latency
MSL	MSL:34	multiple symmetric lipomatosis
MSM	MSM:358	men who have sex with men
MSM	MSM:11	methylsulfonylmethane
MSOF	MSOF:40	multiple system organ failure
MSOF	MSOF:18	multisystem organ failure
MSO	MSO:12	lmethioninedlsulfoximine
MSO	MSO:11	management services organization
MSO	MSO:18	medial superior olivary nucleus
MSO	MSO:60	medial superior olive
MSP	MSP:48|msp:3	major sperm protein
MSP	MSP:5|msp:2	major surface protease
MSP	MSP:13	maximum squeeze pressure
MSP	MSP:8|msp:1	microspectrophotometric
MSP	MSP:19|msp:1	microspectrophotometry
MSP	MSP:8	myelencephalonspecific protease
MSRV	MSRV:9	modified semisolid rappaportvassiliadis
MSRV	MSRV:8	multiple sclerosisassociated retrovirus
MSR	MSR:10	monosynaptic
MSR	MSR:73	monosynaptic reflex
MSSA	MSSA:11	methicillinsensitive
MSSA	MSSA:6	methicillinsensitive s aureus
MSSA	MSSA:57	methicillinsensitive staphylococcus aureus
MSSA	MSSA:24	methicillinsusceptible
MSSA	MSSA:2	methicillinsusceptible s aureus
MSSA	MSSA:50	methicillinsusceptible staphylococcus aureus
MSS	MSS:9	marinescosjogren syndrome
MSS	MSS:7	marshallsmith syndrome
MSS	MSS:15	maternal serum screening
MSS	MSS:7	moderate splenomegaly syndrome
MST	MST:5	maximal stimulation test
MST	MST:5	mental arithmetic stress test
MST	MST:5	mental stress test
MST	MST:8	microbial source tracking
MST	MST:24	minimum spanning tree
MST	MST:8	montenegro skin test
MST	MST:32	multiple subpial transection
MST	MST:22	multisystemic therapy
MSU	MSU:87	monosodium urate
MSU	MSU:10	monosodium urate crystals
MSU	MSU:9	state university
MSWI	MSWI:26	municipal solid waste incineration
MSWI	MSWI:38	municipal solid waste incinerator
MS	MS:9	chinese meishan
MS	MS:9	magnetic source
MS	MS:23	magnetic stimulation
MS	MS:27	mainstream
MS	MS:17	mainstream smoke
MS	MS:7	malignant schwannoma
MS	MS:5	manchester scale
MS	MS:8	marbling score
MS	MS:5	marijuana smokers
MS	MS:14	mass screening
MS	MS:8	mass spectral
MS	MS:46	mass spectrometer
MS	MS:127	mass spectrometric
MS	MS:19	maternal separation
MS	MS:46	maternal serum
MS	MS:7	meal size
MS	MS:30	mean sensitivity
MS	MS:41|Ms:1	mechanosensitive
MS	MS:35	medial septal
MS	MS:88	medial septum
MS	MS:9	median sternotomy
MS	MS:14	mental stress
MS	MS:10	methionine synthetase
MS	MS:9	middle suprasylvian
MS	MS:12|ms:1	mild steel
ms	ms:30|MS:1|mS:1	milliseconds
MS	MS:267	mitral stenosis
MS	MS:5	molar substitution
MS	MS:78	morphine sulfate
MS	MS:31	motion sickness
ms	ms:5|MS:2|m-s:1|M-S:1	mucosaltoserosal
MS	MS:9	multiplescattering
MS	MS:9	multiple sderosis
MS	MS:9	murashigeskoog
MS	MS:117|ms:9	mutans streptococci
MS	MS:7	mutator strain
MS	MS:49|Ms:1	mycoplasma synoviae
MT-MMP	MT-MMP:19	membranetype matrix metalloproteinase
MT-MMP	MT-MMP:7	membranetype mmp
MT-MMPs	MT-MMPs:27	membranetype matrix metalloproteinases
MT-MMPs	MT-MMPs:14	membranetype mmps
MTAL	MTAL:5|mTAL:4	medullary tal
MTAL	MTAL:9|mTAL:7|mtal:1	medullary thick ascending limb of henle
MTA	MTA:28	deoxymethylthioadenosine
MTA	MTA:10	medial temporal lobe atrophy
MTA	MTA:118	mineral trioxide aggregate
MTA	MTA:8	moving time average
MTA	MTA:6	multisite multimodal treatment study of children with attentiondeficithyperactivity disorder
MTA	MTA:12	multitargeted antifolate
MTA	MTA:5	myoclonic twitch activity
MTC	MTC:89	magnetization transfer contrast
MTC	MTC:29	major translocation cluster
MTC	MTC:5	mass transfer area coefficients
MTC	MTC:107	medullary thyroid cancer
MTC	MTC:9	microwave tissue coagulation
MTC	MTC:14	microwave tissue coagulator
MTC	MTC:9	muscletendon complex
MTD	MTD:23	amplified mycobacterium tuberculosis direct test
MTD	MTD:136	determine the maximumtolerated dose
MTD	MTD:5	mannitol dehydrogenase
MTD	MTD:10	maximum tolerated dosage
MTD	MTD:9|Mtd:4	methadone
MTD	MTD:11	tension dysphonia
MTF	MTF:4	formylation of initiator methionyltrna by methionyltrna formyltransferase
MTF	MTF:10	metrifonate
MTF	MTF:6	multipletube fermentation
MTF	MTF:9	treatment facility
MTHFR	MTHFR:739|Mthfr:3|MT-HFR:1	methylenetetrahydrofolate reductase
MTHFR	MTHFR:24	methylenetetrahydrofolate reductase gene
MTP-PE	MTP-PE:13	muramyl tripeptide
MTP-PE	MTP-PE:30|MTPPE:2	muramyl tripeptide phosphatidylethanolamine
MTP	MTP:26	first metatarsophalangeal
MTP	MTP:14	maltose tetrapalmitate
MTP	MTP:7	median time to progression
MTP	MTP:7	median time to tumor progression
MTP	MTP:14	medical termination of pregnancy
MTP	MTP:196	microsomal triglyceride transfer protein
MTP	MTP:5	microtubule proteins
MTP	MTP:9	treatment project
MTR	MTR:12	mithramycin
MTR	MTR:7	mt ratios
MTR	MTR:7	mucociliary transport rate
MTSEA	MTSEA:7|MTS-EA:1	aminoethyl methanethiosulfonate
MTSEA	MTSEA:13|MT-SEA:1	methanethiosulfonate ethylammonium
MTSET	MTSET:7|MTS-ET:2	trimethylammoniumethylmethanethiosulfonate
MTSET	MTSET:7|MTS-ET:1	methanethiosulfonate ethyltrimethylammonium
MTT	MTT:8	malignant triton tumor
MTT	MTT:19	meal tolerance test
MTT	MTT:5	mitochondrial dehydrogenase activity
MTT	MTT:10	myoblast transfer therapy
MTT	MTT:35	tetrazolium dye
MTU	MTU:10	malignant teratoma undifferentiated
MTU	MTU:29	methylthiouracil
MTU	MTU:5	muscletendon unit
MTV	MTV:88|Mtv:4	mammary tumor virus
MTV	MTV:6	maximum tolerable volume
MTV	MTV:5	maximum tolerated volume
MTX	MTX:9	hmethotrexate
MTX	MTX:4|Mtx:1	agonist methoxamine
MTX	MTX:72	maitotoxin
MTX	MTX:15	maurotoxin
MTX	MTX:4|Mtx:3|mtx:1	mosquitocidal toxin
MT	MT:16	 alphamethyltestosterone
MT	MT:20	alphamethyltestosterone
MT	MT:2	amt and methoxytryptamine
MT	MT:259	magnetization transfer
MT	MT:10	maintenance therapy
MT	MT:8|Mt:4	malpighian tubules
MT	MT:10|mt:4	matingtype
MT	MT:9	membrane type
MT	MT:19	methanethiol
MT	MT:27	methyltestosterone
MT	MT:10	methyltrienolone
mT	MT:14|mT:14	middle t
MT	MT:64	middle temporal
MT	MT:73	middle temporal area
MT	MT:68	middle temporal visual area
mT	mT:8|MT:1	millitesla
MT	MT:8|mt:1	morphological transformation
MT	MT:65	motor threshold
MT	MT:7	myoblast transplantation
MT	MT:8	myogenic tone
MUA	MUA:7	mercaptoundecanoic acid
MUA	MUA:57	multiple unit activity
MUA	MUA:63	multiunit activity
MUC	MUC:10	mucosal ulcerative colitis
MUC	MUC:10	transtransmuconaldehyde
MUNE	MUNE:18	motor unit number estimate
MUNE	MUNE:38	motor unit number estimation
MUPs	MUPs:38|mups:2|Mups:1	major urinary proteins
MUPs	MUPs:51	motor unit potentials
MUP	MUP:37|Mup:2	major urinary protein
MUP	MUP:10	maximum urethral pressure
MVA	MVA:43	manual vacuum aspiration
MVA	MVA:43	mevalonate
MVA	MVA:51	mevalonic acid
MVA	MVA:127	mitral valve area
MVA	MVA:29	modified vaccinia ankara
MVA	MVA:92	modified vaccinia virus ankara
MVA	MVA:18	multivariate analysis
MVCs	MVCs:38	maximal voluntary contractions
MVCs	MVCs:23	motor vehicle collisions
MVCs	MVCs:37	motor vehicle crashes
MVC	MVC:276	maximum voluntary contraction
MVC	MVC:9	minute virus of canines
MVC	MVC:12	motor vehicle collision
MVC	MVC:25	voluntary contraction force
MVC	MVC:7	voluntary contraction strength
MVD	MVD:130	microvascular decompression
MVD	MVD:19	mitral valve disease
MVD	MVD:25	multivessel disease
MVE-2	MVE-2:6	maleic anhydride divinyl ether
MVE-2	MVE-2:9	maleic anhydride divinyl ether copolymer
MVE	MVE:68	murray valley encephalitis
MVE	MVE:27	murray valley encephalitis virus
MVM	MVM:14	microvillous membrane
MVM	MVM:18	microvillus membrane
MVM	MVM:6	syncytiotrophoblast microvillous
MVO2	MVO2:64|MVo2:4	myocardial o consumption
MVO2	MVO2:8|MVo2:1	myocardial oxygen uptake
MVO	MVO:8	maximal venous outflow
MVO	MVO:11	maximum venous outflow
MVP	MVP:44|mvp:1	major vault protein
MVP	MVP:10	microvascular pressure
MVP	MVP:1	mitomycin vinblastine and cisplatin
MVP	MVP:438	mitral valve prolapse
MVP	MVP:8	mitral valvuloplasty
MVR-PCR	MVR-PCR:9	minisatellite variant repeat mapping by pcr
MVR-PCR	MVR-PCR:1	minisatellite variant repeat mapping by the polymerase chain reaction
MVR	MVR:20	minisatellite variant repeat
MVR	MVR:7	mitral valve regurgitation
MVR	MVR:17|MVr:2	mitral valve repair
MVT	MVT:12	mesenteric vein thrombosis
MVT	MVT:20	mesenteric venous thrombosis
MVT	MVT:15	monomorphic ventricular tachycardia
MVV	MVV:67|mvv:2	maedivisna virus
MVV	MVV:4	minute ventilation volume
MVV	MVV:145	voluntary ventilation
MV	MV:10|M-V:1	maedivisna
MV	MV:17	maternal vein
MV	MV:12	maternal venous
MV	MV:17	maturation value
MV	MV:14|mv:1|Mv:1	mechanically ventilated
MV	MV:12	megavoltage
MV	MV:38	methyl viologen
MV	MV:9	microvessels
MV	MV:16	microvibration
MV	MV:31|mv:2|Mv:1	microvilli
MWC	MWC:6	maximal working capacity
MWC	MWC:15	monodwymanchangeux
MWC	MWC:6	work capacity
MWD	MWD:12	maximal walking distance
MWD	MWD:19	maximum walking distance
MWD	MWD:14	molecular weight distribution
MWM	MWM:7	mediumweight molecules
MWM	MWM:135	morris water maze
MWT	MWT:38	maintenance of wakefulness test
MWT	MWT:5	walk time
MW	MW:13	highmolecularweight
MW	MW:92|mw:3	microwave
MW	MW:5	millimeter waves
MW	MW:9	munichwistar
Mw	Mw:12|MW:2	slope
Mw	Mw:5	weightaverage molar mass
MX	MX:10	methoxyamine
MX	MX:18	musk xylene
MZ	MZ:14	identical
MZ	MZ:123	marginal zone
MZ	MZ:650|mz:1|Mz:1	monozygotic
MZ	MZ:10	monozygotic twins
MZ	MZ:42|Mz:2	monozygous
ManNAc	ManNAc:9	nacetyldmannosamine
ManNAc	ManNAc:24|manNac:1	nacetylmannosamine
MbCO	MbCO:10	carbonmonoxy myoglobin
MbCO	MbCO:13	carboxymyoglobin
MB	MB:11	marginal band
MB	MB:13	maternal behavior
MB	MB:48|Mb:1	medulloblastoma
MB	MB:10|mb:6|M-B:3	membranebound
MB	MB:7|mb:3	mesiobuccal
MB	MB:11	molecular beacon
MB	MB:130	multibacillary
MB	MB:11	myocardial bridge
MB	MB:7	myocardial bridging
MDE	MDE:13	methylenedioxyethylamphetamine
MDE	MDE:14	nethylmethylenedioxyamphetamine
MeHg	MeHg:86|Me-Hg:1|meHg:1	methyl mercury
MeHg	MeHg:6	methyl mercury chloride
MeCP2	MECP2:3|MeCP2:3	methylcpgbinding protein
MeCP2	MeCP2:13|MECP2:8	methylcpg binding protein 
MECs	MECs:20|mecs:1	mammary epithelial cells
MECs	MECs:6	minimal effective concentrations
MEL	MEL:28|Mel:20	melphalan
MEL	MEL:17	mouse erythroleukaemia
MEL	MEL:6	mouse erythroleukemic
MEL	MEL:27	murine erythroleukaemia
MEL	MEL:252	murine erythroleukemia
MEL	MEL:13	murine erythroleukemic
MER	MER:27	methanol extraction residue
MER	MER:8	methanol extraction residue of bacillus calmetteguerin
MER	MER:12	methanol extraction residue of bcg
MER	MER:5	molar esterification rate
mesna	mesna:5|MESNA:3	mercaptoethane sulphonate
mesna	mesna:11|Mesna:4|MESNA:2|MesNa:1	sodium mercaptoethane sulfonate
mesna	mesna:7|Mesna:3|MESNA:1	sodium mercaptoethanesulfonate
MIA	MIA:33	melanoma inhibitory activity
MIA	MIA:7	methylisobutyl amiloride
MIA	MIA:16|Mia:3	mianserin
MLA	MLA:23	medical library association
MLA	MLA:78	methyllycaconitine
MLA	MLA:7|mLA:1	minimum lumen area
MLA	MLA:22	mouse lymphoma assay
MLS	MLS:17	macrolidelincosamidestreptogramin
MLS	MLS:13	maximum likelihood score
MLS	MLS:26	microphthalmia with linear skin defects
MLS	MLS:8	myxoid liposarcomas
MLS	MLS:9	platelet mean life span
MnDPDP	MnDPDP:18|Mn-DPDP:9|MN-DPDP:1	mangafodipir trisodium
MnDPDP	MnDPDP:9|Mn-DPDP:1	manganese dipyridoxyl diphosphate
MN	MN:9	mauthner neurons
MN	MN:9	meal number
MN	MN:26	median nerve
MN	MN:19	melanocytic nevi
MN	MN:10	mental nerve
MN	MN:16	methyl nicotinate
MN	MN:402|Mn:4	micronucleus
MON	MON:12|Mon:7	monensin
MON	MON:6|Mon:3	moniliformin
MPH	MPH:22	male pseudohermaphroditism
MPH	MPH:6	methylphenidate hydrochloride
MscL	MscL:1	mechanosensitive channel with very large conductance
MscL	MscL:10	mechanosensitive ion channel
MTS	MTS:13|M-t-S:1	matchingtosample
MTS	MTS:97	mesial temporal sclerosis
MTs	MTs:298|Mts:2|MTS:2	metallothioneins
MTS	MTS:51	methanethiosulfonate
MTs	MTs:412|Mts:18|mts:3	microtubules
MTS	MTS:17	mitochondrial targeting sequence
MTS	MTS:9	mitochondrial targeting signal
MTs	MTs:7	motor thresholds
MTS	MTS:34	muirtorre syndrome
MTS	MTS:7	testing system
N0	N0:9	clinically negative
N0	N0:6	clinically negative neck
N0	N0:5	lymph node involvement
N1	N1:16|n1:1	negative peak
N1	N1:22	negative wave
N1	N1:14	negativity
NAA/Cr	NAA/Cr:5	creatine ratio
NAA/Cr	NAA/Cr:10	nacetylaspartatecreatine
NAC	NAC:13	antioxidant nacetylcysteine
NAC	NAC:32	antioxidant nacetyllcysteine
NAC	NAC:5	component of ad amyloid
NAC	NAC:113|NAc:2|N-ac:1|nAC:1	nacetyl cysteine
NAC	NAC:14	nacetyl lcysteine
NAC	NAC:13	nacetylcystein
NAC	NAC:1008|N-ac:5|N-Ac:5|Nac:2|NAc:2	nacetylcysteine
NAC	NAC:14	nasal allergen challenge
NAC	NAC:20	nascent polypeptideassociated complex
NAC	NAC:9	needle aspiration cytology
NAC	NAC:9	nippleareola complex
NADH-TR	NADH-TR:7	nadh tetrazolium reductase
NADH-TR	NADH-TR:10	nicotinamide adenine dinucleotide tetrazolium reductase
NADH	NADH:2	nicotinamide adenine dinucleotide reduced
NADH	NADH:159	reduced nicotinamide adenine dinucleotide
NADPH	NADPH:2	adenine dinucleotide phosphate reduced form
NADPH	NADPH:7	nicotinamide adenine dinucleotide phosphate reduced
NAGM	NAGM:5	normalappearing gray matter
NAGM	NAGM:5	normal appearing grey matter
NAG	NAG:11	nacetylbdglucosaminidase
NAG	NAG:36	nacetylglucosaminidase
NAG	NAG:11	nacetylglutamate
NAG	NAG:29	urinary nacetylbetaglucosaminidase
NALT	NALT:12	lymphoid tissues
NALT	NALT:53	nasalassociated lymphoid tissue
NAL	NAL:11	nacystelyn
NAL	NAL:26|Nal:16	nalidixic acid
NAL	NAL:7|Nal:3	naltrexone
NAPQI	NAPQI:4	metabolite nacetylpbenzoquinoneimine
NAPQI	NAPQI:58	nacetylpbenzoquinone imine
NAP	NAP:20|Nap:4	naproxen
NAP	NAP:12	napvsipq
NAP	NAP:19	nerve action potential
NAP	NAP:71|N-AP:1	neutrophil alkaline phosphatase
NAP	NAP:8	nucleoacidic protein
NASS	NASS:12	national automotive sampling system
NASS	NASS:12	north american spine society
NAS	NAS:74|N-aS:1|N-AS:1	nacetylserotonin
NAs	NAs:7	naphthenic acids
NAS	NAS:11	national academy of sciences
NAS	NAS:31	neonatal abstinence syndrome
NAS	NAS:12	normative aging study
NAS	NAS:63	nucleus accumbens septi
NAs	NAs:23	nursing assistants
NAT1	NAT1:4|NAT-1:1	arylamine nacetyltransferase
NAT1	NAT1:38	nacetyltransferase 
NAT	NAT:15	nacetyl transferase
NAT	NAT:11	nacetyltransferase activity
NAT	NAT:11	neospora agglutination test
NAT	NAT:19|NA-T:1	noradrenaline transporter
NAT	NAT:8	nucleic acid amplification techniques
NAT	NAT:30	nucleic acid amplification technology
NAT	NAT:17	nucleic acid amplification testing
NAT	NAT:32	nucleic acid testing
NAT	NAT:14	serotoninnacetyltransferase
NACS	NACS:18	adaptive capacity scores
NACS	NACS:7	neurologic and adaptive capacity score
NBA	NBA:19	born alive
NBA	NBA:13	nbromoacetamide
NBD1	NBD1:13|NBD-1:1	nucleotide binding domain
NBD1	NBD1:9|NBD-1:1	nucleotidebinding domain 
NBD-Cl	NBD-Cl:9	chloronitrobenzofurazan
NBD-Cl	NBD-Cl:10	chloronitrobenzoxadiazole
NBD-Cl	NBD-Cl:37|NBDCl:1|Nbd-Cl:1	chloronitrobenzooxadiazole
NBD	NBD:23	nitrobenzoxadiazolyl
NBD	NBD:11	neurobehcets disease
NBF	NBF:38	nerve blood flow
NBF	NBF:10	neutral buffered formalin
NBL	NBL:11	neuroblastic layer
NBL	NBL:17	newborn larvae
NBMPR	NBMPR:6	binding of hnitrobenzylthioinosine
NBMPR	NBMPR:6	nitrobenzylmercaptopurine ribonucleoside
NBMPR	NBMPR:11	nitrobenzylmercaptopurine riboside
NBMPR	NBMPR:9	pnitrobenzylthioinosine
NBM	NBM:24|N-BM:1	normal bone marrow
NBM	NBM:237|nbm:35|nBM:27|nbM:20|Nbm:4|NBm:4|NbM:2	nucleus basalis magnocellularis
NBP	NBP:13	pnitrobenzylpyridine
NBP	NBP:10	nonbacterial prostatitis
NBS	NBS:99|N-BS:1	nbromosuccinimide
NBS	NBS:22	national bureau of standards
NBs	NBs:19|Nbs:4	neuroblasts
NBs	NBs:22|NBS:1	neuroblastomas
NBS	NBS:26	newborn screening
NBS	NBS:125	nijmegen breakage syndrome
NBs	NBs:57	nuclear bodies
NBTI	NBTI:13	snitrobenzylthioinosine
NBTI	NBTI:11	spnitrobenzylthioinosine
NBT	NBT:112	nitro blue tetrazolium
NBT	NBT:11	nitroblue tetrazolium dye
NBT	NBT:16	nitroblue tetrazolium test
NBT	NBT:5	nitrotetrazolium blue
NBT	NBT:8	normal brain tissue
NBT	NBT:9	reduction test
NBW	NBW:67	normal birth weight
NBW	NBW:22	normal birthweight
NB	NB:9	negative binomial
NB	NB:9|Nb:2	neurobiotin
NB	NB:19	neuroborreliosis
NB	NB:10	neuromedin b
NB	NB:8	nile blue
Nb	Nb:34|NB:9	nippostrongylus brasiliensis
NB	NB:40	nitrobenzene
NB	NB:40|Nb:2	nitrogen balance
NB	NB:9	nitrosobenzene
Nb	Nb:14	noble
NB	NB:32	normalized blur
NB	NB:9|Nb:1	novobiocin
NB	NB:23	nutrient broth
NCA	NCA:13	nested clade analysis
NCA	NCA:12	neurocirculatory asthenia
NCA	NCA:74	neutrophil chemotactic activity
NCA	NCA:31	nonspecific crossreacting antigen
NCA	NCA:18	normal coronary arteries
NCC	NCC:8	cytotoxic cell
NCC	NCC:99	neurocysticercosis
NCC	NCC:45	nonspecific cytotoxic cells
NCC	NCC:8	nucleated cell count
NCE	NCE:5	naca exchanger
NCE	NCE:13	new chemical entity
NCEP	NCEP:9	national cholesterol education panel
NCEP	NCEP:327	national cholesterol education program
NCIs	NCIs:8	neuronal cytoplasmic inclusions
NCIs	NCIs:10	noncompetitive inhibitors
NCI	NCI:31	negative chemical ionization
NCI	NCI:18	nuclear contour index
NCM	NCM:19|Ncm:1	caudomedial neostriatum
NCM	NCM:9	nailfold capillary microscopy
NCM	NCM:18	neurocutaneous melanosis
NCM	NCM:12	nitrocellulose membrane
NCP	NCP:12	neurocybernetic prosthesis
NCP	NCP:9|ncp:8	noncytopathic
NCP	NCP:8	nucleus caudatus putamen
NCR	NCR:18	natural cytotoxicity receptors
NCR	NCR:15	nitrogen catabolite repression
NCR	NCR:7	noncoding regions
NCR	NCR:26	noncontingent reinforcement
NCR	NCR:30	normotensive control rats
NCSE	NCSE:29	neurobehavioral cognitive status examination
NCSE	NCSE:54	nonconvulsive status epilepticus
NCS	NCS:15	nchlorosuccinimide
NCs	NCs:14	nanocrystals
NCS	NCS:35	national comorbidity survey
NCS	NCS:17	neurocardiogenic syncope
NCS	NCS:15	noncrystallographic symmetry
NCs	NCs:34	normal controls
NCs	NCS:5|NCs:5	normal control subjects
NCS	NCS:5	nuclear channel system
NCs	NCs:14	nucleated cells
NCS	NCS:14	nucleus centralis superior
NCT	NCT:13	nchlorotaurine
NCT	NCT:48	neutron capture therapy
NCT	NCT:24	number connection test
N-CWS	N-CWS:7|N-cws:1	cell wall skeleton of nocardia rubra
N-CWS	N-CWS:50	nocardia rubra cell wall skeleton
NC	NC:9	 noncoding
NC	NC:204	change
NC	NC:11	nanocapsules
NC	NC:14	neck circumference
NC	NC:20	nephrocalcin
NC	NC:21|nc:1	nephrocalcinosis
NC	NC:6	neurological complications
NC	NC:11	nitrosocimetidine
NC	NC:14	nonclassical
NC	NC:5	normal children
NC	NC:12	normal comparison
NC	NC:10	normal control group
NC	NC:5	normal cycling
NC	NC:15	normocholesterolemic
NC	NC:29	north carolina
NC	NC:13	nucleus caudatus
NC	NC:6|nc:1	nucleus circularis
NC	NC:8	onto nitrocellulose
NC	NC:10	patients with neurocysticercosis
NDA	NDA:23	naphthalenedicarboxaldehyde
NDA	NDA:49	new drug application
NDF	NDF:31	neu differentiation factor
NDF	NDF:164	neutral detergent fiber
NDI	NDI:29	national death index
NDI	NDI:20	neck disability index
NDI	NDI:147|N-DI:1	nephrogenic diabetes insipidus
NDO	NDO:21	naphthalene dioxygenase
NDO	NDO:9	neurogenic detrusor overactivity
ND	ND:11	nadh dehydrogenase
ND	ND:15|Nd:1	nadphdiaphorase
ND	ND:37|Nd:1	nandrolone decanoate
ND	ND:24	neck dissection
Nd	Nd:15	negative difference
Nd	Nd:12	neodymium
ND	ND:9	neurologic deficit
ND	ND:13	neutral density
ND	ND:14	nicotine dependence
ND	ND:9	nocodazole
ND	ND:9	nondemented
ND	ND:9	nondisabled
ND	ND:13	nordiazepam
ND	ND:34	normal diet
ND	ND:12	normally developing
ND	ND:29	norrie disease
ND	ND:5|nd:3	not detected
ND	ND:19|nD:1	nucleus of darkschewitsch
NEB	NEB:10	nebulizer
NEB	NEB:12	negative energy balance
NECA	NECA:40	nethylcarboxamideadenosine
NECA	NECA:4	agonist nethylcarboxamidoadenosine
NECA	NECA:41	nethylcarboxamidoadenosine
NEC	NEC:618	necrotizing enterocolitis
NEC	NEC:17	neuroendocrine carcinoma
NEC	NEC:8	noise equivalent count
NED	NED:185|ned:1	evidence of disease
NED	NED:9	neuroendocrine differentiation
NEL	NEL:2	net energy of lactation
NEL	NEL:5	noeffect level
NEP	NEP:29	needle exchange program
NEP	NEP:38	negative expiratory pressure
NEP	NEP:38|Nep:1	neprilysin
NEP	NEP:9	neuroepithelial
NEP	NEP:432	neutral endopeptidase
NEP	NEP:9	neutral endopeptidase 
NEP	NEP:9	neutral endopeptidase ec 
NEP	NEP:16	neutral metalloendopeptidase
NES	NES:15	neurobehavioral evaluation system
NES	NES:18	neurological evaluation scale
NES	NES:11	night eating syndrome
NES	NES:30	nuclear export sequence
Ne	Ne:12	effective size
Ne	Ne:5|NE:2	error negativity
NE	NE:24	lnorepinephrine
NE	NE:14	necrotic enteritis
NE	NE:11	neonatal encephalopathy
NE	NE:85	nephropathia epidemica
NE	NE:10	net energy
NE	NE:335|ne:1	neuroendocrine
NE	NE:12	neuroepithelium
NE	NE:12	neutropenic enterocolitis
NE	NE:225	neutrophil elastase
NE	NE:24	nocturnal enuresis
NE	NE:81	noradrenergic
NE	NE:7	norepinephrine levels
NE	NE:166	nuclear envelope
NE	NE:5	nutcracker esophagus
NE	NE:11	nutritional encephalomalacia
NE	NE:13	release of hnorepinephrine
NF-IL6	NF-IL6:5	nuclear factor for interleukin expression
NF-IL6	NF-IL6:5	nuclear factor il
NF1	NF1:35|NF-1:9	neurofibromatosis type i
NF1	NF1:9|Nf1:1	neurofibromin
NF2	NF2:135|NF-2:6|Nf2:1	neurofibromatosis 
NF2	NF2:215|NF-2:8|Nf2:2	neurofibromatosis type 
NF2	NF2:11|NF-2:2	neurofibromatosis type ii
NFA	NFA:13	nearfatal asthma
NFA	NFA:20	niflumic acid
NFCS	NFCS:12	nationwide food consumption survey
NFCS	NFCS:13	neonatal facial coding system
NFD	NFD:17	nephrogenic fibrosing dermopathy
NFD	NFD:13	neurofibrillary degeneration
NF-H	NF-H:4|NFH:2	heavy neurofilament
NF-H	NF-H:12|NFH:2	heavy neurofilament subunit
NF-H	NF-H:13|NFH:7|Nf-H:1	high molecular weight neurofilament protein
NF-H	NF-H:9|NFH:1	neurofilament heavy
NF-H	NF-H:6|NFH:1	subunit of neurofilaments
NFI	NFI:16	nerve function impairment
NFI	NFI:91|NF-I:25	nuclear factor i
NF-L	NF-L:7	light neurofilament
NFL	NFL:14	national football league
NFL	NFL:80	nerve fiber layer
NF-L	NF-L:11	neurofilamentl
NF-L	NF-L:17|NFL:5	neurofilament light
NF-L	NF-L:12|NFL:1	neurofilament light chain
NF-L	NF-L:6|NFL:1	neurofilament light subunit
NF-M	NF-M:6	middle molecular weight neurofilament protein
NF-M	NF-M:14|NFM:5	neurofilament
NFP	NFP:130	natural family planning
NFP	NFP:11	notforprofit
NFS	NFS:6	fertility survey
NFS	NFS:5	national food survey
NFs	NFs:123|Nfs:1	neurofilaments
NFs	NFs:9	nod factors
NFs	NFs:10	nursing facilities
NF	NF:9	hearts
NF	NF:39	nanofiltration
NF	NF:25	native ferritin
NF	NF:80	necrotizing fasciitis
NF	NF:172	neurofibromatosis
NF	NF:9	nissen fundoplication
NF	NF:13	nitrofurazone
NF	NF:15|nF:1	nodular fasciitis
NF	NF:17	nonfailing
NF	NF:6	normal fibroblasts
NGA	NGA:14	galactosylneoglycoalbumin
NGA	NGA:9	neuroglandular antigen
NGC	NGC:11	neuroglycan c
NGC	NGC:9|nGC:1|NGc:1	nucleus gigantocellularis
NGT	NGT:17	nominal group technique
NGT	NGT:276|nGT:1	normal glucose tolerance
NHBE	NHBE:65	normal human bronchial epithelial
NHBE	NHBE:15	normal human bronchial epithelial cells
NHC	NHC:15	nheterocyclic carbene
NHC	NHC:6	nonhistone chromosomal
NHP	NHP:14	natural head position
NHP	NHP:15	natural head posture
NHP	NHP:4|Nhp:1|NhP:1|nhp:1	nonhuman primate
NHP	NHP:13	nonhistone proteins
NHP	NHP:18	normal human plasma
NHP	NHP:290	nottingham health profile
NHP	NHP:14	nursing home placement
NHS	NHS:11	nancehoran syndrome
NHS	NHS:20	national health system
NHS	NHS:5	normal healthy subjects
NHS	NHS:29	normal human sera
NHS	NHS:274|nHS:1	normal human serum
NHS	NHS:7	normal human subjects
NHS	NHS:18	nurses health study
NIA	NIA:28	national institute on aging
NIA	NIA:27	neurolepticinduced akathisia
NIA	NIA:11	nucleus interpositus anterior
NICTH	NICTH:10	cell tumor hypoglycemia
NICTH	NICTH:5	nonislet cell tumour hypoglycaemia
NIDDM	NIDDM:7	diabetes mellitus type ii
NIDDM	NIDDM:10	diabetic subjects
NIDDM	NIDDM:18	noninsulin dependent
NIDDM	NIDDM:2455	noninsulindependent diabetes mellitus
NIDDM	NIDDM:6	noninsulindependent dm
NIDDM	NIDDM:12	noninsulindependent
NIH	NIH:582	national institutes of health
NIH	NIH:16	neointimal hyperplasia
NIH	NIH:19	normalized index of hemolysis
NIL	NIL:9	nearisogenic line
NIL	NIL:17	neurointermediate lobe of the pituitary
NIP	NIP:9	negative inspiratory pressure
NIP	NIP:13	neurolepticinduced parkinsonism
NIP	NIP:5|Nip:4	normal immunosuppressive protein
NIP	NIP:8	nucleus interpositus posterior
NIRF	NIRF:10	nearinfrared fluorescence
NIRF	NIRF:7	nearinfrared fluorescent
NIS	NIS:10	information system
NIS	NIS:50	nai symporter
NIS	NIS:40	national immunization survey
NIS	NIS:28	nationwide inpatient sample
NIS	NIS:10	neuropsychological impairment scale
NIS	NIS:26	newly independent states
NIS	NIS:73	sodium iodide symporter
Ni	Ni:9	inhibitory guanine nucleotidebinding protein
NI	NI:10	intake
NI	NI:7	neurological impairment
NI	NI:10	neurologically impaired
Ni	Ni:197	nickel
NI	NI:16	northern ireland
NI	NI:22|Ni:1	nucleus isthmi
NI	NI:14	water immersion to the neck
NJ	NJ:10|N-J:1	neighbourjoining
NJ	NJ:37	new jersey
NK1	NK1:4|NK-1:1	neurokinin receptors
NK1	NK1:19|NK-1:4	substance p receptor
NKCC	NKCC:30	natural killer cell cytotoxicity
NKCC	NKCC:12	nk cell cytotoxicity
NKC	NKC:18	natural killer cytotoxicity
NKC	NKC:13	nk gene complex
NKH	NKH:13	nonketotic hyperglycinaemia
NKH	NKH:8	nonketotic hyperglycemia
NKH	NKH:33	nonketotic hyperglycinemia
NK	NK:9	natural
NK	NK:7	natural killer activity
NK	NK:70	natural killing
NK	NK:8	normal kidneys
NLA	NLA:11	naphthoxylactic acid
NLA	NLA:27	neuroleptanalgesia
NLD	NLD:16	nasolacrimal duct
NLD	NLD:11	necrobiosis lipoidica diabeticorum
NLD	NLD:17	nonverbal learning disabilities
NLK	NLK:7|Nlk:3	nemolike kinase
NLK	NLK:15	neuroleukin
NLP	NLP:59	natural language processing
NLP	NLP:10	programming
NLSs	NLSs:37	nuclear localization sequences
NLSs	NLSs:123	nuclear localization signals
NLS	NLS:9	neonatal lupus syndrome
NLS	NLS:8	nonlinear least squares
NLS	NLS:11	nonlinear schrodinger
NL	NL:13	children with normal language
NL	NL:6	native liver
NL	NL:22	necrobiosis lipoidica
NL	NL:27	neural lobe
NL	NL:8	normal liver
NL	NL:10	normolipidemic
NMA	NMA:11	nmethylacetamide
NMA	NMA:10	nnitrosonmethylaniline
NMA	NMA:10	nnitrosomethylaniline
NMA	NMA:7	national medical association
NMA	NMA:9	normal mode analysis
NMB	NMB:34	neuromuscular block
NMB	NMB:31	neuromuscular blockade
NMB	NMB:16	neuromuscular blocking
NMC	NMC:13|NmC:1	neuromedin c
NMC	NMC:8	nucleus magnocellularis
NMDAR1	NMDAR1:7	nmethyldaspartate receptor 
NMDAR1	NMDAR1:7	nmda receptor subunit
NMDA	NMDA:34	nmethyldasparate
NMDA	NMDA:10	nmethyldaspartic
NMDA	NMDA:524|NM-DA:1	nmethyldaspartic acid
NMD	NMD:37	nonsensemediated decay
NMD	NMD:105	nonsensemediated mrna decay
NMES	NMES:26	 national medical expenditure survey
NMES	NMES:59	neuromuscular electrical stimulation
NMES	NMES:9	nonmilk extrinsic sugars
NMN	NMN:11|NM-N:3	neuromedin n
NMN	NMN:38	nicotinamide mononucleotide
NMP	NMP:11	methylpyrrolidinone
NMP	NMP:15	nucleoside monophosphate
NMRD	NMRD:33	nuclear magnetic relaxation dispersion
NMRD	NMRD:12	respiratory disease
NMR	NMR:9	classically conditioned nictitating membrane response
NMR	NMR:15	neonatal mortality rate
NMS	NMS:6	antagonist nmethylscopolamine
NMS	NMS:24	neurally mediated syncope
NMS	NMS:338	neuroleptic malignant syndrome
NMS	NMS:31	normal mouse serum
NMTT	NMTT:16	nmethyltetrazolethiol
NMTT	NMTT:8|N-MTT:1	nmethylthiotetrazole
NMT	NMT:30|Nmt:7	myristoylcoaprotein nmyristoyltransferase
NMT	NMT:12	nmyristoyl transferase
NMT	NMT:10|nmt:1	neuromuscular transmission
NMT	NMT:6	norepinephrine nmethyltransferase
NMU	NMU:54	nnitrosomethylurea
NMU	NMU:34|NmU:16	neuromedin u
NMU	NMU:47	nitrosomethylurea
NM	NM:17	nemaline myopathy
NM	NM:14	neoplastic meningitis
NM	NM:31	neuromelanin
NM	NM:24|N-M:3|nm:2|n-m:2	neuromuscular
NM	NM:58	nictitating membrane
NM	NM:11	nitrosomorpholine
NM	NM:27	nodular melanoma
NM	NM:8	normal mice
NM	NM:9	normal mucosa
NM	NM:11	normorphine
NM	NM:59	nuclear matrix
NM	NM:15	nuclear medicine
NNK	NNK:17	methylnitrosaminopyridylbutanone
NNK	NNK:27	nmethylnnitrosaminopyridylbutanone
NNK	NNK:19	nnitrosomethylaminopyridylbutanone
NNN	NNN:31	nnitrosonornicotine
NNN	NNN:12	nitrosonornicotine
nNOS	nNOS:5	neuronal isoform
nNOS	nNOS:9	neuronal nosynthase
NNS	NNS:6	 national natality survey
NNS	NNS:11	national nutrition survey
NNT	NNT:3	calculate the relative benefit and the numberneededtotreat
NNT	NNT:7	needed to be treated
NO(x)	NO(x):6	nitrate and nitrite
NO(x)	NO(x):7	nitric oxide metabolites
NO(x)	NO(x):7	nitrite and nitrate
NOAEL	NOAEL:19	observable adverse effect level
NOAEL	NOAEL:66	observed adverse effect level
NOA	NOA:5	men with nonobstructive azoospermia
NOA	NOA:18	nonobstructive azoospermia
NOD	NOD:8	nocturnal oxygen desaturation
NOD	NOD:7	nocturnal oxyhemoglobin desaturation
NOD	NOD:714	nonobese diabetic
NOD	NOD:7	nonobese diabetic mouse
NOESY	NOESY:92	nuclear overhauser effect spectroscopy
NOESY	NOESY:9	nuclear overhauser enhancement
NOESY	NOESY:6	twodimensional noe
NOF	NOF:12	national osteoporosis foundation
NOF	NOF:17	neurite outgrowth factor
NOM	NOM:170	natural organic matter
NOM	NOM:16|Nom:7|nom:1	nomifensine
NOM	NOM:25	nonoperative management
NOM	NOM:19	normal oral mucosa
NOR	NOR:17|Nor:5|nor:3	nitric oxide reductase
NOR	NOR:7|Nor:1|nor:1	norgestomet
NOR	NOR:60|nor:1	nucleolus organizer region
NOR	NOR:15	nucleolus organizing region
NOR	NOR:12	nucleus olfactoretinalis
NOS	NOS:10|NOs:2	nitric oxide synthesis
NOS	NOS:45	nitric oxide synthetase
NOS	NOS:60	nosynthase
NOS	NOS:111|nos:2	not otherwise specified
NOX	NOX:10|Nox:3|nox:1	nadh oxidase
NOX	NOX:8|Nox:7	nadph oxidase
NOx	NOx:15	nitrite plus nitrate
NOx	NOx:18	plasma nitritenitrate
NO	NO:8	nitric oxide gas
NO	NO:64|no:1	nitrogen monoxide
NO	NO:7|N-o:1|no:1	nodes
NO	NO:7	nucleolus organizer
NP1	NP1:7	neuronal pentraxin 
NP1	NP1:9	nuclease p
NPA	NPA:4	agonist npropylnorapomorphine
NPA	NPA:12	asparagineprolinealanine
NPA	NPA:25	nnpropylnorapomorphine
NPCs	NPCs:31	nasopharyngeal carcinomas
NPCs	NPCs:32	neural progenitor cells
NPCs	NPCs:139	nuclear pore complexes
NPC	NPC:92	nasopharyngeal cancer
NPC	NPC:5	near point of convergence
NPC	NPC:5	nearpoint of convergence
NPC	NPC:13	net protein catabolism
NPC	NPC:50|NP-C:23	niemannpick disease type c
NPC	NPC:11|NP-C:4	niemannpick type c disease
NPC	NPC:10	nonparenchymal liver cells
NPC	NPC:5|nPC:1	nucleus of the posterior commissure
NPD	NPD:13	narcissistic personality disorder
NPD	NPD:14	nasal potential difference
NPD	NPD:10	nocturnal paroxysmal dystonia
NPD	NPD:6	normal protein diet
NPEOs	NPEOs:11	nonylphenol ethoxylates
NPEOs	NPEOs:9	nonylphenol polyethoxylates
NPE	NPE:46	neurogenic pulmonary edema
NPE	NPE:26	nonpigmented ciliary epithelial
NPE	NPE:9	nonpigmented ciliary epithelium
NPE	NPE:23	nonpigmented epithelial
NPE	NPE:8	nonpigmented epithelium
NPF	NPF:5	neuritepromoting factor
NPF	NPF:28	neuropeptide f
NPG	NPG:10	nphenylglycine
NPG	n-PG:4|NPG:4|nPG:1	npropyl gallate
NPG	NPG:23	normal pressure glaucoma
NPHS	NPHS:83	national population health survey
NPHS	NPHS:10	northwick park heart study
NPH	NPH:51	neutral protamine hagedorn
NPH	NPH:218	normal pressure hydrocephalus
NPH	NPH:8	nph insulin
NPH	NPH:19|nph:4	nucleus prepositus hypoglossi
NPH	NPH:16	patients with normalpressure hydrocephalus
NPL	NPL:10	linkage analysis
NPL	NPL:13	national physical laboratory
NPM	NPM:9	npyrenylmaleimide
NPM	NPM:13	nphenylmaleimide
NPM	NPM:68	nucleophosmin
NPM	NPM:12	nucleophosminb
NPN	NPN:8	nonprotein n
NPN	NPN:4	probe nphenylnaphthylamine
NPO	NPO:10	nucleus pontis oralis
NPO	NPO:27|nPO:1|npo:1|Npo:1	nucleus preopticus
NPPB	NPPB:8	channel blocker nitrophenylpropylaminobenzoate
NPPB	NPPB:10	normal perfusion pressure breakthrough
NPP	NPP:13	net primary production
NPP	NPP:14	net primary productivity
NPP	NPP:7	new permeation pathways
NPP	NPP:13|nPP:4	nonphytate p
NPP	NPP:11|nPP:1	nonphytate phosphorus
NPP	NPP:15	nuclear power plant
NPP	NPP:16|npp:1	nucleus preopticus periventricularis
NPRO	NPRO:69|N-Pro:1|NPro:1	nnitrosoproline
NPRO	NPRO:12|NPro:1	nitrosoproline
NPSH	NPSH:5|NP-SH:1	nonprotein sulfhydryl groups
NPSH	NPSH:7|NP-SH:4	nonprotein sulphydryl
NPSH	NPSH:8	nonprotein thiols
NPSLE	NPSLE:11|NP-SLE:1	neuropsychiatric sle
NPSLE	NPSLE:32|NP-SLE:5	neuropsychiatric systemic lupus erythematosus
NPTR	NPTR:15	national pediatric trauma registry
NPTR	NPTR:14	nocturnal penile tumescence and rigidity
NPT	NPT:7	nasal provocation testing
NPT	NPT:16	nasopharyngeal temperature
NPT	NPT:9	near patient testing
NPT	NPT:125	nocturnal penile tumescence
NPT	NPT:12|npt:2	nonpermissive temperature
NPY-LI	NPY-LI:9	neuropeptide y
NPY-LI	NPY-LI:4|NPYLI:1	neuropeptide ylike immunoreactive
NPY-LI	NPY-LI:85|NPYLI:11|NPY-li:2|NPY-Li:1	neuropeptide ylike immunoreactivity
NPY-LI	NPY-LI:34|NPY-li:3|NPYLI:1|NPY-Li:1	npylike immunoreactivity
NPY-IR	NPY-IR:9|NPY-ir:7	neuropeptide yimmunoreactive
NPY-IR	NPY-IR:8|NPY-ir:3|NPYir:1	npyimmunoreactive
NPY	NPY:12	neuropeptide
NPY	NPY:93	neuropeptide tyrosine
NPs	NPs:27	nanoparticles
NPs	NPs:12|Nps:1	nasal polyps
NPs	NPs:53	natriuretic peptides
NPs	NPs:29	neuritic plaques
NPS	NPS:12	neuropathic pain scale
NPS	NPS:14	noise power spectra
NPS	NPS:8	nonpoint source
NPs	NPs:9	noun phrases
NP	NP:20	hydroxynitrophenyl acetyl
NP	NP:9	hydroxynitrophenylacetyl
NP	NP:7	alcohol nonpreferring
NP	NP:19	antihydroxynitrophenylacetyl
NP	NP:18	hapten hydroxynitrophenylacetyl
NP	NP:45	influenza virus nucleoprotein
NP	NP:5	metabolite norpropoxyphene
NP	NP:35	nasal polyposis
NP	NP:80	nasopharyngeal
NP	NP:17	nasopharynx
NP	NP:16	neck pressure
NP	NP:15	necrotizing pancreatitis
NP	NP:23	negative priming
NP	NP:11	neuritic plaque
NP	NP:11	neuropathic pain
NP	NP:36|Np:4	neurophysin
NP	NP:32	neuropsychiatric
NP	NP:97	neuropsychological
NP	NP:8	normal plasma
NP	NP:11	normal pregnancy
NP	NP:9	normal pregnant
NP	NP:6	normal pregnant women
NP	NP:8	normal prostate
NP	NP:52	nosocomial pneumonia
NP	NP:13	noun phrase
NP	NP:12	nucleoproteins
NP	NP:31|Np:2	nucleoside phosphorylase
NP	NP:57	nucleus pulposus
NP	NP:29	pnonylphenol
NQR	NQR:10	nadhquinone reductase
NQR	NQR:15	nuclear quadrupole resonance
NR2B	NR2B:6	nmda receptor b
NR2B	NR2B:8|NR2b:1	receptor subunit b
NRA	NRA:10	neuroretinal rim area
NRA	NRA:14	nitrate reductase activity
NRA	NRA:19	nucleus retroambiguus
NRC	NRC:14	conditioner
NRC	NRC:90	national research council
NRC	NRC:12	neo red cells
NRC	NRC:49	nuclear regulatory commission
NREM	NREM:16	eye movement sleep
NREM	NREM:14	nonrapideyemovement
NRH	NRH:42	nodular regenerative hyperplasia
NRH	NRH:9	nodular regenerative hyperplasia of the liver
NRK	NRK:11	normal rat kidney cells
NRK	NRK:6	rat kidney fibroblasts
NRL	NRL:151	natural rubber latex
NRL	NRL:4|Nrl:3	neural retina leucine zipper
NRL	NRL:10|nrl:1	nucleus recessus lateralis
NRL	NRL:11	nucleus reticularis lateralis
NRS	NRS:18|nrs:1	negative regulator of splicing
NRS	NRS:126	normal rabbit serum
NRT	NRT:26	neural response telemetry
NRT	NRT:21|nRT:8|nRt:5	nucleus reticularis thalami
NR	NR:10	natural resistance
NR	NR:23	neural retina
NR	NR:19	neuroretina
NR	NR:124	neutral red
NR	NR:17	nitroreductase
NR	NR:29	normotensive rats
NR	NR:12	responders
NSC	NSC:25	neurosecretory cells
NSC	NSC:8	nonstructural carbohydrate
NSF	NSF:83	nethylmaleimidesensitive factor
NSF	NSF:78	nethylmaleimidesensitive fusion protein
NSF	NSF:42	national service framework
NSG	NSG:9	necrotizing sarcoid granulomatosis
NSG	NSG:34|nsg:1	neurosecretory granules
NSI	NSI:6	needlestick injury
NSI	NSI:6	nitrogen solubility index
NSI	NSI:16	nonsyncytiuminducing
NSI	NSI:7	normalized slope index
NSI	NSI:11	nutrition screening initiative
NSN	NSN:26	nephrotoxic serum nephritis
NSN	NSN:5	nicotinestimulated neurophysin
NSOM	NSOM:16	nearfield scanning optical microscope
NSOM	NSOM:32	nearfield scanning optical microscopy
NSP	NSP:7	neuroendocrinespecific protein
NSP	NSP:10	neurotoxic shellfish poisoning
NSP	NSP:23	neurotropin
NSP	NSP:8	neutrophil storage pool
NSR	NSR:11	negative slope resistance
NSR	NSR:68	normal sinus rhythm
NSS	NSS:25	neurological severity score
NSS	NSS:32	neurological soft signs
NSS	NSS:11	neuropathy symptom score
NSS	NSS:15	normal sheep serum
NSTs	NSTs:8	nerve sheath tumors
NSTs	NSTs:27|NSTS:1	nonstress tests
NST	NST:9	nocistatin
NST	NST:37	nonstress test
NST	NST:6	nondirective supportive therapy
NST	NST:9	nonstress testing
NST	NST:12	nutrition support team
NSV	NSV:11	neuroadapted sindbis virus
NSV	NSV:19	noscalpel vasectomy
NS	NS:21	 nacl
NS	NS:16|Ns:1	nanospheres
NS	NS:10	naproxen sodium
NS	NS:8	nasal secretions
NS	NS:73	natural suppressor
NS	NS:15	neck suction
NS	NS:6|N-S:1	negative symptoms
NS	NS:13|Ns:1	neostriatum
NS	NS:26	nervous system
NS	NS:10|ns:1	neurosecretory
NS	NS:9	nevus sebaceus
NS	NS:9	nigrostriatal
NS	NS:20	nodular sclerosing
NS	NS:69	nodular sclerosis
NS	NS:9|ns:2	nonsignificant
NS	NS:51	noonan syndrome
NS	NS:8	normal salt
NS	NS:8|ns:2|Ns:1	normal serum
NS	NS:10	normal skin
NS	NS:67	novelty seeking
NS	NS:15	nutritional status
NS	NS:7	nutritional support
NTA	NTA:12	natural thymocytotoxic autoantibody
NTA	NTA:60|nta:1	nitrilotriacetate
NTA	NTA:10	thymocytotoxic autoantibodies
NTB	NTB:33	naltriben
NTB	NTB:13	necrotizing tracheobronchitis
NTB	NTB:16	netobimin
NTD	NTD:42|N-td:2|NtD:1	nterminal domain
NTD	NTD:12	normalized total dose
NTE	NTE:10	nasal transitional epithelium
NTE	NTE:160	neuropathy target esterase
NTE	NTE:88	neurotoxic esterase
NTG	NTG:5	nontoxic goiter
NTG	NTG:11	normotriglyceridemic
NTI	NTI:3	delta opioid receptor antagonist naltrindole
NTI	NTI:8	patients with nonthyroidal illnesses
NTL	NTL:9	neartotal laryngectomy
NTL	NTL:31	netilmicin
NTM	NTM:9	nontuberculous mycobacteriosis
NTM	NTM:10	nontuberculous mycobacterium
NTPase	NTPase:37	nucleoside triphosphatase
NTPase	NTPase:11	nucleoside triphosphate hydrolase
NTP	NTP:5	national tb control programme
NTP	NTP:214	national toxicology program
NTP	NTP:10	national tuberculosis control programme
NTP	NTP:23	national tuberculosis programme
NTR	NTR:5|ntr:1	escherichia coli nitroreductase
NTR	NTR:5	nadpthioredoxin reductase
NTR	NTR:18|NT-r:1|NT-R:1	neurotensin receptor
ntr	ntr:6|Ntr:4	nitrogen regulation
ntr	ntr:5|NTR:3|Ntr:1	nitrogen regulatory
NTS	NTS:50	nephrotoxic serum
NTs	NTs:9	neuroblastic tumors
NTs	NTs:63|Nts:1	neurotrophins
NTS	NTS:20	nevada test site
NTS	NTS:7	nontranscribed strand
NTS	NTS:5	nontyphi salmonellae
NTS	NTS:10	nontyphoidal salmonella
NTS	NTS:5	nucleolar targeting signal
NTS	NTS:451|nTS:24|nts:3|Nts:1	nucleus tractus solitarii
NTS	NTS:597|nTS:24|nts:4|nTs:1	nucleus tractus solitarius
NTS	NTS:8|nTS:1	solitary nucleus
NTS	NTS:20|nTS:1	solitary tract nucleus
NTx	NTX:2|Ntx:2|NTx:2	collagen i
NTx	NTx:6|NTX:3	i collagen crosslinked ntelopeptide
NTx	NTx:4|NTX:2	nterminal telopeptide
NTx	NTx:14|NTX:3|nTx:3	neonatally thymectomized
NTX	NTX:20|NTx:2	noxiustoxin
NTX	NTX:8	opioid antagonist naltrexone
NTx	NTx:7|NTX:2	telopeptides
NTx	NTx:5|NTX:1|N-Tx:1	type i collagen crosslinked ntelopeptides
NTX	NTX:6|NTx:5|Ntx:1	urinary ntelopeptide
NT	NT:25	botulinum neurotoxin
NT	NT:18|Nt:4	nterminal
NT	NT:14	natural t
NT	NT:10	neural tube
NT	NT:869|Nt:1	neurotensin
NT	NT:56|Nt:6	neutralization
NT	NT:38|Nt:10	neutralizing
NT	NT:9	nick translation
NT	NT:12|N-T:1	nontrained
NT	NT:13	nontypeable
NT	NT:5	normal training
NT	NT:9	normotension
NT	NT:65	normotensive subjects
NT	NT:10	normotest
NT	NT:9	normothermia
NT	NT:48	northern territory
NT	NT:175	nuchal translucency
NT	NT:25	nuchal translucency thickness
NT	NT:149	nuclear transfer
NT	NT:17	nucleation time
NVB	NVB:16	navelbine
NVB	NVB:16	neurovascular bundle
NVD	NVD:6	neovascularization of the disc
NVD	NVD:9	neurovesical dysfunction
NVD	NVD:8	optic disc
NVP	NVP:6	nausea and vomiting during pregnancy
NVP	NVP:117|Nvp:4	nevirapine
NVSS	NVSS:10	national vital statistics system
NVSS	NVSS:6	normal variant short stature
NV	NV:11	nausea and vomiting
NV	NV:21	normal volunteers
NV	NV:81	norwalk virus
NV	NV:6|Nv:5	per unit volume
NV	NV:10	retinal neovascularization
NW	NW:25|Nw:1	normal weight
NW	NW:7	normal wistar
NW	NW:5	normal women
NW	NW:6	normotensive wistar
NYHA	NYHA:985	new york heart association
NYHA	NYHA:4	new york heart association classification
NYS	NYS:48	new york state
NYS	NYS:10|Nys:3	nystatin
NY	NY:24	new york
NY	NY:39	nuclear yellow
Na/K	Na/K:11	sodiumpotassium
Na/K	Na/K:5	sodiumpotassium ratio
Na/K	Na/K:4	sodium to potassium
NAA	NAA:41	nacetyllaspartate
NAA	NAA:424|Naa:5	nacetylaspartate
NAA	NAA:14	nacetylaspartic acid
NAA	NAA:13	naphthalene acetic acid
NAA	NAA:12	neutral amino acids
NAA	NAA:105	neutron activation analysis
NAA	NAA:17	nucleic acid amplification
NAE	NAE:10	neoplastic angioendotheliomatosis
NAE	NAE:9	neoplastic angioendotheliosis
NAE	NAE:33	net acid excretion
NAF	NAF:18|Naf:2|naf:1	nafenopin
NAF	NAF:9	national abortion federation
NAF	NAF:8	neutrophilactivating factor
NAF	NAF:44	nipple aspirate fluid
NAI	NAI:9|N-AI:1	nacetylimidazole
NAI	NAI:19	nonaccidental injury
NAO	NAO:17	nonyl acridine orange
NAO	NAO:26	north atlantic oscillation
Neoral	Neoral:18|neoral:1	cyclosporine microemulsion
Neoral	Neoral:9	formulation of cyclosporin
NeuN	NeuN:17	neuronspecific nuclear protein
NeuN	NeuN:14	neuronal nuclear antigen
NG	NG:71|ng:1	nasogastric
NG	NG:9	net grainsnucleus
NG	NG:7	neutrophil granulocytes
NG	NG:9	nitrosoguanidine
NG	NG:21	nodose ganglia
NG	NG:26	nodose ganglion
NG	NG:12|Ng:2	norgestrel
NG	NG:11	normal glucose
NG	NG:20|ng:1	nuclear grade
NIR	NIR:15	nearinfrared interactance
NIR	NIR:5	nearinfrared radiation
NiSO4	NiSO4:15	nickel sulfate
NiSO4	NiSO4:9	nickel sulphate
NIC	NIC:14	neonatal intensive care
NIC	NIC:12|Nic:7|nic:1	nicorandil
NIC	NIC:48|Nic:21	nicotine
NIC	NIC:7|Nic:1	nicotinic acid
NIC	NIC:51	nursing interventions classification
NN	NN:7|nn:1|N-N:1|n-n:1	nearestneighbor
NN	NN:8	neoplastic nodules
NPI	NPI:132	neuropsychiatric inventory
NPI	NPI:54	nottingham prognostic index
NuMA	NuMA:9	nuclear mitotic apparatus
NuMA	NuMA:32	nuclear mitotic apparatus protein
O2-	O2-:15	superoxide ion
O2-	O2-:8	superoxide production
OA1	OA1:15	ocular albinism
OA1	OA1:17|Oa1:1	ocular albinism type 
OAD	OAD:21	obliterative airway disease
OAD	OAD:15	obstructive airways disease
OAD	OAD:10	overanxious disorder
OAG	OAG:16	oleoylacetylracglycerol
OAG	OAG:86|OaG:1	oleoylacetylsnglycerol
OAG	OAG:9	oleylacetylglycerol
OAG	OAG:1	tpa and oleoylacetylglycerol
OAR	OAR:11	office of aids research
OAR	OAR:17	ottawa ankle rules
OASIS	OASIS:11	organization to assess strategies for ischemic syndromes
OASIS	OASIS:13	outcome and assessment information set
OAS	OAS:30	oacetyllserine
OAS	OAS:45	oral allergy syndrome
OAS	OAS:24	overt aggression scale
OA	OA:16	actively sensitized to ovalbumin
OA	OA:2	guinea pigs sensitized with ovalbumin
OA	OA:38	human osteoarthritic
OA	OA:41	normal and osteoarthritic
OA	OA:11	obstructive azoospermia
OA	OA:96	occupational asthma
OA	OA:29	oesophageal atresia
OA	OA:11	oleic
OA	OA:233	oleic acid
OA	OA:11	open adrenalectomy
OA	OA:40	open appendectomy
OA	OA:95	ophthalmic artery
OA	OA:10	oral appliance
OA	OA:3255	osteoarthritis
OA	OA:23	patients with osteoarthrosis
OA	OA:48	phosphatase inhibitor okadaic acid
OA	OA:1	rats sensitized to ovalbumin
OBP	OBP:5	hsv originbinding protein
OBP	OBP:18	odorantbinding protein
OBP	OBP:19|oBP:1	office blood pressure
OBP	OBP:19	origin binding protein
OBR	OBR:5	origin of bidirectional dna replication
OBR	OBR:9	origin of bidirectional replication
OBs	OBs:8	olfactory bulbs
OBs	OBs:18|Obs:3	osteoblasts
OB	OB:18|ob:8|Ob:1	leptin
ob	ob:14|OB:3	obese gene
OB	OB:130	obliterative bronchiolitis
OB	OB:22	olfactory bulbectomized
OB	OB:9	oligoclonal igg bands
ob	ob:16|OB:1	osteoblastenriched
OB	OB:12|ob:1	osteoblastlike
OB	OB:9|ob:3	osteoblastic
OB	OB:8	otilonium bromide
OB	OB:20	oxidative burst
OB	OB:5|ob:4	product of the obesity
OCB	OCB:29	olivocochlear bundle
OCB	OCB:13	organizational citizenship behavior
OCD	OCD:15	occupational contact dermatitis
OCD	OCD:5	organconfined disease
OCD	OCD:9	oxygen cost diagram
OCLs	OCLs:38|Ocls:1	osteoclastlike cells
OCLs	OCLs:15	osteoclastlike multinucleated cells
OCP	OCP:90|ocp:1	octacalcium phosphate
OCP	OCP:64	ocular cicatricial pemphigoid
OCP	OCP:11	onchocerciasis control program
OCP	OCP:23	onchocerciasis control programme
OCP	OCP:22	onchocerciasis control programme in west africa
OCP	OCP:11	open circuit potential
OCR	OCR:20	cancer registry
OCR	OCR:17	ocular counterrolling
OCR	OCR:21	oculocardiac reflex
OCT	OCT:47	oxacalcitriol
OCT	OCT:17	optical coherence tomographic
OCT	OCT:719	optical coherence tomography
OCT	OCT:24|Oct:1	organic cation transporter
OCT	OCT:16|Oct:1	ornithine carbamoyl transferase
OCT	OCT:20	ornithine carbamyl transferase
OCL	OCL:23|Ocl:1|ocl:1	osteoclast
OCL	OCL:12|Ocl:2	osteoclastlike cell
OCs	OCs:6	concentrations of persistent organochlorines
OCS	OCS:25	obsessivecompulsive symptoms
OCs	OCs:34	obstetric complications
OCS	OCS:17	octachlorostyrene
OCS	OCS:45	open canalicular system
OCS	OCS:29|OCs:1	oral contraceptive steroids
OCS	OCS:8|OCs:1	oral corticosteroids
OCs	OCs:9	organic cations
OCs	OCs:15	organochlorine contaminants
OC	OC:1	obsessive or compulsive
OC	OC:11	occipital cortex
OC	OC:11	oleoresin capsicum
OC	OC:36	olivocochlear
OC	OC:11	open cholecystectomies
OC	OC:10	open colectomy
OC	OC:20	oral candidiasis
OC	OC:124	oral contraception
OC	OC:11	organ culture
OC	OC:39	organ of corti
OC	OC:106	organic carbon
OC	OC:123	organochlorine
OC	OC:19	osteochondrosis
OC	OC:9	outer cortex
OC	OC:56	ovarian cancer
OC	OC:7	oxidized cellulose
ODC	ODC:2353|odc:8|Odc:7	ornithine decarboxylase
ODC	ODC:34	ornithine decarboxylase activity
ODE	ODE:6	odemethyl encainide
ODE	ODE:8	odesmethyl encainide
ODE	ODE:11	ordinary differential equation
ODF	ODF:42|Odf:1	osteoclast differentiation factor
ODF	ODF:20	outer dense fibers
ODI	ODI:33	oswestry disability index
ODI	ODI:47	oxygen desaturation index
ODN	ODN:2	endogenous benzodiazepine receptor ligand octadecaneuropeptide
ODN	ODN:16	open donor nephrectomy
ODQ	ODQ:9	guanylate cyclase inhibitor
ODQ	ODQ:4	inhibitor hoxadiazoloalphaquinoxalinone
ODQ	ODQ:11	oswestry disability questionnaire
ODQ	ODQ:4	soluble guanylyl cyclase inhibitor hoxadiazoloaquinoxalinone
ODV	ODV:3	active metabolite odesmethylvenlafaxine
ODV	ODV:24	occlusionderived virus
ODS	ODS:34	octadecylsilane
ODS	ODS:29	octadecylsilica
ODS	ODS:6	osmotic demyelination syndrome
ODS	ODS:33	osteogenic disorder shionogi
ODS	ODS:9	silica gel
OD	OD:10	development
OD	OD:32	ocular dominance
OD	OD:17	oesophageal dysfunction
OD	OD:7	oocyte donation
OD	OD:10	orthostatic dysregulation
OD	OD:15|od:1	outer diameter
OEC	OEC:10	olfactory ensheathing cell
OEC	OEC:10	oviductal epithelial cells
OEC	OEC:50	oxygenevolving complex
OEP	OEP:19	common antigen
OEP	OEP:9	common protective antigen
OE	OE:120|oe:1	olfactory epithelium
OE	OE:11	otitis externa
OE	OE:11	outer envelope
OFC	OFC:14	head circumference
OFC	OFC:16	occipitofrontal circumference
OFC	OFC:95|OfC:1	orbitofrontal cortex
OFD	OFD:13	open flap debridement
OFD	OFD:12|O-F-D:1	oralfacialdigital
OF	OF:27	opacity factor
OF	OF:7	oral fluid
OF	OF:8	orbital fibroblasts
OF	OF:9	organ failure
OF	OF:19	osmotic fragility
OF	OF:10	osteitis fibrosa
OGD	OGD:17	oesophagogastroduodenoscopy
OGD	OGD:46	oxygen and glucose deprivation
OGD	OGD:107	oxygenglucose deprivation
OGP	OGP:24	osteogenic growth peptide
OGP	OGP:8	oviductspecific glycoprotein
OGT	OGT:5	effects of orengedokuto
OGT	OGT:16	oglcnac transferase
OG	OG:11	noctylbetadglucopyranoside
OG	OG:26	octyl glucoside
OG	OG:16	octylglucoside
OHAs	OHAs:13	oral hypoglycaemic agents
OHAs	OHAs:14	oral hypoglycemic agents
OHP	OHP:26	high pressure
OHP	OHP:13	oregon health plan
OHS	OHS:23	obesity hypoventilation syndrome
OHS	OHS:22	occupational health and safety
OHS	OHS:11	ontario health survey
OHS	OHS:7	oxford hip score
OHT	OHT:100	ocular hypertension
OHT	OHT:10	orthotopic heart transplant
OHT	OHT:49|oHT:1	orthotopic heart transplantation
OH	OH:9	hydroxy
OH	OH:18	occupational health
OH	OH:108	orthostatic hypotension
OIA	OIA:8	oilinduced arthritis
OIA	OIA:15	optical immunoassay
OIH	OIH:13	iorthoiodohippurate
OIH	OIH:18	orthoiodohippurate
OI	OI:32	orthostatic intolerance
OI	OI:8	ovulation induction
OI	OI:108	oxygenation index
OJ	OJ:41	obstructive jaundice
OJ	OJ:11	orange juice
OKT3	OKT3:6|OKT-3:1	anticd antibodies
OKT3	OKT3:7	murine monoclonal anticd antibody
OKT3	OKT3:13|OKT-3:2	muromonabcd
OLA	OLA:37	oligonucleotide ligation assay
OLA	OLA:6	ouabainlike activity
OLC	OLC:6	oligodendrocytelike cells
OLC	OLC:17	ouabainlike compound
OLF	OLF:19	ossification of the ligamentum flavum
OLF	OLF:17	ouabainlike factor
OLM	OLM:9	ocular larva migrans
OLM	OLM:15	outer limiting membrane
OLP	OLP:255	oral lichen planus
OLP	OLP:11	oropharyngeal leak pressure
OL	OL:6	optic layer
OL	OL:11	oral leukoplakia
OMC	OMC:33	open mitral commissurotomy
OMC	OMC:12	ostiomeatal complex
OMI	OMI:78	old myocardial infarction
OMI	OMI:11	oocyte maturation inhibitor
OMPC	OMPC:10	otitis media purulenta chronica
OMPC	OMPC:10	outer membrane protein complex
OMP	OMP:129	olfactory marker protein
OMP	OMP:22|Omp:1	orotidine monophosphate
OMT	OMT:14	omethyltransferase
OMT	OMT:10	ocular microtremor
OMT	OMT:44	osteopathic manipulative treatment
OM	OM:9	occupational medicine
OM	OM:15	olfactory mucosa
OM	OM:9	oncomodulin
OM	OM:62	oncostatin m
OM	OM:24	operative mortality
OM	OM:24	optical microscopy
OM	OM:9	oral mucosa
OM	OM:14	oral mucositis
OM	OM:21|O-M:5	osbornemendel
OM	OM:26	osteomalacia
OM	OM:20	osteomyelitis
OM	OM:201	otitis media
OM	OM:25	outer medulla
OM	OM:11	ovulation method
ONH	ONH:190|onh:1	optic nerve head
ONH	ONH:15	optic nerve hypoplasia
ONSD	ONSD:11	optic nerve sheath decompression
ONSD	ONSD:8	optic nerve sheath diameter
ONS	ONS:19	office for national statistics
ONS	ONS:33	oncology nursing society
ONS	ONS:9	optic nerve section
ON	ON:8|on:1	depolarizing
ON	ON:26	olfactory nerve
ON	ON:5|on:4	onset
ON	ON:5	onufs nucleus
ON	ON:178	optic neuritis
ON	ON:63	osteonecrosis
OO	OO:21|oo:3	orbicularis oculi
OO	OO:10	osteoid osteoma
OPA	OPA:11	derivatization with ophthaldialdehyde
OPA	OPA:6|opa:1	occupational physical activity
OPA	OPA:22	ocular pulse amplitude
Opa	Opa:14	opacityassociated
Opa	Opa:7	opacity proteins
OPA	OPA:6	opsonophagocytic activity
OPA	OPA:7	opsonophagocytic assay
OPA	OPA:20	orthophthalaldehyde
OPA	OPA:18	ovine pulmonary adenocarcinoma
OPCAB	OPCAB:147|OP-CAB:3	offpump coronary artery bypass
OPCAB	OPCAB:11	offpump coronary artery bypass surgery
OPCs	OPCs:43	oligodendrocyte precursor cells
OPCs	OPCs:36	oligodendrocyte progenitor cells
OPC	OPC:6	involuntary outpatient commitment
OPC	OPC:39	oropharyngeal candidiasis
OPC	OPC:9	ovine pulmonary carcinoma
OPD	OPD:26|o-PD:9|opd:1	ophenylenediamine
OPD	OPD:8	other personality disorders
OPD	OPD:11	otopalatodigital
OPG	OPG:19	oculoplethysmography
OPG	OPG:537|opg:1	osteoprotegerin
OPIDN	OPIDN:61	delayed neuropathy
OPIDN	OPIDN:17	organophosphorus compoundinduced delayed neurotoxicity
OPIDN	OPIDN:18	organophosphorus esterinduced delayed neurotoxicity
OPLL	OPLL:170|opll:1	ossification of the posterior longitudinal ligament
OPLL	OPLL:22	ossification of the posterior longitudinal ligament of the spine
OPO	OPO:22	optical parametric oscillator
OPO	OPO:21	organ procurement organization
OPP	OPP:33|o-PP:1	ophenylphenol
OPP	OPP:40	ocular perfusion pressure
OPP	OPP:13	office of pesticide programs
Opp	Opp:19|opp:10	oligopeptide permease
Opp	Opp:10	oligopeptide transport system
OPP	OPP:9	organophosphate poisoning
OPP	OPP:17	orthophenylphenol
OPP	OPP:13	ovine progressive pneumonia
OPU	OPU:8	oocyte pickup
OPU	OPU:27	ovum pickup
OPV	OPV:14	oral poliovaccine
OPV	OPV:11	oral poliovirus
OPV	OPV:159	oral poliovirus vaccine
OPV	OPV:9	orthopoxvirus
OPZ	OPZ:18	oltipraz
OPZ	OPZ:27|OpZ:12	opsonized zymosan
OPS	OPS:11	objective pain scale
OPS	OPS:5	objective pain score
OPs	OPs:51	organophosphates
OPs	OPs:7	organophosphate insecticides
OPs	OPs:7|OPS:1	organophosphate pesticides
OPs	OPs:16	organophosphorus insecticides
OPS	OPS:5	orpington prognostic score
OPS	OPS:20	orthogonal polarization spectral
OPs	OPs:134|Ops:2	oscillatory potentials
OP	OP:42	tertoctylphenol
OP	OP:10	ophenanthroline
OP	OP:9	obesityprone
OP	OP:7	opening pressure
OP	OP:10	opponens pollicis
OP	OP:17	organizing pneumonia
OP	OP:23	organophosphorous
OP	OP:215	organophosphorus
OP	OP:10	oropharyngeal
OP	OP:8|op:1	oropharynx
OP	OP:8	osmotic pressure
OP	OP:95|Op:1	osteoporosis
OP	OP:9	osteoporotic
OP	OP:13	outpatient
ORBC	ORBC:7	ox erythrocytes
ORBC	ORBC:11	ox red blood cells
ORCC	ORCC:13	outwardly rectifying chloride channel
ORCC	ORCC:5	outwardly rectifying cl channels
ORD	ORD:21	optical rotatory dispersion
ORD	ORD:14	outer ring deiodination
ORL1	ORL1:6|ORL-1:1	endogenous ligand of the opioid receptorlike 
ORL1	ORL1:7|ORL-1:5	opioid receptorlike receptor
ORs	ORs:20	odorant receptors
ORs	ORs:30|ors:1	olfactory receptors
ORs	ORs:20	operating rooms
ORs	ORs:10	orienting responses
ORT	ORT:271	oral rehydration therapy
ORT	ORT:14	ornithobacterium rhinotracheale
ORT	ORT:7	orthodromic reciprocating tachycardia
ORX	ORX:13|orx:3	orchidectomy
ORX	ORX:16|orx:1	orchiectomized
OSA	OSA:315	obstructive sleep apnoea
OSA	OSA:5	ordered subset analysis
OSA	OSA:23	osteosarcoma
OSC	OSC:11	orthogonal signal correction
OSC	OSC:19	oxidosqualene cyclase
OSE	OSE:26	ovarian surface epithelial
OSE	OSE:92	ovarian surface epithelium
OS	OS:10	core oligosaccharide
OS	OS:9|os:1	ocimum sanctum
OS	OS:16	oligosaccharides
OS	OS:9	omenn syndrome
OS	OS:13	onestep
OS	OS:28	open splenectomy
OS	OS:9	open surgery
OS	OS:8	opitz syndrome
OS	OS:9	oppositesex
OS	OS:18|O-S:1	ouabainsensitive
OS	OS:18|os:1	overshoot
OTA	OTA:15	office of technology assessment
OTA	OTA:11	oxytocin antagonist
OTB	OTB:10	ochratoxin b
OTB	OTB:10	operant test battery
OTB	OTB:9	oxitropium bromide
OTC	OTC:17	loxothiazolidinecarboxylate
OTC	OTC:17	loxothiazolidinecarboxylic acid
OTC	OTC:203|otc:2	oxytetracycline
OTM	OTM:14	olive tail moment
OTM	OTM:11	orthodontic tooth movement
OTS	OTS:14	octadecyltrichlorosilane
OTS	OTS:10	overtraining syndrome
OTR	OTR:12	ocular tilt reaction
OTR	OTR:11|OTr:1|OT-R:1	ot receptors
OTR	OTR:11	oxygen transfer rate
OT	OT:11	occlusion time
OT	OT:11	ocular torsion
OT	OT:9	old tuberculin
OT	OT:58	olfactory tubercle
OT	OT:15	oligosaccharyl transferase
OT	OT:7	operating theatre
OT	OT:32	optic tectum
OT	OT:35	optic tract
OT	OT:12	oral tolerance
OT	OT:18	orthostatic tremor
OVD	OVD:19	occlusal vertical dimension
OVD	OVD:9	ophthalmic viscosurgical device
OVLT	OVLT:86|ovlt:1	organum vasculosum laminae terminalis
OVLT	OVLT:103	organum vasculosum of the lamina terminalis
OVX	OVX:54|ovx:7|Ovx:3	after ovariectomy
OVX	OVX:11|ovx:2|Ovx:1	oophorectomized
OVX	OVX:28|ovx:2|OvX:2|Ovx:1	ovariectomised
OVX	OVX:12|ovx:2	ovariectomized rats
OV	OV:4	liver fluke opisthorchis viverrini
OV	OV:19	orf virus
OWAS	OWAS:7	ovako working posture analysing system
OWAS	OWAS:6	ovako working posture analysis system
OND	OND:18|Ond:5	ondansetron
OND	OND:14	other neurological disease
OND	OND:65	patients with other neurological diseases
OND	OND:8	patients with other neurological disorders
OpMNPV	OpMNPV:6	multicapsid nuclear polyhedrosis virus of orgyia pseudotsugata
OpMNPV	OpMNPV:9	orgyia pseudotsugata mnpv
OpMNPV	OpMNPV:14	orgyia pseudotsugata multicapsid nuclear polyhedrosis virus
OpMNPV	OpMNPV:6	orgyia pseudotsugata multicapsid nucleopolyhedrovirus
OpMNPV	OpMNPV:14	orgyia pseudotsugata multinucleocapsid nuclear polyhedrosis virus
Orn	Orn:7|ORN:3	lornithine
Orn	Orn:42|ORN:10|orn:1	ornithine
OU	OU:11	observation unit
OU	OU:7|O-U:2	ornsteinuhlenbeck
OX	OX:23	optic chiasm
Ox	Ox:23|OX:2|ox:1	oxalate
Ox	Ox:6|OX:5	oxandrolone
OX	OX:19|Ox:3	oxazepam
Ox	Ox:7|ox:5|OX:1	oxidized
P/S	P/S:7	fatty acid ratio
P/S	P/S:19	polyunsaturatedsaturated
P/S	P/S:9	polyunsaturatedsaturated fatty acid
P/S	P/S:6	polyunsaturated to saturated fat
P/S	P/S:14	polyunsaturated to saturated fatty acid
P0.1	P0.1:7	after the onset of inspiration
P0.1	P0.1:88|p0.1:1	mouth occlusion pressure
P0.1	P0.1:10|p0.1:1	respiratory drive
P0	P0:9	isometric tension
P0	P0:5	major myelin glycoprotein
P0	P0:18|P-0:1	newborn
P0	P0:64	protein zero
P1CP	P1CP:6	carboxyterminal propeptide of type  procollagen
P1CP	P1CP:8	carboxyterminal propeptide
P1	P1:6|P-1:1	first peak
P1	P1:5	first phalanx
P1	P1:10	first positive peak
P1	P1:9	first postnatal day
p21	p21:6	cyclindependent kinase inhibitor pwafcip
p21	p21:7	inhibitor pwafcip
p21	p21:8|P21:1	protein product
p21	p21:10	ras gene product
P2	P2:9	crude mitochondrial
P2	P2:5	crude mitochondrial pellet
P2	P2:20	crude synaptosomal
P2	P2:7	positive peak
P2	P2:9	purinergic
P50	P50:9|p50:1	halfsaturation pressure
P50	P50:7	halfsaturation pressure of hemoglobin
P50	P50:3|p50:1	hemoglobin is  saturated
P50	P50:16|p50:2|P-50:1	oxygen affinity
P5C	P5C:6	delta pyrrolinecarboxylate
P5C	P5C:19|P-5-C:2	pyrrolinecarboxylate
PAA	PAA:5	period amplitude analysis
PAA	PAA:13	phosphonoacetate
PAA	PAA:7	pulmonary artery aneurysm
PABA	PABA:9|pABA:3	paminobenzoate
PABA	PABA:197|pABA:11|p-ABA:1	paminobenzoic acid
PABA	PABA:96|pABA:8	paraaminobenzoic acid
PACNS	PACNS:17	primary angiitis of the central nervous system
PACNS	PACNS:8	primary angiitis of the cns
PACs	PACs:12	premature atrial contractions
PACs	PACs:8	prostatic adenocarcinomas
PACs	PACs:15	pulmonary artery catheters
PACT	PACT:13	prescribing analysis and cost
PACT	PACT:3	program for assertive community treatment
PAC	PAC:11|pac:2	penicillin acylase
PAC	PAC:11	perennial allergic conjunctivitis
PAC	PAC:7	peritoneal adherent cells
PAC	PAC:13	perturbed angular correlation
PAC	PAC:6	perturbed angular correlation of gammarays
PAC	PAC:9	plasma arc curing
PAC	PAC:10	portacath
PAC	PAC:13	postacute care
PAC	PAC:48	powdered activated carbon
PAC	PAC:10	premature atrial contraction
PAC	PAC:11	pulmonary artery catheterization
PAC	PAC:8	pulmonary artery constriction
PAD	PAD:26	peptidylarginine deiminase
PAD	PAD:18	percutaneous abscess drainage
PAD	PAD:492	peripheral arterial disease
PAD	PAD:21	preoperative autologous donation
PAD	PAD:8	primary affective disorders
PAD	PAD:80	primary afferent depolarization
PAD	PAD:18	public access defibrillation
PAD	PAD:7	pulsatile assist device
PAEs	PAEs:16	phthalic acid esters
PAEs	PAEs:36	postantibiotic effects
PAE	PAE:18	air embolism
PAE	PAE:31	porcine aortic endothelial
PAF	PAF:19|pAF:1	paroxysmal af
PAF	PAF:178|Paf:8|PAf:6|paf:1	paroxysmal atrial fibrillation
PAF	PAF:20	population attributable fraction
PAF	PAF:6	posterior auditory field
PAF	PAF:22	premenstrual assessment form
PAF	PAF:52	pure autonomic failure
PAGE	PAGE:14	polyacrylamide gels
PAGE	PAGE:992	polyacrylamide gel electrophoresis
PAGE	PAGE:12	polyacrylamide gel electrophoretic
PAG	PAG:9	midbrain periaqueductal grey region
PAG	PAG:12	periaqueductal gray area
PAG	PAG:14	periaqueductal gray region
PAG	PAG:122	periaqueductal grey
PAG	PAG:6	periaqueductal grey area
PAG	PAG:49	periaqueductal grey matter
PAG	PAG:13|pAg:10	protein agold
PAH	PAH:1	inulin or paraaminohippurate
PAH	PAH:5	pamino hippurate
PAH	PAH:395	paminohippurate
PAH	PAH:121	paminohippuric acid
PAH	PAH:5	paraamino hippurate
PAH	PAH:20	paraaminohippurate
PAH	PAH:13	phenylalanine hydroxylase gene
PAH	PAH:6	postatrophic hyperplasia
PAH	PAH:21	predicted adult height
PAH	PAH:5	primary adrenal hyperplasia
PAH	PAH:201	pulmonary arterial hypertension
PAH	PAH:31	pulmonary artery hypertension
PAI-1	PAI-1:9	inhibitor of plasminogen activator
PAI-1	PAI-1:15|pAI-1:1	plasminogen activatorinhibitor
PAI-1	PAI-1:5	plasminogen activator inhibitor antigen
PAI-1	PAI-1:16|PAI1:1	plasminogen activator inhibitor type i
PAI-1	PAI-1:108	type  plasminogen activator inhibitor
PAIS	PAIS:10	partial androgen insensitivity syndrome
PAIs	PAIs:25|Pais:2|pais:1	pathogenicity islands
PAIs	PAIs:24	plasminogen activator inhibitors
PAIS	PAIS:30	psychosocial adjustment to illness scale
PAI	PAI:10	percutaneous acetic acid injection
PAI	PAI:7	percutaneous alcohol injection
PAI	PAI:12	periapical index
PAI	PAI:17	personality assessment inventory
PAI	PAI:21	physical activity index
PAI	PAI:6	primary adrenal insufficiency
PALA	PALA:36	nphosphonacetyllaspartic acid
PALA	PALA:10	phosphonacetyllaspartate
PALS	PALS:28	pediatric advanced life support
PALS	PALS:12	periarterial lymphatic sheath
PALS	PALS:9	periarterial lymphoid sheath
PAL	PAL:10	attachment loss
PAL	PAL:5	passive avoidance learning
PAL	PAL:26|Pal:2	peptidoglycanassociated lipoprotein
PAL	PAL:68	physical activity level
PAL	PAL:10	probing attachment levels
PAL	PAL:33	pyothoraxassociated lymphoma
PAMPA	PAMPA:8	parallel artificial membrane permeability assay
PAMPA	PAMPA:9	parallel artificial membrane permeation assay
PAM	PAM:9	alphaamidating monooxygenase
PAM	PAM:108	peptidylglycine alphaamidating monooxygenase
PAM	PAM:5	periodic acidmethenamine silver
PAM	PAM:30	potential acuity meter
PAM	PAM:14	pregnancyassociated malaria
PAM	PAM:24	primary acquired melanosis
PAM	PAM:21	primary amebic meningoencephalitis
PAM	PAM:12	primary amoebic meningoencephalitis
PAM	PAM:19	pulmonary alveolar microlithiasis
PANDAS	PANDAS:7	autoimmune neuropsychiatric disorders associated with streptococcal infection
PANDAS	PANDAS:13|PANDAs:1	pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections
PANSS	PANSS:385	positive and negative syndrome scale
PANSS	PANSS:12	positive and negative syndrome scale for schizophrenia
PAN	PAN:15	aminonucleoside of puromycin
PAN	PAN:16	periodic alternating nystagmus
PAN	PAN:28	peroxyacetyl nitrate
PAN	PAN:11	positional alcohol nystagmus
PAN	PAN:21	posterior articular nerve
PAN	PAN:27	puromycin aminonucleoside nephrosis
Pao	Pao:20|PaO:2|PAO:1	airway opening
Pao	Pao:32|PaO:5	airway opening pressure
PAO	PAO:37	peak acid output
PAO	PAO:9|pAO:1	peripheral arterial occlusion
PAO	PAO:61	polyamine oxidase
PAPS	PAPS:9	phosphoadenosine phosphosulphate
PAPS	PAPS:33	adenosine phosphate phosphosulfate
PAPS	PAPS:12	adenosine phosphate phosphosulphate
PAPS	PAPS:16|pAPS:2	primary aps
PAPs	PAPs:7	pulmonary artery pressures
PAPs	PAPs:14	purple acid phosphatases
PAR-2	PAR-2:72|PAR2:9	proteaseactivated receptor
PAR-2	PAR-2:33|PAR2:12	proteinaseactivated receptor
PARP	PARP:4|Parp:1	cleavage of polyadpribosepolymerase
PARP	PARP:2	cleavage of the polyadpribosepolymerase
PARP	PARP:33|parp:2	procyclic acidic repetitive protein
PARs	PARs:8	population attributable risks
PARs	PARs:125	proteaseactivated receptors
PARs	PARs:34	proteinaseactivated receptors
PAR	PAR:20	pyridylazoresorcinol
PAR	PAR:11|par:1	paracetamol
PAR	PAR:37	participatory action research
PAR	PAR:9	passive anterior rhinomanometry
PAR	PAR:10	passive avoidance reaction
PAR	PAR:27	passive avoidance response
PAR	PAR:52	peer assessment rating
PAR	PAR:59	perennial allergic rhinitis
PAR	PAR:50	photosynthetically active radiation
PAR	PAR:11	physical activity recall
PAR	PAR:11	platelet aggregate ratio
PAR	PAR:9	platelet aggregation rate
PAR	PAR:7	pulmonary arterial resistance
PAR	PAR:18|PaR:1	pulmonary arteriolar resistance
PASAT	PASAT:24	paced auditory serial addition task
PASAT	PASAT:41	paced auditory serial addition test
PASP	PASP:7	pancreasspecific protein
PASP	PASP:11	polymerassisted solutionphase
PASP	PASP:32|PAsP:3	pulmonary artery systolic pressure
PAT	PAT:17	paroxysmal atrial tachycardia
PAT	PAT:12|pat:1	patagialis
PAT	PAT:8	phosphinothricin acetyltransferase
PAT	PAT:12	platelet aggregation test
PAT	PAT:12	proficiency analytical testing
PAV	PAV:7	porcine aortic valve
PAV	PAV:57	proportional assist ventilation
PAS	PAS:7	atrial stimulation
PAS	PAS:9	paminosalicylate
PAS	PAS:5	paired associative stimulation
PAS	PAS:57|pas:1	paraaminosalicylic acid
PAS	PAS:10	patient administration system
PAS	PAS:35	perarntsim
PAS	PAS:12	perceptual aberration scale
PAS	PAS:17	periodic acidschiff reagent
PAS	PAS:13	peripheral anionic site
PAS	PAS:8	peripheral anterior synechia
PAS	PAS:25	peripheral anterior synechiae
PAS	PAS:6	personality assessment schedule
PAs	PAs:6	phosphatidic acids
PAS	PAS:15	photoacoustic spectroscopy
PAS	PAS:8	physical activity score
PAS	PAS:13	physical anhedonia scale
PAS	PAS:72	physicianassisted suicide
PAS	PAS:4	platelet additive solution
PAs	PAs:9	pleomorphic adenomas
PAs	PAs:31	polyamines
PAS	PAS:13|pas:1	posterior airway space
PAS	PAS:6	preautophagosomal structure
PAS	PAS:19	premorbid adjustment scale
PAS	PAS:6	psychiatric assessment schedule
PAs	PAs:65	pyrrolizidine alkaloids
PA	PA:17	abscess
Pa	Pa:4|PA:3	acidic protein
PA	PA:6|Pa:2|pa:1	agreement
Pa	Pa:1	apparent permeability coefficient to albumin
Pa	Pa:10|PA:1	childrens hospital of philadelphia
Pa	Pa:7|PA:2	childrens hospital of pittsburgh
PA	PA:11	paleostriatum augmentatum
PA	PA:13	panic attacks
Pa	Pa:9|PA:1	paranoia
PA	PA:65	particle agglutination
PA	PA:5	particle agglutination test
PA	PA:69	passive avoidance
PA	PA:15	pennsylvania
PA	PA:8	perceptual asymmetry
PA	PA:8	performance assessment
PA	PA:29	perinatal asphyxia
PA	PA:7	permeabilityarea product
PA	PA:10	permeabilitysurface area product
PA	PA:39	pernicious anaemia
PA	PA:43	pernicious anemia
PA	PA:39	phenylacetate
PA	PA:6	phonological awareness
PA	PA:42	phosphatidate
PA	PA:30	photoacoustic
PA	PA:31	phthalic anhydride
PA	PA:31	physician assistant
PA	PA:16	pilocytic astrocytoma
PA	PA:13	plaque area
PA	PA:21	plasminogen activation
PA	PA:26	polyacrylate
PA	PA:17	polyamide
PA	PA:39	positive affect
PA	PA:9	positive affectivity
PA	PA:11|pa:1	postabsorptive
PA	PA:36|P-A:4|pa:1	posterioranterior
Pa	Pa:6|PA:4	pregnancyassociated
PA	PA:8	preinfarction angina
PA	PA:17	premature adrenarche
PA	PA:9	primary angioplasty
PA	PA:14	proanthocyanidin
PA	PA:89	procainamide
PA	PA:5	progressive aphasia
PA	PA:10	propionic acidaemia
PA	PA:23	propionic acidemia
PA	PA:11	proton affinity
PA	PA:17	pseudoaneurysm
PA	PA:112|Pa:28	pseudomonas aeruginosa
PA	PA:6	psoriatic arthropathy
PA	PA:6	pullulan acetate
PA	PA:14	pulmonary angiography
PA	PA:22	pulmonary atresia
PA	PA:26	pulse amplitude
PA	PA:10	pyloric atresia
PA	PA:6	pyrophosphate arthropathy
PA	PA:5	solitary parathyroid adenoma
Pa	Pa:7	university of pittsburgh
PBC	PBC:1400	primary biliary cirrhosis
PBC	PBC:5	protected brush catheter
PBDEs	PBDEs:200|PBDES:1	polybrominated diphenyl ethers
PBDEs	PBDEs:14	polybrominated diphenylethers
PBD	PBD:25	biliary drainage
PBD	PBD:20	pancreaticobiliary diversion
PBD	PBD:12	pigeon breeders disease
PBD	PBD:11	polybutadiene
PBD	PBD:10	proliferative breast disease
PBD	PBD:10	pyrrolocbenzodiazepine
PBE	PBE:12	bifunctional enzyme
PBE	PBE:9	peripheral blood eosinophils
PBF	PBF:8	binding factor
PBF	PBF:16	percent body fat
PBF	PBF:11	percentage body fat
PBG	PBG:36	phenylbiguanide
PBG	PBG:9	photonic band gap
PBG	PBG:8	pressure breathing during g
PBG	PBG:10	progesteronebinding globulin
PBI	PBI:23	papillary bleeding index
PBI	PBI:102	parental bonding instrument
PBI	PBI:8	partial breast irradiation
PBI	PBI:16	penile brachial index
PBI	PBI:36|pbi:2	proteinbound iodine
PBL	PBL:7	plasmablastic lymphoma
PBL	PBL:21	portal branch ligation
PBL	PBL:9	primary breast lymphoma
PBMA	PBMA:7	program budgeting and marginal analysis
PBMA	PBMA:15	programme budgeting and marginal analysis
PBMV	PBMV:12	percutaneous balloon mitral valvotomy
PBMV	PBMV:31	percutaneous balloon mitral valvuloplasty
PBM	PBM:6	benefit management
PBM	PBM:34	pancreaticobiliary maljunction
PBM	PBM:19	peak bone mass
PBM	PBM:13|pbm:1	peribacteroid membrane
PBM	PBM:6	pharmacy benefit manager
PBM	PBM:6	poultry byproduct meal
PBN	PBN:6	agent alphaphenylntbutylnitrone
PBN	PBN:47	alphaphenylntertbutylnitrone
PBN	PBN:17	ntbutylalphaphenylnitrone
PBN	PBN:24|PbN:6	parabrachial nuclei
PBN	PBN:9	phenyl ntertbutyl nitrone
PBN	PBN:6	spin trap alphaphenyl ntertbutyl nitrone
PBN	PBN:12	spin trap ntertbutylalphaphenylnitrone
PBPK	PBPK:293|PB-PK:45|pbpk:3	physiologically based pharmacokinetic
PBPK	PBPK:8|PB-PK:1	physiologically based pharmacokinetic model
PBP	PBP:10	progressive bulbar palsy
PBP	PBP:18	prostatic binding protein
PBR	PBR:10	parabrachial region
PBR	PBR:10	peptidebinding region
PBR	PBR:116|pBR:2	peripheral benzodiazepine receptor
PBR	PBR:94	peripheraltype benzodiazepine receptor
PBS	PBS:29	pharmaceutical benefits scheme
PBS	PBS:45	phosphate buffer solution
PBS	PBS:9	pulsating bubble surfactometer
PBS	PBS:3	saline ph 
PBT	PBT:10	peripheral blood t
PBT	PBT:14|PB-T:1	peripheral blood t cells
PBT	PBT:13	pulmonary barotrauma
PBV	PBV:13	balloon valvuloplasty
PBV	PBV:53	pulmonary blood volume
PB	PB:12|Pb:3|pB:1	barometric pressure
PB	PB:24	parabrachial
Pb	Pb:16	paracoccidioides brasiliensis
PB	PB:6	particle beam
PB	PB:101	paucibacillary
PB	PB:10	pencil beam
PB	PB:9	pentobarbital sodium
PB	PB:9	pentobarbitone
PB	PB:11	peribrachial
PB	PB:64	periodic breathing
PB	PB:8	peroneus brevis
PB	PB:12|Pb:1	phenobarbital sodium
PB	PB:131|Pb:2	phenobarbitone
PB	PB:36	phosphate buffer
Pb	Pb:6|PB:3	plasmodium berghei
PB	PB:34|P-B:2	poissonboltzmann
PB	PB:25|Pb:1	polar body
PB	PB:9|Pb:1	polybrene
PB	PB:9	postburn
PB	PB:10	primebond 
PB	PB:9	primed burst
PB	PB:10|Pb:1	probenecid
PB	PB:10	prostate brachytherapy
PB	PB:8	protein breakdown
PB	PB:21	prussian blue
PB	PB:13	pulmonary blastoma
PB	PB:5|Pb:2	rat probasin
PB	PB:9	sodium phenylbutyrate
PC12	PC12:27|PC-12:4	rat phaeochromocytoma
PC12	PC12:270|PC-12:23	rat pheochromocytoma
PC12	PC12:35|PC-12:9	rat pheochromocytoma cells
PC20	PC20:2	fev by  of baseline
PC20	PC20:5	provocative concentration causing a  fall in fev from baseline
PC20	PC20:12	provocative concentration of histamine causing a  fall in fev
PC20	PC20:14	provocative concentration of methacholine causing a  fall in fev
PC-3	PC-3:9|PC3:5	human prostate
PC-3	PC-3:10|PC3:2	human prostate cancer cells
PCA	PCA:185|pCA:13|p-CA:4|P-CA:1	pchloroamphetamine
PCA	PCA:8	parietal cell
PCA	PCA:28	passive cutaneous anaphylactic
PCA	PCA:425	passive cutaneous anaphylaxis
PCA	PCA:8	patientcontrolled analgesic
PCA	PCA:11	pentachloroanisole
PCA	PCA:4	percent cortical area
PCA	PCA:64	perchloric acid
PCA	PCA:15	plate count agar
PCA	PCA:64	portacaval anastomosis
PCA	PCA:19	portocaval anastomosis
PCA	PCA:87	postconceptional age
PCA	PCA:11	posterior cerebral
PCA	PCA:19|pCA:1	posterior cortical atrophy
PCA	PCA:126	posterior cricoarytenoid
PCA	PCA:32	posterior cricoarytenoid muscle
PCA	PCA:4	probe competition assay
PCA	PCA:4	protein fragment complementation assay
PCA	PCA:15|pca:4|Pca:1	protocatechuate
PCA	PCA:27	protocatechuic acid
PCA	PCA:10	weeks postconceptional age
PCBs	PCBs:14	polychlorinated biphenyl congeners
PCBs	PCBs:49	polychlorobiphenyls
PCB	PCB:24	paracervical block
PCB	PCB:33	phycocyanobilin
PCB	PCB:8	placentalumbilical cord blood
PCB	PCB:13	printed circuit board
PCB	PCB:8	psoas compartment block
PCCs	PCCs:7	poison control centers
PCCs	PCCs:21	prothrombin complex concentrates
PCC	PCC:5	patientcentered care
PCC	PCC:10	percutaneous cervical cordotomy
PCC	PCC:9	peripheral cholangiocarcinoma
PCC	PCC:10|pcc:3	pigeon cytochrome c
PCC	PCC:5	plasma corticosterone concentration
PCC	PCC:5|pcc:1	plasma cortisol concentration
PCC	PCC:10	poison control center
PCC	PCC:5	postcoital contraception
PCC	PCC:19	posterior cingulate cortex
PCC	PCC:181	premature chromosome condensation
PCC	PCC:35	prematurely condensed chromosomes
PCC	PCC:5	primary care center
PCC	PCC:14	primary care centre
PCC	PCC:9	pyridinium chlorochromate
PCDDs	PCDDs:336|PCDDS:1	polychlorinated dibenzopdioxins
PCDDs	PCDDs:31	polychlorinated dibenzodioxins
PCDDs	PCDDs:7	polychlorinated dioxins
PCF	PCF:8	photonic crystal fiber
PCF	PCF:14	platelet contractile force
PCF	PCF:11	polycationic ferritin
PCF	PCF:6	polycationized ferritin
PCF	PCF:10	posterior cranial fossa
PCG	PCG:25	phonocardiogram
PCG	PCG:13	plasma cell granuloma
PCG	PCG:29	primary congenital glaucoma
PCH	PCH:23	paroxysmal cold hemoglobinuria
PCH	PCH:8	photon counting histogram
PCH	PCH:13	pulmonary capillary hemangiomatosis
PCI	PCI:18	partial coherence interferometry
PCI	PCI:7	peritoneal cancer index
PCI	PCI:8	phenomenology of consciousness inventory
PCI	PCI:12	photochemical internalisation
PCI	PCI:15	photochemical internalization
PCI	PCI:25	physiological cost index
PCI	PCI:61	pneumatosis cystoides intestinalis
PCI	PCI:11	positive chemical ionization
PCI	PCI:17	potato carboxypeptidase inhibitor
PCI	PCI:5	proliferating cell index
PCI	PCI:123	prophylactic cranial irradiation
PCI	PCI:113	protein c inhibitor
PCL	PCL:12	pacing cycle length
PCL	PCL:19	plasma cell leukaemia
PCL	PCL:69	plasma cell leukemia
PCL	PCL:47	polycaprolactone
PCL	PCL:9	posterior collagenous layer
PCL	PCL:270	posterior cruciate ligament
PCL	PCL:13	primary cardiac lymphoma
PCL	PCL:9	primary cerebral lymphoma
PCL	PCL:9	ptsd checklist
PCL	PCL:5	purkinje cell layer
PCMBS	PCMBS:30|pCMBS:11|p-CMBS:2|pcmbs:1	pchloromercuribenzene sulfonate
PCMBS	PCMBS:3|pCMBS:3|p-CMBS:1	pchloromercuribenzene sulphonate
pCMBS	pCMBS:14|PCMBS:6|p-CMBS:3	pchloromercuribenzenesulfonate
pCMBS	pCMBS:6|PCMBS:3	pchloromercuribenzenesulphonate
pCMPS	pCMPS:4|PCMPS:3|p-CMPS:1	pchloromercuriphenyl sulfonate
pCMPS	pCMPS:7|PCMPS:2|p-CMPS:2	pchloromercuriphenylsulfonate
PCM	PCM:6	pericellular matrix
PCM	PCM:36	pericentriolar material
PCM	PCM:4	sera from patients with paracoccidioidomycosis
PCN	PCN:49	percutaneous nephrostomy
PCN	PCN:70	pregnenolone alphacarbonitrile
PCO	PCO:21	photocatalytic oxidation
PCO	PCO:20	polycystic ovarian
PCO	PCO:49	posterior capsular opacification
PCO	PCO:220	posterior capsule opacification
PCO	PCO:7	potassium channel opener
PCO	PCO:9	pulp canal obliteration
PCPs	PCPs:5	peptidyl carrier proteins
PCPS	PCPS:109	percutaneous cardiopulmonary support
PCPS	PCPS:21	percutaneous cardiopulmonary support system
PCPs	PCPs:121	primary care physicians
PCPs	PCPs:9	primary care practitioners
PCPs	PCPs:42	primary care providers
PCP	PCP:12	hphencyclidine
PCP	PCP:559|pcp:1	pentachlorophenol
PCP	PCP:20	peptidyl carrier protein
PCP	PCP:1205	phencyclidine
PCP	PCP:18	phencyclidine hydrochloride
PCP	PCP:10	phenolchloroformpetroleum ether
PCP	PCP:55	planar cell polarity
PCP	PCP:10	pneumococcal capsular polysaccharide
PCP	PCP:1042|PcP:10|Pcp:1|pcp:1	pneumocystis carinii pneumonia
PCP	PCP:14	pneumocystis carinii pneumonitis
PCP	PCP:42	primary care provider
PCP	PCP:10|pCP:1	procollagen cproteinase
PCP	PCP:6	protein c activation peptide
PCR-SSP	PCR-SSP:18	pcr amplification with sequencespecific primers
PCR-SSP	PCR-SSP:13	polymerase chain reactionsequencespecific primer
PCR-SSP	PCR-SSP:33	polymerase chain reaction using sequencespecific primers
PCR-SSP	PCR-SSP:12	polymerase chain reaction with sequence specific primers
pCREB	pCREB:10|p-CREB:1	phosphorylated camp response elementbinding protein
pCREB	pCREB:32|P-CREB:10|p-CREB:9|PCREB:1	phosphorylated creb
pCR	pCR:15|PCR:2	complete remission
PCR	PCR:10	enzymatic amplification
pCR	pCR:38|PCR:7	pathologic complete response
PCr	PCr:12	phosphocreatinine
PCR	PCR:8	plaque control record
PCr	PCr:12|Pcr:7|P-Cr:3|pCr:2	plasma creatinine
PCr	PCr:6|Pcr:3	plasma creatinine concentration
PCR	PCR:10	polymerase chain
PCR	PCR:13	polymerase chain reaction amplification
PCR	PCR:20	polymerase chain reaction assay
PCR	PCR:25	polymerase chain reaction method
PCR	PCR:26	polymerase chain reaction technique
PCR	PCR:51	principal component regression
PCR	PCR:97|pcr:10	protein catabolic rate
PCR	PCR:9	psychiatric case register
PCS	PCS:7	care services
PCS	PCS:8	pain catastrophizing scale
PCS	PCS:6	palliative care service
PCS	PCS:6	paracingulate sulcus
PCS	PCS:25	patientcontrolled sedation
PCS	PCS:44	patterns of care study
PCs	PCs:10	penicillins
PCs	PCs:11	pericytes
PCS	PCS:33	physical
PCS	PCS:10	physical component scale
PCS	PCS:11	physical component score
PCS	PCS:5	physical component summary score
PCs	PCs:30	phytochelatins
PCS	PCS:8	phytochelatin synthase
PCs	PCs:54	plasma cells
PCs	PCs:198|PCS:2|Pcs:1	platelet concentrates
PCS	PCS:17	portacaval shunted
PCS	PCS:10	portacaval shunting
PCS	PCS:6	postconcussion symptoms
PCS	PCS:7	postconcussive symptoms
PCS	PCS:5	premature centromere separation
PCS	PCS:5	premature chromatid separation
PCs	PCs:51|PCS:1	principal components
PCs	PCs:31	proprotein convertases
PCs	PCs:146	purkinje cells
PCTs	PCTs:5	clinical trials
PCTs	PCTs:5	placebocontrolled trials
PCTs	PCTs:15|Pcts:1	plasmacytomas
PCTs	PCTs:11	polychlorinated terphenyls
PCTs	PCTs:9	postcoital tests
PCTs	PCTs:7	primary care teams
PCTs	PCTs:36	primary care trusts
PCT	PCT:4	papillary cystic tumor
PCT	PCT:17	parasite clearance time
PCT	PCT:7	perfusion ct
PCT	PCT:25	photochemical treatment
PCT	PCT:11	photochemotherapy
PCT	PCT:18	polychemotherapy
PCT	PCT:321|Pct:1	porphyria cutanea tarda
PCT	PCT:22	positron computed tomography
PCT	PCT:9	postcoital testing
PCT	PCT:16	primary care trust
PCT	PCT:6|P-CT:1	primary chemotherapy
PCT	PCT:25	proximal convoluted
PCT	PCT:9	pupil cycle time
PCU	PCU:21	palliative care unit
PCU	PCU:7|PC-U:3	unawareness
PCV2	PCV2:30|PCV-2:6	porcine circovirus 
PCV2	PCV2:6|PCV-2:1	type  porcine circovirus
PCV	PCV:19	haematocrit
PCV	PCV:55	parietal cell vagotomy
PCV	PCV:12	peanut clump virus
PCV	PcV:5|PCV:5|pcV:3	phenoxymethylpenicillin
PCV	PCV:27	polypoidal choroidal vasculopathy
PCV	PCV:52	porcine circovirus
PCV	PCV:9	pressure control ventilation
PCV	PCV:33	pressurecontrolled ventilation
PCW	PCW:8	cell walls
PCW	PCW:18|Pcw:1	pulmonary capillary wedge
PCr/Pi	PCr/Pi:14	phosphate ratio
PCr/Pi	PCr/Pi:14	phosphocreatineinorganic phosphate
PCr/Pi	PCr/Pi:12	ratio of phosphocreatine to inorganic phosphate
PC	PC:17	antiphosphocholine
PC	PC:33	antiphosphorylcholine
Pc	Pc:53|PC:5	capillary pressure
PC	PC:8	cells of the parvocellular
PC	PC:11	cine phasecontrast
Pc	Pc:7|pc:1	corrected p
PC	PC:7	egg lecithin
PC	PC:19	liver parenchymal cells
PC	PC:17	pachyonychia congenita
PC	PC:17	pacinian corpuscle
PC	PC:23	pancreatic carcinoma
PC	PC:29	paramyotonia congenita
PC	PC:9	parenchymal
PC	PC:16	parietal cortex
PC	PC:11	patients with pancreatic cancer
PC	PC:10	patients with prostatic cancer
PC	PC:9	pelvic control
PC	PC:9	pentose cycle
PC	PC:20	percutaneous cholecystostomy
PC	PC:27	peritoneal carcinomatosis
PC	PC:9	pharyngeal constrictor
PC	PC:43	phase contrast
PC	PC:12	phosphocitrate
PC	PC:19|Pc:1	phycocyanin
PC	PC:16	pineal calcification
PC	PC:6	plasma concentrations
PC	PC:36|Pc:12|pc:5	plastocyanin
PC	PC:5	pneumotaxic center
PC	PC:49	polycarbonate
PC	PC:10	polycarbophil
Pc	Pc:59|PC:5	polycomb
PC	PC:11|pc:3|P-C:1	positive control
pc	pc:12|PC:3	post coitum
pc	pc:11|PC:6	postcoitus
PC	PC:11|pc:6	postconception
PC	PC:5	posterior canal
PC	PC:29	posterior chamber
PC	PC:8	posterior compartment
PC	PC:9	preconditioned
PC	PC:10	prednicarbate
PC	PC:5	preoperative complications
PC	PC:90	primary care
PC	PC:16	primary closure
PC	PC:14	procerebral
PC	PC:14	procerebrum
PC	PC:9	procollagen
PC	PC:16	proprotein convertase
PC	PC:10	propylene carbonate
PDA	PDA:18	cispiperidine dicarboxylic acid
PDA	PDA:6	dorsal aortic blood pressure
PDA	PDA:12	pancreaticoduodenal artery
PDA	PDA:7	panic disorder and agoraphobia
PDA	PDA:690	patent ductus arteriosus
PDA	PDA:28	photodiode array
PDA	PDA:4	polymorphic delta activity
PDA	PDA:13	population and community development association
PDA	PDA:19	posterior descending artery
PDA	PDA:31	potato dextrose agar
PDA	PDA:11	prolonged depolarizing afterpotential
PDBu	PDBu:13|PDBU:2	hphorboldibutyrate
PDBu	PDBu:11	phorbol ester
PDB	PDB:21	pagets disease of bone
PDB	PDB:208	protein data bank
PDB	PDB:11	protein databank
PDC-E2	PDC-E2:7	e component of the pyruvate dehydrogenase complex
PDC-E2	PDC-E2:4	e subunit of pyruvate dehydrogenase complex
PDCs	PDCs:14|pDCs:13	plasmacytoid dcs
PDCs	PDCs:29|pDCs:28|P-DCs:3	plasmacytoid dendritic cells
PDC	PDC:10	dialysis capacity
PDC	PDC:4	parkinsonismdementia complex on guam
PDC	PDC:19	paroxysmal dystonic choreoathetosis
PDC	PDC:9	poorly differentiated carcinoma
PDDs	PDDs:7	depth doses
PDDs	PDDs:41	pervasive developmental disorders
PDD	PDD:17	papillomatous digital dermatitis
PDD	PDD:10	percent depth dose
PDD	PDD:21	percentage depth dose
PDD	PDD:25	photodynamic diagnosis
PDD	PDD:11	prescribed daily dose
PDD	PDD:15	primary degenerative dementia
PDD	PDD:8	pulse dye densitometry
PDE4	PDE4:28|PDE-4:2	phosphodiesterase type 
PDE4	PDE4:14|PDE-4:3	type  phosphodiesterase
PDE	PDE:28	campphosphodiesterase
PDE	PDE:23	cyclic nucleotide phosphodiesterases
PDE	PDE:20|pde:1	partial differential equation
PDE	PDE:8	peritoneal dialysate effluent
PDE	PDE:27	peritoneal dialysis effluent
PDE	PDE:47	pulsed doppler echocardiography
PDFs	PDFs:17	peritoneal dialysis fluids
PDFs	PDFs:18|pdfs:9	probability density functions
PDF	PDF:46	peptide deformylase
PDF	PDF:17|pdf:1	pigmentdispersing factor
PDF	PDF:8	primary dysfunction
PDG	PDG:17	phenyldiguanide
PDG	PDG:29	phosphatedependent glutaminase
PdG	PdG:9|PDG:2	pregnanediol alphaglucuronide
PdG	PdG:16|PDG:2	pregnanediolglucuronide
PdG	PdG:15|Pdg:2|PDG:1	pregnanediol glucuronide
PdG	PdG:9	propanodeoxyguanosine
PDH	PDH:25	dogs with pituitarydependent hyperadrenocorticism
PDH	PDH:21	pigmentdispersing hormone
PDH	PDH:9	progressive disseminated histoplasmosis
PDL	PDL:14	pancreatic duct ligation
PDL	PDL:29	polydlysine
PDMS	PDMS:11	peabody developmental motor scales
PDMS	PDMS:21|PD-MS:3	plasma desorption mass spectrometry
PDQ	PDQ:12	personality diagnostic questionnaire
PDQ	PDQ:22	physician data query
PDR	PDR:27	desk reference
PDR	PDR:5	pancreaticoduodenal resection
PDR	PDR:6	phthalate dioxygenase reductase
PDR	PDR:20|Pdr:2	pleiotropic drug resistance
PDR	PDR:285	proliferative diabetic retinopathy
PDR	PDR:11	proliferative dr
PDSS	PDSS:9	panic disorder severity scale
PDSs	PDSs:27	paroxysmal depolarization shifts
PDSs	PDSs:12	paroxysmal depolarizing shifts
PDSS	PDSS:9	postpartum depression screening scale
PDS	PDS:9	dental services
PDs	PDs:6	paroxysmal discharges
PDS	PDS:12	pendred syndrome
PDS	PDS:7	pendred syndrome gene
PDS	PDS:13	peritoneal dialysis solution
PDs	PDs:149|PDS:2	personality disorders
PDS	PDS:23|Pds:6|pds:3	phytoene desaturase
PDS	PDS:19	pigment dispersion syndrome
PDS	PDS:40	plasmaderived serum
PDS	PDS:14	polydioxanon
PDS	PDS:107	polydioxanone
PDS	PDS:10	polydioxanone suture
PDs	PDs:33	population doublings
PDS	PDS:5	posttraumatic diagnostic scale
PDs	PDs:11	potential differences
PDS	PDS:14	power density spectrum
PDS	PDS:18	power doppler sonography
PDs	PDs:16	program directors
PDS	PDS:8	progressive deterioration scale
PDS	PDS:10	public dental service
PDTC	PDTC:309	pyrrolidine dithiocarbamate
PDTC	PDTC:54	pyrrolidinedithiocarbamate
PDT	PDT:20	pedigree disequilibrium test
PDT	PDT:42	percutaneous dilatational tracheostomy
PDT	PDT:6	percutaneous dilatational tracheotomy
PDT	PDT:33	percutaneous dilational tracheostomy
PDT	PDT:9	percutaneous dilational tracheotomy
PDT	PDT:48	photodynamic treatment
PDT	PDT:9	population doubling time
PDV	PDV:9	patent ductus venosus
PDV	PDV:12	phocid distemper virus
PDV	PDV:29	phocine distemper virus
PDV	PDV:5	plasmaderived vaccine
PDV	PDV:70	portaldrained viscera
PDZ	PDZ:6	largezona occludens
PDZ	PDZ:9	psddlgazo
PDZ	PDZ:21	psddlgzo
PDI	PDI:5	delusions inventory
PDI	PDI:1	pain and disability index
PDI	PDI:29	power doppler imaging
PDI	PDI:16	protein disulphideisomerase
PDI	PDI:19	psoriasis disability index
PEA	PEA:6	hreceptor agonist pyridylethylamine
PEA	PEA:21	palmitoylethanolamide
PEA	PEA:17	peak endocardial acceleration
PEA	PEA:19	phacoemulsification and aspiration
PEA	PEA:10	phenethyl alcohol
PEA	PEA:9	phenethylamine
PEA	PEA:8	phenyl ethyl alcohol
PEA	PEA:28	pulseless electrical activity
PEB	PEB:1	cisplatin etoposide bleomycin
PEB	PEB:15	phycoerythrobilin
PECs	PECs:7	parietal epithelial cells
PECS	PECS:6	patient evaluation and conference system
PECs	PECs:57	peritoneal exudate cells
PECS	PECS:10	picture exchange communication system
PECs	PECs:11	pigmented epithelial cells
PECs	PECs:15	predicted environmental concentrations
PEC	PEC:9|pec:1	phycoerythrocyanin
PEC	PEC:19	polyelectrolyte complex
PEC	PEC:10	porcine enteric calicivirus
PEC	PEC:22	predicted environmental concentration
PEDV	PEDV:35	porcine epidemic diarrhea virus
PEDV	PEDV:16	porcine epidemic diarrhoea virus
PED	PED:40	pediatric emergency department
PED	PED:32	pigment epithelial detachment
PED	PED:9	potential energy distribution
PEEPi	PEEPi:21	intrinsic peep
PEEPi	PEEPi:64|Peepi:1	intrinsic positive endexpiratory pressure
PEEP	PEEP:21	positive and expiratory pressure
PEEP	PEEP:19	positive endexpiratory pressure ventilation
PEF	PEF:5	belongs to the pentaefhand
PEF	PEF:17|Pef:5	pefloxacin
PEG-SOD	PEG-SOD:16	polyethylene glycolconjugated superoxide dismutase
PEG-SOD	PEG-SOD:11|PEGSOD:1	polyethylene glycolsuperoxide dismutase
PEG	PEG:11	pegylated
PEG	PEG:565	percutaneous endoscopic gastrostomy
PEG	PEG:20	pneumoencephalography
PEG	PEG:4	polyethylene glycol solution
PEG	PEG:9	polyethylenglycol
PEH	PEH:8	papillary endothelial hyperplasia
PEH	PEH:11	postexercise hypotension
PEH	PEH:10	pseudoepitheliomatous hyperplasia
PEITC	PEITC:96	phenethyl isothiocyanate
PEITC	PEITC:9	phenethylisothiocyanate
PEI	PEI:7	excretion index
PEI	PEI:8	patient enablement instrument
PEI	PEI:231	percutaneous ethanol injection
PEI	PEI:10	postejaculatory interval
PEI	PEI:15	prince edward island
PELs	PELs:18	permissible exposure limits
PELs	PELs:15	primary effusion lymphomas
PEL	PEL:15	peritoneal exudate lymphocytes
PEL	PEL:11	permissible exposure level
PEM	PEM:19	paraneoplastic encephalomyelitis
PEM	PEM:31	pediatric emergency medicine
PEM	PEM:50	peritoneal exudate macrophages
PEM	PEM:17	polioencephalomalacia
PEM	PEM:9	polyelectrolyte multilayer
PEM	PEM:9	positron emission mammography
PEM	PEM:39	prescriptionevent monitoring
PEM	PEM:4	protein energy malnourished
PEO	PEO:9	polyethyleneoxide
PEO	PEO:55	progressive external ophthalmoplegia
PEPI	PEPI:20	postmenopausal estrogenprogestin interventions
PEPI	PEPI:21	preejection period index
PEP	PEP:14	pepleomycin
PEP	PEP:18	phosphoenol pyruvate
PEP	PEP:18	polyestradiol phosphate
PEP	PEP:45	positive expiratory pressure
PEP	PEP:7	preejection time
PEP	PEP:24	primer extension preamplification
PEP	PEP:5	progestagenassociated endometrial protein
PERG	PERG:9	pattern electroretinography
PERG	PERG:18|P-ERG:2	pattern erg
PERT	PERT:12	productenhanced reverse transcriptase
PERT	PERT:5	program evaluation and review technique
PER	PER:61	peak ejection rate
PER	PER:10	per protein
PER	PER:10|Per:1	period protein
PER	PER:21	proboscis extension reflex
PER	PER:14	proboscis extension response
PETCO2	PETCO2:4|PetCO2:2|PEtco2:1|PET-CO2:1|Petco2:1|petCO2:1	endtidal carbon dioxide partial pressure
PETCO2	PETCO2:5|PetCO2:2	endtidal co partial pressure
PETCO2	PETCO2:12|PetCO2:1	endtidal co pressure
PETCO2	PETCO2:14|PetCO2:4	endtidal co tension
PETCO2	PETCO2:9|PetCO2:1	endtidal partial pressure of carbon dioxide
PET	PET:12	functional
PET	PET:7	pancreatic endocrine tumors
PET	PET:13	paraffinembedded tissue
PET	PET:4|pET:2	patulous eustachian tube
PET	PET:37|PeT:2	photoinduced electron transfer
PET	PET:10	polyester
PET	PET:5	polyethylene terephtalate
PET	PET:15	polyethyleneterephthalate
PET	PET:21	positron emission tomograph
PET	PET:201	positron emission tomographic
PET	PET:11	preeclamptic toxaemia
PES	PES:9	paclitaxeleluting stents
PES	PES:16|pes:1	pharyngoesophageal segment
PEs	PEs:14	phosphatidylethanolamines
PEs	PEs:7	phthalate esters
PES	PES:16	polyethersulfone
PES	PES:6	postenumeration survey
PES	PES:11	postextrasystolic
PES	PES:6	preepiglottic space
PES	PES:9	primary empty sella
PES	PES:124	programmed electrical stimulation
PES	PES:15	psychiatric emergency service
PE	PE:3	ace inhibitor perindopril
PE	PE:6	after phacoemulsification
PE	PE:59	agonist phenylephrine
PE	PE:10	cisplatinetoposide
PE	PE:11	days postexposure
Pe	Pe:4|PE:1	early promoter
PE	PE:19	elastase
PE	PE:11	element
PE	PE:11|Pe:2	errors
Pe	Pe:5	error positivity
PE	PE:21	parietal endoderm
PE	PE:13	pectinesterase
PE	PE:18	pectus excavatum
PE	PE:9	pemphigus erythematosus
PE	PE:38	pericardial effusion
PE	PE:48	peritoneal exudate
Pe	Pe:4|PE:2	periventricular hypothalamic nucleus
PE	PE:11	persistent estrus
PE	PE:13	petroleum ether
PE	PE:14	pharyngoesophageal
PE	PE:18	phosphorylethanolamine
PE	PE:49	physical education
PE	PE:45	physical examination
PE	PE:10	physical exercise
PE	PE:9	phytoestrogens
PE	PE:16	pigment epithelial
PE	PE:33	pigment epithelium
PE	PE:12	pigmented ciliary epithelial
PE	PE:21	pigmented epithelial
PE	PE:20	pigmented epithelium
PE	PE:8	plasma epinephrine
PE	PE:15	plasma extravasation
PE	PE:44	plating efficiency
PE	PE:13	polyelectrolyte
PE	PE:231	polyethylene
PE	PE:6	porcine pancreatic endocrine
PE	PE:9	portoenterostomy
PE	PE:16|pe:1	postexposure
PE	PE:13	potential energy
PE	PE:9	power of exclusion
PE	PE:10	precedence effect
PE	PE:9	prediction error
PE	PE:16	preeclamptic
PE	PE:40	premature ejaculation
PE	PE:4	preoperative portal embolization
PE	PE:11	probability of exclusion
PE	PE:10	proliferative enteritis
PE	PE:10	proliferative enteropathy
PE	PE:8	prolonged exposure
PE	PE:11	protective efficacy
PE	PE:114	pseudomonas exotoxin
PE	PE:55|Pe:1	pulmonary emboli
PE	PE:45	pulmonary embolus
PE	PE:18	pulmonary emphysema
PF4	PF4:27|PF-4:21	platelet factor
PF4	PF4:15|PF-4:3|Pf4:2	platelet factor four
PFA-100	PFA-100:21|PFA100:1	platelet function analyser
PFA-100	PFA-100:34|PFA100:1	platelet function analyzer
PFA	PFA:42	phosphonoformate
PFA	PFA:59	phosphonoformic acid
PFA	PFA:10	principal factor analysis
PFA	PFA:10	profunda femoris artery
PFB	PFB:27	pentafluorobenzyl
PFB	PFB:10	perflubron
PFB	PFB:10	pseudofolliculitis barbae
PFCs	PFCs:28	perfluorocarbons
PFCs	PFCs:19	perfluorochemicals
PFCs	PFCs:19	plaqueforming cells
PFC	PFC:9	pairfed control
PFC	PFC:12	patientfocused care
PFC	PFC:21	persistent fetal circulation
PFC	PFC:10	plasma fibrinogen concentration
PFC	PFC:24	prefrontal cortical
PFDA	PFDA:18	perfluorondecanoic acid
PFDA	PFDA:53	perfluorodecanoic acid
PFD	PFD:16	paired filtration dialysis
PFD	PFD:8	pelvic floor dysfunction
PFD	PFD:20	perfluorodecalin
PFD	PFD:14	photon flux density
PFD	PFD:23	proteinfree diet
PFE	PFE:9	papillary fibroelastoma
PFE	PFE:6	pressurised fluid extraction
PFE	PFE:6	pressurized fluid extraction
PFG	PFG:6	pulsed field gel
PFG	PFG:52|pfg:1	pulsed field gradient
PFH	PFH:29	perifornical hypothalamus
PFH	PFH:15	progressive facial hemiatrophy
PFI	PFI:18	flow index
PFI	PFI:32	progressionfree interval
PFM	PFM:8	peak flow meter
PFM	PFM:19	pelvic floor muscle
PFM	PFM:32	porcelainfusedtometal
PFOB	PFOB:15	perfluoroctylbromide
PFOB	PFOB:13	perfluorooctyl bromide
PFOB	PFOB:21	perfluorooctylbromide
PFOS	PFOS:31	perfluorooctane sulfonate
PFOS	PFOS:12	perfluorooctane sulfonic acid
PFOS	PFOS:25	perfluorooctanesulfonate
PFO	PFO:306	patent foramen ovale
PFO	PFO:9	perfluoronoctane
PFO	PFO:20|pfo:1	perfringolysin o
PFP	PFP:18	patellofemoral pain
PFP	PFP:12	pentafluoropropionyl
PFP	PFP:6|Pfp:5|pfp:3	perforin
PFP	PFP:9	peripheral facial palsy
PFP	PFP:21	plateletfree plasma
PFP	PFP:17|Pfp:1	poreforming protein
PFR	PFR:7	flow rates
PFR	PFR:14	paraflagellar rod
PFR	PFR:33	peak flow rate
PFR	PFR:9	plain film radiography
PFs	PFs:17|Pfs:1	parallel fibers
PFs	PFs:9	periplasmic flagella
PFS	PFS:9	piper fatigue scale
PFS	PFS:31	primary fibromyalgia syndrome
PFS	PFS:29	progressionfree
PFS	PFS:553	progressionfree survival
PFs	PFs:7	protection factors
PFS	PFS:14	pyrogenfree saline
PF	PF:5	 added poultry fat
PF	PF:11	effect was the prevented fraction
PF	PF:7	fracture face
PF	PF:4|Pf:4|pf:1	nucleus parafascicularis
PF	Pf:2|PF:2	nucleus parafascicularis thalami
Pf	Pf:5	osmotic water
Pf	Pf:11	osmotic water permeability coefficient
PF	PF:14	paeoniflorin
PF	PF:11|pf:1	pair fed
PF	PF:9	pancreatic fistula
Pf	Pf:17|PF:14	parafascicular nucleus
PF	PF:9	parafollicular
PF	PF:10	pars flaccida
PF	PF:19|P-F:1	patellofemoral
PF	PF:27	peak flow
PF	PF:17	peak force
PF	PF:11	peak frequency
PF	PF:11	permeability factor
PF	PF:9|Pf:1	photofrin
PF	PF:15	physical function
PF	PF:38	physical functioning
PF	PF:6	plasma fibrinogen
PF	PF:30|Pf:3	pleural fluid
PF	PF:30	posterior fossa
PF	PF:6	preterm formula
PF	PF:13	primary fibromyalgia
PF	PF:14	proflavine
PF	PF:14	proteinfree
PF	PF:11	protoplasmic face
PF	PF:8	protoplasmic fracture
PF	PF:38	pulmonary fibrosis
PF	PF:32	purkinje fibers
PF	PF:17	purpura fulminans
PGA	PGA:27	global assessment
PGA	PGA:35	penicillin g acylase
PGA	PGA:13	polyglandular autoimmune
PGA	PGA:8	polyglandular autoimmune syndrome
PGA	PGA:176|PgA:1	polyglycolic acid
PGA	PGA:23|PGa:1	polyglycolide
PGA	PGA:13	propylene glycol alginate
PGC	PGC:24|-PGC:2	glomerular capillary hydraulic pressure
pGC	pGC:5|PGC:1	particulate guanylate cyclase
pGC	pGC:6	particulate guanylyl cyclase
PGC	PGC:31	porous graphitic carbon
PGC	PGC:10	porous graphitized carbon
PGE	PGE:8	eseries prostaglandins
PGE	PGE:10	graphite electrode
PGE	PGE:20	primary generalized epilepsy
PGE	PGE:32|PgE:1	prostaglandins of the e series
PGFM	PGFM:14	dihydroketoprostaglandin f
PGFM	PGFM:6	prostaglandin f alpha metabolite
PGI2	PGI2:8	ketopgf alpha
PGI2	PGI2:14	prostacycline
PGI	PGI:8	patient generated index
PGI	PGI:26|PG-I:3|PgI:2	pepsinogen i
PGI	PGI:6|Pgi:2|pgi:1	phosphoglucoisomerase
PGI	PGI:77|pgi:7|Pgi:6	phosphoglucose isomerase
PGL	PGL:5	hereditary paraganglioma
PGL	PGL:92	persistent generalized lymphadenopathy
PGL	PGL:9	phenolic glycolipid
PGL	PGL:25	primary gastric lymphoma
PGM	PGM:16	gastric mucin
PGM	PGM:21	peptidoglycan monomer
PGN	PGN:78	peptidoglycan
PGN	PGN:10	perigeniculate
PGN	PGN:27	perigeniculate nucleus
PGN	PGN:24	proliferative glomerulonephritis
PGPH	PGPH:8	peptide hydrolyzing
PGPH	PGPH:7	peptidylglutamylpeptide hydrolyzing
P-gp	P-gp:7|Pgp:2	antipglycoprotein
P-gp	P-gp:8|Pgp:2	pglycoprotein 
PGP	PGP:7|PG-P:2	phosphatidylglycerophosphate
PGP	PGP:30	phosphoglycolate phosphatase
PGP	PGP:7|pgp:1	prepaid group practice
PGP	PGP:136	protein gene product
PGSE	PGSE:10|pgse:1	gradient spinecho
PGSE	PGSE:20	pulsed gradient spin echo
PGST	PGST:6|P-GST:1	placental glutathione stransferase
PGST	PGST:7	placental isozyme of glutathione stransferase
PGS	PGS:6	gelatin sponge
PGS	PGS:8	paraglottic space
PGs	PGs:19	polygalacturonases
PGS	PGS:9	prostaglandin synthase
PGs	PGs:23	prothoracic glands
PG	PG:13	isoprostaglandin
PG	PG:37	cartilage proteoglycan
PG	PG:9	glands
PG	PG:5	glomerular capillary hydrostatic pressure
PG	PG:10|Pg:1	panax ginseng
PG	PG:15	pancreatic glucagon
PG	PG:16	pancreaticogastrostomy
PG	PG:5	paracervical ganglia
PG	PG:7	parotid gland
PG	PG:19	pathological gambling
PG	PG:25	pemphigoid gestationis
PG	PG:43|Pg:9	pentagastrin
PG	PG:10	percutaneous gastrostomy
PG	PG:14	periglomerular
PG	PG:13	petrosal ganglion
PG	PG:6	phenolphthalein glucuronide
PG	PG:21	phosphatidyl glycerol
PG	PG:7	pigmentary glaucoma
PG	PG:11	placebo group
PG	PG:7|Pg:5	plakoglobin
PG	PG:127|pg:1	plasma glucose
PG	PG:72	polygalacturonase
PG	PG:5	polypoid growth
PG	PG:12	proguanil
PG	PG:45	propyl gallate
PG	PG:226	propylene glycol
PG	PG:3|pG:3	protein g
PG	PG:6	proximal gastrectomy
PG	PG:102	pyoderma gangrenosum
PG	PG:13	pyogenic granuloma
PG	PG:29	pyrolytic graphite
PG	PG:25	serum pepsinogen
PHAHs	PHAHs:9|pHAHs:1	planar halogenated aromatic hydrocarbons
PHAHs	PHAHs:23	polyhalogenated aromatic hydrocarbons
PHA-LCM	PHA-LCM:9	conditioned by leukocytes in the presence of phytohemagglutinin
PHA-LCM	PHA-LCM:5	medium conditioned by phytohemagglutininstimulated leukocytes
pHa	pHa:13	arterial blood ph
pHa	pHa:49	arterial ph
PHA	PHA:7	persistent primitive hypoglossal artery
PHA	PHA:15	phaseolus vulgaris
PHA	PHA:15	phaseolus vulgaris agglutinin
PHA	PHA:17	phytohaemagglutin
PHA	PHA:14	phytohaemaglutinin
PHA	PHA:12	phytohaemoagglutinin
PHA	PHA:43|pha:1	phytohemagglutin
PHA	PHA:40	phytohemaglutinin
PHA	PHA:11	phytohemoagglutinin
PHA	PHA:12	polybetahydroxyalkanoate
PHA	PHA:9|pHA:1	porous hydroxyapatite
PHA	PHA:13	posterior hypothalamic area
PHA	PHA:9	primary hyperaldosteronism
PHA	PHA:7	production of polyhydroxyalkanoates
PHA	PHA:6	proper hepatic artery
PHA	PHA:35	pseudohypoaldosteronism
PHB	PHB:17	polybetahydroxybutyric acid
PHB	PHB:84	polyhydroxybutyrate
PHCs	PHCs:14	health centers
PHCs	PHCs:6	primary health centres
PHC	PHC:521|phc:1	primary health care
PHC	PHC:7	primary health centers
PHC	PHC:14	primary health centre
PHC	PHC:11	primary healthcare
PHC	PHC:9	primary hepatic cancer
PHC	PHC:24	primary hepatic carcinoma
PHC	PHC:9	primary hepatocellular cancer
PHC	PHC:118	primary hepatocellular carcinoma
PHF	PHF:30	parathyroid hypertensive factor
PHF	PHF:13	potomac horse fever
PHF	PHF:8	precultured heart fragments
PHG	PHG:23	parahippocampal gyrus
PHG	PHG:63	portal hypertensive gastropathy
PHG	PHG:15	pulmonary hyalinizing granuloma
PHHI	PHHI:11	persistent hyperinsulinaemic hypoglycaemia of infancy
PHHI	PHHI:55	persistent hyperinsulinemic hypoglycemia of infancy
PHN	PHN:85|pHN:2	passive heymann nephritis
PHN	PHN:10	public health nurse
PHN	PHN:11	public health nursing
PHP	PHP:24	patients with pseudohypoparathyroidism
PHP	PHP:19	pyridoxalated hemoglobin polyoxyethylene conjugate
PHQ	PHQ:24	patient health questionnaire
PHQ	PHQ:16	phenylhydroquinone
PHS	PHS:12	pallisterhall syndrome
PHS	PHS:12	physicians health study
PHS	PHS:12	pooled human serum
PHS	PHS:7	prolene hernia system
PHS	PHS:158	public health service
PHS	PHS:34	pulmonary hypertension syndrome
PHT	PHT:6	passive haemagglutination test
PHT	PHT:21	portal hypertensive
PHT	PHT:6	postmenopausal hormone therapy
PHx	PHx:2	after a  partial hepatectomy
PHx	PHx:5	liver regeneration after partial hepatectomy
PIBF	PIBF:10	progesterone induced blocking factor
PIBF	PIBF:7	protein named the progesteroneinduced blocking factor
PIB	PIB:23	partial ileal bypass
PIB	PIB:16	polyisobutylene
PIB	PIB:14	propranololinduced bronchoconstriction
PICCs	PICCs:61	peripherally inserted central catheters
PICCs	PICCs:16	peripherally inserted central venous catheters
PICP	PICP:98|P-I-CP:1	carboxyterminal propeptide of type i procollagen
PICP	PICP:7	i carboxyterminal propeptide
PICP	PICP:8	procollagen i carboxyterminal propeptide
PICP	PICP:5	procollagen type i cterminal peptide
PICP	PICP:8	procollagen type i cterminal propeptide
PICP	PICP:4	procollagen type i carboxyterminal extension peptide
PICP	PICP:8	procollagen type i carboxyterminal propeptide
PICP	PICP:8	type i procollagen carboxyterminal propeptide
PICs	PICs:7	persistent inward currents
PICs	PICs:22	preintegration complexes
PIC	PIC:5	islet cells
PIC	PIC:10	paediatric intensive care
PIC	PIC:11	particleincell
PIC	PIC:25	personality inventory for children
PIC	PIC:34	phosphoinositidase c
PIC	PIC:91	polymorphism information content
PIC	PIC:39	preinitiation complex
PID	PID:6	phosphotyrosine interaction domain
PID	PID:9	photoionization detector
PID	PID:15|pid:2	postinoculation day
PID	PID:6	preimplantation diagnosis
PID	PID:11	primary immunodeficiencies
PID	PID:8	primary immunodeficiency diseases
PID	PID:34	proportionalintegralderivative
PIE	PIE:59	positive inotropic effect
PIE	PIE:10	pulmonary infiltration with eosinophilia
PIE	PIE:43	pulmonary interstitial emphysema
PIF	PIF:52	peak inspiratory flow
PIF	PIF:15	prolactin inhibiting factor
PIF	PIF:8	pulmonary interstitial fibrosis
PIH	PIH:7	postinjection hours
PIH	PIH:7	postinoculation hour
PIH	PIH:363	pregnancyinduced hypertension
PIH	PIH:53	pyridoxal isonicotinoyl hydrazone
PIIINP	PIIINP:35	aminoterminal propeptide of type iii procollagen
PIIINP	PIIINP:7|P-III-NP:1	aminoterminal propeptide
PIIINP	PIIINP:4|PII-INP:1	procollagen iii peptide
PIIINP	PIIINP:8	procollagen type iii aminoterminal peptide
PIIINP	PIIINP:9|P-III-NP:2	propeptide of procollagen type iii
PIIINP	PIIINP:12	propeptide of type iii collagen
PIIIP	PIIIP:10|P-III-P:2	procollagen type iii
PIIIP	PIIIP:11|P-III-P:9	type iii procollagen peptide
PIL	PIL:10	patient information leaflet
PIL	PIL:7	purpose in life test
PIMs	PIMs:10	phosphatidylinositol mannosides
PIMs	PIMs:51|PIMS:2	pulmonary intravascular macrophages
PINP	PINP:14	procollagen type i nterminal propeptide
PINP	PINP:29	propeptide of type i procollagen
PINP	PINP:5	type i procollagen aminoterminal propeptide
PIN	PIN:23	posterior interosseous nerve
PIN	PIN:9	posterior intralaminar nucleus
PIN	PIN:375	prostatic intraepithelial neoplasia
PIOL	PIOL:12	phakic intraocular lens
PIOL	PIOL:15	primary intraocular lymphoma
PI-PLC	PI-PLC:283|PIPLC:73|PiPLC:1|piPLC:1	phosphatidylinositolspecific phospholipase c
PI-PLC	PI-PLC:4|PIPLC:1	phosphatidylinositolspecific plc
PIP	PIP:5	carboxyterminal propeptide of procollagen type i
PIP	PIP:10	peak inflation pressures
PIP	PIP:10|PI-P:1	phosphatidylinositol monophosphate
PIP	PIP:7	prevention of immune precipitation
PIP	PIP:14	prolactininducible protein
PIP	PIP:9	prostatic inhibin peptide
PIP	PIP:197	proximal interphalangeal
PIR	PIR:10|Pir:1	piracetam
PIR	PIR:15	postinhibitory rebound
PIR	PIR:16	protein information resource
PISF	PISF:7	periimplant sulcular fluid
PISF	PISF:6	periimplant sulcus fluid
PITC	PITC:14	phenyl isothiocyanate
PITC	PITC:37	phenylisothiocyanate
PIT	PIT:15	pancreatic islet transplantation
PIT	PIT:20|pit:7	pituitary
PIT	PIT:12	plasma iron turnover
PIT	PIT:9	tosylate
PIV	PIV:47	particle image velocimetry
PIV	PIV:13	pulsatility index for veins
PIXE	PIXE:141	xray emission
PIXE	PIXE:10	xray emission analysis
PKCs	PKCs:19	protein kinases c
PKCs	PKCs:25	protein kinase cs
PKD1	PKD1:7	polycystic kidney disease  gene
PKD1	PKD1:6|Pkd1:1	polycystic kidney disease gene
PKD	PKD:21	paroxysmal kinesigenic dyskinesia
PKD	PKD:76	protein kinase d
PKI	PKI:2	inhibitor of the campdependent protein kinase
PKI	PKI:9	public key infrastructure
PKR	PKR:48	doublestranded rnaactivated protein kinase
PKR	PKR:53|pkr:1	doublestranded rnadependent protein kinase
PKR	PKR:51	protein kinase r
PKU	PKU:876	phenylketonuria
PKU	PKU:35	phenylketonuric
PK	PK:11	k permeability
PK	PK:9	perilla ketone
PK	PK:6	plasma potassium
PK	PK:6	plasma potassium concentration
PK	PK:9	potassium permeability
PK	PK:38	proteinase k
PK	PK:7	serum pyruvatekinase
PLB	PLB:9	breathing
PLB	PLB:6	percutaneous liver biopsy
PLB	PLB:19	phospholipase b
PLB	PLB:20	primary lymphoma of bone
PLC	PLC:5	lung centroid pressure
PLC	PLC:7	pathological laughing and crying
PLC	PLC:6	peripheral lymphocyte count
PLC	PLC:9	pigmented lesion clinic
PLC	PLC:11	pityriasis lichenoides chronica
PLC	PLC:5	prelysosomal compartment
PLC	PLC:162	primary liver cancer
PLC	PLC:24	primary liver carcinoma
PLC	PLC:39	propionyllcarnitine
PLDR	PLDR:9	potentially lethal damage recovery
PLDR	PLDR:39	potentially lethal damage repair
PLD	PLD:9	partial lipodystrophy
PLD	PLD:30	pegylated liposomal doxorubicin
PLD	PLD:9	pulsed laser deposition
PLE	PLE:13	liver esterase
PLE	PLE:14	paraneoplastic limbic encephalitis
PLE	PLE:16	pressurised liquid extraction
PLE	PLE:40	pressurized liquid extraction
PLE	PLE:38	proteinlosing enteropathy
PLF	PLF:31	perilymphatic fistula
PLF	PLF:13	peritoneal lavage fluid
PLF	PLF:20	placental isoferritin
PLF	PLF:11	posterolateral fusion
PLF	PLF:19	proliferin
PLGA	PLGA:12	polyllactidecoglycolide
PLGA	PLGA:30	polymorphous lowgrade adenocarcinoma
PLG	PLG:1	coglycolide
PLG	PLG:24	lprolyllleucylglycinamide
PLG	PLG:24	prolylleucylglycinamide
PLL	PLL:31	posterior longitudinal ligament
PLL	PLL:77	prolymphocytic leukemia
PLMs	PLMs:12|PLMS:4	periodic leg movements
PLMS	PLMS:21	periodic leg movements in sleep
PLMs	PLMs:10|PLMS:2	periodic limb movements
PLMS	PLMS:33	periodic limb movements in sleep
PLM	PLM:9	percent labeled mitoses
PLM	PLM:5	percentage labelled mitoses
PLM	PLM:28|Plm:1	phospholemman
PLM	PLM:11	phospholipomannan
PLM	PLM:21	polarized light microscopy
PLP	PLP:10	myelin proteolipid
PLP	PLP:150|Plp:4	myelin proteolipid protein
PLP	PLP:10	parathyroid hormonelike peptide
PLP	PLP:36	periodatelysineparaformaldehyde
PLP	PLP:21	phantom limb pain
PLP	PLP:22	plasma pyridoxalphosphate
PLP	PLP:16	proteolipid apoprotein
PLP	PLP:24|Plp:1	proteolipid protein gene
PLRV	PLRV:17	potato leafroll luteovirus
PLRV	PLRV:53	potato leafroll virus
PLS	PLS:59|PLs:1	papillonlefevre syndrome
PLS	PLS:11	perpendicular light scatter
PLS	PLS:46	primary lateral sclerosis
PLS	PLS:15	projections to latent structures
PLS	PLS:14	prostaglandinlike substances
PLT	PLT:10	pancreolauryl test
PLT	PLT:126|Plt:14|plt:6	platelet
PLT	PLT:10	posterolateral thoracotomy
PLT	PLT:32	primed lymphocyte test
PLT	PLT:9	primed lymphocyte testing
PLT	PLT:62	primed lymphocyte typing
PLV	PLV:5|Plv:1	lv pressure
PLV	PLV:60	partial left ventriculectomy
PLV	PLV:156	partial liquid ventilation
PLZF	PLZF:23	promyelocytic leukemia zinc finger
PLZF	PLZF:7	promyelocytic leukemia zinc finger protein
PL	PL:7|Pl:1	lateral pulvinar
PL	PL:6|pl:4|pL:2	leftward promoter
PL	PL:22	pancreatic lipase
PL	PL:21	perilymph
PL	PL:10	perivitelline layer
PL	PL:26	peroneus longus
PL	PL:41	persistent lymphocytosis
PL	PL:66	photoluminescence
PL	PL:194|pl:43|Pl:4	placebo
PL	PL:97	placental lactogen
PL	PL:17|pl:1	plasmin
PL	PL:29|pl:1	polyllysine
PL	PL:21|pl:3|P-L:1	posterolateral
PL	PL:10	poultry litter
PL	PL:39	preferential looking
PL	PL:18|pl:2	prelimbic
PM10	PM10:11	inhalable particles
PM10	PM10:12	particles with a  cutoff aerodynamic diameter of  microm
PM10	PM10:8	particulate air pollution
PM10	PM10:5	particulate matter less than  microm in aerodynamic diameter
PM10	PM10:1	particulate matter of less than  microm in diameter
PM10	PM10:9	particulate pollution
PM2.5	PM2.5:1	 microm aerodynamic diameter
PM2.5	PM2.5:7	aerodynamic diameter less than  microm
PM2.5	PM2.5:7|PM-2.5:1	aerodynamic diameter less than or equal to  microm
PM2.5	PM2.5:5	less than  microns in aerodynamic diameter
PMA	PMA:21	 betaphorbolmyristateacetate
PMA	PMA:11|p-MA:1	pmethoxyamphetamine
PMA	PMA:12	phorbol myristate
PMA	PMA:21	phorbol myristic acid
PMA	PMA:16	phorbolester
PMA	PMA:47	postmenstrual age
PMA	PMA:6	premenstrual asthma
PMA	PMA:9	protein kinase c activator
PMCA	PMCA:16|Pmca:1	plasma membrane calcium atpase
PMCA	PMCA:20	plasma membrane calcium pump
PMCA	PMCA:9	protein misfolding cyclic amplification
PMCT	PMCT:37	percutaneous microwave coagulation therapy
PMCT	PMCT:10	postmortem computed tomography
PMC	PMC:10	papillary microcarcinoma
PMC	PMC:20	percutaneous mitral commissurotomy
PMC	PMC:48	peritoneal mast cells
PMC	PMC:20	pharmacokinetic modulating chemotherapy
PMC	PMC:21	pontine micturition center
PMC	PMC:9|pmc:1	primary mesenchyme cell
PMC	PMC:68	pseudomembranous colitis
PMC	PMC:6	rat peritoneal mc
PMd	PMd:10	dorsal premotor
PMd	PMd:7|PMD:2	dorsal premotor area
PMd	PMd:32|PMD:1	dorsal premotor cortex
PMD	PMD:91	pelizaeusmerzbacher disease
PMD	PMD:8	pellucid marginal degeneration
PMD	PMD:17	piecemeal degranulation
PMD	PMD:13	polarization mode dispersion
PMD	PMD:25	progressive muscular dystrophy
PMEA	PMEA:17	phosphonomethoxyethyladenine
PMEA	PMEA:6	phosphonomethoxyethyl adenine
PMEs	PMEs:17	phosphomonoesters
PMEs	PMEs:9	progressive myoclonus epilepsies
PME	PME:14	particle mesh ewald
PME	PME:12|pme:1	pectin methyl esterase
PME	PME:49|pme:1	pectin methylesterase
PME	PME:9	pectinmethylesterase
PME	PME:9	phosphatidylmonomethylethanolamine
PME	PME:17	progressive myoclonic epilepsy
PMF	PMF:39	peptide mass fingerprinting
PMF	PMF:15	positive matrix factorization
PMF	PMF:18|pmf:2	potential of mean force
PMF	PMF:21	primary myelofibrosis
PMF	PMF:53	progressive massive fibrosis
PMF	PMF:24|pmf:18	proton motive force
PMF	PMF:13	pulsed magnetic fields
pMHC	pMHC:12|P-MHC:1|p-MHC:1	peptidemajor histocompatibility complex
pMHC	pMHC:13	peptidemhc
PMH	PMH:23	princess margaret hospital
PMH	PMH:7	pure motor hemiparesis
PMI	PMI:12	pain management index
PMI	PMI:55	perioperative myocardial infarction
PMI	PMI:39|pmi:2	phosphomannose isomerase
PMI	PMI:68|pmi:1	postmortem interval
PMLS	PMLS:21	posteromedial lateral suprasylvian
PMLS	PMLS:14	posteromedial lateral suprasylvian area
PML	PML:2	fasting and postmethionine load
PML	PML:26	paramedian lobule
PML	PML:13	posterior mitral leaflet
PML	PML:35	progressive multifocal leucoencephalopathy
PML	PML:525	progressive multifocal leukoencephalopathy
PML	PML:135	promyelocytic leukemia
PML	PML:12	promyelocytic leukemia gene
PML	PML:75	promyelocytic leukemia protein
PMMA	PMMA:9	bone cement
PMMA	PMMA:19	polymethylmetacrylate
PMM	PMM:26	pentamethylmelamine
PMM	PMM:34|Pmm:1|pmm:1	phosphomannomutase
PMM	PMM:9	prevention of maternal mortality
PMNL	PMNL:14	granulocytes
PMNL	PMNL:15	neutrophil
PMNs	PMNs:12	phrenic motoneurons
PMNs	PMNs:53	polymorphonuclear granulocytes
PMNs	PMNs:12	polymorphonuclear neutrophil granulocytes
PMN	PMN:55	human polymorphonuclear
PMN	PMN:6	polymorphonuclear cell count
PMN	PMN:17	polymorphonuclear neutrophilic granulocytes
PMO	PMO:9	phosphorodiamidate morpholino oligomers
PMO	PMO:17	postmenopausal osteoporosis
PMP22	PMP22:8|PMP-22:2	peripheral myelin protein
PMP22	PMP22:11|Pmp22:1|PMP-22:1	peripheral myelin protein  gene
PMPs	PMPs:19	patient management problems
PMPs	PMPs:23	peroxisomal membrane proteins
PMP	PMP:21	phenylmethylpyrazolone
PMP	PMP:10|Pmp:1	peroxisomal membrane protein
PMP	PMP:4	plasma membrane potential
PMP	PMP:34	pseudomyxoma peritonei
PMP	PMP:11	pyridoxamine phosphate
PMR	PMR:7	palmomental reflex
PMR	PMR:5	percutaneous myocardial laser revascularization
PMR	PMR:302	polymyalgia rheumatica
PMR	PMR:26	progressive muscle relaxation
PMR	PMR:42|pmr:4	proton magnetic resonance
PMS	PMS:4	iu pregnant mares serum gonadotrophin
PMS	PMS:13	periodic movements in sleep
PMS	PMS:7	personal medical services
PMS	PMS:86	phenazine methosulfate
PMS	PMS:28	phenazine methosulphate
PMs	PMs:10	plasma membranes
PMs	PMs:24	poor metabolisers
PMs	PMs:124	poor metabolizers
PMS	PMS:8	premenstrual symptoms
PM	PM:5|pm:1	intrapulmonary metastasis
PM	PM:11	medial pulvinar
PM	PM:9	palatal myoclonus
PM	PM:9	partial mole
PM	PM:12|Pm:3	pasteurella multocida
PM	PM:41	patients with polymyositis
PM	PM:45|Pm:1	pectoralis major
PM	PM:8	perfect match
PM	PM:9	periodontal mechanosensitive
PM	PM:5	peritoneal mesothelioma
PM	PM:20	peritrophic matrix
PM	PM:8	placental malaria
PM	PM:7	pleural mesothelioma
PM	PM:10|P-M:1	ponsmedulla
PM	PM:17	postmenopausal
PM	PM:7	prediction model
PM	PM:18	premotor
PM	PM:16|pM:1	prophylactic mastectomy
PM	PM:18	prospective memory
PM	PM:18|pm:1	psoas major
PM	PM:10	psychological mindedness
PM	PM:25	pulmonary macrophages
PM	PM:14	pulmonary metastases
PM	PM:5	pyogenic meningitis
PM	PM:38	pyridoxamine
PNAd	PNAd:9	peripheral lymph node addressin
PNAd	PNAd:20	peripheral node addressin
PnC	PnC:17|PNC:1	caudal pontine reticular nucleus
PnC	PnC:8	pneumococcal cpolysaccharide
PNC	PNC:13	prenatal care
PNC	PNC:9	purine nucleotide cycle
PND	PND:5	nipple discharge
PND	PND:7	phrenic nerve discharge
PND	PND:28	postnatal depression
PND	PND:37	principal neutralizing determinant
PND	PND:20	principal neutralizing domain
PNE	PNE:13	nerve evaluation
PNE	PNE:52|P-NE:4|pNE:3|PNe:2	plasma norepinephrine
PNE	PNE:37	primary nocturnal enuresis
PNE	PNE:10	pulmonary neuroendocrine
PNF	PNF:21	prednisolone farnesylate
PNF	PNF:29	proprioceptive neuromuscular facilitation
PNH	PNH:203	paroxysmal nocturnal haemoglobinuria
PNH	PNH:514	paroxysmal nocturnal hemoglobinuria
PNH	PNH:15	periventricular nodular heterotopia
PNI	PNI:9	field of psychoneuroimmunology
PNI	PNI:14	nerve injury
PNI	PNI:39|pni:1	perineural invasion
PNI	PNI:29	prognostic nutritional index
PNI	PNI:21	protease nexin i
PNPase	PNPase:82|PNP-ase:1	polynucleotide phosphorylase
PNPase	PNPase:20	purine nucleoside phosphorylase
PNs	PNs:11	cc propriospinal neurones
PNS	PNS:13|Pns:1|PnS:1	panax notoginseng saponins
PNS	PNS:13	paraneoplastic neurological syndromes
PNS	PNS:8	perineural spread
PNs	PNs:12	perineuronal nets
PNs	PNs:6	persistent nodules
PNS	PNS:16	primary nephrotic syndrome
PNs	PNs:29	projection neurons
PNs	PNs:13	purkinje neurons
PNS	PNS:8|PnS:1	saponins of panax notoginseng
PNU	PNU:13	npropylnnitrosourea
PNU	PNU:7|pnu:1	protein nitrogen units
PNA	PNA:84	arachis hypogaea
PNa	PNa:9	na permeability
PNA	PNA:16	nitrogen appearance
pNA	pNA:12|PNA:6|p-NA:2	pnitroaniline
PNA	PNA:721	peanut agglutinin
PNA	PNA:40	phrenic nerve activity
PNA	PNA:17|pNA:2|P-NA:1	plasma noradrenaline
pNA	pNA:7|PNA:6|P-NA:1	plasma noradrenaline concentration
PNa	PNa:7|P-Na:1|pNa:1	plasma sodium
PNa	PNa:11|pNa:3	plasma sodium concentration
PNA	PNA:6	polynitroxyl albumin
PNA	PNA:19	postnatal age
PN	PN:5	cerebellar purkinje neurons
Pn	Pn:10|PN:1	net photosynthesis
Pn	Pn:13|PN:1	net photosynthetic rate
Pn	Pn:7|PN:2	pacemaker nucleus
PN	PN:10	palmerston north
PN	PN:19	papillary or nodular
PN	PN:15	parenteral nutrient
PN	PN:8	partial nephrectomy
PN	PN:15	partner notification
PN	PN:4	peripheral lymph nodes
PN	PN:85	peripheral nerve
PN	PN:9	peripheral neuroepithelioma
PN	PN:6|P-N:3	phosphoramidate
PN	PN:28	phrenic nerve
PN	PN:30|Pn:1	pontine nuclei
PN	PN:10	pontine nucleus
PN	PN:73|pn:5|Pn:1	postnatal
PN	PN:24	processing negativity
PN	PN:15	pronuclear
PN	PN:19	pronuclei
PN	PN:19	pronucleus
PN	PN:6	pulp necrosis
PN	PN:6	purkinje neuron
PN	PN:27	pyelonephritis
Pn	Pn:8	streptococcus pneumoniae ra
PO/AH	PO/AH:12	preopticanterior hypothalamic
PO/AH	PO/AH:4	preoptic anterior hypothalamus
PO/AH	PO/AH:9	preoptic area and anterior hypothalamus
PO2	PO2:18|pO2:4|Po2:2	partial pressure of o
PO2	PO2:4|pO2:2	tissue oxygenation
POC	POC:23	particulate organic carbon
POC	POC:6	peroperative cholangiography
POC	POC:14	products of conception
POE	POE:19	physician order entry
POE	POE:27	polyoxyethylene
POF	POF:13	ossifying fibroma
POF	POF:220	premature ovarian failure
POH	POH:32	perillyl alcohol
POH	POH:5	pressure overload hypertrophy
POI	POI:15	personal orientation inventory
POI	POI:15	postoperative ileus
POM	POM:10	nucleus preopticus medialis
POM	POM:14	particulate organic matter
POM	POM:9	pivaloyloxymethyl
POM	POM:8	polycyclic organic matter
POM	POM:15	purulent otitis media
PON1	PON1:37	human serum paraoxonase
PON1	PON1:9|Pon1:1	paraoxonase gene
PON	PON:12	preoptic nucleus
PON	PON:7	pretectal olivary nucleus
POPC	POPC:10	palmitoyloleoylsnglycerophosphatidylcholine
POPC	POPC:8	membranes composed of palmitoyloleoylsnglycerophosphocholine
POPC	POPC:9	palmitoyloleoyl phosphatidylcholine
POP-Q	POP-Q:10|POPQ:8	pelvic organ prolapse quantification
POP-Q	POP-Q:5|POPQ:4	pelvic organ prolapse quantification system
POPs	POPs:173	persistent organic pollutants
POPs	POPs:5	progestinonly pills
POP	POP:22	pelvic organ prolapse
POP	POP:10	persistent organic pollutant
POP	POP:14|PoP:2	plaster of paris
POP	POP:6	progestogenonly pill
POP	POP:16|Pop:1	prolyl oligopeptidase
PORT	PORT:41	patient outcomes research team
PORT	PORT:10|PoRT:1	postoperative radiotherapy
POR	POR:20	nadphprotochlorophyllide oxidoreductase
POR	POR:9|Por:1	porfiromycin
POTS	POTS:24	postural orthostatic tachycardia syndrome
POTS	POTS:43	postural tachycardia syndrome
POW	POW:9	powassan
POW	POW:8	prisoner of war
PP1C	PP1C:4|PP1c:3	catalytic subunit of pp
PP1C	PP-1c:2|PP1C:2|PP1c:1|PP-1C:1	catalytic subunit of protein phosphatase
PP1	PP1:8	aminomethylphenyltbutylpyrazolodpyrimidine
PP1	PP1:29|PP-1:2	type  protein phosphatase
PP2Ac	PP2Ac:5|PP2A-C:1|PP2AC:1	catalytic subunit of ppa
PP2Ac	PP2Ac:11|PP2AC:1	catalytic subunit of protein phosphatase a
PPC	PPC:10|ppc:1	peak plasma concentration
PPC	PPC:10	phenprocoumon
PPC	PPC:26	polyenylphosphatidylcholine
PPC	PPC:10	posterior parietal
PPC	PPC:100	posterior parietal cortex
PPC	PPC:9	primary peritoneal carcinoma
PPC	PPC:14	pushpull cannula
PPDK	PPDK:14|PPdK:1	pyruvate orthophosphate dikinase
PPDK	PPDK:26	pyruvate phosphate dikinase
PPD	PPD:20	pocket probing depth
PPD	PPD:6	postpartum day
PPD	PPD:46	postpartum depression
PPD	PPD:35|ppd:4	proximal pars distalis
PPD	PPD:3	purified protein derivative from tuberculin
PPD	PPD:14	purified protein derivative of mycobacterium tuberculosis
PPD	PPD:9	tuberculin skin test
PPE	PPE:17	palmarplantar erythrodysesthesia
PPE	PPE:62	personal protective equipment
PPE	PPE:28	plasma protein extravasation
PPE	PPE:96	porcine pancreatic elastase
PPE	PPE:6	preparticipation physical examination
PPE	PPE:9	pruritic papular eruption
PPF	PPF:129|ppf:1	pairedpulse facilitation
PPF	PPF:13	papillary plasma flow
PPF	PPF:14	periportal fibrosis
PPF	PPF:44	photosynthetic photon flux
PPF	PPF:5	plasmapolymerized film
PPF	PPF:27	plasma protein fraction
PPF	PPF:15|ppf:1	propentofylline
PPF	PPF:7	proplatelet formation
PPF	PPF:9	pterygopalatine fossa
PPG	PPG:12	photoplethysmograph
PPG	PPG:19	photoplethysmographic
PPG	PPG:69	photoplethysmography
PPG	PPG:8	postprandial glucose
PPG	PPG:11	postprandial plasma glucose
PPG	PPG:10|PpG:1	pterygopalatine ganglion
PPG	PPG:26	pyloruspreserving gastrectomy
PPHN	PPHN:37	persistent pulmonary hypertension
PPHN	PPHN:10	persistent pulmonary hypertension of the neonate
PPHN	PPHN:151	persistent pulmonary hypertension of the newborn
PPIs	PPIs:16	patient package inserts
PPIs	PPIs:10	polyphosphoinositides
PPIs	PPIs:221	proton pump inhibitors
PPK	PPK:33|ppk:8|Ppk:1	polyphosphate kinase
PPK	PPK:11	population pharmacokinetic
PPL	PPL:10	penicilloylpolylysine
PPL	PPL:14|pPL:1	porcine pancreatic lipase
PPL	PPL:10	posterior probability of linkage
PPL	PPL:6	purified phospholipids
PPMS	PPMS:21|PP-MS:3	primary progressive ms
PPMS	PPMS:37|PP-MS:2	primary progressive multiple sclerosis
PPN	PPN:9	pedunculopontine
PPN	PPN:61	pedunculopontine nucleus
PPN	PPN:20	peripheral parenteral nutrition
PPO	PPO:14	diphenyloxazole
PPO	PPO:22	peak power output
PPO	PPO:35|P-PO:1	platelet peroxidase
PPO	PPO:90	polyphenol oxidase
PPO	PPO:14	polyphenoloxidase
PPO	PPO:54	preferred provider organization
PPPD	PPPD:27|PpPD:1	pyloruspreserving pancreaticoduodenectomy
PPPD	PPPD:35|PpPD:6	pyloruspreserving pancreatoduodenectomy
PPP	PPP:9	palatopharyngoplasty
PPP	PPP:53	palmoplantar pustulosis
PPP	PPP:96|ppp:1	pentose phosphate pathway
PPP	PPP:6	plasma proteome project
PPP	PPP:56	platelet poor plasma
PPP	PPP:39	polyphloretin phosphate
PPP	PPP:13	primary proliferative polycythaemia
PPP	PPP:8	pulmonary perfusion pressure
PPP	PPP:16	pushpull perfusion
PPP	PPP:44	pustulosis palmaris et plantaris
PPP	PPP:14	pustulosis palmoplantaris
PPRE	PPRE:29	peroxisome proliferator response element
PPRE	PPRE:17	ppar response element
PPR	PPR:7	averaged photopalpebral reflex
PPR	PPR:9	pairedpulse ratio
PPR	PPR:13	patientpractitionerremedy
PPR	PPR:12	pentatricopeptide repeat
PPR	PPR:57	peste des petits ruminants
PPR	PPR:6	pthpthrp receptor
PPS	PPS:15	parapharyngeal space
PPS	PPS:11	pentosan polysulfate sodium
PPS	PPS:9	pentose phosphate shunt
PPS	PPS:5	perforant path stimulation
PPS	PPS:6	peripheral pulmonary stenosis
PPs	PPs:77	peroxisome proliferators
PPs	PPs:58|Pps:3	peyers patches
PPS	PPS:16	postpericardiotomy syndrome
PPS	PPS:8	preputial separation
PPS	PPS:282	prospective payment system
PPs	PPs:15	slow waves or pacesetter potentials
PPT	PPT:6	paw pressure threshold
PPT	PPT:15	pedunculopontine tegmental
PPT	PPT:13	pedunculopontine tegmentum
PPT	PPT:18	phosphinothricin
PPT	PPT:29	physical performance test
PPT	PPT:6	platelet production time
PPT	PPT:67|ppt:2	polypurine tract
PPT	PPT:88	preprotachykinin
PPT	PPT:8	propyl pyrazole triol
PPV	PPV:10|ppv:1	paroxysmal positional vertigo
PPV	PPV:151|ppV:4|ppv:1	pars plana vitrectomy
PPV	PPV:12	patent processus vaginalis
PPV	PPV:6	phakomatosis pigmentovascularis
PPV	PPV:6	phobic postural vertigo
PPV	PPV:31	plum pox potyvirus
PPV	PPV:84	plum pox virus
PPV	PPV:24	pneumococcal polysaccharide vaccine
PPV	PPV:146	porcine parvovirus
PPB	PPB:13	permanent prostate brachytherapy
PPB	PPB:26	pleuropulmonary blastoma
PPB	PPB:22	positive pressure breathing
PPI	PPI:9	pairedpulse index
PPI	PPI:8	patient package insert
PPI	PPI:5	peptidyl prolyl cistrans isomerase
PPI	PPI:6	postpartum interval
PPI	PPI:8|ppI:3	preproinsulin
PPI	PPI:450|ppi:1	prepulse inhibition
PPI	PPI:11	prepulse inhibition of acoustic startle
PPI	PPI:33	present pain intensity
PPI	PPI:7	proteinprotein interaction
PPI	PPI:8	psychopathic personality inventory
PPI	PPI:7	pulse polio immunization
PPI	PPI:13	purified pork insulin
PP	PP:10	pacesetter potentials
PP	PP:11|pp:1	pairedpulse
PP	PP:952|pp:3	pancreatic polypeptide
PP	PP:7	parkinsonian patients
PP	PP:7	particulate p
PP	PP:8	particulate phosphorus
PP	PP:32	peak power
PP	PP:19	pentose phosphate
PP	PP:6|pp:1	percent positivity
PP	PP:66|pp:2	perforant path
PP	PP:12|pp:3	perforant pathway
PP	PP:5	peripeduncular nucleus
PP	PP:38|pp:6|Pp:1	periportal
PP	PP:6	plasma perfusion
PP	PP:11	pleural plaques
PP	PP:46|Pp:2	pneumoperitoneum
PP	PP:114|pp:1	polypropylene
PP	PP:33	posterior pituitary
PP	PP:6	posterior pretectal nucleus
PP	PP:63|pp:34	postpartum
PP	PP:22|pp:9	postprandial
PP	PP:9	precautionary principle
PP	PP:23	precocious pubarche
PP	PP:11	premature pubarche
PP	PP:6	preparatory period
PP	PP:11	prepubertal periodontitis
PP	PP:49	primary progressive
PP	PP:9	prone position
PP	PP:8	proteose peptone
PP	PP:47	protoporphyrin
PP	PP:7	pulsatile perfusion
PP	PP:14|pp:1|P-P:1	pulse
PP	PP:309|Pp:2	pulse pressure
PP	PP:10	pulsus paradoxus
PQ	PQ:16	phenanthrenequinone
PQ	PQ:24	plastoquinone
PQ	PQ:40	primaquine
PR8	PR8:8	apuerto rico
PR8	PR8:6|PR-8:1	influenza virus apr
PRA	PRA:11	participatory rural appraisal
PRA	PRA:5	pcrrestriction enzyme analysis
PRA	PRA:10	plaque reduction assay
pRb	pRb:5|pRB:1	p and retinoblastoma
pRb	pRb:7|pRB:4	product of the retinoblastoma gene
pRb	pRb:4|pRB:2	product of the retinoblastoma tumor suppressor gene
PRC	PRC:13	packed red cells
PRC	PRC:48	peoples republic of china
PRC	PRC:13	plasma renin concentrations
PRC	PRC:11	proximal row carpectomy
PRC	PRC:9	response curves
PRE	PRE:9	photoreactivating enzyme
PRE	PRE:9	positive regulatory element
PRE	PRE:10	posttranscriptional regulatory element
PRE	PRE:9	progressive resistance exercise
PRE	PRE:11	relaxation enhancement
PRF	PRF:9	partial reinforcement
PRF	PRF:8	personality research form
PRF	PRF:44|pRF:12	pontine reticular formation
PRF	PRF:16	prolactinreleasing factor
PRF	PRF:20	proton resonance frequency
PRF	PRF:26|prf:1	pulse repetition frequency
PRG	PRG:8	pontine respiratory group
PRG	PRG:8	prolinerich glycoprotein
PRINS	PRINS:50	primed in situ labeling
PRINS	PRINS:29	primed in situ labelling
PRINS	PRINS:7	situ dna synthesis
PRISM	PRISM:74	pediatric risk of mortality
PRISM	PRISM:6	pediatric risk of mortality score
PRKO	PRKO:12	pr knockout
PRKO	PRKO:16	progesterone receptor knockout
PRK	PRK:204	excimer laser photorefractive keratectomy
PRK	PRK:34	phosphoribulokinase
PRK	PRK:8|pRK:1	primary rabbit kidney
PRL	PRL:13	photoreactivating light
PRL	PRL:14	preferred retinal locus
PRL	PRL:8	prolactin levels
PRM	PRM:9	particle repositioning maneuver
PRM	PRM:42	primidone
PRN	PRN:9|prn:4	asneeded
PRN	PRN:29	paramedian reticular nucleus
PRN	PRN:27	plaque reduction neutralization
PRN	PRN:1	practice and research network
PRN	PRN:8|prn:7	pro re nata
PROM	PROM:31	passive range of motion
PROM	PROM:8	premature rupture of membrane
PRP-T	PRP-T:1	conjugated with tetanus toxoid
PRP-T	PRP-T:22	toxoid conjugate
PRP	PRP:10	haemophilus influenzae type b capsular polysaccharide
PRP	PRP:7	pacaprelated peptide
PRP	PRP:73	panretinal photocoagulation
PRP	PRP:17	penicillinresistant pneumococci
PRP	PRP:34	pityriasis rubra pilaris
PRP	PRP:15	polyribosyl ribitol phosphate
PRP	PRP:30	polyribosylribitol phosphate
PRP	PRP:9	polyribosylribitolphosphate
PRP	PRP:39	primary raynauds phenomenon
PRP	PRP:31	prolinerich polypeptide
PRP	PRP:29	psychological refractory period
PRP	PRP:10	pulmonary rehabilitation program
PRQ	PRQ:10	personal resource questionnaire
PRQ	PRQ:6	pressurerate quotient
PRR	PRR:12	parietal reach region
PRR	PRR:11	pattern recognition receptors
PRR	PRR:14	postreplication repair
PRR	PRR:21	prolinerich region
PRR	PRR:10	water proton relaxation rate
PRSS1	PRSS1:23	cationic trypsinogen
PRSS1	PRSS1:11	cationic trypsinogen gene
PRS	PRS:7	parryromberg syndrome
PRs	PRs:26	partial remissions
PRs	PRs:195|PRS:1	partial responses
PRS	PRS:8	phosphoribosylpyrophosphate synthetase
PRS	PRS:13	photon radiosurgery system
PRS	PRS:15	pierre robin sequence
PRS	PRS:36	plasma renin substrate
PRS	PRS:7	postreperfusion syndrome
PRS	PRS:7	postribosomal supernatant
PRs	PRs:138|prs:1	pregnancy rates
PRs	PRs:11	proteases
PRTH	PRTH:8	pituitary resistance
PRTH	PRTH:11	pituitary resistance to thyroid hormone
PRT	PRT:43	photoradiation therapy
PRT	PRT:12	plasma recalcification time
PRT	PRT:19	progressive resistance training
PRT	PRT:9	proton radiation therapy
PrV	PrV:16	nucleus principalis
PrV	PrV:8	principal sensory nucleus
PR	PR:22	expression of pathogenesisrelated
PR	PR:9	paeoniae radix
PR	PR:9	pain relief
PR	PR:7	panoramic radiography
PR	PR:9	pars recta
PR	PR:9	partial regression
PR	PR:26	partial responders
PR	PR:8	passive recovery
PR	PR:9	pattern recognition
PR	PR:9|pr:2	pattern reversal
PR	PR:9	perirenal
PR	PR:17	phenol red
PR	PR:20	photoreactivation
PR	PR:25	pityriasis rosea
PR	PR:5	placental restriction
PR	PR:9	plain radiography
PR	PR:10	plaque reduction
PR	PR:9	pneumatic retinopexy
PR	PR:15	polymorphic reticulosis
Pr	Pr:8|PR:2	prealbumin
Pr	Pr:6|PR:3	pregnant
PR	PR:94	progressive ratio
PR	PR:33	projection reconstruction
PR	PR:10|pr:1	proliferative retinopathy
PR	PR:10|pr:1	prorenin
PR	PR:6	protein restriction
PR	PR:12	pseudorabies
PR	PR:14	puerto rico
PR	PR:50	pulmonary regurgitation
PR	PR:27	pulmonary rehabilitation
PR	PR:10|Pr:6	release
Pr	Pr:6|pr:1	release probability
PR	PR:9	retention
PR	PR:11	under a progressiveratio
PR	PR:10	viral proteinase
PSA	PSA:16	biochemical
PSA	PSA:15	persistent sciatic artery
PSA	PSA:21	pisum sativum
PSA	PSA:15	polar surface area
PSA	PSA:138	polysialic acid
PSA	PSA:17	population spike amplitude
PSA	PSA:10	porcine serum albumin
PSA	PSA:12	potentiometric stripping analysis
PSA	PSA:53	power spectral analysis
PSA	PSA:15	puromycinsensitive aminopeptidase
PSB	PSB:72	protected specimen brush
PSB	PSB:10	protected specimen brushing
PSB	PSB:15|pSB:1	protonated schiff base
PSCs	PSCs:15	perisynaptic schwann cells
PSCs	PSCs:12	posterior subcapsular cataracts
PSCs	PSCs:46	postsynaptic currents
PSC	PSC:4	echinococcus granulosus protoscoleces
PSC	PSC:26	pediatric symptom checklist
PSC	PSC:10	peripheral blood stem cell
PSC	PSC:13	platelet shape change
PSC	PSC:37	posterior subcapsular
PSC	PSC:8	postsynaptic current
PSC	PSC:535	primary sclerosing cholangitis
PSC	PSC:12	sdz psc 
PSD-95	PSD-95:20|PSD95:3	postsynaptic density
PSD-95	PSD-95:11|PSD95:4	postsynaptic density protein 
PSDs	PSDs:89|psds:1	postsynaptic densities
PSDs	PSDs:9	presynaptic dendrites
PSD	PSD:10	dementia
PSD	PSD:39	paradoxical sleep deprivation
PSD	PSD:24	partial sleep deprivation
PSD	PSD:31	particle size distribution
PSD	PSD:6|Psd:1|psd:1	phosphatidylserine decarboxylase
PSD	PSD:5	poststenotic dilatation
PSE	PSE:44	partial splenic embolization
PSE	PSE:7	photosensitive epilepsy
PSE	PSE:12	point of subjective equality
PSE	PSE:112	present state examination
PSE	PSE:47	proximal sequence element
PSF	PSF:9	peak systolic frequency
PSF	PSF:10	polypyrimidine tractbinding proteinassociated splicing factor
PSGs	PSGs:14	polysomnograms
PSGs	PSGs:14	pregnancyspecific glycoproteins
PSG	PSG:7	peak systolic gradient
PSG	PSG:6	peak systolic pressure gradient
PSG	PSG:25	polysomnogram
PSG	PSG:52|psg:1	polysomnographic
PSG	PSG:331	polysomnography
PSG	PSG:9|psg:1	posterior silk gland
PSG	PSG:4	prostate secretory granules
PSK	PSK:20	polysaccharide k
PSK	PSK:28|PS-K:5	proteinbound polysaccharide
PSM	PSM:6	porcine stomach mucin
PSM	PSM:4	porcine submaxillary mucin
PSM	PSM:42|psm:3	presomitic mesoderm
PSM	PSM:9	propagated sensation along meridians
PSN	PSN:6	pontosubicular necrosis
PSN	PSN:6	pontosubicular neuron necrosis
PSN	PSN:9	principal sensory nucleus of the trigeminal nerve
PSN	PSN:11	sensory neuropathy
PSN	PSN:8	splanchnic nerve
PSO	PSO:10	particle swarm optimization
PSO	PSO:6	providersponsored organization
PSP	PSP:26	pancreatic spasmolytic polypeptide
PSP	PSP:24	pancreatic stone protein
PSP	PSP:95	paralytic shellfish poisoning
PSP	PSP:29	parotid secretory protein
PSP	PSP:19	peak systolic pressure
PSP	PSP:46	phenolsulfonphthalein
PSP	PSP:18	phenyl saligenin phosphate
PSP	PSP:13	phosphoserine phosphatase
PSP	PSP:11	photostimulable phosphor
PSP	PSP:11	polysaccharide peptide
PSP	PSP:6	polystyrene particles
PSP	PSP:6	postsynaptic potentiation
PSP	PSP:45	primary spontaneous pneumothorax
PSP	PSP:662	progressive supranuclear palsy
PSP	PSP:40|psp:6|PsP:2	pseudopregnancy
PSP	PSP:23|psp:7	pseudopregnant
PSR	PSR:10|PS-R:1	phosphatidylserine receptor
PSR	PSR:18	proliferative sickle retinopathy
PSR	PSR:19	protein synthesis rate
PSSM	PSSM:11	polysaccharide storage myopathy
PSSM	PSSM:8	scoring matrix
PSS	PSS:32	perceived stress scale
PSS	PSS:6	phosphatidylserine synthase
PSS	PSS:33	physiological saline solution
PSS	PSS:121	physiological salt solution
PSs	PSs:23	polysaccharides
PSs	PSs:41	population spikes
PSS	PSS:6	portosystemic shunting
PSS	PSS:8	postsystolic shortening
pSS	pSS:160|PSS:35|pSs:2|p-SS:1|P-SS:1	primary sjogrens syndrome
pSS	pSS:10|PSS:3|P-SS:1	primary ss
PSS	PSS:26	progressive systemic scleroderma
PSS	PSS:465|pss:1	progressive systemic sclerosis
PSS	PSS:6	severity score
PST	PST:42|Pst:5	pancreastatin
PST	PST:7|P-ST:4	phenol st
PST	PST:10|P-ST:1	phenol sulphotransferase
PST	PST:26	phenolsulfotransferase
pST	pST:75|PST:14|pst:1	porcine somatotropin
pST	pST:7	porcine st
PST	PST:9	primary systemic therapy
Pst	Pst:1	pseudomonas syringae pv tomato
Pst	Pst:7	recoil pressure
PSV	PSV:9	peak systolic
PSV	PSV:9	peanut stunt virus
PSV	PSV:12	primary systemic vasculitides
PSV	PSV:12	proximal selective vagotomy
PSbMV	PSbMV:6	pea seedborne mosaic potyvirus
PSbMV	PSbMV:9	pea seedborne mosaic virus
PS	PS:5|ps:1	capillary diffusion capacity
PS	PS:13	contractile properties analyzed included peak shortening
PS	PS:6	drosophila positionspecific
PS	PS:10	mutations in the presenilin
PS	PS:11	pachytene spermatocytes
PS	PS:12|P-S:4	palmazschatz
PS	PS:444	paradoxical sleep
ps	ps:14|PS:4	parallelstranded
PS	PS:12	partial seizures
PS	PS:31	pathologic stage
PS	PS:13|ps:1	pathological stage
PS	PS:17	peak slope
PS	PS:10	pentasaccharide
PS	PS:6	peritoneal sclerosis
PS	PS:10	phosphatidyllserine
PS	PS:17	photic stimulation
PS	PS:10	photostimulation
PS	PS:122	photosystem
PS	PS:14	physiological saline
PS	PS:14	phytosterols
ps	ps:9	picosecond
PS	PS:6	planar scintigraphy
PS	PS:209|Ps:1	polystyrene
PS	PS:26	polysulphone
PS	PS:7|pS:2	porcine serum
PS	PS:6	porcine stable kidney
PS	PS:10|ps:1	power spectra
PS	PS:10	power spectrum
PS	PS:9	pregnenolone sulphate
PS	PS:11	prenatal stress
PS	PS:11|P-S:4	prenatally stressed
PS	PS:5	preparatory signal
PS	PS:42	pressure support
PS	PS:9	primary snoring
PS	PS:15	primitive streak
PS	PS:12	principal sulcus
PS	PS:43|Ps:1	protamine sulfate
PS	PS:10	protamine sulphate
PS	PS:15|Ps:11	psoriasis
PS	PS:8	psychogenic seizures
PS	PS:11	pubertal spurt
PS	PS:13	pulmonary sequestration
PS	PS:70	pulmonary stenosis
PS	PS:38	pulmonary surfactant
PS	PS:9	pyloric sphincter
PS	PS:6	pyriform sinus
PS	PS:11|P-S:2	pyrimethaminesulfadoxine
PS	PS:10	symptoms
PTB	PTB:7	patellar tendon bearing
PTB	PTB:6	phosphotyrosinebinding domain
PTB	PTB:24	preterm birth
PTB	PTB:20|pTB:1	pulmonary tb
PTCA	PTCA:10	percutaneous transluminal coronary angiography
PTCA	PTCA:18	pyrroletricarboxylic acid
PTCR	PTCR:15	percutaneous transluminal coronary recanalization
PTCR	PTCR:7	percutaneous transluminal coronary revascularization
PTCs	PTCs:34	papillary thyroid carcinomas
PTCs	PTCs:10	peritubular capillaries
PTCs	PTCs:29	premature termination codons
PTCs	PTCs:24	psychophysical tuning curves
PTC	PTC:9	ability to taste phenylthiocarbamide
PTC	PTC:19	papillary
PTC	PTC:21	peptichemio
PTC	PTC:5	phase transition curve
PTC	PTC:17	phenylthiocarbamyl
PTC	PTC:10	plugged telescoping catheter
PTC	PTC:16	portal triad clamping
PTC	PTC:19	premature termination codon
PTC	PTC:6	tuning curve
PTD	PTD:10	arrowtrerotola percutaneous thrombolytic device
PTD	PTD:9	peak tension developed
PTD	PTD:10	percutaneous transhepatic drainage
PTD	PTD:8	percutaneous transluminal dilatation
PTD	PTD:16	persistent trophoblastic disease
PTD	PTD:7	posttetanic depression
PTD	PTD:17	primary torsion dystonia
PTD	PTD:21	pyrithiamineinduced thiamine deficiency
PTEN	PTEN:15	phosphatase and tensin homolog
PTEN	PTEN:9	phosphatase and tensin homolog deleted on chromosome 
PTEN	PTEN:7	phosphatase and tensin homolog deleted on chromosome ten
PTEN	PTEN:7	phosphatase and tensin homologue
PTE	PTE:48	parathyroid extract
PTE	PTE:21	phosphotriesterase
PTE	PTE:38	pulmonary thromboendarterectomy
PTFE	PTFE:9	polytetraflouroethylene
PTFE	PTFE:59	polytetrafluorethylene
PTF	PTF:14	patient treatment file
PTF	PTF:13	primary tissue failure
PTF	PTF:10	tissue fraction
PTHrP	PTHrP:242|PTHRP:29|PTH-rP:11|PTHrp:6|PTH-rp:5|PthrP:1|PTH-RP:1|PTHr-P:1|Pthrp:1	parathyroid hormonerelated peptide
PTHrP	PTHrP:686|PTH-rP:43|PTHRP:20|PTHrp:7|PTH-rp:5|PTH-RP:2	parathyroid hormonerelated protein
PTH	PTH:214	parathormone
PTH	PTH:20	parathyrin
PTH	PTH:4	parathyroid hormone 
PTH	PTH:8	parathyroid hormone gene
PTH	PTH:11	parathyroid hormone levels
Pth	Pth:17|PTH:2	peptidyltrna hydrolase
PTH	PTH:34|Pth:4	phenylthiohydantoin
Pth	Pth:9	pressure threshold
PTNs	PTNs:37|PTNS:2	pyramidal tract neurons
PTNs	PTNs:10	pyramidal tract neurones
PTN	PTN:103|Ptn:2	pleiotrophin
PTN	PTN:37	posterior tibial nerve
PTO	PTO:9	percutaneous transhepatic obliteration
PTO	PTO:11	person tradeoff
PTO	PTO:6	portal triad occlusion
PTPs	PTPs:9	previously treated patients
PTPs	PTPs:217	protein tyrosine phosphatases
PTP	PTP:21	percutaneous transhepatic portography
PTP	PTP:150	permeability transition pore
PTP	PTP:13	phosphate transport protein
pTP	pTP:2	precursor to terminal protein
pTP	pTP:22	preterminal protein
PTP	PTP:6	pretest probability
PTP	PTP:9	prohormone thiol protease
PTP	PTP:12	protein tyrosine phosphorylation
PTR	PTR:14	pressure transmission ratio
PTR	PTR:11	prothrombin time ratio
PTS	PTS:28	pediatric trauma score
PTS	PTS:9	peroxisome targeting signal
PTs	PTs:18	phage types
PTS	PTS:20|Pts:2	phosphotransferase
PTs	PTs:7	phyllodes tumors
PTs	PTs:13	physical therapists
PTS	PTS:8	posttraumatic syringomyelia
PTS	PTS:16	posttraumatic stress
PTs	PTs:18	prothrombin times
PTS	PTS:13	proximal tubular segments
PTs	PTs:20	proximal tubules
PTS	PTS:7	proximal tubule segments
PTT	PTT:10	betapropanoylbetatolyltropane
PTT	PTT:7	partial thromboplastin
PTT	PTT:16	posterior tibial tendon
PTT	PTT:109	protein truncation test
PTV	PTV:17	patient triggered ventilation
PTV	PTV:15	punta toro virus
PTX	PTX:23|PTx:11|Ptx:1	after parathyroidectomy
PTX	PTX:11	antagonist picrotoxin
PTX	PTX:58|PTx:2	palytoxin
PTX	PTX:104|PTx:3|ptx:1	parathyroidectomized
PTX	PTX:11	picrotoxinin
PTX	PTX:23	piritrexim
PTX	PTX:26|Ptx:1	pneumothorax
PTZ	PTZ:14	pentetrazol
PTZ	PTZ:459	pentylenetetrazol
PTZ	PTZ:210	pentylenetetrazole
PTZ	PTZ:10	pentylentetrazol
PTZ	PTZ:15	phenothiazine
pT	pT:5	depth of tumor invasion
Pt	Pt:6	isometric twitch
pt	pt:14|PT:1	paralytic tremor
PT	PT:93|pt:3|Pt:1	pars tuberalis
PT	PT:45	patellar tendon
PT	PT:88|pT:1	peak torque
PT	PT:12	percutaneous tracheostomy
PT	PT:13	perinuclear theca
PT	PT:82	permeability transition
PT	PT:5	permissive temperature
PT	PT:14	pertussis toxoid
PT	PT:9	photothermal
PT	PT:96	physical therapy
PT	PT:21	physical training
PT	PT:24	physiotherapy
PT	PT:9	picrotoxin
PT	PT:56	planum temporale
pt	pt:8|Pt:1	plastid
Pt	Pt:218|PT:2	platinum
PT	PT:21|pt:4	posttreatment
PT	PT:10	posterior tibial
PT	PT:13|Pt:3	pretectum
PT	PT:37	preterm
PT	PT:17	primary thrombocythaemia
PT	PT:10	primary thrombocythemia
PT	PT:4|pT:1	primary tumour
PT	PT:54	proficiency testing
PT	PT:15	proton transfer
PT	PT:12	proximal
PT	PT:10	ptaquiloside
PT	PT:14	pulmonary trunk
PT	PT:83|Pt:1	pyramidal tract
PT	PT:16|pT:1	tumors
pT	pT:6|p-T:1	tumor stage
Pt	Pt:7|PT:1	twitch force
PUBS	PUBS:25	percutaneous umbilical blood sampling
PUBS	PUBS:10	purple urine bag syndrome
PUFA	PUFA:15	polyunsaturated
PUFA	PUFA:16	polyunsaturated fa
PUF	PUF:9|pUF:3	plasma ultrafiltrate
PUF	PUF:38	polyurethane foam
PUs	PUs:18	polyurethanes
PUs	PUs:11	pressure ulcers
PUVA	PUVA:26	longwave ultraviolet light
PUVA	PUVA:9	plus uva radiation
PUVA	PUVA:32	psoralen plus uva
PUVA	PUVA:11	psoralenuva
PUVA	PUVA:12	uva irradiation
Pu	Pu:5	operon promoter
PU	PU:41	peptic ulcer
PU	PU:46|pu:2	perfusion units
Pu	Pu:12|PU:2	plutonium
PU	PU:15	proteinuria
Pu	Pu:8	urea permeability
PVA	PVA:5	pemphigus vulgaris antigen
PVA	PVA:359	polyvinyl alcohol
PVA	PVA:7	polyvinyl alcohol particles
PVA	PVA:46	polyvinylalcohol
PVA	PVA:122|P-VA:1	pressurevolume area
PVCs	PVCs:98	premature ventricular complexes
PVCs	PVCs:147	premature ventricular contractions
PVC	PVC:9	paravestibular canaliculus
PVC	PVC:430	polyvinyl chloride
PVC	PVC:156	polyvinylchloride
PVC	PVC:8	prevacuolar compartment
PVC	PVC:12	vaginal cornification
PVDF	PVDF:148|PVdF:2	polyvinylidene difluoride
PVDF	PVDF:59	polyvinylidene fluoride
PVD	PVD:400	peripheral vascular disease
PVD	PVD:6	portal vein diameter
PVD	PVD:104	posterior vitreous detachment
PVE	PVE:7	partial volume effect
PVE	PVE:10	plasma volume expansion
PVE	PVE:47	portal vein embolization
PVE	PVE:149	prosthetic valve endocarditis
PVE	PVE:17	pseudostratified ventricular epithelium
PVF	PVF:13	polyvinyl formal
PVF	PVF:8|PVf:1	primary ventricular fibrillation
PVF	PVF:49	pulmonary venous flow
PVG	PVG:10	periventricular gray
PVG	PVG:6	portal venous gas
PVH	PVH:23	hypothalamic paraventricular nucleus
PVH	PVH:25	paraventricular
PVH	PVH:36	paraventricular hypothalamic nucleus
PVH	PVH:5|PV-H:3	perivenous hepatocytes
PVH	PVH:25	periventricular haemorrhage
PVH	PVH:9	periventricular hemorrhage
PVI	PVI:24	protracted venous infusion
PVI	PVI:13	pulmonary vein isolation
PVL	PVL:20|pvl:1	pantonvalentine leukocidin
PVL	PVL:257	periventricular leukomalacia
PVL	PVL:11	periventricular lucency
PVL	PVL:7	portal hypertension induced by partial portal vein ligation
PVL	PVL:10	portal veinligated
PVL	PVL:13	proliferative verrucous leukoplakia
PVM	PVM:12	parasitophorous vacuolar membrane
PVM	PVM:26|pvm:1	parasitophorous vacuole membrane
PVM	PVM:55	pneumonia virus of mice
PVM	PVM:11	potato virus m
PVN	PVN:49	hypothalamic paraventricular
PVN	PVN:5	predictive value negative
PvO2	PvO2:23|PVO2:17|PVo2:1	mixed venous oxygen tension
PvO2	PvO2:3|pVO2:1	venous oxygen pressure
PVOD	PVOD:14	pulmonary vascular obstructive disease
PVOD	PVOD:24	pulmonary venoocclusive disease
PVO	PVO:27	paraventricular organ
PVO	PVO:9	portal vein occlusion
PVO	PVO:14	pulmonary venous obstruction
PVP	PVP:14	peripheral venous pressure
PVP	PVP:65	polyvinyl pyrrolidone
PVP	PVP:13	portal vein pressure
PVP	PVP:15	portal venous phase
PVP	PVP:9	positionvestibularpause
PVP	PVP:45	posteroventral pallidotomy
PVP	PVP:16	predictive value positive
PVR	PVR:36|Pvr:3	poliovirus receptor
PVR	PVR:12	postvoid residual volume
PVR	PVR:524	proliferative vitreoretinopathy
PVR	PVR:17	pulmonary valve replacement
PVR	PVR:20	residual urine
PVR	PVR:38	residual urine volume
PVs	PVs:18	papillomaviruses
PVS	PVS:15	penile vibratory stimulation
PVS	PVS:17	peritoneovenous shunt
PVS	PVS:11	perivascular space
PVS	PVS:24|PvS:1	perivitelline space
PVS	PVS:71|Pvs:1	persistent vegetative state
PVS	PVS:9	polyvinyl sulfate
PVS	PVS:5	portal vein stenosis
PVS	PVS:13	potato virus s
PVS	PVS:54	programmed ventricular stimulation
PVS	PVS:12	pubovaginal sling
PVS	PVS:6	pulmonary valve stenosis
PVs	PVs:97	pulmonary veins
PVS	PVS:12	venous sampling
PVTT	PVTT:9	portal vein tumor thrombosis
PVTT	PVTT:14	portal vein tumor thrombus
PVT	PVT:8	paraventricular nucleus of the thalamus
PVT	PVT:108	portal vein thrombosis
PVT	PVT:15	psychomotor vigilance task
PV	PV:18	parietal ventral area
PV	PV:44	patients with polycythaemia vera
PV	PV:6	patients with psoriasis vulgaris
PV	PV:30|pv:2|pV:1	peak velocity
PV	PV:287|Pv:3	pemphigus vulgaris
PV	PV:13	periventricular
PV	PV:17	peroxide value
PV	PV:13|pV:3	pervanadate
PV	PV:11	phenyl valerate
PV	PV:10	pichinde virus
PV	PV:15	pityriasis versicolor
PV	PV:71|pv:2|Pv:1	plasma viscosity
PV	PV:114	poliovirus
PV	PV:12|pv:2	postvaccination
PV	PV:11	pravastatin
PV	PV:11	processus vaginalis
PV	PV:14	pulmonary valve
PV	PV:35	pulmonary venous
PV	PV:17|P-V:15	static pressurevolume
PWA	PWA:17	people with aids
PWA	PWA:9	pulse wave analysis
PWA	PWA:9	wave amplitude
PWC	PWC:20|pwc:1	physical work capacity
PWC	PWC:15	physical working capacity
PWD	PWD:10	duration of filtered pwave
PWD	PWD:5	wave doppler
PWT	PWT:5	paw withdrawal threshold
PWT	PWT:38	posterior wall thickness
PWS	PWS:9	paternal
PWS	PWS:22	praderwilli
PWS	PWS:462	praderwilli syndrome
PWS	PWS:9	prince william sound
PWS	PWS:15	treatment of portwine stains
PW	PW:45|pW:1	posterior wall
PW	PW:8	pulse width
PW	PW:15|pw:2	pulsedwave
Px	Px:5|PX:1	 pancreatectomized
Px	Px:3|px:1|PX:1	after  pancreatectomy
Px	Px:14	partial pancreatectomy
PX	PX:47	phox homology
PX	PX:26|Px:18|px:1	pinealectomy
PYP	PYP:12	mtcpyrophosphate
PYP	PYP:94|pyp:2	photoactive yellow protein
PYP	PYP:11	tcm pyrophosphate
PYR	PYR:3|P-YR:1|pyr:1	personyears at risk
PYR	PYR:6|Pyr:5	pyrazole
Pyr	Pyr:17|PYR:11|pyr:3	pyruvate
Pyr	Pyr:30|PYR:5|pyr:1	urinary pyridinoline
PZA	PZA:163|pza:1	pyrazinamide
PZA	PZA:25	pyrazoloacridine
PZ	PZ:57	peripheral zone
PZ	PZ:8|Pz:2	piezoelectric
PZ	PZ:9	promazine
PZ	PZ:15	protein z
PaCO2	PaCO2:13|Paco2:1	arterial carbon dioxide partial pressure
PaCO2	PaCO2:27|paCO2:2|PaCO-2:1|Paco2:1|PACO2:1	arterial carbon dioxide pressure
PaCO2	PaCO2:34|Paco2:2	arterial co partial pressure
PaCO2	PaCO2:12|Paco2:1	arterial co pressure
PaCO2	PaCO2:19|Paco2:2	arterial partial pressure of co
PaCO2	PaCO2:14|Paco2:1|PACO2:1	carbon dioxide tensions
PaCO2	PaCO2:14|paCO2:1	partial pressure of carbon dioxide in arterial blood
PaCO2	PaCO2:11	partial pressure of co in arterial blood
PaO(2)	PaO(2):21	arterial oxygen tension
PaO(2)	PaO(2):7	arterial partial pressure of oxygen
PaO2	PaO2:27|paO2:1|Pao2:1	arterial o partial pressure
PaO2	PaO2:27|Pao2:2|paO2:1|PAO2:1	arterial oxygen partial pressure
PaO2	PaO2:22|Pao2:1	arterial oxygenation
PaO2	PaO2:1	arterial partial pressure for oxygen
PaO2	PaO2:15|Pao2:4	arterial partial pressure of o
PaO2	PaO2:18|Pao2:1	partial pressure of oxygen in arterial blood
PAP	PAP:29|p-AP:5|pAP:5	paminophenol
PAP	PAP:61	pancreatitisassociated protein
Pap	Pap:518|PAP:1	papanicolaou
Pap	Pap:18	papanicolau
PAP	PAP:10	paraaminophenol
PAP	PAP:9	phosphatidic acid phosphohydrolase
PAP	PAP:9	plasminalpha antiplasmin
PAP	PAP:14	plasminalpha antiplasmin complex
PAP	PAP:12	plasminantiplasmin
PAP	PAP:77	pokeweed antiviral protein
PAP	PAP:61	polya polymerase
PAP	PAP:8	postactivation potentiation
PAP	PAP:8	prostatic acid phosphate
PAP	PAP:138|Pap:1	pulmonary alveolar proteinosis
Pap	Pap:10|pap:7|PAP:1	pyelonephritisassociated pili
PC1	PC1:11	first principal component
PC-1	PC-1:6	pancreatic cancer cell line
PC-1	PC-1:9	plasma cell membrane glycoprotein
PC1	PC1:13|PC-1:1	polycystin
PHR	PHR:8	percentage hepatic replacement
PHR	PHR:5	personal health record
PIM	PIM:7	paediatric index of mortality
PIM	PIM:10	pediatric index of mortality
PIM	PIM:21|Pim:4	pimozide
PIM	PIM:10	polymorphic immunodominant molecule
PJ	PJ:8	pancreatic juice
PJ	PJ:19|P-J:1	pancreaticojejunostomy
PLA	PLA:123	polylactic acid
PLA	PLA:12	processed lipoaspirate
PLA	PLA:15	pyogenic liver abscess
PMV	PMV:6	avian paramyxovirus
PMV	PMV:17	mosaic virus
PMV	PMV:12	percutaneous mitral balloon valvotomy
PMV	PMV:6	percutaneous mitral valvotomy
PMV	PMV:33	percutaneous mitral valvuloplasty
PMV	PMV:15	prolonged mechanical ventilation
POS	POS:11	palliative care outcome scale
POS	POS:17	photoreceptor outer segments
POS	POS:14	pointofservice
PPA	PPA:7	parahippocampal place area
PPA	PPA:10	passive peritoneal anaphylaxis
PPA	PPA:127|Ppa:2	phenylpropanolamine
PPA	PPA:15	phenylpropanolamine hydrochloride
PPA	PPA:10	phenylpyruvic acid
PPA	PPA:22	pipemidic acid
PPA	PPA:28	porcine pancreatic alphaamylase
PPA	PPA:11	postpartum amenorrhea
PPA	PPA:56	primary progressive aphasia
PRH	PRH:7	postocclusive reactive hyperemia
PRH	PRH:7	primary rat hepatocytes
PRP-D	PRP-D:10	diphtheria toxoid
PRP-D	PRP-D:11	toxoid conjugate vaccine
PrP-res	PrP-res:4|PrPres:1	proteaseresistant isoform
PrP-res	PrP-res:7|PrPres:3|PrPRES:1	proteaseresistant prp
PSTs	PSTs:12	paralytic shellfish toxins
PSTs	PSTs:8|P-STs:1	phenol sulfotransferases
PSY	PSY:8|Psy:5|psy:4	phytoene synthase
PSY	PSY:8|Psy:2	psyllium
PtiO2	ptiO2:3|PtiO2:3	brain tissue oxygenation
PtiO2	PtiO2:6|ptiO2:1	oxygen pressure
PTM	PTM:7	perceptual template model
PTM	PTM:8	posttranslational modification
PTM	PTM:11	pretibial myxedema
PTM	PTM:17	proximal tibial metaphysis
PvCO2	PvCO2:9|PVCO2:7|Pv-CO2:1	mixed venous pco
PvCO2	PvCO2:5|PVCO2:3	venous carbon dioxide tension
Py	Py:16	nmethylpyrrole
PY	PY:6	peptide y
PY	PY:13|py:7|p-y:2	per  personyears
PY	PY:14|py:9	person years
Py	Py:23|PY:2|py:1	polyoma
Py	Py:16|PY:14|py:1	pyrene
PY	PY:4|Py:3	pyronin y
Py	Py:14|PY:1	pyrrole
QAP	QAP:18	quality assurance program
QAP	QAP:8	quality assurance project
Qa	Qa:7	access blood flow
Qa	Qa:7|QA:3	access flow
QA	QA:6	electron acceptor
QA	QA:15	glomerular plasma flow
QA	QA:26	glomerular plasma flow rate
QA	QA:5	primary quinone
QA	QA:6	primary quinone acceptor
QA	QA:16	quality assessment
QA	QA:21	quaternary ammonium
QB	QB:13	quiet breathing
QB	QB:13	secondary quinone
QB	QB:4	secondary quinone acceptor
QCA	QCA:8	quantitative coronary analysis
QCA	QCA:11	quantitative coronary angiographic
QCA	QCA:140|qCA:1	quantitative coronary angiography
QCA	QCA:16	quantitative coronary arteriography
QD	QD:4|Qd:3	dialysate flow
QD	QD:8|qd:1	once a day
QD	QD:17	quantum dot
QEEG	QEEG:50|qEEG:48	quantitative eeg
QEEG	QEEG:9|qEEG:8	quantitative electroencephalogram
QEEG	QEEG:16|qEEG:7	quantitative electroencephalographic
QEEG	QEEG:34|qEEG:20|q-EEG:2	quantitative electroencephalography
QF-PCR	QF-PCR:7|QFPCR:1	quantitative fluorescent pcr
QF-PCR	QF-PCR:16	quantitative fluorescent polymerase chain reaction
QF	QF:36	quadriceps femoris
QF	QF:14|Q-F:4	quantityfrequency
QGS	QGS:6	quantitative gated single photon emission computed tomography
QGS	QGS:33	quantitative gated spect
QI	QI:202	quality improvement
QI	QI:11	quality index
QI	QI:23	quetelet index
QL	QL:91|Ql:2	lymph flow
QL	QL:13	lymph flow rate
QM/MM	QM/MM:16	quantum mechanicsmolecular mechanics
QM/MM	QM/MM:30	quantum mechanicalmolecular mechanical
QM	QM:34	quality management
QM	QM:11	quantum mechanics
QM	QM:26	quantum mechanical
QM	QM:16|Q-M:1	quinacrine mustard
QO2	QO2:20|Qo2:1	o delivery
QO2	QO2:7|QO-2:1|qO2:1	respiration
QPCR	QPCR:43|Q-PCR:34|qPCR:27|q-PCR:1	quantitative pcr
QPCR	QPCR:38|Q-PCR:25|qPCR:18|q-PCR:2	quantitative polymerase chain reaction
QRT-PCR	QRT-PCR:8|qRT-PCR:5|QRTPCR:1|Q-Rt-PCR:1|Q-RT-PCR:1	quantitative realtime polymerase chain reaction
QRT-PCR	QRT-PCR:5|qRT-PCR:2|Q-RT-PCR:2	quantitative reverse transcriptionpcr
QS	QS:9	quiet
QS	QS:29	quinacrine sterilization
QS	QS:5	quinidine sulfate
QTcd	QTcd:6|QTcD:4|QTc-d:2	corrected qt dispersion
QTcd	QTcd:11|QTcD:1	corrected qtd
QTcd	QTcd:8|QTc-d:1|QTcD:1	qtc dispersion
QTc	QTc:9|Q-Tc:1	bazetts formula
QTc	QTc:11|Q-Tc:1	corrected
QTc	QTc:128	corrected qt
QTc	QTc:33|QTC:1	qt interval corrected for heart rate
QUIN	QUIN:5	agonist quinpirole
QUIN	QUIN:18|Quin:1	quinolinate
QUIS	QUIS:8|quis:4	quisqualic
QUIS	QUIS:32|quis:10|Quis:1	quisqualic acid
QUS	QUS:15	quantitative ultrasonometry
QUS	QUS:313|qUS:2	quantitative ultrasound
QWB	QWB:36	quality of wellbeing
QWB	QWB:36	quality of wellbeing scale
QW	QW:3|qw:3	once weekly
QW	QW:15|Qw:3	quiet wakefulness
QW	QW:11|Qw:1	quiet waking
Qp/Qs	Qp/Qs:11	pulmonary to systemic blood flow
Qp/Qs	Qp/Qs:6|QP/QS:1	pulmonary to systemic blood flow ratio
Qp/Qs	Qp/Qs:18|QP/QS:1	pulmonary to systemic flow ratio
Qp/Qs	Qp/Qs:16	ratio of pulmonary to systemic flow
Qs/Qt	Qs/Qt:10	intrapulmonary shunting
Qs/Qt	Qs/Qt:17|QS/QT:4|Qs/QT:2|QS/Qt:1	pulmonary shunt
R0	R0:6	basic reproduction number
R0	R0:25	complete resection
R0	R0:29|R-0:1	curative resection
R0	R0:8	reproduction ratio
R1881	R1881:18|R-1881:1	hmethyltrienolone
R1881	R1881:15	synthetic androgen methyltrienolone
R18	R18:10|R-18:1	octadecyl rhodamine b chloride
R18	R18:12|R-18:1	octadecylrhodamine
R18	R18:8	octadecylrhodamine b
R18	R18:10	octadecylrhodamine b chloride
R5	R5:11	ccrdependent
R5	R5:15	ccrusing
rAAV	rAAV:5	adenoassociated viral vectors
rAAV	rAAV:40	recombinant aav
rAAV	rAAV:36	recombinant adenoassociated viral
rAAV	rAAV:10	recombinant adenoassociated viral vector
rAAV	rAAV:9	recombinant adenoassociated virus type 
RAA	RAA:10	renal artery aneurysm
RAA	RAA:78|R-A-A:9	reninangiotensinaldosterone
RAA	RAA:9	right aortic arch
RAA	RAA:37	right atrial appendage
RACK1	RACK1:8|RACK-1:3	receptor for activated c kinase
RACK1	RACK1:11|RACK-1:1	receptor for activated c kinase 
RAC	RAC:20	rabbit articular chondrocytes
RAC	RAC:11|rac:2	ractopamine
RAC	RAC:11|rac:1	radial alveolar count
RAC	RAC:31	recombinant dna advisory committee
RAG	RAG:15	rat male accessory glands
RAG	RAG:13	retinoyl betaglucuronide
RAI	RAI:35	resident assessment instrument
RAI	RAI:22	ritchie articular index
Raji	Raji:7	human burkitts lymphoma
Raji	Raji:5|raji:1	human lymphoblastoid cells
RAL	RAL:11	relative adduct labeling
RAL	RAL:14	relative attachment level
RAL	RAL:10	retinaldehyde
RANKL	RANKL:167|RANK-L:3	receptor activator of nfkappab ligand
RANKL	RANKL:18	receptor activator of nuclear factorkappa b ligand
RANKL	RANKL:66|RANK-L:1	receptor activator of nuclear factorkappab ligand
RANTES	RANTES:21	regulated on activation normal t cell expressed and secreted
RANTES	RANTES:5	regulated upon activation normal tcell expressed and secreted
RAN	RAN:24|Ran:5	ranitidine
RAN	RAN:14	rapid automatized naming
RAO	RAO:27	renal artery occlusion
RAO	RAO:49	right anterior oblique
RAO	RAO:18	rotational acetabular osteotomy
RAPD	RAPD:9	amplified polymorphic dna fingerprinting
RAPD	RAPD:5	arbitrary primers
RAPD	RAPD:188	random amplification of polymorphic dna
RAPD	RAPD:873|RAP-D:1	random amplified polymorphic dna
RAPD	RAPD:19	random amplified polymorphic dna analysis
RAPD	RAPD:30	relative afferent pupillary defect
RAP	RAP:194	receptorassociated protein
RAP	RAP:95	recurrent abdominal pain
RAP	RAP:11	regional acceleratory phenomenon
RAP	RAP:8	rehabilitation activities profile
RAP	RAP:46	renal arterial pressure
RAP	RAP:5	resistancearea product
RAP	RAP:10	retinal angiomatous proliferation
RARS	RARS:15	ra with ring sideroblasts
RARS	RARS:16	refractory anemia with ring sideroblasts
RARS	RARS:35	refractory anemia with ringed sideroblasts
RAST	RAST:12	ige antibodies
RAST	RAST:11|Rast:1	radioallergosorbenttest
RAST	RAST:41	radioallergosorbent
RAST	RAST:16	radioallergosorbent testing
RAS	RAS:11	aortic strips
RAS	RAS:9	rate of ankle swelling
RAS	RAS:91	recurrent aphthous stomatitis
RAS	RAS:11	renal artery stenoses
RAS	RAS:253	renal artery stenosis
RAS	RAS:17	retinoic acid syndrome
RA	RA:12|Ra:1	afferent arteriolar resistance
Ra	Ra:10|RA:2	arterial resistance
RA	RA:32	nucleus robustus archistriatalis
RA	RA:121	radial artery
RA	RA:23	radiographic absorptiometry
Ra	Ra:11	ragged
RA	RA:77	rapidly adapting
RA	RA:9	rat aorta
RA	RA:48|ra:1	rectus abdominis
RA	RA:93	refractory anaemia
RA	RA:238	refractory anemia
RA	RA:11	regional anaesthesia
RA	RA:10	regional anesthesia
RA	RA:18	relative anisotropy
RA	RA:7	repeated acquisition
Ra	Ra:10	resistance to reabsorption of csf
RA	RA:8	retinol acetate
RA	RA:19	retrograde amnesia
RA	RA:40	rheumatoid
RA	RA:23	rheumatoid arthritic
RA	RA:11	rheumatoid arthritis patients
RA	RA:8	ricin a chain
RA	RA:12	right
RA	RA:13	right atria
RA	RA:11	risk area
RA	RA:97	robust nucleus of the archistriatum
RA	RA:58	room air
RA	RA:30	rotational atherectomy
RA	RA:12	rounded atelectasis
rBCG	rBCG:7	bacillus calmetteguerin
rBCG	rBCG:20	recombinant bcg
RBC	RBC:59|Rbc:1	ranitidine bismuth citrate
RBC	RBC:23	rotating biological contactor
RBD	RBD:13	ras binding domain
RBD	RBD:25	receptorbinding domain
RBD	RBD:23	recurrent brief depression
RBD	RBD:7	regional basic diet
RBD	RBD:22	right brain damage
RBD	RBD:26	rna binding domain
RBE	RBE:12	binding element
RBE	RBE:18	relative biological efficiency
RBE	RBE:6	revbinding element
RBF	RBF:11	blood flows
RBF	RBF:59	radial basis function
RBF	RBF:1155|rbf:3	renal blood flow
RBM	RBM:14	rat bone marrow
RBM	RBM:8	rnabinding motif
RBM	RBM:14	roll back malaria
RBT	RBT:9	random breath testing
RBT	RBT:19	rifabutin
RBT	RBT:23	rose bengal test
RBV	RBV:8	relative bioavailability
RBV	RBV:13	relative biological value
Rb	Rb:10	minnesota r
rb	rb:15|Rb:4	rabbit
RB	RB:13|Rb:1	rebreathing
rb	rb:11	recombinant bovine
RB	RB:28	repetition blindness
RB	RB:47	respiratory burst
Rb	Rb:13|RB:11	retinoblastoma susceptibility
Rb	Rb:20|RB:7	retinoblastoma susceptibility gene product
Rb	Rb:21|RB:15	retinoblastoma tumor suppressor protein
RB	RB:14	rhodamine b
RB	RB:9	rice bran
Rb	Rb:40	robertsonian
RB	RB:10|R-B:2	rohonbeard
RB	RB:104|rb:1|Rb:1	rose bengal
RCA	RCA:14	red cell aggregation
RCA	RCA:12	replicationcompetent adenovirus
RCA	RCA:9	retrochiasmatic area
RCA	RCA:14	ricinus communis agglutinin i
RCA	RCA:8	root cause analysis
RCA	RCA:4|rca:3|Rca:2	rubisco activase
RCCs	RCCs:10	cell concentrates
RCCs	RCCs:9	cleft cysts
RCCs	RCCs:14	rapid cooling contractures
RCCs	RCCs:177	renal cell carcinomas
RCC	RCC:8	cell count
RCC	RCC:8	rapid cooling contracture
RCC	RCC:14	rathkes cleft cyst
RCC	RCC:121	renal cell cancer
RCE	RCE:15	rabbit corneal epithelial
RCE	RCE:6	relative coefficient of excretion
RCE	RCE:7	retinoblastoma control element
RCF	RCF:9	radiochromic film
RCF	RCF:16	red cell folate
RCF	RCF:9	refractory ceramic fibres
RCF	RCF:9	responder cell frequency
RCMV	RCMV:62|R-CMV:1	rat cytomegalovirus
RCMV	RCMV:12	red clover mottle virus
RCM	RCM:16	radiocontrast media
RCM	RCM:58	radiographic contrast media
RCM	RCM:7	radiographic contrast medium
RCM	RCM:36	red cell mass
RCM	RCM:4	reflectance confocal microscopy
RCM	RCM:12	reflection contrast microscopy
RCM	RCM:17	restrictive cardiomyopathy
RCNMV	RCNMV:11	red clover necrotic mosaic dianthovirus
RCNMV	RCNMV:20	red clover necrotic mosaic virus
RCN	RCN:9	raccoon poxvirus
RCN	RCN:8	radiocontrast nephropathy
RCN	RCN:16|Rcn:1	royal college of nursing
RCP	RCP:36	radiochemical purity
RCP	RCP:11	receptor component protein
RCP	RCP:9	respiratory compensation point
RCP	RCP:86	retrograde cerebral perfusion
RCP	RCP:16	retruded contact position
RCP	RCP:23	riboflavin carrier protein
RCR	RCR:27	replicationcompetent retrovirus
RCR	RCR:10	respiratory control rate
RCR	RCR:112	respiratory control ratio
RCR	RCR:14	rolling circle replication
Rcs	Rcs:8	collateral system
Rcs	Rcs:12	collateral system resistance
RCS	RCS:9	rat chondrosarcoma
RCs	RCs:85	reaction centers
RCs	RCs:8	reaction centres
RCS	RCS:20	recombinant congenic strains
RCS	RCS:7	recurrent carotid stenosis
RCs	RCs:12	relative contents
RCs	RCs:10	renal carcinomas
RCs	RCs:7	renshaw cells
RCS	RCS:8	repeated cold stress
RCs	RCs:6	replication complexes
RCS	RCS:199	royal college of surgeons
RCTs	RCTs:143	randomized clinical trials
RCTs	RCTs:26|RCTS:1	randomized controlled clinical trials
RCTs	RCTs:587|RCTS:1	randomized controlled trials
RCT	RCT:35	radiochemotherapy
RCT	RCT:56	randomised controlled trials
RCT	RCT:8	renal cell tumors
RCT	RCT:59	reverse cholesterol transport
RCT	RCT:9	root canal treatment
RCV	RCV:39	red cell volume
RCV	RCV:5	replicationcompetent virus
RDA	RDA:68	recommended daily allowance
RDA	RDA:161	representational difference analysis
RDD	RDD:16	random digit dialing
RDD	RDD:45	rosaidorfman disease
RDEB	RDEB:10	recessive dystrophic eb
RDEB	RDEB:63|R-DEB:1	recessive dystrophic epidermolysis bullosa
RDE	RDE:10	receptordestroying enzyme
RDE	RDE:17	rotating disk electrode
RDI	RDI:9	recommended daily intake
RDI	RDI:225	respiratory disturbance index
RDP	RDP:10	ribosomal database project
RDP	RDP:7	rumen degradable protein
RDP	RDP:7	ruminally degradable protein
RDS	RDS:8	renal duplex sonography
RDS	RDS:34	replicative dna synthesis
RDS	RDS:1161	respiratory distress syndrome
RDT	RDT:7	regular dialysis therapy
RDT	RDT:55	regular dialysis treatment
RDT	RDT:18	regular hemodialysis treatment
RDT	RDT:9	remaining dentin thickness
RDT	RDT:7	remaining dentine thickness
RDV	RDV:12	rice dwarf phytoreovirus
RDV	RDV:28	rice dwarf virus
Rd	Rd:36|RD:1	glucose disposal
Rd	Rd:9	glucose disposal rate
RD	RD:26	human rhabdomyosarcoma
RD	RD:25	raphe dorsalis
Rd	Rd:16	rate of disappearance
Rd	Rd:10	rate of glucose disappearance
RD	RD:13	raynauds disease
RD	RD:13	reading disabled
RD	RD:14	recession depth
RD	RD:9	rectal distension
RD	RD:21	redistribution
RD	RD:10	reference diameter
RD	RD:15	regular diet
RD	RD:9	regulatory domain
RD	RD:15	reiters disease
RD	RD:11	relative dispersion
RD	RD:10	renal dysfunction
RD	RD:15	residual disease
RD	RD:19	respiratory distress
RD	RD:16	rheumatic diseases
Rd	Rd:15|rd:1	rubredoxin
RD	RD:7	runt domain
REACH	REACH:10	reaching for excellence in adolescent care and health
REACH	REACH:10	resources for enhancing alzheimers caregiver health
REA	REA:9	rapid epidemiological assessment
REA	REA:8	repressor of estrogen receptor activity
REC	REC:15	gingival recession
REC	REC:9	rabbit ear chamber
REC	REC:11	rat embryo cells
REC	REC:20|Rec:3|rec:1	recovery
REF	REF:8|Ref:3	reference
REF	REF:9|rEF:8|R-EF:1	regional ejection fraction
REF	REF:21	restriction endonuclease fingerprinting
REM	REM:69	rapid eye movement sleep
REM	REM:24	relative electrophoretic mobility
REM	REM:14	reticular erythematous mucinosis
RER+	RER+:11	replication error phenotype
RER+	RER+:12	replication error positive
RER	RER:14	recurrent exertional rhabdomyolysis
RER	RER:206	respiratory exchange ratio
RER	RER:654|rER:135|r-ER:6|rer:6	rough endoplasmic reticulum
RES	RES:20|res:2|Res:1	reserpine
RES	RES:23|res:8|Res:1	resveratrol
RES	RES:447|res:1	reticuloendothelial system
RET	RET:9|Ret:2	receptor tyrosine kinase
RET	RET:78	resonance energy transfer
RET	RET:7|ret:1	ret protooncogene
REV-T	REV-T:16	reticuloendotheliosis virus
REV-T	REV-T:12|Rev-T:6	reticuloendotheliosis virus strain t
REV	REV:10	reverse phase evaporation
REV	REV:7	reversephase evaporation vesicles
REZ	REZ:25	root entry zone
REZ	REZ:12	root exit zone
RE	RE:6	cells of the reticuloepithelial
RE	RE:8|Re:2	efferent arteriolar resistance
RE	RE:6	patients with rasmussen encephalitis
RE	RE:5	rapid ejaculation
RE	RE:24	rasmussens encephalitis
RE	RE:44	reflux esophagitis
RE	RE:7	rejection episodes
RE	RE:6	relative enhancement
RE	RE:26	relative error
RE	RE:6	removal efficiency
RE	RE:12	respiratory epithelium
RE	RE:7	response entropy
RE	RE:21|Re:1	restriction enzyme
RE	RE:9	retained energy
RE	RE:5	reticular nucleus
RE	RE:6	reticularis thalami
RE	RE:8	retinal extract
RE	RE:9	right ear
RE	RE:9	rolandic epilepsy
RE	RE:34	running economy
RE	RE:25	thalamic reticular
RFB	RFB:7	radialflow bioreactor
RFB	RFB:16	replication fork barrier
RFC	RFC:81|RF-C:43	replication factor c
RFC	RFC:6	residual feed consumption
RFI	RFI:10	relapsefree interval
RFI	RFI:14|rFI:1	relative fluorescence intensity
RFI	RFI:8	renal failure index
RFLP	RFLP:19	restriction fragment length polymorphic
RFLP	RFLP:20	restriction fragment length polymorphism analysis
RFP	RFP:32	request for proposal
RFP	RFP:11|rfp:1	restriction fragment pattern
RFP	RFP:5	restrictive filling pattern
RFP	RFP:11|rfp:4|Rfp:1	ret finger protein
RFP	RFP:14	rifampin
RFR	RFR:38	radiofrequency radiation
RFR	RFR:13	red cell filtration rate
RFR	RFR:37	renal functional reserve
RFS	RFS:6	reflux finding score
RFS	RFS:18	relapsefree
RFS	RFS:319	relapsefree survival
RFs	RFs:18	release factors
RFs	RFs:77	rheumatoid factors
RF	RF:1266|rf:42|Rf:1	radiofrequency
RF	RF:15	recirculation fraction
RF	RF:44	regurgitant fraction
RF	RF:46	reissners fiber
RF	RF:14	reissners fibre
RF	RF:50|Rf:14	respiratory frequency
RF	RF:7	resting flux
RF	RF:10	restricted daily feeding
RF	RF:21	restricted feeding
RF	RF:13	retroperitoneal fibromatosis
RF	RF:124	rheumatic fever
RGAs	RGAs:17	resistance gene analogs
RGAs	RGAs:12	resistance gene analogues
RGDS	RGDS:136	argglyaspser
RGDS	RGDS:9	arginineglycineaspartic acidserine
RGD	RGD:567	argglyasp
RGD	RGD:31	arginineglycineaspartate
RGD	RGD:150	arginineglycineaspartic acid
RGM	RGM:19	rapidly growing mycobacteria
RGM	RGM:8	reactive gaseous mercury
RGP	RGP:5	rabies virus glycoprotein
RGP	RGP:21	radial growth phase
RG	RG:24	red gastrocnemius
RG	RG:8|R-G:6|r-g:2	redgreen
RG	RG:8|Rg:1	reference group
RG	RG:22	renormalization group
RG	RG:10	rhamnogalacturonan
Rg	Rg:11	rodgers
Rg	Rg:11	rough
rha	rha:11	lrhamnose
RHA	RHA:13	regional health authority
rha	rha:7|RHA:1|Rha:1	rhamnose
RHA	RHA:9	right hepatic artery
RHA	RHA:11	roman high avoidance
RHDV	RHDV:58	rabbit haemorrhagic disease virus
RHDV	RHDV:39	rabbit hemorrhagic disease virus
RHD	RHD:18	rel homology domain
RHD	RHD:146|Rhd:1	rheumatic heart disease
RHD	RHD:21	right hemisphere damage
RHL	RHL:17	recurrent herpes labialis
RHL	RHL:13	respiratory heat loss
RHR	RHR:9	rel homology region
RHR	RHR:7	relative hazard rate
RHR	RHR:17	renovascular hypertensive rats
RHR	RHR:10|rHR:1	resting heart rate
RHT	RHT:15	regional hyperthermia
RHT	RHT:78	retinohypothalamic tract
RHT	RHT:10	ruthenium hexammine trichloride
RIA	RIA:22	radioimmune assay
RIA	RIA:14	radioimmuno assay
RIA	RIA:13	radioimmunological assay
RIF	RIF:11	radiationinduced fibrosis
RIF	RIF:8	renal interstitial fibrosis
RIF	RIF:15	renal interstitial fluid
RIF	RIF:20	rigid internal fixation
RIF	RIF:6	rosette inhibitory factor
RII	RII:15	radioimmunoimaging
RII	RII:13	regulatory
RII	RII:4|R-II:1	regulatory subunit of type ii campdependent protein kinase
RII	RII:36|R-II:1	type ii receptor
RII	RII:19	type ii regulatory subunit
RIL	RIL:14	rabbit ileal loop
RIL	RIL:28	recombinant inbred line
RIND	RIND:10	reversible ischemic neurologic deficit
RIND	RIND:18	reversible ischemic neurological deficit
RIPA	RIPA:11	ristocetininduced platelet agglutination
RIPA	RIPA:28	ristocetininduced platelet aggregation
RIP	rip:4|RIP:4	nucleus raphe interpositus
RIP	RIP:9	radioimmune precipitation
RIP	RIP:70	radioimmunoprecipitation
RIP	RIP:32	receptorinteracting protein
RIP	RIP:15|Rip:2	regulated intramembrane proteolysis
RIP	RIP:55	repeatinduced point mutation
RIP	RIP:11	respiratory inductance plethysmograph
RIP	RIP:19	respiratory inductance plethysmography
RIP	RIP:23	respiratory inductive plethysmograph
RIP	RIP:57	respiratory inductive plethysmography
RIP	RIP:6	rnaiiiinhibiting peptide
RIP	RIP:5	under the control of the rat insulin promoter
RIST	RIST:13	radioimmunosorbent test
RIST	RIST:12	rapid insulin sensitivity test
RITA	RITA:9	intervention treatment of angina
RITA	RITA:8	radiofrequency interstitial tumor ablation
RITA	RITA:36	right internal thoracic artery
RIT	RIT:3|Rit:1	ht antagonist ritanserin
RIT	RIT:8	repetitive irritation test
RIT	RIT:13|R-IT:1	rush immunotherapy
RJ	RJ:11	rio de janeiro
RJ	RJ:28	royal jelly
RLA	RLA:8	radioligand assay
RLA	RLA:8	reninlike activity
RLE	RLE:27	rat liver epithelial
RLE	RLE:10	rat lung endothelial
RLF	RLF:9	rat lung fibroblasts
RLF	RLF:46	relaxinlike factor
RLF	RLF:44	retrolental fibroplasia
RLKs	RLKs:16	receptorlike kinases
RLKs	RLKs:8	receptorlike protein kinases
RLM	RLM:7	latex microspheres
RLM	RLM:14	rat liver mitochondria
RLV	RLV:7	liver volume
RLV	RLV:49	rauscher leukemia virus
RLS	RLS:344	restless legs syndrome
RLS	RLS:15	righttoleft shunt
RL	RL:14	form of ringer lactate
RL	RL:11	latency
RL	RL:231|Rl:7	lung resistance
RL	RL:8	red light
RL	RL:8	reinforcement learning
RL	RL:6|Rl:1	resistance of the lung
RL	RL:9	right lateral
R-L	R-L:8	right minus left
R-L	R-L:18|RL:2|R--L:1	righttoleft
RL	RL:71	ringers lactate
RL	RL:6	ringers lactate solution
RMC	RMC:10	rat mast cells
RMC	RMC:11	rat peritoneal mast cells
RME	RME:8	normal rat mammary epithelial
RME	RME:41	rapid maxillary expansion
RME	RME:53|Rme:1	receptormediated endocytosis
RME	RME:16	resting metabolic expenditure
RMF	RMF:6|rmf:1	remanent magnetic field
RMF	RMF:15	ribosome modulation factor
RMI	RMI:17	reticulocyte maturity index
RMI	RMI:30	rivermead mobility index
RMS40	RMS40:7	 ms of the qrs complex
RMS40	RMS40:1	voltage in the terminal  ms
RMSSD	RMSSD:13|rMSSD:3	root mean square of successive differences
RMSSD	RMSSD:4|r-MSSD:3	root mean square successive difference
RMS	RMS:10	rat milk substitute
RMS	RMS:12	respiratory muscle strength
RMS	RMS:55	rostral migratory stream
RMS	RMS:7	signal amplitude
RMT	RMT:9	random matrix theory
RMT	RMT:11	recognition memory test
RMT	RMT:18|rMT:5	resting motor threshold
RNA	RNA:735	northern
RNA	RNA:21	radionuclide angiocardiography
RNA	RNA:64	renal nerve activity
RNA	RNA:28	renal sympathetic nerve activity
RND	RND:35|rND:2	radical neck dissection
RND	RND:14	resistancenodulationcell division
RNFL	RNFL:203	retinal nerve fiber layer
RNFL	RNFL:51	retinal nerve fibre layer
RNFLT	RNFLT:9	retinal nerve fiber layer thickness
RNFLT	RNFLT:8	retinal nerve fibre layer thickness
RNOS	RNOS:8	reactive nitrogen oxide species
RNOS	RNOS:5	reactive nitrogen oxygen species
RNP	RNP:6	ribonuclear protein
RNP	RNP:10	ribonucleoprotein complex
RNP	RNP:11	rnaprotein
RNs	RNs:19	recombination nodules
RNs	RNs:197|RNS:1	registered nurses
RNTCP	RNTCP:8	revised national tb control programme
RNTCP	RNTCP:17	revised national tuberculosis control programme
ROA	ROA:12	radiographic osteoarthritis
ROA	ROA:27	raman optical activity
ROA	ROA:11	regurgitant orifice area
ROB	ROB:5|rOB:2	rat osteoblasts
ROB	ROB:7	rat osteoblastlike
ROCs	ROCs:21	receiver operating characteristics
ROCs	ROCs:9	receptoroperated ca channels
ROC	ROC:5	receptoroperated channels
ROC	ROC:5|roc:5	rocuronium
ROESY	ROESY:10	rotating frame nuclear overhauser effect spectroscopy
ROESY	ROESY:5	rotating frame nuclear overhauser enhancement spectroscopy
ROK	ROK:13	republic of korea
ROK	ROK:12	rhokinase
ROM	ROM:25	range of movement
ROM	ROM:10	recurrent otitis media
ROM	ROM:4	rupture of the membranes
ROP	ROP:741|RoP:1	retinopathy of prematurity
ROP	ROP:13	ringopening polymerization
Ros	Ros:6|ROS:1	oscillatory resistance
ROS	ROS:10	oxygen radicals
ROS	ROS:23	rat osteosarcoma
ROS	ROS:28	reactive oxygen
ROS	ROS:6	reactive oxygen substances
Ros	Ros:9	respiratory resistance
ROU	ROU:13	recurrent oral ulcers
ROU	ROU:10	recurrent oral ulceration
Ro	Ro:4	csf outflow resistance
Ro	Ro:13	net reproductive rate
RO	RO:15	reality orientation
RO	RO:20	relative odds
RO	RO:86	reverse osmosis
RPA	RPA:9	approach
RPA	RPA:229	protection assay
RPA	RPA:8	random phase approximation
RPA	RPA:9	rapid plate agglutination
rPA	rPA:7	recombinant pa
rPA	rPA:16	recombinant protective antigen
RPA	RPA:56	recursive partitioning analysis
RPA	RPA:10	recursive partitioning and amalgamation
RPA	RPA:10	retropharyngeal abscess
RPA	RPA:15	reversed passive arthus
RPA	RPA:38|rPA:1	right pulmonary artery
RPB1	RPB1:6|Rpb1:1	largest subunit
RPB1	RPB1:5|rpb1:2|Rpb1:2	largest subunit of rna polymerase ii
RPC	RPC:9	peritoneal cells
RPC	RPC:11	radiological physics center
RPC	RPC:10	reactive perforating collagenosis
RPC	RPC:10	recurrent pyogenic cholangitis
RPC	RPC:24	reversedphase chromatography
RPE	RPE:450	perceived exertion
RPE	RPE:13	rapid palatal expansion
RPE	RPE:866|rpe:1	retinal pigment epithelial
RPE	RPE:89	retinal pigment epithelial cells
RPE	RPE:1615|rpe:3	retinal pigment epithelium
RPF	RPF:11	rate of pacemaker firing
RPF	RPF:11	renal plasma flow rate
RPF	RPF:45	retroperitoneal fibrosis
RPH	RPH:9	retinyl palmitate hydrolase
RPH	RPH:7	royal perth hospital
R-PIA	R-PIA:13|RPIA:1	nrphenylisopropyladenosine
R-PIA	R-PIA:2|RPIA:1	receptor agonist rphenylisopropyl adenosine
RPI	RPI:5|Rpi:3	ribosephosphate isomerase
RPI	RPI:8	rna polymerase i
RPLC	RPLC:10|RP-LC:1	reversedphase liquid chromatographic
RPLC	RPLC:95|RP-LC:15	reversedphase liquid chromatography
RPM	RPM:14	rat pleural mesothelial
RPM	RPM:11	ravens progressive matrices
RPM	RPM:18|R-PM:1	resident peritoneal macrophages
RPO	RPO:12	red palm oil
RPO	RPO:11|rpo:1|Rpo:1	reticularis pontis oralis
RPP	RPP:20	radical perineal prostatectomy
RPP	RPP:73	rapidly progressive periodontitis
RPP	RPP:149	renal perfusion pressure
RPR	RPR:139	rapid plasma reagin
RPR	RPR:13	rapid plasma reagin test
RPs	RPs:9	refractory periods
RPs	RPs:9	released proteins
RPs	RPs:12|rps:1	ribosomal proteins
RPTC	RPTC:15	renal proximal tubular cells
RPTC	RPTC:13	renal proximal tubule cells
RPTE	RPTE:7	proximal tubular epithelial
RPTE	RPTE:6	proximal tubule epithelial
RPV	RPV:9	rabbit poxvirus
RPV	RPV:98	rinderpest virus
Rp	Rp:18|RP:5	peripheral airway resistance
Rp	Rp:12|RP:8|rP:1	progesterone receptor
RP	RP:24	radiation pneumonitis
RP	RP:307	radical prostatectomy
RP	RP:30	rapid prototyping
RP	RP:234	raynauds phenomenon
RP	RP:10	reaction product
RP	RP:6	reactivity pattern
RP	RP:38	readiness potential
RP	RP:20	recognition potential
RP	RP:10	red pulp
RP	RP:14	regulatory particle
RP	RP:9	regulatory peptides
RP	RP:28	relapse prevention
RP	RP:11|rp:2	relative potency
RP	RP:14	relative power
RP	RP:9	resting pressure
RP	RP:10	retained placenta
RP	RP:14	reticulated platelets
RP	RP:551|rp:1	retinitis pigmentosa
RP	RP:78|rp:1	retinyl palmitate
RP	RP:15	retrograde pyelography
RP	RP:34|Rp:1	retroperitoneal
RP	RP:6	retruded position
RP	RP:14|rp:1	reversephase
RP	RP:106	reversedphase
RP	RP:11	rheumatoid polyarthritis
RP	RP:10	rinderpest
RP	RP:8	rock phosphate
RP	RP:11	roller pump
RRC	RRC:8	renal renin content
RRC	RRC:28	residency review committee
RRF	RRF:7	raggedred fibres
RRF	RRF:99	residual renal function
RRF	RRF:11	retrorubral field
RRF	RRF:49	ribosome recycling factor
RRMS	RRMS:6|RR-MS:4	relapsingremitting
RRMS	RRMS:54|RR-MS:14	relapsingremitting ms
RRMS	RRMS:83|RR-MS:18	relapsingremitting multiple sclerosis
RRMs	RRMs:7	retinoidrelated molecules
RRMs	RRMs:69	rna recognition motifs
RRM	RRM:6	random regression model
RRM	RRM:19	reduced renal mass
RRM	RRM:9|rrm:1	resonant recognition model
RRP	RRP:184|rrP:1	radical retropubic prostatectomy
RRP	RRP:34	readily releasable pool
RRP	RRP:77	recurrent respiratory papillomatosis
RRP	RRP:15	relative refractory period
RRT	RRT:27	regimenrelated toxicity
RRT	RRT:4	relative retention time
RRT	RRT:298	renal replacement therapy
RRV	RRV:14	rhesus monkey rhadinovirus
RRV	RRV:8	rhesus rhadinovirus
RRV	RRV:41	rhesus rotavirus
RRV	RRV:57|RRv:4	ross river virus
RR	RR:27|R-R:1	patients with relapsingremitting
RR	RR:20	recovery room
RR	RR:32	relapsing remitting
RR	RR:7	relative recovery
RR	RR:5	relative risk of death
RR	RR:17	renin release
RR	RR:13	respiratory rates
RR	RR:10	response regulator
RR	RR:15	reversal reaction
RR	RR:21	reverse redistribution
RR	RR:14	righting reflex
RR	RR:26	ross river
RR	RR:9	roundup ready
RSA	RSA:14	hippocampal rhythmic slow activity
RSA	RSA:21	hippocampal rhythmical slow activity
RSA	RSA:39	radiostereometric analysis
RSA	RSA:17	radiostereometry
RSA	RSA:13	republic of south africa
RSA	RSA:228	respiratory sinus arrhythmia
RSA	RSA:62	roentgen stereophotogrammetric analysis
RSCA	RSCA:9	reference strand mediated conformation analysis
RSCA	RSCA:7	reference strandmediated conformational analysis
RSDR	RSDR:9|RSDr:7	repeatability relative standard deviations
RSDR	RSDR:19	reproducibility relative standard deviations
RSE	RSE:20	refractory status epilepticus
RSE	RSE:14	selfesteem scale
RSF	RSF:13	raw soya flour
RSF	RSF:18	rheumatoid synovial fibroblasts
RSM	RSM:26	radix salviae miltiorrhizae
RSM	RSM:17|Rsm:1	rapeseed meal
RSM	RSM:4	receptor surface model
RSM	RSM:6	response surface method
RSM	RSM:25	restriction site mutation
RSPs	RSPs:7	recombinant subviral particles
RSPs	RSPs:6	restriction site polymorphisms
RSP	RSP:10	regulated secretory pathway
RSP	RSP:11	respirable suspended particles
RSR	RSR:6	relative survival rates
RSR	RSR:38	renin secretion rate
RSS	RSS:7	responsive search score
RSS	RSS:23	russellsilver syndrome
RSV	RSV:9	regurgitant stroke volume
RSV	RSV:10	respiratory syncytial viral
RSV	RSV:617|rsv:1	rous sarcoma virus
RSV	RSV:9	saphenous vein
RS	RS:10	arginineserinerich
RS	RS:9	radical surgery
RS	RS:34	radiosurgery
RS	RS:13	raman spectroscopy
RS	RS:20	rankin scale
RS	RS:10|rS:1	rat serum
rs	rs:9	recombinant soluble
RS	RS:156|R-S:36	reedsternberg
RS	RS:71	reiters syndrome
RS	RS:7	related medullary inhibitory reticulospinal
RS	RS:28|Rs:1	remote sensing
RS	RS:9	renin secretion
RS	RS:11	renin substrate
RS	RS:5	repeated sequences
RS	RS:98	resistant starch
RS	RS:9	response signal
RS	RS:16	restraint scale
RS	RS:49	reyes syndrome
RS	RS:16	rio grande do sul
RS	RS:6|Rs:1	robin sequence
RS	RS:9	rubrospinal
rs	rs:10	steadystate fluorescence anisotropy
Rs	Rs:5|rs:3|RS:1	stokes radii
Rs	Rs:14|rs:5|RS:5|r-s:1	stokes radius
RS	RS:15	xlinked juvenile retinoschisis
RTA	RTA:5	chain of ricin
RTA	RTA:124	renal tubular acidosis
RTA	RTA:15|Rta:2	replication and transcription activator
RTA	RTA:28	retinal thickness analyzer
RTA	RTA:14	ricin toxin a chain
RTA	RTA:9	royal thai army
RTD	RTD:6	rate of torque development
RTD	RTD:15	renal tubular dysgenesis
RTD	RTD:16	residence time distribution
RTD	RTD:5	respiratory tract disease
RTD	RTD:16	routine test dilution
RTE	RTE:69	rat tracheal epithelial
RTE	RTE:39	readytoeat
RTE	RTE:7	renal tubular epithelium
RTF	RTF:11	regeneration and tolerance factor
RTF	RTF:30	rete testis fluid
RTIs	RTIs:37	reproductive tract infections
RTIs	RTIs:74	respiratory tract infections
RTIs	RTIs:22	reverse transcriptase inhibitors
RT-PCR	RT-PCR:18	chain reaction assay
RT-PCR	RT-PCR:2993|RT--PCR:1|rt-pcr:1|rt-PCR:1|rtPCR:1|RTPCR:1	reverse transcriptasepolymerase chain reaction
RT-PCR	RT-PCR:5	reverse transcription and polymerase chain reaction technique
RTV	RTV:83|Rtv:3|rtv:1	ritonavir
RTV	RTV:5	roomtemperature vulcanizing
RTX	RTX:18	hresiniferatoxin
RTX	RTX:13	raltitrexed
RTX	RTX:94	resiniferatoxin
RTX	RTX:11	rituximab
RTH	RTH:129	resistance to thyroid hormone
RTH	RTH:9	thyroid hormone resistance
RTs	RTs:12	respiratory therapists
RTs	RTs:62	reverse transcriptases
RTS	RTS:80	revised trauma score
RTS	RTS:32	rothmundthomson syndrome
RTS	RTS:45|RTs:1	rubinsteintaybi syndrome
Rt	Rt:10|RT:1	nucleus rotundus
RT	RT:8	radiation treatment
RT	RT:29	radiotherapy alone
RT	RT:34	reactive thrombocytosis
RT	RT:12	realtime
RT	RT:10|rt:1	reciprocal translocations
RT	RT:7	reciprocating tachycardia
RT	RT:18	recurrent tonsillitis
RT	RT:12	relaxation training
RT	RT:35	resistance training
RT	RT:17	respiratory tract
RT	RT:14	response times
RT	RT:23	resting tension
Rt	Rt:5|RT:4	reticular
RT	RT:14	reverse transcribed
RT	RT:131|rt:4|Rt:2|rT:1	room temperature
Rt	Rt:4|RT:3	total vascular resistance
RT	RT:9	tumor
RUL	RUL:21	right unilateral
RUL	RUL:20	right upper lobe
RUS	RUS:5	realtime ultrasonography
RUS	RUS:5	renal ultrasonography
RUS	RUS:8	ultrasound spectroscopy
RV/TLC	RV/TLC:5	ratio of residual volume to total lung capacity
RV/TLC	RV/TLC:8	residual volumetotal lung capacity
RVA	RVA:14	retinal vessel analyzer
RVA	RVA:28|RVa:3	right ventricular apex
RVD	RVD:22|rVD:1	rat vas deferens
RVD	RVD:364	regulatory volume decrease
RVD	RVD:18	renovascular disease
RVD	RVD:7	right ventricular dimension
RVD	RVD:11	right ventricular dysfunction
RVD	RVD:17	right ventricular dysplasia
RVF	RVF:138	rift valley fever
RVF	RVF:15	right ventricular failure
RVI	RVI:90	regulatory volume increase
RVI	RVI:29	right ventricular infarction
RVL	RVL:9	nucleus reticularis rostroventrolateralis
RVL	RVL:9	rostral ventrolateral reticular nucleus
RVP	RVP:12	rapid ventricular pacing
RVP	RVP:14	rat ventral prostate
RVP	RVP:26|RVp:1	right ventricular pressure
RVR	RVR:8	renal vein renin
RVR	RVR:14	repetitive ventricular response
RVR	RVR:9|Rvr:1	resistance to venous return
RV	RV:24	rappaportvassiliadis
RV	RV:26	rat virus
RV	RV:11	renal vein
RV	RV:6	renal venous
RV	RV:12	retinal vasculitis
RV	RV:12	retroviral vector
RV	RV:21	rheumatoid vasculitis
RV	RV:104|Rv:2	rotavirus
RWM	RWM:55	regional wall motion
RWM	RWM:52	round window membrane
RW	RW:22	ragweed
RW	RW:10	relative weight
RW	RW:61	round window
RyR2	RyR2:31|RyR-2:1|RYR-2:1	cardiac ryanodine receptor
RyR2	RyR2:4|RYR2:2	ryanodine receptor 
RY	RY:6|R-Y:3	purinepyrimidine
RY	RY:8|R-Y:2	rouxeny
RAF	RAF:9	relative activity factor
RAF	RAF:10	repetitive atrial firing
RalGDS	RalGDS:7|Ral-GDS:2	ral gdp dissociation stimulator
RalGDS	RalGDS:9|ralGDS:2	ral guanine nucleotide dissociation stimulator
rbcL	rbcL:15	carboxylaseoxygenase
rbcL	rbcL:7	large subunit gene
rbcL	rbcL:5	large subunit of ribulosebisphosphate carboxylase
Renca	Renca:8|RENCA:2	murine renal carcinoma
Renca	Renca:10|RENCA:6|renca:2|RenCa:1	murine renal cell carcinoma
Rh	Rh:8	antid
RH	RH:12	radial haemolysis
RH	RH:21	radical hysterectomy
RH	RH:11	reactive hyperaemia
RH	RH:12	reduced haloperidol
RH	RH:5	rel homology
RH	RH:7	relative hypoglycemia
RH	RH:11	renal hypercalciuria
RH	RH:67	reproductive health
RH	RH:12	resistant hepatocyte
RH	RH:4	rgs homology
RH	Rh:5|RH:5	rhein
Rh	Rh:62|rh:3|RH:1	rhesus
Rh	Rh:11|rh:1|RH:1	rhodamine
RH	RH:11|rh:1	righthanded
Rmax	Rmax:5	maximum relaxation
Rmax	Rmax:6	removal rate
Rm	Rm:57|RM:2|rm:1	membrane resistance
Rm	Rm:16	membrane resistivity
RM	RM:13	radical mastectomy
RM	RM:5	radioactive microspheres
RM	RM:34|rm:3|Rm:1	raphe magnus
RM	RM:19	recurrent miscarriage
RM	RM:10	red marrow
RM	RM:6	red muscle
RM	RM:9	reissners membrane
Rm	Rm:12|RM:3	relative mobility
RM	RM:9	relative movement
RM	RM:37	repetition maximum
RM	RM:9	respiratory muscle
RM	RM:7	risk management
RM	RM:4	rough microsomal membranes
RM	RM:11	rough microsomes
RN	RN:19	radical nephrectomy
RN	RN:34|Rn:1	radionuclide
RN	RN:129	red nucleus
RN	RN:33	reflux nephropathy
RN	RN:5	rheumatoid nodules
Rrs	Rrs:14|RRS:2	resistance of the respiratory system
Rrs	Rrs:80|RRS:5	respiratory system resistance
Rrs	Rrs:60	total respiratory resistance
RTP	RTP:27	replication terminator protein
RTP	RTP:13	room temperature phosphorescence
RTP	RTP:18	treatment planning
RyRs	RyRs:9	release channels
RyRs	RyRs:168|RYRs:10|ryRs:1	ryanodine receptors
RyR3	RyR3:11|RYR3:2|RyR-3:1	ryanodine receptor type 
RyR3	RyR3:8	type  ryanodine receptor
S/D	S/D:47	systolicdiastolic
S/D	S/D:19	systolicdiastolic ratio
S/D	S/D:14	systolic to diastolic
S/S	S/S:13	solidificationstabilization
S/S	S/S:10|s/s:3	stabilizationsolidification
S1	S1:6	early proximal tubule
S1	S1:8	excited singlet
S1	S1:24	first heart sound
S1	S1:6	first sacral
S1	S1:15	first stimulus
S1	S1:6|S-1:4	myosin
S1	S1:1	myosin and subfragment
S1	S1:213|S-1:83	myosin subfragment 
S1	S1:9	subunit
S1	S1:10	warning
S2	S2:11	allele
S2	S2:16	drosophila schneider 
S2	S2:19	extrastimulus
S2	S2:17	premature stimulus
S2	S2:14	second heart sound
S2	S2:26	second stimulus
S3	S3:9	proximal tubule
S3	S3:14	sacral
S3	S3:24	third heart sound
S4	S4:9	fourth heart sound
S4	S4:6	fourth transmembrane segment
S9	S9:14|S-9:9	 x g supernatant
S9	S9:21	metabolic activation
S9	S9:6|S-9:3	preparations
S9	S9:5|S-9:4	supernatants
SAA	SAA:21|SaA:1	serum amyloida
SAA	SAA:6	serum anticholinergic activity
SAA	SAA:83	severe aplastic anaemia
SAA	SAA:203|sAA:2	severe aplastic anemia
SAA	SAA:11	splenic artery aneurysms
SAA	SAA:20	sulfur amino acid
SABP	SABP:5	secretory actinbinding protein
SABP	SABP:14	systemic arterial blood pressure
SAB	SAB:5	solidadherent bacteria
SAB	SAB:31	spontaneous abortion
SAB	SAB:10	spontaneous alternation behavior
SAB	SAB:21	staphylococcus aureus bacteremia
SAB	SAB:7	subarachnoid block
SACs	SACs:19	stretchactivated channels
SACs	SACs:10	stretchactivated ion channels
SAD	SAD:14	sagittal abdominal diameter
SAD	SAD:23	secalonic acid d
SAD	SAD:15	singlewavelength anomalous diffraction
SAD	SAD:13	singlewavelength anomalous dispersion
SAD	SAD:20	sinoaortic baroreceptor denervation
SAD	SAD:6	source to axis distance
SAD	SAD:14|sAD:1	sporadic ad
SAD	SAD:11|sAD:3	sporadic alzheimers disease
SAD	SAD:8	succinic acid dimethyl ester
SAECG	SAECG:59|SA-ECG:2	signalaveraged ecg
SAECG	SAECG:41	signalaveraged electrocardiography
SAE	SAE:8	signalaveraged electrocardiogram
SAE	SAE:9	stimulated acoustic emission
SAE	SAE:24	subcortical arteriosclerotic encephalopathy
SAF	SAF:9	activating factor
SAF	SAF:45	scrapieassociated fibrils
SAGB	SAGB:25	swedish adjustable gastric band
SAGB	SAGB:7	swedish adjustable gastric banding
SAGE	SAGE:357	serial analysis of gene expression
SAGE	SAGE:6	systematic assessment of geriatric drug use via epidemiology
SAG	SAG:6	sensitive to apoptosis gene
SAG	SAG:16	sodium antimony gluconate
SAG	SAG:10|SAg:1	statoacoustic ganglion
SAHS	SAHS:37	sleep apneahypopnea syndrome
SAHS	SAHS:44	sleep apnoeahypopnoea syndrome
SAH	SAH:10	selfassessed health
SAH	SAH:6	severe alcoholic hepatitis
SAH	SAH:491	subarachnoid haemorrhage
SAH	SAH:8	subarachnoid hemorrhages
SAH	SAH:11	systemic arterial hypertension
SAIDS	SAIDS:13	simian acquired immune deficiency syndrome
SAIDS	SAIDS:29|sAIDS:1	simian acquired immunodeficiency syndrome
SAI	SAI:20|SA-I:1	slowly adapting type i
SAI	SAI:12|S-AI:1	state anxiety inventory
SALS	SALS:14|sALS:10|s-ALS:1	sporadic als
SALS	SALS:23|sALS:12|S-ALS:3	sporadic amyotrophic lateral sclerosis
SAL	SAL:31|Sal:2	salsolinol
SAL	SAL:7	sensorineural acuity level
SAL	SAL:10	short attack latency
SAMP8	SAMP8:11|SAM-P8:2	senescenceaccelerated mice
SAMP8	SAMP8:12|SAM-P8:1	senescenceaccelerated mouse
SAMs	SAMs:182|SAMS:2	selfassembled monolayers
SAMs	SAMs:9	shoot apical meristems
SAM	SAM:6	activity monitor
SAM	SAM:26	salicylamide
SAM	SAM:13	scanning acoustic microscope
SAM	SAM:26	scanning acoustic microscopy
SAM	SAM:64	shoot apical meristem
SAM	SAM:12	sinusoidal amplitude modulation
SAM	SAM:7	smokingattributable mortality
SAM	SAM:26	sterile alpha motif
SAM	SAM:8	substrateattached material
SAM	SAM:11	surface active material
SAM	SAM:10	surfaceassociated material
SAM	SAM:19	synthetic aperture magnetometry
SAM	SAM:62	systolic anterior motion
SAM	SAM:19	systolic anterior motion of the mitral valve
SAM	SAM:10	systolic anterior movement
SaO2	SaO2:7	oxygen saturations
SaO2	SaO2:4	saturation of oxygen
SAO	SAO:17	southeast asian ovalocytosis
SAO	SAO:52	splanchnic artery occlusion
SAPS	SAPS:49	scale for the assessment of positive symptoms
SAPS	SAPS:90	simplified acute physiology score
SAP	SAP:9	assessment of personality
SAP	SAP:18	sensory action potential
SAP	SAP:7	serum acid phosphatase
SAP	SAP:53|sAP:10|S-AP:5|s-AP:2	serum alkaline phosphatase
SAP	SAP:45	serum amyloid p
SAP	SAP:83|sAP:1	severe acute pancreatitis
SAP	SAP:46|sAP:1	stable angina pectoris
SAP	SAP:34	standard automated perimetry
SAP	SAP:9	steroidogenesis activator polypeptide
SAP	SAP:16	stressactivated protein
SAP	SAP:7	symptom association probability
SAP	SAP:217|sAP:1	systolic arterial pressure
SARA	SARA:11	sexually acquired reactive arthritis
SARA	SARA:12	smad anchor for receptor activation
SARA	SARA:11	subacute ruminal acidosis
SARs	SARs:12	scaffoldassociated regions
SARs	SARs:10	scaffold attachment regions
SARs	SARs:46	specific absorption rates
SAR	SAR:3|sar:2	patients with sarcoidosis
SAR	SAR:16	scaffold attachment region
SAR	SAR:131	seasonal allergic rhinitis
SAR	SAR:9	slowly adapting pulmonary stretch receptor
SAR	SAR:6	slowly adapting receptors
SAR	SAR:6	slowly adapting stretch receptors
SAR	SAR:13	synthetic aperture radar
SAR	SAR:119	systemic acquired resistance
SAR	SAR:5	systemic anaphylactic reaction
SASP	SASP:30	salazosulfapyridine
SASP	SASP:10	salazosulphapyridine
SASP	SASP:28	salicylazosulfapyridine
SASP	SASP:1	small acidsoluble proteins
SAS	SAS:22	selfrating anxiety scale
SAS	SAS:223	sleep apnea syndrome
SAS	SAS:19	social adjustment scale
SAS	SAS:24	subaortic stenosis
SAS	SAS:32	subarachnoid space
SAS	SAS:8	surfaceactive substances
SAS	SAS:15	surface anatomy scanning
SAS	SAS:26	sympathoadrenal system
SAT	SAT:11	african territories
SAT	SAT:6	selfadministered therapy
SAT	SAT:26	serine acetyltransferase
SAT	SAT:41	serum agglutination test
SAT	SAT:11	soil aquifer treatment
SAT	SAT:33	spontaneous autoimmune thyroiditis
SAT	SAT:8	subacute stent thrombosis
SAT	SAT:7	subacute thrombosis
SAT	SAT:7	substance abuse treatment
SA	SA:10	cocaine selfadministration
SA	SA:8	heroin selfadministration
SA	SA:18|Sa:1	sarcoidosis
SA	SA:7	satellite association
SA	SA:9	separation anxiety
SA	SA:16	septic arthritis
SA	SA:9	serrated adenoma
SA	SA:12	serratus anterior
SA	SA:8	serum aldosterone
SA	SA:11|S-A:1	shortaxis
SA	SA:7	sideroblastic anaemia
SA	SA:50	simulated annealing
SA	SA:7	sinus arrhythmia
SA	SA:5	situation awareness
SA	SA:10	skeletal age
SA	SA:34	sleep apnea
SA	SA:12	sleep apnoea
SA	SA:8	slide agglutination
SA	SA:76	slowly adapting
SA	SA:9	sodium alginate
SA	SA:13	south africa
SA	SA:16	south african
SA	SA:19	south australia
SA	SA:15	spectral analysis
SA	SA:8	spherical aberration
SA	SA:15	spinal anaesthesia
SA	SA:19	spinal anesthesia
SA	SA:13	splenic artery
SA	SA:19	spontaneous activity
SA	SA:11	spontaneous alternation
SA	SA:52|sa:1	stable angina
SA	SA:10	state anxiety
SA	SA:13	status asthmaticus
SA	SA:35	stearylamine
SA	SA:61	streptavidin
SA	SA:21	streptococcal antigen
SA	SA:36	stretchactivated
SA	SA:24	substance abuse
SA	SA:10	succinic anhydride
SA	SA:40	succinylacetone
SA	SA:9	sulcus angle
SA	SA:9	sulfanilamide
SA	SA:54|Sa:14	surface area
SA	SA:10	surgery alone
SA	SA:21	sympathoadrenal
SBA	SBA:44	glycine max
SBA	SBA:56	serum bactericidal activity
SBA	SBA:17	serum bactericidal antibody
SBA	SBA:12	serum bactericidal assay
SBA	SBA:19	sheep blood agar
SBA	SBA:22	sodium benzylidenelascorbate
SBA	SBA:290	soybean agglutinin
SBC	SBC:20	selective brain cooling
SBC	SBC:8|sbc:1	simple bone cyst
SBC	SBC:7	superficial bladder cancer
SBD	SBD:15	selective bowel decontamination
SBD	SBD:15	starchbinding domain
SBE	SBE:10	starch branching enzyme
SBE	SBE:34	subacute bacterial endocarditis
SBH	SBH:5	sabra hypertensionprone
SBH	SBH:10	saltsensitive
SBH	SBH:26|SbH:1	sequencing by hybridization
SBH	SBH:25	southern blot hybridization
SBH	SBH:21	subcortical band heterotopia
SBI	SBI:11	screening and brief intervention
SBI	SBI:15	serious bacterial infection
SBI	SBI:4	severe brain injury
SBI	SBI:11	silent brain infarction
SBI	SBI:6	small bowel injury
SBI	SBI:30	sulcus bleeding index
SBO	SBO:6	side branch occlusion
SBO	SBO:11	spina bifida occulta
sBPT	sBPT:7|SBPT:1	specific bronchial provocation test
sBPT	sBPT:7	specific bronchial provocative test
SBP	SBP:5	serotonin binding proteins
SBP	SBP:10	soybean peroxidase
SBP	SBP:187	spontaneous bacterial peritonitis
SBP	SBP:389|sBP:4	systolic bp
SBR	SBR:8	salivabinding region
SBR	SBR:1	scarff bloom and richardson
SBR	SBR:14	scarffbloomrichardson
SBR	SBR:60|SBr:1	small bowel resection
SBR	SBR:9	spontaneous baroreflex
SBR	SBR:6	stillbirth rate
SBR	SBR:12	styrenebutadiene rubber
SBS	SBS:10	secondary bilateral synchrony
SBS	SBS:113	short bowel syndrome
SBS	SBS:15	spinobulbospinal
SBS	SBS:13	stimulated brillouin scattering
SBV	SBV:7	sacbrood virus
SBV	SBV:9	shed blood volume
SB	SB:6|Sb:3	saccharomyces boulardii
SB	SB:13	schiff base
SB	SB:11	scleral buckling
SB	SB:18	serum bilirubin
SB	SB:37	single bond
SB	SB:11	singlebreath
SB	SB:9	sinus bradycardia
SB	SB:12	sleep bruxism
SB	SB:34	sleeping beauty
SB	SB:46|S-B:1	small bowel
SB	SB:22	southern blot
SB	SB:14	southern blotting
SB	SB:4|sb:1	specific binding
SB	SB:58	spina bifida
SB	SB:48|sb:1	spontaneous breathing
SB	SB:8	strand breaks
SC115	SC115:26|SC-115:1	shionogi carcinoma 
SC115	SC115:7	shionogi mouse mammary carcinoma
SCAD	SCAD:35	shortchain acylcoa dehydrogenase
SCAD	SCAD:16	spontaneous coronary artery dissection
SCAG	SCAG:11	sandoz clinical assessment geriatric
SCAG	SCAG:10	sandoz clinical assessment geriatric scale
SCA	SCA:10	selective coronary angiography
SCA	SCA:6	senescent cell antigen
SCA	SCA:6	sex chromosome abnormalities
SCA	SCA:6	structural chromosomal aberration
SCA	SCA:23	sudden cardiac arrest
SCA	SCA:61	superior cerebellar artery
SCA	SCA:13	suppressor cell activity
SCCE	SCCE:11	squamous cell carcinoma of the esophagus
SCCE	SCCE:23	stratum corneum chymotryptic enzyme
SCCM	SCCM:6|SC-CM:1	sertoli cellconditioned medium
SCCM	SCCM:14	society of critical care medicine
SCCs	SCCs:9	semicircular canals
SCCs	SCCs:5	solitary chemosensory cells
SCCs	SCCs:12	squamous cell cancers
SCCs	SCCs:388	squamous cell carcinomas
SCD	SCD:27	patients with spinocerebellar degeneration
SCD	SCD:16	scalp current density
SCD	SCD:7	sequential compression device
SCD	SCD:27	sister chromatid differentiation
SCD	SCD:10	spinocerebellar degenerations
SCD	SCD:8	spondylocostal dysostosis
SCD	SCD:9	spreading cortical depression
SCD	SCD:72|Scd:3|scd:1	stearoylcoa desaturase
SCD	SCD:5	stromelysin catalytic domain
SCD	SCD:20	subacute combined degeneration
SCD	SCD:11	systemic carnitine deficiency
SCE	SCE:14	specialized columnar epithelium
SCE	SCE:10	stilescrawford effect
SCFE	SCFE:10	slipped capital femoral epiphyses
SCFE	SCFE:138|scfe:2	slipped capital femoral epiphysis
SCF	SCF:12	selfconsistent field
SCF	SCF:10	slow coronary flow
SCF	SCF:9	supercritical fluid
SCG	SCG:5	alkaline singlecell gel
SCG	SCG:7	alkaline singlecell gel electrophoresis
SCG	SCG:24	single cell gel
SCG	SCG:133	sodium cromoglycate
SCG	SCG:19	superior cervical
SCG	SCG:222|scg:1	superior cervical ganglia
SCG	SCG:528|scg:2	superior cervical ganglion
SCID	SCID:18|scid:2	cb scidscid
SCID	SCID:124|scid:27	severe combined immune deficiency
SCID	SCID:101|scid:3	severe combined immunodeficiency disease
SCID	SCID:12|scid:1	severe combined immunodeficiency syndrome
SCID	SCID:704|scid:75|Scid:5	severe combined immunodeficient
SCID	SCID:8	severe combined immunodeficient mice
SCID	SCID:14	structured clinical interview for dsmiii
SCI	SCI:44	science citation index
SCI	SCI:20	silent cerebral infarction
SCI	SCI:7	spinal cord impairment
SCI	SCI:11	spinal cord ischemia
SCJ	SCJ:24	squamocolumnar junction
SCJ	SCJ:19	sternoclavicular joint
SCLCs	SCLCs:19	small cell lung cancers
SCLCs	SCLCs:28	small cell lung carcinomas
SCLE	SCLE:25	subacute cutaneous le
SCLE	SCLE:99	subacute cutaneous lupus erythematosus
SCLs	SCLs:11	soft contact lenses
SCLs	SCLs:9	synthetic combinatorial libraries
SCL	SCL:13|SCl:1	serum copper levels
SCL	SCL:69	sinus cycle length
SCL	SCL:75	skin conductance level
SCL	SCL:7	spindle cell lipoma
SCL	SCL:27|scl:1	stem cell leukemia
SCMC	SCMC:9	mucus contact
SCMC	SCMC:47	spontaneous cellmediated cytotoxicity
SCMV	SCMV:9	simian cytomegalovirus
SCMV	SCMV:12	sugarcane mosaic virus
SCM	SCM:11	secretory cell metaplasia
SCM	SCM:9	serumcontaining medium
SCM	SCM:5	solidscorrected milk
SCM	SCM:9	spleen conditioned medium
SCM	SCM:16|scm:1	split cord malformation
SCM	SCM:80	sternocleidomastoid
SCM	SCM:38	sternocleidomastoid muscle
SCM	SCM:7	streptococcal cell membrane
SCM	SCM:1	structuredness of the cytoplasmic matrix
SCM	SCM:7	surface complexation model
SCN	SCN:13	severe chronic neutropenia
SCN	SCN:67	severe congenital neutropenia
SCN	SCN:18	solid cell nests
SCN	SCN:12	soybean cyst nematode
SCN	SCN:12	special care nursery
SCN	SCN:40	suprachiasmatic
SCN	SCN:562	suprachiasmatic nuclei
SCN	SCN:10	suprachiasmatic nuclei of the hypothalamus
SCN	SCN:25	suprachiasmatic nucleus of the hypothalamus
SCOD	SCOD:13|sCOD:1	soluble chemical oxygen demand
SCOD	SCOD:9	soluble cod
SCORAD	SCORAD:13	scoring of atopic dermatitis
SCORAD	SCORAD:2	scoring of atopic dermatitis index
SCO	SCO:6|Sco:1	antagonist scopolamine
SCO	SCO:5	sertoli cell only syndrome
SCO	SCO:164	subcommissural organ
SCPs	SCPs:28|SCPS:1	slow cortical potentials
SCPs	SCPs:18	small cardioactive peptides
SCP	SCP:73	selective cerebral perfusion
SCP	SCP:10	sheep choroid plexus
SCP	SCP:11	single cell protein
SCP	SCP:12	small cardioactive peptide
SCP	SCP:15	supercooling point
sCR1	sCR1:23	soluble complement receptor 
sCR1	sCR1:35	soluble complement receptor type 
sCR1	sCR1:13	soluble cr
SCRs	SCRs:65	short consensus repeats
SCRs	SCRs:62	skin conductance responses
SCR	SCR:14|scr:2	scarecrow
SCR	SCR:14	selective catalytic reduction
SCR	SCR:9	shumiya cataract rat
SCT	SCT:5	cell tumors
sCT	sCT:252|SCT:87|S-CT:5|sCt:4|s-CT:4	salmon calcitonin
sCT	sCT:17|SCT:3|s-CT:1	salmon ct
SCT	SCT:5	silica clotting time
SCT	SCT:13	social cognitive theory
SCT	SCT:8	solid and cystic tumor
SCT	SCT:18	spinal cord transection
SCT	SCT:9	spinocerebellar tract
SCT	SCT:30|SCt:1	spinocervical tract
SCT	SCT:36|sCT:2|S-CT:2	spiral computed tomography
SCT	SCT:20|sCT:2|S-CT:1	spiral ct
SCT	SCT:7	subcutaneous connective tissue
SCV	SCV:19	salmonellacontaining vacuole
SCV	SCV:33	sensory conduction velocity
SCV	SCV:11|ScV:1	subclavian vein
SCV	SCV:10	variants
SCH	SCH:9|Sch:1	cell hyperplasia
SCH	SCH:9|Sch:1	sch 
SCH	SCH:8	spinal cord homogenate
SCH	SCH:5	suprachoroidal hemorrhage
SCS	SCS:9	saethrechotzen syndrome
SCs	SCs:113|Scs:3	schwann cells
SCS	SCS:7	selfcontrol schedule
SCS	SCS:23	somatic cell score
SCS	SCS:8	spatial contrast sensitivity
SCS	SCS:244	spinal cord stimulation
SCS	SCS:8	spinal cord stimulator
SCS	SCS:14|Scs:1	succinylcoa synthetase
SCs	SCs:86	synaptonemal complexes
SC	SC:36|sc:20	administered subcutaneously
SC	SC:8|sc:1	c disease
SC	SC:10	cortex
SC	SC:10	culture
SC	Sc:3|SC:3	immature rat sertoli cells
SC	SC:4|sc:1	nucleus subcoeruleus
SC	SC:7	scatter correction
SC	SC:25	schlemms canal
SC	SC:14	sclerosing cholangitis
SC	SC:42	scrotal circumference
SC	SC:9	sebaceous carcinoma
SC	SC:12	selenite cystine
SC	SC:7|sc:1|Sc:1	selfcompatible
SC	SC:11	semicarbazide
SC	SC:7|sc:1	semicircular canal
SC	SC:15	seroconversion
SC	SC:13	sickle cellhaemoglobin c
SC	SC:12	sigmoid colon
SC	SC:7	sildenafil citrate
SC	SC:5	specific concordance
SC	SC:10	speech produced during simultaneous communication
SC	SC:22	standard care
SC	SC:23	stem cell
SC	SC:9	stepped care
SC	SC:11	stomach cancer
SC	SC:393|sc:5	stratum corneum
SC	SC:8|sc:1	subtilisin carlsberg
SC	SC:25|sc:11	supercoiled
SC	SC:12	superconducting
SC	SC:11|sc:3	supercritical
SC	SC:25	superior colliculi
SC	SC:11	supportive counseling
SC	SC:24	sydenhams chorea
SC	SC:9	synovial chondromatosis
SC	SC:13	tcm sulfur colloid
SDAT	SDAT:1	senile dementia alzheimertype
SDAT	SDAT:196|sDAT:1	senile dementia of the alzheimer type
SDA	SDA:16	sabouraud dextrose agar
SDA	SDA:19	sexually dimorphic area
SDA	SDA:20	sialodacryoadenitis
SDA	SDA:7	sodium diacetate
SDA	SDA:18	specific dynamic action
SDA	SDA:8	stepwise discriminant analysis
SDA	SDA:34	strand displacement amplification
SDC	SDC:36|sdc:1	salivary duct carcinoma
SDC	SDC:28	serum digoxin concentration
SDD	SDD:85	selective decontamination of the digestive tract
SDD	SDD:30	selective digestive decontamination
SDD	SDD:29	smallest detectable difference
SDD	SDD:4	standard deviation of differences
SDD	SDD:11	standard deviation of the difference
SDD	SDD:2	subantimicrobial dose of doxycycline
SDE	SDE:7	simultaneous distillation extraction
SDE	SDE:8	standarddose epinephrine
SDE	SDE:13	subdural empyema
SDG	SDG:18	secoisolariciresinol diglucoside
SDG	SDG:19	secoisolariciresinol diglycoside
SDG	SDG:18	sucrose density gradient
SDH	SDH:19	serine dehydratase
SDH	SDH:18	stepdown heating
SDH	SDH:182|sdh:1	succinic dehydrogenase
SDH	SDH:9	succinodehydrogenase
SDH	SDH:12|sDH:1	superficial dorsal horn
SDI	SDI:7	lupus international collaborating clinicsamerican college of rheumatology damage index
SDI	SDI:46	succinate dehydrogenase inhibition
SDL	SDL:15	selfdirected learning
SDL	SDL:8	statedependent learning
SDL	SDL:6	stepdown latency
SDM	SDM:12	shared decision making
SDM	SDM:12	sitedirected mutagenesis
SDM	SDM:47	sulfadimethoxine
SDM	SDM:14	sulphadimethoxine
SDRs	SDRs:10	shortchain dehydrogenasesreductases
SDRs	SDRs:6	specificitydetermining residues
SDRs	SDRs:10	spraguedawley rats
SDR	SDR:40	selective dorsal rhizotomy
SDR	SDR:6	shortduration response
SDR	SDR:9	social disruption
SDR	SDR:6	spatial delayed response
SDR	SDR:13	spontaneous dwarf rat
SDS	SDS:20	height sd score
SDS	SDS:157	selfrating depression scale
SDS	SDS:24	severity of dependence scale
SDS	SDS:35	shwachmandiamond syndrome
SDS	SDS:38	shydrager syndrome
SDS	SDS:445	sodium dodecyl sulphate
SDS	SDS:165	sodium dodecylsulfate
SDS	SDS:52	sodium dodecylsulphate
SDS	SDS:6	stent delivery system
SDS	SDS:35	sudden death syndrome
SDS	SDS:24	symptom distress scale
SD	SD:6	children with speech delay
SD	SD:9	depletion
SD	SD:125|S-D:18	male spraguedawley
SD	SD:21	seborrheic dermatitis
SD	SD:11	seborrhoeic dermatitis
SD	SD:26|Sd:1	segregation distorter
SD	SD:13	selective decontamination
SD	SD:20	selfdirectedness
SD	SD:28	semantic dementia
SD	SD:8|S-D:2	semantic differential
SD	SD:18	serologically defined
SD	SD:21	sexual dysfunction
SD	SD:108|S-D:4	shinedalgarno
SD	SD:5	sleep disorders
SD	SD:8	social desirability
SD	SD:9	solid dispersion
SD	SD:2	solvent and detergent
SD	SD:26	somatization disorder
SD	SD:39	spasmodic dysphonia
SD	SD:22	spatial disorientation
SD	SD:11|Sd:6|sd:1	spermidine
SD	SD:14	splice donor
SD	SD:284	spreading depression
SD	SD:9	stable
SD	SD:360	stable disease
SD	SD:12	standard diet
SD	SD:10	steroiddependent
SD	SD:6	striated duct
SD	SD:6	stroke distance
SD	SD:13	sudden deafness
SD	SD:61	sudden death
SD	SD:23	swine dysentery
SEAR	SEAR:12	southeast asia region
SEAR	SEAR:9	surfactantenhanced aquifer remediation
SEA	SEA:7	patients with stable exertional angina
SEA	SEA:4	schistosoma mansoni eggs
SEA	SEA:5	soluble egg antigen preparation
SEA	SEA:5|--SEA:1	southeast asia
SEA	SEA:9|--SEA:1	southeast asian
SEA	SEA:28	spinal epidural abscess
SEA	SEA:5	spontaneous electrical activity
SEA	SEA:6	statistical energy analysis
SEB	SEB:8|SE-B:1	enterotoxinb
SEB	SEB:549|seb:2	staphylococcal enterotoxin b
SEB	SEB:7	surrogate endpoint biomarker
SECM	SECM:18	scanning electrochemical microscope
SECM	SECM:82	scanning electrochemical microscopy
SED	SED:16	serious emotional disturbance
SED	SED:27	spondyloepiphyseal dysplasia
SED	SED:12|SE-D:1	staphylococcal enterotoxin d
SED	SED:15	strain energy density
SEEG	SEEG:12	stereoelectroencephalographic
SEEG	SEEG:15	stereoelectroencephalography
SEE	SEE:11	salisbury eye evaluation
SEE	SEE:7	standard error of estimation
SEE	SEE:12	staphylococcal enterotoxin e
SEF	SEF:4	salivary excretion fraction
SEF	SEF:10	sclerosing epithelioid fibrosarcoma
SEF	SEF:10	sinusoidal endothelial fenestrae
SEF	SEF:48	spectral edge frequency
SEF	SEF:7	staphylococcal enterotoxin f
SEF	SEF:5	suction effusion fluid
SEF	SEF:7	supplementary eye fields
SEH	SEH:18	spinal epidural hematoma
SEH	SEH:8	subependymal hemorrhage
SEK	SEK:14	swedish crowns
SEK	SEK:28	swedish kronor
SELEX	SELEX:47	systematic evolution of ligands by exponential enrichment
SELEX	SELEX:6	vitro selection
SEL	SEL:8	size exclusion limit
SEL	SEL:15	socioeconomic level
SEL	SEL:10	spinal epidural lipomatosis
SEL	SEL:24	subependymal layer
sEMG	sEMG:20|SEMG:17	surface electromyographic
sEMG	sEMG:14|SEMG:9	surface emg
SEMS	SEMS:6|S-EMS:1	metallic stent
SEMS	SEMS:6	selfexpandable metallic stents
SEMS	SEMS:14	selfexpanding metal stents
SEMS	SEMS:8	selfexpanding metallic stents
SEM	SEM:1	avs and simultaneously extracted metals
SEM	SEM:16	scanning electron
SEM	SEM:21	scanning electron micrographs
SEM	SEM:203|sEM:1	scanning electron microscopic
SEM	SEM:14	scanning electronmicroscopy
SEM	SEM:6	standard error of measurements
SEM	SEM:4|SEm:1	standard error of the measurement
SEM	SEM:14	structural equation model
SEM	SEM:82	structural equation modeling
SEM	SEM:23	structural equation modelling
SEM	SEM:2	studied with scanning
SEM	SEM:9	subendothelial matrix
SEPs	SEPs:6	somatosensory evoked responses
SEPS	SEPS:25	subfascial endoscopic perforator surgery
SEPS	SEPS:14	subfascial endoscopic perforator vein surgery
SEPs	SEPs:18	syringe exchange programs
SEP	SEP:35	sclerosing encapsulating peritonitis
SEP	SEP:19	socioeconomic position
SEP	SEP:37	standard error of prediction
SEP	SEP:11	syringe exchange program
SES	SES:5	rosenberg selfesteem scale
SES	SES:17	socioeconomic
SES	SES:1009|ses:1	socioeconomic status
SET	SET:9	single electron transfer
SET	SET:16	single embryo transfer
SE	SE:16	clearfil se bond
SE	SE:51	conventional spinecho
SE	SE:9	energy
SE	SE:9	exposure
SE	SE:14	extraction
SE	SE:16	mean standard error
SE	SE:141|Se:2	salmonella enteritidis
SE	SE:18	secondary electron
SE	SE:9	secondary erythrocytosis
Se	Se:14|SE:1|se:1	secretor
Se	Se:1045|SE:13|-Se:1	selenium
SE	SE:24	selfefficacy
SE	SE:27	selfesteem
SE	SE:12	serine esterase
SE	SE:6	shannon entropy
SE	SE:74	shared epitope
SE	SE:9	side effects
SE	SE:6	silicone elastomer
SE	SE:14	sleep efficiency
SE	SE:16	southeast
SE	SE:203	spin echo
SE	SE:13	spongiform encephalopathy
SE	SE:20	squalene epoxidase
SE	SE:8	standard errors
SE	SE:14	staphylococcal exotoxins
SE	SE:18|Se:4	staphylococcus epidermidis
SE	SE:14|S-E:5	starredwards
SE	SE:10	state entropy
SE	SE:502	status epilepticus
SE	SE:20	stress echocardiography
SE	SE:11	subendothelium
SE	SE:29	t and tweighted spinecho
SE	SE:76	tweighted spinecho
SF2	SF2:6	superfamily 
SF2	SF2:2	surviving fraction to  gy
SF-36	SF-36:9	item shortform
SF-36	SF-36:10|SF36:1	functioning
SF-36	SF-36:11	instrument
SF-36	SF-36:83	medical outcomes study item shortform health survey
SF-36	SF-36:22	medical outcomes study short form
SF-36	SF-36:6	medical outcomes study short form item questionnaire
SF-36	SF-36:16	shortform
SF-36	SF-36:11|SF36:2	short form  health survey questionnaire
SF-36	SF-36:9	short form item
SF-36	SF-36:11	short form  questionnaire
SF-36	SF-36:7|SF36:2	short form health survey questionnaire
sFas	sFas:134|s-Fas:1|sFAS:1	soluble fas
sFas	sFas:8|sFAS:1	soluble fas antigen
SFA	SFA:7	feed arteries
SFA	SFA:11	saturated fa
SFA	SFA:9	spike frequency adaptation
SFA	SFA:9	suppressive factor of allergy
SFEMG	SFEMG:26|SF-EMG:1	singlefiber electromyography
SFEMG	SFEMG:16	single fiber emg
SFEMG	SFEMG:17	single fibre electromyography
SFE	SFE:224	supercritical fluid extraction
SFE	SFE:6|sfe:2	surface free energy
SFF	SFF:5	solid freeform fabrication
SFF	SFF:23	speaking fundamental frequency
SFG	SFG:8|SfG:5	scope for growth
SFG	SFG:93	spotted fever group
SFG	SFG:22	sum frequency generation
SFG	SFG:10	superior frontal gyrus
SFI	SFI:4	effect of shenfu injection
SFI	SFI:21	sciatic function index
SFI	SFI:33	sciatic functional index
SFMC	SFMC:21	soluble fibrin monomer complexes
SFMC	SFMC:38	synovial fluid mononuclear cells
SFM	SFM:25	scanning force microscope
SFM	SFM:74	scanning force microscopy
SFM	SFM:12	screenfilm mammography
SFM	SFM:19	serumfree media
SFM	SFM:70	serumfree medium
SFM	SFM:14|SfM:1	structurefrommotion
SFP	SFP:28|sfp:1	screen filtration pressure
SFP	SFP:35	stopflow pressure
SFS	SFS:12	social functioning scale
SFs	SFs:8	stress fibers
SFS	SFS:13	synchronous fluorescence spectrophotometry
SFS	SFS:10	synchronous fluorescence spectroscopy
SFs	SFs:10	synovial fluids
SFT	SFT:6	sabinfeldman test
SFT	SFT:25	skinfold thickness
SFV	SFV:482	semliki forest virus
SFV	SFV:8	simian foamy viruses
sFv	sFv:15|SFv:1	singlechain antibody
sFv	sFv:36|SFv:1	singlechain fv
SFV	SFV:24	superficial femoral vein
SF	SF:17	fibers
SF	SF:7|S-F:2	screenfilm
SF	SF:6	seizure free
SF	SF:130|sF:2|S-f:1	serum ferritin
SF	SF:10|s-F:2	serum folate
SF	SF:41|S-F:1|sf:1	serumfree
SF	SF:7	sexual function
SF	SF:11	sham feeding
SF	SF:10	shortterm fluctuation
SF	SF:53	shortening fraction
SF	SF:27	silk fibroin
SF	SF:9	slaframine
SF	SF:21	social functioning
SF	SF:21	sodium ferulate
SF	SF:6	soluble fiber
SF	SF:36|sF:1	soluble fibrin
SF	SF:13|sf:1	sorbitolfermenting
SF	SF:8	space flight
SF	SF:46|sf:1	spatial frequency
SF	SF:15	spotted fever
SF	SF:21	stone formers
SF	SF:9	superficial
SF	SF:8|Sf:1	surfactant
SF	SF:19	surviving fraction
SF	SF:5	sustained field
SF	SF:11	sylvian fissure
SF	SF:11|S-F:1	symphysisfundus
SGA	SGA:16	small for gestational age infants
SGA	SGA:96	subjective global assessment
SGC	SGC:9	gland carcinoma
SGC	SGC:14	small granulecontaining
SGC	SGC:5|sgc:1	softgel capsule
sGC	sGC:221|SGC:5|s-GC:1	soluble guanylate cyclase
sGC	sGC:210|SGC:7	soluble guanylyl cyclase
SGC	SGC:14|sgc:1	stratum griseum centrale
SGD	SGD:11	granule deficiency
SGD	SGD:17	saccharomyces genome database
SGD	SGD:13	specific growth delay
SGF	SGF:39	simulated gastric fluid
SGF	SGF:6	slow graft function
SGO	SGO:11	society of gynecologic oncologists
SGO	SGO:7	splanchnic glucose output
SGP	SGP:5	cell surface sialoglycopeptide
SGP	SGP:15|Sgp:1	sialoglycoprotein
SGP	SGP:9	strain gauge plethysmography
SGP	SGP:10	stratum griseum profundum
SGs	SGs:8|SGS:1	salivary glands
SGS	SGS:68	stratum griseum superficiale
SGs	SGs:14	stress granules
SGS	SGS:28	subglottic stenosis
SGs	SGs:8	sweat glands
SG	SG:9|Sg:3	glucose effectiveness at basal insulin
SG	SG:13|sg:4|Sg:1	pneumophila serogroup
SG	SG:9	santa gertrudis
SG	SG:14	sarcoglycan
SG	SG:9	sclareol glycol
SG	SG:5	soybeanderived sterylglucoside
SG	SG:66|sg:1	specific gravity
SG	SG:27	spiral ganglion
sg	sg:12|SG:1	staggerer
SG	SG:27	stellate ganglion
SG	SG:15	stratum granulosum
sg	sg:38|SG:5	subgenomic
SG	SG:99	substantia gelatinosa
SG	SG:11	subtotal gastrectomy
SG	SG:11	superficial gastritis
SG	SG:12|Sg:9	suprageniculate nucleus
SG	SG:13	sympathetic ganglia
sham	sham:8|SHAM:2	shamadrenalectomized
sham	sham:5|SHAM:4|Sham:2	shamoperated animals
sham	sham:6|SHAM:1	shamoperated group
sham	sham:12|SHAM:9	shamoperated rats
SHA	SHA:6	humic acid
SHA	SHA:13|sHA:11|S-HA:7	salivacoated hydroxyapatite
SHA	SHA:15	sinusoidal harmonic acceleration
SHC	SHC:14	spontaneously hypercholesterolemic
SHC	SHC:15|shc:1	squalenehopene cyclase
SHC	SHC:3|Shc:3	src homology and collagen protein
SHE	SHE:23	subclinical hepatic encephalopathy
SHE	SHE:230	syrian hamster embryo
SHF	SHF:10	schistosomal hepatic fibrosis
SHF	SHF:11	simian hemorrhagic fever
SHF	SHF:8	systolic heart failure
SHG	SHG:20	sonohysterography
SHG	SHG:7	static handgrip
SHG	SHG:9	sustained handgrip
SHI	SHI:15	health insurance
SHI	SHI:11	second harmonic imaging
SHI	SHI:33	severe head injury
SHP	SHP:18	schonleinhenoch purpura
SHP	SHP:19	short heterodimer partner
SHP	SHP:33|Shp:1	small heterodimer partner
SHP	SHP:16	summertype hypersensitivity pneumonitis
SHRSP	SHRSP:6|SHR-SP:2|SHRsp:1	spontaneously hypertensive strokeprone
SHRSP	SHRSP:26|SHR-SP:10|SHRsp:2	strokeprone spontaneously hypertensive
SHR	SHR:11	okamoto strain
SHR	SHR:20	rats with spontaneous hypertension
SHR	SHR:9	spontaneous histamine release
SHR	SHR:3	spontaneously hypertensive rats of the munster strain
SHR	SHR:7	spontaneously hypertensive rate
SHS	SHS:21	secondhand smoke
SHS	SHS:17	sliding hip screw
SHS	SHS:17	strong heart study
SHS	SHS:15	swollen head syndrome
SH	SH:11	hepatitis
SH	SH:8|Sh:1	hypotension
SH	SH:8	sclerosing hemangioma
SH	SH:9	secondary hypertension
SH	SH:9	severe hypoglycaemia
SH	SH:19	severe hypoglycemia
SH	SH:8	sima de los huesos
SH	SH:6	simple hyperplasia
SH	SH:16	sinus histiocytosis
SH	SH:18	sitting height
SH	SH:51	small hydrophobic
SH	SH:8	soybean hulls
SH	SH:11	spigelian hernia
SH	SH:259	spontaneously hypertensive
SH	SH:6	squamous hyperplasia
SH	SH:39	standard heparin
SH	SH:13|Sh:1	sternohyoid
SH	SH:10	subcortical hyperintensities
SH	SH:5	subtractive hybridization
SH	SH:25|-SH:10	sulphydryl
SH	SH:8	systemic hypertension
SIADH	SIADH:127	syndrome of inappropriate antidiuretic hormone secretion
SIADH	SIADH:19	syndrome of inappropriate secretion of adh
SIADH	SIADH:214	syndrome of inappropriate secretion of antidiuretic hormone
SIB	SIB:16	severe impairment battery
SIB	SIB:11	simultaneous integrated boost
SICH	SICH:5|sICH:1	spontaneous intracerebral hemorrhage
SICH	SICH:4|sICH:2	symptomatic intracranial hemorrhage
SICU	SICU:17	surgical icu
SICU	SICU:173|sICU:2	surgical intensive care unit
SIC	SIC:11	specific inhalation challenge
SIC	SIC:10|Sic:8	streptococcal inhibitor of complement
SIF	SIF:8	serum inhibitory factors
SIF	SIF:109	small intensely fluorescent
SIH	SIH:12	salicylaldehyde isonicotinoyl hydrazone
SIH	SIH:55	spontaneous intracranial hypotension
SIH	SIH:20	stressinduced hyperthermia
SII	SII:5	bilateral second sensory cortices
SII	SII:12|S-II:1	second somatosensory
SII	SII:25	second somatosensory cortex
SII	SII:14	secondary somatosensory
SII	SII:9	secondary somatosensory cortices
SII	SII:18	speech intelligibility index
SIMCA	SIMCA:23	soft independent modeling of class analogy
SIMCA	SIMCA:14	soft independent modelling of class analogy
SIMS	SIMS:147|SI-MS:5	secondary ion mass spectrometry
SIMS	SIMS:17	secondary ion mass spectroscopy
SIM	SIM:11	sandimmune
SIM	SIM:251	selected ion monitoring
SIM	SIM:10	selected ion monitoring mode
SIM	SIM:18	specialized intestinal metaplasia
SIN-1	SIN-1:7	morpholino sydnonimine
SIN-1	SIN-1:22|SIN1:1	morpholinosydnonimine hydrochloride
SIN-1	SIN-1:8	morpholinosydnonimine nethylcarbamide
SIN-1	SIN-1:4	donor morpholinosydnoniminenethylcarbamide
SIN-1	SIN-1:21|Sin-1:1	linsidomine
SIN-1	SIN-1:10	linsidomine chlorhydrate
SIN-1	SIN-1:5	nitric oxide donor morpholinosydnonimine
SIN	SIN:10	salpingitis isthmica nodosa
SIN	SIN:29|sin:1|Sin:1	selfinactivating
SIN	SIN:25	septation initiation network
SIP	SIP:45	scheduleinduced polydipsia
SIP	SIP:12	selectively infective phage
SIP	SIP:344	sickness impact profile
SIP	SIP:10	steroidogenesisinducing protein
SIP	SIP:8	sympathetically independent pain
SIRS	SIRS:50	soluble immune response suppressor
SIRs	SIRs:37	standardised incidence ratios
SIRs	SIRs:163	standardized incidence ratios
SIRS	SIRS:10	structured interview of reported symptoms
SIRS	SIRS:549	systemic inflammatory response syndrome
SIR	SIR:7|Sir:5	silent information regulator
SIR	SIR:14	single isomorphous replacement
SIR	SIR:10	speech intelligibility rating
SIR	SIR:87	standardised incidence ratio
SIR	SIR:6	standardized incidence rate
SIS	SIS:8	impingement syndrome
SIS	SIS:7	secretory immune system
SIS	SIS:9	skin immune system
SIS	SIS:101	small intestinal submucosa
SIS	SIS:27|sis:1	small intestine submucosa
SIS	SIS:11	stroke impact scale
SIS	SIS:7	suicidal intent scale
SIS	SIS:6	suicide intent scale
SITA	SITA:10	swedish interactive threshold algorithm
SITA	SITA:7	swedish interactive thresholding algorithm
SITS	SITS:6	acetamidoisothiocyanodisulfonic stilbene
SITS	SITS:11	acetamidoisothiocyanostilbenedisulfonate
SITS	SITS:65	acetamidoisothiocyanostilbenedisulfonic acid
SITS	SITS:8	acid stilbene
SIT	SIT:9	small intestinal transit
SIT	SIT:10	small intestinal transplantation
SIT	SIT:9	social identity theory
SIT	SIT:27	sperm immobilization test
SIT	SIT:24	sterile insect technique
SIT	SIT:6	stress inoculation training
SIG	SIG:11	special interest group
SIG	SIG:9	strong ion gap
SI	SI:11	first somatic sensory area
SI	SI:8	first somatosensory area
SI	SI:90|si:1	sacroiliac
SI	SI:14	sacroiliitis
SI	SI:83	selfincompatibility
SI	SI:13	selfincompatible
SI	SI:8	sensory integration
SI	SI:9	sequential injection
SI	SI:43|Si:1	serum iron
si	si:10	short interfering
SI	SI:9	silent ischemia
Si	Si:14|SI:4	silica
Si	Si:91|SI:1	silicon
SI	SI:21	simulated ischemia
SI	SI:11	situs inversus
si	si:12	small interfering
SI	SI:19	small intestinal
SI	SI:35	social interaction
SI	SI:7	social isolation
SI	SI:5	somatosensory area i
SI	SI:31	special intervention
SI	SI:6	specific insulin
SI	SI:40	spectroscopic imaging
SI	SI:11	spinal cord isolation
SI	SI:15	splenic irradiation
SI	SI:11	sputum induction
SI	SI:39	stimulation indices
SI	SI:8	stoichiometry of inhibition
SI	SI:14	stress incontinence
SI	SI:58	substantia innominata
SI	SI:110|S-I:5	sucraseisomaltase
SI	SI:11	suicidal ideation
SI	SI:13	syncytiainducing
SK	SK:18	seborrheic keratosis
SK	SK:9|S-K:7|s-K:4	serum potassium
SK	SK:7|S-K:5	shwachmankulczycki
SK	SK:11|sK:1	small conductance
SK	SK:6	smallconductance caactivated k
SK	SK:8	small conductance caactivated k
SK	SK:9	solar keratoses
SK	SK:12	solar keratosis
SK	SK:7	stromal keratitis
SLAM	SLAM:28	signaling lymphocytic activation molecule
SLAM	SLAM:47	systemic lupus activity measure
SLAP	SLAP:6|Slap:2	srclike adaptor protein
SLAP	SLAP:6	superior labral anterior posterior
SLAP	SLAP:3	superior labrum anterior and posterior
SLAP	SLAP:9	superior labrum anteriorposterior
SLA	SLA:1	sandblasted largegrit acidetched
SLA	SLA:1	sandblasted acidetched
SLA	SLA:15	soluble liver antigen
SLA	SLA:30	specific leaf area
SLA	SLA:22	spontaneous locomotor activity
SLC	SLC:9	small luteal cells
SLC	SLC:38	sodiumlithium countertransport
SLC	SLC:6	sodiumlithium countertransport activity
SLC	SLC:6|Slc:1	solute carrier
SLC	SLC:9	synovial lining cells
SLD	SLD:13	sexlinked dwarf
SLD	SLD:36	sublethal damage
SLEDAI	SLEDAI:9	disease activity
SLEDAI	SLEDAI:127|SLE-DAI:1	sle disease activity index
SLEDAI	SLEDAI:52	systemic lupus erythematosus disease activity index
SLE	SLE:159	louis encephalitis
SLE	SLE:16	slit lamp examination
SLE	SLE:22	systemic le
SLE	SLE:14	systemic lupus
SLE	SLE:27|sLE:1	systemic lupus erythematodes
SLE	SLE:69	systemic lupus erythematosis
SLE	SLE:28	systemic lupus erythematous
SLE	SLE:9	systemic lupus erythmatosus
SLI	SLI:173	children with specific language impairment
SLI	SLI:9	language impaired
SLI	SLI:10	specific language impairments
SLI	SLI:10	specifically languageimpaired
SLL	SLL:42	secondlook laparotomy
SLL	SLL:47	small lymphocytic lymphoma
SLM	SLM:12	spatial light modulator
SLM	SLM:20	supported liquid membrane
SLNs	SLNs:19	solid lipid nanoparticles
SLNs	SLNs:14|SLN-s:1	superior laryngeal nerves
SLN	SLN:19	sarcolipin
SLN	SLN:9	solid lipid nanospheres
SLN	SLN:10	superior laryngeal
SLO	SLO:155	scanning laser ophthalmoscope
SLO	SLO:25	scanning laser ophthalmoscopy
SLO	SLO:30	smithlemliopitz
SLP-76	SLP-76:6	domaincontaining leukocyte protein of  kda
SLP-76	SLP-76:9|Slp-76:1	phosphoprotein of  kda
SLPI	SLPI:9	secretory leucocyte proteinase inhibitor
SLPI	SLPI:134	secretory leukocyte protease inhibitor
SLPI	SLPI:26	secretory leukocyte proteinase inhibitor
SLPI	SLPI:52	secretory leukoprotease inhibitor
SLPs	SLPs:6	slayer proteins
SLPs	SLPs:33|S-LPs:1	speechlanguage pathologists
SLPs	SLPs:10	surface layer proteins
SLP	SLP:46	scanning laser polarimetry
SLP	SLP:7	silkworm larvae plasma
SLP	SLP:10	speechlanguage pathologist
SLP	SLP:8	spontaneous lymphocyte proliferation
SLR	SLR:10	shinnarle roux
SLR	SLR:5	shortlatency response
SLR	SLR:13	straight leg raise
SLR	SLR:20	straight leg raising
SLR	SLR:8	subthalamic locomotor region
SLs	SLs:8|SLS:1	sarcomere lengths
SLS	SLS:12	segmentlongspacing
SLS	SLS:12	selective laser sintering
SLs	SLs:14	sensation levels
SLs	SLs:16|Sls:5	sesquiterpene lactones
SLS	SLS:59	sjogrenlarsson syndrome
SLS	SLS:227	sodium lauryl sulfate
SLS	SLS:145	sodium lauryl sulphate
SLs	SLs:10	sphingolipids
SLS	SLS:19	static light scattering
SLS	SLS:30	streptolysin s
SLTs	SLTs:22	shigalike toxins
SLTs	SLTs:25	speech and language therapists
SLT	SLT:21	selective laser trabeculoplasty
SLT	SLT:7	single lung transplant
SLT	SLT:10	specificlocus test
SLT	SLT:32	speech and language therapy
SLT	SLT:12	split liver transplantation
SL	SL:13	cardiac sarcolemma
SL	SL:19	cardiac sarcolemmal
SL	SL:9	db sensation level
SL	SL:14	layer
SL	SL:20	scapholunate
SL	SL:6	sham laparotomy
SL	SL:8	short latency
SL	SL:11	sleep latency
SL	SL:16	smyth line
SL	SL:6	sodium lactate
SL	SL:6	spin lock
SL	SL:13	spiral ligament
SL	SL:104|sl:1	spliced leader
SL	SL:16	stemloop
SL	SL:9	stereolithographic
SL	SL:24	stride length
SL	SL:10	structured lipids
SL	SL:26|sl:2	sublingual
SL	SL:9	surface laplacian
SL	SL:8	surrogate light
SL	SL:11	suspensory ligament
SMAF	SMAF:13	functional autonomy measurement system
SMAF	SMAF:9	superior mesenteric artery flow
SMAS	SMAS:59	superficial musculoaponeurotic system
SMAS	SMAS:22	superior mesenteric artery syndrome
SMA	SMA:182|sma:2|-SMA:1	muscle actin
SMA	SMA:8	shape memory alloy
SMA	SMA:9	small mesenteric arteries
SMA	SMA:17	snow mountain agent
SMA	SMA:13	specific methanogenic activity
SMA	SMA:5	spontaneous mechanical activities
SMA	SMA:58	spontaneous motor activity
SMA	SMA:22	styrene maleic anhydride
SMA	SMA:21	superior mesenteric
SMA	SMA:10	superior mesenteric arterial
SMA	SMA:9	supplementary motor
SMA	SMA:9	supplementary motor cortex
SMB	SMB:16	behavior
SMB	SMB:39	simulated moving bed
SMB	SMB:13|SmB:3	somatomedin b
SMB	SMB:17	suckling mouse brain
SMB	SMB:10	syncromateb
SMCD	SMCD:12	schmid metaphyseal chondrodysplasia
SMCD	SMCD:36	systemic mast cell disease
SMCP	SMCP:8	sheep mast cell proteinase
SMCP	SMCP:10	submucous cleft palate
SMC	SMC:11	sialomucin complex
SMC	SMC:10	sinusoidal modulated currents
SMG	SMG:10	streptococcus milleri group
SMG	SMG:20	submandibular ganglion
SMG	SMG:11	submandibular salivary glands
SMG	SMG:9	superior mesenteric ganglion
SMG	SMG:12|SmG:2	supramarginal gyrus
SMM	SMM:12	smethylmethionine
SMM	SMM:36	scintimammography
SMM	SMM:14|S-MM:1	smoldering multiple myeloma
SMM	SMM:14	stepwise mutation model
SMM	SMM:12|Smm:1	sulfamonomethoxine
SMM	SMM:9	sulphamonomethoxine
SMN	SMN:2|Smn:1	survival motor neuron protein
SMN	SMN:38	survival of motor neurons
SMON	SMON:9	subacute myelooptic neuropathy
SMON	SMON:33	subacute myeloopticoneuropathy
SMP	SMP:24|smp:1	bovine heart submitochondrial particles
SMP	SMP:13	schwann cell myelin protein
SMP	SMP:14	skim milk powder
SMP	SMP:13	soluble microbial products
SMP	SMP:6	submucous plexus
SMP	SMP:31	sympathetically maintained pain
SMRs	SMRs:114	standardised mortality ratios
SMRs	SMRs:254	standardized mortality ratios
SMR	SMR:13	sensorimotor rhythm
SMR	SMR:13	severe mental retardation
SMR	SMR:56	sleeping metabolic rate
SMR	SMR:9	small multidrug resistance
SMR	SMR:9	standard mortality rate
SMR	SMR:7	submucous resection
SMS	SMS:71	smithmagenis syndrome
SMS	SMS:40	space motion sickness
SMS	SMS:6	sphingomyelin synthase
SMS	SMS:45	stiffman syndrome
SMT	SMT:28	smethylisothiourea
SMT	SMT:19	smethylisothiourea sulfate
SMT	SMT:6	second malignant tumors
SMT	SMT:31	spinal manipulative therapy
SMT	SMT:6	stress management training
SMVT	SMVT:7	sodiumdependent multivitamin transporter
SMVT	SMVT:25	sustained monomorphic ventricular tachycardia
SMV	SMV:17	skeletal muscle ventricle
SMV	SMV:20	soybean mosaic virus
SMV	SMV:78	superior mesenteric vein
SNAP-25	SNAP-25:9|SNAP25:1	kda synaptosomalassociated protein
SNAP-25	SNAP-25:7	synaptosomalassociated protein
SNAP-25	SNAP-25:11|SNAP25:2	synaptosomeassociated protein
SNAP-25	SNAP-25:37|SNAP25:4|Snap25:1	synaptosomeassociated protein of  kda
SNAP	SNAP:12	snitrosonacetylpenicillamine
SNAP	SNAP:22	donor snitrosonacetylpenicillamine
SNAP	SNAP:10	nitric oxide donor snitrosonacetylpenicillamine
SNAP	SNAP:30	snitrosonacetyl penicillamine
SNAP	SNAP:11	snitrosonpenicillamine
SNAP	SNAP:10	schedule for nonadaptive and adaptive personality
SNAP	SNAP:33	score for neonatal acute physiology
SNA	SNA:31	sambucus nigra
SNA	SNA:45	sambucus nigra agglutinin
SNA	SNA:9	sinus node artery
SNA	SNA:208	sympathetic nerve activity
SNB	SNB:102	sentinel node biopsy
SNB	SNB:133	spinal nucleus of the bulbocavernosus
SND	SND:16	selective neck dissection
SND	SND:18	sinus node disease
SND	SND:42	sinus node dysfunction
SND	SND:66	striatonigral degeneration
SND	SND:122	sympathetic nerve discharge
SNOM	SNOM:18	scanning nearfield optical microscope
SNOM	SNOM:35	scanning nearfield optical microscopy
SNRPN	SNRPN:7	polypeptide n gene
SNRPN	SNRPN:11	small nuclear ribonucleoprotein polypeptide n
SNR	SNR:45	signaltonoise
SNR	SNR:9	supernumerary ribs
SNV	SNV:52	sin nombre virus
SNV	SNV:67	spleen necrosis virus
SNV	SNV:11	systemic necrotizing vasculitis
SN	SN:9	nerves
SN	SN:12	neurons
SN	SN:23	secretoneurin
SN	SN:12	selection negativity
SN	SN:9	semantic network
SN	SN:10	sensory neuron
SN	SN:38|sN:7	sentinel lymph node
SN	SN:14	serum neutralisation
SN	SN:25	serum neutralizing
SN	SN:16	sin nombre
SN	SN:15	single nephron
SN	SN:65	sinus node
SN	SN:6	spitz nevus
SN	SN:26	spontaneous nystagmus
SN	SN:17	streptonigrin
SN	SN:18|Sn:2	sural nerve
SOCS	SOCS:154|Socs:3	cytokine signaling
SOCS	SOCS:28	cytokine signalling
SOCs	SOCs:11	organic compounds
SOCs	SOCs:16	storeoperated ca channels
SOCs	SOCs:30	storeoperated channels
SOC	SOC:13	selforganized criticality
SOC	SOC:146|SoC:1	sense of coherence
SOC	SOC:15	sense of coherence scale
SOC	SOC:11	shamoperated control
SOC	SOC:20	soil organic carbon
SOC	SOC:11	stage of change
SOC	SOC:11	standard of care
SOC	SOC:7	storeoperated ca channel
SOC	SOC:15	storeoperated calcium
SOC	SOC:101	superior olivary complex
SODA	SODA:7	sequential occupational dexterity assessment
SODA	SODA:7	severity of dyspepsia assessment
SOD	SOD:29	septooptic dysplasia
SOD	SOD:43	sphincter of oddi dysfunction
SOD	SOD:32	superoxide dismutase activity
SOD	SOD:5	superoxide dismutase enzyme
SOFA	SOFA:18	sepsisrelated organ failure assessment
SOFA	SOFA:55	sequential organ failure assessment
SOL	SOL:22	sleep onset latency
SOL	SOL:30|Sol:10|sol:1	soleus muscle
SOL	SOL:5	spaceoccupying lesions
SOM	SOM:139	secretory otitis media
SOM	SOM:59	soil organic matter
SOM	SOM:21	sphincter of oddi manometry
SOM	SOM:9	superior oblique myokymia
SOPs	SOPs:9	sensory organ precursors
SOPs	SOPs:25	standard operating procedures
SOP	SOP:21	sensory organ precursor
SOP	SOP:7	superior oblique palsy
SOS	SOS:13	sucrose octasulfate
SOS	SOS:36	swedish obese subjects
SOT	SOT:6	annual meeting of the society of toxicology
SOT	SOT:26	sensory organization test
SOT	SOT:10	squamous odontogenic tumor
SOA	SOA:23	secondary organic aerosol
SOA	SOA:145	stimulus onset asynchrony
SOA	SOA:18	sucrose octaacetate
SO	SO:9	output
SO	SO:11	significant other
SO	SO:9	sleep onset
SO	SO:11	slow oscillator
SO	SO:13	slowoxidative
SO	SO:204	sphincter of oddi
SO	SO:50	stratum opticum
SO	SO:10	stratum oriens
SO	SO:23	styrene oxide
SO	SO:17	sulfite oxidase
SO	SO:27	superior oblique
SO	SO:15	supraoptic nucleus
SO	SO:16	sympathetic ophthalmia
SP1	SP1:16|SP-1:1|sp-1:1	pregnancyspecific betaglycoprotein
SP1	SP1:26|SP-1:2	schwangerschaftsprotein 
SPAP	SPAP:4|sPAP:1	secreted placental alkaline phosphatase
SPAP	SPAP:6|sPAP:5|s-PAP:1	systolic pulmonary arterial pressure
SPAP	SPAP:17|sPAP:6	systolic pulmonary artery pressure
SpA	SpA:20|SPA:1	patients with spondyloarthropathy
SPA	SPA:9	polysaccharide antigen
SpA	SpA:12	protein a of staphylococcus aureus
SPA	SPA:7	protein antigen
SPA	SPA:77	scintillation proximity assay
SPA	SPA:19	serum plate agglutination
SPA	SPA:1	sheep with pulmonary adenomatosis
SPA	SPA:6	soluble protective antigen
SPA	SPA:91	sperm penetration assay
SpA	SpA:10	spondyloarthritides
SpA	SpA:17	spondyloarthritis
SpA	SpA:71|SPA:2	spondyloarthropathies
SPA	SPA:17	spontaneous physical activity
SPA	SPA:45	spontaneous platelet aggregation
SPA	SPA:6	standard peritoneal permeability analysis
SPA	SPA:21	stimulationproduced analgesia
SPA	SPA:10	subperiosteal abscess
SPA	SPA:7	suprapubic aspiration
SP-A	SP-A:8|SPA:1	surfactant apoprotein
SP-A	SP-A:13	surfactant protein
SP-A	SP-A:62	surfactant proteina
SPB	SPB:18	solitary plasmacytoma of bone
SPB	SPB:153	spindle pole body
SPC	SPC:8	salivary protein complex
SPC	SPC:25	saturated phosphatidylcholine
SPC	SPC:4	second primary cancer
SPC	SPC:14	soy protein concentrate
SPC	SPC:9|spc:1	spermatocytes
SPC	SPC:9	sphingosylphosphocholine
SPC	SPC:82	sphingosylphosphorylcholine
SPC	SPC:15	standard plate count
SPC	SPC:35	statistical process control
SPC	SPC:10	subtilisinlike proprotein convertase
SPC	SPC:12	summary of product characteristics
SPD	SPD:12	lstepholidine
SPD	SPD:83	schizotypal personality disorder
SPD	SPD:13	stepholidine
SPD	SPD:32	storage pool deficiency
SPD	SPD:8	storage pool disease
SPD	SPD:17	subcorneal pustular dermatosis
SPD	SPD:15	synpolydactyly
SPECT	SPECT:7	myocardial scintigraphy
SPECT	SPECT:88	single photon emission ct
SPECT	SPECT:9	tomographic imaging
SPECT	SPECT:11	tomoscintigraphy
SPE	SPE:15	serum protein electrophoresis
SPE	SPE:9	solar particle events
SPE	SPE:878	solidphase extraction
SPE	SPE:7	substance p endopeptidase
SPE	SPE:27	sucrose polyester
SPGR	SPGR:22	spoiled gradientecho
SPGR	SPGR:2	spoiled gradient recalled acquisition in steady state
SPGR	SPGR:14	spoiled grass
SPG	SPG:57	schizophyllan
SPG	SPG:29	sizofiran
SPG	SPG:9	spastic paraplegia
SPG	SPG:12	spermatogonia
SPG	SPG:17	sphenopalatine ganglion
SP-IR	SP-IR:15|SP-ir:3|sP-IR:1|SPir:1	substance pimmunoreactive
SP-IR	SP-IR:7|SP-ir:3|SPIR:1	substance p immunoreactivity
SPI	SPI:7	singlepoint imaging
SPI	SPI:82	soy protein isolate
SPK	SPK:17	simultaneous pancreas and kidney
SPK	SPK:14	simultaneous pancreas and kidney transplantation
SPK	SPK:63	simultaneous pancreaskidney
SPK	SPK:24	simultaneous pancreaskidney transplantation
SPK	SPK:16	transplant
SPL	SPL:7	phage lysate
SPL	SPL:26	superior parietal lobule
SPMS	SPMS:32|SP-MS:6	secondary progressive ms
SPMS	SPMS:15|SP-MS:1	secondary progressive multiple sclerosis
SPMs	SPMs:20	statistical parametric maps
SPMs	SPMs:21	synaptic plasma membranes
SpO2	SpO2:14|SPO2:1	oxygen saturation by pulse oximetry
SpO2	SpO2:9|Spo2:1	pulse oxymetry
SPPS	SPPS:32	solidphase peptide synthesis
SPPS	SPPS:9	stable plasma protein solution
SPP	SPP:12	signal peptide peptidase
SPP	SPP:17	skin perfusion pressure
SPP	SPP:10	sodium pentosan polysulphate
SPP	SPP:8	stromal processing peptidase
SPQ	SPQ:23	methoxynsulfopropylquinolinium
SPQ	SPQ:28	schizotypal personality questionnaire
SPRs	SPRs:5	prevalence ratios
SPRs	SPRs:5	scattertoprimary ratios
SPR	SPR:25	selective posterior rhizotomy
SPR	SPR:9	skin potential reflex
SPR	SPR:10	skin potential response
SPR	SPR:14	slide positivity rate
SPR	SPR:17|SP-R:1	sp receptor
SPR	SPR:670	surface plasmon resonance
SPTs	SPTs:13	second primary tumors
SPTs	SPTs:74|SPTS:1	skin prick tests
SPTs	SPTs:17	subjectperformed tasks
SPT	SPT:5	psulfophenyl theophylline
SPT	SPT:7	second primary tumor
SPT	SPT:47	serine palmitoyltransferase
SPT	SPT:9	singleparticle tracking
SPT	SPT:6	sleep period time
SPT	SPT:32	supportive periodontal therapy
SPT	SPT:8	supportive periodontal treatment
SPV	SPV:106|spV:2|SpV:1	selective proximal vagotomy
SPV	SPV:8	stratum periventriculare
SPV	SPV:11	swinepox virus
SPV	SPV:22	systolic pressure variation
SPS	SPS:8	semipermeable surface
SPs	SPs:87	senile plaques
SPs	SPs:11	silent periods
SPS	SPS:18	simple partial seizures
SPS	SPS:9	simulated public speaking
SPs	SPs:11	slow potentials
SPS	SPS:9	sodium polyanetholesulfonate
SPs	SPs:64	standardized patients
SPS	SPS:25	stiffperson syndrome
SPs	SPs:9|sps:6	stress proteins
SPS	SPS:10	suicide probability scale
SPs	SPS:3|SPs:3	sulfated polysaccharides
SQDG	SQDG:12	sulfoquinovosyl diacylglycerol
SQDG	SQDG:19	sulfoquinovosyldiacylglycerol
SQ	SQ:11	quality
SQ	SQ:10	semiquinone
SQ	SQ:10	speed quotient
SQ	SQ:15|Sq:1	squalene
SQ	SQ:21	symptom questionnaire
SR-PGA	SR-PGA:16	selfreinforced polyglycolic acid
SR-PGA	SR-PGA:21	selfreinforced polyglycolide
SR-PLLA	SR-PLLA:9	selfreinforced polyllactic acid
SR-PLLA	SR-PLLA:38	selfreinforced polyllactide
SRA	SRA:13	regression analysis
SRA	SRA:9	serum resistance associated
SRA	SRA:12|sra:1	specific radioactivity
SRA	SRA:14	steroid receptor rna activator
SRBC	SRBC:20	antisheep erythrocyte
SRBC	SRBC:114|sRBC:4|Srbc:1	sheep red blood cell
SR-BI	SR-BI:5	class b type i scavenger receptor
SR-BI	SR-BI:39|SRBI:1	scavenger receptor bi
SR-BI	SR-BI:118|SRB-I:1|SRBI:1	scavenger receptor class b type i
SRB	SRB:9	senegal river basin
SRB	SRB:7	sex ratio at birth
SRB	SRB:114	sulfatereducing bacteria
SRB	SRB:9	sulfatereducing bacterium
SRB	SRB:47	sulforhodamine b
SRCA	SRCA:17	specific red cell adherence
SRCA	SRCA:83	subrenal capsule assay
SRC	SRC:5	scid repopulating cells
SRC	SRC:21	scleroderma renal crisis
SRC	SRC:18	sheep red cells
SRC	SRC:18	steroid receptor coactivator
SRC	SRC:22	stimulusresponse compatibility
SRC	SRC:32|src:2	subrenal capsule
SRD	SRD:5	sarcinricin domain
SRD	SRD:5	signal response domain
SRD	SRD:24	subnucleus reticularis dorsalis
SRD	SRD:5	substancerelated disorder
SRD	SRD:14	sucroserich diet
SREs	SREs:31	serum response elements
SREs	SREs:16	skeletalrelated events
SRE	SRE:9	skeletalrelated event
SRE	SRE:10|SR-E:2	syringomycin e
SRF	SRF:11	repetitive firing
SRF	SRF:375	serum response factor
SRF	SRF:11	specific resistance to filtration
SRF	SRF:7	split renal function
SRF	SRF:43	subretinal fluid
SRF	SRF:10	subretrofacial
SRF	SRF:12	subretrofacial nucleus
SRH	SRH:46	selfrated health
SRH	SRH:38	single radial haemolysis
SRH	SRH:15	single radial hemolysis
SRH	SRH:5	subretinal hemorrhage
SRI	SRI:32	serotonin reuptake inhibitor
SRI	SRI:21	strain rate imaging
SRI	SRI:38	surface regularity index
SRK	SRK:8	s locus receptor kinase
SRK	SRK:10	s receptor kinase
SRK	SRK:13	shaking rat kawasaki
SRO	SRO:12	shortest region of overlap
SRO	SRO:24	smallest region of overlap
SRP	SRP:110	scaling and root planing
SRP	SRP:7	signal recognition protein
SRP	SRP:30	soluble reactive phosphorus
SRR	SRR:8	skin resistance response
SRR	SRR:7	steroidresistant rejection
SRS	SRS:26	savannah river site
SRS	SRS:9	scoliosis research society
SRS	SRS:18	sex reassignment surgery
SRS	SRS:55	silverrussell syndrome
SRS	SRS:7	simple random sampling
SRS	SRS:94	somatostatin receptor scintigraphy
SRS	SRS:14	stimulated raman scattering
SRS	SRS:15	subretinal space
SRS	SRS:4	supervision rating scale
SRT	SRT:10	reaction time task
SRT	SRT:15	selective reminding test
SRT	SRT:65|srt:1	simple reaction time
SRT	SRT:33	sludge retention time
SRT	SRT:25	solids retention time
SRT	SRT:67	stereotactic radiotherapy
SRT	SRT:11	surfactant replacement therapy
SRT	SRT:11|S-RT:1|SR-T:1	sustainedrelease theophylline
SRT	SRT:9	symptom rating test
SRV	SRV:15	simian retrovirus
SRV	SRV:6	street rabies virus
SRY	SRY:6|Sry:2	region y gene
SRY	SRY:2	sex determining region of the y
SRY	SRY:18|Sry:2	sexdetermining region of the y chromosome
SRY	SRY:20	sexdetermining region y
SR	SR:15	racer
SR	SR:10	saccharopolyspora rectivirgula
SR	SR:11	salt resistant
SR	SR:47	sarcoplasmic reticular
SR	SR:6	sarcoplasmic reticulum membranes
SR	SR:14	saturation recovery
SR	SR:12	selfreinforced
SR	SR:8	sensory rhodopsin
SR	SR:37	serineargininerich
SR	SR:12	sex ratio
SR	SR:7	shift reagent
SR	SR:20	silicone rubber
SR	SR:258	sinus rhythm
SR	SR:8	skin resistance
SR	SR:9	spontaneous regression
SR	SR:6	spontaneous remission
SR	SR:7	spontaneous respiration
SR	SR:7	stapedial reflex
SR	SR:9	stapedius reflex
SR	SR:48	stochastic resonance
SR	SR:5	storage phosphor radiography
SR	SR:33	strain rate
SR	SR:27|sr:1	stratum radiatum
SR	SR:7	stretch reflex
SR	SR:19	superior rectus
SR	SR:15	sustained responders
SR	SR:43	sustained response
SR	SR:19	synaptic ribbons
SR	SR:32	synchrotron radiation
SR	SR:13	systematic review
SSA	SSA:14	senile systemic amyloidosis
SSA	SSA:29	singlestrand annealing
SSA	SSA:8	skin nerve sympathetic activity
SSA	SSA:67	social security administration
SSA	SSA:13	specific surface area
SSA	SSA:41|sSA:2	subsaharan africa
SSA	SSA:14	succinic semialdehyde
SSA	SSA:10	sulfosalicylic acid
SSA	SSA:8	superoxide scavenging activity
SSB	SSB:6|ssb:1	escherichia coli singlestrand binding
SSB	SSB:16	escherichia coli singlestranded dna binding protein
SSB	SSB:10	short spike bursts
SSB	SSB:4|ssb:1	single strand breakage
SSB	SSB:65|ssb:2|Ssb:1	singlestranded dnabinding protein
SSC	SSC:11	porcine chromosome
SSC	SSC:6	scientific and standardization committee
SSC	SSC:26	stretchshortening cycle
SSD	SSD:18	sexual size dimorphism
SSD	SSD:16	sourcesurface distance
SSD	SSD:17	sourcetosurface distance
SSD	SSD:7	sterolsensing domain
SSE	SSE:16	skin selfexamination
SSE	SSE:4	sodium salicylate extract
SSE	SSE:8	stage selector element
SSF	SSF:48	simultaneous saccharification and fermentation
SSF	SSF:9	skinfolds
SSF	SSF:49	solidstate fermentation
SSF	SSF:12	soluble suppressor factor
SSG	SSG:9	salivary gland
SSG	SSG:21	sodium stibogluconate
SSH	SSH:29|Ssh:1	snowshoe hare
SSH	SSH:205	suppression subtractive hybridization
SSI	SSI:6	scale for suicide ideation
SSI	SSI:8	strength strain index
SSI	SSI:71	streptomyces subtilisin inhibitor
SSI	SSI:5	stress strain index
SSI	SSI:147	supplemental security income
SSI	SSI:18	synthetic sentence identification
SSM	SSM:7	scaled subprofile model
SSM	SSM:19	skinsparing mastectomy
SSM	SSM:6	slippedstrand mispairing
SSM	SSM:10	subsarcolemmal mitochondria
SSN	SSN:9	social security number
SSN	SSN:14	superior salivatory nucleus
SSO	SSO:5|sso:2	singlestrand origin
SSO	SSO:17	sunflower seed oil
SSP	SSP:5	inhibitor staurosporine
SSP	SSP:8	sagittal sinus pressure
SSP	SSP:11	secondary spontaneous pneumothorax
SSP	SSP:14	sequencespecific primer
SSP	SSP:12	slice sensitivity profile
SSP	SSP:5|Ssp:1|ssp:1	stringent starvation protein
SSRs	SSRs:84	simple sequence repeats
SSRs	SSRs:28	sympathetic skin responses
SSR	SSR:8	signal sequence receptor
SSR	SSR:19	spinal stretch reflex
SSS	SSS:11	saltsugar solution
SSS	SSS:46	scandinavian stroke scale
SSS	SSS:160|sss:1	sick sinus syndrome
SSS	SSS:45	stanford sleepiness scale
SSS	SSS:16	summed stress score
SSS	SSS:103	superior sagittal sinus
SSS	SSS:11	synthetic serum substitute
SST	SST:10	sclerosing stromal tumor
SST	SST:17	sea surface temperature
SST	SST:14	shosaikoto
SST	SST:12	short synacthen test
SST	SST:10	simple shoulder test
SST	SST:17	social skills training
SST	SST:11	sperm storage tubules
SST	SST:12	submacular surgery trials
SSVEP	SSVEP:6	steadystate visual evoked potential
SSVEP	SSVEP:7	steadystate visually evoked potential
SSV	SSV:18	short saphenous vein
SSV	SSV:54	simian sarcoma virus
SS	SS:5	glands from patients with sjogrens syndrome
SS	SS:6	salbutamol sulfate
SS	SS:10	salmonellashigella
SS	SS:14	salt sensitive
SS	SS:13	scleroderma systematica
SS	SS:8	segmental shortening
SS	SS:77	selfstimulation
SS	SS:18	septic shock
SS	SS:9	serum
SS	SS:8	sewage sludge
SS	SS:12	short stature
SS	SS:16	sidestream smoke
SS	SS:20	simple spike
SS	SS:12	social support
SS	SS:9	spermatocytic seminoma
SS	SS:84|ss:2|Ss:1	stainless steel
SS	SS:11	starch synthase
SS	SS:14|Ss:2	steroidsensitive
SS	SS:8	straight sinus
SS	SS:9	stresssusceptible
SS	SS:24	subsarcolemmal
SS	SS:10	supersaturation
SS	SS:11	supraspinatus
SS	SS:10	sympathetic stimulation
SS	SS:13	synchronized sleep
SS	SS:5	systolic segment shortening
SS	SS:10	systolic shortening
STa	STa:6	escherichia coli heatstable toxin
STa	STa:10|STA:2	heatstable enterotoxin of escherichia coli
STA	STA:8	solanum tuberosum agglutinin
STA	STA:15	spiketriggered averaging
STA	STA:9	standard tube agglutination
STA	STA:80	superficial temporal artery
STA	STA:25	systematic toxicological analysis
STB	STB:11	serum total bilirubin
STB	STB:10	stobadine
STCs	STCs:11	serum theophylline concentrations
STCs	STCs:12	suppression tuning curves
STC	STC:5|sTC:2	serum total cholesterol
STC	STC:75	stanniocalcin
STC	STC:7	subtotal colectomy
STDP	STDP:41	plasticity
STDP	STDP:8	shortterm dynamic psychotherapy
STEMI	STEMI:11	patients with stelevation myocardial infarction
STEMI	STEMI:64	stsegment elevation myocardial infarction
STF	STF:12	seminiferous tubule fluid
sTF	sTF:11	soluble tf
STF	STF:8	soluble thymic factor
sTF	sTF:10	soluble tissue factor
STF	STF:9	subeschar tissue fluid
STIs	STIs:347	sexually transmitted infections
STIs	STIs:18	structured treatment interruptions
STIs	STIs:35	systolic time intervals
STI	STI:16	speech transmission index
STI	STI:13	stereotactic irradiation
STM	STM:7	salmonella typhimurium mitogen
STM	STM:62	scanning tunneling microscope
STM	STM:140	scanning tunneling microscopy
STM	STM:15	scanning tunnelling microscope
STM	STM:36	scanning tunnelling microscopy
STM	STM:15|stm:2	shoot meristemless
STM	STM:9	shootmeristemless
STM	STM:130	shortterm memory
STM	STM:29	signaturetagged mutagenesis
STM	STM:8	symptothermal method
stn	stn:7|Stn:2	salmonella enterotoxin
stn	stn:10|STN:1	stomatogastric nerve
STP	STP:63	shortterm potentiation
STP	STP:7	soil test phosphorus
STP	STP:11	stiripentol
STP	STP:12	superior temporal polysensory area
STP	STP:9	supratemporal plane
STs	STs:11	cytosolic sulfotransferases
STS	STS:6	selegiline transdermal system
STs	STs:38	sequence types
STS	STS:33	sittostand
STS	STS:27	society of thoracic surgeons
STS	STS:13	sodium tetradecyl sulfate
STS	STS:80	sodium thiosulfate
STS	STS:6	sodium thiosulphate
STS	STS:116|Sts:5	steroid sulfatase
STS	STS:28|Sts:2	steroid sulphatase
STS	STS:15	stilbene synthase
STS	STS:5	subthreshold stimulation
STS	STS:120|STs:3|sts:1	superior temporal sulcus
STT	STT:17	schirmer tear test
STT	STT:6	shortterm tests
STT	STT:15	soft tissue tumors
STT	STT:19	spinothalamic
STT	STT:126	spinothalamic tract
STZ-D	STZ-D:13	streptozocininduced diabetes
STZ-D	STZ-D:28	streptozocininduced diabetic
STZ	STZ:85	streptozocin
STZ	STZ:24	streptozotocininduced
STZ	STZ:7	streptozotocininduced diabetic
ST	ST:11	heat stable
ST	ST:31|st:2	heatstable toxin
ST	ST:2	pkc inhibitor staurosporine
ST	ST:7	saturation transfer
ST	ST:19	scala tympani
ST	ST:13	secondary thrombocytosis
ST	ST:7	seizure threshold
ST	ST:10	selftranscendence
ST	ST:14	seminiferous tubules
ST	ST:73|St:8	semitendinosus
ST	ST:9	septal thickness
ST	ST:17	sequence type
ST	ST:4|st:3|S-T:1	serum testosterone
ST	ST:6|St:1	shell thickness
ST	ST:8|st:1	shortterm
ST	ST:36|S-T:3	sialyltransferase
ST	ST:9	signal transduction
ST	ST:5	silent thyroiditis
ST	ST:14	sinus tachycardia
ST	ST:6	skin testing
ST	ST:8|st:7	small t antigen
ST	ST:10	solid tumors
ST	ST:36	spasmodic torticollis
ST	ST:3|-ST:2	stsegment depression
ST	ST:5	stsegment elevation
ST	ST:7|st:1	standard therapy
ST	ST:8	standard treatment
ST	ST:11	stanozolol
ST	ST:11|St:1	starch
ST	ST:45	sterigmatocystin
ST	ST:35	strength training
ST	ST:49|st:1	stria terminalis
ST	ST:8|St:6	styrene
ST	ST:59|St:1	sulfotransferase
ST	ST:9	supportive therapy
ST	ST:9	surgical tracheostomy
ST	ST:9	swine testicular
ST	ST:14	swine testis
ST	ST:36	syncytiotrophoblast
ST	ST:11	synovial tissues
SUA	SUA:58|SUa:1|sUA:1	serum uric acid
SUA	SUA:34	single umbilical artery
SUDEP	SUDEP:37	sudden unexpected death in epilepsy
SUDEP	SUDEP:12	sudden unexplained death in epilepsy
SUDs	SUDs:8	singleuse devices
SUDs	SUDs:36|SUDS:1	substance use disorders
SUR1	SUR1:33|Sur1:1	sulfonylurea receptor
SUR1	SUR1:26	sulfonylurea receptor 
SUVs	SUVs:70	small unilamellar vesicles
SUVs	SUVs:83	standardized uptake values
SUZI	SUZI:34	subzonal insemination
SUZI	SUZI:9	subzonal sperm injection
SVA	SVA:5	simvastatin hydroxy acid
SVA	SVA:11	supraventricular arrhythmias
SVCO	SVCO:13	superior vena cava obstruction
SVCO	SVCO:9	superior vena caval obstruction
SVC	SVC:19	slow vital capacity
SVC	SVC:466	superior vena cava
SVC	SVC:27	superior vena caval
SVD	SVD:14	single vessel disease
SVD	SVD:151	singular value decomposition
SVD	SVD:21	small vessel disease
SVD	SVD:35	structural valve deterioration
SVD	SVD:9	subcortical vascular dementia
SVD	SVD:25	swine vesicular disease
SVE	SVE:14	soil vapor extraction
SVE	SVE:10	subcortical vascular encephalopathy
SVF	SVF:7	seminal vesicle fluid
SVF	SVF:6	stromavascular fraction
SVR	SVR:11	surgical ventricular restoration
SVR	SVR:36	sustained viral response
SVR	SVR:42	sustained virologic response
SVR	SVR:89	sustained virological response
SVR	SVR:36	systemic
SVT	SVT:5	sinus venous thrombosis
SVT	SVT:12	superficial vein thrombosis
SVT	SVT:7	superficial venous thrombosis
SVT	SVT:9	supraventricular
SVV	SVV:54	simian varicella virus
SVV	SVV:6	small vessel vasculitis
SVV	SVV:37|svv:1	subjective visual vertical
SVs	SVs:9	splice variants
SVs	SVs:43	synaptic vesicles
SV	SV:18	scala vestibuli
SV	SV:7	selective vagotomy
SV	SV:13	shell vial
SV	SV:22	simple virilizing
SV	SV:9	single ventricle
SV	SV:10	slow vacuolar
SV	SV:27	spontaneous ventilation
SV	SV:39	stria vascularis
SV	SV:23	systemic vasculitis
SWAP	SWAP:8	adult worm antigens
SWAP	SWAP:8	soluble adult worm antigenic preparation
SWAP	SWAP:24	worm antigen preparation
SWDs	SWDs:13	spikeandwave discharges
SWDs	SWDs:4	spike wave discharges
SWM	SWM:10	segmental wall motion
SWM	SWM:22	spatial working memory
SWs	SWs:13	sex workers
SWs	SWs:18	slow waves
SWS	SWS:39	sturgeweber syndrome
SWS	SWS:9	stuvewiedemann syndrome
SWT	SWT:10	shuttle walk test
SWT	SWT:10	shuttle walking test
SWT	SWT:14|sWT:3	systolic wall thickening
SW	SW:5	forced swimming
SW	SW:6	generalized spike and wave
SW	S-W:3|SW:3	generalized spikewave
SW	SW:20	saltwasting
SW	SW:10|sw:1	spikeandwave
SW	SW:8	stab wounds
SW	SW:10	steroid withdrawal
SW	SW:73	stroke work
SW	SW:31|Sw:4	swainsonine
SXA	SXA:10	single energy xray absorptiometry
SXA	SXA:14	single xray absorptiometry
SAC	SAC:5	ion channels
SAC	SAC:18	sallyl cysteine
SAC	SAC:24	sallylcysteine
SAC	SAC:27	seasonal allergic conjunctivitis
SAC	SAC:6	segmental antigen challenge
SAC	SAC:9	spindle assembly checkpoint
SAC	SAC:29	splenic adherent cells
SAC	SAC:15|Sac:1	staphylococcus aureus cowan
SAC	SAC:27	staphylococcus aureus cowan 
SAC	SAC:16	staphylococcus aureus cowan i strain
SAC	SAC:7	staphylococcus aureus cowan strain
SAC	SAC:14	staphylococcus aureus cowan strain 
SAC	SAC:48	staphylococcus aureus cowan strain i
SAC	SAC:34	systemic arterial compliance
SAN	SAN:9	sinoatrial
SAN	SAN:11	spinal accessory nerve
SCAP	SCAP:9	severe communityacquired pneumonia
SCAP	SCAP:35	srebp cleavageactivating protein
SCAP	SCAP:13	syringocystadenoma papilliferum
Sf9	Sf9:8|SF9:1	expressed in insect
Sf9	Sf9:12|SF9:2|Sf-9:1	spodoptera frugiperda cells
SGE	SGE:8	generalized epilepsy
SGE	SGE:6	starch gel electrophoresis
SIA	SIA:20	sequential injection analysis
SIA	SIA:53	stressinduced analgesia
SIA	SIA:9	stressinduced antinociception
SIA	SIA:10	strip immunoblot assay
SIA	SIA:25	surgically induced astigmatism
Skuse	Skuse:8	aedes notoscriptus
Skuse	Skuse:6	ochlerotatus notoscriptus
SMI	SMI:11	effect of shenmai injection
SmI	SmI:5	rat somatosensory
SMI	SMI:7	respimat soft mist inhaler
SMI	SMI:26	serious mental illness
SMI	SMI:9	seriously mentally ill
SMI	SMI:11	severely mentally ill
SMI	SMI:17	silent myocardial ischaemia
SmI	SmI:21	somatosensory cortex
SMI	SMI:20	sperm motility index
SMI	SMI:11	structure model index
SMD	SMD:7	meningococcal disease
SMD	SMD:18	senile macular degeneration
SMD	SMD:7	spondylometaphyseal dysplasia
SMD	SMD:21	standardized mean differences
SMD	SMD:9	steered molecular dynamics
SPM	SPM:17	scanning probe microscopy
SPM	SPM:14	spontaneous pneumomediastinum
SPM	SPM:196	statistical parametric mapping
SPM	SPM:97	suspended particulate matter
SP	SP:7	cd or cd singlepositive
SP	SP:19	cd singlepositive
SP	SP:9	plate
SP	SP:7|Sp:2	power
Sp	Sp:22|sp:4|SP:1	schizosaccharomyces pombe
SP	SP:14|sp:1	sclerosing peritonitis
SP	SP:7	secondary polycythemia
SP	SP:80|Sp:1	seminal plasma
SP	SP:37	senile plaque
SP	SP:7|Sp:2	septum
SP	SP:10|Sp:1	seropositive
SP	SP:79	side population
SP	SP:61|sp:1	single positive
SP	SP:8	sleep paralysis
SP	SP:28	slow pathway
SP	SP:26	smooth pursuit
SP	SP:61|Sp:1	social phobia
SP	SP:10	sodium pentobarbital
SP	SP:8|sp:2	solid phase
SP	SP:8|Sp:5	spasmolytic polypeptide
Sp	Sp:8|SP:4|sp:1	spectinomycin
Sp	Sp:11|SP:2	spectrin
Sp	Sp:13|SP:5	spermine
Sp	Sp:12	spiroiminodihydantoin
SP	SP:25|Sp:7	spleen
SP	SP:13|Sp:1	splenius
Sp	Sp:35	splotch
SP	SP:51|Sp:9	spontaneous pneumothorax
SP	SP:9|Sp:2	spore photoproduct
SP	SP:8	storage phosphor
SP	SP:16	stratum pyramidale
SP	SP:11|S-P:4	streptavidinperoxidase
SP	SP:9	subplate
SP	SP:44	sulfapyridine
SP	SP:14	sulphadoxinepyrimethamine
SP	SP:16	sulphapyridine
SP	SP:17	superficial peroneal
SP	SP:7	supine position
SP	SP:8	synthetic peptides
SP	SP:11	synthetic pyrethroid
SP	SP:48	systolic pressure
STD	STD:21	saturation transfer difference
STD	STD:7	seminiferous tubular diameter
STD	STD:14	shortterm depression
StAR	StAR:190|Star:1|STAR:1|star:1|stAR:1	steroidogenic acute regulatory
StAR	StAR:303|STAR:4|stAR:2|Star:1|star:1	steroidogenic acute regulatory protein
SU	SU:16	stroke unit
SU	SU:11|Su:3	sucrose
SU	SU:48|Su:5	sulfonylurea
SU	SU:13|Su:1	sulphonylurea
SU	SU:6|Su:1	surface envelope glycoprotein
SU	SU:7	surface envelope protein
SU	SU:29|Su:1	surface glycoprotein
SU	SU:5	surface subunit
SU	SU:17	surface unit
SU	SU:8|S-U:1	swimup
T/N	T/N:7	normal tissue
T/N	T/N:12	tumornormal
T0	T0:8|t0:2	operation
T0	T0:7|t0:2|T-0:1	study
T1	T1:14	 month
T1	T1:20	first response
T1	T1:8|T-1:1	first thoracic
T1	T1:50	first twitch
T1	T1:3	first twitch of the tof
T1	T1:7	first twitch of the trainoffour
T1	T1:14	longitudinal relaxation
T1	T1:4	lowest excited triplet
T1	T1:12	spinlattice relaxation
T2	T2:7|t2:2	 months later
T2	T2:7|t2:2	minutes
T2	T2:17	mitochondrial acetoacetylcoa thiolase
T2	T2:7	second target
T2	T2:7	second thoracic
T2	T2:6	spinspin relaxation
T2	T2:6	stage b
T2	T2:16|t2:1	years later
T3	T3:11	itriiodothyronine
T3	T3:9	advanced
T3	T3:15|t3:3	after
T3	T3:7	thyroid hormone triiodolthyronine
T3	T3:6	total t
T3	T3:19	triidothyronine
T3	T3:12|t3:1	triiodothyronin
T3	T3:14	triiodothyroxine
T3	T3:13	triodothyronine
T4	T4:14	locally advanced
T4	T4:452|T-4:5	serum thyroxine
T4	T4:6	thyroxine level
T4	T4:13	tripchlorolide
TAA	TAA:7	tertamyl alcohol
TAA	TAA:12|-TAA:1	thoracoabdominal aneurysm
TAA	TAA:12	thoracoabdominal aortic aneurysm
TAA	TAA:7	thoracoabdominal asynchrony
TAA	TAA:26	total antioxidant activity
TAA	TAA:8	tumorassociated ag
TAA	TAA:11	tumorassociated ags
TAB	TAB:9	temporal artery biopsy
TAB	TAB:13	total androgen blockade
Tac	Tac:9|TAC:3	interleukin  receptor
Tac	Tac:5	interleukin receptor alpha chain
TAC	TAC:14	teller acuity cards
TAC	TAC:9	total abdominal colectomy
TAC	TAC:10	transformationcompetent artificial chromosome
TAC	TAC:25	transverse aortic constriction
TAD	TAD:29	thiazolecarboxamide adenine dinucleotide
TAD	TAD:40	transactivation domain
TAD	TAD:13	transcription activation domain
TAD	TAD:11	transcriptional activation domain
TAD	TAD:13	transient acantholytic dermatosis
TAE	TAE:10	tilt aftereffect
TAE	TAE:384	transcatheter arterial embolization
TAE	TAE:11	transcatheter arterial embolization therapy
TAE	TAE:1	treated by either transarterial embolization
TAFIa	TAFIa:14	activated tafi
TAFIa	TAFIa:9	fibrinolysis inhibitor
TAF	TAF:10	aspirate fluid
TAF	TAF:10	studies on the function of concentration maintenance
TAF	TAF:14	thoughtaction fusion
TAI	TAI:5	thoracoabdominal irradiation
TAI	TAI:19	timed artificial insemination
TAI	TAI:10	transcatheter arterial infusion
TAI	TAI:19	traumatic axonal injury
TAL	TAL:9	taste aversion learning
TAL	TAL:5	tendoachilles lengthening
TAL	TAL:8	thin agar layer
TAL	TAL:9|tal:2	transaldolase
TAMs	TAMs:8	thymidine analogue mutations
TAMs	TAMs:29	tumorassociated macrophages
TAM	TAM:11|Tam:1	tamoxifen citrate
TAM	TAM:22	total active motion
TAM	TAM:23	transient abnormal myelopoiesis
TAO	TAO:53	thromboangiitis obliterans
TAO	TAO:17	thyroidassociated orbitopathy
TAO	TAO:41	triacetyloleandomycin
TAO	TAO:44|Tao:1	troleandomycin
TAO	TAO:14	trypanosome alternative oxidase
TAP	TAP:11	triaminopyrimidine
TAP	TAP:9	peptide transporter
TAP	TAP:30	tandem affinity purification
TAP	TAP:29	tick anticoagulant peptide
TAP	TAP:13|tap:1	tracheal antimicrobial peptide
TAP	TAP:8	transmembrane action potential
TAP	TAP:38	transporter associated with antigen presentation
TAP	TAP:232	transporter associated with antigen processing
TAP	TAP:12	treatment of agerelated macular degeneration with photodynamic therapy
TAP	TAP:15	tricuspid annuloplasty
TAR	TAR:10	tat protein with the transactivation responsive region
TAR	TAR:8	thoracic aortic rupture
TAR	TAR:7	thrombocytopeniaabsent radius
TAR	TAR:10	thrombocytopenia and absent radii
TAR	TAR:2	thrombocytopenia and absent radius
TAR	TAR:19	tissueair ratio
TAR	TAR:5|tar:3	transactivation responsive element
TAR	TAR:21	transformationassociated recombination
TAR	TAR:12	traumatic aortic rupture
TAS	TAS:4	termination associated sequence
TAS	TAS:138	total antioxidant status
TAS	TAS:16	transabdominal sonography
Tat	Tat:3|TAT:1	hiv transactivator
TAT	TAT:37	thematic apperception test
TAT	TAT:101|T-AT:1	thrombinantithrombin
TAT	TAT:101|T-AT:2	thrombinantithrombin iii
TAT	TAT:7	total adipose tissue
Tat	Tat:11|tat:11|TAT:2	transactivator
TAT	TAT:9|Tat:5	transactivator of transcription
TAT	TAT:37	tray agglutination test
TAT	TAT:32	turnaround time
TAT	TAT:9	tyrosine amino transferase
TAT	TAT:283|Tat:3	tyrosine aminotransferase
TAV	TAV:11	time average velocity
TAV	TAV:20	tomato aspermy virus
Ta	Ta:14|ta:1|TA:1	air temperatures
TA	TA:7	patients with takayasu arteritis
TA	TA:5|Ta:3	t cells
Ta	Ta:35	tabby
TA	TA:87	takayasus arteritis
TA	TA:61	tannic acid
Ta	Ta:14	tantalum
TA	TA:10	technology assessment
TA	TA:7	teichoic acids
TA	TA:64	telomerase activity
TA	TA:5	temporal artery
TA	TA:21	thoracic aorta
TA	TA:16	thyroarytenoid muscle
TA	TA:647|ta:1|Ta:1	tibialis anterior
TA	TA:32	tibialis anterior muscle
TA	TA:13	titratable acidity
TA	TA:22	tonic accommodation
TA	TA:9|Ta:1	total area
TA	TA:10	toxic adenoma
TA	TA:9	tracheal agenesis
TA	TA:26	transabdominal
TA	TA:11	transactivation
TA	TA:6	transient absorption
TA	TA:5	transit amplifying
TA	TA:10	transplant arteriosclerosis
TA	TA:16	triamterene
TA	TA:17	tricuspid annulus
TA	TA:22	tricuspid atresia
TA	TA:17	truncus arteriosus
TA	TA:5|Ta:2	tryptamine
TA	TA:5	tumour antigens
TA	TA:17	tunica albuginea
TBAR	TBAR:5	thiobarbituric acid reactive products
TBAR	TBAR:6	thiobarbituric acid reactive substances
TBC	TBC:8|tBC:1	tertbutylcatechol
TBC	TBC:5	tertiary butyl catechol
TBC	TBC:7	total bacterial count
TBE	TBE:12	tracheobronchial epithelial
TBE	TBE:17	trisborateedta
TBF	TBF:13	terbinafine
TBF	TBF:9	tertbutyl formate
TBF	TBF:8	thermal biofeedback
TBF	TBF:19	tickborne fever
TBF	TBF:59	total body fat
TBG	TBG:326	thyroxinebinding globulin
TBG	TBG:11	trophoblastic beta glycoprotein
TBHQ	tBHQ:4|TBHQ:4|t-BHQ:2	tbutylhydroquinone
TBHQ	TBHQ:4|t-BHQ:3	tertbutyl hydroquinone
TBHQ	TBHQ:38|tBHQ:31|t-BHQ:6|t-b-HQ:1	tertbutylhydroquinone
TBHQ	TBHQ:9	tertiary butylhydroquinone
TBIAb	TBIAb:8|TBI-ab:1	inhibiting antibodies
TBIAb	TBIAb:4	tsh binding inhibiting antibody
TBII	TBII:8	thyrotrophin binding inhibiting immunoglobulins
TBII	TBII:12	thyrotropin binding inhibiting immunoglobulins
TBII	TBII:17	thyrotropin binding inhibitor immunoglobulin
TBI	TBI:24	brain injured
TBI	TBI:12	traumatic braininjured
TBI	TBI:13	traumatically braininjured
TBI	TBI:7	tsh binding inhibition
TBM	TBM:12	total body mass
TBM	TBM:7	trabecular bone mass
TBM	TBM:13	tracheobronchomalacia
TBM	TBM:17	tumorbearing mice
TBPS	TBPS:12	binding of stbutylbicyclophosphorothionate
TBPS	TBPS:31	tbutylbicyclophosphorothionate
TBPS	TBPS:9	tertbutylbicyclophosphorothionate
TBP	TBP:443|tbp:1	tatabinding protein
TBP	TBP:5	tata boxbinding polypeptide
TBP	TBP:9	trinbutyl phosphate
TBP	TBP:29	tributyl phosphate
TBSA	TBSA:244|tbsa:1	total body surface area
TBSA	TBSA:10	tuberculostearic acid
TBT	TBT:5	effects of trinbutyltin chloride
TBT	TBT:7	template bleeding time
TBT	TBT:13	trinbutyltin
TBT	TBT:296	tributyltin
TBV	TBV:64	total blood volume
TBV	TBV:51	trabecular bone volume
TBW	TBW:524	total body water
TBW	TBW:53	total body weight
TCAs	TCAs:10	thalamocortical axons
TCAs	TCAs:432|TCAS:1	tricyclic antidepressants
TCAs	TCAs:10	tricyclic antidepressant drugs
TCA	TCA:10	trichloroanisole
TCA	TCA:6	temporal clustering analysis
TCA	TCA:8	total circulatory arrest
TCA	TCA:25	total colonic aganglionosis
TCA	TCA:35	transluminal coronary angioplasty
TCA	TCA:321|tca:1	tricarboxylic acid
TCA	TCA:19	tricarboxylic acid cycle
TCA	TCA:14	tricyclic
TCBS	TCBS:6	citrate bile salts sucrose
TCBS	TCBS:8	thiosulfatecitratebile saltssucrose
TCBS	TCBS:6	thiosulphatecitratebile saltssucrose
TCCS	TCCS:20	transcranial colorcoded realtime sonography
TCCS	TCCS:22	transcranial colorcoded sonography
TCC	TCC:10	bladder cancer
TCC	TCC:18	tai chi chuan
TCC	TCC:6	total cell count
TCC	TCC:6	total coliform counts
TCC	TCC:9	total contact cast
TCC	TCC:10	total contact casting
TCC	TCC:9	transcervical cell
TCC	TCC:30	transitional cell cancer
TCC	TCC:23	transitional cell carcinoma of the bladder
TCC	TCC:10	transitional cell carcinoma of the urinary bladder
TCD50	TCD50:7	control dose 
TCD50	TCD50:8|TCD-50:1	tumor control dose
TCDD	TCDD:11	htetrachlorodibenzopdioxin
TCDD	TCDD:13	tetrachlorodibenzoparadioxin
TCDD	TCDD:10	tetrachlorodibenzodioxin
TCDO	TCDO:17	tetrachlorodecaoxide
TCDO	TCDO:5	tetrachlorodecaoxygen anion complex
TCD	TCD:601|TcD:1	transcranial doppler
TCD	TCD:239|TcD:1	transcranial doppler sonography
TCD	TCD:115	transcranial doppler ultrasonography
TCD	TCD:101	transcranial doppler ultrasound
TCD	TCD:13	transverse cerebellar diameter
TCE	TCE:15	control element
TCE	TCE:5	metabolites trichloroethanol
TCF	TCF:9	temperature coefficient of frequency
TCF	TCF:17	tissue cage fluid
TCF	TCF:8	tissue chamber fluid
TCI	TCI:163	temperament and character inventory
TCI	TCI:7	testicular circulatory isolation
TCI	TCI:7	transcobalamin i
TCI	TCI:17	transcutaneous immunization
TCI	TCI:7	transitory cognitive impairment
T-CLL	T-CLL:7|TCLL:1	tcell chronic lymphocytic leukaemia
T-CLL	T-CLL:30	tcell chronic lymphocytic leukemia
TCL	TCL:9	tcell lymphoma
TCL	TCL:7	tachycardia cycle length
TCL	TCL:16	transverse carpal ligament
TCM	TCM:16	tissue culture medium
TCM	TCM:12	trichlormethiazide
TCM	TCM:11	trichloromethane
TCP	TCP:14	thienylcyclohexylpiperidine
TCP	TCP:28	trichloropyridinol
TCP	TCP:6	inhibitor tranylcypromine
TCP	TCP:13	piperidine
TCP	TCP:10|tcp:2|Tcp:1	toxin coregulated pilus
TCP	TCP:17	toxincoregulated pili
TCP	TCP:8	transcutaneous cardiac pacing
TCP	TCP:134	tricalcium phosphate
TCP	TCP:9	tricalciumphosphate
TCP	TCP:11	tricresylphosphate
TCP	TCP:10	tropical calcific pancreatitis
TCRB	TCRB:10	trichlorobetadribofuranosylbenzimidazole
TCRB	TCRB:10|Tcrb:1	receptor beta chain
Tcr	Tcr:6|TcR:1	resistance to tetracycline
TCR	TCR:6	t cell antigen receptor complex
TCR	TCR:28|TcR:1	t cell receptor for antigen
Tcr	Tcr:10	t complex responder
Tcr	Tcr:9|TcR:1	tetracyclineresistant
TCR	TCR:15	transcriptional control region
TCT	TCT:24	thyrocalcitonin
TCT	TCT:16	tracheal cytotoxin
TCT	TCT:28	transmission computed tomography
TCT	TCT:9	transmission ct
TCT	TCT:6	tube coagulase test
TCV	TCV:10	t cell vaccination
TCV	TCV:10	tall cell variant
TCV	TCV:24	turkey coronavirus
TCV	TCV:63	turnip crinkle virus
TCS	TCS:8	magnetic transcranial stimulation
TCS	TCS:26	tethered cord syndrome
TCs	TCs:27	tetracyclines
TCs	TCs:11	tetracycline antibiotics
TCS	TCS:17	transcranial sonography
TCS	TCS:71	trichosanthin
TCs	TCs:12	tuning curves
tcu-PA	tcu-PA:7	active twochain upa
tcu-PA	tcu-PA:4|tcuPA:2|Tc-uPA:2|tc-u-PA:1	twochain urokinase
tcu-PA	tcu-PA:8	twochain urokinasetype plasminogen activator
Tc	Tc:13|tc:1|TC:1	cell cycle
TC	TC:9	cellobiose
Tc	Tc:18|TC:3|T-c:1	colonic
Tc	Tc:51|TC:5	cytotoxic t
TC	TC:6	human teratocarcinoma
Tc	Tc:13	t cytotoxic
TC	TC:18	taurocholic acid
Tc	Tc:5	taxuyunnanine c
Tc	Tc:22|tc:1|TC:1	technetium
TC	TC:22	temporal cortex
TC	TC:42	terminal cisternae
TC	TC:35	testicular cancer
TC	TC:10	testosterone cypionate
TC	TC:95|T-C:6	thalamocortical
TC	TC:72	therapeutic community
TC	TC:8	thoracic circumference
TC	TC:16	thyroid cancer
TC	TC:12	thyroid carcinoma
TC	TC:14|Tc:9|tc:7	time constant
TC	TC:9|Tc:1	tinospora cordifolia
TC	TC:31	tissue culture
TC	TC:17	total carbon
TC	TC:19	total carnitine
TC	TC:10	transcarboxylase
TC	TC:15	transcervical
TC	TC:40	transcobalamin
Tc	Tc:11	transition temperatures
TC	TC:11	trauma center
TC	TC:6|Tc:3	tubocurarine
TC	TC:14	tumoral calcinosis
TD50	TD50:9	carcinogenic potency
TD50	TD50:10	median toxic dose
TDC	TDC:40	taurodeoxycholate
TDC	TDC:9	titanocene dichloride
TDC	TDC:17|Tdc:5|tdc:1	tryptophan decarboxylase
TDD	TDD:6	thiamine deficient diet
TDD	TDD:12	thoracic duct drainage
TDF	TDF:11	tenofovir
TDF	TDF:17	testisdetermining factor
TDF	TDF:1	time dose and fractionation
TDF	TDF:55	total dietary fiber
TDF	TDF:9	total dietary fibre
TDF	TDF:10	transdermal fentanyl
TDH	TDH:18	texas department of health
TDH	TDH:4|tdh:2|Tdh:1	threonine dehydrogenase
TDI	TDI:15	thought disorder index
TDI	TDI:131|TDi:1	tissue doppler imaging
TDI	TDI:68	tolerable daily intake
TDI	TDI:8	total dose infusion
TDI	TDI:9	transition dyspnea index
TDLUs	TDLUs:6	terminal duct lobular units
TDLUs	TDLUs:7	terminal ductal lobular units
TDL	TDL:18	thoracic duct lymph
TDL	TDL:96	thoracic duct lymphocytes
TDM	TDM:310	therapeutic drug monitoring
TDM	TDM:9	tomodensitometry
TDM	TDM:56	trehalose dimycolate
TDO	TDO:9	toluene dioxygenase
TDO	TDO:8	trichodentoosseous syndrome
TDO	TDO:25|TdO:6	tryptophan dioxygenase
TDP	TDP:10	tetradecapeptide
TDP	TDP:12	timedependent potentiation
TDS	TDS:10	testicular dysgenesis syndrome
TDS	TDS:13	timedependent sensitization
TDS	TDS:21	total defect score
TDS	TDS:12	total diet study
TDS	TDS:28	total dissolved solids
TDS	TDS:17	transdermal delivery system
TDS	TDS:8	trichuris dysentery syndrome
Td	Td:14	denaturation temperature
Td	Td:27|TD:13|td:6	doubling time
TD	TD:27	tdependent
TD	TD:39	tangier disease
TD	TD:561	tardive dyskinesia
TD	TD:8	temporal difference
Td	Td:8	tetanus and diphtheria toxoids
Td	Td:9|TD:1|td:1	tetanusdiphtheria
Td	Td:5	tetanusdiphtheria toxoid
TD	TD:36	thanatophoric dysplasia
TD	TD:72|Td:1	thermodilution
TD	TD:29	thiamine deficiency
TD	TD:5	thiamine deficient
TD	TD:22	thoracic duct
td	td:10	thymidylate synthase gene
TD	TD:97	tibial dyschondroplasia
TD	TD:12|Td:1|td:1	time delay
TD	TD:26	tissue doppler
TD	TD:14	total deviation
TD	TD:8	total dose
TD	TD:24	tourettes disorder
TD	TD:7|td:2	transdermal
td	td:18	transformationdefective
TD	TD:11	travelers diarrhea
Td	Td:8	treponema denticola
TD	TD:9	triple dose
TD	TD:24|tD:3	true digestibility
TD	TD:11	true protein digestibility
TD	TD:13	tryptophan depletion
TD	TD:5	typical development
TD	TD:26	typically developing
TEAM	TEAM:7	transfemoral endovascular aneurysm management
TEAM	TEAM:8	trauma evaluation and management
TEA	TEA:10	ctetraethylammonium
TEA	TEA:7	carotid thromboendarterectomy
TEA	TEA:14	tetraethylammonium bromide
TEA	TEA:137	tetraethylammonium chloride
TEA	TEA:16	thoracic epidural anaesthesia
TEA	TEA:48	thoracic epidural analgesia
TEA	TEA:59	thoracic epidural anesthesia
TEA	TEA:8	total elbow arthroplasty
TEA	TEA:33|tea:1	triethanolamine
TEA	TEA:79	triethylamine
TEB	TEB:12	terminal end bud
TEB	TEB:28	thoracic electrical bioimpedance
TEB	TEB:11	transient electric birefringence
TED	TED:23	thromboembolic disease
TED	TED:30	thyroid eye disease
TEE	TEE:226	total energy expenditure
TEE	TEE:25	transesophageal echocardiogram
TEE	TEE:60	transesophageal echocardiographic
TEE	TEE:13	transesophageal echography
TEF-1	TEF-1:18	transcription enhancer factor
TEF-1	TEF-1:19	transcriptional enhancer factor
TEFRA	TEFRA:9	tax equity and fiscal responsibility act
TEFRA	TEFRA:9	tax equity and fiscal responsibility act of 
TEF	TEF:23	thermic effect of feeding
TEF	TEF:58	thermic effect of food
TEF	TEF:26	toxic equivalency factor
TEF	TEF:7	tracheoesophageal fistulas
TEGDMA	TEGDMA:46|TEG-DMA:1	triethylene glycol dimethacrylate
TEGDMA	TEGDMA:23	triethyleneglycol dimethacrylate
TEGDMA	TEGDMA:9	triethyleneglycoldimethacrylate
TEG	TEG:5	tetraethylene glycol
TEG	TEG:10	thrombelastogram
TEG	TEG:28	thrombelastograph
TEG	TEG:63	thrombelastography
TEG	TEG:15	thromboelastogram
TEG	TEG:18	thromboelastograph
TEG	TEG:65	thromboelastography
TEG	TEG:5	triethylene glycol
TEL	TEL:8|Tel:2	telencephalon
TEL	TEL:13	tetraethyl lead
TEMPO	TEMPO:16|Tempo:4|TEM-PO:1	tetramethylpiperidineoxyl
TEMPO	TEMPO:7|Tempo:1	tetramethylpiperidinenoxyl
TEM	TEM:1	technical error measurement
TEM	TEM:25	thermic effect of a meal
TEM	TEM:85	transanal endoscopic microsurgery
TEM	TEM:45|tem:1	transendothelial migration
TEM	TEM:281	transmission electron microscope
TEM	TEM:103	transmission electron microscopic
TEM	TEM:25	transverse electromagnetic
TEM	TEM:66|tem:1	triethylenemelamine
TEN	TEN:36	total enteral nutrition
TEN	TEN:240	toxic epidermal necrolysis
TEOAEs	TEOAEs:89	transient evoked otoacoustic emissions
TEOAEs	TEOAEs:43	transiently evoked otoacoustic emissions
TEP	TEP:11	endoscopic totally extraperitoneal inguinal hernioplasty
TEP	TEP:8	extraperitoneal approach
TEP	TEP:17	total extraperitoneal
TEP	TEP:43	totally extraperitoneal
TEP	TEP:40	tracheoesophageal puncture
TES	TES:7	total error score
TES	TES:17	transthoracic endoscopic sympathectomy
TES	TES:6	treadmill exercise score
TEV	TEV:29	tobacco etch potyvirus
TEV	TEV:86|Tev:1	tobacco etch virus
TE	TE:6|Te:2|te:1	duration of expiration
TE	TE:71	testosterone enanthate
TE	TE:23|Te:2	thioesterase
TE	TE:18	thromboembolic
TE	TE:56	thromboembolism
TE	TE:38|T-E:1	thymic epithelial
TE	TE:8	thymic epithelium
TE	TE:5	time to echo
TE	TE:15	tissue engineering
TE	TE:5	tonic extension
TE	TE:5	total energy
TE	TE:10	toxic encephalopathy
TE	TE:28	toxoplasma encephalitis
TE	TE:62	toxoplasmic encephalitis
TE	TE:14	trabeculectomy
TE	TE:11	tracheal epithelial
TE	TE:59|T-E:2|t-e:1	tracheoesophageal
TE	TE:18	tropoelastin
TFA	TFA:6	timefrequency analysis
TFA	TFA:4|TFa:3	tissue factor activity
TFA	TFA:29|tFA:1|t-FA:1	trans fatty acids
TFA	TFA:12	trifluoroacetate
TFA	TFA:17|Tfa:1	trifluoroacetyl
TFC	TFC:27	thyroid follicular cells
TFC	TFC:10	timi frame count
TFC	TFC:31	triangular fibrocartilage
TFE	TFE:20	tetrafluoroethylene
TFE	TFE:9	watertrifluoroethanol
TFI	TFI:7	treatmentfree interval
TFI	TFI:15	tubal factor infertility
TFL	TFL:15	tensor fascia lata
TFL	TFL:9	tensor fasciae latae
TFP	TFP:11	mitochondrial trifunctional protein
TFP	TFP:405|tfp:1|Tfp:1	trifluoperazine
TFTs	TFTs:9	thyroid function tests
TFTs	TFTs:10	transistors
TFT	TFT:7	thin film transistor
TFT	TFT:13	thought field therapy
TFT	TFT:5	thyroid function test
TFT	TFT:57	trifluorothymidine
TFX	TFX:22	thymus extract
TFX	TFX:11	thymus factor x
TF	TF:20|Tf:2	mtctetrofosmin
TF	TF:7	inhibition of the nociceptive tailflick
TF	TF:70	tail flick
TF	TF:6	tailflick reflex
TF	TF:12|Tf:1	tetrofosmin
TF	TF:9	thickening fraction
TF	TF:54	thomsenfriedenreich
TF	TF:10	tibiofemoral
TF	TF:12|T-F:2|t-f:2	timefrequency
TF	TF:8	total fat
TF	TF:18	transfer factors
TF	TF:12	transfer function
TF	TF:6	transport fraction
TF	TF:8	treatment failure
TF	TF:9	tubular fluid
TF	TF:19	typhoid fever
TGA	TGA:11	thioglycolic acid
TGA	TGA:136	transient global amnesia
TGA	TGA:262	transposition of the great arteries
TGEV	TGEV:54	transmissible gastroenteritis coronavirus
TGEV	TGEV:249	transmissible gastroenteritis virus
TGFA	TGFA:21|TGFa:3|Tgfa:2|TGF-a:2	transforming growth factor alpha
TGFA	TGFA:13|TG-FA:2	triglyceride fatty acids
TGI	TGI:5	thyroid growth stimulating immunoglobulins
TGI	TGI:49	tracheal gas insufflation
TGM	TGM:12	total gaseous mercury
TGM	TGM:3|Tgm:3|TgM:2	transgenic mouse
TGT	TGT:7	thrombin generation time
TGT	TGT:31|Tgt:4|tgt:1	trnaguanine transglycosylase
TGT	TGT:6	tumor growth time
TGr	TGr:5|TGR:1	thioguanine resistant
TGr	TGr:7	frequency of thioguanineresistant
TGR	TGR:4	hypertensive tgrmren rats
TGR	TGR:11	tgrmren
TG	TG:4|Tg:1	fc receptors for igg
Tg	Tg:9	glass transition
TG	TG:13|Tg:1	glucuronide
TG	TG:7	low density lipoprotein vldltriglyceride
TG	TG:27|Tg:1	plasma triacylglycerol
TG	TG:254|Tg:1	plasma triglyceride
Tg	Tg:221|TG:26|tg:2	serum thyroglobulin
Tg	Tg:12|tg:6|TG:1	tcrtransgenic
TG	TG:10	tetragastrin
TG	TG:12	thermogravimetric
TG	TG:23|Tg:1	thioglycollate
TG	TG:11	thrombin generation
Tg	Tg:16|TG:11	thymine glycol
TG	TG:23	thyroid gland
TG	TG:38	total gastrectomy
TG	TG:13	training group
Tg	Tg:10|tg:7|TG:3	transgene
TG	TG:17	treatment group
TG	TG:9	trigeminal
TG	TG:84	trigeminal ganglia
TG	TG:6	triglyceride concentration
TG	TG:7	triglyceride levels
TG	TG:11	tumour growth
TG	TG:12	typhus group
THB	THB:17	tetrahydroberberine
THB	THB:19	toddhewitt broth
THC	THC:9	delta tetrahydrocannabinol
THC	THC:110	tetrahydrocannabinol
THC	THC:10	tetrahydrocurcumin
THC	THC:18	total haemocyte count
THC	THC:9	total hydrocarbon
THE	THE:31	tetrahydrocortisone
THE	THE:14	tonic hindlimb extension
THE	THE:29	transhiatal esophagectomy
THF	THF:9	monotetrahydrofuran
THF	THF:12	tetrahydrofolic acid
THF	THF:177|thf:2	tetrahydrofuran
THF	THF:9	thymic hormone
THF	THF:28	thymic humoral factor
TH-IR	TH-IR:22|TH-ir:13|THir:3|THIR:1	thimmunoreactive
TH-IR	TH-IR:15|TH-ir:4|THir:2|THIR:1	tyrosine hydroxylase immunoreactivity
THI	THI:10	acetyltetrahydroxybutylimidazole
THI	THI:16	temperaturehumidity index
THI	THI:17	tinnitus handicap inventory
THI	THI:47	tissue harmonic imaging
THI	THI:11	traumatic head injury
THL	THL:19	tetrahydrolipstatin
THL	THL:14	transvaginal hydrolaparoscopy
THL	THL:9	true histiocytic lymphoma
THP-1	THP-1:7	human monocytes
THP-1	THP-1:6	human monocytic
THP-1	THP-1:15|THP1:1	monocytic cells
THP-1	THP-1:9	monocytic leukemia
THP	THP:9	rotetrahydropyranyladriamycin
THP	THP:9	otetrahydropyranyladriamycin
THP	THP:77	pirarubicin
THP	THP:10	tetrahydropalmatine
THP	THP:52	tetrahydropapaveroline
THP	THP:20	trihexyphenidyl
THR	THR:8	transient hyperaemic response
THR	THR:6	transient hyperemic response
T-H	T-H:5|TH:4	after traumahemorrhage
T-H	T-H:6	following traumahemorrhage
Th	Th:115|TH:15	helper t
Th	Th:7|TH:3	helper t lymphocytes
TH	TH:12	homogenate
TH	TH:5	nicotinamide nucleotide transhydrogenase
TH	TH:12|T-H:2	tammhorsfall
TH	TH:23	target height
TH	TH:9	tec homology
TH	TH:18	tension headache
TH	TH:19|Th:12	thalamus
Th	Th:14	thorium
TH	TH:13	triamcinolone hexacetonide
TH	TH:10	tyrosine hydroxylase gene
TIA-1	TIA-1:11|TIA1:1|Tia-1:1	intracellular antigen
TIA-1	TIA-1:16	tcell intracellular antigen
TIA	TIA:15	thin layer immunoassay
TIA	TIA:11	thrombosisinducing activity
TIA	TIA:10	thymidine incorporation assay
TIA	TIA:5	trabeculariris angle
TIA	TIA:15	trypsin inhibitor activity
TIA	TIA:15	turbidimetric immunoassay
TIBC	TIBC:7	serum iron and total iron binding capacity
TIBC	TIBC:86	total ironbinding capacity
TIC	TIC:5	intensity curve
TIC	TIC:8	thyroid iodine content
TIC	TIC:18|Tic:1	ticarcillin
TIC	TIC:22	trypsin inhibitory capacity
TIDA	TIDA:31	tuberoinfundibular dopamine
TIDA	TIDA:122|TI-DA:1	tuberoinfundibular dopaminergic
TIE	TIE:15	inhibitory element
TIE	TIE:34	toxicity identification evaluation
TIGR	TIGR:12	glucocorticoid response protein
TIGR	TIGR:7	trabecular meshwork inducible glucocorticoid response
TIMI	TIMI:465	thrombolysis in myocardial infarction
TIMI	TIMI:16	thrombolysis in myocardial infarction trial
TIMI	TIMI:9	thrombolysis in myocardial ischemia
TIMPs	TIMPs:7	tissue inhibitors of matrix metalloproteinase
TIMPs	TIMPs:12	tissue inhibitors of metalloproteases
TIMPs	TIMPs:19	tissue inhibitors of metalloproteinase
TIN	TIN:18	testicular intraepithelial neoplasia
TIN	TIN:70	tubulointerstitial nephritis
TIPS	TIPS:24	transjugular intrahepatic portosystemic shunting
TIPS	TIPS:22	transjugular intrahepatic portosystemic stentshunt
TIP	TIP:12	tonoplast intrinsic protein
TIP	TIP:9	tubularized incised plate
TIR	TIR:19	tollinterleukin receptor
TIR	TIR:22	total internal reflection
TIR	TIR:20	translation initiation region
TIS	TIS:9	information services
TIS	TIS:7	total irritation score
TIS	TIS:21|tis:1	transcription initiation site
TIVA	TIVA:76	total intravenous anaesthesia
TIVA	TIVA:96	total intravenous anesthesia
TIV	TIV:14	tipula iridescent virus
TIV	TIV:8	total intracranial volume
TIV	TIV:4	trivalent inactivated influenza vaccine
Ti	Ti:7|TI:5	duration of inspiration
TI	TI:65|Ti:12|ti:3	inspiratory duration
Ti	Ti:5	t cell antigen receptor
Ti	Ti:6	t cell receptor
TI	TI:25|T-I:1	tindependent
TI	TI:8	thalassaemia intermedia
TI	TI:13	thalassemia intermedia
TI	TI:10	theca interna
TI	TI:40	therapeutic index
TI	TI:9	thermodynamic integration
TI	TI:7	thoracic electrical impedance
TI	TI:10	thoracic irradiation
TI	TI:5	threshold intensity
TI	TI:8	thymic irradiation
Ti	Ti:1	time in inspiration
Ti	Ti:13|TI:1	titanium alloy
TI	TI:67	tonic immobility
TI	TI:8|Ti:1	transcallosal inhibition
TI	TI:8	treatment interruption
TI	TI:9	tricuspid incompetence
TI	TI:24	tricuspid insufficiency
TI	TI:11	true insulin
TI	TI:13	tuberoinfundibular
TI	TI:19|ti:1	tubulointerstitial
TK-	TK-:23|tk-:3	thymidine kinasedeficient
TK-	TK-:18|tk-:2|Tk-:1	thymidine kinasenegative
TKs	TKs:28|Tks:1	tachykinins
TKs	TKs:25	tyrosine kinases
TLA	TLA:5	thetalike activity
TLA	TLA:7	total lesion area
TLA	TLA:23	toxoplasma lysate antigen
TLCO	TLCO:36|Tlco:1	carbon monoxide transfer factor
TLCO	TLCO:5|TLco:2	diffusion capacity
TLCO	TLCO:8	lung transfer factor for co
TLCO	TLCO:27|Tlco:1|TLco:1|TlCO:1	transfer factor for carbon monoxide
TLC	TLC:19	taurolithocholate
TLC	TLC:14	thinlayer
TLC	TLC:744|tlc:2	thinlayer chromatography
TLC	TLC:20	total leukocyte count
TLC	TLC:595	total lung capacity
TLDs	TLDs:22|TLDS:1	thermoluminescence dosemeters
TLDs	TLDs:15	thermoluminescent detectors
TLD	TLD:30	thermoluminescence dosimetry
TLD	TLD:58	thermoluminescent dosimetry
TLE	TLE:774	temporal lobe epilepsy
TLE	TLE:10	transducinlike enhancer of split
TLI	TLI:41|T-LI:4	thymidine labeling index
TLI	TLI:21	thymidine labelling index
TLI	TLI:247	total lymphoid irradiation
TLI	TLI:21	trypsinlike immunoreactivity
TLN	TLN:9|tln:1	telencephalin
TLN	TLN:15	thermolysin
TLS	TLS:22	translesion dna synthesis
TLS	TLS:45	translesion synthesis
TLS	TLS:10	trnalike structure
TLS	TLS:58	tumor lysis syndrome
TLV	TLV:8	tidal liquid ventilation
TLV	TLV:10	total liquid ventilation
TLV	TLV:7	total liver volume
TLV	TLV:10	total lung volume
TLV	TLV:20	twolung ventilation
TLM	TLM:12	thiolactomycin
TLM	TLM:5	triplelayer model
TLM	TLM:16	twolayer method
TL	TL:14	tail length
TL	TL:12	temporal lobectomy
TL	TL:102	thermoluminescence
TL	TL:51	thermoluminescent
TL	TL:11|T-L:3	thoracolumbar
TL	TL:11	thymus leukemia antigen
TL	TL:7	thyroid lymphoma
TL	TL:9	tomato lectin
TL	TL:8	tonsillar lymphocytes
TL	TL:18	total laryngectomy
TL	TL:22	total length
TL	TL:9	tracheal ligation
TL	TL:10	transfer latency
TL	TL:11	tubal ligation
TMA-DPH	TMA-DPH:12	trimethylaminodiphenylhexatriene
TMA-DPH	TMA-DPH:8	trimethylammonium diphenylhexatriene
TMAO	TMAO:50|TMA-O:1	trimethylamine oxide
TMAO	TMAO:23	trimethylarsine oxide
TMA	TMA:12	trimethylangelicin
TMA	TMA:11	thermomechanical analysis
TMA	TMA:12	thyroid microsomal antibodies
TMA	TMA:143	trimellitic anhydride
TMA	TMA:113	trimethylamine
TMB-8	TMB-8:18	trimethoxybenzoate hydrochloride
TMB-8	TMB-8:14	trimethoxybenzoic acid diethylaminooctyl ester
TMB-8	TMB-8:3	intracellular ca antagonist nndiethylaminooctyltrimethoxybenzoate
TMC	TMC:17	ntrimethyl chitosan chloride
TMC	TMC:8	tonsillar mononuclear cells
TMC	TMC:9	trapeziometacarpal
TMC	TMC:9	trimethylene carbonate
t-MDS	t-MDS:13|tMDS:3	therapyrelated myelodysplasia
t-MDS	t-MDS:21|tMDS:3	therapyrelated myelodysplastic syndrome
TMD	TMD:5	membrane disease
TMD	TMD:9|tMD:1	targeted molecular dynamics
TMD	TMD:39	temporomandibular dysfunction
TMD	TMD:10	tibial muscular dystrophy
TMD	TMD:14	total mood disturbance
TMD	TMD:30	transient myeloproliferative disorder
TME	TME:146	total mesorectal excision
TME	TME:35	transmissible mink encephalopathy
TME	TME:10	true metabolisable energy
TME	TME:25	true metabolizable energy
TMH	TMH:5	tata memorial hospital
TMH	TMH:17	transmembrane helix
TMI	TMI:18	three mile island
TMI	TMI:9	transient myocardial ischemia
TMI	TMI:8	transmandibular implant
TMI	TMI:8	transmural myocardial infarction
TMPD	TMPD:43	nnnntetramethylpphenylenediamine
TMPD	TMPD:13	tetramethylpphenylenediamine
TMPase	TMPase:11	thiamine monophosphatase
TMPase	TMPase:12|Tm-Pase:1	trimetaphosphatase
TMP	TMP:16	trimethylpentane
TMP	TMP:13	effects of tetramethylpyrazine
TMP	TMP:13	thiamine monophosphate
TMP	TMP:7	tocopherolmediated peroxidation
TMP	TMP:41	transmembrane potential
TMP	TMP:31	transmembrane pressure
TMP	TMP:16	trimetaphan
TMP	TMP:235|Tmp:16	trimethoprim
TMP	TMP:16	trimethylpsoralen
TMR	TMR:23	tetramethylrhodamine
TMR	TMR:10	topical magnetic resonance
TMR	TMR:36	transmyocardial revascularization
TMR	TMR:12	transverse microradiography
TMS	TMS:11	nnntrimethylsphingosine
TMS	TMS:9	transcranial magnetic
TMS	TMS:9	transcranial magnetic stimuli
TMs	TMs:7	transmembrane helices
TMS	TMS:142|-TMS:1	trimethylsilyl
TMs	TMs:13|Tms:3|tms:1	tropomyosins
TMT	TMT:9	tarsometatarsal
TMT	TMT:19	thiol methyltransferase
TMT	TMT:74	trail making test
TMT	TMT:209	trimethyltin
TMT	TMT:24	trimethyltin chloride
TMV	TMV:19	tobacco mosaic tobamovirus
TMV	TMV:537	tobacco mosaic virus
TMV	TMV:21	tracheal mucus velocity
TMZ	TMZ:112	temozolomide
TMZ	TMZ:83|Tmz:1	trimetazidine
TNFR1	TNFR1:7|TNF-R1:3	tnf receptor type 
TNFR1	TNFR1:7|TNFR-1:3|TNF-R1:3	tumor necrosis factor receptor type 
TNFbp	TNFbp:8|TNF-BP:4|TNF-bp:3	tnf binding protein
TNFbp	TNFbp:5|TNF-BP:3|TNF-bp:1	tumor necrosis factor binding protein
TNF	TNF:16	tnfalpha
TNF	TNF:19	tumor necrosis factorcachectin
TNM	TNM:2	nodes and metastases
TNM	TNM:62	tetranitromethane
TNP-LPS	TNP-LPS:26	trinitrophenyllipopolysaccharide
TNP-LPS	TNP-LPS:15	trinitrophenylated lipopolysaccharide
TNP	TNP:5|Tnp:1	hapten trinitrophenyl
TNP	TNP:25	trinitrophenol
TNP	TNP:123	trinitrophenyl
TNP	TNP:6	trinitrophenyl hapten
TNP	TNP:28	trinitrophenylated
TNS	TNS:2	fluorescent probe ptoluidinylnaphthalenesulfonate
TNS	TNS:7	transdermal nicotine system
TNS	TNS:23	transient neurologic symptoms
TNS	TNS:11	tumor necrosis serum
TNZ	TNZ:10	thermoneutral zone
TNZ	TNZ:8|Tnz:1	tinidazole
TOC	Toc:5|TOC:5	tocopherol
TOC	TOC:272	total organic carbon
TOC	TOC:7	total organic carbon content
TOC	TOC:8	turkey osteomyelitis complex
TOC	TOC:4	tylosis oesophageal cancer
TOF	TOF:34|ToF:2	time of flight
TOF	TOF:7	trainoffour stimulation
TOH	TOH:17|ToH:1	tower of hanoi
TOH	TOH:18	transient osteoporosis of the hip
TOI	TOI:15	tissue oxygenation index
TOI	TOI:11	trial outcome index
TOM	TOM:10	toxic oxygen metabolites
TOM	TOM:8	translocase of the outer membrane
TOM	TOM:7|Tom:2	translocase of the outer mitochondrial membrane
TOPV	TOPV:14	trivalent oral polio vaccine
TOPV	TOPV:11	trivalent oral poliovirus vaccine
TOP	TOP:81	termination of pregnancy
TOP	TOP:12	thimet oligopeptidase
TOS	TOS:154	thoracic outlet syndrome
TOS	TOS:76	toxic oil syndrome
TO	TO:36	thiazole orange
TO	TO:12	timeout
TO	TO:44	tracheal occlusion
TO	TO:18	tracheobronchopathia osteochondroplastica
TO	TO:30	triolein
TO	TO:18	tryptophan oxygenase
TO	TO:18	turbulence onset
TP-5	TP-5:36|TP5:22	thymopentin
TP-5	TP-5:15|TP5:6	thymopoietin pentapeptide
TPA	TPA:16	otetradecanoylacetate
tPA	tPA:8|t-PA:6|TPA:3	alteplase
TPA	TPA:7	phorbol diester
TPA	TPA:17	phorbol ester tetradecanoylphorbolacetate
TPA	TPA:15	terephthalic acid
TPA	TPA:126	tetradecanoyl phorbol acetate
TPA	TPA:84	tetradecanoylphorbol acetate
TPA	TPA:12	texture profile analysis
TPA	TPA:14	timeresolved phosphorescence anisotropy
t-PA	t-PA:3|tPA:1	tissue activator of plasminogen
tPA	tPA:15|t-PA:14|TPA:1	tissue type
t-PA	t-PA:4|tPA:2	tissuetype plasminogen
t-PA	t-PA:1222|tPA:482|TPA:60|tPa:3|T-PA:3|t-pA:2|t-pa:1|tpA:1	tissuetype plasminogen activator
TPA	TPA:10	tripropylamine
TPA	TPA:10	tumor promoter
TPA	TPA:13	twophoton absorption
TPC	TPC:8|TPc:1	nucleus tegmenti pedunculopontinus pars compacta
TPC	TPC:13	total peripheral conductance
TPC	TPC:6	total phenolic content
TPC	TPC:20	total plasma cholesterol
TPC	TPC:8	total plate count
TPE	TPE:17	position effect
TPE	TPE:69	therapeutic plasma exchange
TPE	TPE:13	total pelvic exenteration
TPE	TPE:51	tropical pulmonary eosinophilia
TPE	TPE:10	twophoton excitation
TPG	TPG:11|tpg:1	total product generated
TPG	TPG:13	transpulmonary gradient
TPHA	TPHA:19	treponema pallidum haemagglutination
TPHA	TPHA:36	treponema pallidum haemagglutination assay
TPHA	TPHA:7	treponema pallidum haemagglutination test
TPHA	TPHA:25	treponema pallidum hemagglutination
TPHA	TPHA:15	treponema pallidum hemagglutination assay
TPI	TPI:13	treatment priority index
TPI	TPI:16	triphosphoinositide
TPI	TPI:12	tumor profile index
T-PLL	T-PLL:16	tcell prolymphocytic leukaemia
T-PLL	T-PLL:38	tcell prolymphocytic leukemia
T-PLL	T-PLL:14	tprolymphocytic leukaemia
T-PLL	T-PLL:19	tprolymphocytic leukemia
TPMT	TPMT:11	thiopurine methyl transferase
TPMT	TPMT:172	thiopurine methyltransferase
TPMT	TPMT:73	thiopurine smethyltransferase
TPM	TPM:217	topiramate
TPM	TPM:34	total particulate matter
TPN	TPN:5	total parenteral
TPN	TPN:32	total parenteral nutrient
TPN	TPN:1964	total parenteral nutrition
TPP	TPP:7	sodium tripolyphosphate
TPP	TPP:11	tegmental pedunculopontine nucleus
TPP	TPP:14	tetraphenylphosphonium
TPP	TPP:41|Tpp:1	thiamin pyrophosphate
TPP	TPP:85	thiamine pyrophosphate
TPP	TPP:8	threephase partitioning
TPP	TPP:7	thrust plate prosthesis
TPP	TPP:41	thyrotoxic periodic paralysis
TPP	TPP:15	tolpa peat preparation
TPP	TPP:16	total plasma protein
TPP	TPP:9	transpulmonary pressure
TPP	TPP:11	triphenyl phosphate
TPP	TPP:18	triphenyl phosphite
TPP	TPP:9	triphenylphosphate
TPP	TPP:13	triphenylphosphine
TPP	TPP:6	tympanometric peak pressure
TPQ	TPQ:18	trihydroxyphenylalanine quinone
TPQ	TPQ:11	topaquinone
TPQ	TPQ:115	tridimensional personality questionnaire
TPR	TPR:13	tetratricopeptide
TPR	TPR:9	total peripheral
TPS	TPS:9	specific
TPS	TPS:6	theta pulse stimulation
TPS	TPS:15	thinplate spline
TPS	TPS:6	time to peak shortening
TPS	TPS:4|tPS:3	total protein s
TPTX	TPTX:169|T-PTX:3|TPTx:1	thyroparathyroidectomized
TPTX	TPTX:50|TPTx:1|T-PTX:1	thyroparathyroidectomy
TPT	TPT:7	tactual performance test
TPT	TPT:79|Tpt:2	topotecan
TPT	TPT:5	triose phosphatephosphate translocator
TPT	TPT:9	triphalangeal thumb
TPT	TPT:9	triphenyltin chloride
TP	TP:10|t-p:1	tail pinch
TP	TP:18	tea polyphenols
TP	TP:16	tender points
TP	TP:8	tensor palatini
TP	TP:60	terminal protein
TP	TP:629|Tp:8|tp:1	testosterone propionate
TP	TP:23	thinprep
TP	TP:9	thinprep pap test
TP	TP:17	thrombocytopenia
TP	TP:11	thrombocytopenic purpura
TP	TP:6	thromboxane aprostaglandin endoperoxide
TP	TP:11	thromboxane receptor
TP	TP:13|Tp:1	thymopoietin
TP	TP:15	tibialis posterior
TP	TP:20	tooth pulp
TP	TP:9	torsades de pointes
TP	TP:22|tP:2	total p
TP	TP:13	total pancreatectomy
TP	TP:105|T-P:6	total phosphorus
TP	TP:50	total power
TP	TP:7|Tp:1	transit peptide
TP	TP:10	transperitoneal
TP	TP:8	tryptophan pyrrolase
TP	TP:10	tube precipitin
TP	TP:11|Tp:1	turning point
TP	TP:7|Tp:4	tyrophagus putrescentiae
TQ	TQ:27	thymoquinone
TQ	TQ:6	tinnitus questionnaire
TRAF6	TRAF6:6|Traf6:2	tnf receptorassociated factor 
TRAF6	TRAF6:19|TRAF-6:1	tumor necrosis factor receptorassociated factor 
TRAM	TRAM:23	transverse rectus abdominis muscle
TRAM	TRAM:147	transverse rectus abdominis musculocutaneous
TRAM	TRAM:101	transverse rectus abdominis myocutaneous
TRAMP	TRAMP:24	transgenic adenocarcinoma of the mouse prostate
TRAMP	TRAMP:5	tyrosinerich acidic matrix protein
TRANCE	TRANCE:9	tnfrelated activationinduced cytokine
TRANCE	TRANCE:5|trance:1	tumor necrosis factorrelated activationinduced cytokine
TRAP	TRAP:8	tartrateresistant acid phosphatase activity
TRAP	TRAP:248|Trap:1	telomeric repeat amplification protocol
TRAP	TRAP:29	thrombin receptor agonist peptide
TRAP	TRAP:16	thrombospondinrelated adhesive protein
TRAP	TRAP:32	thrombospondinrelated anonymous protein
TRAP	TRAP:18	total radicaltrapping antioxidant parameter
TRAP	TRAP:27	total radicaltrapping antioxidant potential
TRAP	TRAP:16	total reactive antioxidant potential
TRAP	TRAP:39	trp rnabinding attenuation protein
TRAP	TRAP:28	twin reversed arterial perfusion
TRA	TRA:6	repeat array
TRA	TRA:32	theory of reasoned action
TRA	TRA:5	timereversing array
TRA	TRA:8	traumatic rupture of the aorta
TRA	TRA:8	traumatic rupture of the thoracic aorta
TRC	TRC:8	total renin concentration
TRC	TRC:11	total ridge count
TRD	TRD:9	traction retinal detachment
TRD	TRD:11	tractional retinal detachment
TRD	TRD:12	transcriptional repression domain
TRD	TRD:25|trd:1	transmission ratio distortion
TRD	TRD:11|TrD:2	trinidad donkey
TRF	TRF:21	restriction fragments
TRF	TRF:21	terminal renal failure
TRF	TRF:55|T-RF:7	terminal restriction fragment
TRF	TRF:30	thyrotropinreleasing factor
TRF	TRF:11	timeresolved fluorescence
TRF	TRF:12	tocotrienolrich fraction
TRG	TRG:8	receptor gamma
TRG	TRG:9	regression grade
TRG	TRG:9	trigeminal root ganglion
TRH	TRH:14	protirelin
trh	trh:6|TRH:1	thermostable direct hemolysinrelated hemolysin
TRH	TRH:116	thyroliberin
TRH	TRH:158	thyrotrophin releasing hormone
trh	trh:8|Trh:1	trachealess
TRM	TRM:147	transplantrelated mortality
TRM	TRM:57	treatmentrelated mortality
TRNOE	TRNOE:20|trNOE:6|TR-NOE:1|TrNOE:1	transferred nuclear overhauser effect
TRNOE	TRNOE:8|trNOE:1	transferred nuclear overhauser enhancement
TRPV1	TRPV1:7	transient receptor potential vanilloid receptor 
TRPV1	TRPV1:8|TRPV-1:1	transient receptor potential vanilloid type 
TRs	TRs:7	tandem repeats
TRs	TRs:13|trs:1	terminal repeats
TRs	TRs:148	thyroid hormone receptors
TRS	TRS:5	timeresolved spectroscopy
TRS	TRS:12	transrectal sonography
TRS	TRS:9	treatmentresistant schizophrenia
TRS	TRS:24	tubuloreticular structures
TRT	TRT:21	thoracic radiation therapy
TRT	TRT:27	thoracic radiotherapy
TRT	TRT:18	tinnitus retraining therapy
TRT	TRT:17	turkey rhinotracheitis
TRUS	TRUS:294	transrectal ultrasound
TRUS	TRUS:9	transrectal us
TR	TR:14	repetition
TR	TR:18	taste reactivity
tr	tr:8|TR:1	temperatureresistant
TR	TR:10	texas red
TR	TR:6	thiazin red
TR	TR:18	tiazofurin
TR	TR:9	timeresolved
tr	tr:6|TR:3	trachea
TR	TR:21|tr:7	trained
TR	TR:7	transitional region
TR	TR:10	trapezius
TR	TR:15	treadmill running
tr	tr:10|Tr:6	trembler
TR	TR:213	tricuspid regurgitation
TR	TR:6	trp repressor
TR	TR:42	trypanothione reductase
TR	TR:5|tr:4	trypsin
TR	TR:5|tr:1	turnover rates
TSAb	TSAb:5	stimulating autoantibodies
TSAb	TSAb:4|TSAB:2	thyroid stimulating
TSA	TSA:6	thyroidstimulating activity
TSA	TSA:12	total shoulder arthroplasty
TSA	TSA:70	total sialic acid
TSA	TSA:38	tryptic soy agar
TSA	TSA:6|Tsa:1	typespecific antigen
TSA	TSA:42	tyramide signal amplification
TSBAb	TSBAb:11|TSBab:1|TSBAB:1	blocking antibodies
TSBAb	TSBAb:20|TSBAB:1	thyroid stimulation blocking antibody
TSB	TSB:33	total serum bilirubin
TSB	TSB:70	tryptic soy broth
TSB	TSB:54	trypticase soy broth
TSC	TSC:8	sulfur colloid
TSC	TSC:14	thiosemicarbazide
TSC	TSC:8	thymic stromal cells
TSC	TSC:13	total serum cholesterol
TSC	TSC:234	tuberous sclerosis complex
TSD	TSD:76	taysachs disease
TSD	TSD:33	temperaturedependent sex determination
TSD	TSD:96	total sleep deprivation
TSF	TSF:13	triceps skin fold
TSF	TSF:36	triceps skinfold
TSF	TSF:6	twelvestep facilitation
TSH	TSH:12	antithyrotropin
tsh	tsh:7	gene teashirt
TSH	TSH:38	serum thyrotrophin
tsh	tsh:5|Tsh:4	temperaturesensitive hemagglutinin
TSH	TSH:11	thyrotropic
TSH	TSH:2181	thyrotropin
TSH	TSH:10	thyrotropine
TSI	TSI:6	thromboxane synthetase inhibitor
TSI	TSI:9	tobramycin solution for inhalation
TSI	TSI:13	transferrin saturation index
TSMCs	TSMCs:13	canine cultured tracheal smooth muscle cells
TSMCs	TSMCs:8	cultured canine tracheal smooth muscle cells
TSM	TSM:10	microscope
TSM	TSM:10	thickness shear mode
TSM	TSM:125	tracheal smooth muscle
TSP/HAM	TSP/HAM:8	tropical spastic paraparesishtlv associated myelopathy
TSP/HAM	TSP/HAM:26	tropical spastic paraparesishtlviassociated myelopathy
TSP	TSP:11	temperaturesensitive period
TSP	TSP:18	thermospray
TSP	TSP:21|tsp:1	total serum protein
TSP	TSP:33	total suspended particles
TSP	TSP:16	total suspended particulate matter
TSP	TSP:12	traveling salesman problem
TSP	TSP:29	trisodium phosphate
TSR	TSR:7	thrombospondin type  repeat
TSR	TSR:16	total systemic resistance
TSS	TSS:73	total suspended solids
TSS	TSS:26	total symptom score
TSS	TSS:262	toxic shock syndrome
TSS	TSS:26	transsphenoidal surgery
TST	TST:19	tail skin temperature
TST	TST:107	total sleep time
TST	TST:5	transition state theory
TST	TST:16	triple stimulation technique
TST	TST:23	tuberculin skin testing
TSWV	TSWV:16	tomato spotted wilt tospovirus
TSWV	TSWV:82	tomato spotted wilt virus
TT4	TT4:15|tT4:2	total thyroxin
TT4	TT4:93|tT4:9|t-T4:1	total thyroxine
TTA	TTA:42	tetradecylthioacetic acid
TTA	TTA:7	transtibial amputation
TTA	TTA:36	transtracheal aspiration
TTD	TTD:7	thought translation device
TTD	TTD:6	time to detection
TTD	TTD:92	trichothiodystrophy
TTE	TTE:18	transthoracic echocardiographic
TTE	TTE:260	transthoracic echocardiography
TTF	TTF:32	tetrathiafulvalene
TTF	TTF:98	time to treatment failure
TTKG	TTKG:11	transtubular potassium concentration gradient
TTKG	TTKG:8	transtubular potassium gradient
TTM	TTM:8	tensor tympani muscle
TTM	TTM:12	total tumor mass
TTM	TTM:63	transtheoretical model
TTM	TTM:16	trichotillomania
TTN	TTN:10	transient tachypnea of the newborn
TTN	TTN:7	transient tachypnoea of the newborn
TTN	TTN:10	triakontatetraneuropeptide
TTO	TTO:21	tea tree oil
TTO	TTO:9	time to occlusion
TTO	TTO:8	time trade off
TTO	TTO:18	time tradeoff
TTP	TTP:10	protein tristetraprolin
TTP	TTP:9	thiamin triphosphate
TTP	TTP:766	thrombotic thrombocytopenic purpura
TTP	TTP:30	time to pregnancy
TTP	TTP:219|TtP:1	time to progression
TTP	TTP:53	time to tumor progression
TTP	TTP:8	tolpa torf preparation
TTS	TTS:18	tarsal tunnel syndrome
TTS	TTS:8	twintotwin transfusion syndrome
TTS	TTS:36	type iii secretion
TTT	TTT:5	tear thinning time
TTT	TTT:7	thymol turbidity test
TTT	TTT:111	transpupillary thermotherapy
TT	TT:4|Tt:1	breath duration
TT	TT:10|tt:1	genotype
TT	TT:7	talar tilt
TT	TT:6	test treatment
TT	TT:10	testicular torsion
TT	TT:12	tetrathionate
TT	TT:41	therapeutic touch
TT	TT:17	thiotepa
TT	TT:8	thrombin times
TT	TT:38	thrombolytic therapy
TT	TT:22	thrombotest
TT	TT:5|Tt:2	tissue thickness
TT	TT:67|tT:3|T-T:1	total testosterone
TT	TT:29	total thyroidectomy
TT	TT:28	tracheal tube
TT	TT:9	tube thoracostomy
TT	TT:64	tuberculoid
TT	TT:16	tuberculoid leprosy
TUG	TUG:14	timed up and go
TUG	TUG:5	timed up and go test
TUG	TUG:7	timed upgo
TUG	TUG:5	timed upgo test
TUNEL	TUNEL:14|Tunel:1	dutp nickendlabeling
TUNEL	TUNEL:5	nick end labeling assay
TUNEL	TUNEL:63	nick endlabelling
TUNEL	TUNEL:14	tdtmediated dutpbiotin nick endlabeling
TUNEL	TUNEL:15	terminal deoxynucleotidyl transferasemediated dutp nickend labelling
TURBT	TURBT:3|TUR-Bt:2	transurethral bladder tumor resection
TURBT	TURBT:20|TUR-Bt:16|TUR-BT:9|TURBt:2|TUR-bt:1	transurethral resection of bladder tumor
TURBT	TURBT:1	transurethral resection of the bladder tumour
TURP	TURP:17	transurethral prostate resection
TURP	TURP:85|TUR-P:10	transurethral prostatectomy
TURP	TURP:19|TUR-P:2	transurethral prostatic resection
TURP	TURP:616|TUR-P:58	transurethral resection of the prostate
TU	TU:7	 tuberculin units
TU	TU:56	testosterone undecanoate
TU	TU:17	thiouracil
TU	TU:30|tu:1|Tu:1	thiourea
TU	TU:7	toxic unit
TVP	TVP:18	tensor veli palatini
TVP	TVP:7	textured vegetable protein
TVP	TVP:14	truncal vagotomy and pyloroplasty
TVR	TVR:77	target vessel revascularization
TVR	TVR:39	tonic vibration reflex
TVR	TVR:45	tricuspid valve replacement
TVS	TVS:9	transplant vascular sclerosis
TVS	TVS:146	transvaginal sonography
TVS	TVS:11	tubulovesicular structures
TVT	TVT:212	tensionfree vaginal tape
TVT	TVT:10	tensionfree vaginal tape procedure
TVT	TVT:10	trivittatus
TW	TW:7	tap water
TW	TW:15	total work
TW	TW:14	tripterygium wilfordii
TW	TW:6	tympanometric width
Tw	Tw:3	water at temperatures
Tw	Tw:13|TW:1	water temperature
Tx	Tx:8|TX:2	after kidney transplantation
Tx	Tx:25|TX:4|tx:1	after renal transplantation
Tx	Tx:28|tx:5|TX:1	after transplantation
Tx	Tx:6|TX:2|tx:1	kidney transplants
Tx	Tx:9|TX:1	rats were thyroidectomized
Tx	Tx:18|TX:6	thymectomized
Tx	Tx:38|TX:25	thyroidectomy
Tx	Tx:7|TX:3	transplant recipients
Tx	Tx:5|TX:5	transplanted
TACE	TACE:37	tnfalpha converting enzyme
TACE	TACE:6	transarterial chemoembolisation
TACE	TACE:36	tumor necrosis factoralpha converting enzyme
TBS	TBS:20	bethesda system
TBS	TBS:18	tensile bond strength
TBS	TBS:11	total body scan
TBS	TBS:18	townesbrocks syndrome
TBS	TBS:9	trisbuffered saline
Tb	Tb:14	terbium
TB	TB:9	testosterone buciclate
TB	TB:26|Tb:3	theobromine
TB	TB:12	thiobenzamide
TB	TB:15|Tb:2	thoroughbred
TB	TB:9	tissue basophils
TB	TB:37	toluidine blue
TB	TB:47	total body
TB	TB:21|T-B:2	tracheobronchial
TB	TB:13	trapezoid body
TB	TB:9	tributyrin
TB	TB:42	triceps brachii
TB	TB:10	trisborate
TB	TB:45|Tb:1	trypan blue
Tb	Tb:9	trypanosoma brucei
TB	TB:35|Tb:1	tuberculous
TB	TB:75	tumorbearing
TDR	TDR:17	special program for research and training in tropical diseases
TDR	TDR:11	time domain reflectometry
TDR	TDR:37	transmural dispersion of repolarization
TDT	TDT:7	transmission disequilibrium
TDT	TDT:13	transmission disequilibrium testing
TDT	TDT:5	transmission test for linkage disequilibrium
TDT	TDT:12|Tdt:1	tumor doubling time
TEQ	TEQ:12	toxic equivalence
TEQ	TEQ:19	toxic equivalency
TEQ	TEQ:8	toxic equivalent quantity
tetr	TetR:13|tetr:13|tetR:3	tet repressor
tetr	tetr:25|Tetr:1	tetracycline repressor
Tfm	Tfm:34|tfm:5|TFM:4	testicular feminization
Tfm	Tfm:11|tfm:3	testicular feminization mutation
Tfm	Tfm:28|tfm:3	testicular feminized
Tfm	Tfm:3|TFM:2|tfm:2	testicular feminized male
TGB	TGB:86	tiagabine
TGB	TGB:24	triple gene block
Th1	Th1:13	ifngamma
Th1	Th1:5|Th-1:3|TH1:2	proinflammatory
Th1	Th1:5|TH1:1	type  t helper cell
Th2	Th2:5	thelper  cell
Th2	Th2:44|TH2:3	t helper cell type 
Th2	Th2:6	type  cells
Th2	Th2:4|TH2:2	type  helper t cells
THAM	THAM:1	tris hydroxymethyl aminomethane
THAM	THAM:17	tromethamine
Thy	Thy:11|T-hy:1	hypothalamic
Thy	Thy:28	hypothalamic temperature
Tmax	Tmax:9	maximum temperature
Tmax	Tmax:5|tmax:3	peak plasma concentrations
Tmax	Tmax:2|tmax:1	time at which cmax was reached
Tmax	Tmax:7|tmax:7	time to peak plasma concentration
TNAP	TNAP:9|TN-AP:1	tissue nonspecific alkaline phosphatase
TNAP	TNAP:8|tnAP:1|TN-AP:1	tissuenonspecific alkaline phosphatase
TNA	TNA:19	total nutrient admixture
TNA	TNA:10	transthoracic needle aspiration
TN	TN:109|Tn:23	tenascin
TN	TN:30|tn:1	terminal nerve
TN	TN:26	tetranectin
TN	TN:13	thermoneutral
TN	TN:8	thyroid nodules
TN	TN:11	tibial nerve
TN	TN:77|T-N:13|tN:1	total nitrogen
TN	TN:20	toxin neutralization
TN	TN:11	triple negative
TN	TN:18	true negative
TN	TN:8	tumor necrosis
TOR	TOR:67|Tor:5|ToR:1	target of rapamycin
TOR	TOR:27|Tor:8	toremifene
TPD	TPD:9	temperatureprogrammed desorption
TPD	TPD:22	tidal peritoneal dialysis
TRIM	TRIM:15	trifluoromethylphenyl imidazole
TRIM	TRIM:16	tripartite motif
Tris-BP	Tris-BP:8	flame retardant trisdibromopropylphosphate
Tris-BP	Tris-BP:5|tris-bp:1	trisdibromopropyl phosphate
TrkA	TrkA:11|trkA:10	ngf receptor
TrkA	TrkA:3|trkA:2	tyrosine kinase receptor
TSE	TSE:31	testicular selfexamination
TSE	TSE:13	transition state ensemble
TSE	TSE:5	trophoblastspecific element
TSV	TSV:30	taura syndrome virus
TSV	TSV:5|TsV:3	tityus serrulatus venom
TSV	TSV:17	tobacco streak virus
TTR	TTR:11	thermotolerance ratio
TTR	TTR:584|ttr:3	transthyretin
Tty	Tty:17	tympanic
Tty	Tty:33|TTY:1	tympanic temperature
TuMV	TuMV:10	turnip mosaic potyvirus
TuMV	TuMV:34	turnip mosaic virus
TV	TV:6	tacaribe virus
TV	TV:65	television
TV	TV:13	transvaginal
TV	TV:30|Tv:5	trichomonas vaginalis
TV	TV:47	tricuspid valve
TV	TV:25	truncal vagotomy
Tyr	Tyr:10|tyr:2	ltyrosine
tyr	tyr:32|Tyr:19	tyrosinase
tyr	tyr:9|Tyr:1	tyrosinase gene
Tyr	Tyr:13|tyr:1	tyrosinated
U46619	U46619:7	thromboxane a analog
U46619	U46619:7|U-46619:6	thromboxane analogue
U46619	U46619:5|U-46619:2	thromboxane mimetic
UAC	UAC:17	umbilical artery catheter
UAC	UAC:13	urinary albumin concentration
UAE	UAE:127	united arab emirates
UAE	UAE:323|U-AE:1	urinary albumin excretion
UAE	UAE:8	urinary excretion of albumin
UAE	UAE:94	uterine artery embolization
UASB	UASB:29	upflow anaerobic sludge bed
UASB	UASB:128	upflow anaerobic sludge blanket
UAS	UAS:10	ultrasonically activated scalpel
UAS	UAS:21	upstream activation site
UAS	UAS:33	upstream activator sequence
UA	UA:20	umbilical arterial
UA	UA:15|uA:2	undifferentiated arthritis
UA	UA:15	uranyl acetate
UA	UA:244|Ua:2	uric acid
UA	UA:15	urinalysis
UA	UA:11	urinary amylase
UA	UA:9|Ua:1	uterine arteries
UBC	UBC:8|Ubc:6	ubiquitinconjugating enzyme
UBC	UBC:8	unipolar brush cell
UBC	UBC:13	university of british columbia
UBC	UBC:9	urinary bladder cancer
UBM	UBM:18	ultrasound biomicroscope
UBM	UBM:164	ultrasound biomicroscopy
UCA	UCA:18	contrast agent
UCA	UCA:17	transurocanic acid
UCA	UCA:10	ultrasound contrast agents
UCA	UCA:50	urocanic acid
UCM	UCM:12	uncontrolled manifold
UCM	UCM:16	unresolved complex mixture
UCVA	UCVA:11	uncorrected
UCVA	UCVA:238	uncorrected visual acuity
UC	UC:12|uc:1	ultracentrifugation
UC	UC:34	umbilical cord
UC	UC:12	undifferentiated carcinoma
UC	UC:42	unesterified cholesterol
UC	UC:15	university of california
UC	UC:13	urothelial carcinoma
UC	UC:88	usual care
UC	UC:12	uterine contractions
UDPGT	UDPGT:8|UDP-GT:3	microsomal udpglucuronyltransferase
UDPGT	UDPGT:3|UDP-GT:2|UDPG-T:1	uridine diphosphate glucuronyltransferase
UDPG	UDPG:9	uridine diphosphate glucose
UDPG	UDPG:15|UDPg:1	uridine diphosphoglucose
UD	UD:15	ulcer disease
UD	UD:7|ud:3	ultradistal
UEDVT	UEDVT:10	deep vein thrombosis
UEDVT	UEDVT:11	upper extremity deep venous thrombosis
UES	UES:5	undifferentiated embryonal sarcoma
UES	UES:148	upper esophageal sphincter
UFC	UFC:103|U-FC:1	urinary free cortisol
UFC	UFC:8	urinary free cortisol excretion
UFT	UFT:1	tegafur with uracil
UFT	UFT:23	uracil and tegafur
UF	UF:27|uf:2|Uf:2	ultrafiltrate
UF	UF:324|uf:3	ultrafiltration
UF	UF:34	unfractionated
UF	UF:15	urinary flow
uGH	uGH:10|U-GH:2|u-GH:2	urinary gh
uGH	uGH:9|U-GH:6|UGH:5|u-GH:3	urinary growth hormone
UGT	UGT:10	udpglucuronosyl transferase
UGT	UGT:4	uridine diphosphate glucuronosyl transferase
UGT1A1	UGT1A1:6	bilirubin udpglucuronosyltransferase
UGT1A1	UGT1A1:5	bilirubin udpglucuronosyltransferase gene
UGT1A1	UGT1A1:7	phenol udpglucuronosyltransferase
UGT1A1	UGT1A1:6|UGT-1A1:2	udpglucuronosyltransferase 
UGTs	UGTs:125|UGTS:1	udpglucuronosyltransferases
UGTs	UGTs:6	uridine diphosphate glucuronosyltransferases
UG	UG:17	unleaded gasoline
UG	UG:45|Ug:1	uteroglobin
UHC	UHC:11	university healthsystem consortium
UHC	UHC:10	university hospital consortium
UH	UH:9	unfavorable histology
UH	UH:14	university hospital
UIC	UIC:9	university of illinois at chicago
UIC	UIC:11	urinary iodine concentration
UIP	UIP:14	undegradable intake protein
UIP	UIP:141	usual interstitial pneumonia
UI	UI:22	ulcer index
UI	UI:11	unexplained infertility
UI	UI:16	unsaturation index
UI	UI:275	urinary incontinence
UI	UI:21	urinary iodine
UI	UI:28	urotensin i
UKM	UKM:9	universiti kebangsaan malaysia
UKM	UKM:13|UkM:1	urea kinetic model
UKM	UKM:30	urea kinetic modeling
UKM	UKM:12	urea kinetic modelling
ULO	ULO:30	unilateral ovariectomy
ULO	ULO:15	unilaterally ovariectomized
ULV	ULV:11	ultralow volume
ULV	ULV:31	upper limit of vulnerability
UM	UM:22	utilization management
UM	UM:10	uveal melanoma
UNDP	UNDP:7	un development program
UNDP	UNDP:6	united nations development program
UNE	UNE:19|UN-E:1	ulnar neuropathy at the elbow
UNE	UNE:5|UNe:2|U-NE:1	urinary norepinephrine
UNFPA	UNFPA:9	un fund for population activities
UNFPA	UNFPA:49	un population fund
UNFPA	UNFPA:16	united nations fund for population activities
UNFPA	UNFPA:56	united nations population fund
uNK	uNK:26|unk:1|u-NK:1	uterine natural killer
uNK	uNK:10	uterine nk
UNaV	UNaV:10	sodium excretion rate
UNaV	UNaV:38	urinary excretion of sodium
UN	UN:12	undernourished
UN	UN:40	united nations
UN	UN:32	uranyl nitrate
UN	UN:47	urea nitrogen
uPA	uPA:12|u-PA:5	urokinase pa
uPA	uPA:386|u-PA:72|UPA:9	urokinase plasminogen activator
uPA	uPA:951|u-PA:420|UPA:25|U-PA:2|uPa:2|u-Pa:1	urokinasetype plasminogen activator
UPP	UPP:17	ubiquitinproteasome pathway
UPP	UPP:18	urethral pressure profilometry
UP	UP:27|up:1	unipolar
UP	UP:21	universal precautions
UP	UP:10|Up:1	upstream
UP	UP:7	ureteral pressure
UP	UP:24	urticaria pigmentosa
UP	UP:14	uttar pradesh
URE	URE:15	upstream regulatory element
URE	URE:9	urethane
URR	URR:69	upstream regulatory region
URR	URR:75	urea reduction ratio
URS	URS:8	upstream repression sequence
URS	URS:19	ureterorenoscopy
URS	URS:26	ureteroscopy
UR	UR:9|Ur:1	uridine
UR	UR:10	urinary retention
UR	UR:36	utilization review
USAID	USAID:21	united states agency for international development
USAID	USAID:69	us agency for international development
USC	USC:12	university of southern california
USC	USC:13	uterine serous carcinoma
USE	USE:18	ultrasonic examination
USE	USE:14	upstream sequence element
USH1	USH1:8|USH-1:1	usher syndrome type 
USH1	USH1:11	usher syndrome type i
USI	USI:7	ultrasonic investigation
USI	USI:9	ultrasound investigation
USI	USI:10	universal salt iodization
USI	USI:30	urinary stress incontinence
USI	USI:12	urodynamic stress incontinence
uSpA	uSpA:12|USpA:2	undifferentiated spa
uSpA	uSpA:12|USpA:4|uSpa:1|USpa:1	undifferentiated spondyloarthropathy
USPIO	USPIO:53	ultrasmall superparamagnetic iron oxide
USPIO	USPIO:8	ultrasmall superparamagnetic iron oxide particles
USP	USP:7	ultraspiracle protein
USP	USP:61	united states pharmacopeia
USP	USP:21	united states pharmacopoeia
US	US:8|Us:5	short unique
US	US:34	sonographic
US	US:102	sonography
US	US:38	ultrasonic
US	US:20	ultrasonographically
US	US:13	ultrasound examination
US	US:8	ultrasound imaging
UTC	UTC:14	ultrasonic tissue characterization
UTC	UTC:10	undifferentiated thyroid carcinoma
UTR	UTR:301|utr:2	 untranslated region
UTR	UTR:14	 and  untranslated regions
UTS	UTS:51	ullrichturner syndrome
UTS	UTS:46	ultimate tensile strength
UT	UT:92	untrained
UT	UT:19	untrained subjects
UT	UT:26	untreated
UT	UT:12	utricular
UUI	UUI:12	urge urinary incontinence
UUI	UUI:5	urinary urge incontinence
UVA	UVA:19|UV-A:2	longwave ultraviolet
UVA	UVA:42|UV-A:22	ultravioleta
UV	UV:6	ultraviolet absorption
UV	UV:71|Uv:2|uv:2	umbilical vein
UV	UV:6	urinary flow rate
UV	UV:24|Uv:1|uV:1	urinary volume
UV	UV:73|Uv:1	urine volume
UW	UW:17	university of washington
UW	UW:460	university of wisconsin
UB	UB:5	ultimobranchial body
UB	UB:5	upper body
UB	UB:27	ureteric bud
UB	UB:24	urinary bladder
UKA	UKA:23	unicompartmental knee arthroplasty
UKA	UKA:8	urinary kallikrein activity
UL	UL:9	tolerable upper intake level
UL	UL:61	unilateral labyrinthectomy
UL	UL:25	unique long
UL	UL:8	upper limb
V1	V1:22	central compartment
V1	V1:26	primary visual area
V1	V1:271|V-1:1	primary visual cortex
V1	V1:72	striate cortex
V1	V1:18	vascular
V1	V1:16|V-1:1	vasopressor
V2R	V2R:14|V2-R:1	v vasopressin receptor
V2R	V2R:15	vasopressin v receptor
V2	V2:25	antidiuretic
V2	V2:24	second visual area
V2	V2:7	visual area 
V2	V2:3	volume of the peripheral compartment
V3	V3:1	mandibular division of the trigeminal nerve
V3	V3:47	third variable
V3	V3:26|v3:1	third variable domain
V3	V3:31	third variable region
V3	V3:10	variable region 
V79	V79:23|V-79:5	chinese hamster cells
V79	V79:9|V-79:2	chinese hamster fibroblasts
VADs	VADs:21	venous access devices
VADs	VADs:96|VADS:1	ventricular assist devices
VAD	VAD:9	vascular atherosclerotic disease
VAD	VAD:14	vertebral artery dissection
VAD	VAD:19	vibroacoustic disease
VAD	VAD:11	vincristineadriamycindexamethasone
VAD	VAD:63	vitamin a deficiency
VAPS	VAPS:9	visual analog pain scale
VAPS	VAPS:7	visual analog pain score
VAS	VAS:7	vagal afferent stimulation
VAs	VAs:13|VAS:1	ventricular arrhythmias
VAS	VAS:15	ventricular assist system
VAs	VAs:18	vertebral arteries
VAS	VAS:10	vibroacoustic stimulation
VAS	VAS:24	visual analog score
VAS	VAS:15	visual analogue
VAS	VAS:5	visual analogue scale of pain
VAs	VAs:8	volatile anesthetics
VATS	VATS:279|Vats:1	videoassisted thoracic surgery
VATS	VATS:15	videoassisted thoracic surgical
VATS	VATS:261	videoassisted thoracoscopic surgery
VATS	VATS:8	videoassisted thoracoscopic surgical
VATS	VATS:19	videoassisted thoracoscopy
VAT	VAT:20	variable antigen type
VAT	VAT:5	variant antigenic type
VAT	VAT:10	vascular access thrombosis
VAT	VAT:35	ventilatory anaerobic threshold
VAT	VAT:10	ventricular activation time
VAT	VAT:14	vestibular autorotation test
VAT	VAT:90	visceral adipose tissue
VA	VA:8	adenovirus virusassociated
VA	VA:65|Va:4	alveolar ventilation
VA	VA:5|Va:4	apical membrane voltage
VA	VA:5	patients with vasospastic angina
VA	VA:6|V-A:4	retrograde
VA	VA:9	vaccenic acid
VA	VA:9	vacuum aspiration
VA	VA:13	variant angina
VA	VA:32	vascular access
VA	VA:21	ventral anterior
VA	VA:11	ventral anterior nucleus
VA	VA:10	ventralis anterior
VA	VA:6	ventricular aneurysm
VA	VA:10|V-A:1	ventriculoarterial
VA	VA:27	veratryl alcohol
VA	VA:23	verbal autopsy
VA	VA:23|Va:1	vessel area
VA	VA:24	vestibular aqueduct
VA	VA:166	veterans administration
VA	VA:15	villous atrophy
VA	VA:18	vinyl acetate
VA	VA:9	viscum album
VA	VA:552|Va:1	visual acuity
VA	VA:11	voluntary activation
VBAC	VBAC:13	vaginal birth after caesarean
VBAC	VBAC:43	vaginal birth after cesarean
VBAC	VBAC:12	vaginal birth after cesarean delivery
VBAC	VBAC:23	vaginal birth after cesarean section
VBI	VBI:10	ventral blood island
VBI	VBI:40	vertebrobasilar insufficiency
VBM	VBM:3|V-B-M:1	bleomycin and methotrexate
VBM	VBM:8	vascular basement membrane
VBM	VBM:8	visual backward masking
VBM	VBM:72	voxelbased morphometry
VBS	VBS:7	vertebrobasilar system
VBS	VBS:9	visible burrow system
VCA	VCA:7	vero cell assay
VCA	VCA:6	viral capsid
VCC	VCC:8	vibrio cholerae cytolysin
VCC	VCC:8	vienna challenge chamber
VCD	VCD:13	vinylcyclohexene diepoxide
VCD	VCD:7	vacuum constriction device
VCD	VCD:18	vibrational cd
VCD	VCD:93	vibrational circular dichroism
VCD	VCD:10	vitreous chamber depth
VCD	VCD:27	vocal cord dysfunction
VCI	VCI:28	vascular cognitive impairment
VCI	VCI:8|vci:1	vena cava inferior
VCM	VCM:17	vancomycin hydrochloride
VCM	VCM:63	vinyl chloride monomer
VCN	VCN:105	ventral cochlear nucleus
VCN	VCN:33	vibrio cholerae neuraminidase
VCP	VCP:31	vaccinia virus complement control protein
VCP	VCP:26	valosincontaining protein
VCP	VCP:11	ventriculocisternal perfusion
VCP	VCP:14	vocal cord paralysis
VCR	VCR:15	vestibulocollic reflex
VCR	VCR:4	video cassette recorder
VCR	VCR:24	vincristine sulfate
VCS	VCS:5	closure system
VCS	VCS:8	vaginalcervical stimulation
VCS	VCS:14	vaginocervical stimulation
VCS	VCS:11	vascular closure staple
VCS	VCS:13	visual contrast sensitivity
VCT	VCT:17	voluntary counseling and testing
VCT	VCT:30	voluntary counselling and testing
VCV	VCV:12	volumecontrolled ventilation
VCV	VCV:17|V-C-V:2|v-c-v:1	vowelconsonantvowel
Vc	Vc:23	trigeminal subnucleus caudalis
VC	VC:11	vapnikchervonenkis
VC	VC:9	variance components
VC	VC:13	variation coefficient
VC	VC:6	vascular calcification
VC	VC:6	vehicle control
VC	VC:12	veiled cells
VC	VC:17|Vc:1	vena cava
VC	VC:9	venous capacitance
VC	VC:32	verrucous carcinoma
Vc	Vc:7|VC:3	vibrio cholerae
VC	VC:21	vinyl carbamate
VC	VC:17	virtual colonoscopy
VC	VC:93	visual cortex
VC	VC:65|Vc:6|V-C:1	vitamin c
VC	VC:16|vc:2	vitelline coat
Vc	Vc:7|VC:2	voltage
VD/VT	VD/VT:16|Vd/Vt:2	dead space to tidal volume
VD/VT	VD/VT:19|Vd/Vt:4|VD/Vt:1	dead space to tidal volume ratio
VD/VT	VD/VT:4|Vd/Vt:1	ventilation fraction
VDRL	VDRL:116	venereal disease research laboratory
VDRL	VDRL:8	venereal disease research laboratory test
VDR	VDR:6	dihydroxyvitamin d receptors
VDR	VDR:23	vitamin d receptor gene
VDS	VDS:6	ventral derotation spondylodesis
VDS	VDS:8	verbal descriptor scale
VDS	VDS:117	vindesine
VDS	VDS:9	vindesine sulfate
VDT	VDT:28	display terminals
VDT	VDT:62	video display terminal
VDT	VDT:49	visual display terminal
VDT	VDT:12	volume doubling time
VDU	VDU:12	display units
VDU	VDU:34	visual display unit
VE/VCO2	VE/VCO2:7|VE/VCo2:1|VE/Vco2:1	carbon dioxide production
VE/VCO2	VE/VCO2:7	ventilatory equivalent for carbon dioxide
VE/VO2	VE/VO2:8	ventilatory equivalent
VE/VO2	VE/VO2:11	ventilatory equivalent for o
VE/VO2	VE/VO2:16|Ve/VO2:1	ventilatory equivalent for oxygen
VEE	VEE:143	venezuelan equine encephalitis
VEE	VEE:91	venezuelan equine encephalomyelitis
VEGFR	VEGFR:24|VEGF-R:5|VEGF-r:1	vascular endothelial growth factor receptor
VEGFR	VEGFR:12	vegf receptors
VES	VES:31|VEs:4	ventricular extrasystoles
VES	VES:7	visual erotic stimulation
VES	VES:36	vitamin e succinate
VET	VET:10	ventricular ejection time
VET	VET:12	vietnam era twin
VE	VE:19	vaccine effectiveness
VE	VE:29	vaccine efficacy
VE	VE:10	variable error
VE	VE:15	vascular endothelial
VE	VE:27	venezuelan encephalitis
VE	VE:22|Ve:1	ventilatory
VE	VE:30|vE:1	virtual endoscopy
VE	VE:39	virtual environment
VE	VE:21	visceral endoderm
VE	VE:10	vital exhaustion
VE	VE:152|vE:1|V-E:1	vitamin e
VE	VE:38	vitelline envelope
VE	VE:94	volume expansion
VFI	VFI:21	venous filling index
VFI	VFI:17	voluntary food intake
VFP	VFP:18	ventricular fluid pressure
VFP	VFP:19	vibrating flow pump
VFP	VFP:9	vocal fold paralysis
VFs	VFs:10	virulence factors
VFs	VFs:11	visual fields
VFT	VFT:153	ventricular fibrillation threshold
VFT	VFT:8	verbal fluency test
VF	VF:6|Vf:1	fresh gas flow
VF	VF:5|Vf:2	ventilatory frequency
VF	VF:9	ventral funiculus
VF	VF:6	ventricular function
VF	VF:12	verbal fluency
VF	VF:7	vesicular fluid
VF	VF:5	virulence factor
VF	VF:21	visceral fat
VF	VF:80	visual field
VF	VF:7	vitreous fluid
VHD	VHD:41	valvular heart disease
VHD	VHD:15	viral haemorrhagic disease
VHF	VHF:8	high frequency
VHF	VHF:13	viral hemorrhagic fever
VHF	VHF:18	visual halffield
VHL	VHL:6|Vhl:1	von hippellindau gene
VHL	VHL:18|vHL:3	von hippellindau syndrome
VHL	VHL:11|vhl:1	von hippellindau tumor suppressor gene
VHS	VHS:13	veterans health study
VHS	VHS:30	viral haemorrhagic septicaemia
VHS	VHS:17	viral hemorrhagic septicemia
vhs	vhs:42|Vhs:7|VHS:1	virion host shutoff
vhs	vhs:8|Vhs:1	virion host shutoff protein
VH	VH:9	heavy chain variable domain
VH	VH:27	vaginal hysterectomy
VH	VH:5	variable genes
VH	VH:29	variable heavy chain
VH	VH:5	variable region heavy chain
VH	VH:20	vehicle
VH	VH:9	ventral hippocampal
VH	VH:11	ventral horn
VH	VH:42	viral hepatitis
VH	VH:13	visual hallucinations
VH	VH:6	vitreous hemorrhage
VH	VH:12	vitreous humor
VIA	VIA:10	video image analysis
VIA	VIA:7	virus infection associated
VIA	VIA:2	visual inspection using acetic acid
Vim	Vim:9|VIM:3	ventral intermediate
Vim	Vim:10|VIM:8	ventral intermediate nucleus
Vim	Vim:6|VIM:1	ventral intermediate nucleus of the thalamus
Vim	Vim:21|VIM:10	ventralis intermedius
VIN	VIN:24	vulval intraepithelial neoplasia
VIN	VIN:106	vulvar intraepithelial neoplasia
VIP	VIP:3161	vasoactive intestinal peptide
VIP	VIP:2409|vip:1	vasoactive intestinal polypeptide
VIP	VIP:26	ventral intraparietal area
VIP	VIP:12	visual immunoprecipitate assay
VIP	VIP:9	visual impairment project
VIQ	VIQ:11	verbal intelligence quotient
VIQ	VIQ:44	verbal iq
VKH	VKH:22	vogtkoyanagiharada disease
VKH	VKH:10|V-K-H:1	vogtkoyanagiharada syndrome
VLA	VLA:12	late activation
VLA	VLA:5	late activation antigens
VLDL	VLDL:9	lipoprotein cholesterol
VLDL	VLDL:25	verylowdensity
VLED	VLED:9	low energy diet
VLED	VLED:18	verylowenergy diet
VLF	VLF:37	low frequency
VLF	VLF:29	ventrolateral funiculus
VLF	VLF:9	verylowfrequency
VLM	VLM:8	ventrolateral medulla oblongata
VLM	VLM:29	visceral larva migrans
vlPAG	vlPAG:8|VLPAG:1	ventrolateral pag
vlPAG	vlPAG:29|VLPAG:2	ventrolateral periaqueductal gray
VLPO	VLPO:13|vLPO:1	ventrolateral preoptic area
VLPO	VLPO:13	ventrolateral preoptic nucleus
VLC	VLC:10	long chain
VLC	VLC:18	visible lightcured
VLS	VLS:47	vascular leak syndrome
VLS	VLS:9	ventrolateral striatum
VL	VL:7	light chain variable domain
VL	VL:11	light chain variable region
VL	VL:16|Vl:1	variable
VL	VL:17	vastus lateralis muscle
VL	VL:17	ventral lateral nucleus
VL	VL:94|vl:9|Vl:1	ventrolateral
VL	VL:24	ventrolateral nucleus
VL	VL:3	ventrolateral nucleus of the thalamus
VL	VL:11	ventrolateral thalamic nucleus
VMD	VMD:7	vertebral mineral density
VMD	VMD:6|VmD:1	volume median diameter
VMH	VMH:12	hypothalamic ventromedial nucleus
VMH	VMH:137	ventromedial hypothalamic
VMH	VMH:10	ventromedial hypothalamic nuclei
VMH	VMH:395|VmH:1	ventromedial hypothalamus
VMO	VMO:10	vaccinia melanoma oncolysate
VMO	VMO:20	vastus medialis oblique
VMO	VMO:23	vastus medialis obliquus
VMR	VMR:22	vasomotor reactivity
VMR	VMR:8	vasomotor rhinitis
VMs	VMs:9	vascular malformations
VMs	VMs:13	venous malformations
VMS	VMS:36	ventral medullary surface
VMS	VMS:1	ventral surface of medulla
VNC	VNC:27|vNC:1	ventral nerve cord
VNC	VNC:24	vestibular nuclear complex
VNC	VNC:19	vestibular nucleus complex
VNP	VNP:10	vasonatrin peptide
VNP	VNP:12	ventricular natriuretic peptide
VNS	VNS:176	vagus nerve stimulation
VNS	VNS:11	vomeronasal system
VNT	VNT:12	virus neutralisation test
VNT	VNT:14	virus neutralization test
VN	VN:8	vagus nerve
VN	VN:10	vestibular neuritis
VN	VN:34|Vn:2	vestibular nuclei
VN	VN:16	vestibular nucleus
VN	VN:24	virus neutralisation
VN	VN:9	virus neutralising
VN	VN:19|vn:1	vomeronasal
VO2max	VO2max:57|Vo2max:1	maximal aerobic capacity
VO2max	VO2max:5|Vo2max:1	maximal exercise
VO2max	VO2max:85|Vo2max:4	maximal o consumption
VO2max	VO2max:22|Vo2max:1	maximal oxygen intake
VO2max	VO2max:95|Vo2max:3	maximum oxygen consumption
VO2	VO2:38|Vo2:2	metabolic rate
VO2	VO2:9	o intake
VO2	VO2:250|Vo2:17	o uptake
VO2	VO2:15|Vo2:3	oxygen consumption per beat
VO2	VO2:11	oxygen intake
VOCs	VOCs:35	volatile organic chemicals
VOCs	VOCs:518	volatile organic compounds
VOC	VOC:18	vasoocclusive crisis
VOC	VOC:10	voltageoperated ca channel
VOD	VOD:258	venoocclusive disease
VOD	VOD:23	venoocclusive disease of the liver
VOT	VOT:8	hooper visual organization test
VOT	VOT:8	venous occlusion test
Vo	Vo:11	subnucleus oralis
Vo	Vo:10	trigeminal nucleus oralis
VO	VO:49	vaginal opening
Vo	Vo:6	velocity of shortening
VO	VO:40|vo:1	venous occlusion
VO	VO:8	venous outflow
Vo	Vo:16|VO:1	void volume
Vo	Vo:5|VO:1	volume intercept
VPA	VPA:10	vaginal pulse amplitude
VPA	VPA:6	valproate sodium
VPA	VPA:4|v-PA:4|vPA:1	vascular plasminogen activator
VPA	VPA:10	vigorous physical activity
VPCs	VPCs:111	ventricular premature complexes
VPCs	VPCs:63	ventricular premature contractions
VPCs	VPCs:25	vulval precursor cells
VPL	VPL:2	nucleus of thalamus
VPL	VPL:25	nucleus ventralis posterolateralis
VPL	VPL:22	ventral posterior lateral
VPL	VPL:18	ventral posterior lateral nucleus
VPL	VPL:16	ventral posterolateral
VPL	VPL:17	ventral posterolateral nucleus
VPL	VPL:32	ventroposterolateral
VPL	VPL:19	ventroposterolateral nucleus
VPL	VPL:10	vertical partial laryngectomy
VPT	VPT:66	vibration perception threshold
VPT	VPT:20	vibratory perception threshold
VPI	VPI:8|VPi:1	inferior
VPI	VPI:9|VPi:1	inferior nucleus
VPI	VPI:30	velopharyngeal incompetence
VPI	VPI:51	velopharyngeal insufficiency
VPI	VPI:11	vibrio pathogenicity island
VPI	VPI:18	visible plaque index
Vp	Vp:5	correction for the residual plasma volume
Vp	Vp:6|VP:1	principal sensory trigeminal nucleus
VP	VP:52	variegate porphyria
VP	VP:27	vascular parkinsonism
VP	VP:32	vascular permeability
VP	VP:21|V-P:2|v-p:1	velopharyngeal
VP	VP:10|Vp:1	ventral
VP	VP:69	ventral pallidum
VP	VP:6	ventral posterior
VP	VP:83	ventral prostate
VP	VP:5	ventralis posterior
VP	VP:15	ventroposterior
VP	VP:10	ventroposterior nucleus
VP	VP:7	viral protein
VP	VP:10	vulnerable period
VR1	VR1:10	vanilloid
VR1	VR1:29	vanilloid receptor subtype 
VR1	VR1:20|VR-1:2	vanilloid receptor type 
VRE	VRE:17	vancomycinresistant enterococcal
VRE	VRE:412	vancomycinresistant enterococci
VRE	VRE:86	vancomycinresistant enterococcus
VRS	VRS:8	verbal rating score
VRS	VRS:11	volume reduction surgery
VRT	VRT:12	virtual reality therapy
VRT	VRT:9	visual reaction time
VRT	VRT:11	volume rendering technique
VR	VR:9	valsalva ratio
VR	VR:28	valve replacement
VR	VR:11	vascular reactivity
VR	VR:16	venous return
VR	VR:10	ventilation rate
VR	VR:7	ventilatory response
VR	VR:18|vr:1	ventral root
VR	VR:11	ventricular rate
VR	VR:8	vesamicol receptor
VR	VR:241	virtual reality
VR	VR:9	visual reproduction
VR	VR:30	vocational rehabilitation
VR	VR:32	volume rendering
VSA	VSA:32	vasospastic angina
VSA	VSA:26	ventral septal area
VSA	VSA:10	volatile substance abuse
VSD	VSD:12	vaccine safety datalink
VSD	VSD:16	vascular surface density
VSD	VSD:17	virtually safe dose
VSD	VSD:9	voltagesensitive dye
VSR	VSR:21	ventricular septal rupture
VSR	VSR:15	vestibulospinal reflex
VSV-G	VSV-G:35|VSVG:3	vesicular stomatitis virus
VSV-G	VSV-G:12|VSVG:3	vesicular stomatitis virus g
VSV-G	VSV-G:21|VSVG:5	vesicular stomatitis virus g protein
VSV-G	VSV-G:36|VSVG:7|VSVg:2	vesicular stomatitis virus glycoprotein
VSV-NJ	VSV-NJ:6	vesicular stomatitis virus new jersey
VSV-NJ	VSV-NJ:3	vesicular stomatitis virus new jersey serotype
VT/TI	VT/TI:88|VT/Ti:14|VT/tI:3|Vt/Ti:1	mean inspiratory flow
VT/TI	VT/TI:17|VT/Ti:4|Vt/Ti:1|VT/tI:1	mean inspiratory flow rate
VT/VF	VT/VF:24	ventricular tachycardiafibrillation
VT/VF	VT/VF:13	ventricular tachycardiaventricular fibrillation
VTA	VTA:8	ventral tegmental
VTA	VTA:1133|vta:1	ventral tegmental area
VTA	VTA:12	ventral tegmental area of tsai
VTEC	VTEC:1	verocytotoxinproducing e coli
VTEC	VTEC:1	verotoxinproducing e coli
VTs	VTs:10	ventricular tachyarrhythmias
VTs	VTs:44	ventricular tachycardias
VTs	VTs:17	verotoxins
VT	VT:4	exposure to the trichothecene vomitoxin
VT	VT:5	insertion of ventilation tubes
VT	VT:46	vasotocin
VT	VT:37|vT:1	venous thrombosis
VT	VT:5	venous tone
VT	VT:6	ventilating tubes
VT	VT:12	ventilation tube
VT	VT:8	ventral tegmentum
VT	VT:15	vero cytotoxin
VT	VT:25	verocytotoxin
VT	VT:5	vocational training
VT	VT:5	volume transmission
VVF	VVF:11	vesicovaginal fistula
VVF	VVF:6	vesicovaginal fistulae
VVI	VVI:26	ventricular
VVI	VVI:19	ventricular demand
VVI	VVI:4	ventricular demand pacemaker
VVI	VVI:19	ventricular inhibited
VVS	VVS:29	vasovagal syncope
VVS	VVS:34	vulvar vestibulitis syndrome
VV	VV:7|Vv:4	vascular volume
VV	VV:12	venous volume
VWM	VWM:6|vWM:1	verbal working memory
VWM	VWM:11	white matter
VX	VX:11	methylphosphonothioate
VX	VX:15	methylphosphonothiolate
VX	VX:13	verruciform xanthoma
VB	VB:78|Vb:1	ventrobasal
VB	VB:67|Vb:1	ventrobasal complex
VB	VB:4	ventrobasal nucleus of the thalamus
VB	VB:10	ventrobasal thalamus
VB	VB:28	vertebral body
VB	VB:15|V-B:2	vertebrobasilar
VB	VB:13	virtual bronchoscopy
VCO2	VCO2:13|Vco2:1	carbon dioxide excretion
VCO2	VCO2:24|Vco2:1	co elimination
VCO2	VCO2:12|Vco2:2	co excretion
VD	VD:11|Vd:1	dead space volume
VD	VD:18	vaginal delivery
VD	VD:20	vas deferens
VD	VD:10	vascular density
VD	VD:22	ventricular dilator
VD	VD:6	vessel diameter
VD	VD:9|vd:1	vessel disease
VD	VD:5	voiding dysfunction
VEC	VEC:9|vec:1|Vec:1	vecuronium
VEC	VEC:12	velocityencoded cine
VEC	VEC:6	videoenhanced contrast
VG	VG:8|Vg:3	glomerular volume
VG	VG:9	graft
VG	VG:6	vein grafts
VG	VG:9	ventriculography
VG	VG:12	vestibular ganglion
Vmax	Vmax:7	expiratory flow rates
Vmax	Vmax:25	maximal activity
Vmax	Vmax:10	maximal expiratory flow
Vmax	Vmax:26	maximal rate
Vmax	Vmax:21	maximal rate of depolarization
Vmax	Vmax:9	maximal rate of transport
Vmax	Vmax:13|vmax:1	maximal transport capacity
Vmax	Vmax:6	maximal uptake rate
Vmax	Vmax:6	maximal velocity of uptake
Vmax	Vmax:15	maximum expiratory flow
Vmax	Vmax:45	maximum rate of depolarization
Vmax	Vmax:10	maximum rate of metabolism
Vmax	Vmax:47	maximum rate of rise
Vmax	Vmax:12	maximum rate of rise of action potential
Vmax	Vmax:7	maximum rate of rise of the action potential upstroke
Vmax	Vmax:6	maximum rate of uptake
Vmax	Vmax:9	maximum uptake rate
Vmax	Vmax:3	maximum velocity of reaction
Vmax	Vmax:29	maximum velocity of shortening
Vmax	Vmax:5	maximum velocity of transport
Vmax	Vmax:16	phase  depolarization
Vmax	Vmax:15	upstroke velocity of the action potential
VM	VM:15	vacuolar myelopathy
VM	VM:44	valsalva maneuver
VM	VM:14	valsalva manoeuvre
VM	VM:39	ventral mesencephalic
VM	VM:57	ventral mesencephalon
VM	VM:11	ventricular muscle
VM	VM:12|Vm:2	ventromedial thalamic nucleus
VPM	VPM:7|VPm:1	nucleus of the thalamus
VPM	VPM:15	nucleus ventralis posteromedialis
VPM	VPM:28	ventral posterior medial
VPM	VPM:13	ventral posterior medial nucleus
VPM	VPM:8	ventral posteromedial thalamic nucleus
VPM	VPM:7|VPm:3	ventroposterior medial
VSP	VSP:13|vsp:2	short patch
VSP	VSP:10	variantspecific surface protein
VSP	VSP:7	variant surface protein
VSP	VSP:36	ventricular septal perforation
VSS	VSS:6	vancouver scar scale
VSS	VSS:10	visual sexual stimulation
VSS	VSS:30	volatile suspended solids
VS	VS:5	gain of the vestibulospinal
VS	VS:6	vagal nerve stimulation
VS	VS:12|Vs:2	vagal stimulation
VS	VS:25	vegetative state
VS	VS:14	ventral striatum
VS	VS:19	ventricular septum
VS	VS:7	vibration syndrome
VS	VS:10	viridans streptococci
VS	VS:9	visual scoring
VS	VS:31	volatile solids
W/A	W/A:10|w/a:1	weightage
W/A	W/A:10|w/a:1	weight for age
w/o/w	w/o/w:6|W/O/W:5	emulsion
w/o/w	w/o/w:44|W/O/W:32	waterinoilinwater
W-7	W-7:18|W7:2	calmodulin antagonist
W-7	W-7:1	calmodulin antagonist naminohexylchloronaphthalenesulfonamide
W-7	W-7:15|W7:4	naminohexylchloronaphthalene sulfonamide
W-7	W-7:4|W7:2	naminohexylchloronaphthalene sulphonamide
W-7	W-7:16|W7:2	naminohexylchloronaphthalenesulfonamide hydrochloride
WAI	WAI:16	work ability index
WAI	WAI:7	working alliance inventory
WAP	WAP:119|Wap:4|wap:1	whey acidic protein
WAP	WAP:8	wireless application protocol
WAS	WAS:21	ward atmosphere scale
WAS	WAS:15	waste activated sludge
WAS	WAS:251	wiskottaldrich syndrome
WBA	WBA:8	whole blood assay
WBA	WBA:12	wholebody autoradiography
WBCs	WBCs:24	leukocytes
WBCs	WBCs:182|wbcs:1	white blood cells
WBCs	WBCs:10	white blood cell counts
WBC	WBC:70	white blood count
WBC	WBC:9	wholebody counter
WBRT	WBRT:8	whole brain irradiation
WBRT	WBRT:27	whole brain radiation therapy
WBS	WBS:23	warnerbratzler shear
WBS	WBS:15	whole blood serum
WBS	WBS:9	wholebody scanning
WBS	WBS:9|wbs:1	whole body scintigraphy
WBS	WBS:36	wiedemannbeckwith syndrome
WBS	WBS:61	williamsbeuren syndrome
WBS	WBS:11	wound breaking strength
WB	WB:11	weightbearing
WB	WB:98|Wb:1|wb:1	western blotting
WB	WB:10	western immunoblot
WB	WB:11	western immunoblotting
WB	WB:49|Wb:2	wheat bran
WB	WB:7	white bread
WCH	WCH:41	white coat hypertension
WCH	WCH:6	womens and childrens hospital
WCST	WCST:17	wisconsin card sorting task
WCST	WCST:332	wisconsin card sorting test
WC	WC:13	tungsten carbide
WC	WC:8	warm controls
WC	WC:20|W-C:4	watsoncrick
WC	WC:10	weight cycling
WC	WC:25	white carneau
WC	WC:11	white composite
WC	WC:29	workers compensation
WC	WC:9	writers cramp
WDTC	WDTC:11	welldifferentiated thyroid cancer
WDTC	WDTC:9	welldifferentiated thyroid carcinoma
WD	WD:9	trpasp
WD	WD:20	wallerian degeneration
WD	WD:14	water deprivation
WD	WD:5	western diet
WD	WD:16	winter dysentery
WEE	WEE:59	western equine encephalitis
WEE	WEE:6	western equine encephalitis virus
WEE	WEE:62	western equine encephalomyelitis
WFA	WFA:9	wistaria floribunda
WFA	WFA:10	wistaria floribunda agglutinin
WFA	WFA:25	wisteria floribunda agglutinin
WFS	WFS:9	wolfram syndrome
WFS	WFS:40	world fertility survey
WF	WF:9	donortype
WF	WF:9	weilfelix
WF	WF:52	working formulation
WF	WF:10	wound fluid
WGA-HRP	WGA-HRP:19	horseradish peroxidase conjugated with wheat germ agglutinin
WGA-HRP	WGA-HRP:7	wheat germ agglutininconjugated hrp
WGA-HRP	WGA-HRP:120	wheat germ agglutinin conjugated to horseradish peroxidase
WGA-HRP	WGA-HRP:163	wheat germ agglutininhorseradish peroxidase
WGA-HRP	WGA-HRP:22	wheat germ agglutininhorseradish peroxidase conjugate
WGA-HRP	WGA-HRP:8	wheat germ agglutininhrp
WGA	WGA:13	triticum vulgare
WGA	WGA:81	triticum vulgaris
WGA	WGA:17	whole genome amplification
WG	WG:595|W-G:1	wegeners granulomatosis
WG	WG:19	weight gain
WG	WG:10	wheat gluten
WG	WG:9	white
WG	WG:28	white gastrocnemius
WG	WG:5	working group
WHHL	WHHL:29	watanabe heritable hyperlipidaemic
WHHL	WHHL:228	watanabe heritable hyperlipidemic
WHO	WHO:8	grade iii
WHO	WHO:238	world health organisation
WHR	WHR:5	ratio of waisttohip circumference
WHR	WHR:6	waist to hip circumference
WHR	WHR:10	waisttohip ratios
WKY	WKY:2	normotensive control the wistarkyoto rat
WKY	WKY:4	normotensive rats of the wistarkyoto strain
WKY	WKY:8	wistarkyoto control
WKY	WKY:40	wistar kyoto rat
WK	WK:11	wistar kyoto
WK	WK:8	wistarkyoto rats
WLB	WLB:17	western ligand blot
WLB	WLB:30	western ligand blotting
WL	WL:5	waitlist control
WL	WL:7	waiting list
WL	WL:27	weight loss
WL	WL:42	white leghorn
WL	WL:15	white light
WL	WL:12	working length
WMC	WMC:15	white matter changes
WMC	WMC:8	working memory capacity
WMD	WMD:20	weapons of mass destruction
WMD	WMD:10	white matter damage
WMD	WMD:7	white muscle disease
WMS	WMS:30	wall motion score
WMS	WMS:59	wechsler memory scale
WMS	WMS:17	williams syndrome
WMS	WMS:8	wriggle mouse sagami
WM	WM:27	waldenstroms macroglobulinaemia
WM	WM:27	water maze
WM	WM:17	western medicine
WM	WM:10	wheat middlings
WM	WM:11	white men
WM	WM:9	whole milk
WM	WM:266	working memory
WM	WM:19|Wm:2	wortmannin
WN	WN:10	wellnourished
WN	WN:14|wN:1	white noise
WOMAC	WOMAC:41	western ontario and mcmaster universities
WOMAC	WOMAC:8	western ontario and mcmaster universities osteoarthritis
WOMAC	WOMAC:75	western ontario and mcmaster universities osteoarthritis index
WOMAC	WOMAC:8	western ontario mcmaster
WPW	WPW:276|W-P-W:5	wolffparkinsonwhite
WPW	WPW:69|W-P-W:2	wolffparkinsonwhite syndrome
WP	WP:1	increase in number of the weibelpalade
WP	WP:26	washed platelets
WP	WP:13	water placebo
WP	WP:19	wettable powder
WP	WP:7	whey protein
WP	WP:6	wolfgram protein
WRN	WRN:11	werner protein
WRN	WRN:21	werner syndrome
WRN	WRN:7	werner syndrome gene
WRN	WRN:15	werner syndrome protein
WR	WR:11	waldeyers ring
WR	WR:23	walter reed
WR	WR:8	water absorption response
WR	WR:20	western reserve
WR	WR:11	wheel running
WR	WR:6	wild running
WR	WR:25	wistar rats
WR	WR:41	work rate
WS	WS:15	wall stress
WS	WS:9	warning signal
WS	WS:15|W-S:4	warthinstarry
WS	WS:14	wheat straw
WS	WS:6|Ws:3	withania somnifera
WT1	WT1:6|WT-1:1	tumor gene 
WT1	WT1:5|WT-1:2	wilms tumor gene product
WT1	WT1:7|wt1:2	wilms tumor suppressor
WT1	WT1:29|WT-1:4|wt1:3|Wt-1:1	wilms tumor suppressor gene
WW	WW:20	watchful waiting
WW	WW:6	weaning weights
WA	WA:10	wall area
WA	WA:9	warmacclimated
WA	WA:2	weight age
WA	WA:85|Wa:7	western australia
WA	WA:9	western australian
WI	WI:5	t and tweighted images
WI	WI:24|Wi:1	warm ischemia
WI	WI:86	water immersion
WI	WI:10	weight index
Wmax	Wmax:13|WMAX:1	maximal workload
Wmax	Wmax:8	maximum work capacity
X4	X4:14	cxcr
X4	X4:9	cxcrdependent
X4	X4:10	cxcrusing
XAS	XAS:9	xray absorption
XAS	XAS:9	xray absorption spectroscopic
XAS	XAS:114	xray absorption spectroscopy
XD	XD:9	xanthoma disseminatum
XD	XD:10	xenodiagnosis
XG	XG:14	xanthan gum
XG	XG:21	xyloglucan
XLA	XLA:50|X-LA:2	xlinked agammaglobulinaemia
XLA	XLA:182|X-LA:5	xlinked agammaglobulinemia
XLP	XLP:29	xlinked lymphoproliferative
XLP	XLP:82	xlinked lymphoproliferative disease
XLP	XLP:52	xlinked lymphoproliferative syndrome
XN	XN:9	night blindness
XN	XN:13|Xn:1	xanthohumol
XPD	XPD:6|XP-D:5	xeroderma pigmentosum complementation group d
XPD	XPD:13|XP-D:5	xeroderma pigmentosum group d
XP-E	XP-E:3|XPE:2	xeroderma pigmentosum complementation group e
XP-E	XP-E:6|XPE:2	xeroderma pigmentosum group e
XPS	XPS:13	xray photoelectron spectroscopic
XPS	XPS:470	xray photoelectron spectroscopy
XTT	XTT:13	hydroxide
XTT	XTT:5	tetrazolium salt
YAP	YAP:5	alu polymorphism
YAP	YAP:16|Yap:1	yesassociated protein
YES	YES:22	yeast estrogen screen
YES	YES:9	yeast extract sucrose
YSM	YSM:56|ysm:1	years since menopause
YSM	YSM:15	yolk sac membrane
Yq	Yq:5	long arm of the y chromosome
Yq	Yq:10	y chromosome long arm
YS	YS:36	yolk sac
YS	YS:10	yoshida sarcoma
ZAP-70	ZAP-70:9|ZAP70:1	zetaassociated protein 
ZAP-70	ZAP-70:7|Zap-70:1	zetaassociated protein of  kda
ZD	ZD:12	zenkers diverticulum
ZD	ZD:17	zinc deficiency
ZE	ZE:13|Z-E:4	zollingerellison
ZE	ZE:17	zone electrophoresis
ZIO	ZIO:18	zinciodideosmium
ZIO	ZIO:19	zinc iodideosmium tetroxide
ZP3	ZP3:7|Zp3:1	zona pellucida 
ZP3	ZP3:8	zona pellucida glycoprotein 
ZP	ZP:9	zeta potential
ZP	ZP:374|zp:5|Zp:1	zona pellucida
ZF	ZF:74|zF:2|zf:1	zona fasciculata
ZF	ZF:14	zucker fatty
[3H]NMS	[3H]NMS:13	nhmethylscopolamine
[3H]NMS	[3H]NMS:8	nmethylhscopolamine
[Ca(2+)](i)	[Ca(2+)](i):12	intracellular calcium levels
[Ca(2+)](i)	[Ca(2+)](i):53	intracellular free ca concentration
[Ca2+]c	[Ca2+]c:10	cytoplasmic free calcium concentration
[Ca2+]c	[Ca2+]c:15	cytosolic calcium concentration
[Ca2+]i	[Ca2+]i:6	calcium transients
[Ca2+]i	[Ca2+]i:1	concentration in cytosol
[Ca2+]i	[Ca2+]i:39	cytosolic ca concentrations
[Ca2+]i	[Ca2+]i:34	cytosolic ca level
[Ca2+]i	[Ca2+]i:123	cytosolic free ca
[Ca2+]i	[Ca2+]i:31	cytosolic free ca concentrations
[Ca2+]i	[Ca2+]i:13	cytosolic free calcium levels
[Ca2+]i	[Ca2+]i:25	free cytosolic ca
[Ca2+]i	[Ca2+]i:21	free cytosolic calcium
[Ca2+]i	[Ca2+]i:5	increase cytosolic ca concentration
[Ca2+]i	[Ca2+]i:19	increase in cytosolic ca
[Ca2+]i	[Ca2+]i:18	intracellular ca activity
[Ca2+]i	[Ca2+]i:19	intracellular ca levels
[Ca2+]i	[Ca2+]i:14	intracellular calcium activity
[Ca2+]i	[Ca2+]i:27	intracellular free ca concentrations
[Cl-]i	[Cl-]i:8|[Cl]i:2	intracellular chloride concentration
[Cl-]i	[Cl-]i:3	intracellular cl
[Mg2+]i	[Mg2+]i:6	free mg concentrations
[Mg2+]i	[Mg2+]i:4	intracellular free magnesium
[Mg2+]i	[Mg2+]i:9	intracellular free magnesium concentration
[Mg2+]i	[Mg2+]i:13	intracellular free mg
[Mg2+]i	[Mg2+]i:13	intracellular mg concentration
[Mg2+]o	[Mg2+]o:11	extracellular magnesium ions
[Mg2+]o	[Mg2+]o:10	extracellular mg concentration
[Na+]o	[Na+]o:6	external na
[Na+]o	[Na+]o:23	extracellular na concentration
[Na+]o	[Na+]o:9	extracellular sodium concentration
A2	A2:5	atrial extrastimulus
A2	A2:8	component of the second heart sound
ACL	ACL:11	adenocarcinoma of the lung
ACL	ACL:21	adjective check list
ACL	ACL:77	american cutaneous leishmaniasis
ACL	ACL:12	anterior cruciate
aCL	aCL:17	anticardiolipin antibody
aCL	aCL:18|a-CL:2|ACL:2|A-CL:1	antibodies to cardiolipin
A-LAK	A-LAK:8|ALAK:2|aLAK:1	adherent lak
A-LAK	A-LAK:17|ALAK:1	adherent lymphokineactivated killer
A-LAK	A-LAK:6	adherent lymphokineactivated killer cells
aPKC	aPKC:17	atypical pkc
aPKC	aPKC:47|a-PKC:1	atypical protein kinase c
ACA	ACA:20	acetoxychavicol acetate
ACA	ACA:54	acrodermatitis chronica atrophicans
ACA	ACA:15	active cutaneous anaphylaxis
ACA	ACA:4	adaptive conjoint analysis
aca	aca:4|ACA:4	adenylyl cyclase
ACA	ACA:6|Aca:2	aminocaproic acid
ACA	ACA:6	anticentromere autoantibodies
ACA	ACA:10|aca:2	anticomplementary activity
aca	aca:6|ACA:2	automatic clinical analyzer
ADD	ADD:6	acute diarrheal disease
ADD	ADD:14	afterdischarge duration
ADD	ADD:9	androstadienedione
ADD	ADD:11	anterior disc displacement
ADD	ADD:174|add:5	attention deficit disorder
ADD	ADD:5	surgical induction of anterior disk displacement
ADN	ADN:13	associate degree nursing
ADN	ADN:11	electrical stimulation of the aortic depressor nerve
adr	adr:5	adrenergic receptor
adr	adr:12	adrenodoxin reductase
AGEs	AGEs:125	advanced glycation endproducts
AGEs	AGEs:88|ages:3	advanced glycosylation end products
AH	AH:9	abdominal hysterectomy
AH	AH:13	abductor hallucis
AH	AH:12	absolute humidity
AH	AH:21	absorptive hypercalciuria
AH	AH:6	adenoid hypertrophy
AH	AH:60	adenomatous hyperplasia
AH	AH:10	adult height
AH	AH:43	alcoholic hepatitis
AH	AH:10	alveolar hemorrhage
AH	AH:10	ancestral haplotype
AH	AH:5	aniline hydrochloride
AH	AH:7	anterior horn
AH	AH:11	anterior hypothalamic
AH	AH:17	aqueous humour
Ah	Ah:43|AH:12	aromatic hydrocarbon
AH	AH:21	artificial heart
Ah	Ah:161|AH:19	aryl hydrocarbon
AH	AH:16	assisted hatching
AH	AH:10	ataxic hemiparesis
AH	AH:14|A-H:6	atriohis
AH	AH:48	atypical hyperplasia
AH	AH:9	autonomic hyperreflexia
AH	AH:3	paf acetylhydrolase
AH	AH:19	patients with acute hepatitis
AH	AH:6	rat ascites hepatoma
AI	AI:12	acute ileus
AI	AI:15|ai:2	adequate intake
AI	AI:6|ai:2	adrenal incidentalomas
AI	AI:14|ai:3	adrenal insufficiency
ai	ai:6	airway inflammation
AI	AI:68|ai:6	amelogenesis imperfecta
AI	AI:14|ai:4	anchorageindependent
AI	AI:13|ai:1	aortic incompetence
AI	AI:80|ai:8	aortic insufficiency
AI	AI:7|ai:4	apoptotic
AI	AI:256|ai:48|Ai:2	apoptotic index
AI	AI:55|ai:8	artificial intelligence
AI	AI:21|ai:5	artificially inseminated
AI	AI:6|ai:3	associationinduction
AI	AI:4|ai:3	astragalus injection
ai	ai:9|AI:4	axonal injury
AI	AI:6|ai:2	primary auditory area
AI	AI:12|ai:1	primary auditory field
AK	AK:34|A-K:1|ak:1	aboveknee
AK	AK:12|ak:1	acanthamoeba keratitis
AK	AK:91	actinic keratosis
AK	AK:23	activated killer
AK	AK:18|ak:2	astigmatic keratotomy
aK	aK:4|ak:2	extracellular potassium activity
aK	aK:4|AK:2|ak:2	k activity
alpha	alpha:7	calcium absorption
alpha	alpha:8	intrinsic activity
alpha	alpha:7	molecular polarizability
alpha	alpha:8	separation factors
alum	alum:10	aluminium hydroxide gel
alum	alum:19	aluminum hydroxide gel
alum	alum:14	aluminum sulfate
anergy	anergy:8	functional inactivation
anergy	anergy:20	unresponsiveness
APT	APT:26|apt:2	applied potential tomography
APT	APT:36	atopy patch test
ara-A	ara-A:49|araA:19|Ara-A:7|ARA-A:5|AraA:3	betadarabinofuranosyladenine
ara-A	ara-A:34|Ara-A:27|ARA-A:11|araA:4|AraA:3|Ara-a:1	adenine arabinoside
ara-A	ara-A:5|Ara-A:2|araA:2	arabinosyladenine
ara-A	ara-A:9|Ara-A:3|AraA:1	vidarabine
Ara-C	Ara-C:12|ara-C:8|ARA-C:5|araC:3	arabinosyl cytosine
Ara-C	Ara-C:122|ara-C:121|ARA-C:33|AraC:31|araC:14|ara-c:5|ARAC:2	cytarabine
Ara-C	AraC:4|Ara-C:4|ARA-C:2|araC:2|ara-C:1	cytosinebetadarabinofuranoside
ARMS	ARMS:29	alveolar rhabdomyosarcoma
ARMS	ARMS:125|arms:1	amplification refractory mutation system
AW	AW:7|Aw:3	active wakefulness
AW	AW:12|Aw:1|aW:1	active waking
AW	AW:8	anterior wall
AW	AW:5	ash weight
b/b	b/b:10	belgrade
b/b	b/b:18	belgrade laboratory
bDNA	bDNA:7	branched dna signal amplification
bDNA	bDNA:5	versant hcv rna  assay
bGH	bGH:86	bovine gh
bGH	bGH:190|BGH:13|b-GH:2	bovine growth hormone
bNED	bNED:10	biochemical no evidence of disease
bNED	bNED:8	freedom from biochemical failure
BPE	BPE:35	benign prostatic enlargement
BPE	BPE:34|bPE:1	bovine pituitary extract
bTSH	bTSH:7	bovine thyroidstimulating hormone
bTSH	bTSH:15|b-TSH:3	bovine thyrotropin
bZIP	bZIP:64|bZip:14|b-Zip:3	basic leucine zipper
bZIP	bZIP:8|b-ZIP:1|B-ZIP:1	leucinezipper
baPWV	baPWV:26|BAPWV:1|ba-PWV:1	brachialankle pulse wave velocity
baPWV	baPWV:14	brachialankle pwv
beta	beta:10	buffer capacity
beta	beta:14	buffering power
beta	beta:20	elimination
beta	beta:7	human fibroblast
beta	beta:12|Beta:1	regression coefficient
beta	beta:18	skeletofusimotor
beta	beta:5	spectral exponent
beta	beta:7	stiffness index
beta	beta:7	stiffness parameter
BRA	BRA:9	bilateral renal agenesis
BRA	BRA:9	boneresorbing activity
BUT	BUT:5	biopsy urease test
BUT	BUT:20|but:1	tear film breakup time
cALL	cALL:11|c-ALL:5|C-ALL:4	common acute lymphoblastic leukaemia
cALL	cALL:22|c-ALL:6|C-ALL:4|CALL:1	common acute lymphoblastic leukemia
cAMP	cAMP:1085|camp:2	adenosine cyclic monophosphate
cAMP	cAMP:10	cyclic amp
cAMP	cAMP:7	monophosphoric acid
c-ANCA	c-ANCA:5|C-ANCA:3|cANCA:1	cytoplasmic pattern
c-ANCA	c-ANCA:4|C-ANCA:4|cANCA:3	cytoplasmic staining pattern
cDNA	cDNA:19	complementary
cDNA	cDNA:90	complementary deoxyribonucleic acid
cDNA	cDNA:1189|CDNA:2	complementary dna
cDNA	cDNA:18	dna complementary to rna
cGH	cGH:6	canine gh
cGH	cGH:11	chicken gh
cICAM-1	cICAM-1:11	circulating icam
cICAM-1	cICAM-1:29	circulating intercellular adhesion molecule
cLPM	cLPM:17	canalicular
cLPM	cLPM:10	canalicular liver plasma membrane
cNOS	cNOS:88	constitutive nitric oxide synthase
cNOS	cNOS:34|c-NOS:1	constitutive no synthase
cNOS	cNOS:50|c-NOS:3	constitutive nos
CAPE	CAPE:144|cape:1	caffeic acid phenethyl ester
CAPE	CAPE:8	clifton assessment procedures for the elderly
CAPS	CAPS:10	activator protein for secretion
CAPs	CAPs:7|CAPS:1	air particles
CAPS	CAPS:21	cardiac arrhythmia pilot study
CAPs	CAPs:7	cardioacceleratory peptides
CAPS	CAPS:19	catastrophic antiphospholipid syndrome
CAPs	CAPs:7	clathrinassociated proteins
CAPs	CAPs:116|cAPs:5|caps:3	compound action potentials
CAPs	CAPs:7	effects of subchronic exposures to concentrated ambient particles
CARDIA	CARDIA:106|cardia:2	coronary artery risk development in young adults
CARDIA	CARDIA:5	coronary artery risk development in young adults study
CARP	CARP:13|carp:2	cardiac ankyrin repeat protein
CARP	CARP:10	catchrelaxing peptide
CART	CART:9	classification and regression tree analysis
CART	CART:123	cocaine and amphetamineregulated transcript
CART	CART:5	combination antiretroviral therapy
CAT	CAT:8|cat:2	agglutination test
CAT	CAT:5	carnitine acyltransferase
cat	cat:6|CAT:3	catalase activity
cat	cat:13|Cat:3	cathepsin
cat	cat:13|CAT:2	cationic amino acid transporter
CAT	CAT:7	chlamydia antibody testing
cat	cat:28|CAT:24	chloramphenicol acetyltransferase gene
CAT	CAT:8	chloramphenicol acyltransferase
CAT	CAT:5|cat:2	cognitive analytic therapy
CAT	CAT:5|cat:1	column agglutination technology
CAT	CAT:43|cat:5	computed axial tomography
CAT	CAT:20	computer assisted tomography
CAT	CAT:9|cat:3	computerized adaptive testing
CAT	CAT:11|cat:2	computerized axial tomographic
CAT	CAT:116|cat:9	computerized axial tomography
CAV	CAV:11	canine adenovirus
CAV	CAV:116	cardiac allograft vasculopathy
CAV	CAV:38	chicken anaemia virus
CAV	CAV:51	chicken anemia virus
CBT	CBT:7	caffeine breath test
CBT	CBT:7	childhood brain tumors
CBT	CBT:211	cognitivebehavioral therapy
CBT	CBT:45	cognitivebehavioral treatment
CBT	CBT:12	computerbased training
CBT	CBT:31|cBT:3	core body temperature
CCC	CCC:5	child care center
CCC	CCC:13	chlorocholine chloride
CCC	CCC:9	chronic calculous cholecystitis
CCC	CCC:5	chronic chagas disease cardiomyopathy
CCC	CCC:10	chronic chagasic cardiomyopathy
CCC	CCC:16	clear cell carcinoma
CCC	CCC:13	concordance correlation coefficient
CCC	CCC:12	confronting cisternae
CCC	CCC:12	continuous circular capsulorhexis
CCC	CCC:64	continuous curvilinear capsulorhexis
CCC	CCC:6	continuous curvilinear capsulorrhexis
CDE	CDE:5	cholinedeficient ethioninesupplemented
CDE	CDE:6	convectiondispersion equation
CDE	CDE:15	dust extract
CDE	CDE:12	ethionine
CE-MRA	CE-MRA:35|CEMRA:5|ce-MRA:1	contrastenhanced magnetic resonance angiography
CE-MRA	CE-MRA:11|ceMRA:4|CEMRA:3	contrastenhanced mr angiography
CE-MRA	CE-MRA:8|CEMRA:3|ce-MRA:2	contrastenhanced mra
CFU/ml	CFU/ml:4|cfu/mL:1|cfu/ml:1	colony forming unitsml
CFU/ml	CFU/ml:10|CFU/mL:5|cfu/ml:5|cfu/mL:2	colonyforming units per milliliter
CHART	CHART:31	continuous hyperfractionated accelerated radiotherapy
CHART	CHART:32	craig handicap assessment and reporting technique
CHI	CHI:11	contrast harmonic imaging
CHI	CHI:11	creatinine height index
CHR	CHR:4|chr:1	calgary health region
CHR	CHR:7|chr:2	complete hematologic remission
CHR	CHR:13|chr:4	complete hematologic response
CHR	CHR:6|chr:1	complete hematological remission
CHR	CHR:16	contact hypersensitivity reaction
CHR	CHR:12	homology region
COL2A1	COL2A1:36|Col2a1:5|col2a1:1	type ii collagen gene
COL2A1	COL2A1:23|Col2a1:1	type ii procollagen
COL2A1	COL2A1:22|Col2a1:1	type ii procollagen gene
con	con:42|Con:2	concentric
con	con:10	control trial
CPs	CPs:7	capsid proteins
CPS	CPS:39	carbamoyl phosphate synthetase
CPS	CPS:14	carbamoylphosphate synthetase
CPS	CPS:16	carbamyl phosphate synthetase
CPS	CPS:7	cardioplegic solution
CPS	CPS:32	cardiopulmonary support
CPS	CPS:10	cerebral protein synthesis
CPs	CPs:18	chlorophenols
CPS	CPS:7	clinical pharmacokinetic service
CPS	CPS:7	clinical prediction of survival
CPS	CPS:6	coagulasepositive staphylococci
CPs	CPs:14	coat proteins
CPS	CPS:12	cognitive performance scale
CPS	CPS:21	contact photosensitivity
CPS	CPS:61	current population survey
CPs	CPs:17	cysteine proteinases
CPS	CPS:6	diphosphate synthase
CPS	CPS:5	patients with chest pain syndrome
CPS	CPS:17	synthetase i
CRIB	CRIB:10	cdcrac interactive binding
CRIB	CRIB:29	clinical risk index for babies
CRP	CRP:12	canalith repositioning procedure
CRP	CRP:10	cardiac rehabilitation program
CRP	CRP:36	collagenrelated peptide
CRP	CRP:12	confluent and reticulated papillomatosis
cryo-EM	cryo-EM:43|cryoEM:5|Cryo-EM:1	cryoelectron microscopy
cryo-EM	cryo-EM:5|cryoEM:5	electron cryomicroscopy
cya	cya:7	adenyl cyclase
cya	cya:10	adenylate cyclase gene
dHGF	dHGF:11	deleted form of hepatocyte growth factor
dHGF	dHGF:5	deletion variant of hepatocyte growth factor
dNTP	dNTP:48	deoxynucleoside triphosphate
dNTP	dNTP:57	deoxyribonucleoside triphosphate
dNTP	dNTP:14	deoxyribonucleotide
dSSc	dSSc:9	diffuse cutaneous systemic sclerosis
dSSc	dSSc:10	diffuse ssc
DTF	DTF:15	directed transfer function
DTF	DTF:9	dorsal tegmental field
DTC	DTC:94	differentiated thyroid cancer
DTC	DTC:37	directtoconsumer
DTC	DTC:8	disseminated tumor cells
DTC	DTC:8|dtc:2	dithiocarbamate
dUMP	dUMP:9	deoxyuridinemonophosphate
dUMP	dUMP:15	deoxyuridine monophosphate
dUMP	dUMP:9	deoxyuridylate
db/db	db/db:8	diabetic mouse
db/db	db/db:59|DB/DB:1	genetically diabetic
DBT	DBT:10	deep body temperature
DBT	DBT:26	dialectical behavior therapy
DBT	DBT:78	dibenzothiophene
DBT	DBT:6	dibutyltin dichloride
DD-PCR	DD-PCR:19|ddPCR:10|DDPCR:6	differential display pcr
DD-PCR	DD-PCR:16|ddPCR:8|DDPCR:6	differential display polymerase chain reaction
delta	delta:12	chemical shifts
delta	delta:7	electrical distance
DFR	DFR:25	delayed footpad reaction
DFR	DFR:10	dihydroflavonol reductase
DLK	DLK:54	diffuse lamellar keratitis
DLK	DLK:9	dual leucine zipperbearing kinase
dmPGE2	dmPGE2:14|DMPGE2:3|dm-PGE2:1	dimethyl pge
dmPGE2	dmPGE2:38|DMPGE2:13|dm-PGE2:3|DmPGE2:3	dimethyl prostaglandin e
Dmin	Dmin:5	minimum diameter
Dmin	Dmin:5	minimum target dose
DNs	DNs:6	descending neurons
DNs	DNs:18	district nurses
DNS	DNS:14	dysplastic naevus syndrome
DNS	DNS:38	dysplastic nevus syndrome
DNs	DNs:20	dysplastic nodules
DO	DO:8|do:1	days open
DO	DO:22|do:1	detrusor overactivity
DO	DO:212|do:15	dissolved oxygen
DO	DO:63|do:4	distraction osteogenesis
DO	DO:7|do:2	hlado
dP/dt	dP/dt:5|dP/dT:3|dp/dt:3	cardiac contractility
dP/dt	dP/dt:7|Dp/Dt:1|DP/Dt:1|dp/dt:1	left ventricular contractility
dP/dt	dP/dt:5	pressure with respect to time
dP/dt	dP/dt:4|dp/dt:3	rate of left ventricular pressure rise
dP/dt	dP/dt:10|dp/dt:1	rate of rise of left ventricular pressure
DRA	DRA:60|dra:1	dialysisrelated amyloidosis
DRA	DRA:13|Dra:1	downregulated in adenoma
DRM	DRM:18	deeseroedigermcdermott
DRM	DRM:9	doramectin
dsDNA	dsDNA:10|ds-DNA:1	deoxyribonucleic acid
dsDNA	dsDNA:9	doublestranded
dsDNA	dsDNA:336|ds-DNA:16|DSDNA:3	doublestranded dna
dsRNA	dsRNA:7|ds-RNA:2	doublestranded ribonucleic acid
dsRNA	dsRNA:629|ds-RNA:7|dsRna:1|DSRNA:1	doublestranded rna
ds	ds:10|DS:1	antidouble stranded
DS	DS:6	dahl saltsensitive hypertensive
DS	DS:23	dahl saltsensitive rats
ds	DS:5|ds:5	decayed surfaces
DS	DS:8	depressive symptoms
DS	DS:198|ds:9	dermatan sulfate
DS	DS:66|ds:2	dermatan sulphate
DS	DS:22	desynchronized sleep
DS	DS:78|ds:17	dextran sulfate
DS	DS:12|ds:1	diagnostic score
DS	DS:28|ds:1	diameter stenosis
DS	DS:9|ds:1	diazepamsensitive
DS	DS:18	digital subtraction
DS	DS:14	direct stenting
DS	DS:6	direction selectivity
DS	DS:7	directional selectivity
DS	DS:29|ds:2	directionally selective
DS	DS:12|ds:1	disseminated sclerosis
DS	DS:6	distribution space
DS	DS:10|ds:1	doppler sonography
DS	DS:15	duodenal switch
DS	DS:9	duplex sonography
DS	DS:8|ds:3	dyad symmetry
EH	EH:37	eclosion hormone
EH	EH:19	endometrial hyperplasia
Eh	Eh:9|EH:4	entamoeba histolytica
EH	EH:8	environmental heating
EH	EH:6	episodic hypoxia
EH	EH:8	epoxide hydrase
EH	EH:33	eps homology
EH	EH:11	essential hyperhidrosis
EH	EH:13	essential hypertensive patients
Eh	Eh:10|eH:1|EH:1	oxidationreduction potential
eIF4GI	eIF4GI:7	eukaryotic initiation factor gi
eIF4GI	eIF4GI:7	eukaryotic translation initiation factor gi
EI	EI:9	early intervention
EI	EI:10|Ei:1	electron impact ionization
EI	EI:8	electron ionisation
EI	EI:73	electron ionization
EI	EI:20	emotional intelligence
EI	EI:33	enzyme i
EI	EI:10	enzymeinhibitor complex
EI	EI:10	erythema infectiosum
ePTFE	ePTFE:21|e-PTFE:7|E-PTFE:1	expanded polytetrafluorethylene
ePTFE	ePTFE:4|e-PTFE:3	expanded polytetrafluoroethylene membrane
ear	ear:8	allergeninduced early
EAR	EAR:11|ear:1	aneurysm repair
ear	ear:13	early asthmatic reaction
ear	ear:28|EAR:1	early asthmatic response
EAR	EAR:26|ear:2	estimated average requirement
ECoG	ECoG:44|ECOG:2	electrocortical
ECoG	ECoG:20|ECOG:2	electrocortical activity
ECoG	ECoG:73	electrocorticographic
ECoG	ECoG:26|ECOG:1	intraoperative electrocorticography
EGG	EGG:23	electrogastrographic
EGG	EGG:155	electrogastrography
EGG	EGG:9	electroglottograph
EGG	EGG:23	electroglottographic
EGG	EGG:28	electroglottography
env	env:406|Env:6|ENV:1	envelope
env	env:23	envelope gene
env	env:8	envelope glycoprotein complex
epg	epg:12|EPG:10|EpG:1	egg counts
epg	epg:43|EPG:31	eggs per gram
epg	epg:19|EPG:13	eggs per gram of faeces
epg	epg:13|EPG:12	eggs per gram of feces
epg	epg:4|EPG:3	eggs per gram of stool
EPG	EPG:10	electropalatographic
EPG	EPG:38	electropalatography
EPG	EPG:14	ethanolamine phosphoglycerides
exp	exp:10|Exp:2	experimental
exp	exp:6	two experiments
FH	FH:35|fH:22	factor h
FH	FH:234	familial hypercholesterolaemia
FH	FH:15	familial hypercholesterolaemic
FH	FH:24	familial hypercholesterolemic
FH	FH:25	favorable histology
FH	FH:9	fibrous histiocytoma
FH	FH:18|F-H:3	ficollhypaque
FH	FH:52	final height
FH	FH:10	follicular hyperplasia
FH	FH:14	formin homology
FH	FH:7	frankfort horizontal
FH	FH:51	fulminant hepatitis
FH	FH:18	fumarate hydratase
FH	FH:8|Fh:2	recovery ratio
fMRI	fMRI:2225|FMRI:54|f-MRI:4|FM-RI:1	functional magnetic resonance imaging
fMRI	fMRI:463|FMRI:7|f-MRI:2	functional mri
FADD	FADD:72	fasassociated death domain
FADD	FADD:56	fasassociated death domain protein
FADD	FADD:14	fasassociated protein with death domain
FADD	FADD:7	fasassociating protein with death domain
FAST	FAST:29	focused abdominal sonography for trauma
FAST	FAST:15	functional assessment staging
FISH	FISH:387|fish:2	fluorescence in situ hybridisation
FISH	FISH:7	fluorescence in situ hybridization technique
FISH	FISH:108	fluorescent in situ hybridisation
FISH	FISH:10	situ hybridization analysis
free	free:9	nonproteinbound
free	free:15	unconjugated
free	free:13	unesterified
GCG	GCG:5|GCg:3	gallocatechin gallate
GCG	GCG:6	genetics computer group
GADA	GADA:7	gad antibody
GADA	GADA:5|GAD-A:1	glutamic acid decarboxylase autoantibodies
ghosts	ghosts:21|Ghosts:1	erythrocyte membranes
ghosts	ghosts:4	red cell membranes
glu	glu:816|Glu:42|GLU:13	glutamate
glu	glu:98|Glu:2|-GLU:1|GLU:1	glutamic acid
Glx	Glx:15	glutamateglutamine
Glx	Glx:9	glutamine and glutamate
GL	GL:10|gl:2	gastrocnemius lateralis
gl	gl:28	glomerular layer
gl	gl:19	glucose
gl	gl:11|GL:1	glycolipid
gl	gl:12	glycoprotein l
gl	gl:12	glycyrrhizic acid
GL	GL:9|gl:1	human granulosaluteal
GL	GL:14	pulmonary conductance
GSA	GSA:15|gsa:2	glutamate semialdehyde
GSA	GSA:8|gsa:3|GS-A:1	groupspecific antigen
GSA	GSA:46	guanidinosuccinic acid
hAAT	hAAT:11	human alpha antitrypsin
hAAT	hAAT:11	human alphaantitrypsin
hANP	hANP:103|h-ANP:8|HANP:6	human atrial natriuretic peptide
hANP	hANP:15	human atrial natriuretic polypeptide
hGHRH	hGHRH:10	human ghreleasing hormone
hGHRH	hGHRH:8|hGH-RH:3|h-GH-RH:1	human growth hormonereleasing hormone
hH1	hH1:5	cardiac sodium channels
hH1	hH1:14	human heart
hH1	hH1:7	na channel
HLH	HLH:36	haemophagocytic lymphohistiocytosis
HLH	HLH:236|H-L-H:3|hlh:1|h-l-h:1	helixloophelix
HLH	HLH:88	hemophagocytic lymphohistiocytosis
hLH	hLH:87|HLH:8	human luteinizing hormone
hLH	hLH:12	human lutropin
HLT	HLT:19|H-LT:1	heartlung transplant
HLT	HLT:31	heartlung transplantation
hOB	hOB:29|HOB:9	human osteoblastlike
hOB	hOB:9|HOB:4	human osteoblastic
hOB	HOB:4|hOB:4	human osteoblastic cells
hOGG1	hOGG1:3|hOgg1:2	human oxoguanine dna glycosylase
hOGG1	hOGG1:7	human oxoguanine dna glycosylase 
HPG	HPG:90|H-P-G:3	hypothalamicpituitarygonadal
HPG	HPG:25	hypothalamopituitarygonadal
HPG	HPG:9	hypothalamuspituitarygonadal
HPL	HPL:8	fatty acid hydroperoxide lyase
HPL	HPL:25|hPL:3	human pancreatic lipase
HPL	HPL:15	human peripheral lymphocytes
HpSA	HpSA:16	helicobacter pylori stool antigen
HpSA	HpSA:14|HPSA:1	stool antigen test
hTERT	hTERT:17	catalytic subunit of human telomerase
hTERT	hTERT:37|hTert:1	human telomerase catalytic subunit
hTERT	hTERT:5|hTert:2	human telomerase gene
hTERT	hTERT:11	telomerase reverse transcriptase gene
hTPO	hTPO:12	human thrombopoietin
hTPO	hTPO:20	human thyroid peroxidase
HDP	HDP:10	human dental pulp
HDP	HDP:7	hypertensive disorders of pregnancy
HELP	HELP:10	extracorporeal lowdensity lipoprotein precipitation
HELP	HELP:23	heparininduced extracorporeal ldl precipitation
HELP	HELP:7	hospitalized elderly longitudinal project
HIM	HIM:19	health information management
HIM	HIM:9	hyperigm
HIM	HIM:11	inductive microenvironment
HLOD	HLOD:12|H-LOD:2|hlod:1	heterogeneity lod
HLOD	HLOD:8	heterogeneity lod score
hnRNP	hnRNP:5|HnRNP:1	heterogeneous nuclear ribonucleoprotein particles
hnRNP	hnRNP:14	heterogeneous nuclear rnp
HOG	HOG:10	glycerol response
HOG	HOG:9	human oligodendroglioma
HOSE	HOSE:28|hOSE:3	human ovarian surface epithelial
HOSE	HOSE:12	human ovarian surface epithelium
hs-CRP	hs-CRP:81|hsCRP:50|HSCRP:4|HS-CRP:2|hsC-rp:1	highsensitivity creactive protein
hs-CRP	hs-CRP:16|hsCRP:9	highsensitivity crp
hsp70	hsp70:3|hsp-70:2|HSP-70:1	heat shock gene
hsp70	hsp70:4|HSP70:1	heat shock protein  gene
HSP70	HSP70:3|HSP-70:2|Hsp70:2|hsp70:1	heat shock protein  kd
HSP70	HSP70:4|hsp70:1	heat shock protein family
HUT	HUT:170	headup tilt
HUT	HUT:12	headup tilt testing
HUT	HUT:8	hyperplasia of usual type
HUT	HUT:7	tilt table testing
i.a.	i.a.:22	artery
i.a.	i.a.:9	injected intraarterially
i.c.v.	i.c.v.:141|I.C.V.:1	administered intracerebroventricularly
i.c.v.	i.c.v.:14	pretreatment
i.c.	i.c.:27	after intracerebral
i.c.	i.c.:6	carotid artery
i.c.	i.c.:12	injected intracisternally
i.c.	i.c.:15	intracutaneous
i.c.	i.c.:6	mice injected intracerebrally
i.c.	i.c.:5	mice inoculated intracerebrally
i.d.	i.d.:9	intraduodenal administration
i.d.	i.d.:5	mgkg intraduodenally
i.g.	i.g.:97|I.G.:2	intragastric
i.g.	i.g.:46|I.G.:1	intragastrically
i.pl.	i.pl.:68	intraplantar
i.pl.	i.pl.:18	intrapleural
i.t.	i.t.:43	injected intrathecally
i.t.	i.t.:6	injected intratumorally
i.t.	i.t.:9	injection
i.t.	i.t.:13	intrathoracic
i.v.	i.v.:177|I.V.:3	administered intravenously
i.v.	i.v.:12	injections
i.v.	i.v.:14	intravenous administration
i.v.	i.v.:26	intravenous injection
I/M	I/M:11	inspection and maintenance
I/M	I/M:6	intimamedia ratio
I/M	I/M:11	intimatomedia
I/M	I/M:9	intimalmedial
ICGN	ICGN:11	icrderived glomerulonephritis
ICGN	ICGN:11|IC-GN:3	immune complex glomerulonephritis
iCGRP	iCGRP:17|i-CGRP:1	immunoreactive calcitonin generelated peptide
iCGRP	iCGRP:11|i-CGRP:3	immunoreactive cgrp
ICT	ICT:47|Ict:1	contraction time
ICT	ICT:22	immunochromatographic test
iCT	iCT:59|ICT:4|I-CT:1|i-CT:1	immunoreactive calcitonin
iCT	iCT:9	immunoreactive ct
ICT	ICT:9	impression cytology with transfer
ICT	ICT:8|iCT:1	initial collecting tubule
ICT	ICT:5	intensified conventional therapy
ICT	ICT:7	intensified conventional treatment
ICT	ICT:5	intraoral cariogenicity test
ICT	ICT:17|IC-T:1	intracoronary thrombolysis
ICT	ICT:19	intramolecular charge transfer
iPTH	iPTH:10|IPTH:2	immunoreactive parathormone
iPTH	iPTH:55|i-PTH:2|IPTH:2	immunoreactive pth
iPTH	iPTH:23|I-PTH:1	intact parathormone
ICER	ICER:59	incremental costeffectiveness ratio
ICER	ICER:62	inducible camp early repressor
icv	icv:1	administered either intracerebroventricularly
ICV	ICV:18	ileocecal valve
ICV	ICV:5	internal cerebral vein
ICV	ICV:25	intracranial volume
icv	icv:3|ICV:2	third cerebroventricle
IDE	IDE:6|ide:3	erythropoiesis
IDE	IDE:8|ide:1	inner dental epithelium
IDE	IDE:14|ide:4	investigational device exemption
indels	indels:15	insertions and deletions
indels	indels:8|INDELs:1|InDels:1	insertionsdeletions
indels	indels:4|InDels:1	insertiondeletion polymorphisms
ind	ind:12	indapamide
ind	ind:7|Ind:2	indeterminate
IND	IND:8|ind:2	inflammatory neurological diseases
IND	IND:47|ind:6	intestinal neuronal dysplasia
IND	IND:37|ind:2	investigational new drug
IND	IND:19	investigational new drug application
IQ	IQ:10	aminomethylhimidazofquinoline
IQ	IQ:25	aminomethylimidazofquinoline
IQ	IQ:12	fquinoline
IQ	IQ:10	ilimaquinone
IQ	IQ:39|iq:1	intelligence
IQ	IQ:11	interquartile
ir-TRH	ir-TRH:7|IR-TRH:2	immunoreactive thyrotropinreleasing hormone
ir-TRH	ir-TRH:22|IR-TRH:12	immunoreactive trh
IR-ANP	IR-ANP:23|irANP:16|ir-ANP:10|IrANP:1	immunoreactive anp
IR-ANP	IR-ANP:5|irANP:3|ir-ANP:2|IrANP:2	plasma levels of immunoreactive atrial natriuretic peptide
IVC	IVC:1134	inferior vena cava
IVC	IVC:64	inferior vena caval
IVC	IVC:27	inspiratory vital capacity
IVC	IVC:30	intravenous cholangiography
IVT	IVT:8|ivt:1	ventricle
IVT	IVT:8	ventricular tachycardia
k(cat)	k(cat):12	catalytic constant
k(cat)	k(cat):8	catalytic rate constant
K1	K1:5	ligand transport
K1	K1:13	phylloquinone
Kv	Kv:18|KV:2	voltagegated
Kv	Kv:51|KV:3	voltagegated potassium
KBP	KBP:4	kainate binding protein
KBP	KBP:9	kallikreinbinding protein
kcat	kcat:7|Kcat:2	catalytic rate
kcat	kcat:5|Kcat:1	turnover rate
Kg	Kg:5|KG:4	glucose disappearance
Kg	Kg:6|KG:3|kg:1	glucose disappearance constant
lambda	lambda:12	population growth rate
lambda	lambda:14	reorganization energy
lev	lev:39|Lev:4	levamisole
lev	lev:59|Lev:20	levetiracetam
LGG	LGG:8|L-GG:2	lactobacillus gg
LGG	LGG:12	lactobacillus rhamnosus gg
LGG	LGG:7	lactobacillus rhamnosus strain gg
LIPID	LIPID:15	longterm intervention with pravastatin in ischaemic disease
LIPID	LIPID:12|lipid:2	longterm intervention with pravastatin in ischemic disease
LLR	LLR:6	longlatency reflexes
LLR	LLR:8	lower lip retraction
LOAD	LOAD:25	lateonset ad
LOAD	LOAD:34	lateonset alzheimers disease
LSP	LSP:22	life skills profile
LSP	LSP:12|lsp:1	liverspecific lipoprotein
LSP	LSP:15	liverspecific membrane lipoprotein
LTK	LTK:17	laser thermal keratoplasty
LTK	LTK:17	laser thermokeratoplasty
LTK	LTK:8|ltk:1	leukocyte tyrosine kinase
lung	lung:7	remote organ
lung	lung:6	target organ
m/z	m/z:13|M/Z:1	masscharge
m/z	m/z:19	masstocharge
m/z	m/z:14	masstocharge ratio
MCG	MCG:27	magnetocardiogram
MCG	MCG:29	magnetocardiographic
MCG	MCG:44	magnetocardiography
MCG	MCG:8	mast cell granules
MCG	MCG:13	medical college of georgia
MCG	MCG:9	membranecoating granules
MCG	MCG:25	midbrain central gray
MCS	MCS:20	mechanical circulatory support
MCS	MCS:6	mental component scale
MCS	MCS:11	mental component score
MCS	MCS:7	mesocaval shunt
MCS	MCS:13	minimally conscious state
MCS	MCS:20	motor cortex stimulation
MCS	MCS:8	multicellular spheroids
MCS	MCS:12	multiple chemical sensitivity syndrome
MF	MF:12	fibres
MF	MF:4	increase in mutation frequency
MF	MF:5	marrow fibrosis
MF	MF:9	medium fat
MF	MF:24	membrane filter
MF	MF:11|mF:1	membrane filtration
MF	MF:4|mf:1	membrane fractions
MF	MF:31	methyl farnesoate
MF	MF:28	microfilament
mf	mf:7|MF:4|Mf:1	microfilaremia
mf	mf:70|MF:13|Mf:7|mF:1	microfilaria
mf	mf:28|Mf:5|MF:4	microfilarial
MF	MF:38	microfiltration
MF	MF:7|Mf:5	micropolyspora faeni
MF	MF:9	midfrequency
MF	MF:7	milk fat
MF	MF:9	mitotic figures
MF	MF:6	mitral flow
MF	MF:44	mometasone furoate
MF	MF:14	morphogenetic furrow
MF	MF:9	mossy fibre
MF	MF:9	motherfed
MF	MF:11	muscle fibers
MF	MF:503|Mf:1	mycosis fungoides
MF	MF:9	myelinated fibers
MF	MF:6	sequential methotrexate and fluorouracil
mGnRH	mGnRH:23|m-GnRH:1	mammalian gnrh
mGnRH	mGnRH:14|MGnRH:1	mammalian gonadotropinreleasing hormone
mIgM	mIgM:31	membrane igm
mIgM	mIgM:10	membrane immunoglobulin m
mRNA	mRNA:14	gene expression
mRNA	mRNA:889|m-RNA:2|MRNA:1	messenger ribonucleic acid
MAN	MAN:11|man:1	magnocellular nucleus of the anterior neostriatum
MAN	MAN:10	medial articular nerve
MAN	MAN:7|man:2	methacrylonitrile
mdx	mdx:9|MDX:1	dystrophic mouse
mdx	mdx:26|MDX:1	dystrophindeficient
mdx	mdx:5	dystrophindeficient mice
MeCCNU	MeCCNU:10|Me-CCNU:3	chloroethylmethylcyclohexylnitrosourea
MeCCNU	MeCCNU:8|Me-CCNU:1	chloroethyltransmethylcyclohexylnitrosourea
min	min:9	 minutes
min	min:33	medial interlaminar nucleus
MKP-1	MKP-1:36	map kinase phosphatase
MKP-1	MKP-1:35	mapk phosphatase
MKP-1	MKP-1:7	mitogenactivated protein kinase phosphatase
MMHg	MMHg:6	monomethyl mercury
MMHg	MMHg:9	monomethylmercury
MM-LDL	MM-LDL:9|mmLDL:3|mm-LDL:2	minimally modified ldl
MM-LDL	MM-LDL:4|mmLDL:1|MmLDL:1|mm-LDL:1	minimally oxidized ldl
MOM	MOM:11	metalonmetal
MOM	MOM:10	midecamycin acetate
MOM	MOM:15	miocamycin
MOM	MOM:13	miokamycin
MOM	MOM:9	mucoid otitis media
mo	mo:20	ab initio molecular orbital
MO	MO:4|mo:1	excitant and inflammatory irritant mustard oil
MO	MO:14|mo:8	medulla oblongata
MO	MO:14|mo:3	membrane oxygenator
MO	MO:50|mo:13	menhaden oil
MO	MO:7|mo:6	methyl orange
mo	mo:93|Mo:7	molybdenum
mo	mo:35|Mo:2	monocyte
mo	mo:18|Mo:1	monocytesmacrophages
mo	mo:9|Mo:1	monoolein
mo	mo:8|Mo:6	morbid obesity
mo	mo:11|Mo:1	morbidly obese
mo	mo:9	mottled
mo	mo:5	sodium molybdate
MRCA	MRCA:20	magnetic resonance coronary angiography
MRCA	MRCA:22	recent common ancestor
MS-PCR	MS-PCR:9	mutagenically separated pcr
MS-PCR	MS-PCR:11	mutagenically separated polymerase chain reaction
MuSK	MuSK:27|MUSK:1	musclespecific kinase
MuSK	MuSK:21	musclespecific receptor tyrosine kinase
MU	MU:54|mu:3	 million units
mu	mu:9	attenuation coefficient
mu	mu:13	dipole moment
MU	MU:7|mu:2	megaunits
MU	MU:18|mu:8|Mu:2	monitor unit
mu	mu:66|MU:63	motor unit
mu	mu:26|Mu:1	murine
mu	mu:6|Mu:3	robertsons mutator
mu	mu:5	shear elastic modulus
N2	N2:15	dinitrogen
N2	N2:6	nitrogen gas
NH	NH:10	amide
NH	NH:11	neonatal hemochromatosis
NH	NH:25	neonatal hepatitis
NH	NH:28|Nh:2	neurohypophysis
NH	NH:5	nodular hyperplasia
NH	NH:10	norharman
NH	NH:18	normal host
nPNA	nPNA:8	normalized protein equivalent of nitrogen appearance
nPNA	nPNA:6|NPNA:1	normalized protein nitrogen appearance
NRBCs	NRBCs:10	nucleated erythrocytes
NRBCs	NRBCs:41|nRBCs:5	nucleated red blood cells
NcAMP	NcAMP:8|ncAMP:2	nephrogenous camp
NcAMP	NcAMP:9|N-cAMP:1	nephrogenous cyclic adenosine monophosphate
NcAMP	NcAMP:15|N-cAMP:1|N-CAMP:1	nephrogenous cyclic amp
NPR-A	NPR-A:11|NPRA:2|Npra:1|NPr-A:1	natriuretic peptide receptor
NPR-A	NPR-A:19|NPRA:4	natriuretic peptide receptora
NRP	NRP:5	national registry of patients
NRP	NRP:15	neonatal resuscitation program
nu/+	nu/+:9	heterozygote
nu/+	nu/+:6|Nu/+:2	heterozygous littermates
nu/+	nu/+:9	normal littermates
nu/nu	nu/nu:99|Nu/Nu:3	athymic nude
nu/nu	nu/nu:39|Nu/Nu:3	congenitally athymic
nude	nude:6	congenitally thymusdeficient
nude	nude:9	hypothymic
nude	nude:10	immunodeficient
nvCJD	nvCJD:8	new variant cjd
nvCJD	nvCJD:8|nv-CJD:1	new variant of creutzfeldtjakob disease
OAT	OAT:15|O-AT:5	oacetyltransferase
OAT	OAT:10|o-AT:1	oaminoazotoluene
OAT	OAT:28	oligoasthenoteratozoospermia
OAT	OAT:48|oat:1	oral anticoagulant therapy
OAT	OAT:18	oral anticoagulant treatment
OAT	OAT:21|Oat:2|oat:1	organic anion transporter
OAT	OAT:88	ornithine aminotransferase
OAT	OAT:16	ornithinedeltaaminotransferase
ob/ob	ob/ob:219|Ob/Ob:1	genetically obese
ob/ob	ob/ob:14	genetically obese mice
ob/ob	ob/ob:28	leptindeficient
ob/ob	ob/ob:33	obese hyperglycaemic
one	one:14	bleeding
one	one:9	leukemia
one	one:9	obstruction
one	one:9	pancreatitis
oriT	oriT:75	origin of transfer
oriT	oriT:12	transfer origin
or	or:6|OR:3	nadphcytochrome p reductase
or	or:9	ocular retardation
or	or:12|OR:3	odds ration
or	or:32	odorant receptor
or	or:24	oestrogen receptor
or	or:58	olfactory receptor
or	or:12|OR:5	open repair
or	or:12|OR:2	operations research
or	or:8	opioid receptors
or	or:8|OR:1	optical rotation
or	or:6	orienting reaction
or	or:14	orienting reflex
or	or:53	orienting response
or	or:4|OR:1	outflow resistance
or	or:19|OR:6	ovulation rate
or	or:4|OR:2	relative risk
or	or:8	right operator
p.i.	p.i.:6	 weeks postinoculation
p.i.	p.i.:7	days postinjection
p.i.	p.i.:32	post injection
p.i.	p.i.:14	postimmunization
p.o.	p.o.:16	oral administration
p.o.	p.o.:14	oral gavage
p.o.	p.o.:15	perorally
pANCA	pANCA:15|p-ANCA:9|P-ANCA:6	perinuclear anca
pANCA	pANCA:5|p-ANCA:2|P-ANCA:2	perinuclear staining pattern
pAVP	pAVP:14|PAVP:12|Pavp:1|p-AVP:1	plasma arginine vasopressin
pAVP	PAVP:4|pAVP:4|Pavp:1	plasma arginine vasopressin concentration
PCMB	PCMB:70|pCMB:29|p-CMB:10	pchloromercuribenzoate
PCMB	PCMB:30|pCMB:12|p-CMB:5	pchloromercuribenzoic acid
PCMB	PCMB:4|p-CMB:2|pCMB:1	pchloromercuric benzoate
PEMT	PEMT:8|PeMT:1	phosphatidylethanolamine methyltransferase
PEMT	PEMT:24|PeMT:3	phosphatidylethanolamine nmethyltransferase
pFSH	pFSH:13	porcine folliclestimulating hormone
pFSH	pFSH:12	porcine fsh
PGH	PGH:9	phosphoglycolohydroxamate
pGH	pGH:29	porcine gh
pGH	pGH:68|PGH:6	porcine growth hormone
PGH	PGH:22	prostaglandin endoperoxide
PH1	PH1:73|PH-1:2	primary hyperoxaluria type 
PH1	PH1:7|PH-1:1	primary hyperoxaluria type i
PHMB	PHMB:6|p-HMB:1	phydroxymercuribenzoic acid
PHMB	PHMB:35	polyhexamethylene biguanide
PHM	PHM:13	partial hydatidiform mole
PHM	PHM:9	peptide histidinemethionine
PHM	PHM:35	peptidylglycine alphahydroxylating monooxygenase
PHI	PHI:10	peptide hi
PHI	PHI:16	peptide histidineisoleucine
PHI	PHI:2	peptide with nterminal histidine and cterminal isoleucine amide
PHI	PHI:58|Phi:3	phosphohexose isomerase
PHI	PHI:10	phosphohexoseisomerase
PHI	PHI:10	private health insurance
PHV	PHV:59	peak height velocity
PHV	PHV:11	peptide histidine valine
PHV	PHV:11	prosthetic heart valves
pH	pH:15|PH:1	acidity
PH	PH:8|-PH:1	history
pH	pH:16|PH:1	hydrogen ion concentration
PH	PH:18	hyperplasia
PH	PH:17	palmar hyperhidrosis
PH	PH:9	partially hepatectomized
PH	PH:8	peak height
PH	PH:9	periventricular heterotopia
PH	PH:12|Ph:8	phenol
PH	PH:509|Ph:6	pleckstrin homology
PH	PH:54	posterior hypothalamus
PH	PH:20	postural hypotension
PH	PH:24|Ph:2	prepositus hypoglossi
PH	PH:17	proportional hazards
PH	PH:10|Ph:1	pubic hair
PH	PH:21	pulmonary hemorrhage
PH	PH:24	pulmonary hypoplasia
pIgR	pIgR:36|pIg-R:1	polymeric ig receptor
pIgR	pIgR:94|PIGR:5|PIgR:4|pIg-R:4|pigR:1	polymeric immunoglobulin receptor
PIs	PIs:20	phosphoinositides
PIs	PIs:343	protease inhibitors
PI	PI:3|P-I:2	days postirradiation
PI	PI:27|pi:7	hr postinoculation
PI	PI:6	hydrolysis of hphosphatidylinositol
PI	PI:16	hydrolysis of phosphoinositides
PI	PI:14|Pi:1	inferior pulvinar
Pi	Pi:27	inorganic orthophosphate
Pi	Pi:14	inorganic p
PI	PI:17	inositol phospholipid
Pi	Pi:10	interstitial fluid hydrostatic pressure
PI	PI:13	padua inventory
PI	PI:18	pain intensity
PI	PI:30	pancreatic insufficiency
PI	PI:10	pars intercerebralis
PI	PI:80|pi:3|Pi:3	pars intermedia
PI	PI:9	peak intensity
PI	PI:15	performance improvement
PI	PI:9	peripheral iridectomy
PI	PI:64|pi:2	persistently infected
PI	PI:11	phosphatidylinositide
PI	PI:21	phosphoinositol
PI	PI:9	phosphotyrosine interaction
PI	PI:24	plaque
PI	PI:12	plasma insulin
PI	PI:31	pneumatosis intestinalis
PI	PI:17	polyphosphoinositide
PI	PI:9	porcine insulin
PI	PI:5	positive ion
PI	PI:17|pi:5	postinjection
PI	PI:10	primary isolates
PI	PI:16	principal investigator
PI	PI:42|Pi:1	proactive interference
PI	PI:38|Pi:2	proinsulin
PI	PI:13	proliferation indices
PI	PI:767|Pi:6|pI:1	propidium iodide
PI	PI:13	protein i
PI	PI:10	pulmonary insufficiency
PI	PI:6	pulsatility indexes
PI	PI:34	pulse interval
PI	PI:8	putatively immune
PI	PI:12|pi:5	weeks postinoculation
PI	PI:5|P-I:1	weeks postirradiation
PKA	PKA:28	prekallikrein activator
PKA	PKA:21|PK-A:7	protein kinasea
pMDIs	pMDIs:39|pMDIS:1	metered dose inhalers
pMDIs	pMDIs:14|p-MDIs:1	pressurized metereddose inhalers
PMT	PMT:7	pacemakermediated tachycardia
PMT	PMT:7	parent management training
PMT	PMT:39|Pm-T:1	pasteurella multocida toxin
PMT	PMT:9	percutaneous mechanical thrombectomy
PMT	PMT:34	photomultiplier tube
PMT	PMT:18	premenstrual tension
PMT	PMT:7	premotor time
PMT	PMT:17	protection motivation theory
PMT	PMT:15	putrescine nmethyltransferase
PNP	PNP:95|pNP:23|p-NP:16|pnp:1	pnitrophenol
PNP	PNP:5|pNP:4	paranitrophenol
PNP	PNP:66	paraneoplastic pemphigus
PNP	PNP:14	pediatric nurse practitioner
PNP	PNP:8	platelet neutralization procedure
PNP	PNP:9	poissonnernstplanck
PNP	PNP:14	posterior neuropore
PNP	PNP:12	pyridoxine phosphate
PNSP	PNSP:1	penicillinnonsusceptible s pneumoniae
PNSP	PNSP:7	penicillinnonsusceptible streptococcus pneumoniae
POA	POA:33|poa:1	pancreatic oncofetal antigen
POA	POA:7|Poa:1	phenoxyacetic acid
POA	POA:10	preoptic
POA	POA:1	preoptic and anterior hypothalamus
POA	POA:7	preoptic area of the hypothalamus
POA	POA:10	pyrazinoic acid
pQCT	pQCT:9	peripheral qct
pQCT	pQCT:251|PQCT:5|pQ-CT:1	peripheral quantitative computed tomography
pVHL	pVHL:20	vhl protein
pVHL	pVHL:16	von hippellindau protein
PACE	PACE:9|PA-CE:1	electrophoresis
PACE	PACE:38	program of allinclusive care for the elderly
PCD	PCD:9|pcd:1	detection
PCD	PCD:18	papillary collecting duct
PCD	PCD:82|pcd:1	paraneoplastic cerebellar degeneration
PCD	PCD:25	percutaneous catheter drainage
PCD	PCD:14	plasma cell dyscrasia
PCD	PCD:28	premature centromere division
PCD	PCD:107	primary ciliary dyskinesia
PCD	PCD:705|pcd:6	programmed cell death
PCD	PCD:8	pterinacarbinolamine dehydratase
PDP	PDP:11	pachydermoperiostosis
PDP	PDP:16	parallel distributed processing
PDP	PDP:2	population and development program
PDP	PDP:6	process dissociation procedure
PDP	PDP:11	pyruvate dehydrogenase phosphatase
PD	PD:10	after pancreaticoduodenectomy
PD	PD:14	after pancreatoduodenectomy
PD	PD:8	along the proximodistal
PD	PD:7	cell membrane potential
PD	PD:6	coronary artery
Pd	Pd:5|PD:2	diastolic pressure
PD	PD:11	disease of bone
PD	PD:10	disease progression
PD	PD:17	paired domain
PD	PD:16	pancreas divisum
PD	PD:15	pancreatic duct
PD	PD:417|Pd:1	panic disorder
PD	PD:10	parkinsonian
PD	PD:9	parkinsonism
PD	PD:64|Pd:1|pd:1	pars distalis
PD	PD:9	perfusion defect
PD	PD:9	peripheral dose
PD	PD:13	peritoneal dialysate
PD	PD:1388|pd:1	peritoneal dialysis
PD	PD:8	peritoneal drainage
PD	PD:12	persistent diarrhea
PD	PD:12	persistent diarrhoea
PD	PD:9	pharmacokinetic pkpharmacodynamic
PD	PD:23	phosphate depletion
PD	PD:11	plasma desorption
PD	PD:12|Pd:7	plasmodesmata
PD	PD:6	platelet deposition
PD	PD:7	pneumatic dilatation
PD	PD:9	pneumatic dilation
PD	PD:11	postural drainage
PD	PD:9	potential difference across the cell membrane
PD	PD:12	power density
PD	PD:49	power doppler
PD	PD:7|Pd:1|pd:1	preferred direction
PD	PD:8|pd:1	prism dioptres
PD	PD:11	prisoners dilemma
PD	PD:20|Pd:1	probing pocket depth
PD	PD:11	progressed
PD	PD:8	prolidase deficiency
PD	PD:13	protein degradation
PD	PD:5	protein deposition
PD	PD:33	proton density
PD	PD:9|P-D:5	proximaldistal
PD	PD:10|Pd:4|pd:2	pseudodeficiency
Pd	Pd:14|PD:3	psychopathic deviate
PD	PD:22	pulsed doppler
PD	PD:10	pupillary diameter
PD	PD:47	pyloric dilator
phox	phox:6|Phox:1	phagocyte nadph oxidase
phox	phox:12	phagocyte oxidase
PIA	PIA:10	nlphenylisopropyladenosine
PIA	PIA:40	nphenylisopropyladenosine
PIA	PIA:34	phenylisopropyladenosine
PIA	PIA:25	polysaccharide intercellular adhesin
PIA	PIA:6	pontine inhibitory area
PIA	PIA:23	pristaneinduced arthritis
PIA	PIA:9	processingindependent analysis
PIA	PIA:5	receptor agonist nphenylisopropyladenosine
PODs	PODs:25	pml oncogenic domains
PODs	PODs:42	postoperative days
polh	polh:13|Polh:2	polyhedrin
polh	polh:8	polyhedrin gene
po	po:7|PO:2	administered
PO	PO:3|po:1	granulosa cells of preovulatory
Po	Po:6|po:3	maximum isometric force
Po	Po:7|po:3	maximum isometric tension
Po	Po:5|po:3	maximum isometric tetanic force
PO	PO:19|po:6	palm oil
po	po:6|PO:3	parietooccipital
PO	PO:11	peanut oil
PO	PO:6|po:1	perceptual organization
PO	PO:6	personality organization
PO	PO:7|po:4	phenol oxidase
PO	PO:48|po:19	phenoloxidase
PO	PO:26|po:15|P-O:1	phosphodiester
po	po:9	polyolefin
po	po:6	posterior complex
po	po:10	posterior group of thalamic nuclei
po	po:12	posterior nuclear group
po	po:8	posterior nucleus
PO	PO:11|po:5	principal olive
Po	Po:6|po:1	probability of being open
Po	Po:7|po:3	probability of channel opening
po	po:5|Po:1	probability of opening
Po	Po:3|po:2	probability of the channel being open
PO	PO:5	prostate only
PO	PO:8|po:4	protein oxidation
ppGpp	ppGpp:23	guanosine bispyrophosphate
ppGpp	ppGpp:12	guanosine diphosphate diphosphate
ppGpp	ppGpp:68	guanosine tetraphosphate
PPH	PPH:4|PP-H:3	periportal hepatocytes
PPH	PPH:24	postpartum haemorrhage
PPH	PPH:26	postpartum hemorrhage
PPH	PPH:31	postprandial hypotension
PPH	PPH:417	primary pulmonary hypertension
PPM	PPM:14	polypropylene mesh
PPM	PPM:7	professional practice model
psi	psi:8|Psi:1	packaging
Psi	Psi:6|psi:5	packaging signal
PSI	PSI:24	parenting stress index
PSI	PSI:8	paul scherrer institute
PSI	PSI:26	pneumonia severity index
PSI	PSI:16	population services international
psi	psi:8|PSI:1	pounds per square inch
psi	psi:46|Psi:20|PSI:1	pseudouridine
Psi	Psi:5|psi:4	water potential
PTA	PTA:12	pancreas transplantation alone
PTA	PTA:13	parallel tubular arrays
PTA	PTA:6	patellar tilt angle
PTA	PTA:23	peritonsillar abscess
PTA	PTA:12|pta:5	persistent truncus arteriosus
PTA	PTA:71|pta:2	phosphotungstic acid
PTA	PTA:4	pontine taste area
PTA	PTA:20	predicted transmitting abilities
PTA	PTA:7	prothymosin alpha
PTI	PTI:3|pti:2	pancreatic trypsin inhibitor
PTI	PTI:9|PtI:1	pressuretime integral
PUN	PUN:16	plasma urea n
PUN	PUN:37	plasma urea nitrogen
R2	R2:10|r2:1	variability
R2	R2:10|r2:3	variation
rCBF	rCBF:4|r-CBF:2	cerebral perfusion
rCBF	rCBF:113|r-CBF:1|RCBF:1	regional cbf
rCBF	rCBF:8	regional cerebral bloodflow
RCL	RCL:19	reactive center loop
RCL	RCL:10	reactive centre loop
RC	RC:22	fetal rat calvaria
RC	RC:11	radical cystectomy
RC	RC:5	rapid cycling
RC	RC:17	reaction centre
RC	RC:14	recombinant congenic
RC	RC:5	rectal cancer
RC	RC:8	referred care
RC	RC:17	regenerated cellulose
RC	RC:7	reliable change
RC	RC:12	replication complex
RC	RC:24	respiratory chain
RC	RC:29	resting zone
RC	RC:49|rc:1	rib cage
RC	RC:9	rotator cuff
rDNA	rDNA:4	genes coding for rrna
rDNA	rDNA:710	ribosomal dna
rEpo	rEpo:5|rEPO:3|r-epo:2|r-EPO:1	recombinant epo
rEpo	rEpo:25|rEPO:21|r-EPO:15|r-Epo:3|R-EPO:1	recombinant erythropoietin
rFSH	rFSH:15|r-FSH:6	recombinant follicle stimulating hormone
rFSH	rFSH:48	recombinant fsh
rFVIII	rFVIII:25|r-FVIII:1	recombinant factor viii
rFVIII	rFVIII:23|r-FVIII:1	recombinant fviii
rG-CSF	rG-CSF:11|rGCSF:2	granulocyte colony stimulating factor
rG-CSF	rG-CSF:48|rGCSF:1	recombinant granulocyte colonystimulating factor
rGM-CSF	rGM-CSF:14	granulocytemacrophage colony stimulating factor
rGM-CSF	rGM-CSF:12	recombinant gmcsf
rGM-CSF	rGM-CSF:40	recombinant granulocytemacrophage colonystimulating factor
rHDL	rHDL:43|R-HDL:2|r-HDL:1	reconstituted hdl
rHDL	rHDL:6|R-HDL:1	reconstituted highdensity lipoprotein
ri	ri:7|Ri:2	internal longitudinal resistance
ri	ri:5|Ri:1	internal radius
RI	RI:37	radioisotope
RI	RI:6	radionuclide imaging
RI	RI:330|ri:1|Ri:1	recombinant inbred
RI	RI:8	recurrent inhibition
RI	RI:9	regular insulin
RI	RI:18	relapse incidence
RI	RI:12	renal impairment
RI	RI:36|Ri:1	renal insufficiency
RI	RI:7	reperfusion injury
RI	RI:24	replicative intermediate
RI	RI:8	resistance indexes
RI	RI:9	respiratory insufficiency
RI	RI:9	retroactive interference
RI	RI:18|Ri:9	ribonuclease inhibitor
RI	RI:4|Ri:2	ribonuclease inhibitor protein
RI	RI:5|R-I:1	type i campdependent protein kinase
RI	RI:6|R-I:1	type i regulatory
RI	RI:14|R-I:1	type i regulatory subunit
RK	RK:157	radial keratotomy
RK	RK:18	remnant kidney
rTFPI	rTFPI:14	recombinant tfpi
rTFPI	rTFPI:14|r-TFPI:1	recombinant tissue factor pathway inhibitor
rTMS	rTMS:37|RTMS:1	repetitive tms
rTMS	rTMS:440|RTMS:5|r-TMS:1	repetitive transcranial magnetic stimulation
rTNF	rTNF:8	necrosis factor alpha
rTNF	rTNF:18	recombinant tnf
rTNF	rTNF:53|RTNF:1|r-TNF:1	recombinant tumor necrosis factor
rt-PA	rt-PA:22	recombinant tpa
rt-PA	rt-PA:280|rtPA:104|rTPA:38|r-TPA:19|r-tPA:12|rt-Pa:2|rtpa:1|Rt-PA:1	recombinant tissue plasminogen activator
rt-PA	rt-PA:292|rTPA:17|rtPA:14|r-tPA:5|r-t-PA:2|r-TPA:1|RTPA:1|rT-PA:1	recombinant tissuetype plasminogen activator
RADS	RADS:41	reactive airways dysfunction syndrome
RADS	RADS:11	reynolds adolescent depression scale
RAD	RAD:6|rad:1	reactive airway disease
RAD	RAD:9	renal tubule assist device
RAGE	RAGE:7	age receptor
RAGE	RAGE:19	receptor for advanced glycation endproducts
RAM	RAM:36	radial arm maze
RAM	RAM:10|ram:3	random access memory
RAM	RAM:21	restricted access material
RAM	RAM:10	restricted access media
RANK	RANK:7	receptor activator of nfkappa b
RANK	RANK:8	receptor activator of nuclear factor kappa b
RARE	RARE:64	rapid acquisition with relaxation enhancement
RARE	RARE:17	recaassisted restriction endonuclease
rat	rat:1	allogeneic or a xenogeneic
rat	rat:8	animal model
rat	rat:10	heterologous
rat	rat:12	homologous
rat	rat:36	mammalian
rbGH	rbGH:10	recombinant bovine gh
rbGH	rbGH:9|r-bGH:3	recombinant bovine growth hormone
reg	reg:15|Reg:1	regenerating
reg	reg:12	regenerating gene
rep-PCR	rep-PCR:13|REP-PCR:1|Rep-PCR:1	repetitive element sequencebased pcr
rep-PCR	rep-PCR:9|REP-PCR:1	repetitive sequencebased pcr
rhBMP-2	rhBMP-2:28	recombinant human bmp
rhBMP-2	rhBMP-2:16	recombinant human bone morphogenetic protein
rhFSH	rhFSH:6|r-hFSH:2|r-HFSH:1	recombinant human follicle stimulating hormone
rhFSH	rhFSH:34|r-hFSH:17	recombinant human fsh
rhGH	rhGH:9|r-hGH:4	recombinant hgh
rhGH	rhGH:135|r-hGH:5|rh-GH:1|rHGH:1	recombinant human gh
rhGH	rhGH:446|r-hGH:28|rHGH:12|rh-GH:3|R-hGH:1|r-hgh:1|RHGH:1|RH-GH:1	recombinant human growth hormone
rhHGF	rhHGF:10|r-hHGF:3|rh-HGF:2	recombinant human hepatocyte growth factor
rhHGF	rhHGF:14|rh-HGF:2	recombinant human hgf
rhIGF-1	rhIGF-1:9	recombinant human igf
rhIGF-1	rhIGF-1:8	recombinant human insulinlike growth factor
rhM-CSF	rhM-CSF:9	recombinant human mcsf
rhM-CSF	rhM-CSF:33|rhMCSF:1	recombinant human macrophage colonystimulating factor
rhNGF	rhNGF:28	recombinant human nerve growth factor
rhNGF	rhNGF:13	recombinant human ngf
rhSOD	rhSOD:3|rh-SOD:2|r-h-SOD:1	recombinant human sod
rhSOD	rhSOD:7|r-hSOD:6|rh-SOD:4|r-h-SOD:3|r-HSOD:3|RH-SOD:2|rH-SOD:1|rHSOD:1	recombinant human superoxide dismutase
rhTPO	rhTPO:20|rhTpo:2	recombinant human thrombopoietin
rhTPO	rhTPO:11|rhTpo:2	recombinant human tpo
rhTSH	rhTSH:22	recombinant human thyroidstimulating hormone
rhTSH	rhTSH:26	recombinant human thyrotropin
rhTSH	rhTSH:58	recombinant human tsh
rho	rho:9	conductance ratio
rho	rho:13|Rho:4	correlation
rho	rho:11|Rho:2	rhodamine 
rho	rho:30|Rho:8|RHO:1	rhomboid
riMLF	riMLF:1	rostral interstitial nucleus of mlf
riMLF	riMLF:40	rostral interstitial nucleus of the medial longitudinal fasciculus
RIN	RIN:27|rin:2	rat insulinoma
RIN	RIN:4|rin:2	rat insulinoma cell line
RIS	RIS:75	radioimmunoscintigraphy
RIS	RIS:6|RIs:1	recombinant inbred strains
RIs	RIs:11	replication intermediates
RIs	RIs:11	replicative intermediates
RIs	RIs:8	resistive indexes
ris	ris:15|Ris:1	risedronate
ris	ris:16|RIS:3	risperidone
ROD	ROD:11|rod:2	relative optical density
ROD	ROD:55|rod:1	renal osteodystrophy
ROLL	ROLL:8	occult lesion localization
ROLL	ROLL:7	radioguided occult lesion localisation
RP-HPLC	RP-HPLC:13|RPHPLC:1	reversephase hplc
RP-HPLC	RP-HPLC:22|rpHPLC:2|RPHPLC:2	reversedphase hplc
rpoB	rpoB:6	beta subunit of rna polymerase
rpoB	rpoB:8	rna polymerase beta subunit
rpoB	rpoB:11	rna polymerase gene
rscu-PA	rscu-PA:5	recombinant singlechain upa
rscu-PA	rscu-PA:13|r-scu-PA:4	recombinant singlechain urokinasetype plasminogen activator
sAML	sAML:4|s-AML:3	secondary acute myeloid leukemia
sAML	sAML:7|SAML:3|s-AML:1	secondary aml
SBT	SBT:12	sequencing based typing
SBT	SBT:5	short blessed test
SBT	SBT:26	sulbactam
sCJD	sCJD:18	sporadic cjd
sCJD	sCJD:36	sporadic creutzfeldtjakob disease
SDNA	SDNA:9	standard deviation of nuclear area
SDNA	SDNA:7|SD-NA:1	standard deviation of nucleolar area
sEPSCs	sEPSCs:15	spontaneous epscs
sEPSCs	sEPSCs:51|SEPSCs:2	spontaneous excitatory postsynaptic currents
sFlt-1	sFlt-1:4|SFlt-1:1	soluble receptor
sFlt-1	sFlt-1:5|sFlt1:1	soluble vegf receptor 
sHLA-I	sHLA-I:8|S-HLA-I:1	class i antigens
sHLA-I	sHLA-I:16|S-HLA-I:1|sHLAI:1	soluble hla class i
sIL-2R	sIL-2R:8|SIL-2R:1	soluble interleukin receptor levels
sIL-2R	sIL-2R:4	soluble receptors for il
sIPSCs	sIPSCs:59	spontaneous inhibitory postsynaptic currents
sIPSCs	sIPSCs:23	spontaneous ipscs
sIgM	sIgM:67	surface igm
sIgM	sIgM:11	surface immunoglobulin m
S-ODNs	S-ODNs:10|sODNs:2|S-ODns:1	phosphorothioate oligodeoxynucleotides
S-ODNs	S-ODNs:15|SODNs:1	phosphorothioate oligonucleotides
sTNFR1	sTNFR1:9|sTNF-R1:2|STNFR1:1	soluble tnf receptor 
sTNFR1	sTNF-R1:3|sTNFR1:3	soluble tumor necrosis factor receptor 
sTNF-RI	sTNF-RI:3|sTNFRI:2|sTNFR-I:1|sTNFr-I:1	necrosis factor receptor type i
sTNF-RI	sTNF-RI:3|sTNFR-I:2|sTNFRI:2	soluble tnf receptor i
sTNF-RI	sTNF-RI:7|sTNFRI:2|sTNF-rI:1	soluble tumor necrosis factor receptor i
SX	SX:13|Sx:1	sympathectomized
SX	SX:9|Sx:2	syndrome x
scFvs	scFvs:13|ScFvs:1	singlechain antibodies
scFvs	scFvs:11	singlechain antibody fragments
scFvs	scFvs:9	singlechain fv fragments
scFvs	scFvs:14	singlechain fvs
scFvs	scFvs:9	singlechain variable fragments
SCC	SCC:7|scc:6	cholesterol sidechain cleavage
SCC	SCC:214|scc:5	shortcircuit current
SCC	SCC:29	spinal cord compression
SCC	SCC:4	squamous cell carcinoma of the cervix
SCC	SCC:7	squamous cell carcinoma of the skin
SCC	SCC:16	squamous cell carcinomarelated antigen
scu-PA	scu-PA:14	singlechain upa
scuPA	scuPA:3|scu-PA:1	single chain upa
scuPA	scuPA:7|scu-PA:4|Sc-uPA:1	singlechain urokinase
scu-PA	scu-PA:66|scuPA:7|sc-uPA:2|Sc-uPA:1|SCU-PA:1	singlechain urokinasetype plasminogen activator
sec	sec:8|SEC:1	secretin
sec	sec:21	secretory
SEC	SEC:25	series elastic component
SEC	SEC:9	serpinenzyme complex
SEC	SEC:6|sec:1	sizeexclusion chromatographic
SEC	SEC:58|sec:5	spontaneous echo contrast
SEC	SEC:15|sec:2	spontaneous echocardiographic contrast
SEC	SEC:9	standard error of calibration
sec	sec:3|SEC:3	superficial esophageal carcinoma
SEC	SEC:11	surface epithelial cells
SEC	SEC:11	swine endothelial cell
SER	SER:8|ser:1	scanning equalization radiography
SER	SER:20|ser:1	sebum excretion rate
SER	SER:26|ser:3	sensitizer enhancement ratio
SER	SER:275|ser:32|sER:16|Ser:7|s-ER:1|S-ER:1	smooth endoplasmic reticulum
SER	SER:9	spherical equivalent refraction
SH2	SH2:15	src homology
SH2	SH2:6	src homology  domain
shock	shock:6	acute circulatory failure
shock	shock:4|SHOCK:3	emergently revascularize occluded coronaries for cardiogenic shock
sigma	sigma:20	standard deviation
sigma	sigma:6	surface charge density
sm	sm:11	expression of alphasmooth muscle
SM	SM:8|sm:2	margin
SM	SM:10	memory
Sm	Sm:29|SM:2|sm:1	nucleus submedius
SM	SM:9|Sm:1|sm:1	salmeterol
SM	SM:20|sm:7|Sm:4	salvia miltiorrhiza
SM	SM:9	scala media
Sm	Sm:5|SM:3	schistosoma mansoni
sm	sm:12	selective mutism
SM	SM:10	selfmonitoring
SM	SM:45|Sm:1|sm:1	semimembranosus
SM	SM:10|Sm:3|sm:1	serum somatomedin
SM	SM:13|sm:1	skim milk
SM	SM:8|Sm:2	slow myosin
Sm	Sm:5|sm:1	smith antigen
sm	sm:9	smokers
Sm	Sm:9	sparsomycin
SM	SM:12	standard model
SM	SM:11	steatocystoma multiplex
SM	SM:10	sternomastoid
Sm	Sm:4|SM:4	streptococcus mutans
SM	SM:8|sm:2	streptomycin sulfate
SM	SM:6	stress management
SM	SM:12	submandibular
SM	SM:9|sm:8	submucosal
SM	SM:9	syringomyelia
SM	SM:48|sm:7	systemic mastocytosis
snRNPs	snRNPs:129	small nuclear ribonucleoproteins
snRNPs	snRNPs:72	small nuclear ribonucleoprotein particles
snRNPs	snRNPs:12	small nuclear rnps
SNGFR	SNGFR:9|sngfr:1	filtration rates
SNGFR	SNGFR:113|sngfr:1	single nephron glomerular filtration rate
SNs	SNs:6	culture supernatants
SNs	SNs:29	sensory neurons
SNs	SNs:30	sentinel nodes
SOF	SOF:11|sof:1	serum opacity factor
SOF	SOF:9	soluble organic fraction
SOF	SOF:33	synthetic oviduct fluid
SOF	SOF:18	synthetic oviductal fluid
SPF	SPF:3	cells in sphase
SPF	SPF:39|SpF:1	dna ploidy and sphase fraction
SPF	SPF:8	sphase cells
SPF	SPF:14	sphase fractions
SPF	SPF:4|Spf:3	subparafascicular thalamic nucleus
SPF	SPF:14	supernatant protein factor
SPH	SPH:11|sPH:1	secondary pulmonary hypertension
SPH	SPH:10	superporous hydrogel
SRL	SRL:11	skin resistance level
SRL	SRL:25|sRL:13	specific lung resistance
ssDNA	ssDNA:10	singlestranded
ssDNA	ssDNA:467|ss-DNA:15|SSDNA:2	singlestranded dna
STEM	STEM:1	scanning and transmission electron microscope
STEM	STEM:111|stem:5	scanning transmission electron microscopy
STG	STG:4|sTG:2|S-Tg:1	serum triglycerides
STG	STG:100	stomatogastric ganglion
STG	STG:96	superior temporal gyrus
STR	STR:32|str:2	scotopic threshold response
STR	STR:5	stsegment resolution
str	str:7|Str:3	strictosidine synthase
str	str:24|Str:4	strychnine
STR	STR:16	subtotal resection
SUs	SUs:6	stroke units
SUs	SUs:11	sulfonylureas
syn	syn:5	activities of glycogen synthase
syn	syn:18	syncytial
t1/2	t1/2:28|T1/2:5	elimination halflives
t1/2	t1/2:68|T1/2:26	half life
t1/2	t1/2:8	halflife of elimination
t1/2	t1/2:9|T1/2:4	half lives
t-AML	t-AML:28|tAML:1	therapyrelated acute myeloid leukemia
t-AML	t-AML:13|tAML:2	therapyrelated aml
TBA	TBA:51|tBA:1	tertbutyl alcohol
TBA	TBA:14	tertiary butyl alcohol
TBA	TBA:44	tetrabutylammonium
TBA	TBA:20|tBA:1	total bile acids
TBA	TBA:9	transluminal balloon angioplasty
TBA	TBA:30|TbA:1	trenbolone acetate
tHcy	tHcy:9	total homocysteine
tHcy	tHcy:9	total homocysteine concentration
tHcy	tHcy:81|tHCY:1|tHCy:1|t-Hcy:1	total plasma homocysteine
tRNA	tRNA:35	transfer ribonucleic acid
tRNA	tRNA:157	transfer rna
TACI	TACI:4	caml interactor
TACI	TACI:8	cyclophilin ligand interactor
tau	tau:28|Tau:1	circadian period
tau	tau:10	decay rate
tau	tau:5	dosing interval
tau	tau:14	efficacy
tau	tau:32	freerunning period
tau	tau:8	period length
tau	tau:22|Tau:4	pressure decay
tau	tau:5	tau protein
tau	tau:7	time constant of decay
tau	tau:29|Tau:1	time constant of isovolumic relaxation
tau	tau:12|Tau:1	time constant of lv relaxation
tau	tau:10|TAU:2|Tau:1	time constant of relaxation
TcPO2	TcPO2:6|TcpO2:4|TCPO2:2|tcPO2:2|tcpO2:1	transcutaneous oximetry
TcPO2	TcPO2:6|tcpO2:3|tcPO2:3|TcPo2:1|TCPO2:1	transcutaneous partial pressure of oxygen
TEC	TEC:9	total eosinophil count
TEC	TEC:37	transient erythroblastopenia of childhood
TEC	TEC:19|tec:1	transluminal extraction catheter
TEC	TEC:24	triethyl citrate
TET	TET:8	transcutaneous energy transfer
TET	TET:12	treadmill exercise test
TET	TET:10	triethyl tin
TET	TET:72	triethyltin
TET	TET:13	triethyltin bromide
TET	TET:21	tubal embryo transfer
thal	thal:24	betathalassemia
thal	thal:9|Thal:1	thalassemia
theta	theta:16	conduction velocity
theta	theta:5	contact angles
theta	theta:9	hippocampal theta
theta	theta:7	rhythmic slow activity
TIF	TIF:7	transcription initiation factor
TIF	TIF:12	tubulointerstitial fibrosis
Tlim	Tlim:6|tlim:4|TLIM:1	endurance time
Tlim	Tlim:6|tlim:4	time to exhaustion
TM	TM:15	landsat thematic mapper
Tm	Tm:10	melting point
Tm	Tm:6|tm:2|TM:1	midpoint
TM	TM:2	neurons of the tuberomammillary
Tm	Tm:7	phase transition
TM	TM:11|tm:2	tail moment
TM	TM:47|tm:1|Tm:1	tectorial membrane
TM	TM:27	testicular microlithiasis
TM	TM:17|tm:1	thalassaemia major
TM	TM:31|tm:2	thalassemia major
TM	TM:613|Tm:8|tm:4	thrombomodulin
TM	TM:20	thrombotic microangiopathy
TM	TM:9|tm:1	timolol maleate
TM	TM:7|tm:4	tooth mobility
TM	TM:183|tm:3	trabecular meshwork
TM	TM:60|tm:3	transcendental meditation
TM	TM:17	transformed migraine
TM	TM:12	transitional mucosa
TM	TM:643|tm:7|Tm:4	transmembrane
TM	TM:12	transmembrane region
TM	TM:9	transmembrane subunit
Tm	Tm:30|TM:3|tm:1	transport maximum
TM	TM:24	transverse myelitis
TM	TM:41|tm:2	treadmill
TM	TM:90|Tm:75	tropomyosin
TM	TM:8	tuberomamillary nucleus
TM	TM:9|tm:1	tubular myelin
TM	TM:5	tumour markers
TM	TM:101|tm:10|Tm:4	tunicamycin
TONE	TONE:7	tilted optimized nonsaturating excitation
TONE	TONE:12	trial of nonpharmacologic interventions in the elderly
TorA	TorA:4|torA:1	tmao reductase
TorA	TorA:8|torA:1	trimethylamine noxide reductase
TRI	TRI:9|tri:3	toxics release inventory
TRI	TRI:16	transient radicular irritation
TRI	TRI:6	transradial coronary intervention
TRI	TRI:23	tubuloreticular inclusions
TrkB	TrkB:10|trkB:2	receptor tyrosine kinase b
TrkB	TrkB:4|trkB:3|Trk-B:1	tyrosine receptor kinase b
TRPC	TRPC:17	canonical transient receptor potential
TRPC	TRPC:11|TrpC:1	transient receptor potential channel
TRP	TRP:184|trp:39|Trp:19	transient receptor potential
TRP	TRP:8	tubular reabsorption of phosphorus
TRP	TRP:9	tyrosinaserelated protein
TS	TS:5|ts:2	alphatocopheryl hemisuccinate
ts	Ts:10|ts:10|TS:5	dna synthesis time
Ts	Ts:6|ts:3	duration of s phase
ts	ts:12	patients with turners syndrome
Ts	Ts:10|TS:3	sphase duration
Ts	Ts:53|ts:19|TS:2	suppressor t
Ts	Ts:6|ts:2	suppressor t lymphocytes
Ts	Ts:57|ts:32|TS:13	t suppressor
Ts	Ts:18|ts:4|TS:2	t suppressor cells
Ts	Ts:8|ts:3	tailshort
TS	TS:7|T-S:3|ts:1	takagisugeno
ts	ts:10|TS:1	temperature sensitivity
TS	TS:13|Ts:2|ts:2	tensile strength
TS	TS:12|ts:2	test stimulus
TS	TS:6|ts:4	tetanic stimulation
TS	TS:5|Ts:3|ts:2	thermal sensation
ts	ts:22|Ts:3|TS:3	thermosensitive
TS	TS:24|ts:4	thermostable
TS	TS:9|ts:1	threshold shift
TS	TS:65|ts:27	thymidylate synthetase
ts	TS:3|ts:3	thyroid scintigraphy
TS	TS:17|ts:11	tobacco smoke
ts	ts:10|TS:5	tokishakuyakusan
TS	TS:12|ts:7	torus semicircularis
TS	TS:8	total sleep
TS	TS:26|ts:7	total solids
TS	TS:19|ts:5	tractus solitarius
TS	TS:9|ts:4	transcribed strand
TS	TS:32|ts:17	transition state
TS	TS:6|ts:4	transmural stimulation
TS	TS:4|ts:1	transthoracic sonography
TS	TS:35|ts:20	trauma score
TS	TS:10|ts:7	triangularis sterni
ts	ts:25|TS:24	triceps surae
ts	ts:9|Ts:4|TS:1	trichinella spiralis
TS	TS:6|ts:2	tricuspid stenosis
TS	TS:17	trophoblast stem
TS	TS:4	trypanosoma cruzi transsialidase
TTX-S	TTX-S:45|TTXs:3|TTX-s:2	tetrodotoxinsensitive
TTX-S	TTX-S:18|TTXs:2|TTX-s:1	ttxsensitive
TUNA	TUNA:41	transurethral needle ablation
TUNA	TUNA:12	transurethral needle ablation of the prostate
uPAR	uPAR:7|UPAR:2|uPA-R:1	receptor for upa
uPAR	uPAR:18|u-PAR:5|uPA-R:4	receptor for urokinasetype plasminogen activator
vCJD	vCJD:35	variant cjd
vCJD	vCJD:14|V-CJD:4	variant of creutzfeldtjakob disease
VAR	VAR:6	venoarteriolar reflex
VAR	VAR:15	venoarteriolar response
WHI	WHI:5	weightforheight index
WHI	WHI:124|whi:13	womens health initiative
WPC	WPC:10	weighted pairwise correlation
WPC	WPC:28|wpc:1	whey protein concentrate
WT	WT:4	inhibitor wortmannin
WT	WT:9	walking test
WT	WT:52	wavelet transform
WT	WT:3|wt:2	wildtype cbl
WT	WT:11	wildtype controls
WT	WT:13|Wt:2	wildtype littermates
WT	WT:35|Wt:2	wildtype mice
WT	WT:7|wt:1	wildtype protein
XIAP	XIAP:19|X-IAP:1|Xiap:1|xiap:1	xlinked iap
XIAP	XIAP:49	xlinked inhibitor of apoptosis
XIAP	XIAP:59|Xiap:8|X-IAP:1	xlinked inhibitor of apoptosis protein
xid	xid:6|Xid:2	xlinked immune deficiency
xid	xid:48|Xid:11|XID:4	xlinked immunodeficiency
xid	xid:22|XID:7|Xid:7	xlinked immunodeficient
15d-PGJ(2)	15d-PGJ(2):29|15-d-PGJ(2):2|15dPGJ(2):2	deoxydeltapgj
15d-PGJ(2)	15d-PGJ(2):36|15dPGJ(2):4|15-d-PGJ(2):2	deoxydeltaprostaglandin j
5-HTTLPR	5-HTTLPR:7	functional polymorphism in the upstream regulatory region of the serotonin transporter gene
5-HTTLPR	5-HTTLPR:10	polymorphism in the promoter region of the serotonin transporter gene
5-HTTLPR	5-HTTLPR:7	serotonin transporter promoter polymorphism
8-OH-DPAT	8-OH-DPAT:4	hta receptor agonist
8-OH-DPAT	8-OH-DPAT:11	hydroxydinpropylaminotetralin hydrobromide
8-OH-DPAT	8-OH-DPAT:10	hydroxydinpropylaminotetraline
8-OH-DPAT	8-OH-DPAT:6	agonist hydroxydinpropylaminotetralin
8-OH-DPAT	8-OH-DPAT:4	receptor agonist hydroxydinpropylaminotetralin
8-OH-DPAT	8-OH-DPAT:3	receptor agonist hydroxydipropylaminotetralin
99mTc-DTPA	99mTc-DTPA:10	diethylene triamine pentaacetic acid
99mTc-DTPA	99mTc-DTPA:13|99mTcDTPA:2|99mTC-DTPA:2	diethylenetriamine pentaacetic acid
ADAS-Cog	ADAS-Cog:10|ADAS-cog:6	cognitive subscale of the alzheimers disease assessment scale
ADAS-Cog	ADAS-Cog:5|ADAS-cog:4|ADAScog:1|ADAS-COG:1	disease assessment scalecognitive
AML/TMDS	AML/TMDS:4	acute myeloid leukemia with trilineage myelodysplasia
AML/TMDS	AML/TMDS:6	aml with trilineage myelodysplasia
Avitene	Avitene:12	microfibrillar collagen
Avitene	Avitene:15	microfibrillar collagen hemostat
BS-RNase	BS-RNase:32|BSRNase:1	bovine seminal ribonuclease
BS-RNase	BS-RNase:7|BSRNase:1	bovine seminal rnase
CADASIL	CADASIL:17	cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy
CADASIL	CADASIL:170|cadasil:1|CA-DASIL:1	cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
CFU-GEMM	CFU-GEMM:2	erythroid macrophage megakaryocyte
CFU-GEMM	CFU-GEMM:8|CFUGEMM:1	pluripotent hemopoietic progenitors
CHSE-214	CHSE-214:11	chinook salmon embryo
CHSE-214	CHSE-214:6	chinook salmon embryo cells
CIBIC-Plus	CIBIC-Plus:4|CIBIC-plus:3	clinicians interviewbased impression of change plus caregiver input
CIBIC-Plus	CIBIC-Plus:3|CIBIC-plus:2	interviewbased impression of change with caregiver input
CRABP-II	CRABP-II:6|CRABPII:2|CrabpII:1	cellular retinoic acidbinding protein ii
CRABP-II	CRABP-II:5	retinoic acid binding proteinii
CYP11B2	CYP11B2:97	aldosterone synthase
CYP11B2	CYP11B2:26|Cyp11b2:1	aldosterone synthase gene
DNA-PKcs	DNA-PKcs:19	catalytic subunit of dnapk
DNA-PKcs	DNA-PKcs:42|dna-pkcs:1|DNA-PKCS:1	dnadependent protein kinase catalytic subunit
DNA-PKcs	DNA-PKcs:21	dnapk catalytic subunit
ELISPOT	ELISPOT:13|ELISpot:2	enzymelinked immunosorbent spot
ELISPOT	ELISPOT:224|ELISpot:22|Elispot:6|elispot:2|ELIspot:2|ELI-spot:1|ELI-Spot:1|ELI-SPOT:1	enzymelinked immunospot
ELISPOT	ELISPOT:38|ELISpot:1|Elispot:1	enzymelinked immunospot assay
FEF25-75	FEF25-75:7	forced expiratory flow between  and  of vital capacity
FEF25-75	FEF25-75:2	forced expiratory flow during the middle half of fvc
FEF25-75	FEF25-75:9	forced midexpiratory flow
G-proteins	G-proteins:52	guanine nucleotidebinding proteins
G-proteins	G-proteins:14	guanine nucleotide regulatory proteins
GBV-C/HGV	GBV-C/HGV:2	gb virus c and hepatitis g virus
GBV-C/HGV	GBV-C/HGV:68	gb virus chepatitis g virus
H(+)-ATPase	H(+)-ATPase:15	hadenosinetriphosphatase
H(+)-ATPase	H(+)-ATPase:7	plasma membrane proton pump
HIV/AIDS	HIV/AIDS:32	human immunodeficiency virusacquired immune deficiency syndrome
HIV/AIDS	HIV/AIDS:54|HIV/Aids:1	human immunodeficiency virusacquired immunodeficiency syndrome
HIV/AIDS	HIV/AIDS:8	human immunodeficiency virus and acquired immunodeficiency syndrome
HTLV-I/II	HTLV-I/II:8	human tcell lymphotropic virus types i and ii
HTLV-I/II	HTLV-I/II:8	human tlymphotropic virus types i and ii
HTLV-III/LAV	HTLV-III/LAV:10	human tcell lymphotropic virus type iiilymphadenopathyassociated virus
HTLV-III/LAV	HTLV-III/LAV:25	human tlymphotropic virus type iiilymphadenopathyassociated virus
HTLV-III	HTLV-III:7	human tlymphotropic retrovirus
HTLV-III	HTLV-III:5|HTLVIII:1	human tlymphotropic virus
HTLV-III	HTLV-III:75	human tlymphotropic virus type iii
IalphaI	IalphaI:26|I-alpha-I:1	interalphainhibitor
IalphaI	IalphaI:9|I-alpha-I:2	interalphatrypsin inhibitor
MERIT-HF	MERIT-HF:7	metoprolol crxl randomized intervention trial in chronic heart failure
MERIT-HF	MERIT-HF:7	metoprolol crxl randomized intervention trial in heart failure
Matrigel	Matrigel:12|matrigel:2	basement membrane extract
Matrigel	Matrigel:32|matrigel:2	basement membrane matrix
Matrigel	Matrigel:12|matrigel:1	basement membrane proteins
Matrigel	Matrigel:118|matrigel:20	reconstituted basement membrane
NG108-15	NG108-15:25	neuroblastoma x glioma
NG108-15	NG108-15:17	neuroblastoma x glioma hybrid
NOD/SCID	NOD/SCID:25|NOD/scid:2	nonobese diabeticsevere combined immunodeficiency
NOD/SCID	NOD/SCID:47	nonobese diabeticsevere combined immunodeficient
Neuro-2a	Neuro-2a:6|Neuro-2A:4|neuro-2A:3|neuro-2a:3|Neuro2a:2	neuroblastoma cells
Neuro-2a	Neuro-2A:3|Neuro-2a:3|Neuro2a:2|Neuro2A:2|neuro-2a:2|neuro2a:1	neuroblastoma cell line
O-GlcNAc	O-GlcNAc:14	olinked betanacetylglucosamine
O-GlcNAc	O-GlcNAc:52	olinked nacetylglucosamine
P450c17	P450c17:21|P-450c17:4	 alphahydroxylase
P450c17	P450c17:12|P450C17:1	 alphahydroxylase cytochrome p
P450c17	P450c17:5	cytochrome p alphahydroxylase
P450scc	P450scc:1	cytochrome p for side chain cleavage
P450scc	P450scc:17|p450scc:2|P-450SCC:1	side chain cleavage enzyme
PA-TCH-SP	PA-TCH-SP:13	periodatethiocarbohydrazidesilver proteinate
PA-TCH-SP	PA-TCH-SP:30	periodic acidthiocarbohydrazidesilver proteinate
PEP/LVET	PEP/LVET:4	ratio of the preejection period to left ventricular ejection time
PEP/LVET	PEP/LVET:10	ventricular ejection time ratio
PTH/PTHrP	PTH/PTHrP:7	parathyroid hormoneparathyroid hormonerelated peptide
PTH/PTHrP	PTH/PTHrP:6	parathyroid hormoneparathyroid hormonerelated protein
RASSF1A	RASSF1A:10	ras association domain family a
RASSF1A	RASSF1A:7	ras association domain family a gene
Rp-cAMPS	Rp-cAMPS:7	adenosine cyclic monophosphothioate
Rp-cAMPS	Rp-cAMPS:9|RpcAMPs:1	adenosine cyclic phosphorothioate
Rp-cAMPS	Rp-cAMPS:7	rpadenosine cyclic monophosphothioate
Rp-cAMPS	Rp-cAMPS:6|Rp-cAMPs:2	rpadenosine cyclic monophosphothioate triethylamine
Rubisco	Rubisco:19|RubisCO:3|RuBisCo:2|rubisco:1|RuBisCO:1	ribulosebisphosphate carboxylase
Rubisco	Rubisco:7|RuBisCO:4|RUBISCO:1	ribulose bisphosphate carboxylase
SAPK/JNK	SAPK/JNK:17	stressactivated protein kinase
SAPK/JNK	SAPK/JNK:37	stressactivated protein kinasecjun nterminal kinase
SDS-PAGE	SDS-PAGE:11	polyacrylamide gel electrophoresis in sodium dodecyl sulfate
SDS-PAGE	SDS-PAGE:5	polyacrylamide gel electrophoresis in the presence of sds
SDS-PAGE	SDS-PAGE:24	polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate
SDS-PAGE	SDS-PAGE:8	sodium dodecyl sulfatepolyacrylamide gels
V-PYRRO/NO	V-PYRRO/NO:1	donor ovinyl pyrrolidinyldiazeniumdiolate
V-PYRRO/NO	V-PYRRO/NO:6	ovinyl pyrrolidinyldiazeniumdiolate
WAIS-III	WAIS-III:16	wechsler adult intelligence scaleiii
WAIS-III	WAIS-III:9	wechsler adult intelligence scalethird edition
[35S]GTPgammaS	[35S]GTPgammaS:8|[35S]GTP-gammaS:1	sguanosineothiotriphosphate
[35S]GTPgammaS	[35S]GTPgammaS:15	guanosineosthiotriphosphate
allo-BMT	allo-BMT:8|alloBMT:4	allogeneic bone marrow transplant
allo-BMT	allo-BMT:91|alloBMT:44|AlloBMT:10|Allo-BMT:3|ALLOBMT:1|ALLO-BMT:1	allogeneic bone marrow transplantation
allo-SCT	allo-SCT:6|alloSCT:3|AlloSCT:1	allogeneic stem cell transplant
allo-SCT	allo-SCT:57|alloSCT:27|AlloSCT:3|Allo-SCT:1	allogeneic stem cell transplantation
alpha-hANP	alpha-hANP:62	alphahuman atrial natriuretic peptide
alpha-hANP	alpha-hANP:81|alpha-HANP:1	alphahuman atrial natriuretic polypeptide
alphaCTD	alphaCTD:8	cterminal domain of the rna polymerase alpha subunit
alphaCTD	alphaCTD:5	rna polymerase alpha subunit cterminal domain
alpha-MG	alpha-MG:12|alphaMG:3	alphamethyldglucopyranoside
alpha-MG	alpha-MG:10|alphaMG:1	alphamethyldglucoside
anti-CCP	anti-CCP:8	anticyclic citrullinated peptide antibodies
anti-CCP	anti-CCP:30|Anti-CCP:1	citrullinated peptide
anti-HAV	anti-HAV:59	antibody to hepatitis a virus
anti-HAV	anti-HAV:6	hepatitis a antibodies
anti-HAV	anti-HAV:8	hepatitis a virus antibody
anti-HBs	anti-HBs:146|antiHBs:3|anti-HBS:2|anti-HB-s:1|anti--HBS:1	antibody to hepatitis b surface antigen
anti-HBs	anti-HBs:6|Anti-HBs:1	b surface antibodies
bHLH-Zip	bHLH-Zip:4|bHLH-ZIP:3|bHLHZip:2|bHLHZIP:2|bHLHzip:2|b-HLH-zip:1|bHLH-zip:1	basic helixloophelix leucine zipper
bHLH-Zip	bHLH-Zip:6	encodes a member of the basichelixloophelixleucine zipper
beta-gal	beta-gal:9|beta-Gal:6	betadgalactosidase
beta-gal	beta-gal:11	betagalactosidase gene
compomers	compomers:5	polyacidmodified composite resins
compomers	compomers:9	polyacidmodified resin composites
control	control:8	administered at dietary levels of 
control	control:11	fed diets containing 
control	control:4	sixweekold male spraguedawley rats were fed either normal rat chow
dUTPase	dUTPase:13	deoxyuridine triphosphatase
dUTPase	dUTPase:21	deoxyuridine triphosphate nucleotidohydrolase
dUTPase	dUTPase:9	dutp pyrophosphatase
dP/dtmax	dP/dtmax:5|dp/dtmax:2	left ventricular pressure rise
dP/dtmax	dP/dtmax:1	rate of rise in left ventricular pressure
eIF2alpha	eIF2alpha:6	alphasubunit of eukaryotic initiation factor 
eIF2alpha	eIF2alpha:5|eIF-2alpha:5	alpha subunit of eukaryotic translation initiation factor 
eIF2alpha	eIF2alpha:7|eIF-2alpha:2	phosphorylation of the alpha subunit of eukaryotic initiation factor 
mitoK(ATP)	mitoK(ATP):14	mitochondrial atpsensitive k
mitoK(ATP)	mitoK(ATP):11|mito-K(ATP):1	mitochondrial atpsensitive potassium
mitoK(ATP)	mitoK(ATP):4	mitochondrial atpsensitive potassium channels
p75NGFR	p75NGFR:6|p75-NGFR:3|p75NGFr:2	low affinity nerve growth factor receptor
p75NGFR	p75NGFR:9|p75NGF-R:1	lowaffinity ngf receptor
rMuIFN-gamma	rMuIFN-gamma:11	recombinant murine gamma interferon
rMuIFN-gamma	rMuIFN-gamma:14|rmuIFN-gamma:2	recombinant murine interferongamma
rhDNase	rhDNase:32|rhDNAse:1	recombinant human deoxyribonuclease
rhDNase	rhDNase:15|rh-DNase:1	recombinant human deoxyribonuclease i
rhDNase	rhDNase:19	recombinant human dnase
rhDNase	rhDNase:11	recombinant human dnase i
rhGM-CSF	rhGM-CSF:11	granulocytemacrophage csf
rhGM-CSF	rhGM-CSF:27	recombinant human gmcsf
sIL-1RII	sIL-1RII:5	soluble il receptor ii
sIL-1RII	sIL-1RII:8	soluble il receptor type ii
serpins	serpins:51|SERPINS:1	serine protease inhibitors
serpins	serpins:46|Serpins:3|SERPINS:2	serine proteinase inhibitors
statins	statins:6	hydroxymethylglutaryl coenzyme a reductase
statins	statins:7	inhibitors of hmgcoa reductase
V-ATPase	V-ATPase:15	vacuolar protontranslocating atpase
V-ATPase	V-ATPase:27	vacuolartype hatpase
